{"meta":{"query_hash":"386b2f745ddd","filters":{"venue":"Diabetes Obesity and Metabolism"},"cohort_total":602,"direct_labels_cover":1,"predictions_cover":602,"exported":602,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/386b2f745ddd","api":"https://metacan.xera.ac/api/v1/cohort?venue=Diabetes+Obesity+and+Metabolism"},"results":[{"id":"W1515030747","doi":"10.1111/j.1463-1326.2009.01044.x","title":"Antihyperglycaemic medication modifies factors of postprandial satiety in type 2 diabetes","year":2009,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Regulation of Appetite and Obesity","field":"Neuroscience","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"McGill University Health Centre; Diabète Québec","keywords":"Postprandial; Ghrelin; Internal medicine; Gastric emptying; Endocrinology; Medicine; Leptin; Type 2 diabetes; Crossover study; Meal; Glucagon-like peptide-1; Insulin; Area under the curve; Peptide YY; Diabetes mellitus; Gastric inhibitory polypeptide; Gastrointestinal hormone; Glucagon; Hormone; Peptide hormone; Stomach; Obesity; Neuropeptide; Receptor; Neuropeptide Y receptor","score_opus":0.017800411042103996,"score_gpt":0.22962911092852423,"score_spread":0.21182869988642022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1515030747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97659427,0.0017882346,0.0000013636117,0.020225229,0.0006520452,0.00031956195,0.00008369871,0.000054462365,0.00028115555],"genre_scores_gemma":[0.9434264,0.0024898292,0.00005448,0.05298053,0.00066645525,0.0000059396293,0.00020293993,0.000030042102,0.00014343698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747616,0.0002984323,0.0005209762,0.00062815734,0.00056080334,0.0005154901],"domain_scores_gemma":[0.9986556,0.00040577826,0.0003657928,0.0004080295,0.00007966051,0.00008510409],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002994285,0.00039826133,0.00089031097,0.00042291408,0.00012313254,0.00005746093,0.00037586602,0.0007305928,0.000051753508],"category_scores_gemma":[0.00045507573,0.00035207113,0.00015165805,0.00042965778,0.00032507456,0.0003130251,0.00008986858,0.0008443358,0.000012406443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013433304,0.00081332546,0.57493156,0.0018417705,0.00015693327,0.00004746711,0.0030573353,0.000055149954,0.27938688,0.0017019302,0.12636381,0.011509495],"study_design_scores_gemma":[0.0006439012,0.00011568715,0.70889056,0.00016913017,0.000110878886,5.8909666e-7,0.000012457316,0.00011515606,0.18336463,0.0019120658,0.10414402,0.0005209048],"about_ca_topic_score_codex":0.00004505574,"about_ca_topic_score_gemma":0.000005676219,"teacher_disagreement_score":0.13395903,"about_ca_system_score_codex":0.000023375236,"about_ca_system_score_gemma":0.0000711323,"threshold_uncertainty_score":0.9998931},"labels":[],"label_agreement":null},{"id":"W1606810773","doi":"10.1111/dom.12498","title":"One‐year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26‐week extension to a 26‐week main trial","year":2015,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Johnson and Johnson; Janssen Pharmaceuticals; Novartis Pharmaceuticals Corporation; Novo Nordisk; Sanofi; Merck; Takeda Pharmaceutical Company; Eli Lilly and Company; Boehringer Ingelheim","keywords":"Medicine; Insulin degludec; Liraglutide; Type 2 diabetes; Diabetes mellitus; Internal medicine; Endocrinology; Basal insulin","score_opus":0.01926542420580191,"score_gpt":0.23143813045442665,"score_spread":0.21217270624862475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1606810773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970183,0.0009995585,0.000003341732,0.0001004825,0.00008345448,0.0016174299,0.000052272146,0.000022305616,0.00010288329],"genre_scores_gemma":[0.99836314,0.00022998653,0.0011676805,0.00007228907,0.000018966433,0.000017247712,0.00006778154,0.00002374132,0.00003919835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983922,0.00012520877,0.0005328644,0.0003383411,0.00034682913,0.0002645614],"domain_scores_gemma":[0.99885154,0.0001529647,0.00025031672,0.00025855968,0.0002792786,0.000207351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071480905,0.0002011,0.0008596076,0.000337893,0.000030588133,0.00001124912,0.00006026572,0.000093823124,0.0000021583635],"category_scores_gemma":[0.0005544782,0.00016761624,0.000036257483,0.0004064564,0.00013614762,0.00013028576,0.0001289059,0.00009212589,0.0000014876829],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09169029,0.015161521,0.82250226,0.0012791195,0.00093865464,0.000004841476,0.0053031472,0.000025779867,0.004561906,0.0010195305,0.00030692338,0.057206042],"study_design_scores_gemma":[0.10019892,0.004680919,0.8894945,0.00046291723,0.0004442572,3.890339e-8,0.00008852967,0.000045113553,0.0039922004,0.00019126531,0.00025662914,0.00014474831],"about_ca_topic_score_codex":0.000077405595,"about_ca_topic_score_gemma":0.000022518938,"teacher_disagreement_score":0.06699222,"about_ca_system_score_codex":0.000024068055,"about_ca_system_score_gemma":0.0000505202,"threshold_uncertainty_score":0.6835192},"labels":[],"label_agreement":null},{"id":"W1658549429","doi":"10.1111/dom.12032","title":"Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre‐planned meta‐analysis of phase 3 trials","year":2012,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":350,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Insulin degludec; Insulin glargine; Medicine; Internal medicine; Insulin; Population; Diabetes mellitus; Hypoglycemia; Relative risk; Type 1 diabetes; Randomized controlled trial; Endocrinology; Confidence interval","score_opus":0.10272121858819495,"score_gpt":0.36449144134910333,"score_spread":0.2617702227609084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1658549429","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2842575,0.7131724,0.000004469082,0.000018537625,0.00007514811,0.0020008222,0.00034427037,0.000038006325,0.00008887269],"genre_scores_gemma":[0.033547383,0.96356845,0.0007728607,0.00006183863,0.00016136377,0.0001924414,0.0012815015,0.00009327407,0.00032087867],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9946252,0.0013583465,0.0013943344,0.0009063705,0.0007511712,0.0009645715],"domain_scores_gemma":[0.99589276,0.0011730706,0.001132736,0.0008531324,0.00042903054,0.00051926717],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0041534607,0.0009339126,0.011544297,0.0021330214,0.00011576599,0.00009297915,0.00032635435,0.00045588773,0.00020409474],"category_scores_gemma":[0.00067093625,0.0005502285,0.00072655384,0.00460711,0.0003915957,0.00025355894,0.00025339972,0.0009082475,0.000012134924],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021884288,0.0037113791,0.04087669,0.032585677,0.3733729,0.000040495695,0.000551418,0.000017582182,0.000020236057,0.000098247474,0.00013777132,0.5463992],"study_design_scores_gemma":[0.008155454,0.0010740352,0.023100303,0.00206926,0.6984217,0.0000011728672,0.000034177217,0.0002683817,0.000038597394,0.000020786812,0.26600623,0.0008098921],"about_ca_topic_score_codex":0.00007769958,"about_ca_topic_score_gemma":0.00012838437,"teacher_disagreement_score":0.54558927,"about_ca_system_score_codex":0.000037441394,"about_ca_system_score_gemma":0.00026638384,"threshold_uncertainty_score":0.99969494},"labels":[],"label_agreement":null},{"id":"W1834728684","doi":"10.1111/dom.12582","title":"Frequency of cancer events with saxagliptin in the <scp>SAVOR‐TIMI</scp> 53 trial","year":2015,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Forest Laboratories; Johnson and Johnson; Eisai; Daiichi-Sankyo; Bayer HealthCare; Hadassah Medical Organization; Gilead Sciences; Medtronic; Roche; Merck; GlaxoSmithKline; AstraZeneca; Bristol-Myers Squibb; Pfizer; American Diabetes Association","keywords":"Saxagliptin; Medicine; TIMI; Internal medicine; Placebo; Myocardial infarction; Randomized controlled trial; Cancer; Adverse effect; Oncology; Metformin; Sitagliptin; Thrombolysis; Pathology","score_opus":0.018651721433678856,"score_gpt":0.2511753008881978,"score_spread":0.23252357945451893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1834728684","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.956097,0.014182214,0.0000010540581,0.023319097,0.00065676804,0.0023331621,0.00014269601,0.0000388898,0.0032291086],"genre_scores_gemma":[0.38813144,0.0068523777,0.0015867526,0.5606712,0.013054066,0.0031082903,0.002794791,0.00038479245,0.023416288],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99720895,0.00024664862,0.00047716062,0.00054833054,0.00083542254,0.00068347907],"domain_scores_gemma":[0.9984842,0.00024858903,0.00036052725,0.00063152803,0.00015775411,0.00011738339],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006973495,0.000526487,0.0013313233,0.00034460332,0.00006513822,0.000040974952,0.00032997585,0.00045724318,0.00003424741],"category_scores_gemma":[0.0001436791,0.00032145678,0.00019771098,0.00037885664,0.00017054175,0.00013846104,0.000098171484,0.0009081242,0.000014092179],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018462053,0.0012817709,0.30027616,0.0015341522,0.0021384598,0.00021182078,0.0017652045,0.0000020774366,0.0000657896,0.0002597572,0.68687034,0.005409855],"study_design_scores_gemma":[0.036966622,0.000532927,0.18544437,0.00069397176,0.004574652,0.0000017438281,0.00015673277,0.000005263229,0.0002948661,0.00123218,0.76985985,0.00023680947],"about_ca_topic_score_codex":0.00044985875,"about_ca_topic_score_gemma":0.000102790975,"teacher_disagreement_score":0.56796557,"about_ca_system_score_codex":0.0000637816,"about_ca_system_score_gemma":0.00019402566,"threshold_uncertainty_score":0.99992377},"labels":[],"label_agreement":null},{"id":"W1874041614","doi":"10.1111/dom.12469","title":"Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16‐week, randomized, placebo‐controlled trial","year":2015,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Janssen Biotech; Novo Nordisk; Merck; Eli Lilly and Company","keywords":"Empagliflozin; Medicine; Metformin; Placebo; Randomized controlled trial; Type 2 diabetes; Clinical endpoint; Confidence interval; Internal medicine; Diabetes mellitus; Insulin; Endocrinology","score_opus":0.016243730977527217,"score_gpt":0.24011760220982117,"score_spread":0.22387387123229396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1874041614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842253,0.0038853649,0.0000028984434,0.00013218161,0.0005357986,0.008622793,0.000016914864,0.000050829254,0.002527969],"genre_scores_gemma":[0.998092,0.00034247563,0.00025245995,0.0002423312,0.00011652638,0.0003916592,0.000105356914,0.00003818313,0.0004190363],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968874,0.00046897426,0.0008509523,0.00055479544,0.0006240383,0.00061387103],"domain_scores_gemma":[0.9970873,0.0014522565,0.00043525174,0.00039476098,0.00025698464,0.00037345086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018024971,0.0005212276,0.0034795313,0.00042471298,0.00008890889,0.00005887034,0.00013866505,0.00016678045,0.000020061614],"category_scores_gemma":[0.0016609782,0.00034531145,0.00020823079,0.00037801755,0.00028572787,0.00028575867,0.00011458878,0.00025026713,0.000010508124],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9759441,0.002220636,0.012638028,0.0001000301,0.002247157,0.0000048502784,0.0005281444,0.000013078324,0.000022610004,0.00064413965,0.00007188988,0.005565327],"study_design_scores_gemma":[0.95603424,0.004655071,0.033693917,0.00020787264,0.0035386037,7.0123804e-8,0.000092708455,0.00021409776,0.0002857408,0.00011095853,0.00083604536,0.00033069807],"about_ca_topic_score_codex":0.00004294204,"about_ca_topic_score_gemma":0.000017360398,"teacher_disagreement_score":0.02105589,"about_ca_system_score_codex":0.000100060795,"about_ca_system_score_gemma":0.00012412656,"threshold_uncertainty_score":0.99989986},"labels":[],"label_agreement":null},{"id":"W1920830047","doi":"10.1111/dom.12589","title":"Efficacy and safety of canagliflozin when used in conjunction with incretin‐mimetic therapy in patients with type 2 diabetes","year":2015,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Novo Nordisk; Medtronic; Sanofi-Aventis Korea Company; Janssen Research and Development; Novartis; Eli Lilly and Company","keywords":"Canagliflozin; Medicine; Placebo; Incretin; Type 2 diabetes; Sitagliptin; Glucagon-like peptide 1 receptor; Internal medicine; Pharmacology; Endocrinology; Adverse effect; Dipeptidyl peptidase-4; Urology; Agonist; Diabetes mellitus; Gastroenterology; Receptor","score_opus":0.009532739788251,"score_gpt":0.2029113262920717,"score_spread":0.1933785865038207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1920830047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965313,0.0020383673,0.0000011639781,0.00010481298,0.00005820317,0.00094427576,0.0000070336423,0.000020806485,0.00029401385],"genre_scores_gemma":[0.9990466,0.0002174369,0.0003369982,0.00019587019,0.00001961667,0.000022997603,0.00007150628,0.000019601492,0.00006936711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988586,0.000084852974,0.00022696097,0.0002828869,0.00024961506,0.00029712523],"domain_scores_gemma":[0.9993778,0.000065392676,0.00009218755,0.00019656675,0.00011347559,0.00015461697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033082228,0.00020954663,0.0005826811,0.0002616771,0.000025825571,0.00001784646,0.00004861872,0.000067152905,0.0000119483175],"category_scores_gemma":[0.00005085954,0.00014425784,0.000017543502,0.00031073135,0.00013178222,0.00015129981,0.000041370946,0.00011105317,0.0000016834448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008107373,0.00054929586,0.9890313,0.00006905934,0.00017908473,0.0000020917796,0.0006300297,0.0000054447482,0.000091549184,0.00009557781,0.000033953078,0.0085018845],"study_design_scores_gemma":[0.01933286,0.001278772,0.97635424,0.0001798919,0.00020879529,6.297492e-8,0.000068933325,0.000034496752,0.0009002206,0.000079740494,0.0014002402,0.00016173416],"about_ca_topic_score_codex":0.00025875904,"about_ca_topic_score_gemma":0.0001722557,"teacher_disagreement_score":0.018522123,"about_ca_system_score_codex":0.0000350647,"about_ca_system_score_gemma":0.000048255522,"threshold_uncertainty_score":0.5882664},"labels":[],"label_agreement":null},{"id":"W1924115782","doi":"10.1111/dom.12574","title":"Benefits of combination of insulin degludec and liraglutide are independent of baseline glycated haemoglobin level and duration of type 2 diabetes","year":2015,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Novo Nordisk Fonden; Boehringer Ingelheim; F. Hoffmann-La Roche; Novo Nordisk; Intarcia Therapeutics; Biodel; GlaxoSmithKline; Osiris Therapeutics; Halozyme; Sanofi; Quest Diagnostics; Novartis; Pfizer; Orexigen Therapeutics; AstraZeneca; Eli Lilly and Company","keywords":"Insulin degludec; Medicine; Liraglutide; Glycated haemoglobin; Type 2 diabetes; Internal medicine; Diabetes mellitus; Glycated hemoglobin; Baseline (sea); Endocrinology; Insulin glargine","score_opus":0.04835495310799587,"score_gpt":0.2811609730836879,"score_spread":0.23280601997569206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1924115782","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.460965,0.5380115,0.0000018421142,0.000013513766,0.000068720066,0.0006530854,0.00024610263,0.0000078902685,0.00003234257],"genre_scores_gemma":[0.22678217,0.77219796,0.0003246466,0.0000152346,0.000028738863,0.000021535987,0.00053198927,0.000025673065,0.00007203204],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99782,0.00017347775,0.0010250973,0.0003602252,0.00039460603,0.0002265965],"domain_scores_gemma":[0.997497,0.00017195586,0.0012544786,0.00031738347,0.0006157527,0.00014342632],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008966934,0.00038322865,0.0027642867,0.00049209566,0.000029377688,0.000010179786,0.0001014688,0.0002855496,0.00000822719],"category_scores_gemma":[0.00034029182,0.00031361473,0.00015007371,0.0004287993,0.00021928502,0.0001384135,0.00018930796,0.00014978337,7.1462216e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057125777,0.001277306,0.04714717,0.047557082,0.0015474082,0.0000012556508,0.00022595134,0.0000018495246,0.0002676583,0.0014134783,0.00012199904,0.90038174],"study_design_scores_gemma":[0.011707533,0.0017738306,0.83091503,0.033657305,0.026341313,0.0000039203346,0.0001711372,0.00025102208,0.017173668,0.00086409366,0.07602709,0.0011140576],"about_ca_topic_score_codex":0.000044359975,"about_ca_topic_score_gemma":0.0000122069805,"teacher_disagreement_score":0.8992677,"about_ca_system_score_codex":0.000024966725,"about_ca_system_score_gemma":0.00010544664,"threshold_uncertainty_score":0.9999316},"labels":[],"label_agreement":null},{"id":"W1953794210","doi":"10.1111/dom.12543","title":"Durability and tolerability of dapagliflozin over 52 weeks as add‐on to metformin and sulphonylurea in type 2 diabetes","year":2015,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"AstraZeneca; Bristol-Myers Squibb","keywords":"Dapagliflozin; Placebo; Metformin; Tolerability; Medicine; Internal medicine; Adverse effect; Type 2 diabetes; Diabetes mellitus; Endocrinology; Urology; Gastroenterology","score_opus":0.015671699916392244,"score_gpt":0.2562610136405628,"score_spread":0.24058931372417056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1953794210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922786,0.0050145555,7.4773266e-7,0.00043728008,0.0001735436,0.0008593373,0.000029750061,0.00003564061,0.001170583],"genre_scores_gemma":[0.99816936,0.00029635063,0.0004295803,0.00073961104,0.00005360302,0.000041295156,0.00002776403,0.000017685057,0.00022473032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982853,0.000100900135,0.0003789291,0.0005241337,0.00029312956,0.00041760298],"domain_scores_gemma":[0.9987682,0.00016943563,0.000084220526,0.00040264823,0.00012095786,0.00045454045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095802435,0.00029103376,0.0008906838,0.00024639769,0.000047168567,0.000035890273,0.0000772301,0.00012801189,0.00004065226],"category_scores_gemma":[0.00059527473,0.00023833432,0.00005801137,0.00033341566,0.00019418582,0.00020481896,0.00019837837,0.00015730334,0.000009901941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020026659,0.0006971322,0.96260935,0.0003202915,0.00016360833,0.0000050872836,0.00080543524,0.0000018074619,0.0014956595,0.0015929325,0.00048737222,0.031621046],"study_design_scores_gemma":[0.0028781232,0.0007018813,0.97321206,0.00010113651,0.0003088575,4.904121e-7,0.00013720233,0.00006531659,0.010824176,0.0028324923,0.008702658,0.00023560198],"about_ca_topic_score_codex":0.00016109367,"about_ca_topic_score_gemma":0.00006332619,"teacher_disagreement_score":0.031385444,"about_ca_system_score_codex":0.000043109605,"about_ca_system_score_gemma":0.000048490776,"threshold_uncertainty_score":0.97189915},"labels":[],"label_agreement":null},{"id":"W1965490690","doi":"10.1111/j.1463-1326.2011.01451.x","title":"Regulation of glucagon secretion by zinc: lessons from the β cell‐specific Znt8 knockout mouse model","year":2011,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Glucagon; Endocrinology; Internal medicine; Secretion; Paracrine signalling; Islet; Biology; Glucose homeostasis; Insulin; Enteroendocrine cell; Somatostatin; Zinc; Chemistry; Hormone; Endocrine system; Insulin resistance; Medicine; Receptor","score_opus":0.041407269805514624,"score_gpt":0.2679001325510986,"score_spread":0.226492862745584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965490690","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.063291855,0.9335609,0.0001565372,0.000048575348,0.0002542213,0.00076142396,0.0007779771,0.00006418403,0.0010842895],"genre_scores_gemma":[0.0037989642,0.9907708,0.000454662,0.00015413327,0.00027898833,0.00007382334,0.0017345129,0.000060062943,0.002674011],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99790275,0.00025104286,0.0006639829,0.000541273,0.00029712473,0.0003438212],"domain_scores_gemma":[0.99809325,0.00030657274,0.000527489,0.00073358975,0.00013488876,0.00020421445],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042454147,0.00048945623,0.0020411464,0.00014058137,0.00016291782,0.000037960788,0.00019577408,0.0005085742,0.00019017722],"category_scores_gemma":[0.00009475051,0.0003281806,0.00046934682,0.00023268085,0.000198298,0.00012763328,0.00009331184,0.00043082755,0.000048600894],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008046056,0.0012227386,0.00072096306,0.01351416,0.0012136487,9.4977025e-7,0.001265122,0.0000067910705,0.011215803,0.006021438,0.03338844,0.93134946],"study_design_scores_gemma":[0.0008064147,0.000037453545,0.0012456914,0.0020775842,0.003853021,6.580897e-7,0.00003181692,0.0003270474,0.004492445,0.000649919,0.98610055,0.00037740808],"about_ca_topic_score_codex":0.00007519128,"about_ca_topic_score_gemma":0.0000013329403,"teacher_disagreement_score":0.9527121,"about_ca_system_score_codex":0.000036832644,"about_ca_system_score_gemma":0.00013586339,"threshold_uncertainty_score":0.99991703},"labels":[],"label_agreement":null},{"id":"W1965801257","doi":"10.1111/j.1463-1326.2006.00700.x","title":"Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?","year":2007,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Thiazolidinedione; Insulin; Medicine; Pioglitazone; Internal medicine; Diabetes mellitus; Endocrinology; Type 2 diabetes","score_opus":0.013346234962165197,"score_gpt":0.2751306039873413,"score_spread":0.2617843690251761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965801257","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19011794,0.8090505,0.000008913885,0.000030035175,0.00019308661,0.00044363987,0.00007917427,0.000011202049,0.000065476284],"genre_scores_gemma":[0.016522495,0.98231006,0.00021921645,0.00023222264,0.00042923682,0.00002665373,0.00013567276,0.000045012006,0.00007942939],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982514,0.00032603444,0.0004394631,0.00046589045,0.00016821451,0.00034899884],"domain_scores_gemma":[0.9990126,0.00010355757,0.00025294503,0.00038896484,0.00009929981,0.00014261706],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008164935,0.00040970457,0.0014501424,0.000120605626,0.00012984904,0.000035530735,0.00017931205,0.00044582307,0.000008449743],"category_scores_gemma":[0.00018816345,0.00027094333,0.00027818198,0.00023579197,0.0005656112,0.0000074049667,0.00026600817,0.00034758062,0.0000047462677],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020712835,0.0004656966,0.0012045933,0.01493995,0.0033044436,0.000007998197,0.0005633703,0.0000017456786,0.07781699,0.0017979505,0.0015562336,0.8981339],"study_design_scores_gemma":[0.0014319621,0.000035795354,0.000115286515,0.000565723,0.000754172,0.000024239782,0.00001862635,0.0000022964805,0.05442303,0.00006996899,0.9421692,0.0003897061],"about_ca_topic_score_codex":0.000017203913,"about_ca_topic_score_gemma":0.000003320807,"teacher_disagreement_score":0.940613,"about_ca_system_score_codex":0.0000069179046,"about_ca_system_score_gemma":0.00010495384,"threshold_uncertainty_score":0.99997425},"labels":[],"label_agreement":null},{"id":"W1966459465","doi":"10.1111/dom.12232","title":"Are bedtime nutritional strategies effective in preventing nocturnal hypoglycaemia in patients with type 1 diabetes?","year":2013,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Montreal Clinical Research Institute","funders":"American Diabetes Association","keywords":"Bedtime; Medicine; Type 1 diabetes; Type 2 diabetes; Diabetes mellitus; Medical prescription; Insulin; Regimen; Hypoglycemia; Internal medicine; Pediatrics; Intensive care medicine; Endocrinology; Pharmacology","score_opus":0.01714922819426279,"score_gpt":0.2812323911644366,"score_spread":0.2640831629701738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966459465","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45338205,0.54402333,1.8869827e-7,0.000009747602,0.00010479519,0.002152221,0.00002761876,0.00002030945,0.00027975874],"genre_scores_gemma":[0.028294504,0.9682379,0.00034520472,0.00013503373,0.00044604432,0.000820429,0.0008455683,0.00013275364,0.0007426027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99695444,0.0003600203,0.00057731906,0.0006677012,0.00057274284,0.0008677954],"domain_scores_gemma":[0.99857223,0.0002741271,0.000418989,0.0003086595,0.00020897314,0.0002170106],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006316865,0.0005887374,0.0024242392,0.0009522885,0.00008980866,0.0001797875,0.0002246476,0.00037937408,0.00011550873],"category_scores_gemma":[0.00018466484,0.0004200634,0.00021818285,0.00091670087,0.00018179117,0.00044652773,0.00022359125,0.0011086559,0.00005973812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032376578,0.0010524136,0.52109146,0.02746463,0.0005636366,0.00001890574,0.000043272004,0.0000012722583,0.0000016731545,0.00009705179,0.00018709595,0.4494462],"study_design_scores_gemma":[0.0028006143,0.00016978894,0.86561054,0.019436305,0.0008503636,2.5418097e-7,0.000022380376,0.000014315975,0.0000044781564,0.0002571064,0.11034913,0.00048470605],"about_ca_topic_score_codex":0.0000093934905,"about_ca_topic_score_gemma":0.00000889214,"teacher_disagreement_score":0.4489615,"about_ca_system_score_codex":0.00010388584,"about_ca_system_score_gemma":0.000139251,"threshold_uncertainty_score":0.9998251},"labels":[],"label_agreement":null},{"id":"W1968714039","doi":"10.1111/j.1463-1326.2008.00930.x","title":"Blood pressure changes associated with sibutramine and weight management – an analysis from the 6‐week lead‐in period of the sibutramine cardiovascular outcomes trial (SCOUT)*","year":2008,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; University of Alberta","funders":"","keywords":"Sibutramine; Medicine; Blood pressure; Weight loss; Overweight; Post-hoc analysis; Weight management; Weight gain; Heart rate; Cardiology; Internal medicine; Diastole; Placebo; Weight change; Obesity; Anesthesia; Body weight","score_opus":0.013083279168338692,"score_gpt":0.22332250847425486,"score_spread":0.21023922930591618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968714039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761613,0.021728987,0.000003822234,0.00083408563,0.00009623251,0.0009543888,0.0001546172,0.000024685785,0.00004188308],"genre_scores_gemma":[0.99740887,0.0016244589,0.00006646384,0.00032561796,0.000083866646,0.00006590492,0.00009890078,0.000013266341,0.00031266766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983088,0.00034290348,0.00023461186,0.00040248438,0.0003960962,0.00031512245],"domain_scores_gemma":[0.9990557,0.00014918609,0.00012171514,0.0005040756,0.00006672304,0.00010258985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047831706,0.00026742002,0.0010912436,0.00011574761,0.0002426412,0.000014901383,0.00016052125,0.00013729215,0.000021174343],"category_scores_gemma":[0.0000512014,0.00013955538,0.00026311202,0.00042588994,0.00035346666,0.00008262714,0.00009282438,0.0002255135,4.3339074e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006238999,0.002001712,0.9686417,0.000043666656,0.026357222,0.000084069536,0.0012834176,0.000034136006,0.00028928285,0.000050217808,0.000014130462,0.0005765701],"study_design_scores_gemma":[0.024700245,0.00023619337,0.9285257,0.000033491135,0.042139217,0.0000029986938,0.00012762086,0.00011516979,0.0033285432,0.000032826814,0.00061283115,0.00014514686],"about_ca_topic_score_codex":0.00018386322,"about_ca_topic_score_gemma":0.0003683466,"teacher_disagreement_score":0.04011596,"about_ca_system_score_codex":0.000010255816,"about_ca_system_score_gemma":0.000023949167,"threshold_uncertainty_score":0.56909037},"labels":[],"label_agreement":null},{"id":"W1971679833","doi":"10.1111/j.1463-1326.2008.01022.x","title":"Prodrug delivery of novel PTP1B inhibitors to enhance insulin signalling","year":2009,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"National Institutes of Health","keywords":"Prodrug; Insulin; Pharmacology; Population; Chemistry; Endocrinology; Internal medicine; Medicine; Biology","score_opus":0.0056008183022375245,"score_gpt":0.22662442827250262,"score_spread":0.2210236099702651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971679833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96685886,0.03195966,0.0005780113,0.00013590058,0.000085075495,0.0002600898,0.00007199648,0.000012827486,0.000037601534],"genre_scores_gemma":[0.9939506,0.00046803808,0.004534926,0.0007232948,0.00020225812,0.000013172507,0.000052493237,0.000010203713,0.000045006716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906075,0.000025748997,0.00021320207,0.00033117476,0.00012192055,0.000247212],"domain_scores_gemma":[0.99946225,0.000011068599,0.00008475942,0.00022124719,0.00010440942,0.000116258896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020577844,0.00015841232,0.00023434279,0.00005338377,0.00006114003,0.000018397845,0.00015615774,0.00009501556,0.000003265356],"category_scores_gemma":[0.00014214621,0.00015595424,0.00006151616,0.00012914659,0.000051138395,0.000011056571,0.00010397477,0.0000722677,0.0000028421025],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026766813,0.00016711777,0.0009644183,0.000024730132,0.000021575446,3.6004394e-7,0.000046287474,0.00003951181,0.9832757,0.00040245827,0.00023524888,0.014795819],"study_design_scores_gemma":[0.0002715087,0.00011482185,0.02177702,0.000039191298,0.000026750247,3.720675e-7,0.000006718176,0.00001825696,0.9710341,0.00012040926,0.0064099347,0.00018090276],"about_ca_topic_score_codex":0.000019314795,"about_ca_topic_score_gemma":0.000003922068,"teacher_disagreement_score":0.031491622,"about_ca_system_score_codex":0.0000033702884,"about_ca_system_score_gemma":0.00003477394,"threshold_uncertainty_score":0.63596296},"labels":[],"label_agreement":null},{"id":"W1974288288","doi":"10.1111/dom.12052","title":"Insulin degludec: overview of a novel ultra long‐acting basal insulin","year":2012,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Western University","funders":"Novo Nordisk; National Institute for Health and Care Research","keywords":"Insulin degludec; Insulin; Dosing; Basal (medicine); Pharmacodynamics; Medicine; Endocrinology; Insulin glargine; Internal medicine; Bolus (digestion); Subcutaneous injection; Pharmacokinetics; Basal insulin; Diabetes mellitus; Type 2 diabetes; Hypoglycemia","score_opus":0.11182474375695334,"score_gpt":0.3561623482500433,"score_spread":0.24433760449308994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974288288","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008651727,0.9869956,0.000019538078,0.000038396374,0.0004657591,0.0015094662,0.00012218014,0.000066920635,0.0021304314],"genre_scores_gemma":[0.0016494882,0.99552155,0.0006135217,0.00017159543,0.00060720276,0.000091386966,0.0002882443,0.000103008686,0.00095400104],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99635905,0.00024083859,0.001017832,0.0006463336,0.0007296283,0.0010063193],"domain_scores_gemma":[0.9975976,0.00041429643,0.00058579724,0.0007095311,0.00019570676,0.0004970772],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016868375,0.0007045284,0.0037740364,0.0006919624,0.00013674244,0.00007215292,0.00039728679,0.0005630074,0.00023606495],"category_scores_gemma":[0.00034558296,0.0005368988,0.0008172746,0.00078863004,0.00025213134,0.0002785629,0.00037596133,0.0009923984,0.00010335663],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009563369,0.00094996346,0.0021750445,0.07343478,0.0008786958,0.000005613031,0.000075404074,7.943589e-8,0.000016404096,0.00045206497,0.0000950702,0.9219073],"study_design_scores_gemma":[0.0016306875,0.00006764026,0.015665697,0.012938642,0.0063134334,0.0000026363873,0.000013623641,0.000012928514,0.000077958284,0.00004135121,0.96267956,0.0005558189],"about_ca_topic_score_codex":0.000022213673,"about_ca_topic_score_gemma":0.000003403492,"teacher_disagreement_score":0.9625845,"about_ca_system_score_codex":0.000044211127,"about_ca_system_score_gemma":0.00020916254,"threshold_uncertainty_score":0.99970824},"labels":[],"label_agreement":null},{"id":"W1975929001","doi":"10.1111/dom.12121","title":"Efficacy and safety of lixisenatide once daily versus placebo in type 2 diabetes insufficiently controlled on pioglitazone ( <scp>GetGoal</scp> ‐P)","year":2013,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"American Diabetes Association","keywords":"Lixisenatide; Placebo; Medicine; Pioglitazone; Internal medicine; Adverse effect; Metformin; Type 2 diabetes; Randomized controlled trial; Clinical endpoint; Diabetes mellitus; Endocrinology","score_opus":0.009655752413255798,"score_gpt":0.22764533074075968,"score_spread":0.21798957832750387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975929001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825202,0.008795057,0.0000013653253,0.00024410813,0.00036397303,0.0020606501,0.000012681453,0.00006226792,0.005939652],"genre_scores_gemma":[0.9967822,0.0014154385,0.00032581738,0.00036134812,0.00008504704,0.00011237067,0.000043141437,0.000030472218,0.0008442106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978992,0.00013495644,0.0005042824,0.0004989927,0.00035249183,0.000610088],"domain_scores_gemma":[0.99788845,0.0011453277,0.00018892459,0.0003736523,0.00013887562,0.00026477495],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049843575,0.00037086543,0.0011928156,0.00039185368,0.00009928878,0.000056487883,0.00012457388,0.0001408912,0.000030955816],"category_scores_gemma":[0.0008553099,0.0002992194,0.00011151114,0.00039565185,0.00020944433,0.00021497435,0.00014483702,0.00022664167,0.000043111155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057060192,0.011323931,0.8078892,0.0017779156,0.0048258267,0.0000421921,0.0048264065,0.00016192772,0.03466424,0.018910583,0.0045956452,0.10527606],"study_design_scores_gemma":[0.055829406,0.0010311604,0.928163,0.00029098714,0.0007062239,1.7023957e-7,0.0002741272,0.0005046675,0.0065702186,0.00020269465,0.0062488057,0.00017854429],"about_ca_topic_score_codex":0.000041978426,"about_ca_topic_score_gemma":0.000007588371,"teacher_disagreement_score":0.12027375,"about_ca_system_score_codex":0.000043141274,"about_ca_system_score_gemma":0.000037359798,"threshold_uncertainty_score":0.999946},"labels":[],"label_agreement":null},{"id":"W1979078348","doi":"10.1111/dom.12393","title":"Randomized efficacy and safety trial of once‐daily remogliflozin etabonate for the treatment of type 2 diabetes","year":2014,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"GlaxoSmithKline","keywords":"Tolerability; Type 2 diabetes; Placebo; Medicine; Randomized controlled trial; Pioglitazone; Clinical endpoint; Internal medicine; Diabetes mellitus; Pharmacokinetics; Pharmacology; Adverse effect; Endocrinology","score_opus":0.013940990441817559,"score_gpt":0.2524403988908831,"score_spread":0.23849940844906553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979078348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807145,0.014551398,0.000030517615,0.0004614886,0.00039383592,0.0032409297,0.000027849013,0.000027375969,0.0005520978],"genre_scores_gemma":[0.98746485,0.010374862,0.00082323607,0.0001498259,0.00023291292,0.00015799499,0.00004937645,0.000022778102,0.00072419277],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99854124,0.00017266722,0.00047847786,0.00029570874,0.00019907771,0.00031280916],"domain_scores_gemma":[0.99758995,0.0015651358,0.00023613425,0.00036536556,0.00012968309,0.00011373002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009896145,0.00026291626,0.0014715475,0.000114397124,0.00011048455,0.000019128096,0.00008263051,0.00008977088,0.000015342719],"category_scores_gemma":[0.00039061852,0.000152717,0.00027105602,0.00014764875,0.00036058598,0.00006306713,0.000041652143,0.00005155638,0.0000016257742],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33636966,0.0048300982,0.014109092,0.0010029422,0.0068227225,9.1273176e-7,0.0017574525,0.000017527942,0.003786697,0.022079164,0.00034602598,0.6088777],"study_design_scores_gemma":[0.8498256,0.0022510348,0.048532385,0.00010738373,0.0063991332,1.2466992e-7,0.000034813344,0.001646204,0.011032953,0.00096841884,0.07898935,0.00021259971],"about_ca_topic_score_codex":0.000020004834,"about_ca_topic_score_gemma":0.0000027801225,"teacher_disagreement_score":0.6086651,"about_ca_system_score_codex":0.000012927669,"about_ca_system_score_gemma":0.000025213558,"threshold_uncertainty_score":0.62276185},"labels":[],"label_agreement":null},{"id":"W1979400849","doi":"10.1111/dom.12442","title":"<scp>GPR40</scp> agonists for the treatment of type 2 diabetes: life after ‘TAKing’ a hit","year":2015,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research; Canadian Diabetes Association","keywords":"Free fatty acid receptor 1; Medicine; Type 2 diabetes; Agonist; Clinical trial; Receptor; Diabetes mellitus; Pharmacology; Bioinformatics; Internal medicine; Endocrinology; Biology","score_opus":0.031152300544292563,"score_gpt":0.2842922124606352,"score_spread":0.2531399119163426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979400849","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.059492026,0.9384189,0.000038541257,0.0000063975926,0.00071074674,0.0009880182,0.00028074268,0.000011353663,0.00005326286],"genre_scores_gemma":[0.0021754962,0.99493784,0.00031435658,0.000104820436,0.00093990867,0.00044492458,0.0003679062,0.00006841182,0.0006463184],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982298,0.0001423789,0.00044991696,0.0005301496,0.00017384606,0.00047390864],"domain_scores_gemma":[0.99847466,0.00015941172,0.00043981272,0.00051726494,0.00020559916,0.00020323883],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004353914,0.00050770165,0.0014913543,0.00007496983,0.0001276391,0.00006945914,0.00028365845,0.00048577916,0.000017551316],"category_scores_gemma":[0.0002627526,0.00032219483,0.00063971616,0.0001358803,0.00011191635,0.0000061589435,0.000096870455,0.000105802654,0.0000068197364],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019043431,0.00054775336,0.00041215436,0.006212295,0.002944932,0.000001622592,0.00041419434,0.000003826597,0.0014250621,0.0002574681,0.0025728587,0.9851888],"study_design_scores_gemma":[0.0003970959,0.00035224095,0.00008956397,0.00036763662,0.0018364742,5.366856e-7,0.000021718737,0.0000118686,0.0027246266,0.00008069903,0.9939442,0.00017331346],"about_ca_topic_score_codex":0.0000065589447,"about_ca_topic_score_gemma":0.0000029947855,"teacher_disagreement_score":0.9913714,"about_ca_system_score_codex":0.000017805052,"about_ca_system_score_gemma":0.00023684178,"threshold_uncertainty_score":0.999923},"labels":[],"label_agreement":null},{"id":"W1980475389","doi":"10.1111/j.1463-1326.2011.01481.x","title":"Discordant effects on central obesity, hepatic insulin resistance, and alanine aminotransferase of low‐dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance","year":2011,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Western University; Mount Sinai Hospital","funders":"","keywords":"Internal medicine; Insulin resistance; Metformin; Medicine; Endocrinology; Rosiglitazone; Type 2 diabetes; Thiazolidinedione; Insulin; Fatty liver; Placebo; Impaired glucose tolerance; Diabetes mellitus; Pathology","score_opus":0.0060665584396325635,"score_gpt":0.1889750397118429,"score_spread":0.18290848127221035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980475389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924199,0.0061999736,0.0000025029385,0.0000465584,0.000055915785,0.0011698931,0.00006216981,0.000017883402,0.000025177564],"genre_scores_gemma":[0.9950837,0.004378151,0.00019194518,0.00016083318,0.00001978944,0.00006376015,0.000076205564,0.000017026396,0.000008575886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880594,0.00008879115,0.0002492439,0.0003293562,0.00024271027,0.0002839451],"domain_scores_gemma":[0.9993377,0.00009542883,0.00008735387,0.00018723129,0.000075664706,0.00021663388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013119637,0.00025581918,0.0006046431,0.00014167246,0.00006910633,0.000015700245,0.00004382389,0.000056120316,0.000006010062],"category_scores_gemma":[0.00002672534,0.00017943306,0.00004596315,0.0001643671,0.00011176116,0.00019509475,0.000025590634,0.00010251368,5.0081826e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012857213,0.0045518875,0.98407805,0.00050208886,0.0001491939,0.000024619934,0.0010028612,1.704891e-7,0.00039163808,0.0007183948,0.0000036264719,0.007291764],"study_design_scores_gemma":[0.01532192,0.001090762,0.9339979,0.00054403755,0.00025279186,4.344509e-7,0.00001595417,0.00003143476,0.048290804,0.00027572073,0.000007285236,0.00017092812],"about_ca_topic_score_codex":0.00007813511,"about_ca_topic_score_gemma":0.00004338605,"teacher_disagreement_score":0.050080106,"about_ca_system_score_codex":0.00002144647,"about_ca_system_score_gemma":0.000025965746,"threshold_uncertainty_score":0.7317068},"labels":[],"label_agreement":null},{"id":"W1982905493","doi":"10.1111/dom.12273","title":"Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone","year":2014,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":253,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Canagliflozin; Metformin; Sitagliptin; Medicine; Placebo; Pioglitazone; Internal medicine; Type 2 diabetes; Endocrinology; Adverse effect; Urology; Diabetes mellitus; Gastroenterology; Pharmacology","score_opus":0.0058425061165601816,"score_gpt":0.20625429057641928,"score_spread":0.2004117844598591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982905493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996344,0.0019359934,0.0000015440902,0.00007135732,0.000081404076,0.00062884623,0.000018515992,0.00002107734,0.00089731364],"genre_scores_gemma":[0.9986344,0.00036269822,0.00032655048,0.00035962093,0.000040100582,0.000013166858,0.00006342719,0.000022191296,0.00017786586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871725,0.00006379279,0.0002527305,0.00036426727,0.0002372436,0.0003647198],"domain_scores_gemma":[0.99924576,0.00015914437,0.000095000774,0.0002537894,0.00006236013,0.00018392102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003313789,0.00025971478,0.00067727896,0.000231986,0.00006493923,0.000026777616,0.00005220433,0.00008548043,0.0000215869],"category_scores_gemma":[0.00006929234,0.00019191387,0.00003100032,0.00021860411,0.00016156516,0.00015840592,0.00008933088,0.0001231803,0.0000028208005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028812027,0.0006165051,0.9647123,0.00024664143,0.00028594647,0.0000011378612,0.00014498596,0.000001335439,0.00014056964,0.0021034149,0.00007529476,0.0313837],"study_design_scores_gemma":[0.008789946,0.00089709833,0.9832776,0.00018306125,0.0004830634,6.707671e-8,0.000023733315,0.000058747893,0.00069501065,0.00017187416,0.0052207494,0.0001990038],"about_ca_topic_score_codex":0.000079018224,"about_ca_topic_score_gemma":0.000045434874,"teacher_disagreement_score":0.031184696,"about_ca_system_score_codex":0.000022354101,"about_ca_system_score_gemma":0.000014069149,"threshold_uncertainty_score":0.7826021},"labels":[],"label_agreement":null},{"id":"W1982950261","doi":"10.1111/j.1463-1326.2011.01554.x","title":"Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial","year":2011,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; University of Alberta","funders":"","keywords":"Medicine; Sibutramine; Weight loss; Internal medicine; Cardiology; Obesity","score_opus":0.02690187576765485,"score_gpt":0.24835798550674673,"score_spread":0.22145610973909188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982950261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778377,0.01721112,0.000054176755,0.001191871,0.0014996947,0.001182168,0.00037777153,0.000118786615,0.00052671816],"genre_scores_gemma":[0.9947314,0.0016972144,0.0006654417,0.0012278936,0.00067547965,0.00012389004,0.00032320074,0.000032523996,0.00052292517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968259,0.0004626557,0.00060548686,0.0007685744,0.0007255491,0.0006118386],"domain_scores_gemma":[0.9979386,0.00039774747,0.00013868533,0.0010257963,0.00018500841,0.00031416537],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016487241,0.00049109466,0.0017271921,0.00011643152,0.00038610937,0.00003544797,0.00031010085,0.0002813842,0.00014917829],"category_scores_gemma":[0.0005136438,0.00029947236,0.0018733052,0.00019296723,0.00044456168,0.00019910763,0.00019221501,0.00046899318,0.000068589135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014244892,0.0050485893,0.86166215,0.00011246571,0.093185894,0.00075894926,0.0043669036,0.0000150760025,0.00066786376,0.0022056259,0.002191793,0.015539772],"study_design_scores_gemma":[0.056238838,0.00013866817,0.90544856,0.00003975152,0.008913186,0.000008996918,0.0001274078,0.000012210086,0.005595653,0.0010187816,0.022129886,0.00032809217],"about_ca_topic_score_codex":0.00050592003,"about_ca_topic_score_gemma":0.0000139355125,"teacher_disagreement_score":0.084272705,"about_ca_system_score_codex":0.000056514036,"about_ca_system_score_gemma":0.00009821522,"threshold_uncertainty_score":0.99994576},"labels":[],"label_agreement":null},{"id":"W1985422490","doi":"10.1111/j.1463-1326.2009.01131.x","title":"Multiple molecular targets underlie the antidiabetic effect of <i>Nigella sativa</i> seed extract in skeletal muscle, adipocyte and liver cells","year":2009,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Nigella sativa pharmacological applications","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Nigella sativa; AMPK; Adipocyte; Skeletal muscle; Glucose uptake; Internal medicine; Endocrinology; Insulin; Biology; Protein kinase B; Lipid droplet; Protein kinase A; Pharmacology; Biochemistry; Signal transduction; Adipose tissue; Kinase; Medicine; Traditional medicine","score_opus":0.0063637052549147515,"score_gpt":0.2352502699697273,"score_spread":0.22888656471481256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985422490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840027,0.0141082,0.000058027796,0.00038949662,0.000043061274,0.0010474361,0.000017756194,0.000032760556,0.0003005534],"genre_scores_gemma":[0.99733657,0.0012003811,0.00055728754,0.00077298237,0.000044419197,0.00003058839,0.000011945246,0.000013998725,0.00003184484],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99850833,0.00027323814,0.0002929441,0.0003540657,0.0002100393,0.00036138724],"domain_scores_gemma":[0.99879557,0.00061576057,0.00011110728,0.0002520062,0.000048432517,0.00017711033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004978322,0.00024756938,0.00060325686,0.0000995838,0.0000995556,0.000017670041,0.000116793046,0.00012662506,0.000028777178],"category_scores_gemma":[0.00012262577,0.00016568182,0.00010567448,0.00028126885,0.00025907758,0.00007695811,0.00006194937,0.00032111324,0.000008481606],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025345904,0.0003154281,0.043747015,0.0001252943,0.000059333815,0.000015618363,0.00020551063,0.000009453097,0.93780303,0.00016472989,0.00003845439,0.017490784],"study_design_scores_gemma":[0.001344514,0.0001334699,0.565911,0.000027859744,0.00019493369,0.0000014166452,0.000008426221,0.0003875251,0.4303057,0.00027950385,0.0012946301,0.0001110348],"about_ca_topic_score_codex":0.000022920534,"about_ca_topic_score_gemma":0.0000030384376,"teacher_disagreement_score":0.522164,"about_ca_system_score_codex":0.00001451305,"about_ca_system_score_gemma":0.000021177297,"threshold_uncertainty_score":0.67563087},"labels":[],"label_agreement":null},{"id":"W1987067408","doi":"10.1111/dom.12399","title":"Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double‐blind, active‐controlled, parallel group, multinational clinical trial","year":2014,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Boehringer Ingelheim","keywords":"Linagliptin; Metformin; Medicine; Type 2 diabetes; Internal medicine; Clinical endpoint; Randomized controlled trial; Population; Diabetes mellitus; Confidence interval; Gastroenterology; Adverse effect; Endocrinology; Insulin","score_opus":0.017033997711860458,"score_gpt":0.27282690052652775,"score_spread":0.25579290281466727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987067408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936865,0.00088509545,0.00004463164,0.00016659663,0.00015540287,0.004840417,0.000014818409,0.000035150435,0.00017138886],"genre_scores_gemma":[0.9945844,0.00058117026,0.0037235322,0.0002424504,0.00012335484,0.00042392543,0.00022820603,0.000033992346,0.000058965357],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99742746,0.0004653738,0.0007774647,0.0005379053,0.0004085261,0.00038328592],"domain_scores_gemma":[0.99755746,0.0012769579,0.00047124323,0.00022863058,0.0002640848,0.0002016386],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014527185,0.00040312042,0.0021197384,0.00035786527,0.000101053774,0.00006257089,0.00008870566,0.0001955284,0.000012314378],"category_scores_gemma":[0.00037273482,0.0002761729,0.00012836729,0.00025564202,0.00044914044,0.0002862178,0.00007801542,0.0002627247,8.8153416e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63662684,0.0028421415,0.33252713,0.00013035904,0.0009967472,0.000002333752,0.00025762562,0.000006745423,0.000014806392,0.0012527062,0.000010674538,0.02533188],"study_design_scores_gemma":[0.62204766,0.0015678242,0.373498,0.000104149054,0.0009056221,1.4355459e-7,0.000037036414,0.0012115376,0.000061062805,0.00022236149,0.00014289173,0.00020169333],"about_ca_topic_score_codex":0.00003474016,"about_ca_topic_score_gemma":0.000045874865,"teacher_disagreement_score":0.040970862,"about_ca_system_score_codex":0.000021707501,"about_ca_system_score_gemma":0.000039413473,"threshold_uncertainty_score":0.99996907},"labels":[],"label_agreement":null},{"id":"W1987329229","doi":"10.1111/j.1463-1326.2012.01564.x","title":"Acute high‐intensity interval exercise reduces the postprandial glucose response and prevalence of hyperglycaemia in patients with type 2 diabetes","year":2012,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Cardiovascular and exercise physiology","field":"Medicine","cited_by":274,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; McMaster University","funders":"Canadian Diabetes Association","keywords":"Postprandial; Medicine; Type 2 diabetes; Internal medicine; Diabetes mellitus; Cardiology; Meal; Endocrinology; Heart rate; Blood pressure","score_opus":0.0050670055035314954,"score_gpt":0.19853266683145238,"score_spread":0.19346566132792087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987329229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97590095,0.017611599,1.4748252e-7,0.0049109356,0.00058717513,0.0007773821,0.0001811834,0.000022733504,0.000007907416],"genre_scores_gemma":[0.9829524,0.0035411392,0.00006539497,0.012450801,0.000595722,0.00003204243,0.00023242916,0.00004615125,0.00008391392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778396,0.00034905825,0.00036063927,0.0005281706,0.00039661684,0.00058156427],"domain_scores_gemma":[0.9985505,0.00022318713,0.00019198102,0.0006058222,0.00029828172,0.00013027318],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006422019,0.0004411062,0.001791575,0.00024677147,0.00009153368,0.000025890418,0.00019456897,0.00050520414,0.00002163026],"category_scores_gemma":[0.00015253299,0.00028043392,0.00022472593,0.00024331575,0.00056981633,0.00016533153,0.00024864456,0.0010418294,0.00000564385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07030968,0.0012248678,0.8448382,0.0058155716,0.005182993,0.00014481953,0.0033829387,0.0000018876502,0.015573871,0.000010255593,0.035349347,0.018165564],"study_design_scores_gemma":[0.0025062445,0.00044178744,0.9765927,0.00067292864,0.0036848318,0.000005452835,0.000012559537,0.0000021753826,0.012405794,0.000037283782,0.003321637,0.00031660649],"about_ca_topic_score_codex":0.000043026095,"about_ca_topic_score_gemma":0.0000012316781,"teacher_disagreement_score":0.1317545,"about_ca_system_score_codex":0.000024214574,"about_ca_system_score_gemma":0.00006918319,"threshold_uncertainty_score":0.9999648},"labels":[],"label_agreement":null},{"id":"W1992861325","doi":"10.1111/j.1463-1326.2012.01657.x","title":"Metabolic stress, <scp>IAPP</scp> and islet amyloid","year":2012,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Islet; Proinsulin; Amyloid (mycology); Endocrinology; Internal medicine; Amylin; Prohormone; Insulin; Type 2 diabetes; Insulin resistance; Diabetes mellitus; Biology; Medicine; Hormone; Pathology","score_opus":0.02635643609017033,"score_gpt":0.2664918284569194,"score_spread":0.24013539236674905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992861325","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.046556212,0.9482086,0.000003049045,0.000023576982,0.00071461976,0.00094207807,0.00026747386,0.00015736987,0.0031270366],"genre_scores_gemma":[0.0007051553,0.99356204,0.0003110493,0.0005548692,0.0014888318,0.00015661979,0.00043493765,0.00010197995,0.0026845038],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99686545,0.00028282308,0.00070494105,0.0007697441,0.00041388447,0.0009631775],"domain_scores_gemma":[0.9971469,0.00081760733,0.0003832485,0.00066484686,0.00011222166,0.00087514316],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00061739614,0.00090058346,0.004252704,0.00046062356,0.0002498717,0.00012141488,0.0001723442,0.0006898436,0.00011896624],"category_scores_gemma":[0.000719046,0.00068351184,0.0005352099,0.00045417898,0.00034113423,0.00026070853,0.0002323998,0.0007495422,0.00018068052],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000029418638,0.0005068318,0.01230914,0.029091572,0.0018915139,0.000010818322,0.00026003225,3.8240444e-8,0.000052820407,0.0030122655,0.002724225,0.9501378],"study_design_scores_gemma":[0.0008031775,0.000032107644,0.013353318,0.0025117635,0.012854836,0.000023051995,0.00003851928,0.0000030855142,0.00022166863,0.000098829376,0.9697888,0.00027087788],"about_ca_topic_score_codex":0.000026823187,"about_ca_topic_score_gemma":0.0000010921053,"teacher_disagreement_score":0.96706456,"about_ca_system_score_codex":0.000020832875,"about_ca_system_score_gemma":0.00015581895,"threshold_uncertainty_score":0.9995616},"labels":[],"label_agreement":null},{"id":"W1995169341","doi":"10.1111/dom.12049","title":"Components of metabolic syndrome and 5‐year change in insulin clearance – the Insulin Resistance Atherosclerosis Study","year":2012,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Public Health Ontario; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Center for Research Resources; U.S. Public Health Service","keywords":"Internal medicine; Endocrinology; Insulin resistance; Medicine; Metabolic syndrome; Insulin; Waist; Glucose clamp technique; Diabetes mellitus; Blood pressure; Body mass index; Pancreatic hormone","score_opus":0.02492216230212894,"score_gpt":0.23898175043150308,"score_spread":0.21405958812937415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995169341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8871481,0.111313105,0.0000012502927,0.00011428426,0.00017445335,0.001086142,0.00003153184,0.00002435788,0.00010677171],"genre_scores_gemma":[0.9931873,0.005962885,0.00018655481,0.0002416008,0.00018678016,0.00014365713,0.000008295461,0.000030485116,0.00005244455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980672,0.00032834202,0.0003694337,0.00032775578,0.0004094405,0.00049782166],"domain_scores_gemma":[0.9990113,0.00007769101,0.00013162558,0.0005167902,0.00006519919,0.00019739832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001484563,0.00025064085,0.0010129482,0.00016560826,0.00012356091,0.00002662604,0.00014864332,0.0001158921,0.000020113772],"category_scores_gemma":[0.00012388121,0.0001908895,0.00015024505,0.0004250982,0.0002361116,0.00029277752,0.00014122868,0.00029578074,0.000011880377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008409216,0.0012069821,0.96270365,0.00023126058,0.0004096039,0.0000031993952,0.004968437,3.3069233e-7,0.00046941388,0.0003681786,0.000010628215,0.029544206],"study_design_scores_gemma":[0.0029597643,0.00006362062,0.98771006,0.00016163789,0.00044485592,0.0000023785444,0.00030310644,0.0000086800255,0.0010508723,0.000043790173,0.007062908,0.00018832473],"about_ca_topic_score_codex":0.0017143049,"about_ca_topic_score_gemma":0.00023909422,"teacher_disagreement_score":0.10603919,"about_ca_system_score_codex":0.000008432771,"about_ca_system_score_gemma":0.000012724961,"threshold_uncertainty_score":0.77842486},"labels":[],"label_agreement":null},{"id":"W1995308350","doi":"10.1111/j.1463-1326.2004.00460.x","title":"Current indications for pancreas or islet transplant","year":2004,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Capital District Health Authority","funders":"","keywords":"Medicine; Immunosuppression; Diabetes mellitus; Pancreas transplantation; Transplantation; Pancreas; Intensive care medicine; Islet; Internal medicine; Insulin; Surgery; Kidney transplantation; Endocrinology","score_opus":0.04992811944859253,"score_gpt":0.3487432017012347,"score_spread":0.29881508225264214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995308350","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000594556,0.9949384,0.0002034602,0.000041782103,0.00031526102,0.0019086329,0.0018903028,0.000053497362,0.000054161166],"genre_scores_gemma":[0.00022625386,0.9950023,0.00088821066,0.00007898384,0.00021869551,0.0005077464,0.002750592,0.000044210927,0.000282967],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985148,0.000053236225,0.0004757481,0.0004221124,0.00018826588,0.0003458873],"domain_scores_gemma":[0.9990382,0.00020587066,0.00019377643,0.0002535457,0.000052277293,0.0002562845],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013739453,0.00042679431,0.001864001,0.00023101017,0.00015544101,0.000034960667,0.00010113845,0.00022139466,0.000046531415],"category_scores_gemma":[0.00002748909,0.00026531512,0.0005715481,0.0002079465,0.00006549325,0.00006887331,0.000011122684,0.00024857663,0.000031632808],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035420588,0.0006284741,0.0010322079,0.108856365,0.0013295655,0.000018187979,0.00016492137,8.06643e-8,7.1696684e-7,0.0028885505,0.00003794208,0.88500756],"study_design_scores_gemma":[0.0020799849,0.00006897138,0.0045681265,0.02744784,0.013051031,0.000037234535,0.0000022212582,7.146875e-7,0.00001207431,0.00020925188,0.95223165,0.00029089942],"about_ca_topic_score_codex":0.000009872556,"about_ca_topic_score_gemma":0.0000026342193,"teacher_disagreement_score":0.95219374,"about_ca_system_score_codex":0.000038581973,"about_ca_system_score_gemma":0.00033607148,"threshold_uncertainty_score":0.9999799},"labels":[],"label_agreement":null},{"id":"W1997287686","doi":"10.1111/j.1463-1326.2004.00319.x","title":"Lack of concordance between plasma markers of cardiovascular risk and intima‐media thickness in patients with type 2 diabetes","year":2003,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Cardiovascular Health and Disease Prevention","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"Servier","keywords":"Medicine; Internal medicine; Diabetes mellitus; Intima-media thickness; Type 2 diabetes; Endothelial dysfunction; Waist; C-reactive protein; Atenolol; Endocrinology; Cardiology; Gastroenterology; Inflammation; Body mass index; Carotid arteries; Blood pressure","score_opus":0.009153233178156387,"score_gpt":0.22194591132386085,"score_spread":0.21279267814570446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997287686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97864497,0.020603819,0.00002447155,0.0000052924247,0.00009336835,0.0004582643,0.00006267993,0.000009978215,0.00009716951],"genre_scores_gemma":[0.9978779,0.0014271626,0.0005608423,0.000028040204,0.00003067418,0.000009583997,0.0000476713,0.000014486342,0.0000036715862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985528,0.00026804648,0.00030773645,0.00027057377,0.00033916437,0.00026169774],"domain_scores_gemma":[0.9990398,0.00012795128,0.00013187845,0.00030274928,0.00019433748,0.00020327097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083625,0.0001604602,0.00092635845,0.00014323283,0.000037865117,0.0000061688575,0.00004140015,0.000105003994,0.000007742361],"category_scores_gemma":[0.0004571446,0.00013604866,0.00017688425,0.00029584288,0.00018623489,0.00010140134,0.000031128977,0.00016655085,8.778869e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013224798,0.000114550436,0.9870019,0.0008097688,0.0005318333,8.170409e-7,0.00009364882,0.0000089369305,0.000025647618,0.00004745625,0.0000062481245,0.0112269325],"study_design_scores_gemma":[0.005142678,0.0000760325,0.99071586,0.00019882077,0.0016014219,2.0776864e-7,0.00003398301,0.000012543906,0.0011608439,0.00016122292,0.0007672879,0.00012912198],"about_ca_topic_score_codex":0.000063587446,"about_ca_topic_score_gemma":0.000005500714,"teacher_disagreement_score":0.01923291,"about_ca_system_score_codex":0.000011007549,"about_ca_system_score_gemma":0.00007813451,"threshold_uncertainty_score":0.5547904},"labels":[],"label_agreement":null},{"id":"W1997586858","doi":"10.1111/dom.12068","title":"Newer insulin analogs: advances in basal insulin replacement","year":2013,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Diabetes Canada; University of Toronto; Mount Sinai Hospital","funders":"Novo Nordisk; Amylin Pharmaceuticals; American Diabetes Association","keywords":"Insulin; Insulin degludec; Insulin lispro; Insulin analog; Medicine; Tolerability; Basal (medicine); Insulin glargine; Diabetes mellitus; Basal insulin; Type 2 diabetes; Internal medicine; Pharmacology; Endocrinology; Hypoglycemia; Human insulin; Adverse effect","score_opus":0.027297717722480054,"score_gpt":0.3221910531809734,"score_spread":0.29489333545849333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997586858","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00572019,0.9873297,0.000003454259,0.00010771152,0.00045698558,0.0023796195,0.00003715488,0.000065163134,0.0039000197],"genre_scores_gemma":[0.00014560587,0.9941612,0.00035284113,0.00035626107,0.0004526188,0.0003956223,0.00030888058,0.00006930789,0.0037576957],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963777,0.00033263117,0.00088511617,0.00089013606,0.00058769836,0.000926684],"domain_scores_gemma":[0.9983403,0.00020576766,0.00028507572,0.000671536,0.00011976877,0.00037754505],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011187734,0.00065756065,0.002967874,0.0010057094,0.0001056253,0.0001234199,0.0003296903,0.00044395673,0.0004374255],"category_scores_gemma":[0.00030086772,0.00048233173,0.00040157212,0.00090570614,0.00020596145,0.00040515527,0.0004403239,0.0009511294,0.00033718045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012200285,0.0003910663,0.0018712765,0.01803245,0.00025204135,0.000020029127,0.000039535946,2.5010394e-7,8.586796e-7,0.00035708764,0.0012349782,0.9777882],"study_design_scores_gemma":[0.0014002408,0.000109403634,0.0054685776,0.005919294,0.0009682387,8.2126877e-7,0.0000195841,0.000031021213,0.0000042870674,0.00034036374,0.98526573,0.0004724341],"about_ca_topic_score_codex":0.00002435969,"about_ca_topic_score_gemma":0.000011078393,"teacher_disagreement_score":0.9840308,"about_ca_system_score_codex":0.00007623951,"about_ca_system_score_gemma":0.00017465945,"threshold_uncertainty_score":0.99976283},"labels":[],"label_agreement":null},{"id":"W1997970555","doi":"10.1111/dom.12357","title":"The interleukin‐1 receptor antagonist anakinra improves first‐phase insulin secretion and insulinogenic index in subjects with impaired glucose tolerance","year":2014,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Radboud Universiteit; Novo Nordisk Fonden; European Foundation for the Study of Diabetes","keywords":"Anakinra; Medicine; Internal medicine; Interleukin 1 receptor antagonist; Endocrinology; Placebo; Insulin; Receptor antagonist; Type 2 diabetes; Antagonist; Diabetes mellitus; Impaired glucose tolerance; Interleukin; Insulin resistance; Receptor; Cytokine","score_opus":0.004010870474421166,"score_gpt":0.1989291215263735,"score_spread":0.19491825105195232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997970555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9630598,0.022951312,0.000009571251,0.012967001,0.00028390047,0.00052503456,0.00013790838,0.00002511381,0.000040402614],"genre_scores_gemma":[0.9443892,0.010267678,0.000048839483,0.042864576,0.0009563427,0.000114422175,0.0011292653,0.00007562914,0.00015400174],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975586,0.00023116703,0.00041262116,0.0008123547,0.0002326302,0.00075265195],"domain_scores_gemma":[0.9988684,0.00008567039,0.0003417678,0.00047493388,0.000104584295,0.00012462655],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004434775,0.0005560413,0.0006482707,0.000117592266,0.0003554134,0.00025552782,0.00033192534,0.0008650862,0.000003828288],"category_scores_gemma":[0.00012905781,0.0004219254,0.00013207167,0.00020926885,0.00039903884,0.000021808228,0.0001909575,0.0008067172,0.0000030733195],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027772132,0.0023234321,0.2985397,0.0034522058,0.003906505,0.00012379458,0.0023459145,0.00006196058,0.2654766,0.00020176805,0.25337735,0.16741358],"study_design_scores_gemma":[0.005117781,0.00056517776,0.052226555,0.00023496845,0.00018775808,0.0000038290686,0.00008633253,0.00039632508,0.017232846,0.00016380286,0.92272323,0.0010613891],"about_ca_topic_score_codex":0.00012435958,"about_ca_topic_score_gemma":0.00038091728,"teacher_disagreement_score":0.6693459,"about_ca_system_score_codex":0.000023724388,"about_ca_system_score_gemma":0.000094237694,"threshold_uncertainty_score":0.9998233},"labels":[],"label_agreement":null},{"id":"W2000297042","doi":"10.1111/j.1463-1326.2011.01444.x","title":"Incretin hormones and the expanding families of glucagon‐like sequences and their receptors","year":2011,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"University of Ottawa","keywords":"Biology; Proglucagon; Vertebrate; Subfamily; Receptor; Glucagon; Gene; Genetics; Lineage (genetic); Hormone; Evolutionary biology; Cell biology; Glucagon-like peptide-1; Endocrinology","score_opus":0.02292791986254658,"score_gpt":0.25544055628912127,"score_spread":0.2325126364265747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000297042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12455483,0.87325996,0.0000011302457,0.000035116227,0.00022350438,0.0010007945,0.000031965752,0.000032978944,0.0008597371],"genre_scores_gemma":[0.0077699716,0.9912419,0.00015288232,0.00009282938,0.00010796772,0.00012630287,0.00006071871,0.00003122032,0.00041626082],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984113,0.00023091372,0.00045622623,0.00043273115,0.00013491052,0.00033390574],"domain_scores_gemma":[0.99880946,0.0003639198,0.00032130032,0.00032075026,0.000046426903,0.00013814752],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007444706,0.00050858443,0.0024276143,0.00025590297,0.00016604552,0.00005473845,0.00013898639,0.00020212388,0.000018757171],"category_scores_gemma":[0.00007978285,0.00025950637,0.00025656185,0.00020288494,0.00088250433,0.00012579007,0.00029187457,0.00022117913,0.0000029671096],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002102685,0.00006781161,0.0017859953,0.009062817,0.0011908473,0.0000013530127,0.0013570404,3.7695718e-9,0.000007748991,0.0031550971,0.000121234894,0.98322904],"study_design_scores_gemma":[0.0014162135,0.000098922064,0.003101712,0.003935555,0.004910377,0.00000406663,0.0005452218,0.0000020980096,0.0001280395,0.0006947794,0.984828,0.00033502685],"about_ca_topic_score_codex":0.00009437586,"about_ca_topic_score_gemma":0.000005872036,"teacher_disagreement_score":0.98470676,"about_ca_system_score_codex":0.000011516974,"about_ca_system_score_gemma":0.0000385062,"threshold_uncertainty_score":0.9999857},"labels":[],"label_agreement":null},{"id":"W2002728745","doi":"10.1046/j.1463-1326.2001.00030.x","title":"β‐cell deterioration – prospects for reversal or prevention","year":2001,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Adipose Tissue and Metabolism","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"Mitacs; GlaxoSmithKline","keywords":"Kinesiology; Citation; Library science; Psychology; Medicine; Computer science; Medical education","score_opus":0.020029276995819523,"score_gpt":0.27297458773021227,"score_spread":0.25294531073439275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002728745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908744,0.0060558673,0.0007226479,0.00027373008,0.00031638198,0.0010823546,0.000011441547,0.00008062078,0.0005825204],"genre_scores_gemma":[0.9762831,0.0012340152,0.0058827926,0.000604125,0.00069976423,0.0001126062,0.0000743507,0.000029371371,0.01507991],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99896514,0.000034650104,0.0002218793,0.00030150684,0.00015094427,0.00032588153],"domain_scores_gemma":[0.99937356,0.00003784043,0.00009319924,0.00020245017,0.00011367896,0.0001792572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026191588,0.0001744334,0.00041039722,0.000098344186,0.00014784417,0.000035598518,0.000051408468,0.00012809731,0.00008592091],"category_scores_gemma":[0.00011336374,0.0001379287,0.000103800565,0.00016750468,0.00004914283,0.00025284203,0.00002895931,0.00010233835,0.000022406151],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024929754,0.0033805904,0.20663445,0.002499148,0.00064989686,0.00010697913,0.00346082,0.0000028876932,0.5046512,0.009683837,0.0144432485,0.251994],"study_design_scores_gemma":[0.0059683644,0.00049865444,0.5085514,0.000115249255,0.0012775018,0.000030116644,0.00007881902,0.00017108089,0.05685934,0.0028292984,0.4232312,0.00038893684],"about_ca_topic_score_codex":0.000008027515,"about_ca_topic_score_gemma":0.000008639132,"teacher_disagreement_score":0.44779184,"about_ca_system_score_codex":0.000012127361,"about_ca_system_score_gemma":0.00006470004,"threshold_uncertainty_score":0.5624569},"labels":[],"label_agreement":null},{"id":"W2003806569","doi":"10.1111/j.1463-1326.2007.00805.x","title":"Acute effect of metformin on exercise capacity in active males","year":2007,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Danone Institute of Canada; American Heart Association","keywords":"Metformin; Medicine; Placebo; Crossover study; VO2 max; Ventilatory threshold; Internal medicine; Physical exercise; Cycle ergometer; Body mass index; Diabetes mellitus; Endocrinology; Heart rate; Blood pressure","score_opus":0.007631730136959777,"score_gpt":0.23151106435240026,"score_spread":0.22387933421544048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003806569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.928005,0.07093197,0.000016034213,0.0000035620326,0.00023553983,0.00028527938,0.00008259564,0.000008721471,0.00043132843],"genre_scores_gemma":[0.9781983,0.021176703,0.0001733654,0.00014134066,0.00015606702,0.000028659566,0.000044065375,0.00001931863,0.000062196814],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986384,0.00009713961,0.00026566588,0.00038106687,0.000176626,0.0004411313],"domain_scores_gemma":[0.9993295,0.000059629587,0.00011803491,0.00030392295,0.000055355682,0.0001335215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007910376,0.00025447417,0.00055554067,0.00014884224,0.00005558707,0.000012168153,0.00016547366,0.00022196538,0.000016395206],"category_scores_gemma":[0.00009240421,0.00021522099,0.00013731819,0.00016890136,0.00015703183,0.0000145824,0.000080195314,0.00015868444,0.0000043980885],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091766455,0.00034752671,0.056386247,0.00026481255,0.0003318823,0.000007230852,0.0004080615,0.000008709155,0.34871998,0.00076873484,0.00018649829,0.59165263],"study_design_scores_gemma":[0.0012020655,0.00015412657,0.12126598,0.000042283056,0.00014348047,5.975872e-7,0.000020343892,0.0000039137194,0.85861796,0.00014935916,0.018193966,0.00020589787],"about_ca_topic_score_codex":0.0000308318,"about_ca_topic_score_gemma":0.000042834592,"teacher_disagreement_score":0.59144676,"about_ca_system_score_codex":0.000009598264,"about_ca_system_score_gemma":0.000021784834,"threshold_uncertainty_score":0.87764573},"labels":[],"label_agreement":null},{"id":"W2005227623","doi":"10.1111/j.1463-1326.2009.01110.x","title":"Zinc, a regulator of islet function and glucose homeostasis","year":2009,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Trace Elements in Health","field":"Nursing","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Islet; Glucose homeostasis; Zinc; Endocrinology; Internal medicine; Diabetes mellitus; Pancreas; Insulin; Homeostasis; Biology; Pancreatic islets; Regulator; Insulin resistance; Chemistry; Medicine; Biochemistry; Gene","score_opus":0.022542663804669016,"score_gpt":0.2921141168304629,"score_spread":0.2695714530257939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005227623","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.042951506,0.9548052,0.000003703543,0.00004608098,0.0010139205,0.000844453,0.00021148344,0.000067688154,0.000055989723],"genre_scores_gemma":[0.0017977232,0.9968616,0.000537973,0.00020017399,0.00039525007,0.00002995562,0.00009705206,0.000050794366,0.0000295057],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975163,0.00037480888,0.00072776957,0.0005794531,0.0003026343,0.0004990603],"domain_scores_gemma":[0.9984507,0.0002229125,0.00056832604,0.00048246494,0.00007122408,0.00020437801],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007095791,0.00048051364,0.002231033,0.00035133222,0.00018277678,0.000055526965,0.0001669286,0.0004332156,0.000027742333],"category_scores_gemma":[0.00012696881,0.00042757,0.00024203131,0.00035204258,0.00014745111,0.00020303333,0.00008845704,0.00042517603,0.00000841399],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011638002,0.00013031109,0.00022720738,0.014578894,0.00012362473,5.016799e-7,0.00007141527,3.6409705e-8,0.000007140658,0.0005720037,0.00042643078,0.9838508],"study_design_scores_gemma":[0.00045659774,0.00010672509,0.019180313,0.0029806027,0.0027991498,0.000002663512,0.000009006746,0.0000016056415,0.00008139583,0.0011934614,0.97281694,0.00037152338],"about_ca_topic_score_codex":0.000021940412,"about_ca_topic_score_gemma":0.000004455109,"teacher_disagreement_score":0.98347926,"about_ca_system_score_codex":0.000044641518,"about_ca_system_score_gemma":0.000053912372,"threshold_uncertainty_score":0.9998176},"labels":[],"label_agreement":null},{"id":"W2005561360","doi":"10.1111/dom.12474","title":"Two dose‐ranging studies with <scp>PF</scp> ‐04937319, a systemic partial activator of glucokinase, as add‐on therapy to metformin in adults with type 2 diabetes","year":2015,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Golder Associates (Canada)","funders":"Pfizer","keywords":"Metformin; Glucokinase; Activator (genetics); Type 2 diabetes; Medicine; Internal medicine; Endocrinology; Diabetes mellitus; Cancer research; Receptor","score_opus":0.018849586620283482,"score_gpt":0.2627396493139453,"score_spread":0.24389006269366179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005561360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98313665,0.014227801,0.0000022665313,0.00008833074,0.00017846121,0.0014911215,0.000015289135,0.00007517254,0.00078488275],"genre_scores_gemma":[0.9973777,0.0007960697,0.00052942615,0.0005344891,0.00014172282,0.00023922652,0.000030893025,0.0000459753,0.0003045208],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979196,0.00010099599,0.00033232768,0.0005112138,0.00049883575,0.0006370371],"domain_scores_gemma":[0.9986111,0.00021636455,0.00017416704,0.00039829814,0.0002675482,0.00033254767],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052497315,0.0004247161,0.0011045154,0.00041014972,0.0000730605,0.0000345326,0.00012927744,0.00007758323,0.0000053976028],"category_scores_gemma":[0.0002273333,0.0002748275,0.000072036084,0.00069699023,0.00012903694,0.0002482067,0.00009037109,0.00016165078,0.000020450816],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027741145,0.002806154,0.90587294,0.0018312794,0.0048816376,0.00014474514,0.016058905,0.00017448608,0.0076490636,0.0027114635,0.0015281852,0.053567033],"study_design_scores_gemma":[0.06574185,0.015835796,0.3819085,0.0095755225,0.0030013341,0.000011788164,0.015849125,0.00026287526,0.47513932,0.0005524386,0.031011768,0.0011096784],"about_ca_topic_score_codex":0.000060763872,"about_ca_topic_score_gemma":0.000031584717,"teacher_disagreement_score":0.5239644,"about_ca_system_score_codex":0.00006939013,"about_ca_system_score_gemma":0.00009407132,"threshold_uncertainty_score":0.9999704},"labels":[],"label_agreement":null},{"id":"W2006237207","doi":"10.1046/j.1463-1326.2003.00269.x","title":"A cohort study of reproductive risk factors, weight and weight change and the development of diabetes mellitus","year":2003,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"British Heart Foundation","keywords":"Medicine; Pregnancy; Body mass index; Obstetrics; Weight gain; Diabetes mellitus; Cohort; Gynecology; Cohort study; Internal medicine; Endocrinology; Body weight","score_opus":0.01899358161751241,"score_gpt":0.24616719599321474,"score_spread":0.22717361437570233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006237207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98126465,0.016530583,0.000005634594,0.000091428796,0.00007005014,0.0017871078,0.000024195157,0.000011061035,0.00021528608],"genre_scores_gemma":[0.9959295,0.0030505224,0.00066135084,0.000041485127,0.00003920739,0.00015739133,0.00001727001,0.0000122333495,0.000091060305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981811,0.00031453418,0.0003573665,0.00041275047,0.00042413952,0.0003101232],"domain_scores_gemma":[0.99889314,0.00027282664,0.00018185959,0.00029996564,0.00019322365,0.00015899692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015114311,0.0001987557,0.0006679132,0.00016781592,0.00017628523,0.000018067452,0.0000690223,0.000049535705,0.000018514393],"category_scores_gemma":[0.0005111085,0.0001251573,0.000045019046,0.00020941917,0.00035753546,0.00012206651,0.00012513141,0.00015782865,6.968525e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030399633,0.00052402995,0.9858178,0.0002758419,0.00074628927,4.4122112e-7,0.0057837223,2.0895736e-7,0.00027441923,0.0015055252,0.000022268654,0.005019043],"study_design_scores_gemma":[0.0028142368,0.00013840102,0.9810592,0.000042003343,0.0005516967,1.3404235e-7,0.0008586833,0.000023249004,0.010391691,0.0008713734,0.0031286397,0.00012072257],"about_ca_topic_score_codex":0.00007119464,"about_ca_topic_score_gemma":0.00001905416,"teacher_disagreement_score":0.014664826,"about_ca_system_score_codex":0.00001055763,"about_ca_system_score_gemma":0.000034210414,"threshold_uncertainty_score":0.5103767},"labels":[],"label_agreement":null},{"id":"W2008804979","doi":"10.1046/j.1463-1326.2002.00164.x","title":"Animal models of insulin resistance and cardiovascular disease: some therapeutic approaches using the JCR:LA‐cp rat","year":2002,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Regulation of Appetite and Obesity","field":"Neuroscience","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Citation; Library science; Insulin resistance; Resistance (ecology); Medicine; Gerontology; Internal medicine; Insulin; Computer science; Biology; Ecology","score_opus":0.11004449098840965,"score_gpt":0.265879006246844,"score_spread":0.15583451525843436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008804979","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.042693067,0.95617443,0.00005040534,0.000025816256,0.00010330726,0.00069330813,0.00008738856,0.000031105323,0.00014119575],"genre_scores_gemma":[0.039162017,0.9602939,0.00010267323,0.00006694182,0.0001700758,0.000030184805,0.000006764783,0.000041549083,0.00012589173],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969393,0.0009582966,0.0004638276,0.00076541706,0.0005022035,0.00037095105],"domain_scores_gemma":[0.99838996,0.00036799093,0.00028525916,0.00076054514,0.000036384004,0.00015986149],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071741716,0.0004669128,0.0016242779,0.00015010535,0.0003710683,0.00014717964,0.00039661094,0.00023174011,0.0000063139896],"category_scores_gemma":[0.00009321999,0.0003198973,0.00063493825,0.00036536023,0.0006246513,0.00043104243,0.00021576275,0.0003465038,0.0000022253607],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000477941,0.0005558458,0.00018462459,0.028723026,0.0012416838,0.000028377008,0.0006608865,0.00046604738,0.00046646217,0.13015221,0.000058100046,0.8374149],"study_design_scores_gemma":[0.00042933994,0.00001230127,0.0010414646,0.0019270692,0.0039709583,0.0000063663083,0.000013206453,0.0024400668,0.0006827354,0.0048931395,0.983886,0.0006973617],"about_ca_topic_score_codex":0.0000051866705,"about_ca_topic_score_gemma":3.6648373e-7,"teacher_disagreement_score":0.9838279,"about_ca_system_score_codex":0.000013412224,"about_ca_system_score_gemma":0.000073480485,"threshold_uncertainty_score":0.9999253},"labels":[],"label_agreement":null},{"id":"W2010333163","doi":"10.1111/j.1463-1326.2011.01446.x","title":"Reprogramming gut and pancreas endocrine cells to treat diabetes","year":2011,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Reprogramming; Endocrine system; Enteroendocrine cell; Pancreas; Diabetes mellitus; Endocrinology; Medicine; Biology; Internal medicine; Hormone; Cell; Biochemistry","score_opus":0.030644173342066042,"score_gpt":0.27875949422123475,"score_spread":0.2481153208791687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010333163","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11026077,0.88595355,0.00000365302,0.0000392758,0.00041148515,0.00138947,0.00009705356,0.00019087981,0.0016538498],"genre_scores_gemma":[0.0005636015,0.9929189,0.0016293147,0.0006676255,0.0005995905,0.00032904535,0.00015927383,0.00010934309,0.0030233148],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965776,0.00029085448,0.0007532654,0.0011349721,0.000267365,0.0009759056],"domain_scores_gemma":[0.9973265,0.00041284214,0.00027295397,0.00083166856,0.00012333629,0.0010327246],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00065815053,0.00090583717,0.0039873063,0.00054252724,0.0002039938,0.00012006231,0.00017121539,0.0003955268,0.00018431131],"category_scores_gemma":[0.0004609386,0.00069746043,0.00050121796,0.0004933615,0.00020923991,0.00015091366,0.00027568685,0.000494537,0.00017363131],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008391708,0.00021819289,0.003070402,0.015460062,0.00044199498,0.0000147667615,0.00012057865,1.09679545e-8,0.0002733679,0.0003039322,0.0008513063,0.979237],"study_design_scores_gemma":[0.0008293193,0.00016518414,0.003135244,0.004797601,0.006852264,0.00001467921,0.000018610554,0.0000021420533,0.0009883578,0.0000930417,0.98243433,0.0006692506],"about_ca_topic_score_codex":0.00005190475,"about_ca_topic_score_gemma":0.0000010658248,"teacher_disagreement_score":0.981583,"about_ca_system_score_codex":0.00003799585,"about_ca_system_score_gemma":0.0001087554,"threshold_uncertainty_score":0.99954766},"labels":[],"label_agreement":null},{"id":"W2011760617","doi":"10.1111/j.1463-1326.2011.01383.x","title":"Lipid‐altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials","year":2011,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Ezetimibe; Statin; Medicine; Internal medicine; Diabetes mellitus; Population; Placebo; Gastroenterology; Cholesterol; Lipid profile; Endocrinology; Pharmacology","score_opus":0.059020171091089264,"score_gpt":0.3252401634328464,"score_spread":0.26621999234175714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011760617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962558,0.001658434,0.0001870104,0.000019875586,0.000036820296,0.0013969872,0.0004203048,0.000015182972,0.000009553403],"genre_scores_gemma":[0.9922593,0.0017819669,0.005136122,0.00012728057,0.000041125175,0.000018243867,0.0006071121,0.00002518309,0.0000036719189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99705976,0.00093418907,0.00085622765,0.0005466244,0.00036459567,0.00023857839],"domain_scores_gemma":[0.9981447,0.00026384406,0.0005122708,0.0007160476,0.00016968734,0.00019343429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033767796,0.0002327112,0.0020027112,0.00025271953,0.000051467974,0.000019354584,0.00011895783,0.00011469086,0.00003156469],"category_scores_gemma":[0.00021011126,0.00015565813,0.00008178747,0.00035638546,0.00020425854,0.0002700927,0.000060419592,0.00017614666,1.3685805e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025263329,0.0011347325,0.9368174,0.00010379167,0.0022973116,3.56407e-7,0.0013406407,0.0000014300487,0.00021906504,0.000025085636,0.0000013126784,0.055532537],"study_design_scores_gemma":[0.020581013,0.0013327139,0.9723524,0.00016637407,0.0021538993,5.6883273e-8,0.000103809354,0.0013404143,0.001726215,0.000026729542,0.00004490641,0.00017145659],"about_ca_topic_score_codex":0.00066924404,"about_ca_topic_score_gemma":0.00013066371,"teacher_disagreement_score":0.05536108,"about_ca_system_score_codex":0.000006941192,"about_ca_system_score_gemma":0.000069072405,"threshold_uncertainty_score":0.63475543},"labels":[],"label_agreement":null},{"id":"W2011860054","doi":"10.1111/j.1463-1326.2005.00476.x","title":"Advances in pancreatic islet transplantation in humans","year":2005,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Islet; Transplantation; Islet cell transplantation; Intensive care medicine; Pancreas transplantation; Diabetes mellitus; Internal medicine; Endocrinology; Kidney transplantation","score_opus":0.019874240266731805,"score_gpt":0.29705459823772457,"score_spread":0.2771803579709928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011860054","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.049243767,0.94654787,0.0000036197573,0.000024332505,0.00016811438,0.00074800604,0.000045944074,0.000041858,0.0031764803],"genre_scores_gemma":[0.0012502273,0.99729073,0.00021412378,0.00021621963,0.0002624863,0.00016657224,0.00029806388,0.000033412947,0.0002681352],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980564,0.00019186953,0.000655929,0.00046759783,0.0002045093,0.0004236931],"domain_scores_gemma":[0.9991695,0.0002598979,0.00015918657,0.00024514148,0.000025817017,0.00014041358],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039322572,0.0004157983,0.0024223826,0.00064223644,0.00004475428,0.000025537607,0.00008523357,0.000317309,0.00011394406],"category_scores_gemma":[0.00011031235,0.00034031327,0.00022516258,0.0004748388,0.00008182607,0.00024839197,0.000017600882,0.0004476673,0.000046344787],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012541359,0.00025481,0.013086827,0.020561138,0.000056034773,0.000024677478,0.00022000764,9.0273215e-7,0.000005624547,0.0004259991,0.00002766292,0.96532375],"study_design_scores_gemma":[0.0014805763,0.0000338127,0.027524427,0.011712249,0.0016446728,0.0000059283707,0.000020996322,0.000012047135,0.0000104311885,0.00013795448,0.95706725,0.00034967597],"about_ca_topic_score_codex":0.000023419976,"about_ca_topic_score_gemma":0.00003786986,"teacher_disagreement_score":0.9649741,"about_ca_system_score_codex":0.000057113484,"about_ca_system_score_gemma":0.0001014667,"threshold_uncertainty_score":0.9999049},"labels":[],"label_agreement":null},{"id":"W2012125528","doi":"10.1111/j.1463-1326.2012.01665.x","title":"The safety and efficacy of adding once‐daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries","year":2012,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; University of Calgary","funders":"Novo Nordisk","keywords":"Medicine; Insulin detemir; Adverse effect; Internal medicine; Insulin; Diabetes mellitus; Body mass index; Type 2 diabetes; Type 2 Diabetes Mellitus; Confidence interval; Hypoglycemia; Endocrinology; Insulin glargine","score_opus":0.019326523713890487,"score_gpt":0.31610213927775277,"score_spread":0.2967756155638623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012125528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99455637,0.0037766942,3.898473e-7,0.0003195706,0.0001364186,0.00086450676,0.000009442432,0.000011630457,0.00032498658],"genre_scores_gemma":[0.998063,0.0007156856,0.0005444287,0.0004418834,0.00006986796,0.000017346527,0.000020754087,0.0000189992,0.00010800767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976418,0.00036274354,0.0006089957,0.00029675206,0.00040130306,0.0006884032],"domain_scores_gemma":[0.9978197,0.0014319045,0.00016518362,0.00023210929,0.00014988799,0.00020122256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036313732,0.00019112827,0.00060293643,0.00028107676,0.00009117859,0.00004583558,0.00013573148,0.00011569497,0.000012860686],"category_scores_gemma":[0.0031190503,0.00013154796,0.000035311503,0.00064863113,0.00020641545,0.00039718105,0.00024574078,0.00041265314,0.0000096363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007915712,0.000570109,0.9543321,0.00012398239,0.000067615925,0.00000189831,0.00051538995,0.000003814739,0.000020245703,0.00007760975,0.0000859545,0.043409716],"study_design_scores_gemma":[0.005202661,0.00023577169,0.97249764,0.0003327074,0.000092241906,6.2966954e-8,0.00015760298,0.00012445578,0.00008466974,0.000013707436,0.021110639,0.0001478632],"about_ca_topic_score_codex":0.00003019069,"about_ca_topic_score_gemma":0.000050262708,"teacher_disagreement_score":0.043261852,"about_ca_system_score_codex":0.000039861206,"about_ca_system_score_gemma":0.000053748066,"threshold_uncertainty_score":0.536437},"labels":[],"label_agreement":null},{"id":"W2014308927","doi":"10.1111/j.1463-1326.2011.01521.x","title":"Blockade of kinin B <sub>1</sub> receptor reverses plasma fatty acids composition changes and body and tissue fat gain in a rat model of insulin resistance","year":2011,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Internal medicine; Endocrinology; Insulin resistance; Adipose tissue; Palmitoleic acid; Insulin; Chemistry; Linoleic acid; Biology; Fatty acid; Biochemistry; Medicine","score_opus":0.018423200554444234,"score_gpt":0.22272575889907598,"score_spread":0.20430255834463174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014308927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861042,0.013106007,0.000041228148,0.00014988756,0.0000735574,0.0003387827,0.00008317868,0.00002154694,0.00008159777],"genre_scores_gemma":[0.99337256,0.004280034,0.0020611165,0.00009249284,0.00006160479,0.00001581204,0.000038394635,0.000016617896,0.0000613452],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988834,0.00007723146,0.00033361214,0.00030375758,0.00016746158,0.00023449521],"domain_scores_gemma":[0.9993439,0.00008072269,0.00017932264,0.00017343019,0.000090424786,0.0001322535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026825914,0.00020008712,0.0006394755,0.00019803992,0.00006428838,0.000009692084,0.00005279782,0.00015427609,0.00000836135],"category_scores_gemma":[0.000066797664,0.0001915977,0.000039039332,0.00017709025,0.0002559153,0.00015082172,0.000062420535,0.00011538208,7.0487727e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002934486,0.00024323596,0.1393255,0.0005435794,0.000051137813,0.000002427765,0.0036527158,0.0000035314658,0.84771544,0.0010451904,0.000060245915,0.007063571],"study_design_scores_gemma":[0.0016327804,0.00008044758,0.26598033,0.00030905602,0.00013670421,0.0000012132468,0.00009756055,0.0007891164,0.730158,0.00052133296,0.00015186139,0.00014162081],"about_ca_topic_score_codex":0.000050372586,"about_ca_topic_score_gemma":0.000096741634,"teacher_disagreement_score":0.12665483,"about_ca_system_score_codex":0.000009578929,"about_ca_system_score_gemma":0.000024478251,"threshold_uncertainty_score":0.78131276},"labels":[],"label_agreement":null},{"id":"W2018366759","doi":"10.1111/j.1463-1326.2011.01509.x","title":"What matters in ADVANCE and ADVANCE‐ON","year":2011,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Computer Research Institute of Montréal","funders":"Servier; U.S. Department of Veterans Affairs","keywords":"Medicine; Diabetes mellitus; Blood pressure; Disease; Type 2 diabetes; Internal medicine; Glycated haemoglobin; Intensive care medicine; Cardiology; Endocrinology","score_opus":0.0209471570295346,"score_gpt":0.28055525726273617,"score_spread":0.2596081002332016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018366759","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0058817407,0.99135476,8.3546763e-7,0.00012504174,0.0005964857,0.0012191546,0.00001721343,0.000047795053,0.00075699226],"genre_scores_gemma":[0.00006562871,0.9961401,0.0003020525,0.0014633848,0.0001134625,0.00020062919,0.00009637944,0.00005204007,0.0015663065],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982669,0.00008489435,0.0003805925,0.00063722016,0.0001498888,0.0004805378],"domain_scores_gemma":[0.9990952,0.00009362421,0.00016886195,0.0004166055,0.000021386884,0.00020432244],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022730105,0.0005370905,0.0020984726,0.00039573343,0.000054623113,0.00007351237,0.000106922955,0.00019865461,0.00004012083],"category_scores_gemma":[0.000025268588,0.00041471832,0.0001999558,0.00021631768,0.00011946847,0.00040461347,0.00014108852,0.00030669133,0.00006487839],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007230303,0.00022809661,0.00073119445,0.009587617,0.00022587374,0.00002090807,0.00008216769,3.0917846e-8,3.8375083e-7,0.0014405044,0.00022809274,0.9874479],"study_design_scores_gemma":[0.00089798373,0.00008611467,0.004891743,0.012987337,0.0018260407,0.0000020170849,0.000024296089,8.093233e-7,0.0000069989796,0.0003183105,0.97861016,0.0003482129],"about_ca_topic_score_codex":0.000006482776,"about_ca_topic_score_gemma":0.000005099739,"teacher_disagreement_score":0.9870997,"about_ca_system_score_codex":0.000037919242,"about_ca_system_score_gemma":0.000025610203,"threshold_uncertainty_score":0.9998305},"labels":[],"label_agreement":null},{"id":"W2018970098","doi":"10.1111/j.1463-1326.2009.01090.x","title":"Weight and blood pressure response to weight management and sibutramine in diabetic and non‐diabetic high‐risk patients: an analysis from the 6‐week lead‐in period of the sibutramine cardiovascular outcomes (SCOUT) trial","year":2009,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; University of Alberta","funders":"Abbott Laboratories","keywords":"Sibutramine; Medicine; Diabetes mellitus; Blood pressure; Internal medicine; Weight loss; Overweight; Type 2 diabetes; Insulin; Weight management; Cardiology; Endocrinology; Obesity","score_opus":0.00492548337025824,"score_gpt":0.21812053029063191,"score_spread":0.21319504692037367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018970098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775249,0.019379636,0.000004465973,0.0011120865,0.00011621848,0.0016467172,0.00019321636,0.000014649466,0.000008162286],"genre_scores_gemma":[0.9972375,0.0017943969,0.00019186655,0.00052341516,0.000058339134,0.00006682032,0.00004280308,0.000013987524,0.00007084446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736506,0.0007579387,0.0004566125,0.00063872937,0.00035449406,0.00042716382],"domain_scores_gemma":[0.99868655,0.00032449877,0.00012363998,0.0005938444,0.00005953705,0.00021193679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010275109,0.00036499204,0.0013453712,0.0002977935,0.0001824903,0.000041737065,0.00016738134,0.00017026374,0.00001080678],"category_scores_gemma":[0.00014519878,0.00022428903,0.00019950583,0.0005216626,0.00024998686,0.00013961566,0.00015409154,0.00030216255,6.0083784e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020841348,0.0018656884,0.98606026,0.00006365378,0.0037989696,0.000026298723,0.0014378147,0.000026555563,0.0005101191,0.000031169722,0.000007834616,0.004087522],"study_design_scores_gemma":[0.033228826,0.0006120539,0.9422341,0.00006113643,0.020389687,6.045449e-7,0.00010040206,0.00015245395,0.0024538317,0.00024475987,0.00030575276,0.00021639543],"about_ca_topic_score_codex":0.00021038008,"about_ca_topic_score_gemma":0.00011553385,"teacher_disagreement_score":0.04382614,"about_ca_system_score_codex":0.000016774484,"about_ca_system_score_gemma":0.000020469313,"threshold_uncertainty_score":0.91462415},"labels":[],"label_agreement":null},{"id":"W2019255233","doi":"10.1111/j.1463-1326.2007.00782.x","title":"Regulation of pancreatic β‐cell function by the forkhead protein FoxO1","year":2007,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"FOXO1; Forkhead Transcription Factors; Cell growth; Biology; Internal medicine; Glucagon; Endocrinology; Cell biology; Transcription factor; Cell; Signal transduction; Medicine; Protein kinase B; Insulin; Gene; Biochemistry","score_opus":0.016804715699519863,"score_gpt":0.24815741422377421,"score_spread":0.23135269852425436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019255233","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055176247,0.9427436,0.00069854694,0.000007146623,0.00015712842,0.0009405595,0.00008579521,0.000012574848,0.0001783956],"genre_scores_gemma":[0.03571047,0.96088284,0.00011889484,0.00003587821,0.00023125588,0.00009104143,0.001394339,0.000043562515,0.0014916866],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986175,0.00019099478,0.00042678582,0.00034855094,0.00018781911,0.00022834941],"domain_scores_gemma":[0.9991102,0.000025159901,0.0003370438,0.00038362935,0.00008306917,0.000060877162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043972762,0.00029445693,0.0006476836,0.0000805173,0.000104725004,0.000025364074,0.00014713666,0.00042843918,0.000014574442],"category_scores_gemma":[0.00003202833,0.00021331529,0.0002634753,0.00016122674,0.00012539455,0.000010017141,0.000040330782,0.00015331405,0.0000053322838],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003217469,0.00016556699,0.0002093013,0.010072602,0.0003914914,1.14236165e-7,0.000050214854,0.0000021098463,0.12180395,0.00070185424,0.0015873123,0.8649833],"study_design_scores_gemma":[0.00023677743,0.00006090564,0.0018439278,0.00047331047,0.00081384816,8.108919e-7,0.000005244319,0.0000043954947,0.013144147,0.00011682631,0.98307526,0.00022452025],"about_ca_topic_score_codex":0.0000124423805,"about_ca_topic_score_gemma":0.0000047352814,"teacher_disagreement_score":0.981488,"about_ca_system_score_codex":0.000010307137,"about_ca_system_score_gemma":0.00004632584,"threshold_uncertainty_score":0.86987454},"labels":[],"label_agreement":null},{"id":"W2019550402","doi":"10.1111/j.1463-1326.2010.01271.x","title":"The endoplasmic reticulum stress response in the pancreatic <i>β</i> ‐cell","year":2010,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Unfolded protein response; Endoplasmic reticulum; Cell biology; Cell; Pancreatic islets; Biology; Cell type; Homeostasis; Secretion; Insulin; Endocrinology; Islet; Biochemistry","score_opus":0.01365993165459314,"score_gpt":0.25900318519561155,"score_spread":0.2453432535410184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019550402","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16475055,0.83083797,4.1834204e-7,0.00021896031,0.00048140736,0.0011491497,0.00006711667,0.00003843405,0.002455981],"genre_scores_gemma":[0.0026530148,0.99446684,0.0000580291,0.0006673821,0.0003321366,0.00031690495,0.00007835799,0.000045560868,0.0013817903],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99661803,0.0012177603,0.0006423255,0.000481557,0.00041111003,0.00062922324],"domain_scores_gemma":[0.99458444,0.0038948944,0.00028521795,0.000972434,0.000068486304,0.00019449764],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023296222,0.00053293013,0.0019046069,0.00019811679,0.00035023084,0.00016009061,0.00038207512,0.0004572999,0.000033546006],"category_scores_gemma":[0.001280251,0.0002602174,0.0004342562,0.00047199143,0.00035685164,0.00006997873,0.00009923908,0.0013600404,0.000087644614],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004821784,0.0016353941,0.010291367,0.032081317,0.00084579206,0.00015775254,0.001497861,3.5309913e-7,0.00039654272,0.0035555847,0.004946872,0.94410896],"study_design_scores_gemma":[0.0007645323,0.00007068092,0.0053037563,0.002548579,0.0025824218,0.000021912381,0.00009506138,0.000007682679,0.0001814423,0.00010016428,0.9880471,0.0002766663],"about_ca_topic_score_codex":0.000016671185,"about_ca_topic_score_gemma":0.0000078094545,"teacher_disagreement_score":0.98310024,"about_ca_system_score_codex":0.000023848983,"about_ca_system_score_gemma":0.0002995227,"threshold_uncertainty_score":0.999985},"labels":[],"label_agreement":null},{"id":"W2020158846","doi":"10.1111/j.1463-1326.2009.01152.x","title":"Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neither","year":2009,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Merck","keywords":"Atorvastatin; Ezetimibe; Metabolic syndrome; Medicine; Tolerability; Internal medicine; Type 2 diabetes; Type 2 Diabetes Mellitus; Diabetes mellitus; Endocrinology; Gastroenterology; Acute coronary syndrome; Dyslipidemia; National Cholesterol Education Program; Cholesterol; Adverse effect; Pharmacology; Myocardial infarction","score_opus":0.009547110710946228,"score_gpt":0.22572039570497007,"score_spread":0.21617328499402386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020158846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892407,0.0056064287,0.000057242196,0.0008837779,0.000093252806,0.003715167,0.00032153836,0.00007422411,0.000007651578],"genre_scores_gemma":[0.9915834,0.00019371267,0.0039078235,0.003460993,0.00013161037,0.00039054084,0.00017298595,0.00006431559,0.00009463713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694556,0.00029785212,0.00045808553,0.000709601,0.00070653146,0.0008823514],"domain_scores_gemma":[0.9979397,0.00018504463,0.00018139141,0.0007546134,0.00022245153,0.000716805],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008781971,0.00047737182,0.0012997417,0.00019086941,0.00038694032,0.00007968893,0.0001704886,0.000090079935,0.000038964878],"category_scores_gemma":[0.00012253788,0.00026924515,0.00018141326,0.0005744912,0.00013451066,0.00021711788,0.000075103126,0.00028946722,0.000010251349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034758814,0.00084241515,0.9793307,0.00025113742,0.00049457245,0.000024668014,0.00075729075,0.00015701987,0.000054079126,0.0001635854,0.00021533406,0.014233299],"study_design_scores_gemma":[0.010098901,0.0009804545,0.98126143,0.00025226126,0.0009882072,0.000003690802,0.00007627638,0.00012536875,0.0004045138,0.0001418329,0.0052583013,0.00040879037],"about_ca_topic_score_codex":0.00021152657,"about_ca_topic_score_gemma":0.00011506028,"teacher_disagreement_score":0.013824508,"about_ca_system_score_codex":0.00005781663,"about_ca_system_score_gemma":0.00018144996,"threshold_uncertainty_score":0.999976},"labels":[],"label_agreement":null},{"id":"W2020622760","doi":"10.1111/j.1463-1326.2008.00942.x","title":"Non‐invasive detection of transplanted pancreatic islets","year":2008,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Metabolic Technologies","keywords":"Islet; Transplantation; Medicine; Diabetes mellitus; Islet cell transplantation; Insulin; Pancreatic islets; Immune system; Clinical trial; Immune modulation; Intensive care medicine; Bioinformatics; Internal medicine; Immunology; Endocrinology; Biology","score_opus":0.01853082586857062,"score_gpt":0.252014669935761,"score_spread":0.23348384406719036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020622760","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10819387,0.88958967,0.000018130168,0.0000051843654,0.0002999644,0.0008221939,0.000107222375,0.000062305895,0.0009014528],"genre_scores_gemma":[0.007546081,0.99131364,0.00011521027,0.00009967483,0.00023672014,0.000092570685,0.00021093068,0.000049721213,0.00033543492],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99807304,0.0001255804,0.0006742062,0.0004568919,0.0002874118,0.0003828776],"domain_scores_gemma":[0.9984909,0.00036619752,0.00036011776,0.00039801747,0.00012791416,0.00025679974],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015800066,0.00051400065,0.003394672,0.00042758655,0.00011497314,0.000012797952,0.0000965074,0.00046606734,0.000055041684],"category_scores_gemma":[0.00022314292,0.00039866107,0.0006675806,0.00043678243,0.00019970094,0.00008668724,0.000029750177,0.00038613184,0.000044930825],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004349554,0.0005326066,0.0016021251,0.093011886,0.0023548368,0.000045770517,0.00033481963,1.5647441e-7,0.0032225437,0.000047453606,0.00021507194,0.89858925],"study_design_scores_gemma":[0.002217243,0.00024141444,0.009906415,0.026178263,0.0145392595,0.00015285266,0.000024919003,0.000020967762,0.011231038,0.00003654676,0.934717,0.00073406077],"about_ca_topic_score_codex":0.000028812494,"about_ca_topic_score_gemma":0.0000014766377,"teacher_disagreement_score":0.93450195,"about_ca_system_score_codex":0.000028556518,"about_ca_system_score_gemma":0.00022355866,"threshold_uncertainty_score":0.9998465},"labels":[],"label_agreement":null},{"id":"W2020735006","doi":"10.1111/j.1462-8902.2004.00320.x","title":"Signalling pathways involved in retinal endothelial cell proliferation induced by advanced glycation end products: inhibitory effect of gliclazide","year":2004,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Advanced Glycation End Products research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"Servier","keywords":"Glycation; Gliclazide; Inhibitory postsynaptic potential; Signalling pathways; Cell biology; Chemistry; Signal transduction; Retinal; Signalling; Biochemistry; Receptor; Biology; Neuroscience; Endocrinology; Diabetes mellitus","score_opus":0.00742261289162206,"score_gpt":0.23074816652558183,"score_spread":0.22332555363395978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020735006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533653,0.003468857,0.00024545073,0.00009512728,0.000101433216,0.00064811134,0.00003498516,0.000013514085,0.000056007775],"genre_scores_gemma":[0.9980551,0.0004402296,0.0008389651,0.000051252577,0.00021237238,0.00008309519,0.00025414533,0.000020825302,0.000043996744],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99852514,0.00020111348,0.00029459564,0.00047500152,0.00021791935,0.00028621644],"domain_scores_gemma":[0.9993355,0.00003049522,0.00014730798,0.00024799467,0.00016589284,0.0000727562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062367035,0.0001866848,0.0002573778,0.00010564762,0.00007725733,0.000018073939,0.00012374073,0.00014146115,0.000002951388],"category_scores_gemma":[0.00047034828,0.00018011022,0.000037325754,0.00022305945,0.00008795405,0.00003691199,0.000067624314,0.00018436294,0.0000020880902],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014455065,0.00012285585,0.003970126,0.00017468662,0.000010302142,3.4425148e-7,0.00017623897,0.00021548655,0.9910738,0.00005791403,0.0000083712885,0.0040453095],"study_design_scores_gemma":[0.0019226912,0.00030310062,0.0040057353,0.000033991615,0.0000151299055,3.4582422e-7,0.000027658321,0.000015077637,0.9921881,0.0002496668,0.0010653569,0.00017317693],"about_ca_topic_score_codex":0.000020869375,"about_ca_topic_score_gemma":0.000011358607,"teacher_disagreement_score":0.0038721324,"about_ca_system_score_codex":0.000024402176,"about_ca_system_score_gemma":0.000115823656,"threshold_uncertainty_score":0.73446816},"labels":[],"label_agreement":null},{"id":"W2024436535","doi":"10.1111/dom.12130","title":"Hemin therapy suppresses inflammation and retroperitoneal adipocyte hypertrophy to improve glucose metabolism in obese rats co‐morbid with insulin‐resistant type‐2 diabetes","year":2013,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Internal medicine; Endocrinology; Adipocyte; Adiponectin; GLUT4; Insulin; Insulin resistance; Carbohydrate metabolism; Adipose tissue; Medicine; Biology","score_opus":0.00485499775548432,"score_gpt":0.20063222799004307,"score_spread":0.19577723023455876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024436535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727532,0.026097042,0.000003075884,0.000168853,0.00014247329,0.00063350407,0.000047792048,0.000024325413,0.00012968201],"genre_scores_gemma":[0.9933862,0.0047201607,0.00057701726,0.0005334043,0.0003408128,0.00017215624,0.00010745055,0.000044836324,0.00011797891],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817777,0.00013606266,0.00032049688,0.00061601325,0.00020202753,0.0005476151],"domain_scores_gemma":[0.9989879,0.000028910072,0.00009453673,0.0004127649,0.00017166401,0.00030422592],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024650662,0.00037129357,0.0005050491,0.00013468903,0.00011511173,0.00014796841,0.0001836156,0.00021890803,0.000024567149],"category_scores_gemma":[0.00010961087,0.00029589204,0.00005906622,0.00022358334,0.00014646286,0.000054261738,0.0001234719,0.00017529663,0.000012694293],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014375063,0.00008429696,0.011327413,0.000046853136,0.00009247161,0.0000028938503,0.00015198727,0.000004647832,0.9789898,0.000039663704,0.00017270503,0.008943536],"study_design_scores_gemma":[0.0010950961,0.0002354409,0.1857517,0.00002458541,0.00003789296,7.780826e-7,0.000052073425,0.000043682,0.79417896,0.00005998532,0.018165955,0.00035385013],"about_ca_topic_score_codex":0.00015752004,"about_ca_topic_score_gemma":0.000068739195,"teacher_disagreement_score":0.18481083,"about_ca_system_score_codex":0.00001091233,"about_ca_system_score_gemma":0.00006552497,"threshold_uncertainty_score":0.99994934},"labels":[],"label_agreement":null},{"id":"W2026751220","doi":"10.1111/j.1463-1326.2010.01312.x","title":"Buccal spray insulin in subjects with impaired glucose tolerance: the prevoral study","year":2010,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Postprandial; Insulin; Internal medicine; Impaired glucose tolerance; Medicine; Endocrinology; Meal; Buccal administration; Diabetes mellitus; Insulin resistance; Pharmacology","score_opus":0.00887560486675868,"score_gpt":0.24891153818066994,"score_spread":0.24003593331391126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026751220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952967,0.0015366649,0.0000011749145,0.0006223498,0.00022528542,0.001452368,0.000005254899,0.000050775285,0.00080942246],"genre_scores_gemma":[0.99844694,0.00007255715,0.00012840699,0.00034123106,0.00026114483,0.0000921224,0.000009479291,0.000021421949,0.00062668265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833256,0.00013500838,0.00021365575,0.00036314823,0.0004198207,0.0005358361],"domain_scores_gemma":[0.9991487,0.00009737841,0.000052177882,0.00043778584,0.000083185914,0.00018073015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010598215,0.00021229731,0.00045396195,0.0001823429,0.00016073529,0.00009305248,0.00020609681,0.000092665454,0.00006411444],"category_scores_gemma":[0.00012516718,0.00012067174,0.000057136553,0.00049679546,0.00023906432,0.00018297933,0.00015418357,0.00070704654,0.000021319205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014667393,0.0014321659,0.97689337,0.0001014089,0.00010504602,0.00003365716,0.0010307318,0.0000022430802,0.0040973867,0.00029076054,0.0001076803,0.015758887],"study_design_scores_gemma":[0.0041501294,0.00030547418,0.9860854,0.00004066477,0.00015239783,9.121919e-7,0.0002823535,0.00022754793,0.0031284068,0.00013296826,0.0053300424,0.00016371648],"about_ca_topic_score_codex":0.000051778647,"about_ca_topic_score_gemma":0.0004595465,"teacher_disagreement_score":0.015595171,"about_ca_system_score_codex":0.0000086666205,"about_ca_system_score_gemma":0.00005990736,"threshold_uncertainty_score":0.4920851},"labels":[],"label_agreement":null},{"id":"W2029664649","doi":"10.1111/j.1463-1326.2007.00747.x","title":"PPAR‐alpha: therapeutic role in diabetes‐related cardiovascular disease","year":2007,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Diabetes mellitus; Medicine; Disease; Statin; Clinical trial; Internal medicine; Clinical endpoint; Fenofibrate; Cause of death; Type 2 diabetes; Bioinformatics; Intensive care medicine; Endocrinology; Biology","score_opus":0.015527915947265011,"score_gpt":0.25681104126673754,"score_spread":0.24128312531947252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029664649","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14045328,0.8580549,0.000004503917,0.0000060000193,0.00042422846,0.0007822033,0.00010906051,0.000039260143,0.00012658084],"genre_scores_gemma":[0.018761951,0.9795082,0.00003524841,0.0001375811,0.00038897104,0.00019344727,0.0007020609,0.00012764183,0.00014489911],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99629724,0.0005511427,0.00069122727,0.0011638652,0.00034664752,0.000949882],"domain_scores_gemma":[0.9982246,0.000049347604,0.00021589613,0.0009885438,0.00007654174,0.00044504242],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00095793157,0.00083747966,0.0021646735,0.000360267,0.00013503755,0.00007420892,0.00046097577,0.0010166435,0.00002807163],"category_scores_gemma":[0.00012491347,0.00073923205,0.0011350929,0.0005283192,0.00020804808,0.000018317427,0.0003038454,0.00068324665,0.000037224352],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012240318,0.0003160686,0.0057885423,0.003655948,0.0037396192,0.000013456601,0.000036380057,0.000009039088,0.0014190591,0.00006184363,0.0000594242,0.9848884],"study_design_scores_gemma":[0.0005587497,0.000029245146,0.0017194799,0.0008648869,0.0019705875,0.0000019100883,0.000006065932,0.000008901227,0.0030771473,0.00009360491,0.99080443,0.000864975],"about_ca_topic_score_codex":0.000011584627,"about_ca_topic_score_gemma":0.000002363276,"teacher_disagreement_score":0.990745,"about_ca_system_score_codex":0.000043495816,"about_ca_system_score_gemma":0.00022545482,"threshold_uncertainty_score":0.9995059},"labels":[],"label_agreement":null},{"id":"W2031730303","doi":"10.1111/dom.12428","title":"Long‐term efficacy and safety of canagliflozin over 104 weeks in patients aged 55–80 years with type 2 diabetes","year":2014,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Janssen Research and Development; American Heart Association","keywords":"Canagliflozin; Medicine; Placebo; Blood pressure; Internal medicine; Type 2 diabetes; Endocrinology; Diabetes mellitus; Regimen; Adverse effect; Gastroenterology","score_opus":0.004615864103886198,"score_gpt":0.20171394092333242,"score_spread":0.19709807681944622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031730303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99719834,0.0014572316,0.0000014776892,0.000044378594,0.00012523745,0.0005888132,0.0000148495255,0.000029417346,0.0005402765],"genre_scores_gemma":[0.99882174,0.00028178855,0.0001636898,0.00032053105,0.00005184563,0.000012750307,0.00009085172,0.000025098714,0.00023170543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869394,0.00007603388,0.0002566157,0.00033712556,0.0002443413,0.00039196372],"domain_scores_gemma":[0.9992858,0.00008744917,0.00010564922,0.00028376427,0.000057590452,0.00017975146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027045238,0.00023353194,0.00063699466,0.00021019913,0.000049455553,0.000025461706,0.00007655792,0.00008859684,0.00003953599],"category_scores_gemma":[0.00007151297,0.00018877737,0.0000441117,0.00024479575,0.00014319606,0.00013340333,0.00009970674,0.00013320475,0.0000064395294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012792643,0.00048849505,0.9742357,0.00020104642,0.00023925214,0.000002689112,0.00019882627,0.0000015219903,0.00023873555,0.00017701554,0.00013171314,0.023957081],"study_design_scores_gemma":[0.007835066,0.00037544928,0.98835534,0.00020957379,0.0005115023,6.474124e-8,0.0000074736313,0.000022416109,0.0007274278,0.000044905908,0.0017151302,0.00019563531],"about_ca_topic_score_codex":0.000066475266,"about_ca_topic_score_gemma":0.00008993816,"teacher_disagreement_score":0.023761446,"about_ca_system_score_codex":0.000023010041,"about_ca_system_score_gemma":0.000019784988,"threshold_uncertainty_score":0.76981175},"labels":[],"label_agreement":null},{"id":"W2032883705","doi":"10.1111/dom.12134","title":"A comparison of the assessment and management of cardiometabolic risk in patients with and without type 2 diabetes mellitus in Canadian primary care","year":2013,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; University of Calgary; Centre for Family Medicine; McMaster University; Canadian Heart Research Centre; Hamilton Health Sciences; Western University; University of Toronto; Population Health Research Institute; Université Laval; Université de Montréal; University of British Columbia; Montreal Clinical Research Institute; St. Michael's Hospital","funders":"Merck Canada","keywords":"Medicine; Type 2 Diabetes Mellitus; Primary care; Blood pressure; Diabetes mellitus; Internal medicine; Disease; Type 2 diabetes; Intensive care medicine; Physical therapy; Family medicine; Endocrinology","score_opus":0.006035245437309562,"score_gpt":0.228748609499203,"score_spread":0.22271336406189343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032883705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9642443,0.033859205,6.3076857e-7,0.000025311789,0.000076841156,0.0013618176,0.000040970906,0.000006514244,0.00038439338],"genre_scores_gemma":[0.996948,0.0022677581,0.0005980896,0.000055816996,0.000017897073,0.000056045465,0.000029260314,0.000018468212,0.000008667711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984708,0.000165126,0.00031971963,0.00030526746,0.00033763205,0.00040147244],"domain_scores_gemma":[0.9991141,0.000024264493,0.00013288643,0.000376502,0.0001459551,0.00020631794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037973272,0.00021074606,0.0010540854,0.00029249155,0.00006298379,0.000023508179,0.00009066707,0.000092341856,0.0000043235937],"category_scores_gemma":[0.000018491039,0.00014749957,0.00007451673,0.00041891978,0.000216549,0.00012143705,0.00010479473,0.00021739109,4.6363866e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009603109,0.00011027867,0.8931266,0.0007985779,0.0003195428,3.3257567e-7,0.0005212597,0.000006861752,0.000013145473,0.00003628839,0.00000454684,0.10505294],"study_design_scores_gemma":[0.0028270872,0.00009647236,0.99415374,0.00037052188,0.0006450245,9.9546476e-8,0.00028649502,0.00004669638,0.00038713473,0.00003488295,0.000994888,0.00015695082],"about_ca_topic_score_codex":0.07110742,"about_ca_topic_score_gemma":0.018210933,"teacher_disagreement_score":0.10489599,"about_ca_system_score_codex":0.000054364165,"about_ca_system_score_gemma":0.00009367505,"threshold_uncertainty_score":0.9997042},"labels":[],"label_agreement":null},{"id":"W2033185429","doi":"10.1111/j.1463-1326.2012.01673.x","title":"Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme","year":2012,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Novo Nordisk","keywords":"Liraglutide; Weight loss; Exenatide; Medicine; Placebo; Weight change; Sitagliptin; Internal medicine; Diabetes mellitus; Type 2 diabetes; Endocrinology; Gastroenterology; Obesity","score_opus":0.05835125910981301,"score_gpt":0.2946800038701167,"score_spread":0.23632874476030372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033185429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96661735,0.031393886,0.000021479438,0.00033699127,0.00010398114,0.0012921904,0.00011264844,0.00006188125,0.000059592683],"genre_scores_gemma":[0.9948625,0.00069607014,0.0024639496,0.00089578616,0.0003180018,0.0003030415,0.0003725253,0.000027319686,0.00006082405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977221,0.00031614583,0.00052696915,0.00039692177,0.0003626259,0.0006752521],"domain_scores_gemma":[0.99833626,0.00039197,0.00031922356,0.0004577568,0.00009650868,0.0003982632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015890403,0.00038476978,0.0015842061,0.0002581018,0.00020149423,0.000074272495,0.00014239957,0.000093503666,0.00007404606],"category_scores_gemma":[0.00007417102,0.00021812538,0.0001728562,0.0005378749,0.00022648153,0.00040788043,0.00010455837,0.00012578229,0.0000041442786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096489384,0.0017248956,0.9228727,0.000077745164,0.009267359,0.0000013654801,0.0061377767,3.207526e-7,0.0009032628,0.0003430037,0.000086535336,0.058488514],"study_design_scores_gemma":[0.0040419376,0.00023869838,0.93244874,0.00008640413,0.012875132,1.6867016e-7,0.00058806397,0.00017359786,0.009011773,0.000042800766,0.04021072,0.00028197665],"about_ca_topic_score_codex":0.00010631803,"about_ca_topic_score_gemma":0.00007096638,"teacher_disagreement_score":0.058206536,"about_ca_system_score_codex":0.000024860235,"about_ca_system_score_gemma":0.000034967565,"threshold_uncertainty_score":0.8894895},"labels":[],"label_agreement":null},{"id":"W2034171544","doi":"10.1111/j.1463-1326.2011.01362.x","title":"Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes","year":2011,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Sitagliptin; Postprandial; Type 2 diabetes; Internal medicine; Endocrinology; Diabetes mellitus; Insulin","score_opus":0.010168186497145333,"score_gpt":0.21106722708303688,"score_spread":0.20089904058589156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034171544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963792,0.0010188764,3.1605836e-7,0.000017479571,0.00013075938,0.0011748606,0.000015643447,0.000034201756,0.0012286619],"genre_scores_gemma":[0.9993324,0.000083091065,0.00016226522,0.00020003419,0.00004300415,0.000045458746,0.000037702204,0.000025420855,0.00007061294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987533,0.00011923782,0.00021149509,0.00029979803,0.0002542382,0.0003619161],"domain_scores_gemma":[0.9993667,0.00007892446,0.00009694513,0.00027307752,0.000071196715,0.000113182046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003583068,0.00026723673,0.0006507103,0.00022858074,0.000040610885,0.000011676348,0.000079877515,0.00008833625,0.000086644824],"category_scores_gemma":[0.000054115328,0.00017526721,0.00007208677,0.0002430268,0.000092899754,0.00011902811,0.00004067716,0.00012551872,0.000015714164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016642535,0.0010077833,0.94389594,0.00014540757,0.00028196882,0.0000028691845,0.00032773046,2.661626e-7,0.00046774885,0.0001502006,0.000014707984,0.052041125],"study_design_scores_gemma":[0.008641825,0.00905408,0.92472774,0.00014787682,0.00022807313,2.2703173e-8,0.000004068617,0.0000034425607,0.056641743,0.000056972942,0.00033152962,0.0001626001],"about_ca_topic_score_codex":0.000036425383,"about_ca_topic_score_gemma":0.0000043932373,"teacher_disagreement_score":0.056173995,"about_ca_system_score_codex":0.000014725951,"about_ca_system_score_gemma":0.000014283915,"threshold_uncertainty_score":0.71471894},"labels":[],"label_agreement":null},{"id":"W2037395799","doi":"10.1111/dom.12226","title":"Composite endpoints in trials of type‐2 diabetes","year":2013,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Sitagliptin; Medicine; Saxagliptin; Type 2 diabetes; Exenatide; Linagliptin; Dapagliflozin; Liraglutide; Vildagliptin; Internal medicine; Diabetes mellitus; Clinical trial; Randomized controlled trial; Endocrinology","score_opus":0.056287142802563854,"score_gpt":0.32216846093570106,"score_spread":0.2658813181331372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037395799","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07105812,0.9249426,2.9171792e-7,0.000027128111,0.00046418724,0.0023003172,0.00007880984,0.00004238865,0.001086124],"genre_scores_gemma":[0.0007044882,0.9968405,0.00048226223,0.00011320438,0.00019332446,0.0002112988,0.00044850545,0.00005796387,0.0009485032],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99668354,0.0004909037,0.0014218426,0.00054056884,0.00029856927,0.0005645656],"domain_scores_gemma":[0.99793345,0.00053286034,0.000693452,0.0005258927,0.00009687257,0.0002174973],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014615041,0.0006166949,0.0066670943,0.0007268054,0.000041301126,0.00004704395,0.00019321119,0.00036292372,0.00021601707],"category_scores_gemma":[0.00035635981,0.00044123182,0.00073080347,0.000515679,0.00013710312,0.00014466081,0.00021323857,0.00032577603,0.000112963055],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000059021727,0.0005675863,0.0048955875,0.024046866,0.0015292114,0.000006638185,0.000047347166,7.224058e-8,0.000044904053,0.00042826825,0.00077724643,0.96765035],"study_design_scores_gemma":[0.0014822262,0.0001123682,0.007564543,0.010606727,0.008388178,5.507367e-7,0.0000072308026,0.0000066984667,0.0002649669,0.00021212899,0.9709453,0.00040906528],"about_ca_topic_score_codex":0.000018450566,"about_ca_topic_score_gemma":0.000001712264,"teacher_disagreement_score":0.97016805,"about_ca_system_score_codex":0.000044497046,"about_ca_system_score_gemma":0.00008783441,"threshold_uncertainty_score":0.99980396},"labels":[],"label_agreement":null},{"id":"W2039664878","doi":"10.1111/j.1463-1326.2012.01637.x","title":"Effect of anti‐ <scp>IL</scp> ‐1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo‐controlled trial","year":2012,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Particle Physics","funders":"Novartis Pharmaceuticals Corporation; Novartis","keywords":"Medicine; Canakinumab; Metformin; Internal medicine; Placebo; Insulin; Sulfonylurea; Type 2 diabetes; Endocrinology; Diabetes mellitus; Impaired glucose tolerance; Insulin resistance","score_opus":0.008338072323909101,"score_gpt":0.2653110258040003,"score_spread":0.2569729534800912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039664878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97621745,0.017724076,0.0000046074824,0.00003166387,0.0008506588,0.0046574497,0.00012668493,0.000051989737,0.00033540462],"genre_scores_gemma":[0.99494517,0.0035012315,0.000074805146,0.000103925326,0.0007158067,0.00022312689,0.00023199813,0.000034301993,0.00016961402],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.995853,0.0012956496,0.001332273,0.00039655692,0.0004926728,0.0006298409],"domain_scores_gemma":[0.9949081,0.003277929,0.0007930331,0.000432904,0.00026855103,0.00031947627],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00434021,0.0004550167,0.0034632464,0.00050096604,0.00007880136,0.000022180187,0.00014187522,0.00024511307,0.0000208816],"category_scores_gemma":[0.011833052,0.00030456283,0.0004451256,0.0006033185,0.00029440393,0.00033228527,0.000047231275,0.00022643199,0.000007739571],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9118079,0.0017679649,0.048969068,0.0013858438,0.0008593886,0.0000053799126,0.0015209819,0.00005030944,0.027995318,0.00035555195,0.00013234893,0.005149973],"study_design_scores_gemma":[0.7630779,0.0008520812,0.15161292,0.00049780036,0.0017223065,8.1175557e-7,0.000044358054,0.00075940747,0.08012026,0.000044127195,0.0011151078,0.00015292126],"about_ca_topic_score_codex":0.000080141646,"about_ca_topic_score_gemma":0.000009186354,"teacher_disagreement_score":0.14872998,"about_ca_system_score_codex":0.000021074206,"about_ca_system_score_gemma":0.00016258997,"threshold_uncertainty_score":0.99994063},"labels":[],"label_agreement":null},{"id":"W2040535327","doi":"10.1111/j.1463-1326.2005.00556.x","title":"Reduced left ventricular mass after treatment of obese patients with sibutramine: an echocardiographic multicentre study","year":2006,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton General Hospital","funders":"","keywords":"Sibutramine; Medicine; Placebo; Blood pressure; Body mass index; Cardiology; Internal medicine; Heart rate; Body surface area; Obesity; Weight loss; Left ventricular hypertrophy; Endocrinology","score_opus":0.004058364162573455,"score_gpt":0.21969718355831136,"score_spread":0.2156388193957379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040535327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431086,0.0039344262,0.000003265692,0.000035441528,0.000117857344,0.0014402971,0.00007032977,0.000049952523,0.000037583857],"genre_scores_gemma":[0.9990227,0.0001475651,0.00031881052,0.00006153091,0.000102691214,0.0000728444,0.00016675741,0.000021000216,0.00008604826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984775,0.0001560756,0.0002710803,0.00042932472,0.0002825101,0.00038349652],"domain_scores_gemma":[0.999153,0.0000370617,0.00010217806,0.0003399783,0.00015448421,0.00021326085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106310166,0.00031525083,0.0007122579,0.00020885485,0.00010817145,0.000015441421,0.000055616147,0.00011158578,0.000040910887],"category_scores_gemma":[0.000007347101,0.000220431,0.00014945756,0.00020853616,0.00011976553,0.00014490126,0.000019910063,0.000093731396,0.0000047422204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040656788,0.014548622,0.9816596,0.000057689165,0.00073372974,0.00013967526,0.000349601,0.000011080271,0.0010781613,0.0000054506936,0.000009271378,0.0010005843],"study_design_scores_gemma":[0.012229861,0.0016149192,0.9699164,0.00003428041,0.0031677096,0.0000020798268,0.00008532812,0.000026640137,0.012340418,0.000042533455,0.00033953082,0.00020030854],"about_ca_topic_score_codex":0.000099812416,"about_ca_topic_score_gemma":0.000044530276,"teacher_disagreement_score":0.012933703,"about_ca_system_score_codex":0.00004158194,"about_ca_system_score_gemma":0.000030737123,"threshold_uncertainty_score":0.89889157},"labels":[],"label_agreement":null},{"id":"W2041239330","doi":"10.1111/j.1463-1326.2011.01404.x","title":"High‐density lipoprotein‐cholesterol and not HbA1c was directly related to cardiovascular outcome in PROactive","year":2011,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Eli Lilly and Company","keywords":"Pioglitazone; Medicine; Internal medicine; Blood pressure; Myocardial infarction; Post-hoc analysis; Type 2 diabetes; Cholesterol; Placebo; Cardiology; Stroke (engine); Diabetes mellitus; Endocrinology","score_opus":0.018707300552375503,"score_gpt":0.22895393290745122,"score_spread":0.21024663235507574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041239330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916198,0.005514488,0.00003357272,0.00023904417,0.00023886758,0.0018281819,0.000016133854,0.00009330332,0.000416563],"genre_scores_gemma":[0.9966193,0.00063466135,0.001479566,0.00079246535,0.00013118908,0.00013933984,0.000010517828,0.000040930827,0.00015206888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974555,0.0002682908,0.0004525055,0.00073593255,0.0005079232,0.0005798491],"domain_scores_gemma":[0.99849933,0.000024923253,0.00007121352,0.00077824807,0.00012946152,0.0004968348],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016468255,0.00034514308,0.0014073018,0.00026402698,0.00014514911,0.000034227356,0.00010207855,0.00026675384,0.000016437933],"category_scores_gemma":[0.00016089738,0.00029556485,0.0003608275,0.00036645148,0.00011635653,0.00021533167,0.00017542056,0.00048751163,0.000024471306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003546482,0.0006779708,0.49529034,0.0010032672,0.0036389704,0.00021796855,0.005862459,0.000005459772,0.004676931,0.0015645394,0.000022373048,0.48668507],"study_design_scores_gemma":[0.0025433232,0.00011538355,0.9536745,0.0000951464,0.00070281624,0.000025279816,0.00008109479,0.000009267999,0.040102735,0.0003427687,0.0019950664,0.0003125994],"about_ca_topic_score_codex":0.0062900046,"about_ca_topic_score_gemma":0.00013067917,"teacher_disagreement_score":0.48637247,"about_ca_system_score_codex":0.0000497236,"about_ca_system_score_gemma":0.00004860981,"threshold_uncertainty_score":0.99994963},"labels":[],"label_agreement":null},{"id":"W2041310907","doi":"10.1111/j.1463-1326.2012.01613.x","title":"Factors influencing initial choice of insulin therapy in a large international non‐interventional study of people with type 2 diabetes","year":2012,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sanofi","keywords":"Type 2 diabetes; Medicine; Insulin; Diabetes mellitus; Internal medicine; Endocrinology","score_opus":0.15798927200610685,"score_gpt":0.38128961406848283,"score_spread":0.22330034206237598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041310907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959045,0.0027803443,0.000017229017,0.000120008764,0.00044253597,0.00042925953,0.0001768717,0.000008821423,0.0001204052],"genre_scores_gemma":[0.99931437,0.00006876294,0.00010685646,0.00026227915,0.00015071098,0.000032652955,0.00003546282,0.000014479447,0.000014454984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976087,0.00017460066,0.001554438,0.00023795696,0.00011349803,0.00031077358],"domain_scores_gemma":[0.9981823,0.00039942333,0.0010344193,0.00018911809,0.00010116491,0.00009359498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038231083,0.00015365983,0.0008511939,0.0003904349,0.000056169578,0.000020509753,0.00017845388,0.00008040056,0.00017231893],"category_scores_gemma":[0.0007181804,0.00015568043,0.0000659938,0.00024290777,0.000041455853,0.00062255864,0.000067022076,0.00013143977,0.000012377474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009974302,0.0012931738,0.98835564,0.000099345605,0.00014019795,3.0550094e-8,0.008495961,0.000015961974,0.000025227917,0.0014753458,0.000022805028,0.00006633747],"study_design_scores_gemma":[0.0018604274,0.00018379919,0.99477047,0.000055433327,0.0000107153755,4.455046e-8,0.0016451991,0.0002105348,0.0001815411,0.00023655228,0.0006973578,0.00014792653],"about_ca_topic_score_codex":0.000714552,"about_ca_topic_score_gemma":0.00033485418,"teacher_disagreement_score":0.0068507628,"about_ca_system_score_codex":0.000047293113,"about_ca_system_score_gemma":0.00003741772,"threshold_uncertainty_score":0.6348464},"labels":[],"label_agreement":null},{"id":"W2041447975","doi":"10.1111/j.1463-1326.2009.01157.x","title":"Modulation of nutrient sensing nuclear hormone receptors promotes weight loss through appetite suppression in mice","year":2009,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Endocrinology; Internal medicine; Agonist; Receptor; Nuclear receptor; Appetite; Peroxisome proliferator-activated receptor; Knockout mouse; Weight loss; Chemistry; Activator (genetics); Biology; Medicine; Transcription factor; Obesity; Biochemistry","score_opus":0.005075044985849484,"score_gpt":0.20881025495313071,"score_spread":0.20373520996728123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041447975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960572,0.0032077304,0.00008566724,0.00015411706,0.00016067963,0.00022210534,0.000012411131,0.00001722609,0.00008282173],"genre_scores_gemma":[0.99613655,0.0017828915,0.0016997029,0.00012771013,0.00014002339,0.0000019282436,0.000074339034,0.000017153543,0.000019710611],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988577,0.00011256756,0.00025697157,0.00035422624,0.00014088498,0.00027766923],"domain_scores_gemma":[0.99953353,0.000010104922,0.00012343877,0.00018964999,0.0000723114,0.00007096332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017628752,0.00018897928,0.00028872705,0.00007719202,0.000076656244,0.000018819863,0.00009743869,0.00023114118,0.000006293144],"category_scores_gemma":[0.00006666102,0.00017499534,0.00006365439,0.00017884551,0.00008721448,0.000030113024,0.00006924722,0.0001359913,0.0000020743478],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059778733,0.00016703637,0.006469121,0.000024787612,0.000023453016,5.9909496e-7,0.00029870583,0.000013004288,0.98960155,0.000119009565,0.00011571257,0.0031072465],"study_design_scores_gemma":[0.0007107062,0.00009783602,0.04984078,0.0000651049,0.000018457946,0.0000014294518,0.000027172377,0.00020592907,0.9402792,0.00051617273,0.008036345,0.00020088685],"about_ca_topic_score_codex":0.000013647826,"about_ca_topic_score_gemma":0.0000013033994,"teacher_disagreement_score":0.04932237,"about_ca_system_score_codex":0.000010869587,"about_ca_system_score_gemma":0.000017379305,"threshold_uncertainty_score":0.7136103},"labels":[],"label_agreement":null},{"id":"W2043193063","doi":"10.1111/j.1463-1326.2007.00811.x","title":"Effect of chronic rosiglitazone, metformin and glyburide treatment on β‐cell mass, function and insulin sensitivity in mZDF rats","year":2007,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"Mitacs","keywords":"Rosiglitazone; Internal medicine; Endocrinology; Metformin; Insulin; Medicine; Diabetes mellitus","score_opus":0.005642407623199774,"score_gpt":0.22515794906489622,"score_spread":0.21951554144169644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043193063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817474,0.016913136,0.00003788587,0.000036242945,0.00014469812,0.00050745,0.000014119902,0.00002965237,0.00056940917],"genre_scores_gemma":[0.997782,0.0016793456,0.00011928491,0.000121636025,0.00011314006,0.000014603343,0.000021641095,0.000013720716,0.00013462795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988048,0.00013533332,0.0002626956,0.0003232466,0.00015811811,0.0003158056],"domain_scores_gemma":[0.9989391,0.0005683914,0.000087523986,0.00017403737,0.000033830023,0.00019711198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011566691,0.00024759237,0.0007126779,0.0002441842,0.000066896006,0.000014694772,0.000014655405,0.00014129716,0.000011490233],"category_scores_gemma":[0.00013731161,0.00018616286,0.00006335048,0.00017992368,0.00012388373,0.000111261565,0.00002227234,0.00013847499,0.000004298281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001046013,0.0005853276,0.47814405,0.00072089006,0.00014122097,0.000024463408,0.00020248975,0.0000051215916,0.3920081,0.00033984933,0.000022365359,0.12676011],"study_design_scores_gemma":[0.0046101576,0.0019220823,0.54300857,0.00009010022,0.00034366595,0.0000027889691,0.000024065883,0.00024681332,0.44888172,0.00010316768,0.00064749236,0.00011939364],"about_ca_topic_score_codex":0.00011576134,"about_ca_topic_score_gemma":0.000034726516,"teacher_disagreement_score":0.12664072,"about_ca_system_score_codex":0.000062330466,"about_ca_system_score_gemma":0.00003324756,"threshold_uncertainty_score":0.7591501},"labels":[],"label_agreement":null},{"id":"W2043551382","doi":"10.1111/dom.12456","title":"Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer","year":2015,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Heritage Foundation for Medical Research","keywords":"Observational study; Medicine; Adverse effect; Confounding; Intensive care medicine; Clinical trial; Diabetes mellitus; Randomized controlled trial; Internal medicine; Endocrinology","score_opus":0.01702600455774621,"score_gpt":0.2704242773177059,"score_spread":0.2533982727599597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043551382","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036347922,0.9603063,0.0000052500804,0.000003919524,0.00035118233,0.0016415523,0.00031455173,0.000042153555,0.0009871651],"genre_scores_gemma":[0.0037615157,0.9944835,0.0003080658,0.000054075615,0.00023157294,0.00005271646,0.00046667352,0.00006861897,0.00057326956],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974159,0.0002478274,0.0007386798,0.00055827235,0.0006118409,0.00042749802],"domain_scores_gemma":[0.9979486,0.000085956504,0.0004497351,0.000965418,0.00023168657,0.0003185968],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009823544,0.0005167273,0.0055616084,0.00030952334,0.000031677027,0.000020971605,0.00020142327,0.0003481786,0.000041651034],"category_scores_gemma":[0.000105259445,0.00042528904,0.001241793,0.00027375037,0.00023956156,0.00016466364,0.00014728395,0.00023364434,0.000009194587],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058065387,0.0005787691,0.0030530216,0.010359551,0.009036232,0.000018688124,0.00014805913,5.49502e-7,0.000004821761,0.0004994665,0.00039155927,0.97585124],"study_design_scores_gemma":[0.0031779106,0.00018440138,0.014039089,0.0028075196,0.02563103,0.0000020936395,0.000027552576,0.0000030063575,0.000019613724,0.000044859025,0.9537234,0.00033953367],"about_ca_topic_score_codex":0.00012067061,"about_ca_topic_score_gemma":0.0000042980823,"teacher_disagreement_score":0.97551167,"about_ca_system_score_codex":0.0000492131,"about_ca_system_score_gemma":0.0001767039,"threshold_uncertainty_score":0.9998199},"labels":[],"label_agreement":null},{"id":"W2045272891","doi":"10.1111/j.1463-1326.2012.01658.x","title":"Short‐term intensified insulin treatment in type 2 diabetes: long‐term effects on β‐cell function","year":2012,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Glycemic; Natural history; Context (archaeology); Insulin; Type 2 diabetes; Diabetes mellitus; Term (time); Intensive care medicine; Type 2 Diabetes Mellitus; Endocrinology; Internal medicine","score_opus":0.03544990856842906,"score_gpt":0.2801399588414883,"score_spread":0.24469005027305923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045272891","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36788443,0.62879926,8.356735e-7,0.000009943827,0.0013314129,0.0012959532,0.000024444838,0.00008599151,0.00056777056],"genre_scores_gemma":[0.05822447,0.9382526,0.00003279724,0.00049669953,0.0009801924,0.00032055244,0.0007557211,0.000105160834,0.00083176745],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968009,0.00037466252,0.00074758736,0.0008236207,0.00033501943,0.00091818813],"domain_scores_gemma":[0.9977653,0.0005897179,0.00023936124,0.0007309849,0.00011192781,0.00056271005],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004252348,0.0009980837,0.003670769,0.0007339242,0.00011567065,0.00006611602,0.0001307737,0.0007407854,0.000102729515],"category_scores_gemma":[0.00019110196,0.0007280587,0.000562446,0.0005821792,0.000108364875,0.00016111271,0.00008648839,0.000646883,0.00035635818],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060076054,0.0010487012,0.04420953,0.014858652,0.00054073514,0.000018231603,0.00010671934,7.596112e-8,0.00009042399,0.000030151312,0.00009244173,0.9389443],"study_design_scores_gemma":[0.0032399534,0.0011876301,0.44150904,0.011548991,0.013279339,0.0000049884816,0.000011726814,0.0000064306782,0.0010551444,0.000026368682,0.5270581,0.0010722806],"about_ca_topic_score_codex":0.000009346663,"about_ca_topic_score_gemma":0.0000034325028,"teacher_disagreement_score":0.937872,"about_ca_system_score_codex":0.00022413202,"about_ca_system_score_gemma":0.0001570959,"threshold_uncertainty_score":0.999517},"labels":[],"label_agreement":null},{"id":"W2045790951","doi":"10.1111/dom.12348","title":"Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease","year":2014,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":275,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"American Heart Association","keywords":"Canagliflozin; Medicine; Placebo; Internal medicine; Kidney disease; Renal function; Diabetes mellitus; Empagliflozin; Urology; Type 2 diabetes; Endocrinology; Gastroenterology; Pathology","score_opus":0.003466919050973172,"score_gpt":0.19398320196770036,"score_spread":0.19051628291672718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045790951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99028516,0.008497312,0.0000015601761,0.00015890982,0.0000871281,0.0006536363,0.00003814537,0.000023572255,0.00025458873],"genre_scores_gemma":[0.99797654,0.0011365133,0.0001095305,0.00044642444,0.000056445075,0.000015574667,0.00012227814,0.000021332096,0.00011536965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987628,0.000063736465,0.00022472348,0.00036538666,0.00020925891,0.00037408117],"domain_scores_gemma":[0.99907774,0.00007780388,0.000084403,0.00026242563,0.00005735213,0.00044026357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020246912,0.00024285875,0.0005730134,0.00016734443,0.000063586805,0.000025379708,0.000052658277,0.0000624087,0.000028935745],"category_scores_gemma":[0.00011565827,0.00018596888,0.000031826432,0.00018405683,0.00018333198,0.00014099226,0.00010265204,0.00010274785,0.0000020530547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020585043,0.00042342083,0.9758973,0.0004885362,0.00022019462,0.0000012625839,0.000082736915,0.0000017893774,0.00009671232,0.0007647573,0.00012390417,0.021693528],"study_design_scores_gemma":[0.0090422025,0.0003838558,0.9764097,0.0002571011,0.0007372312,2.4046589e-8,0.000004533543,0.00015420253,0.0003162583,0.00013649391,0.012363429,0.0001949736],"about_ca_topic_score_codex":0.000051209965,"about_ca_topic_score_gemma":0.000027835653,"teacher_disagreement_score":0.021498553,"about_ca_system_score_codex":0.000028253326,"about_ca_system_score_gemma":0.00004824515,"threshold_uncertainty_score":0.7583591},"labels":[],"label_agreement":null},{"id":"W2047199620","doi":"10.1111/dom.12391","title":"Randomized trial showing efficacy and safety of twice‐daily remogliflozin etabonate for the treatment of type 2 diabetes","year":2014,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"GlaxoSmithKline","keywords":"Placebo; Tolerability; Pioglitazone; Medicine; Type 2 diabetes; Randomized controlled trial; Clinical endpoint; Internal medicine; Diabetes mellitus; Adverse effect; Endocrinology","score_opus":0.016460300769629517,"score_gpt":0.25187791448215346,"score_spread":0.23541761371252395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047199620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977327,0.018109096,0.000047161924,0.0003834631,0.00040723546,0.0032388624,0.000023261038,0.00002964068,0.0004342978],"genre_scores_gemma":[0.9918148,0.006079913,0.0009666876,0.00018063815,0.0002550961,0.00015181323,0.000047773086,0.00002520515,0.00047807736],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99847275,0.00017601538,0.00050112815,0.00031115543,0.00020240078,0.00033654424],"domain_scores_gemma":[0.9974291,0.0017514168,0.00022537833,0.00035311084,0.00012490786,0.000116137286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011031207,0.00027590882,0.0014996213,0.00013023404,0.00012558782,0.000023337885,0.00008503221,0.00009205731,0.000015929174],"category_scores_gemma":[0.00042558482,0.00016375678,0.00029502015,0.00015574499,0.00030609762,0.0000773084,0.000046889574,0.00005643979,0.0000013229832],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47273666,0.0039873994,0.020324444,0.0012400163,0.008525568,0.0000011926942,0.0024891135,0.000018051682,0.0075334087,0.01666667,0.00024033172,0.46623716],"study_design_scores_gemma":[0.8883967,0.001896066,0.04271041,0.0001323895,0.0072350944,1.3877214e-7,0.00004802019,0.0016508809,0.011836838,0.0007254557,0.045140192,0.00022783493],"about_ca_topic_score_codex":0.000019401887,"about_ca_topic_score_gemma":0.0000024162484,"teacher_disagreement_score":0.46600932,"about_ca_system_score_codex":0.000013463143,"about_ca_system_score_gemma":0.000022694947,"threshold_uncertainty_score":0.66778076},"labels":[],"label_agreement":null},{"id":"W2048930008","doi":"10.1111/j.1463-1326.2009.01114.x","title":"Lipid receptors and islet function: therapeutic implications?","year":2009,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Diabetes Canada","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research","keywords":"Free fatty acid receptor 1; Receptor; G protein-coupled receptor; Enteroendocrine cell; Insulin; Secretion; Biology; Cell biology; Beta cell; Endocrinology; Islet; Internal medicine; Hormone; Agonist; Endocrine system; Biochemistry; Medicine","score_opus":0.03198999510827581,"score_gpt":0.2871956774012498,"score_spread":0.25520568229297397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048930008","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022241436,0.99391794,0.000016518123,0.0002822362,0.000564176,0.0007651323,0.00003363635,0.00013508293,0.0020611438],"genre_scores_gemma":[0.00022360595,0.99483305,0.00018414206,0.0018704679,0.0008624199,0.000107804284,0.00022567934,0.000040788058,0.0016520584],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982326,0.00015448821,0.0004710408,0.00057981716,0.00017544141,0.00038662745],"domain_scores_gemma":[0.9986674,0.00022409073,0.00021317133,0.00047569166,0.00008943472,0.00033020414],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032527614,0.0004935276,0.0020870531,0.00028574048,0.00021176723,0.000079096695,0.00008569119,0.00041392513,0.00019752982],"category_scores_gemma":[0.00011111022,0.00037416344,0.0003150407,0.00038064335,0.00015258894,0.0001188097,0.000052345134,0.00041609857,0.00008227823],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000054503557,0.00010783982,0.00073302083,0.0031744493,0.00034597525,4.5561848e-7,0.000020913185,9.648795e-9,0.000009821811,0.0014976327,0.0020546513,0.99204975],"study_design_scores_gemma":[0.00050580385,0.00010201478,0.013424781,0.0016271946,0.005056022,0.000015172168,0.000007927635,0.0000015798857,0.00000931763,0.00054977846,0.9783653,0.0003351011],"about_ca_topic_score_codex":0.0000036267468,"about_ca_topic_score_gemma":2.3709782e-7,"teacher_disagreement_score":0.99171466,"about_ca_system_score_codex":0.000027829254,"about_ca_system_score_gemma":0.00011706812,"threshold_uncertainty_score":0.999871},"labels":[],"label_agreement":null},{"id":"W2049014431","doi":"10.1111/j.1463-1326.2009.01130.x","title":"Dietary supplementation of n‐3 PUFA reduces weight gain and improves postprandial lipaemia and the associated inflammatory response in the obese JCR:LA‐cp rat","year":2009,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Heart and Stroke Foundation of Canada","keywords":"Postprandial; Polyunsaturated fatty acid; Internal medicine; Endocrinology; Medicine; Weight gain; Food science; Body weight; Chemistry; Biochemistry; Fatty acid; Diabetes mellitus","score_opus":0.008729512213517438,"score_gpt":0.2680526397257535,"score_spread":0.2593231275122361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049014431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823485,0.008314553,5.264373e-7,0.008455536,0.00013006918,0.0006345203,0.000038035323,0.000015170831,0.00006306345],"genre_scores_gemma":[0.9964161,0.0023969978,0.00008886162,0.0009237219,0.0001000023,0.00002078764,0.0000320989,0.0000084465555,0.00001301637],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99663925,0.0020911915,0.00032957247,0.00023660235,0.00029833918,0.00040505984],"domain_scores_gemma":[0.9982137,0.0013232594,0.0001359908,0.00016838561,0.000056314428,0.00010237076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004419465,0.00016930138,0.00036978567,0.00015615896,0.00033954086,0.00011265897,0.00014870656,0.00012424774,0.000005718928],"category_scores_gemma":[0.0007656613,0.00010388002,0.00005198828,0.00020813291,0.00046180066,0.00029276495,0.000049806506,0.00037421446,6.1581574e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028757585,0.00082887086,0.14849335,0.00044569062,0.0001909811,0.000022679618,0.05809934,0.0000030923343,0.6817469,0.0020590492,0.0020587884,0.07729369],"study_design_scores_gemma":[0.0044077975,0.00036669997,0.9550678,0.00006981363,0.00006845689,0.0000018296154,0.00088344887,0.0001643874,0.035698675,0.0026181408,0.00052411837,0.00012884622],"about_ca_topic_score_codex":0.00013344,"about_ca_topic_score_gemma":0.0000991652,"teacher_disagreement_score":0.8065744,"about_ca_system_score_codex":0.000018321392,"about_ca_system_score_gemma":0.00005003164,"threshold_uncertainty_score":0.42361042},"labels":[],"label_agreement":null},{"id":"W2049459857","doi":"10.1111/j.1463-1326.2005.00503.x","title":"Degradation in insulin sensitivity with increasing severity of the metabolic syndrome in obese postmenopausal women","year":2005,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Université de Montréal","funders":"Canadian Institutes of Health Research; University of Ottawa","keywords":"Metabolic syndrome; Internal medicine; Endocrinology; Insulin resistance; Medicine; Insulin; Insulin sensitivity; Homeostasis; Obesity; Postmenopausal women; Blood pressure; Glucose clamp technique; Glucose homeostasis","score_opus":0.004994784289080499,"score_gpt":0.1951152510699209,"score_spread":0.19012046678084038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049459857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99175936,0.0070512816,0.0000060284838,0.00022886344,0.00006142263,0.0007011434,0.000026346279,0.000027129321,0.00013840242],"genre_scores_gemma":[0.9982623,0.00047257947,0.000758447,0.00031323612,0.0000790019,0.00004219087,0.00001382767,0.00002305559,0.00003536687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997853,0.0005481016,0.0003539573,0.0003551925,0.00040795404,0.0004818431],"domain_scores_gemma":[0.99910545,0.000101888196,0.00012338726,0.00043693685,0.000085321764,0.00014700857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002016182,0.00024673637,0.0009857725,0.00026507772,0.000071606424,0.000023764993,0.000089255984,0.00013673177,0.000010439437],"category_scores_gemma":[0.00028509204,0.00017729586,0.00010536372,0.0006846982,0.00018724083,0.0003274206,0.00009900074,0.00037607594,0.000003419068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020361251,0.00096071605,0.79628,0.00022617073,0.00031627834,0.000044159937,0.0016172396,0.000077322286,0.0038623086,0.00024128189,0.000002408987,0.19616848],"study_design_scores_gemma":[0.0026239774,0.000064290856,0.98441863,0.0001735607,0.00018938369,0.00005018679,0.00010897146,0.0002075537,0.010321654,0.00010577758,0.0015398574,0.0001961412],"about_ca_topic_score_codex":0.004651996,"about_ca_topic_score_gemma":0.0026751142,"teacher_disagreement_score":0.19597234,"about_ca_system_score_codex":0.00006879067,"about_ca_system_score_gemma":0.000111765876,"threshold_uncertainty_score":0.7229915},"labels":[],"label_agreement":null},{"id":"W2051243940","doi":"10.1111/dom.12188","title":"Empagliflozin improves glycaemic and weight control as add‐on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24‐week, randomized, placebo‐controlled trial","year":2013,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":383,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Empagliflozin; Metformin; Pioglitazone; Placebo; Medicine; Type 2 diabetes; Tolerability; Internal medicine; Clinical endpoint; Urology; Diabetes mellitus; Adverse effect; Randomized controlled trial; Gastroenterology; Endocrinology","score_opus":0.0066711662358415694,"score_gpt":0.21346407052343266,"score_spread":0.2067929042875911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051243940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974837,0.0055330144,0.000006032947,0.00047277665,0.00051917863,0.017946012,0.000027141585,0.000100659774,0.0005581555],"genre_scores_gemma":[0.98976773,0.0008733971,0.0004703104,0.0029268204,0.0002651197,0.0032568672,0.00007533028,0.00007396014,0.002290467],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99647814,0.00036658664,0.0007834418,0.00082632346,0.0005789395,0.0009665661],"domain_scores_gemma":[0.99760365,0.0008280604,0.00026072178,0.0005247347,0.00023497584,0.0005478734],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009632438,0.0007344482,0.0030548621,0.0006350843,0.0001540515,0.00015838415,0.00017551589,0.00021513755,0.00024429074],"category_scores_gemma":[0.0006251048,0.0004302123,0.000237648,0.00047658524,0.00022910407,0.0004345422,0.00010042459,0.00029881526,0.000091238515],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9508849,0.002592302,0.0155211445,0.00013214855,0.0028104726,0.0000106617035,0.00073870627,0.00000334299,0.0004203028,0.0003052213,0.00081577065,0.025765037],"study_design_scores_gemma":[0.93658453,0.005688675,0.052021485,0.00019798422,0.0014476231,2.8883255e-7,0.00008536812,0.00024753142,0.00060006883,0.0003489496,0.0022364338,0.0005410432],"about_ca_topic_score_codex":0.000113775444,"about_ca_topic_score_gemma":0.000022583734,"teacher_disagreement_score":0.036500342,"about_ca_system_score_codex":0.00008891771,"about_ca_system_score_gemma":0.000093078546,"threshold_uncertainty_score":0.999815},"labels":[],"label_agreement":null},{"id":"W2052854039","doi":"10.1111/j.1463-1326.2005.00540.x","title":"Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trial","year":2005,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Population Health Research Institute; University Health Network; Hamilton Health Sciences; University of Toronto; Western University","funders":"","keywords":"Medicine; Metformin; Rosiglitazone; Impaired glucose tolerance; Diabetes mellitus; Type 2 diabetes; Internal medicine; Population; Context (archaeology); Insulin resistance; Placebo; Randomized controlled trial; Physical therapy; Endocrinology; Environmental health; Alternative medicine","score_opus":0.032253905362539456,"score_gpt":0.3165672046368674,"score_spread":0.2843132992743279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052854039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88208187,0.11645432,0.00013268048,0.000052737236,0.0004756501,0.00074024167,0.000010631334,0.0000057355437,0.00004612278],"genre_scores_gemma":[0.9898507,0.0035659105,0.0056935544,0.00048747324,0.00025707282,0.000040448445,0.00002494786,0.000022204269,0.000057717883],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99810064,0.0007320111,0.0002876393,0.00031235098,0.00022951509,0.0003378298],"domain_scores_gemma":[0.9990873,0.000060013725,0.00019969027,0.00029091313,0.00024007756,0.00012206076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021578688,0.00020338355,0.00035422746,0.00008856169,0.00028689078,0.0000570387,0.00016772228,0.00019325924,0.000022646245],"category_scores_gemma":[0.00035073332,0.00015721889,0.000097082106,0.00016828312,0.00013735674,0.000027096687,0.00007479286,0.000111596935,4.2318158e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020474143,0.00017845209,0.06811602,0.000059402453,0.00039252534,5.5701435e-8,0.00036875665,0.00033831716,0.1438689,0.00038883262,0.00016008267,0.7859239],"study_design_scores_gemma":[0.013352227,0.00015857727,0.19644278,0.000040209674,0.00056468166,4.3896898e-7,0.00003064679,0.00698347,0.7207589,0.0013129269,0.059847325,0.000507813],"about_ca_topic_score_codex":0.0007522951,"about_ca_topic_score_gemma":0.0011238762,"teacher_disagreement_score":0.7854161,"about_ca_system_score_codex":0.00002849365,"about_ca_system_score_gemma":0.00030209433,"threshold_uncertainty_score":0.64112},"labels":[],"label_agreement":null},{"id":"W2053986195","doi":"10.1111/j.1463-1326.2005.00483.x","title":"X‐PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced‐energy diet. Early response to treatment predicts weight maintenance","year":2005,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Orlistat; Weight loss; Reduction (mathematics); Energy expenditure; Medicine; Obesity; Internal medicine; Mathematics","score_opus":0.012144126247191632,"score_gpt":0.24892018903349084,"score_spread":0.2367760627862992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053986195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99022955,0.0035491888,0.000028835932,0.0046194745,0.00027253033,0.0007939342,0.00003706046,0.00012160958,0.0003478153],"genre_scores_gemma":[0.98726726,0.002506111,0.0018728488,0.0016265647,0.0004044922,0.00030817822,0.000032049385,0.00004777206,0.005934733],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99729973,0.0003497235,0.00040141842,0.00082327134,0.00028561882,0.0008402075],"domain_scores_gemma":[0.99870396,0.00013670935,0.00011048046,0.00040494607,0.00014321775,0.0005006987],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004271076,0.0004995456,0.00085010164,0.0004064066,0.00027170783,0.000050419472,0.00011916454,0.0002196566,0.00005610438],"category_scores_gemma":[0.00009791377,0.0003377732,0.000100785364,0.0005498123,0.00015729749,0.00040492206,0.00006267492,0.00025163338,0.000027146654],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2509142,0.02111973,0.18826136,0.0005677751,0.003832304,0.003155088,0.032884162,0.0009875163,0.3516735,0.0016412451,0.00899367,0.13596946],"study_design_scores_gemma":[0.011621958,0.0030010175,0.76546466,0.000507692,0.0007421368,0.00009820371,0.00009724543,0.00057837524,0.169705,0.00013603846,0.047459286,0.0005883726],"about_ca_topic_score_codex":0.00019758704,"about_ca_topic_score_gemma":0.0004030637,"teacher_disagreement_score":0.57720333,"about_ca_system_score_codex":0.0003940819,"about_ca_system_score_gemma":0.00028357597,"threshold_uncertainty_score":0.99990743},"labels":[],"label_agreement":null},{"id":"W2055789597","doi":"10.1111/j.1463-1326.2011.01469.x","title":"The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern","year":2011,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Type 2 diabetes; Diabetes mellitus; Insulin; Value (mathematics); Medicine; Endocrinology; Computer science","score_opus":0.04938534273080385,"score_gpt":0.30595648186038643,"score_spread":0.25657113912958257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055789597","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014893397,0.9803122,0.000005633185,0.000032322747,0.00020836307,0.003578666,0.000098249104,0.000025798774,0.00084536505],"genre_scores_gemma":[0.0013757382,0.995566,0.00023136123,0.000031905725,0.00015207838,0.00044608486,0.0004090496,0.000055952856,0.0017318139],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99799985,0.00016521793,0.0005840049,0.00043279817,0.00025089367,0.0005672266],"domain_scores_gemma":[0.9983001,0.0004263203,0.00034558537,0.0005301774,0.00027164575,0.00012619112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011715861,0.0003430834,0.001728148,0.00025473555,0.0001723407,0.00003870121,0.00029112317,0.00024197847,0.000032746655],"category_scores_gemma":[0.00024879916,0.00019726813,0.00019998306,0.0006531288,0.00027100483,0.00008256661,0.00012722045,0.00035082217,0.000017478947],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006523468,0.00025036765,0.0030878026,0.024929127,0.00044567217,6.560069e-7,0.00020881562,1.5764209e-7,0.0000054365823,0.0011897975,0.00020524373,0.9696117],"study_design_scores_gemma":[0.0009529551,0.00023579916,0.01414824,0.003447759,0.0019143946,2.4129014e-7,0.00004206453,0.000041577812,0.00004541757,0.00009303048,0.97882503,0.0002535065],"about_ca_topic_score_codex":0.000014808056,"about_ca_topic_score_gemma":0.000031608004,"teacher_disagreement_score":0.97861975,"about_ca_system_score_codex":0.000038174407,"about_ca_system_score_gemma":0.0002759993,"threshold_uncertainty_score":0.8044361},"labels":[],"label_agreement":null},{"id":"W2057340863","doi":"10.1111/j.1463-1326.2011.01476.x","title":"Long in the shade, glucagon re‐occupies centre court","year":2011,"lang":"en","type":"editorial","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"Servier","keywords":"Glucagon; Political science; Medicine; Internal medicine; Insulin","score_opus":0.011931717840016485,"score_gpt":0.23642520831703215,"score_spread":0.22449349047701567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057340863","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6089944,0.016705776,0.000002439066,0.0005476535,0.36535448,0.00072582206,0.00016660155,0.000103894425,0.007398897],"genre_scores_gemma":[0.09698115,0.0071645947,0.00023485713,0.0033432476,0.88526285,0.00012516591,0.001544432,0.00012490923,0.005218799],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974972,0.00018476913,0.0004328521,0.0005578316,0.0007144324,0.00061293994],"domain_scores_gemma":[0.99808884,0.0007542225,0.00019773279,0.00059571036,0.00018786099,0.00017561512],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00093565194,0.00048072456,0.0011435045,0.00028051052,0.0001500739,0.000097924196,0.0002698586,0.00083728856,0.0002544398],"category_scores_gemma":[0.0013912007,0.0003268212,0.00021364952,0.00028925465,0.00022100711,0.00015426335,0.00009942766,0.0011241616,0.00008588156],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007242144,0.00035502922,0.045800254,0.0005111463,0.00018030469,0.000030626445,0.001157925,1.2708853e-7,0.00006404981,0.00031476197,0.94995517,0.001558199],"study_design_scores_gemma":[0.0016493957,0.00004873124,0.15676695,0.00032713293,0.00085086067,9.33415e-7,0.0002631121,0.000013136677,0.0003938302,0.00039619367,0.8389649,0.0003248175],"about_ca_topic_score_codex":0.00023450285,"about_ca_topic_score_gemma":0.0000723445,"teacher_disagreement_score":0.51990837,"about_ca_system_score_codex":0.000033235065,"about_ca_system_score_gemma":0.00018163238,"threshold_uncertainty_score":0.9999184},"labels":[],"label_agreement":null},{"id":"W2059296389","doi":"10.1111/j.1463-1326.2008.00895.x","title":"PROCEED: Prospective Obesity Cohort of Economic Evaluation and Determinants: baseline health and healthcare utilization of the US sample*","year":2008,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"Sanofi","keywords":"Medicine; Overweight; Body mass index; Prospective cohort study; Waist; Obesity; Abdominal obesity; Cohort; Population; Internal medicine; Demography; Environmental health","score_opus":0.03108563416204404,"score_gpt":0.3229494165215878,"score_spread":0.2918637823595438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059296389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858888,0.012160338,0.00000933987,0.00036871442,0.00008777378,0.0013655317,0.00009208061,0.000011693533,0.000015743384],"genre_scores_gemma":[0.993915,0.0052897385,0.00021849936,0.0004494033,0.00003971239,0.000035735517,0.000028984574,0.000007465137,0.000015441756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998894,0.00019606265,0.0003008796,0.00026971614,0.00015928598,0.00018007187],"domain_scores_gemma":[0.9991553,0.0000900679,0.0002860787,0.00014330997,0.0001769081,0.00014837849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071670697,0.00014085378,0.0005268186,0.000073036994,0.00023510527,0.00000337641,0.00003876019,0.00008578881,0.0000108667955],"category_scores_gemma":[0.00020882908,0.00010520372,0.000042216845,0.00008972058,0.00029104273,0.000103591854,0.00005599954,0.00010716179,3.591248e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005751241,0.00024139407,0.99383503,0.00035645362,0.00008030944,3.9290077e-7,0.000836898,0.0000015127997,0.00024245164,0.0001804792,0.000023583343,0.004143978],"study_design_scores_gemma":[0.0018046587,0.00018121966,0.9799521,0.00008318955,0.0003329647,0.000013000007,0.000052003583,0.0012576209,0.01564433,0.0005144045,0.00009060665,0.00007390282],"about_ca_topic_score_codex":0.00035713654,"about_ca_topic_score_gemma":0.000118069314,"teacher_disagreement_score":0.015401879,"about_ca_system_score_codex":0.000057620873,"about_ca_system_score_gemma":0.0003019358,"threshold_uncertainty_score":0.4290083},"labels":[],"label_agreement":null},{"id":"W2059493545","doi":"10.1111/dom.12173","title":"Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: a nested case–control study","year":2013,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Cardiac Ischemia and Reperfusion","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland; University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Diabetes Foundation; Government of Alberta; Canadian Diabetes Association","keywords":"Gliclazide; Medicine; Nested case-control study; Internal medicine; Type 2 diabetes; Cardiology; Diabetes mellitus; Acute coronary syndrome; Case-control study; Myocardial infarction; Insulin; Endocrinology","score_opus":0.005065744187496018,"score_gpt":0.2004459440936458,"score_spread":0.19538019990614977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059493545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971912,0.00024924564,0.0000016896419,0.000016486392,0.00006130842,0.0022768753,0.00014467214,0.00004520345,0.0000133120675],"genre_scores_gemma":[0.9994597,0.000026358603,0.000114772905,0.00010960096,0.000022815662,0.00006904735,0.00010165081,0.00003970991,0.000056385674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980819,0.00025774766,0.00034350101,0.00041919568,0.00045427226,0.00044339054],"domain_scores_gemma":[0.9983918,0.00020162918,0.00028119274,0.00038962616,0.0005136809,0.00022208023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027017496,0.00033728045,0.0011015557,0.0001723476,0.0001114749,0.000027149737,0.00007052149,0.00012466473,0.00002267769],"category_scores_gemma":[0.000105480816,0.00020592945,0.000069942726,0.0004991562,0.00012885235,0.00031481226,0.000054434713,0.00031631358,0.0000032079124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007619801,0.0018130185,0.9934685,0.000037476868,0.0021036284,0.00010622022,0.00049503363,0.00002368196,0.0008522025,6.04476e-7,0.000022642798,0.000314984],"study_design_scores_gemma":[0.019117633,0.00141917,0.97402763,0.000273081,0.0036075262,0.0000091929915,0.00016233385,0.00018125553,0.0009148,0.0000038002997,0.000007696856,0.0002758792],"about_ca_topic_score_codex":0.0004903217,"about_ca_topic_score_gemma":0.00018372803,"teacher_disagreement_score":0.019440897,"about_ca_system_score_codex":0.00003928255,"about_ca_system_score_gemma":0.00007230886,"threshold_uncertainty_score":0.83975595},"labels":[],"label_agreement":null},{"id":"W2059631102","doi":"10.1111/dom.12070","title":"A nine country study of the burden of non‐severe nocturnal hypoglycaemic events on diabetes management and daily function","year":2013,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Novo Nordisk","keywords":"Diabetes mellitus; Medicine; Nap; Diabetes management; Feeling; Nocturnal; Type 1 diabetes; Insulin; Type 2 diabetes; Gerontology; Demography; Pediatrics; Internal medicine; Endocrinology; Psychology","score_opus":0.007226952094115496,"score_gpt":0.22237118938662737,"score_spread":0.21514423729251186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059631102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955407,0.0010031896,0.0000015617987,0.00020443024,0.00021667262,0.0015735144,0.00000977735,0.000014868142,0.001435334],"genre_scores_gemma":[0.9961177,0.00012744062,0.00004541011,0.00017166836,0.0001302884,0.00006431243,0.0000096080075,0.000017486554,0.0033160632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835265,0.00009615619,0.00031631987,0.0003040658,0.00058398646,0.00034681565],"domain_scores_gemma":[0.99914527,0.000067916786,0.00015982368,0.00039055126,0.00011573762,0.00012067305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003939829,0.00020773965,0.0005016347,0.00022063192,0.00012678646,0.000028062412,0.00017598766,0.000074554075,0.00009715085],"category_scores_gemma":[0.000040264316,0.00013276233,0.00007505122,0.00031876806,0.00014121314,0.00015202498,0.00030723523,0.00022883686,0.000009207967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008525145,0.00093924266,0.963086,0.0009564042,0.0009985653,0.0000013485312,0.00053209724,0.000030682728,0.0070648105,0.00011528462,0.0017575559,0.02443277],"study_design_scores_gemma":[0.0036024216,0.0005776992,0.99080145,0.00023550916,0.0006789937,1.8196413e-7,0.00060320256,0.0004171314,0.0013924928,0.00031181445,0.0012492129,0.0001298764],"about_ca_topic_score_codex":0.00007092413,"about_ca_topic_score_gemma":0.0000022235347,"teacher_disagreement_score":0.027715478,"about_ca_system_score_codex":0.000012390195,"about_ca_system_score_gemma":0.000010920769,"threshold_uncertainty_score":0.5413891},"labels":[],"label_agreement":null},{"id":"W2060050338","doi":"10.1111/dom.12075","title":"Assessment of cardiometabolic risk and prevalence of meeting treatment guidelines among patients with type 2 diabetes stratified according to their use of insulin and/or other diabetic medications: results from <scp>INSPIRE ME IAA</scp>","year":2013,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Canadian Institutes of Health Research; Sanofi","keywords":"Medicine; Type 2 diabetes; Diabetes mellitus; Internal medicine; Insulin; Endocrinology; Abdominal obesity; Prospective cohort study; Adipose tissue; Metabolic syndrome","score_opus":0.0205073153259742,"score_gpt":0.24985739572334184,"score_spread":0.22935008039736765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060050338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846231,0.012682418,0.000026653992,0.000025256752,0.00008922732,0.0016119995,0.0008646475,0.00003104507,0.00004567994],"genre_scores_gemma":[0.9881635,0.005393665,0.0059960587,0.00006431388,0.00010260756,0.00012515711,0.00007440115,0.00004009143,0.00004023825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973697,0.0002782356,0.0008774229,0.0005787198,0.00051680603,0.00037908962],"domain_scores_gemma":[0.9968909,0.0007567602,0.00060022925,0.0006746149,0.00077689876,0.00030056562],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000757669,0.00038269363,0.001536281,0.00030221965,0.000102502425,0.000048732945,0.00013192561,0.00015266011,0.000007059054],"category_scores_gemma":[0.0016630075,0.00025195433,0.0001587396,0.0004568794,0.00034254408,0.00035034242,0.00012531302,0.00014321208,7.166484e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021944541,0.00027986162,0.8972749,0.0003757435,0.0013673069,2.4036007e-7,0.00096372137,0.000032686956,0.0022739526,0.000007404205,0.000013884992,0.097388335],"study_design_scores_gemma":[0.0030149093,0.00046452173,0.97201866,0.0007842457,0.0020492484,1.1166094e-7,0.00046052426,0.00043027126,0.020123202,0.000044274035,0.000465275,0.00014476264],"about_ca_topic_score_codex":0.00631189,"about_ca_topic_score_gemma":0.00013279902,"teacher_disagreement_score":0.09724357,"about_ca_system_score_codex":0.00001811525,"about_ca_system_score_gemma":0.00009608548,"threshold_uncertainty_score":0.99999326},"labels":[],"label_agreement":null},{"id":"W2061883499","doi":"10.1111/dom.12262","title":"A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (<scp>BEGIN</scp>: <scp>VICTOZA ADD‐ON</scp>)","year":2014,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Novo Nordisk; American Diabetes Association","keywords":"Insulin degludec; Medicine; Internal medicine; Insulin aspart; Endocrinology; Lira; Metformin; Insulin; Basal insulin; Type 2 diabetes; Hypoglycemia; Diabetes mellitus; Insulin glargine","score_opus":0.021593007188927805,"score_gpt":0.2575520745690506,"score_spread":0.2359590673801228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061883499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891864,0.004386905,0.000012128319,0.000062300336,0.0003554659,0.0010117334,0.00004820399,0.00009017096,0.0048466595],"genre_scores_gemma":[0.9968256,0.00018751126,0.0018549267,0.00039530624,0.00015001888,0.00008119706,0.000110086505,0.00006515606,0.00033019864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99688137,0.00019199341,0.00071030296,0.0006947279,0.0006116474,0.00090998213],"domain_scores_gemma":[0.99694794,0.0013250051,0.0003897064,0.00065365207,0.00025475534,0.00042894788],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000674097,0.0005482399,0.0016924157,0.0007520513,0.00009908957,0.000054604698,0.00027282455,0.00020853241,0.000009484044],"category_scores_gemma":[0.0017963211,0.00047019953,0.00015494136,0.0011481221,0.00021306463,0.00022406445,0.0002274085,0.00032580917,0.000040719406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000420932,0.0056266906,0.9250621,0.0011510338,0.0013200535,0.000014930722,0.004893864,0.00031171882,0.026928408,0.0023608103,0.003454461,0.028454984],"study_design_scores_gemma":[0.011143639,0.0040372894,0.78751546,0.00094232545,0.0010617556,3.159918e-7,0.0006316893,0.000530759,0.14833052,0.00012690909,0.04547911,0.00020018569],"about_ca_topic_score_codex":0.00007217042,"about_ca_topic_score_gemma":0.00017229389,"teacher_disagreement_score":0.13754663,"about_ca_system_score_codex":0.00006791421,"about_ca_system_score_gemma":0.000077457626,"threshold_uncertainty_score":0.999775},"labels":[],"label_agreement":null},{"id":"W2063476025","doi":"10.1111/dom.12465","title":"Incretin‐based medications for type 2 diabetes: an overview of reviews","year":2015,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Systematic review; Checklist; Cochrane Library; Observational study; MEDLINE; Randomized controlled trial; Incretin; Internal medicine; Type 2 diabetes; Diabetes mellitus; Psychology; Endocrinology","score_opus":0.16725277773619593,"score_gpt":0.4005807717538717,"score_spread":0.23332799401767576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063476025","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00075317704,0.9941478,0.0000072744033,0.000063018226,0.00036794072,0.0039786035,0.00023185753,0.000066595574,0.0003837511],"genre_scores_gemma":[0.000022768076,0.9924582,0.0026152057,0.0004962209,0.00030612687,0.0007910669,0.0027607812,0.00007368982,0.00047593797],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973206,0.0002990846,0.0009413208,0.0006057744,0.00033726063,0.00049598474],"domain_scores_gemma":[0.9974497,0.00021381016,0.0006591133,0.0009120428,0.0003124756,0.0004528378],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001644782,0.00059628254,0.0042534075,0.0003823193,0.00008827142,0.00003193417,0.00027941604,0.0003358235,0.00008750575],"category_scores_gemma":[0.0002800574,0.0004381587,0.00064176944,0.0005499433,0.00016686997,0.0001426011,0.000115096875,0.00021395566,0.000041463554],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000053924914,0.0005570656,0.0003100029,0.06807498,0.0009840906,7.262758e-7,0.000047310572,4.9180077e-8,0.0000026459325,0.0011942938,0.0039388994,0.92488456],"study_design_scores_gemma":[0.0009410759,0.00029565816,0.0003606634,0.010767795,0.02057258,2.0185374e-7,0.0000044343788,0.000024796294,0.000013946204,0.00019014762,0.9664755,0.00035318657],"about_ca_topic_score_codex":0.000005384614,"about_ca_topic_score_gemma":0.0000024282194,"teacher_disagreement_score":0.96253663,"about_ca_system_score_codex":0.000053590487,"about_ca_system_score_gemma":0.00033589965,"threshold_uncertainty_score":0.999807},"labels":[],"label_agreement":null},{"id":"W2065380980","doi":"10.1111/j.1463-1326.2012.01602.x","title":"Study of Once Daily Levemir (SOLVE™): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice","year":2012,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"Novo Nordisk","keywords":"Medicine; Insulin; Insulin detemir; Metformin; Diabetes mellitus; Internal medicine; Observational study; Type 2 Diabetes Mellitus; Type 2 diabetes; Cohort; Basal insulin; Endocrinology","score_opus":0.022650359943830196,"score_gpt":0.29206289434808774,"score_spread":0.26941253440425755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065380980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774045,0.020340761,0.0000072098433,0.00011829004,0.00020549912,0.0015726585,0.0000024183787,0.00001735021,0.000331312],"genre_scores_gemma":[0.99786514,0.0008800132,0.0006272757,0.0002710177,0.00022515497,0.000080564816,0.000015256759,0.000024929712,0.000010634292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970344,0.00081238046,0.00092496764,0.00031745044,0.0005119268,0.00039889436],"domain_scores_gemma":[0.99756604,0.0010383893,0.0004529162,0.00046913925,0.0003375246,0.00013597339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003832056,0.00024580877,0.0016137599,0.00026706062,0.00006948198,0.000019291678,0.000146086,0.00015664723,0.0000071754093],"category_scores_gemma":[0.002514249,0.00016312629,0.00014921978,0.0007785969,0.0001559739,0.00052800373,0.00010172395,0.00047292473,0.0000027979581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005969931,0.003072305,0.9503102,0.00014361349,0.00058753364,0.0000040683854,0.016192993,0.000021975084,0.0002696808,0.000106828986,0.0000068946665,0.028686954],"study_design_scores_gemma":[0.015793301,0.0006067967,0.97638094,0.00019013781,0.0009799108,8.1239136e-7,0.0032761618,0.0002780445,0.0015873292,0.0000398489,0.00069119304,0.0001755005],"about_ca_topic_score_codex":0.0026929984,"about_ca_topic_score_gemma":0.0018345547,"teacher_disagreement_score":0.028511453,"about_ca_system_score_codex":0.000026776814,"about_ca_system_score_gemma":0.000113357564,"threshold_uncertainty_score":0.6652097},"labels":[],"label_agreement":null},{"id":"W2066046508","doi":"10.1111/j.1463-1326.2010.01251.x","title":"A placebo‐controlled trial of exenatide twice‐daily added to thiazolidinediones alone or in combination with metformin","year":2010,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Professional Engineers Ontario","funders":"Amylin Pharmaceuticals; Eli Lilly and Company","keywords":"Exenatide; Placebo; Metformin; Medicine; Internal medicine; Clinical endpoint; Type 2 diabetes; Nausea; Adverse effect; Gastroenterology; Diabetes mellitus; Randomized controlled trial; Endocrinology; Insulin","score_opus":0.008773329220469896,"score_gpt":0.23759637324484778,"score_spread":0.2288230440243779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066046508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99379724,0.00024962614,0.000015411675,0.00069266383,0.0002970979,0.003656404,0.000007716707,0.000044411372,0.0012394486],"genre_scores_gemma":[0.99447554,0.000102597456,0.00301597,0.00034322237,0.00012094771,0.00051584805,0.000032713036,0.000020434676,0.0013727162],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99853975,0.00006260771,0.00041718144,0.00030235655,0.00034654263,0.00033158288],"domain_scores_gemma":[0.9990425,0.00021816828,0.00015978588,0.0002795734,0.00011974824,0.00018018577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007623037,0.00024064901,0.0010560685,0.00044510988,0.00005424963,0.000027240534,0.00009427275,0.00010073003,0.00006264568],"category_scores_gemma":[0.0003664884,0.00015515153,0.00009171156,0.00038614767,0.000070470254,0.00020463848,0.00006404243,0.00017305839,0.000008130482],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7203039,0.016313752,0.076647125,0.001104003,0.0033537212,0.00011900325,0.004283996,0.000011538578,0.0713384,0.024985785,0.0014763477,0.08006246],"study_design_scores_gemma":[0.7944591,0.00314716,0.15559733,0.00019534072,0.0017301249,0.0000023663054,0.00022052402,0.00022394743,0.035854608,0.0006284298,0.0075339074,0.00040718485],"about_ca_topic_score_codex":0.000047108253,"about_ca_topic_score_gemma":0.00020286272,"teacher_disagreement_score":0.079655275,"about_ca_system_score_codex":0.000014040976,"about_ca_system_score_gemma":0.00005803845,"threshold_uncertainty_score":0.6326896},"labels":[],"label_agreement":null},{"id":"W2067359845","doi":"10.1046/j.1463-1326.2001.00033.x","title":"PPARγ agonists in type 2 diabetes: how far have we come in ‘preventing the inevitable’? A review of the metabolic effects of rosiglitazone","year":2001,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Citation; Rosiglitazone; Type 2 diabetes; Medicine; Library science; Diabetes mellitus; Endocrinology; Computer science","score_opus":0.01218761175316994,"score_gpt":0.257524190039947,"score_spread":0.24533657828677705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067359845","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13236174,0.86566925,8.028721e-7,0.000090528636,0.00033226734,0.0014636166,0.000052323023,0.0000057670136,0.0000236738],"genre_scores_gemma":[0.014516482,0.9846467,0.00003758621,0.00021136219,0.0001370722,0.0002090202,0.00008745817,0.000056945013,0.00009737526],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963443,0.0013520449,0.00085009146,0.0005779496,0.00028527598,0.00059029873],"domain_scores_gemma":[0.9979127,0.00019432284,0.00081076875,0.00086101925,0.00013389134,0.00008728272],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012498621,0.0005932977,0.0027307875,0.00019029684,0.00007995611,0.0000303585,0.0007666645,0.00049347966,0.0000066441603],"category_scores_gemma":[0.001068451,0.00036191766,0.0005541327,0.0010908361,0.0002782267,0.000019613242,0.00054437196,0.000622573,0.0000013643687],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000154011,0.00092815206,0.034878522,0.2684307,0.0016086807,0.000004109484,0.0002464054,0.000002651872,0.030530125,0.00015385849,0.00045676844,0.6627446],"study_design_scores_gemma":[0.00051010173,0.000049712533,0.003313529,0.046166018,0.0010421462,0.0000022523336,0.000012506458,0.0000024859014,0.039789874,0.000037020414,0.90863097,0.0004434018],"about_ca_topic_score_codex":0.000023134588,"about_ca_topic_score_gemma":0.000020749145,"teacher_disagreement_score":0.90817416,"about_ca_system_score_codex":0.00002275442,"about_ca_system_score_gemma":0.00019983226,"threshold_uncertainty_score":0.9998833},"labels":[],"label_agreement":null},{"id":"W2070814970","doi":"10.1111/j.1463-1326.2004.00441.x","title":"Abdominal obesity predicts declining insulin sensitivity in non‐obese normoglycaemics: the Insulin Resistance Atherosclerosis Study (IRAS)","year":2005,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Waist; Body mass index; Medicine; Overweight; Internal medicine; Insulin resistance; Obesity; Abdominal obesity; Circumference; Endocrinology; Diabetes mellitus","score_opus":0.010801282965756092,"score_gpt":0.22976389815845097,"score_spread":0.2189626151926949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070814970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850614,0.011575928,0.00008320669,0.00044140255,0.0002736832,0.0019409636,0.000055516564,0.000121315774,0.00044657823],"genre_scores_gemma":[0.99452263,0.0017308004,0.0013484404,0.000933876,0.0009759814,0.00014647734,0.000022996097,0.00006349964,0.00025532284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959101,0.0006248757,0.0007821732,0.00093226234,0.0008246192,0.0009259491],"domain_scores_gemma":[0.9977299,0.00034606433,0.00023972128,0.0010841388,0.00022437521,0.00037582792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0043678256,0.0005581662,0.001507217,0.0002694943,0.00045100748,0.00012969463,0.00027916825,0.00029803853,0.000022503236],"category_scores_gemma":[0.0007119264,0.00044397335,0.00041033776,0.0007071442,0.00034744415,0.00043693586,0.00028639153,0.0009875202,0.000057546295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003112186,0.0030448812,0.81135184,0.00024072234,0.0006426515,0.000060086837,0.005634985,0.000073263705,0.0014059176,0.00004363173,0.00021707582,0.17697375],"study_design_scores_gemma":[0.006362613,0.00013774318,0.9788632,0.00029870973,0.0007339266,0.0000056903787,0.00063417427,0.0007563825,0.003659705,0.00009070144,0.008004867,0.000452281],"about_ca_topic_score_codex":0.0016921049,"about_ca_topic_score_gemma":0.008746035,"teacher_disagreement_score":0.17652147,"about_ca_system_score_codex":0.000103226295,"about_ca_system_score_gemma":0.00012355435,"threshold_uncertainty_score":0.9998012},"labels":[],"label_agreement":null},{"id":"W2072396082","doi":"10.1111/dom.12359","title":"Effect of sitagliptin therapy on triglyceride‐rich lipoprotein kinetics in patients with type 2 diabetes","year":2014,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval; Centre hospitalier de l'Université Laval","funders":"Merck","keywords":"Sitagliptin; Internal medicine; Endocrinology; Apolipoprotein B; Very low-density lipoprotein; Triglyceride; Placebo; Crossover study; Type 2 diabetes; Chemistry; Cholesterol; Medicine; Lipoprotein; Insulin; Diabetes mellitus","score_opus":0.003847252317263479,"score_gpt":0.20169237514221577,"score_spread":0.19784512282495229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072396082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99683726,0.0009879961,0.0000010329387,0.00005529915,0.00012780566,0.0010568439,0.000006413168,0.000037843834,0.0008894774],"genre_scores_gemma":[0.99909174,0.00012846489,0.00017306386,0.00025927325,0.00006885369,0.000047610847,0.000059666556,0.00002921154,0.00014209595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986142,0.00015677519,0.00023693347,0.00031835283,0.00030312547,0.0003706148],"domain_scores_gemma":[0.9991869,0.00017290188,0.000111591784,0.00033192168,0.00008185151,0.000114866736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041092513,0.0002829244,0.00073196535,0.00023456494,0.000035979196,0.000019588182,0.000084641586,0.00008972941,0.000028969205],"category_scores_gemma":[0.00012012337,0.00018712014,0.00006360334,0.0003200662,0.00008399563,0.000076850694,0.00004281115,0.00012969432,0.000013112318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005351707,0.001049164,0.89342076,0.00023569318,0.00021225124,8.3608563e-7,0.000081319886,0.000006340286,0.0013120834,0.00018156045,0.00006431094,0.10290052],"study_design_scores_gemma":[0.00883249,0.006567807,0.9197473,0.0001588658,0.00025025304,1.7090954e-8,0.0000021925562,0.0000453749,0.06094743,0.000046072466,0.0032217293,0.0001804739],"about_ca_topic_score_codex":0.000011910592,"about_ca_topic_score_gemma":0.0000031041816,"teacher_disagreement_score":0.102720045,"about_ca_system_score_codex":0.000018132396,"about_ca_system_score_gemma":0.0000081453,"threshold_uncertainty_score":0.7630538},"labels":[],"label_agreement":null},{"id":"W2074091547","doi":"10.1111/dom.12114","title":"Flexibly timed once‐daily dosing with degludec: a new ultra‐long‐acting basal insulin","year":2013,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Toronto; St. Michael's Hospital","funders":"Novo Nordisk Canada","keywords":"Insulin degludec; Dosing; Medicine; Insulin glargine; Basal insulin; Insulin; Basal (medicine); Insulin detemir; Type 2 diabetes; Diabetes mellitus; Endocrinology; Internal medicine; Hypoglycemia; Intensive care medicine","score_opus":0.04250271054545744,"score_gpt":0.31296317966676435,"score_spread":0.2704604691213069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074091547","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009480435,0.9821281,0.00005217035,0.00014721595,0.0003188474,0.0024692449,0.000021243834,0.00019109574,0.0051916437],"genre_scores_gemma":[0.00029975816,0.9807664,0.0020931899,0.00038711802,0.001225846,0.00014606952,0.00028440054,0.00016287089,0.014634341],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99583936,0.0002786333,0.00074829895,0.0010045439,0.0008578501,0.0012712888],"domain_scores_gemma":[0.997415,0.00037629486,0.0004324605,0.00073463074,0.00018324844,0.00085835234],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00083958317,0.00091447635,0.0033169019,0.0007558747,0.00030403482,0.0004118818,0.00043238746,0.00052721996,0.00034804246],"category_scores_gemma":[0.00026648366,0.0006211357,0.00050716224,0.0010030314,0.0002678632,0.00044951928,0.00025545515,0.0012979887,0.00037561174],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020411313,0.00020568389,0.0013726242,0.014629815,0.0008350128,0.0000352803,0.00010393437,2.5855365e-7,0.000012546917,0.00007111382,0.002050728,0.9806626],"study_design_scores_gemma":[0.002019869,0.0001654468,0.0049355635,0.013554923,0.0045154956,0.0000055664827,0.000027134965,0.000024138802,0.00010490166,0.00007818405,0.97377187,0.0007969222],"about_ca_topic_score_codex":0.000085160165,"about_ca_topic_score_gemma":0.000008110057,"teacher_disagreement_score":0.9798657,"about_ca_system_score_codex":0.00007548986,"about_ca_system_score_gemma":0.00054777437,"threshold_uncertainty_score":0.999624},"labels":[],"label_agreement":null},{"id":"W2075427448","doi":"10.1111/j.1463-1326.2007.00788.x","title":"New insights into the molecular mechanisms of priming of insulin exocytosis","year":2007,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research; Connaught Fund; University of Toronto","keywords":"Exocytosis; Insulin; Vesicle; Priming (agriculture); Secretion; Cell biology; Munc-18; Biology; Glucose homeostasis; Exocyst; Secretory Vesicle; Docking (animal); Endocrinology; Biochemistry; Insulin resistance; Medicine; Membrane; Synaptic vesicle","score_opus":0.008944835475021524,"score_gpt":0.22527132123076596,"score_spread":0.21632648575574442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075427448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97836125,0.013711609,0.0062264893,0.00012772891,0.0001420181,0.00020784898,0.0000012772668,0.000021674616,0.0012001265],"genre_scores_gemma":[0.9918916,0.0003320447,0.006953288,0.00061754824,0.000060315997,0.000003054262,0.0000057509346,0.0000110957,0.00012527496],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990275,0.000041088384,0.00031894047,0.00016775873,0.00025010732,0.00019462967],"domain_scores_gemma":[0.9991699,0.00016021934,0.00013725561,0.00026342776,0.00010907,0.00016016167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004235193,0.00013398114,0.0004613012,0.00014876104,0.000058126167,0.000006699049,0.00008300154,0.000097009535,0.00003586024],"category_scores_gemma":[0.0002514179,0.00009043383,0.00010733916,0.00027749874,0.000099022145,0.00006255711,0.000057747435,0.000113797396,0.0000035114845],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055194738,0.00019409947,0.008998575,0.00021832295,0.00021541056,0.000003029954,0.0023341135,0.0000018077656,0.9109409,0.04397808,0.00006294103,0.032997534],"study_design_scores_gemma":[0.00094571104,0.0000719489,0.14789422,0.0000867763,0.00033447114,5.79668e-7,0.00020684696,0.0000365812,0.8396609,0.008058436,0.002622865,0.00008067958],"about_ca_topic_score_codex":0.0001268496,"about_ca_topic_score_gemma":0.0000034690074,"teacher_disagreement_score":0.13889565,"about_ca_system_score_codex":0.000008361952,"about_ca_system_score_gemma":0.000071708,"threshold_uncertainty_score":0.36877844},"labels":[],"label_agreement":null},{"id":"W2077038286","doi":"10.1111/dom.12090","title":"Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease","year":2013,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":486,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"Mitsubishi Tanabe Pharma Corporation; European Foundation for the Study of Diabetes; American Society of Nephrology; American Diabetes Association","keywords":"Canagliflozin; Medicine; Renal function; Placebo; Kidney disease; Internal medicine; Type 2 diabetes; Urology; Diabetes mellitus; Creatinine; Endocrinology; Empagliflozin; Blood urea nitrogen; Gastroenterology","score_opus":0.0051452716821656095,"score_gpt":0.20177999333681063,"score_spread":0.19663472165464502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077038286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826174,0.015535064,6.2157125e-7,0.0004709259,0.000057308767,0.00088577904,0.000016333546,0.000027159631,0.0003894564],"genre_scores_gemma":[0.9967116,0.0022142609,0.00016742134,0.00046772114,0.000050591396,0.000043813852,0.000052765165,0.000019075102,0.00027275566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989049,0.000043787844,0.00019667874,0.00032779638,0.0001515868,0.00037527474],"domain_scores_gemma":[0.9991197,0.00007019559,0.000064529544,0.00022205735,0.000058175905,0.00046536757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014157078,0.00022148105,0.000520496,0.00017640146,0.000057094083,0.000033480435,0.00004752906,0.00005430251,0.00005334604],"category_scores_gemma":[0.00008906772,0.0001665411,0.00002638247,0.00022122334,0.00020113018,0.00018753138,0.00009322254,0.00009887342,0.0000048800207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099470504,0.000317636,0.97760206,0.0007938157,0.0002814578,0.0000072800117,0.00019422238,0.0000016533239,0.0019771636,0.0006894277,0.00031488386,0.017720895],"study_design_scores_gemma":[0.0047821184,0.00023972822,0.9881596,0.00031785516,0.00055441266,2.1663514e-7,0.000025616579,0.00015921472,0.0016722345,0.00017955147,0.003728858,0.00018057029],"about_ca_topic_score_codex":0.00013509644,"about_ca_topic_score_gemma":0.000049031318,"teacher_disagreement_score":0.017540324,"about_ca_system_score_codex":0.00002410413,"about_ca_system_score_gemma":0.00007865745,"threshold_uncertainty_score":0.67913485},"labels":[],"label_agreement":null},{"id":"W2081134608","doi":"10.1111/j.1463-1326.2009.01050.x","title":"Improved cardiovascular health following a progressive walking and dietary intervention for type 2 diabetes","year":2009,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Heart Rate Variability and Autonomic Control","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Pedometer; Medicine; Blood pressure; Body mass index; Type 2 diabetes; Confidence interval; Physical therapy; Randomized controlled trial; Diabetes mellitus; Internal medicine; Physical activity; Endocrinology","score_opus":0.015579853308000543,"score_gpt":0.27486392050602765,"score_spread":0.2592840671980271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081134608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9267284,0.07048368,0.00010900433,0.0012780096,0.00025337143,0.0010598388,0.000012165602,0.000062676656,0.000012831067],"genre_scores_gemma":[0.99667865,0.00029082742,0.0015402565,0.00113303,0.0002204048,0.00004521828,0.00004318711,0.0000129681675,0.000035455585],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998691,0.00010986027,0.00029410253,0.00038178245,0.00010393617,0.00041927755],"domain_scores_gemma":[0.9993369,0.000085628046,0.0000749321,0.00022920026,0.000069972586,0.00020335981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011570452,0.00018352988,0.0007749922,0.00008386298,0.0002057327,0.000055396813,0.000039010152,0.00009954086,0.000004851922],"category_scores_gemma":[0.00023417735,0.00016080694,0.00037588784,0.00010623627,0.000045587323,0.00017545446,0.000033143675,0.00015288389,8.383711e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033240412,0.00032446982,0.015240115,0.00062576047,0.0010260731,0.00000327379,0.0007996595,0.0000014759373,0.020320946,0.00020062037,0.000036940415,0.9613874],"study_design_scores_gemma":[0.0071075996,0.0012297658,0.9386094,0.0006237923,0.001632558,0.0000033848264,0.00016444546,0.006820205,0.0067353174,0.002200471,0.03439116,0.00048186927],"about_ca_topic_score_codex":0.000020932686,"about_ca_topic_score_gemma":0.0000019760103,"teacher_disagreement_score":0.96090555,"about_ca_system_score_codex":0.000026070205,"about_ca_system_score_gemma":0.00006186269,"threshold_uncertainty_score":0.6557517},"labels":[],"label_agreement":null},{"id":"W2081199780","doi":"10.1111/dom.12271","title":"Health status and hypoglycaemia with insulin degludec versus insulin glargine: a 2‐year trial in insulin‐naïve patients with type 2 diabetes","year":2014,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Novo Nordisk","keywords":"Medicine; Insulin glargine; Insulin degludec; Insulin; Internal medicine; Diabetes mellitus; Metformin; Hypoglycemia; Population; Type 2 diabetes; Endocrinology","score_opus":0.007403713643261174,"score_gpt":0.22060987078041594,"score_spread":0.21320615713715477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081199780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991524,0.005640843,0.000004870565,0.00028869128,0.00032448006,0.0016869265,0.000034790908,0.00009056711,0.00040484322],"genre_scores_gemma":[0.99501765,0.0017793471,0.0018130263,0.000704693,0.00017739901,0.00008914338,0.0002857364,0.000055580942,0.00007739756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737936,0.00016473256,0.00041771546,0.0006659241,0.00045654713,0.00091573916],"domain_scores_gemma":[0.9985373,0.00017726008,0.0002101761,0.00041324474,0.0001510955,0.00051089795],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004501392,0.0004655535,0.001104785,0.00035390593,0.00014935038,0.00008593757,0.00010552092,0.00014530595,0.000018215753],"category_scores_gemma":[0.00020079807,0.00034215336,0.000054349824,0.0005723289,0.00019697801,0.0002794886,0.00013002708,0.00031558098,0.00001636283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014777335,0.0015440073,0.9237951,0.0003309366,0.00047095804,0.0000037173863,0.000489776,0.000005007768,0.000016382144,0.00074779673,0.00014299864,0.05767597],"study_design_scores_gemma":[0.13623987,0.004055736,0.8463531,0.000198975,0.00039696082,1.0189461e-7,0.00005376277,0.00007652517,0.0001338949,0.0001057843,0.0120233195,0.0003619597],"about_ca_topic_score_codex":0.0001262273,"about_ca_topic_score_gemma":0.00016199767,"teacher_disagreement_score":0.12146254,"about_ca_system_score_codex":0.000082659564,"about_ca_system_score_gemma":0.00013657182,"threshold_uncertainty_score":0.999903},"labels":[],"label_agreement":null},{"id":"W2081216702","doi":"10.1111/dom.12126","title":"Are users of sulphonylureas at the time of an acute coronary syndrome at risk of poorer outcomes?","year":2013,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Cardiac Ischemia and Reperfusion","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alliance for Canadian Health Outcomes Research in Diabetes; University of Alberta","funders":"Alberta Innovates - Health Solutions; Canadian Diabetes Association","keywords":"Acute coronary syndrome; Medicine; Internal medicine; Cardiology; Diabetes mellitus; Myocardial infarction; Endocrinology","score_opus":0.004917858367688996,"score_gpt":0.2118756143606785,"score_spread":0.20695775599298952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081216702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965977,0.0022962457,1.5812171e-7,0.00023455167,0.00012407797,0.00042084503,0.00019335233,0.00001449423,0.000118578915],"genre_scores_gemma":[0.99778926,0.00044392742,0.000087201035,0.00017265882,0.00002180849,0.000010237178,0.00004927703,0.000017149174,0.0014084528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988558,0.00009497452,0.00031589266,0.00021625144,0.0003047337,0.00021230543],"domain_scores_gemma":[0.99870974,0.0001221439,0.0003827325,0.00048683817,0.00015610691,0.00014242521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027224404,0.00017622592,0.00087222416,0.000071752846,0.00008429286,0.000004049168,0.00010232747,0.00014802867,0.00036773938],"category_scores_gemma":[0.00007768149,0.00010370421,0.00028932138,0.00012087664,0.00031995593,0.00010069612,0.00020929718,0.00013503795,0.000025804376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004180483,0.00014619713,0.79657567,0.00009953998,0.0004476194,0.000005374411,0.00026387913,0.0000013629791,0.20167571,0.0000073162564,0.0003468662,0.00038863812],"study_design_scores_gemma":[0.0009976818,0.000066287765,0.8254105,0.000054367283,0.0010960682,0.000022523405,0.00005941873,0.000025386911,0.17184646,0.000027906599,0.00030360403,0.00008978589],"about_ca_topic_score_codex":0.00024289596,"about_ca_topic_score_gemma":0.000004812267,"teacher_disagreement_score":0.02982925,"about_ca_system_score_codex":0.000015875201,"about_ca_system_score_gemma":0.000020010233,"threshold_uncertainty_score":0.4228935},"labels":[],"label_agreement":null},{"id":"W2082809017","doi":"10.1111/j.1463-1326.2007.00753.x","title":"Initial treatment with fixed‐dose combination rosiglitazone/glimepiride in patients with previously untreated type 2 diabetes","year":2007,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Diabetes Canada; Canadian Diabetes Association; American Diabetes Association","keywords":"Medicine; Rosiglitazone; Glimepiride; Regimen; Internal medicine; Fixed-dose combination; Adiponectin; Type 2 diabetes; Adverse effect; Gastroenterology; Clinical endpoint; Diabetes mellitus; Pharmacology; Endocrinology; Insulin resistance; Insulin; Randomized controlled trial","score_opus":0.006522453057879444,"score_gpt":0.21743710933162655,"score_spread":0.21091465627374711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082809017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935673,0.004245057,0.000012230607,0.000046226796,0.00014129582,0.0014949581,0.000025613692,0.00010400555,0.00036331086],"genre_scores_gemma":[0.9983891,0.00022967496,0.00043365444,0.00024173854,0.00014039504,0.00005650777,0.00034143988,0.000055437275,0.000112043665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977647,0.000120094235,0.00035793887,0.0005266965,0.000471464,0.0007591263],"domain_scores_gemma":[0.9987351,0.0000915421,0.00012928054,0.00043941394,0.00029244032,0.0003122328],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004964624,0.0004186266,0.0009778818,0.0003316501,0.00012884714,0.00005652876,0.00008487102,0.00017728229,0.000022067605],"category_scores_gemma":[0.00007418901,0.00029648966,0.00012563156,0.00055519666,0.00018885675,0.00028074818,0.000037498306,0.00021551117,0.000016243708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048371934,0.0014193556,0.8704415,0.00010942887,0.00056336785,0.00002148084,0.00046034303,0.000004335508,0.0000966727,0.000036422556,0.000015951742,0.12634744],"study_design_scores_gemma":[0.013884136,0.002328835,0.9696739,0.00022118192,0.00091721077,0.0000011837968,0.00005188078,0.000019838475,0.009795548,0.00004410494,0.002696393,0.00036582063],"about_ca_topic_score_codex":0.0008572308,"about_ca_topic_score_gemma":0.0006149449,"teacher_disagreement_score":0.12598163,"about_ca_system_score_codex":0.000118498305,"about_ca_system_score_gemma":0.00009466462,"threshold_uncertainty_score":0.99994874},"labels":[],"label_agreement":null},{"id":"W2083415436","doi":"10.1111/j.1463-1326.2011.01493.x","title":"Achieving a clinically relevant composite outcome of an HbA1c of &lt;7% without weight gain or hypoglycaemia in type 2 diabetes: a meta‐analysis of the liraglutide clinical trial programme","year":2011,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Merck Sharp and Dohme; Novo Nordisk","keywords":"Liraglutide; Medicine; Sitagliptin; Glimepiride; Exenatide; Type 2 diabetes; Internal medicine; Weight loss; Rosiglitazone; Weight gain; Placebo; Diabetes mellitus; Endocrinology; Obesity","score_opus":0.16090406437223578,"score_gpt":0.39536483810216133,"score_spread":0.23446077372992555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083415436","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34956607,0.6466147,0.0000018468461,0.000022269372,0.00035933204,0.003149641,0.00011691728,0.000028595472,0.00014065026],"genre_scores_gemma":[0.029115535,0.9661091,0.0034432407,0.0001760909,0.00018187355,0.00026938843,0.0002514542,0.00009559129,0.00035775764],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99137855,0.0017741219,0.004537857,0.00096443394,0.0006014268,0.0007436279],"domain_scores_gemma":[0.9933177,0.0014269059,0.0029973157,0.0016460757,0.00026994955,0.00034202376],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0051385527,0.0008421239,0.013306402,0.00093865325,0.00006308634,0.00002661678,0.00074268033,0.00065795024,0.00007917055],"category_scores_gemma":[0.0012635774,0.00046033767,0.004640534,0.0020687424,0.0006310013,0.00015073482,0.00053846487,0.00078840856,0.0000035147343],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030799077,0.008197237,0.20021999,0.021302817,0.24820988,0.000013859004,0.0002623112,0.0000014826147,0.000011578055,0.00049595576,0.000023889306,0.5181811],"study_design_scores_gemma":[0.014317426,0.002049755,0.051487084,0.0031075997,0.8185086,5.8697964e-7,0.00001722103,0.00006467793,0.00003148891,0.00005480239,0.10974809,0.0006126661],"about_ca_topic_score_codex":0.00005991661,"about_ca_topic_score_gemma":0.000082196966,"teacher_disagreement_score":0.57029873,"about_ca_system_score_codex":0.000038007965,"about_ca_system_score_gemma":0.00029271463,"threshold_uncertainty_score":0.9997848},"labels":[],"label_agreement":null},{"id":"W2084414747","doi":"10.1111/j.1463-1326.2007.00781.x","title":"Role of the M <sub>3</sub> muscarinic acetylcholine receptor in β‐cell function and glucose homeostasis","year":2007,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"National Institutes of Health","keywords":"Internal medicine; Endocrinology; Muscarinic acetylcholine receptor; Glucose homeostasis; Muscarinic acetylcholine receptor M3; Muscarinic acetylcholine receptor M4; Insulin; Muscarinic acetylcholine receptor M1; Biology; Beta cell; Acetylcholine; Receptor; Chemistry; Insulin resistance; Medicine; Islet","score_opus":0.005872598525084818,"score_gpt":0.20151721148713791,"score_spread":0.1956446129620531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084414747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976349,0.02227608,0.00000764555,0.00011206494,0.00024336291,0.00029978724,0.000015452157,0.000027457456,0.00066912797],"genre_scores_gemma":[0.99707395,0.002039681,0.00012100563,0.0005423764,0.00012302696,0.000008914601,0.00001456423,0.000014382568,0.000062086285],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988675,0.00006482468,0.00030793203,0.00025494135,0.00019981494,0.00030498227],"domain_scores_gemma":[0.9992479,0.00015311314,0.00011205273,0.00025363624,0.000072923816,0.00016035273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065814005,0.00016812884,0.00043564296,0.00017729006,0.00007816523,0.000013363833,0.000054982007,0.00014281544,0.000026193651],"category_scores_gemma":[0.00020891878,0.00012403345,0.00008915302,0.00037892928,0.00014385452,0.000108092776,0.000076663935,0.00022302846,0.0000083928735],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007875138,0.00023263764,0.3101902,0.00010158501,0.000036608475,2.4343151e-7,0.00019107765,5.5867486e-7,0.64786947,0.00016502164,0.00007199304,0.04106184],"study_design_scores_gemma":[0.0013141998,0.00003954152,0.57063913,0.00004122986,0.00014085183,5.489794e-7,0.00014312398,0.00002204306,0.424756,0.0002099438,0.0026208945,0.000072461255],"about_ca_topic_score_codex":0.00002884272,"about_ca_topic_score_gemma":0.000017727272,"teacher_disagreement_score":0.26044896,"about_ca_system_score_codex":0.000017061499,"about_ca_system_score_gemma":0.000033685108,"threshold_uncertainty_score":0.50579375},"labels":[],"label_agreement":null},{"id":"W2086380056","doi":"10.1111/j.1463-1326.2012.01607.x","title":"Utility of non‐high‐density lipoprotein cholesterol in assessing incident type 2 diabetes risk","year":2012,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; St. Michael's Hospital; Mount Sinai Hospital; Western University; University of Toronto","funders":"Canadian Institutes of Health Research; Genentech","keywords":"Type 2 diabetes; High-density lipoprotein; Diabetes mellitus; Cholesterol; Medicine; Internal medicine; Endocrinology","score_opus":0.010115458745603783,"score_gpt":0.24145201480239845,"score_spread":0.23133655605679465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086380056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98600936,0.012127991,0.00004981494,0.00004497165,0.00056495005,0.0008201683,0.00002806452,0.000060978826,0.00029369866],"genre_scores_gemma":[0.9972974,0.00063977024,0.0011897631,0.00020852023,0.0005104401,0.000033546847,0.00003888088,0.000041593976,0.000040092986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970906,0.00039224868,0.0005878842,0.00048724402,0.0005644077,0.0008776344],"domain_scores_gemma":[0.99819285,0.00011527562,0.00028720155,0.0007689096,0.00021840031,0.0004173438],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024519104,0.00038458066,0.0014607703,0.00030346613,0.00014544126,0.00006009995,0.00016298176,0.000296817,0.000057939975],"category_scores_gemma":[0.0006700958,0.00034844448,0.0003181191,0.0005116528,0.00026507155,0.00064709154,0.00021274835,0.00059409,0.000025002162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019723046,0.00048195446,0.77022475,0.00032324297,0.00022513763,0.0000021290682,0.00037271812,0.0000014169157,0.0026630599,0.00001531358,0.000027594482,0.22564295],"study_design_scores_gemma":[0.0016707189,0.000059228067,0.8913603,0.00021407325,0.00063081516,0.0000015168828,0.00007751822,0.00013629724,0.10411816,0.00018061971,0.0012659455,0.00028483247],"about_ca_topic_score_codex":0.008518043,"about_ca_topic_score_gemma":0.00044739872,"teacher_disagreement_score":0.22535811,"about_ca_system_score_codex":0.00002880341,"about_ca_system_score_gemma":0.00007787698,"threshold_uncertainty_score":0.99989676},"labels":[],"label_agreement":null},{"id":"W2088106139","doi":"10.1111/j.1463-1326.2009.01179.x","title":"Errors in patient perception of caloric deficit required for weight loss—observations from the Diet Plate Trial <sup>*</sup>","year":2009,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diet and metabolism studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Caloric theory; Weight loss; Calorie; Medicine; Caloric intake; Obesity; Population; Diabetes mellitus; Gerontology; Physical therapy; Environmental health; Internal medicine; Endocrinology","score_opus":0.027690046632202273,"score_gpt":0.24396540182944704,"score_spread":0.21627535519724478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088106139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9312308,0.0077550784,0.000012899853,0.05679293,0.0010114928,0.0022136946,0.00083555485,0.000042898828,0.00010466619],"genre_scores_gemma":[0.5961821,0.01944883,0.004673422,0.34474045,0.021931952,0.0016198271,0.009436387,0.00028276574,0.0016842639],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99714375,0.00019730775,0.00088491465,0.00063055736,0.000508507,0.0006349674],"domain_scores_gemma":[0.99820244,0.0005217117,0.00039430533,0.0005415856,0.0002470721,0.000092889844],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042309175,0.00053702213,0.0017105079,0.00025515625,0.00022004002,0.000034550834,0.00022340514,0.00070462935,0.000028297418],"category_scores_gemma":[0.0004169573,0.00037744013,0.00047149716,0.00035501574,0.00023836101,0.00017688474,0.00010126938,0.00089418935,0.0000069567036],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010756277,0.0024449248,0.085519455,0.0014160778,0.0022796094,0.00007464375,0.01993247,0.00003786769,0.0008788543,0.00074664253,0.8450141,0.030899104],"study_design_scores_gemma":[0.019374153,0.0004083724,0.40067858,0.00030138387,0.0021340742,4.39511e-7,0.0002925414,0.00011512375,0.00003855677,0.001773516,0.5744605,0.00042272752],"about_ca_topic_score_codex":0.0002836714,"about_ca_topic_score_gemma":0.000025842222,"teacher_disagreement_score":0.3350487,"about_ca_system_score_codex":0.0000439885,"about_ca_system_score_gemma":0.000099233075,"threshold_uncertainty_score":0.99986774},"labels":[],"label_agreement":null},{"id":"W2095497214","doi":"10.1111/j.1463-1326.2006.00639.x","title":"A comparison of insulin aspart and regular insulin in elderly patients with type 2 diabetes","year":2006,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Novo Nordisk","keywords":"Insulin aspart; Medicine; Insulin; Diabetes mellitus; Internal medicine; Endocrinology; Type 2 diabetes; Metformin; Regular insulin; Human insulin; Hypoglycemia","score_opus":0.009411476953642984,"score_gpt":0.224953700820747,"score_spread":0.21554222386710403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095497214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97257334,0.019471066,7.160005e-7,0.00609184,0.00021742609,0.0011018438,0.00007060561,0.00004640718,0.00042676786],"genre_scores_gemma":[0.96522844,0.0007395803,0.0007850814,0.029518193,0.0005248393,0.000093017115,0.0020344614,0.00010361927,0.00097275845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753714,0.00011395738,0.0005909731,0.00063682673,0.0004962044,0.00062489486],"domain_scores_gemma":[0.99880075,0.00010714026,0.00033846675,0.00045106682,0.00018556153,0.00011698039],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002101595,0.0005517525,0.0018095252,0.00052996626,0.00006318346,0.0000511487,0.00012975367,0.00052267796,0.000024377112],"category_scores_gemma":[0.000046450023,0.00044406904,0.00009772454,0.0003962985,0.00025140814,0.00015218227,0.00013484686,0.0007177775,0.000008646345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003928622,0.00088035926,0.92938894,0.0012347917,0.00047124922,0.00001628139,0.00013027817,0.0000017155263,0.00003367738,0.000023456863,0.055642523,0.01213745],"study_design_scores_gemma":[0.0039769486,0.0006946176,0.7930215,0.000650463,0.0011514535,8.697335e-8,0.0000104545,0.00003523548,0.00056644715,0.00015181908,0.1993556,0.00038533926],"about_ca_topic_score_codex":0.00005805742,"about_ca_topic_score_gemma":0.000022609323,"teacher_disagreement_score":0.14371309,"about_ca_system_score_codex":0.000033975713,"about_ca_system_score_gemma":0.00004664266,"threshold_uncertainty_score":0.9998011},"labels":[],"label_agreement":null},{"id":"W2095923443","doi":"10.1111/j.1463-1326.2012.01642.x","title":"Autocrine regulation of insulin secretion","year":2012,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Diabetes Canada; University of Alberta","funders":"Diabetes Research and Wellness Foundation; National Institute for Health and Care Research; Wellcome Trust","keywords":"Autocrine signalling; Paracrine signalling; Insulin; Secretion; Endocrinology; Biology; Internal medicine; Receptor; Cell biology; Biochemistry; Medicine","score_opus":0.032236669992980777,"score_gpt":0.28058472244380017,"score_spread":0.2483480524508194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095923443","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014516382,0.9832242,0.00001565661,0.000016412067,0.00037983124,0.0006287411,0.000049309518,0.00006305194,0.001106377],"genre_scores_gemma":[0.0028834403,0.9949277,0.00038089574,0.00006851133,0.0004809783,0.00004879989,0.00051910576,0.000033489727,0.00065707136],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99851316,0.00013639982,0.0005510246,0.00027485055,0.00023607488,0.0002885056],"domain_scores_gemma":[0.99884236,0.00013152849,0.00035776943,0.00034288518,0.00010929387,0.00021614016],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040141732,0.00032350424,0.0020789132,0.00030123148,0.000053958505,0.00001253891,0.00005906019,0.00032954535,0.00028098503],"category_scores_gemma":[0.00017532292,0.0002500145,0.0003370156,0.0003111763,0.000105713065,0.000118253054,0.00005713932,0.00024713652,0.000055025233],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007123542,0.00018875726,0.0011681361,0.022993159,0.0002962211,4.3783953e-7,0.000047931648,5.368129e-8,0.00010292012,0.0015321497,0.00013857962,0.9735245],"study_design_scores_gemma":[0.000516617,0.000036166977,0.030162986,0.003477053,0.0053772815,0.000005468036,0.000003822275,0.000017465529,0.0001330925,0.00016700664,0.95989007,0.00021295533],"about_ca_topic_score_codex":0.000009902552,"about_ca_topic_score_gemma":2.1817407e-7,"teacher_disagreement_score":0.9733116,"about_ca_system_score_codex":0.000025095938,"about_ca_system_score_gemma":0.00009696418,"threshold_uncertainty_score":0.99999523},"labels":[],"label_agreement":null},{"id":"W2096349641","doi":"10.1111/j.1463-1326.2011.01410.x","title":"Differentiating short‐ and long‐term effects of diet in the obese mouse using <sup>1</sup> H‐nuclear magnetic resonance metabolomics","year":2011,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Fondation pour la Recherche Médicale; Canadian Diabetes Association; Heart and Stroke Foundation of Canada","keywords":"Metabolomics; Metabolite; Obesity; Weaning; Endocrinology; Internal medicine; Biology; Medicine; Bioinformatics","score_opus":0.011486685281290604,"score_gpt":0.21068095048047064,"score_spread":0.19919426519918004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096349641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9245389,0.07499043,0.00002475938,0.000009934624,0.00006407851,0.00028576454,0.000022983791,0.000006893657,0.000056273868],"genre_scores_gemma":[0.9881853,0.010249636,0.0012228094,0.00018593893,0.00008160687,0.000015498574,0.000010850502,0.000024404173,0.000023977642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985961,0.00018808046,0.00029117457,0.0004051127,0.00013652362,0.00038305728],"domain_scores_gemma":[0.9993888,0.00005017438,0.00008884654,0.0003514396,0.000047710975,0.00007302705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037654475,0.00025994188,0.00048559761,0.00010111519,0.00014536318,0.000034028406,0.0002304774,0.0001382486,0.000007583364],"category_scores_gemma":[0.00015345441,0.00020024748,0.00009259392,0.00015500771,0.00023161096,0.000016001955,0.00030069705,0.00016237464,4.0541366e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001190364,0.00044785452,0.5415654,0.00038406157,0.00018030773,0.0000073635506,0.0023766425,0.0000027696608,0.44648284,0.0019845502,0.00002174863,0.006427417],"study_design_scores_gemma":[0.00073575607,0.00020642378,0.9424799,0.00003576892,0.00024676544,0.0000028117577,0.00014144443,0.00032587314,0.054679092,0.00021149778,0.0006604326,0.00027424897],"about_ca_topic_score_codex":0.00003246144,"about_ca_topic_score_gemma":0.000018422905,"teacher_disagreement_score":0.40091446,"about_ca_system_score_codex":0.0000037280283,"about_ca_system_score_gemma":0.000011590458,"threshold_uncertainty_score":0.8165855},"labels":[],"label_agreement":null},{"id":"W2099670937","doi":"10.1111/dom.12494","title":"Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4‐week, randomized, placebo‐controlled trial ( <scp>EASE</scp> ‐1)","year":2015,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Eli Lilly and Company; Boehringer Ingelheim","keywords":"Empagliflozin; Placebo; Medicine; Insulin; Type 2 diabetes; Clinical endpoint; Internal medicine; Diabetes mellitus; Randomized controlled trial; Adverse effect; Endocrinology","score_opus":0.013638609868025108,"score_gpt":0.2461924121162025,"score_spread":0.23255380224817737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099670937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840603,0.0026028398,0.0000053214153,0.0002956636,0.0006607667,0.008428663,0.000013224135,0.00008101661,0.0038522126],"genre_scores_gemma":[0.9930005,0.00009818818,0.0002981996,0.0014015506,0.0004067763,0.00064888585,0.000104927916,0.000060465703,0.0039805127],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99595207,0.000630873,0.0006537033,0.0006746635,0.0010461968,0.0010424873],"domain_scores_gemma":[0.9971098,0.000789021,0.00017944816,0.00050198426,0.0004654384,0.0009543395],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028293615,0.00048295647,0.0023045344,0.000781282,0.000103941886,0.00013812377,0.00026039346,0.00021022867,0.000044375538],"category_scores_gemma":[0.005966654,0.00032760232,0.00022713917,0.0009566046,0.00022534207,0.00029364083,0.00025642884,0.0004516513,0.00026159952],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74794513,0.0041458355,0.23268956,0.00026275156,0.0015461078,0.000023981314,0.0013696199,0.000035949342,0.00006243814,0.0004744045,0.005326334,0.0061178766],"study_design_scores_gemma":[0.9056118,0.00170685,0.08156017,0.00017701733,0.00079467887,7.273913e-8,0.00010496271,0.0003110154,0.00022363661,0.00048309137,0.008814723,0.0002119704],"about_ca_topic_score_codex":0.000036495512,"about_ca_topic_score_gemma":0.000014865239,"teacher_disagreement_score":0.15766667,"about_ca_system_score_codex":0.000058018348,"about_ca_system_score_gemma":0.0002008591,"threshold_uncertainty_score":0.9999176},"labels":[],"label_agreement":null},{"id":"W2102844230","doi":"10.1111/j.1463-1326.2005.00533.x","title":"Elevated C‐reactive protein in Native Canadian children: an ominous early complication of childhood obesity","year":2005,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto; Western University; Mount Sinai Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health","keywords":"Medicine; Adiponectin; Internal medicine; Interquartile range; Metabolic syndrome; Population; C-reactive protein; Insulin resistance; Obesity; Endocrinology; Childhood obesity; Waist; National Health and Nutrition Examination Survey; Overweight; Inflammation; Environmental health","score_opus":0.006843874011588902,"score_gpt":0.21939738582308943,"score_spread":0.21255351181150053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102844230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961232,0.0015763976,0.000006436199,0.00019692963,0.00003620301,0.0013013625,0.00016073152,0.000047305224,0.0005514132],"genre_scores_gemma":[0.99849856,0.000075006945,0.00047499058,0.0002723078,0.000251465,0.000066709596,0.0002714672,0.000021110372,0.00006840195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984698,0.00012369566,0.00038636572,0.00037475015,0.00023953116,0.00040585303],"domain_scores_gemma":[0.99873817,0.000027860106,0.00018100823,0.0003218643,0.0002584298,0.00047268224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029514148,0.00024129204,0.0005869317,0.0004205039,0.00012861802,0.000022282824,0.00012488992,0.00014416694,0.000042689528],"category_scores_gemma":[0.00016717463,0.00023111377,0.000079562626,0.00037572248,0.0001452413,0.00046443148,0.000024690802,0.00021060482,0.00001142869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005470151,0.0018483822,0.9615146,0.0000657973,0.00019081672,0.0000027115382,0.0032281154,0.0000095457,0.009335902,0.004997609,0.00001757338,0.018734284],"study_design_scores_gemma":[0.0017305717,0.00006792121,0.9690078,0.00007293703,0.00019545213,0.0000030201957,0.000051388743,0.00008548598,0.026997073,0.00037245697,0.0012013082,0.00021460418],"about_ca_topic_score_codex":0.018156817,"about_ca_topic_score_gemma":0.010551461,"teacher_disagreement_score":0.01851968,"about_ca_system_score_codex":0.00006210924,"about_ca_system_score_gemma":0.00030296945,"threshold_uncertainty_score":0.9883814},"labels":[],"label_agreement":null},{"id":"W2103828712","doi":"10.1111/j.1463-1326.2008.00994.x","title":"Fifty‐two‐week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy","year":2008,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":294,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"National Institute for Health and Care Research","keywords":"Vildagliptin; Glimepiride; Medicine; Metformin; Type 2 diabetes; Internal medicine; Diabetes mellitus; Type 2 Diabetes Mellitus; Hypoglycemia; Confidence interval; Randomized controlled trial; Gastroenterology; Endocrinology","score_opus":0.009903568371051009,"score_gpt":0.2167715782832629,"score_spread":0.2068680099122119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103828712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911106,0.0065042498,0.0000023262967,0.00013373733,0.000098312186,0.0016020327,0.000019542776,0.00004266024,0.00048653645],"genre_scores_gemma":[0.99571764,0.0027939847,0.00051577366,0.000570754,0.000045613328,0.00005000355,0.00007236044,0.000034749126,0.00019908919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813557,0.0001067239,0.0004691962,0.00043537896,0.00035081655,0.0005022909],"domain_scores_gemma":[0.99889654,0.00026887807,0.00019685911,0.00031908092,0.00012069201,0.00019796031],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003554935,0.00037397552,0.0013704302,0.00033265306,0.00011087679,0.000019155532,0.00009128613,0.00009859424,0.000031649837],"category_scores_gemma":[0.0001063525,0.00026872492,0.00008970731,0.0003312604,0.00021656799,0.00017868113,0.000055453922,0.0001735298,0.000008135734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062400317,0.0031737962,0.94437885,0.00016757654,0.0010311052,0.000014974649,0.0006380076,0.000021647737,0.0003472363,0.0007964219,0.00008603815,0.04310433],"study_design_scores_gemma":[0.050475113,0.0018982791,0.93789804,0.00018113086,0.0005193835,2.3660446e-7,0.000016649823,0.000088999994,0.005075969,0.00009590843,0.0034789867,0.00027127692],"about_ca_topic_score_codex":0.000037065376,"about_ca_topic_score_gemma":0.000009143491,"teacher_disagreement_score":0.04423508,"about_ca_system_score_codex":0.000032379245,"about_ca_system_score_gemma":0.00003824078,"threshold_uncertainty_score":0.9999765},"labels":[],"label_agreement":null},{"id":"W2106144638","doi":"10.1111/j.1463-1326.2009.01057.x","title":"Home telehealth for diabetes management: a systematic review and meta‐analysis","year":2009,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":246,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Telehealth; Medicine; MEDLINE; Telemedicine; Randomized controlled trial; Confidence interval; Meta-analysis; Health care; Quality of life (healthcare); Telecare; Diabetes mellitus; Family medicine; Population; Physical therapy; Nursing; Internal medicine","score_opus":0.044979311744765896,"score_gpt":0.35528001117062386,"score_spread":0.310300699425858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106144638","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000738886,0.9874238,0.000030380294,0.00073467125,0.000059902548,0.011202378,0.00033603492,0.0000890771,0.00004990692],"genre_scores_gemma":[0.00002750002,0.9865275,0.0012154531,0.008331336,0.00012594595,0.0023507695,0.000955117,0.000055714998,0.000410671],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99600655,0.00037766542,0.001634885,0.00081931904,0.0003800834,0.0007814929],"domain_scores_gemma":[0.99733686,0.00040295787,0.00094285415,0.000677431,0.00014175446,0.0004981533],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018218451,0.00076524547,0.013265496,0.00090436335,0.00022482206,0.000056968394,0.00017284343,0.00023750868,0.0000578401],"category_scores_gemma":[0.00012943844,0.00051800546,0.0016212467,0.0011498778,0.00007565497,0.00013513428,0.00008025935,0.00031927793,0.000007531349],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000010829247,0.000072433206,0.000035941986,0.8764689,0.08327388,0.0000026826115,0.000021387626,4.6288724e-9,1.6743552e-8,0.0003574547,0.00042499023,0.039341204],"study_design_scores_gemma":[0.000459761,0.00009902021,0.00035865259,0.026760079,0.7250873,0.000004485928,0.000008219794,0.0000020673542,2.2652915e-7,0.00011397754,0.24679004,0.00031620444],"about_ca_topic_score_codex":0.000007944492,"about_ca_topic_score_gemma":0.0000048003376,"teacher_disagreement_score":0.84970886,"about_ca_system_score_codex":0.000039799426,"about_ca_system_score_gemma":0.000080383135,"threshold_uncertainty_score":0.99972713},"labels":[],"label_agreement":null},{"id":"W2107562831","doi":"10.1111/j.1463-1326.2010.01233.x","title":"Vildagliptin add‐on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2‐year study","year":2010,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"National Institute for Health and Care Research","keywords":"Vildagliptin; Glimepiride; Medicine; Metformin; Diabetes mellitus; Internal medicine; Type 2 diabetes; Gastroenterology; Endocrinology","score_opus":0.008943048231581338,"score_gpt":0.22399462829677433,"score_spread":0.21505158006519298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107562831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994617,0.0004249631,0.0000017399014,0.00041314334,0.00038485893,0.0028100521,0.00018706547,0.0001450223,0.0010161663],"genre_scores_gemma":[0.993709,0.000117748335,0.004124341,0.0004153246,0.00070619746,0.00014468828,0.00013894048,0.0000533251,0.00059038156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740195,0.00011235716,0.00036829003,0.0010302159,0.00052558957,0.0005615705],"domain_scores_gemma":[0.99807805,0.00024431886,0.00020153272,0.0008139149,0.0001900494,0.00047214594],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006075705,0.00050899497,0.0009565243,0.00026006807,0.00025401363,0.00011931469,0.00016422333,0.000104928906,0.00003180329],"category_scores_gemma":[0.00030912654,0.00033297087,0.000054650016,0.00034425975,0.00016221587,0.00019483891,0.00013821569,0.000444639,0.00005578926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026916662,0.017589815,0.7901687,0.0003503894,0.008549449,0.00026844774,0.013699234,0.00004632304,0.05365875,0.0003692288,0.01922299,0.06916004],"study_design_scores_gemma":[0.023985203,0.003201287,0.9052574,0.0002269491,0.002978949,0.0000016952557,0.0004299252,0.000060103037,0.024185263,0.00005756557,0.038992945,0.00062271976],"about_ca_topic_score_codex":0.00017911098,"about_ca_topic_score_gemma":0.00018274528,"teacher_disagreement_score":0.115088716,"about_ca_system_score_codex":0.000017617744,"about_ca_system_score_gemma":0.000047575428,"threshold_uncertainty_score":0.99991226},"labels":[],"label_agreement":null},{"id":"W2111447866","doi":"10.1111/j.1463-1326.2008.01026.x","title":"Effect of antiobesity medications in patients with type 2 diabetes mellitus","year":2009,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Orlistat; Medicine; Sibutramine; Weight loss; Liraglutide; Diabetes mellitus; Type 2 Diabetes Mellitus; Rimonabant; Exenatide; Type 2 diabetes; Phentermine; Management of obesity; Incretin; Internal medicine; Obesity; Endocrinology; Antagonist","score_opus":0.008592925378184008,"score_gpt":0.2911010331813722,"score_spread":0.2825081078031882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111447866","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42639577,0.57241845,1.758125e-7,0.000009570653,0.000097445394,0.0009404024,0.00003964908,0.000021978012,0.00007657996],"genre_scores_gemma":[0.030061468,0.96905935,0.00008324748,0.00009144408,0.0000731541,0.00005617835,0.00049798045,0.000027966827,0.00004918908],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99779004,0.0004727311,0.00051251514,0.00048202294,0.00029847212,0.00044420263],"domain_scores_gemma":[0.99858874,0.00035306907,0.00031577362,0.00039249146,0.00011788254,0.00023202419],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006036039,0.00051144283,0.0030885425,0.0004091149,0.00008800275,0.0000097471075,0.00015547575,0.00041880543,0.000047311063],"category_scores_gemma":[0.00010595532,0.00033714515,0.00024235556,0.0005769334,0.00021995601,0.00009843116,0.00006328208,0.0005001491,0.000022688393],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006926085,0.001615764,0.26247546,0.013801968,0.0010055972,0.000008994247,0.000042798583,1.3164197e-7,0.000002331959,0.00004757,0.000086500084,0.7208436],"study_design_scores_gemma":[0.0044158767,0.0015506229,0.7711923,0.0077125924,0.015252828,0.0000012967354,9.2922943e-7,0.0000022567197,0.0003122574,0.00003282448,0.19908355,0.00044265777],"about_ca_topic_score_codex":0.0000068319573,"about_ca_topic_score_gemma":0.0000024473836,"teacher_disagreement_score":0.720401,"about_ca_system_score_codex":0.000055894146,"about_ca_system_score_gemma":0.00016358033,"threshold_uncertainty_score":0.99990803},"labels":[],"label_agreement":null},{"id":"W2113206514","doi":"10.1111/dom.12529","title":"Islet amyloid inhibitors improve glucose homeostasis in a transgenic mouse model of type 2 diabetes","year":2015,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Islet; Amyloid (mycology); Genetically modified mouse; Glucose homeostasis; Endocrinology; Internal medicine; In vivo; Type 2 diabetes; Transgene; Diabetes mellitus; Apoptosis; Insulin; Secretion; Biology; Chemistry; Medicine; Biochemistry; Insulin resistance","score_opus":0.01756434275765166,"score_gpt":0.22753389156601977,"score_spread":0.2099695488083681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113206514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9608868,0.023164125,0.0000032611597,0.0133676035,0.0006395928,0.0007823819,0.0006453492,0.000095967545,0.0004149494],"genre_scores_gemma":[0.7303134,0.008553354,0.0014055052,0.24815822,0.0035504033,0.0002373249,0.0019749727,0.0003364535,0.0054703504],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99663526,0.00017824957,0.00082995265,0.0007710561,0.0006822624,0.0009032345],"domain_scores_gemma":[0.9980726,0.00020164938,0.00031284068,0.00070928456,0.00038200253,0.0003216087],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006562235,0.000693957,0.002198361,0.0007717703,0.00006115272,0.000042687312,0.00021415208,0.0011706959,0.00007207071],"category_scores_gemma":[0.0004376127,0.0006174176,0.00035334943,0.00054065057,0.0003083546,0.0002135935,0.000102633676,0.0014708204,0.000029920635],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031814186,0.0015459196,0.036917083,0.0077065346,0.0019554656,0.00003066416,0.0020423578,0.000076580895,0.35283804,0.000086235734,0.5824236,0.0140593415],"study_design_scores_gemma":[0.011015282,0.0007887733,0.0053113815,0.0010328909,0.004175603,0.0000014613735,0.00014205213,0.0048070806,0.6754584,0.0018788048,0.29321718,0.0021711055],"about_ca_topic_score_codex":0.00006359041,"about_ca_topic_score_gemma":0.0000038637154,"teacher_disagreement_score":0.32262033,"about_ca_system_score_codex":0.0000815584,"about_ca_system_score_gemma":0.0003687615,"threshold_uncertainty_score":0.9996277},"labels":[],"label_agreement":null},{"id":"W2113411572","doi":"10.1111/j.1463-1326.2010.01254.x","title":"Initial short‐term intensive insulin therapy as a strategy for evaluating the preservation of beta‐cell function with oral antidiabetic medications: a pilot study with sitagliptin","year":2010,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Merck Canada","keywords":"Sitagliptin; Medicine; Metformin; Internal medicine; Insulin; Placebo; Sitagliptin Phosphate; Endocrinology; Diabetes mellitus; Beta cell; Insulin resistance; Type 2 diabetes; Pharmacology; Islet","score_opus":0.0534038358896754,"score_gpt":0.3209368514847031,"score_spread":0.2675330155950277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113411572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948186,0.0008079227,0.00010815935,0.0002922385,0.0001087148,0.0035632367,0.000014387141,0.000042023865,0.00024469834],"genre_scores_gemma":[0.99792975,0.00008301696,0.00064899644,0.00037720782,0.00011432099,0.0005861319,0.000113452355,0.000027094311,0.00012000407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985914,0.00010509574,0.000292261,0.00034045856,0.00039568698,0.0002750757],"domain_scores_gemma":[0.99851173,0.0001864672,0.0001788976,0.00036822126,0.00065819384,0.000096502816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073912466,0.000236237,0.00045623578,0.0001283822,0.00019073868,0.00005273191,0.00011277767,0.00004938569,0.000030741845],"category_scores_gemma":[0.00009097204,0.00013477483,0.000046038393,0.00024799735,0.00019058758,0.0002609039,0.000043712844,0.00020629361,0.0000020411362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044304268,0.0076010725,0.8295591,0.00041805345,0.0030897425,0.0000053030594,0.0034346008,0.00003370589,0.058695726,0.001507083,0.00009693807,0.09112824],"study_design_scores_gemma":[0.008400636,0.022639232,0.9519724,0.00007243405,0.0026893965,9.360315e-7,0.001355576,0.0005101196,0.011553549,0.00037952152,0.00023067076,0.00019552119],"about_ca_topic_score_codex":0.00006873527,"about_ca_topic_score_gemma":0.00009814693,"teacher_disagreement_score":0.1224133,"about_ca_system_score_codex":0.000008235967,"about_ca_system_score_gemma":0.00010727728,"threshold_uncertainty_score":0.5495958},"labels":[],"label_agreement":null},{"id":"W2113724447","doi":"10.1111/j.1463-1326.2011.01495.x","title":"Interleukin‐15 treatment improves glucose homeostasis and insulin sensitivity in obese mice","year":2011,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Glucose homeostasis; Insulin sensitivity; Homeostasis; Endocrinology; Internal medicine; Insulin; Medicine; Insulin resistance","score_opus":0.012434354174829427,"score_gpt":0.2041513459036775,"score_spread":0.19171699172884807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113724447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9527586,0.045412246,0.000006776987,0.000038317117,0.0011120667,0.00019324434,0.000011866732,0.00004482674,0.00042206616],"genre_scores_gemma":[0.9930881,0.0058484166,0.00006223512,0.00020785861,0.000024966475,0.000020256284,0.000045185017,0.000011751445,0.00069119787],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988828,0.00022418091,0.00023314178,0.00032966843,0.000021008103,0.0003092395],"domain_scores_gemma":[0.9995866,0.00008221065,0.00008340853,0.00016711399,0.000042860036,0.000037809885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025450467,0.00022029202,0.00038033558,0.00018553507,0.0001257876,0.000022500644,0.00004683745,0.0001958876,0.00016386197],"category_scores_gemma":[0.00004999204,0.00018803329,0.00006601084,0.00010358428,0.00016244248,0.00026622627,0.000077892015,0.00021790099,0.00010319999],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033383802,0.0010490725,0.031464547,0.000049589205,0.00029330663,0.0000121191115,0.006268982,1.3907432e-7,0.76739216,0.00040807592,0.00027358532,0.19245458],"study_design_scores_gemma":[0.0015409667,0.00015617874,0.50000054,0.000024372986,0.000080031255,0.000016143536,0.0004467207,0.000010605154,0.47388908,0.00009237014,0.023554577,0.00018839569],"about_ca_topic_score_codex":0.0011167515,"about_ca_topic_score_gemma":0.00027404865,"teacher_disagreement_score":0.468536,"about_ca_system_score_codex":0.000030290566,"about_ca_system_score_gemma":0.000016909627,"threshold_uncertainty_score":0.7667775},"labels":[],"label_agreement":null},{"id":"W2114506972","doi":"10.1111/dom.12444","title":"<scp>LEADER</scp> 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the <scp>L</scp> iraglutide <scp>E</scp> ffect and <scp>A</scp> ction in <scp>D</scp> iabetes: <scp>E</scp> valuation of cardiovascular outcome <scp>R</scp> esults ( <scp>LEADER</scp> ) trial: preliminary observations","year":2015,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Novartis Pharma; Novo Nordisk Fonden; Astellas Pharma; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Orexigen Therapeutics; F. Hoffmann-La Roche; Novo Nordisk; Medicines Company; Intarcia Therapeutics; GlaxoSmithKline; Osiris Therapeutics; Halozyme; Sanofi; St. Jude Medical; MannKind Corporation; Pfizer","keywords":"Medicine; Calcitonin; Gerontology; Internal medicine","score_opus":0.04427697335830322,"score_gpt":0.2587140336290045,"score_spread":0.2144370602707013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114506972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91574436,0.06050746,0.000315648,0.00031677692,0.0028579629,0.013435972,0.00077656633,0.0010013652,0.0050439057],"genre_scores_gemma":[0.9573047,0.009871259,0.003069488,0.002493029,0.0025183302,0.004576921,0.004633735,0.0010792873,0.014453217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9698626,0.0056913076,0.0060428414,0.0055427295,0.0058027767,0.0070577874],"domain_scores_gemma":[0.9498673,0.0369542,0.0034215425,0.004764414,0.0023902778,0.0026022792],"candidate_categories":["metaresearch","metaepi_narrow","sts","scholarly_communication","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.017350616,0.0048572123,0.009204896,0.005006119,0.0014296774,0.0013013334,0.0027185031,0.0028796967,0.0000105033605],"category_scores_gemma":[0.07644753,0.004303288,0.0023973472,0.009351858,0.001668585,0.0037098164,0.0016102808,0.0041757924,0.00027227154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001607626,0.0124101015,0.8021524,0.0061901663,0.010785993,0.0005243996,0.05990456,0.009575192,0.0051496136,0.0014648488,0.087287016,0.004394948],"study_design_scores_gemma":[0.073627576,0.005431276,0.62429816,0.0025072538,0.012618636,0.000054812153,0.053568546,0.011583276,0.015944598,0.0021157004,0.1977783,0.00047188636],"about_ca_topic_score_codex":0.0013932972,"about_ca_topic_score_gemma":0.0010822561,"teacher_disagreement_score":0.17785425,"about_ca_system_score_codex":0.001148869,"about_ca_system_score_gemma":0.0014350271,"threshold_uncertainty_score":0.9998703},"labels":[],"label_agreement":null},{"id":"W2117505171","doi":"10.1111/dom.12187","title":"Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years","year":2013,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":295,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Astellas Pharma; AstraZeneca","keywords":"Dapagliflozin; Medicine; Placebo; Insulin; Adverse effect; Diabetes mellitus; Type 2 diabetes; Population; Internal medicine; Urology; Endocrinology","score_opus":0.0043399929951399956,"score_gpt":0.19137911585337625,"score_spread":0.18703912285823626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117505171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648976,0.0023147846,3.4901194e-7,0.00007424539,0.00010743558,0.0007443573,0.000012085909,0.000029145736,0.0002278493],"genre_scores_gemma":[0.99841225,0.0005751522,0.00051000743,0.00023825836,0.00003776668,0.000020010215,0.000063754145,0.000021138456,0.00012166256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887437,0.000046104262,0.00024765093,0.00029377762,0.00020917902,0.00032889852],"domain_scores_gemma":[0.99936473,0.00009585668,0.00009465194,0.00022719613,0.000084153675,0.0001333876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014836412,0.00020054783,0.0005502186,0.00019248914,0.000040171268,0.000031594172,0.00006086034,0.000077471435,0.00009080605],"category_scores_gemma":[0.00007891865,0.00015617574,0.000030288966,0.0002709777,0.00012174523,0.00024180318,0.00010443032,0.00011234832,0.000010351926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006236294,0.0005148385,0.9637934,0.00013390838,0.00019642522,9.226417e-7,0.00017541587,0.0000015079615,0.0003365041,0.00018059881,0.00012605533,0.034478083],"study_design_scores_gemma":[0.0059629777,0.0002912765,0.99078035,0.00019671489,0.00027247277,2.774191e-8,0.000016876887,0.000016785089,0.0007380617,0.00012373719,0.0014353363,0.00016535188],"about_ca_topic_score_codex":0.000085293344,"about_ca_topic_score_gemma":0.0000075589196,"teacher_disagreement_score":0.03431273,"about_ca_system_score_codex":0.000016540282,"about_ca_system_score_gemma":0.000015096513,"threshold_uncertainty_score":0.6368662},"labels":[],"label_agreement":null},{"id":"W2120771901","doi":"10.1111/j.1463-1326.2005.00541.x","title":"Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (&gt;60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study","year":2005,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosiglitazone; Medicine; Glipizide; Tolerability; Placebo; Internal medicine; Type 2 Diabetes Mellitus; Type 2 diabetes; Randomized controlled trial; Diabetes mellitus; Gastroenterology; Insulin; Endocrinology; Adverse effect; Alternative medicine","score_opus":0.005432125892819263,"score_gpt":0.2292860588156759,"score_spread":0.22385393292285663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120771901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950159,0.0015188236,0.0000014657024,0.00013174783,0.00020451621,0.0029087192,0.00007084727,0.00003288625,0.0001151028],"genre_scores_gemma":[0.99884415,0.00020416845,0.00010157871,0.00018542036,0.00012989425,0.00018192134,0.00015019708,0.000033778022,0.00016891364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779785,0.00027618377,0.00055071886,0.00041319008,0.0005224611,0.00043959534],"domain_scores_gemma":[0.9987246,0.00022998934,0.00020905191,0.00048008887,0.00021295971,0.00014332456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008819026,0.00033205643,0.0008414181,0.00032959948,0.00006198586,0.000041183626,0.00017564013,0.00012262534,0.000057968744],"category_scores_gemma":[0.00013729329,0.0002360841,0.00013884027,0.0006296503,0.00010671586,0.00030324806,0.000091464986,0.00015866845,0.000024920544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005881042,0.0027824189,0.9119934,0.00010874832,0.00041177432,0.0000024824483,0.0040488285,0.000013168456,0.005718512,0.00006372912,0.00036696988,0.07390187],"study_design_scores_gemma":[0.0069556865,0.0046939137,0.9552936,0.00012398204,0.00041026503,4.1000945e-8,0.000045185356,0.000019114299,0.031075193,0.000021789974,0.0011672457,0.00019399301],"about_ca_topic_score_codex":0.00016821863,"about_ca_topic_score_gemma":0.00006397835,"teacher_disagreement_score":0.07370787,"about_ca_system_score_codex":0.000044585722,"about_ca_system_score_gemma":0.000025495929,"threshold_uncertainty_score":0.962723},"labels":[],"label_agreement":null},{"id":"W2120993742","doi":"10.1111/dom.12238","title":"Intensification of medication and glycaemic control among patients with type 2 diabetes – the <scp>ADVANCE</scp> trial","year":2013,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Diabetes mellitus; Odds ratio; Confidence interval; Type 2 diabetes; Internal medicine; Randomized controlled trial; Insulin; Logistic regression; Endocrinology","score_opus":0.004643060273135869,"score_gpt":0.1916671397977088,"score_spread":0.18702407952457292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120993742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950168,0.0025326377,0.000015475624,0.00022293687,0.00019007406,0.0017418916,0.0000083813275,0.000032472784,0.00023931348],"genre_scores_gemma":[0.9985015,0.00038037196,0.00015374059,0.00043519353,0.000083971754,0.00014585983,0.00008684297,0.000015191605,0.0001973369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895704,0.00006193718,0.0002354178,0.0002461347,0.00024684388,0.00025263842],"domain_scores_gemma":[0.9989256,0.00021193674,0.0001972367,0.00027239,0.00027381803,0.000118999014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022847955,0.00017417672,0.00041130272,0.00008616718,0.00009029015,0.000034278102,0.00007495121,0.00006887781,0.000012610336],"category_scores_gemma":[0.00027461015,0.00010372988,0.000040334082,0.00015930922,0.00029469395,0.0002513245,0.000039939252,0.00010177671,0.0000081408725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098150136,0.00032208615,0.9819115,0.00009374858,0.00035222166,1.3984538e-7,0.00025332367,6.432973e-7,0.00088042277,0.0003917609,0.00066559704,0.015030446],"study_design_scores_gemma":[0.01641756,0.00037718983,0.9775635,0.00005980567,0.00078840455,4.530365e-8,0.00008197621,0.0001718378,0.0012701247,0.00029923982,0.0029214823,0.000048809838],"about_ca_topic_score_codex":0.00002266574,"about_ca_topic_score_gemma":0.0000029008047,"teacher_disagreement_score":0.016319409,"about_ca_system_score_codex":0.000010820745,"about_ca_system_score_gemma":0.000015622745,"threshold_uncertainty_score":0.42299816},"labels":[],"label_agreement":null},{"id":"W2128093058","doi":"10.1111/dom.12290","title":"Pronounced reduction of postprandial glucagon by lixisenatide: a meta‐analysis of randomized clinical trials","year":2014,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Sanofi","keywords":"Lixisenatide; Postprandial; Meta-analysis; Randomized controlled trial; Glucagon; Medicine; Internal medicine; Reduction (mathematics); Endocrinology; Diabetes mellitus; Type 2 diabetes; Insulin; Mathematics; Liraglutide","score_opus":0.0973132919649313,"score_gpt":0.40441716668855515,"score_spread":0.3071038747236239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128093058","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041417093,0.9899383,0.0000589575,0.000054139527,0.0004459065,0.0047153067,0.00033316622,0.000037998263,0.000274513],"genre_scores_gemma":[0.0015762512,0.9950826,0.00048577687,0.000049222235,0.00024782834,0.0005220146,0.0014561507,0.000042357107,0.0005377976],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98914635,0.0053367335,0.0038913754,0.0007265791,0.0005321202,0.00036681344],"domain_scores_gemma":[0.9919329,0.0034481094,0.0034227245,0.00068854954,0.0002622642,0.00024542585],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.01864252,0.0006700017,0.03187109,0.0010158303,0.000053015556,0.00003084793,0.0001857655,0.0005170221,0.00013514105],"category_scores_gemma":[0.0031121995,0.00041582645,0.011791503,0.0008781713,0.00042047614,0.000101010046,0.00011191357,0.00031647753,0.0000055183036],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020006504,0.0010404151,0.000042839005,0.013375453,0.64606375,6.6000865e-7,0.00006701482,3.65303e-7,0.000009315921,0.00055127376,0.00043034003,0.33641794],"study_design_scores_gemma":[0.025240647,0.00016509694,0.00004141422,0.0006262679,0.7457498,2.8275548e-7,0.000005721564,0.000020216097,0.000087093074,0.000058609614,0.2277661,0.0002387897],"about_ca_topic_score_codex":0.000041210165,"about_ca_topic_score_gemma":0.0000020572793,"teacher_disagreement_score":0.33617914,"about_ca_system_score_codex":0.000022637467,"about_ca_system_score_gemma":0.00013519268,"threshold_uncertainty_score":0.99982935},"labels":[],"label_agreement":null},{"id":"W2133819196","doi":"10.1111/j.1463-1326.2007.00837.x","title":"Metabolomic profiling of dietary‐induced insulin resistance in the high fat–fed C57BL/6J mouse","year":2008,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Metabolomics; Insulin resistance; Metabolite; Internal medicine; Metabolome; Endocrinology; Biology; Insulin; Bioinformatics; Medicine","score_opus":0.014542742527578145,"score_gpt":0.22092888525878343,"score_spread":0.20638614273120529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133819196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738326,0.02498993,0.000018736468,0.00017414488,0.00015867503,0.00034112207,0.000067747846,0.000010907272,0.0004061274],"genre_scores_gemma":[0.9902116,0.006583187,0.0023073987,0.00030220483,0.00018811347,0.00004911666,0.00006302507,0.000020023435,0.00027535306],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983092,0.00020991723,0.00039534026,0.00045691172,0.00021739489,0.00041124108],"domain_scores_gemma":[0.99914455,0.000051005904,0.00017694035,0.000469552,0.000092782444,0.00006517674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053856947,0.00026774852,0.00057725597,0.00012576133,0.00020353621,0.000017209759,0.0003307501,0.00015658166,0.0000070884953],"category_scores_gemma":[0.00023250686,0.00020265943,0.00013196033,0.00030135657,0.00020340752,0.000014111776,0.0001644499,0.00020697786,0.0000028412765],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008787023,0.00023212527,0.02226209,0.00006080241,0.00015571238,0.0000035551134,0.00035666834,0.00000309605,0.9723045,0.0039844657,0.00025973658,0.00028937878],"study_design_scores_gemma":[0.0009714697,0.00007762565,0.39832798,0.000008876333,0.000081661245,0.0000014127354,0.00011710976,0.000006638528,0.5936972,0.0007219018,0.0057462864,0.00024187395],"about_ca_topic_score_codex":0.00006839962,"about_ca_topic_score_gemma":0.00009874204,"teacher_disagreement_score":0.37860733,"about_ca_system_score_codex":0.0000055446976,"about_ca_system_score_gemma":0.000038350798,"threshold_uncertainty_score":0.82642114},"labels":[],"label_agreement":null},{"id":"W2135041172","doi":"10.1111/j.1463-1326.2006.00625.x","title":"Visfatin expression is hormonally regulated by metabolic and sex hormones in 3T3‐L1 pre‐adipocytes and adipocytes","year":2006,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs","keywords":"Internal medicine; Endocrinology; Adipocyte; Hormone; Adipokine; 3T3-L1; Insulin; Endogeny; Chemistry; Biology; Adipose tissue; Insulin resistance; Medicine","score_opus":0.0047910215498751475,"score_gpt":0.21167569187205765,"score_spread":0.2068846703221825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135041172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81587607,0.18269217,0.000015661008,0.00024723745,0.00006780275,0.0005462052,0.00011223617,0.00009748756,0.00034511997],"genre_scores_gemma":[0.985761,0.010823117,0.0007487881,0.0005485773,0.0003239439,0.00007698207,0.00019660071,0.000047918133,0.0014730631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756795,0.00014575661,0.00061137305,0.00069155457,0.00039172292,0.00059161475],"domain_scores_gemma":[0.9987901,0.00014385274,0.00020637283,0.0003476161,0.000121270714,0.00039081502],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041340204,0.000487315,0.0010343874,0.00034304947,0.000233654,0.00012082113,0.00010907525,0.00025747952,0.000053776836],"category_scores_gemma":[0.00014411156,0.00041484353,0.00009933829,0.00033989717,0.00033179807,0.0005283991,0.00012148574,0.00022993573,0.000004156383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022869137,0.0007305963,0.6383252,0.0005298607,0.00028643184,0.000018664055,0.00161253,0.000005332887,0.30283996,0.0019413299,0.0064252,0.0470562],"study_design_scores_gemma":[0.0026009951,0.000044585504,0.83196574,0.00012899519,0.0005883893,0.000010415023,0.00006490456,0.00026683486,0.11335405,0.0010901226,0.049492385,0.00039259964],"about_ca_topic_score_codex":0.00037374438,"about_ca_topic_score_gemma":0.00002807664,"teacher_disagreement_score":0.19364053,"about_ca_system_score_codex":0.000012155385,"about_ca_system_score_gemma":0.000064121006,"threshold_uncertainty_score":0.99983037},"labels":[],"label_agreement":null},{"id":"W2135287300","doi":"10.1111/j.1463-1326.2009.01125.x","title":"Insulin use and increased risk of mortality in type 2 diabetes: a cohort study","year":2009,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; U.S. Department of Veterans Affairs","keywords":"Medicine; Hazard ratio; Insulin; Confidence interval; Proportional hazards model; Diabetes mellitus; Type 2 diabetes; Population; Internal medicine; Cohort; Cohort study; Demography; Endocrinology; Environmental health","score_opus":0.012697734058363311,"score_gpt":0.23904757741599467,"score_spread":0.22634984335763136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135287300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853111,0.012956344,0.0000017441349,0.000020708136,0.0001026696,0.001411331,0.00004899858,0.00005163656,0.000095478215],"genre_scores_gemma":[0.99660933,0.0027066863,0.0002223649,0.00025265498,0.00010827913,0.000029814166,0.00003300219,0.000019844756,0.000018002398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775463,0.0004027599,0.00047188724,0.00052141835,0.00042352002,0.00042578447],"domain_scores_gemma":[0.99864894,0.00012685137,0.00015488054,0.00062347716,0.00017673578,0.0002691206],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018232268,0.0002939204,0.0013689325,0.00026411132,0.00008128223,0.000049215305,0.000095313015,0.00016081633,0.000014581561],"category_scores_gemma":[0.00097565603,0.00025865514,0.00017141695,0.0004761488,0.0001589562,0.00027689786,0.00007076744,0.00034144556,0.0000034592422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004287293,0.0010561119,0.96034616,0.000085194646,0.00061976665,0.000010471616,0.00034950924,0.000001754573,0.00033332084,0.000022349144,0.000016117361,0.03711635],"study_design_scores_gemma":[0.003341265,0.00035765985,0.9911785,0.000088253815,0.0017047449,6.7944774e-7,0.000079753554,0.000092521565,0.001994063,0.00029352464,0.0006202022,0.00024881522],"about_ca_topic_score_codex":0.005634679,"about_ca_topic_score_gemma":0.00041065886,"teacher_disagreement_score":0.036867533,"about_ca_system_score_codex":0.000017539172,"about_ca_system_score_gemma":0.000054624103,"threshold_uncertainty_score":0.9999866},"labels":[],"label_agreement":null},{"id":"W2143906026","doi":"10.1046/j.1463-1326.2000.00107.x","title":"Optimizing insulin delivery: assessment of three strategies in intensive diabetes management","year":2000,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Insulin; Dietary management; Meal; Medicine; Diabetes mellitus; Type 2 diabetes; Metabolic control analysis; Basal insulin; Endocrinology; Internal medicine","score_opus":0.01525380925888541,"score_gpt":0.2711590562942703,"score_spread":0.25590524703538486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143906026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786122,0.004164392,0.000019932031,0.00028893715,0.000083647006,0.0006884454,0.0000102199965,0.000043514498,0.016088743],"genre_scores_gemma":[0.9934142,0.0021024463,0.0033721118,0.00039566625,0.000058303853,0.000052006228,0.000035700574,0.000022146865,0.00054741453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814093,0.00007867096,0.00038876702,0.00039693367,0.0004134387,0.0005812827],"domain_scores_gemma":[0.9992133,0.000073895004,0.000075502954,0.0003275587,0.00016322496,0.00014653541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058964576,0.00024389761,0.0006825218,0.00043801378,0.000077974255,0.000072294366,0.00017645546,0.00009934562,0.0003227424],"category_scores_gemma":[0.000023092862,0.00020953841,0.00011508867,0.0004657469,0.00021810233,0.0003159972,0.00018058823,0.0002900903,0.000015252815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007614158,0.0009964427,0.70543385,0.0017630269,0.0008993171,0.0000565021,0.0005873819,0.000372266,0.003130329,0.009910626,0.00025660705,0.2765175],"study_design_scores_gemma":[0.0023064166,0.00012949252,0.98526657,0.00034409107,0.0002708804,1.4199813e-7,0.00056157634,0.0047843824,0.0012502947,0.0019165418,0.00294377,0.00022584072],"about_ca_topic_score_codex":0.000029387606,"about_ca_topic_score_gemma":0.000017986837,"teacher_disagreement_score":0.27983272,"about_ca_system_score_codex":0.000029245999,"about_ca_system_score_gemma":0.000043712815,"threshold_uncertainty_score":0.8544728},"labels":[],"label_agreement":null},{"id":"W2144790234","doi":"10.1111/j.1463-1326.2007.00725.x","title":"Efficacy of ezetimibe/simvastatin 10/20 and 10/40 mg compared with atorvastatin 20 mg in patients with type 2 diabetes mellitus*","year":2007,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Ezetimibe; Simvastatin; Medicine; Atorvastatin; Type 2 diabetes; Pharmacology; Apolipoprotein B; Internal medicine; Statin; Cholesterol; Endocrinology; Diabetes mellitus","score_opus":0.006956152334018997,"score_gpt":0.218371969766574,"score_spread":0.211415817432555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144790234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917189,0.006862519,0.000027213393,0.00004775482,0.000057631652,0.000920288,0.000048440823,0.000035197707,0.00028208015],"genre_scores_gemma":[0.9968451,0.0001967018,0.0023328974,0.0001871104,0.000091995746,0.000013624746,0.00016178178,0.000039656847,0.00013110577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977749,0.00012782769,0.00044295337,0.00046148416,0.0005812894,0.000611564],"domain_scores_gemma":[0.99857634,0.00015541601,0.00018583718,0.00042285692,0.00030333851,0.00035617943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093515764,0.0003197419,0.0010725338,0.00021822455,0.00009875218,0.000026821499,0.000085234766,0.000117232536,0.000081314145],"category_scores_gemma":[0.000103065526,0.00023163338,0.000080962316,0.00049840123,0.0002441846,0.00014198716,0.000060311504,0.00024104766,0.0000069924295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013167332,0.00083824975,0.9681737,0.00067970995,0.00043799618,0.000010779087,0.00072301016,0.0000130089875,0.0005562815,0.00006849221,0.00013768536,0.02704438],"study_design_scores_gemma":[0.0097571425,0.0005956346,0.9793847,0.0003066574,0.0003694189,8.5128283e-7,0.000091193375,0.00005120531,0.003568857,0.000024565783,0.005573783,0.0002759475],"about_ca_topic_score_codex":0.00008833657,"about_ca_topic_score_gemma":0.000081594895,"teacher_disagreement_score":0.026768433,"about_ca_system_score_codex":0.000024816823,"about_ca_system_score_gemma":0.00009942215,"threshold_uncertainty_score":0.9445735},"labels":[],"label_agreement":null},{"id":"W2145434394","doi":"10.1111/j.1463-1326.2005.00502.x","title":"Insulin increases gelatinase activity in rat glomerular mesangial cells via ERK‐ and PI‐3 kinase‐dependent signalling","year":2005,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Gelatinase; MAPK/ERK pathway; Diabetic nephropathy; Kinase; Matrix metalloproteinase; Internal medicine; Insulin; Endocrinology; Chemistry; Extracellular matrix; Mesangial cell; Cell biology; LY294002; Extracellular; Intracellular; Kidney; Phosphatidylinositol; Biology; Medicine","score_opus":0.004888362261122881,"score_gpt":0.19834206982431354,"score_spread":0.19345370756319066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145434394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853808,0.013716096,0.00034003373,0.000052703286,0.000109822904,0.00028955415,0.000040559706,0.000016216885,0.000054175987],"genre_scores_gemma":[0.99695265,0.0013314318,0.0007976046,0.00032207763,0.0004516679,0.000029557594,0.00003848077,0.00001986638,0.00005666117],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863774,0.0001633945,0.00020455515,0.00046679197,0.00015454376,0.00037296978],"domain_scores_gemma":[0.9994588,0.000023621713,0.00008335199,0.00020533118,0.000039072074,0.00018981301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041079376,0.00024692135,0.0003185969,0.000086213986,0.00012572737,0.000047370464,0.000106555526,0.00022414592,0.000019932417],"category_scores_gemma":[0.000055965393,0.00024458775,0.00007179158,0.00008453729,0.00007271492,0.000032938067,0.00018588382,0.00017587957,0.0000069855123],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050887764,0.00024029914,0.0015479623,0.000035906367,0.000029474993,0.0000059875442,0.00004013781,0.000022367303,0.9886041,0.000059823004,0.000037022062,0.009326023],"study_design_scores_gemma":[0.001096734,0.00008180684,0.0040975595,0.00002510888,0.00005485847,0.0000019071442,0.000013636197,0.00044219085,0.99011517,0.00024408504,0.0035288448,0.00029810597],"about_ca_topic_score_codex":0.000121499004,"about_ca_topic_score_gemma":0.000068067166,"teacher_disagreement_score":0.012384664,"about_ca_system_score_codex":0.000011637998,"about_ca_system_score_gemma":0.000036719026,"threshold_uncertainty_score":0.99739987},"labels":[],"label_agreement":null},{"id":"W2146309429","doi":"10.1111/j.1463-1326.2011.01496.x","title":"Variations in tissue selectivity amongst insulin secretagogues: a systematic review","year":2011,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Cardiac Ischemia and Reperfusion","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Repaglinide; Sulfonylurea receptor; Nateglinide; Glibenclamide; Glipizide; Insulin; Tolbutamide; Glimepiride; Receptor; Chemistry; Pharmacology; Secretagogue; Internal medicine; Gliclazide; Sulfonylurea; Endocrinology; Glucokinase; Medicine; Diabetes mellitus; Metformin; Type 2 diabetes","score_opus":0.0181915316227047,"score_gpt":0.2811520338139581,"score_spread":0.2629605021912534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146309429","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009006071,0.99343425,0.000007970291,0.000019907277,0.00027069668,0.0043515554,0.00005806659,0.00007053778,0.00088641123],"genre_scores_gemma":[0.00017915347,0.99780464,0.00011817181,0.00020078188,0.0002074819,0.0005799838,0.00026173322,0.000054927692,0.0005931146],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99714017,0.0005729722,0.0009966432,0.0006091382,0.0002609266,0.00042013673],"domain_scores_gemma":[0.9982698,0.0002173139,0.0004662882,0.00067456346,0.00012984614,0.00024216647],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012447122,0.0005656308,0.006191342,0.00034362197,0.00009741249,0.000029831595,0.00015038985,0.00055685395,0.00007648835],"category_scores_gemma":[0.0007707174,0.0004014542,0.00064293196,0.0007832249,0.00007469265,0.00011927124,0.00014637354,0.00076870073,0.00012067396],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000012586535,0.00018631597,0.000118908814,0.95090437,0.0002774686,0.0000131818715,0.00011895834,2.930107e-9,0.0000084435405,0.0001491383,0.00013234637,0.048089627],"study_design_scores_gemma":[0.00032592964,0.000023975032,0.00042137573,0.54655033,0.0150602255,0.000048873844,0.0000043307127,0.0000019583497,0.000030388079,0.00002820566,0.4371003,0.00040411128],"about_ca_topic_score_codex":0.00007178415,"about_ca_topic_score_gemma":0.000010093279,"teacher_disagreement_score":0.43696797,"about_ca_system_score_codex":0.00007355486,"about_ca_system_score_gemma":0.00027678462,"threshold_uncertainty_score":0.9998437},"labels":[],"label_agreement":null},{"id":"W2154268206","doi":"10.1111/j.1463-1326.2012.01576.x","title":"Liraglutide: from clinical trials to clinical practice","year":2012,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Novo Nordisk; Eli Lilly and Company","keywords":"Liraglutide; Exenatide; Medicine; Tolerability; Sitagliptin; Regimen; Nausea; Clinical trial; Type 2 diabetes; Internal medicine; Pharmacology; Diabetes mellitus; Adverse effect; Endocrinology","score_opus":0.270250484376392,"score_gpt":0.4984562156673189,"score_spread":0.22820573129092692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154268206","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019873667,0.98713505,0.000018422346,0.00041058034,0.004368925,0.0034445068,0.00023920563,0.00014333248,0.0022525804],"genre_scores_gemma":[0.000050097417,0.9803993,0.006170622,0.003707052,0.0070236106,0.00025696593,0.0006273374,0.00010054731,0.0016644681],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9899658,0.003982468,0.0034713654,0.0011789541,0.0005408984,0.00086049683],"domain_scores_gemma":[0.9876777,0.00823548,0.0013226364,0.0011714476,0.00017472586,0.00141803],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01647908,0.0008542657,0.009489798,0.00030394166,0.00012475281,0.00013959312,0.00031930875,0.0009911102,0.0002610523],"category_scores_gemma":[0.011313876,0.0006014957,0.0023403715,0.00037577932,0.00016680625,0.00030607026,0.0005546319,0.001073124,0.0015083418],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033050033,0.001547516,0.0035300774,0.002225723,0.0047569172,0.000024006618,0.00002905446,5.191586e-9,8.654537e-8,0.00042141593,0.007828992,0.9796032],"study_design_scores_gemma":[0.0016532311,0.00018621248,0.013689552,0.0028561987,0.06516739,0.0000019142235,0.00001211593,6.482934e-7,9.838155e-7,0.00007042259,0.91585183,0.00050947885],"about_ca_topic_score_codex":0.000032390646,"about_ca_topic_score_gemma":0.0000025828551,"teacher_disagreement_score":0.9790937,"about_ca_system_score_codex":0.000047625344,"about_ca_system_score_gemma":0.00022305224,"threshold_uncertainty_score":0.9996436},"labels":[],"label_agreement":null},{"id":"W2154517237","doi":"10.1111/j.1463-1326.2009.01129.x","title":"The response to short‐term intensive insulin therapy in type 2 diabetes","year":2009,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Internal medicine; Diabetes mellitus; Type 2 diabetes; Insulin; Area under the curve; Gastroenterology; Endocrinology","score_opus":0.01483040254068376,"score_gpt":0.25882040029228304,"score_spread":0.24398999775159927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154517237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797712,0.014419049,0.0000013606589,0.004501206,0.00033936102,0.00048207425,0.000006113901,0.00006308597,0.00041657506],"genre_scores_gemma":[0.98520035,0.0021120887,0.00012245016,0.011973145,0.0001500824,0.000023939723,0.000010465902,0.000014251059,0.0003932587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985282,0.00018253313,0.0002805293,0.00031260648,0.00021094653,0.0004852167],"domain_scores_gemma":[0.9986386,0.0004319595,0.00003857579,0.00036379028,0.00025752658,0.00026955802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080137275,0.00022111899,0.00049638445,0.00020128264,0.00016384228,0.00006552497,0.00011552114,0.00011238067,0.000030453812],"category_scores_gemma":[0.0015651983,0.0001468637,0.00007956604,0.00048267914,0.00010284978,0.0000989235,0.00003967548,0.00023641951,0.000045437624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002324273,0.00040469295,0.5296074,0.000025146875,0.00015547966,0.000015783164,0.0016356161,0.000003132876,0.24227293,0.0006053505,0.002600409,0.22034979],"study_design_scores_gemma":[0.0012189136,0.000495068,0.9422177,0.00006678429,0.000046492773,9.107231e-7,0.00012758178,0.00005393814,0.025889924,0.00048493984,0.02922843,0.0001692942],"about_ca_topic_score_codex":0.000005342361,"about_ca_topic_score_gemma":0.0000024745545,"teacher_disagreement_score":0.41261032,"about_ca_system_score_codex":0.000025496594,"about_ca_system_score_gemma":0.00006200402,"threshold_uncertainty_score":0.5988928},"labels":[],"label_agreement":null},{"id":"W2155334088","doi":"10.1111/j.1463-1326.2011.01450.x","title":"Regulation of glucagon secretion by glucose: paracrine, intrinsic or both?","year":2011,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institutes of Health; Medical Research Council; National Institute for Health and Care Research; Canada Research Chairs; Wellcome Trust","keywords":"Paracrine signalling; Glucagon; Secretion; Internal medicine; Endocrinology; Depolarization; Islet; Somatostatin; Blood sugar regulation; Biology; Cell biology; Chemistry; Insulin; Receptor; Medicine","score_opus":0.0281236078666534,"score_gpt":0.2748657014297744,"score_spread":0.246742093563121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155334088","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.040853325,0.95667344,0.000019732022,0.000012219891,0.00039607938,0.0008464816,0.000121283854,0.00007908373,0.0009983219],"genre_scores_gemma":[0.001276131,0.9950024,0.0003516284,0.00012195549,0.00028580736,0.00007937742,0.00082939345,0.000051238865,0.0020020946],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979476,0.00019526303,0.00075773126,0.00048493993,0.00025280708,0.0003616919],"domain_scores_gemma":[0.9983922,0.0002007227,0.00053340936,0.0004839823,0.00013051591,0.00025912403],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000406096,0.0004813361,0.0026156013,0.00031476194,0.0000806698,0.000023013317,0.000109754656,0.0004744309,0.0005057586],"category_scores_gemma":[0.00032961796,0.00034351923,0.0003665179,0.0004335659,0.00016418286,0.00015239543,0.00007246138,0.00032608863,0.000048857113],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060579787,0.0003353655,0.0005545256,0.021057164,0.0005009481,0.000002473719,0.000074524476,2.4329372e-8,0.00036624167,0.0011009339,0.002366445,0.9735808],"study_design_scores_gemma":[0.00089352584,0.00013381198,0.007431884,0.004452601,0.0042289384,0.0000116184,0.000009422057,0.000009077317,0.0010972451,0.00016801569,0.9812217,0.00034215592],"about_ca_topic_score_codex":0.00003352432,"about_ca_topic_score_gemma":0.0000011271225,"teacher_disagreement_score":0.97885525,"about_ca_system_score_codex":0.000035196466,"about_ca_system_score_gemma":0.00017331133,"threshold_uncertainty_score":0.99990165},"labels":[],"label_agreement":null},{"id":"W2158090662","doi":"10.1111/j.1463-1326.2007.00808.x","title":"Rosiglitazone prevents diabetes by increasing beta‐cell mass in an animal model of type 2 diabetes characterized by reduced beta‐cell mass at birth","year":2007,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; McMaster University","funders":"","keywords":"Rosiglitazone; Endocrinology; Internal medicine; Offspring; Medicine; Diabetes mellitus; Impaired glucose tolerance; Type 2 diabetes; Beta cell; Glucose homeostasis; Impaired fasting glucose; Insulin resistance; Pregnancy; Biology; Islet","score_opus":0.011883686419659237,"score_gpt":0.23034477125844519,"score_spread":0.21846108483878596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158090662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846793,0.012866864,0.000039327868,0.00008076277,0.00024166596,0.00094711524,0.000415537,0.00013401288,0.00059543434],"genre_scores_gemma":[0.9945376,0.00066956383,0.0019481034,0.00061534444,0.0001753343,0.00005631526,0.0007421796,0.00010368939,0.0011519046],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99567527,0.00034507902,0.0010643094,0.0009269064,0.000636794,0.0013516457],"domain_scores_gemma":[0.9975009,0.00037914663,0.00047436586,0.00063649024,0.00023208762,0.0007769905],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017821371,0.0006870085,0.0017880242,0.00044976416,0.0002005901,0.00006896244,0.0002755844,0.00046347355,0.00012566507],"category_scores_gemma":[0.0001455716,0.0006551922,0.00023037518,0.00062653556,0.00028595186,0.00059173204,0.00014666026,0.00047100536,0.000022222948],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023737257,0.0006677695,0.3892599,0.00044616053,0.000084287676,0.0000014138817,0.00013720534,0.000003736914,0.60863054,0.0000109296725,0.00018428803,0.0003363894],"study_design_scores_gemma":[0.004492998,0.00040990915,0.1866636,0.00016470284,0.0005085688,3.2064872e-7,0.00006974545,0.0030280268,0.8029077,0.00011095331,0.0010657848,0.000577716],"about_ca_topic_score_codex":0.00003501871,"about_ca_topic_score_gemma":0.0000028538427,"teacher_disagreement_score":0.20259632,"about_ca_system_score_codex":0.000097248936,"about_ca_system_score_gemma":0.00010032451,"threshold_uncertainty_score":0.9995899},"labels":[],"label_agreement":null},{"id":"W2161963078","doi":"10.1111/dom.12340","title":"Gut microbiota, nutrient sensing and energy balance","year":2014,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Diabetes Canada; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Health Canada; University of Toronto; Eidgenössische Technische Hochschule Zürich","keywords":"Gut flora; Gut–brain axis; Enteroendocrine cell; Gastrointestinal tract; Microbiome; Nutrient sensing; Paracrine signalling; Endocrine system; Autocrine signalling; Enteric nervous system; Biology; Medicine; Glucagon-like peptide-1; Neuroscience; Bioinformatics; Immunology; Hormone; Cell biology; Internal medicine; Endocrinology; Signal transduction; Diabetes mellitus; Type 2 diabetes; Receptor","score_opus":0.008222028108562434,"score_gpt":0.24559260304440103,"score_spread":0.2373705749358386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161963078","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010554658,0.98857594,0.00009365053,0.000022209791,0.0003374021,0.00016602593,0.000107463326,0.000014897477,0.00012777407],"genre_scores_gemma":[0.0009603455,0.9962403,0.00039366056,0.0005468746,0.0005811553,0.000007631741,0.00046151548,0.000047034602,0.0007614787],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99818987,0.0002047024,0.0003687562,0.0006889769,0.00006685076,0.00048087563],"domain_scores_gemma":[0.99908656,0.00002787455,0.0002266152,0.00040090186,0.000053873253,0.00020415103],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025912107,0.00045592105,0.0013282008,0.000095187046,0.00018083789,0.000067970315,0.0001453036,0.0005516485,0.000003773868],"category_scores_gemma":[0.00003176251,0.00039853016,0.00021631089,0.00009055096,0.00014796971,0.0000036999995,0.0002517038,0.00020426147,0.0000072927137],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004360059,0.000070934184,0.000088047454,0.010243173,0.00025820947,0.0000027995234,0.000027133206,5.1244935e-8,0.025420891,0.000674106,0.0042776396,0.95893264],"study_design_scores_gemma":[0.00023953104,0.000029143326,0.00046093733,0.0010353356,0.00037356315,0.000023605879,0.0000020667103,0.0000025413879,0.00036757224,0.00003502486,0.99700224,0.00042845533],"about_ca_topic_score_codex":0.00003163293,"about_ca_topic_score_gemma":0.000012885449,"teacher_disagreement_score":0.9927246,"about_ca_system_score_codex":0.000009854506,"about_ca_system_score_gemma":0.00009929359,"threshold_uncertainty_score":0.99984664},"labels":[],"label_agreement":null},{"id":"W2164258738","doi":"10.1111/dom.12431","title":"Dipeptidyl peptidase‐4 inhibitors and the risk of community‐acquired pneumonia in patients with type 2 diabetes","year":2015,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Société Francophone du Diabète","keywords":"Medicine; Community-acquired pneumonia; Pneumonia; Odds ratio; Internal medicine; Diabetes mellitus; Dipeptidyl peptidase-4; Incidence (geometry); Cohort study; Cohort; Logistic regression; Type 2 diabetes; Confidence interval; Intensive care medicine; Endocrinology","score_opus":0.00890503614945085,"score_gpt":0.2122461691177736,"score_spread":0.20334113296832276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164258738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978767,0.0011174141,4.838722e-7,0.00018652562,0.00013446673,0.0004159559,0.000024125458,0.000025710211,0.00021862982],"genre_scores_gemma":[0.99933666,0.00013556873,0.000021844156,0.000374585,0.000051499777,0.000016772205,0.000017027856,0.000015591417,0.000030430252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986926,0.00045348646,0.00025081463,0.00013664836,0.00021708508,0.00024940804],"domain_scores_gemma":[0.9989563,0.00020770585,0.00014073508,0.00031196643,0.0001992726,0.00018398602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007603312,0.00018084614,0.00053114793,0.00015057466,0.0001927015,0.000022070366,0.00007804461,0.000097867836,0.0000033975125],"category_scores_gemma":[0.00034956308,0.000105445935,0.000051613966,0.0003299162,0.00059789367,0.00013531589,0.00009945009,0.0003235824,0.000003121467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077843426,0.00034640922,0.99564373,0.00006062123,0.000107900574,4.0238666e-7,0.001423657,0.0000042315173,0.0010937091,0.00008236844,0.000046488152,0.0011126278],"study_design_scores_gemma":[0.005834361,0.0003031613,0.9902242,0.0000920865,0.00032994332,4.1362716e-7,0.00026035123,0.000029461542,0.001071522,0.00027134578,0.0014592272,0.00012392792],"about_ca_topic_score_codex":0.000120127756,"about_ca_topic_score_gemma":0.00004639822,"teacher_disagreement_score":0.005756518,"about_ca_system_score_codex":0.000013322497,"about_ca_system_score_gemma":0.000047633464,"threshold_uncertainty_score":0.42999604},"labels":[],"label_agreement":null},{"id":"W2164465462","doi":"10.1111/j.1463-1326.2006.00578.x","title":"Synergistic effects of conjugated linoleic acid and chromium picolinate improve vascular function and renal pathophysiology in the insulin‐resistant JCR:LA‐ <i>cp</i> rat","year":2006,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Chromium effects and bioremediation","field":"Environmental Science","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Ministry of Agriculture and Forestry; University of Alberta","funders":"University of Alberta","keywords":"Pathophysiology; Conjugated linoleic acid; Chromium; Chemistry; Internal medicine; Endocrinology; Insulin; Medicine; Renal function; Insulin resistance; Linoleic acid; Biochemistry; Fatty acid","score_opus":0.0015027588222001757,"score_gpt":0.15605655249945857,"score_spread":0.1545537936772584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164465462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99558187,0.0037651213,0.000029515122,0.000036842215,0.00014429883,0.00037876912,0.000010289067,0.000011988074,0.000041340383],"genre_scores_gemma":[0.9991559,0.00049885997,0.000046990874,0.00015544974,0.00008137968,0.000027004637,0.000020970143,0.000007271566,0.0000062065183],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99884737,0.00027700688,0.00020296003,0.00030191577,0.00015005453,0.0002206863],"domain_scores_gemma":[0.99948084,0.00021237557,0.00010598023,0.00014308214,0.000010008594,0.00004773756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045545245,0.00016454994,0.00029793323,0.00004446721,0.0001054294,0.000034917197,0.00007271323,0.00012262174,0.0000054786],"category_scores_gemma":[0.00006440605,0.00011209268,0.000038459293,0.00015920248,0.00034234536,0.00012635298,0.00009496074,0.00013422767,0.000002083123],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003230925,0.00012203226,0.012656704,0.0001131747,0.000011775097,0.0000043635946,0.00010441113,0.000015682304,0.98358566,0.0002527221,0.000022136017,0.0030790507],"study_design_scores_gemma":[0.0013139225,0.00014199811,0.84865373,0.000024302843,0.00011994738,3.4989543e-7,0.00000973015,0.00047966823,0.14678718,0.002075079,0.0002637509,0.00013032096],"about_ca_topic_score_codex":0.0003044986,"about_ca_topic_score_gemma":0.000069466885,"teacher_disagreement_score":0.8367984,"about_ca_system_score_codex":0.000014038823,"about_ca_system_score_gemma":0.0000072210823,"threshold_uncertainty_score":0.4571007},"labels":[],"label_agreement":null},{"id":"W2166886145","doi":"10.1111/dom.12527","title":"Treatment satisfaction in people with type 2 diabetes mellitus treated with once‐weekly dulaglutide: data from the <scp>AWARD</scp> ‐1 and <scp>AWARD</scp> ‐3 clinical trials","year":2015,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Dulaglutide; Medicine; Type 2 Diabetes Mellitus; Liraglutide; Type 2 diabetes; Diabetes mellitus; Internal medicine; Endocrinology","score_opus":0.07220703135005108,"score_gpt":0.3189510850167525,"score_spread":0.24674405366670144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166886145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753067,0.020969074,0.000013649103,0.0004817088,0.0003751798,0.0019782977,0.00027297405,0.00014485982,0.0004575836],"genre_scores_gemma":[0.9871543,0.008156943,0.0009618803,0.0005349086,0.00050867355,0.00015736566,0.0013032698,0.000075630625,0.0011470012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955396,0.00095697376,0.00087985327,0.001177557,0.0005961343,0.0008498853],"domain_scores_gemma":[0.99450153,0.0029477982,0.00045025212,0.0012809709,0.0001915207,0.00062793173],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024641769,0.0006958208,0.002133883,0.00020294101,0.00022228863,0.00022448054,0.00027827217,0.00028081832,0.000010677551],"category_scores_gemma":[0.0017130387,0.00039476983,0.00013805198,0.0006055941,0.0003507747,0.00052615925,0.00026930452,0.00035619905,0.000045292403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007398009,0.00077688653,0.96842235,0.000051838088,0.0019067058,0.00002900545,0.0008698733,0.0000074848294,0.00010959727,0.00009235994,0.00374057,0.02391934],"study_design_scores_gemma":[0.011547561,0.0015358125,0.92332006,0.00017579738,0.004590128,0.000002446443,0.0010239369,0.0005054612,0.0008852076,0.00021936593,0.056062933,0.00013131139],"about_ca_topic_score_codex":0.0016883139,"about_ca_topic_score_gemma":0.0018294222,"teacher_disagreement_score":0.052322365,"about_ca_system_score_codex":0.00012198042,"about_ca_system_score_gemma":0.00023022873,"threshold_uncertainty_score":0.9998504},"labels":[],"label_agreement":null},{"id":"W2171070862","doi":"10.1111/j.1463-1326.2005.00524.x","title":"Glucose control with insulin results in reduction of NF‐κB‐binding activity in mononuclear blood cells of patients with recently manifested type 1 diabetes","year":2005,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Advanced Glycation End Products research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Deutsche Diabetes Gesellschaft; Heart and Stroke Foundation of Canada","keywords":"Electrophoretic mobility shift assay; Western blot; Internal medicine; Endocrinology; Transcription factor; Peripheral blood mononuclear cell; Insulin; P50; NF-κB; Cytoplasm; Diabetes mellitus; Oxidative stress; Glycation; Biology; Molecular biology; Chemistry; Medicine; Biochemistry; In vitro; Gene; Inflammation","score_opus":0.005343959516033108,"score_gpt":0.21513854388560483,"score_spread":0.2097945843695717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171070862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998563,0.0008668718,0.000005061144,0.000055772758,0.000033593755,0.00035670112,0.000074482596,0.000004554432,0.000039996386],"genre_scores_gemma":[0.9982857,0.0006475822,0.00088132854,0.000014974103,0.00004086683,0.000008560728,0.00007133333,0.000015513353,0.00003411652],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988967,0.00013695727,0.00023260748,0.00032783882,0.00016101434,0.00024484622],"domain_scores_gemma":[0.9993068,0.000023763183,0.00017727813,0.00024401803,0.0001934296,0.000054732103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030767152,0.00013327281,0.0002753199,0.00013904386,0.000028615525,0.0000070660967,0.00009582012,0.00009703287,0.0000034180587],"category_scores_gemma":[0.00011149199,0.00011440343,0.000018126982,0.00031121916,0.00010881075,0.00003316963,0.00004350029,0.00013822675,8.50051e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009999254,0.000713183,0.11942496,0.000072153234,0.000061334606,3.5737253e-7,0.00012915529,0.00065933826,0.8702432,0.00000861471,0.000005293738,0.007682508],"study_design_scores_gemma":[0.0029672694,0.00022610846,0.31433302,0.00003309041,0.000023184304,9.7270885e-8,0.000015465725,0.00003100954,0.6818589,0.0000063087277,0.0004088854,0.00009663107],"about_ca_topic_score_codex":0.000018694267,"about_ca_topic_score_gemma":0.000032028383,"teacher_disagreement_score":0.19490807,"about_ca_system_score_codex":0.000010380204,"about_ca_system_score_gemma":0.00004341554,"threshold_uncertainty_score":0.46652365},"labels":[],"label_agreement":null},{"id":"W2171901801","doi":"10.1111/dom.12021","title":"Metformin directly inhibits ghrelin secretion through <scp>AMP</scp> ‐activated protein kinase in rat primary gastric cells","year":2012,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Regulation of Appetite and Obesity","field":"Neuroscience","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Research Nova Scotia; Canadian Institutes of Health Research; Dalhousie University; Heart and Stroke Foundation of Canada","keywords":"Metformin; AMPK; Ghrelin; Internal medicine; Endocrinology; Orexigenic; Protein kinase A; AMP-activated protein kinase; Secretion; Activator (genetics); Chemistry; Biology; Kinase; Medicine; Hormone; Diabetes mellitus; Receptor; Biochemistry; Neuropeptide","score_opus":0.01653617338224082,"score_gpt":0.2241903325024524,"score_spread":0.2076541591202116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171901801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99474543,0.0022960796,0.00011844631,0.000056334095,0.00037964154,0.00080846756,0.000026938527,0.00012618804,0.00144249],"genre_scores_gemma":[0.9962263,0.00056416646,0.0014471562,0.000604636,0.0002339966,0.00006154763,0.00003742669,0.000032005053,0.00079278066],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973733,0.00040085797,0.00041709028,0.0005445883,0.00043728438,0.0008268819],"domain_scores_gemma":[0.9988236,0.00031346528,0.00022233615,0.0003293912,0.000058339887,0.00025290842],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074115896,0.00034652464,0.0005108364,0.0002701568,0.00025580463,0.00010179232,0.0002072448,0.00022468796,0.000030348712],"category_scores_gemma":[0.00052668486,0.00032112186,0.000109223954,0.0009346897,0.00016013406,0.0015876133,0.00017115966,0.00037074147,0.000115685245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000102376935,0.00039264184,0.010793301,0.00008520133,0.000005588832,0.000002717837,0.00064899545,0.0000109298735,0.9848386,0.0012118658,0.00016604262,0.001833857],"study_design_scores_gemma":[0.00069249875,0.000023298437,0.087685704,0.000059646994,0.000027808213,0.0000022454167,0.00002221881,0.00003612188,0.8675714,0.0007839297,0.042940576,0.00015455371],"about_ca_topic_score_codex":0.000045436416,"about_ca_topic_score_gemma":0.0000077906225,"teacher_disagreement_score":0.11726722,"about_ca_system_score_codex":0.000053591262,"about_ca_system_score_gemma":0.000045598423,"threshold_uncertainty_score":0.99992406},"labels":[],"label_agreement":null},{"id":"W2207970920","doi":"10.1111/dom.12624","title":"Patient‐reported outcome results in patients with type 2 diabetes treated with once‐weekly dulaglutide: data from the <scp>AWARD</scp> phase <scp>III</scp> clinical trial programme","year":2015,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Dulaglutide; Exenatide; Medicine; Checklist; Type 2 diabetes; Diabetes mellitus; Internal medicine; Quality of life (healthcare); Physical therapy; Psychology; Endocrinology; Nursing","score_opus":0.08649019103364348,"score_gpt":0.31850987965368993,"score_spread":0.23201968862004646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2207970920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922343,0.001925292,0.0000027963802,0.00021295901,0.0006296862,0.0037607527,0.0004435934,0.00019988135,0.0005907447],"genre_scores_gemma":[0.99156,0.000115422634,0.00076552265,0.0006984436,0.00038489883,0.00015374727,0.00555107,0.00008065298,0.0006902656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99467486,0.00040213726,0.0013812752,0.0013387639,0.001033023,0.0011699196],"domain_scores_gemma":[0.9951032,0.0010373762,0.0007483539,0.0018604017,0.00049634103,0.00075436314],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016222786,0.0006994904,0.0016177926,0.00025827173,0.0001831731,0.00020847954,0.0004958384,0.0002809568,0.000004047366],"category_scores_gemma":[0.0034175522,0.00041329174,0.00013804995,0.0010822745,0.00042658034,0.0005645283,0.0004757082,0.00054566766,0.00003447886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017837881,0.005781343,0.9678286,0.000032288328,0.0014999987,0.00005221808,0.00051228376,0.0000022327104,0.0000066545426,0.000016323298,0.005799074,0.016685229],"study_design_scores_gemma":[0.15631826,0.004677024,0.77846146,0.00017987777,0.002757406,3.0517378e-7,0.00047594978,0.00014585641,0.00021481716,0.000058054153,0.05656619,0.00014482006],"about_ca_topic_score_codex":0.00022024983,"about_ca_topic_score_gemma":0.00009438411,"teacher_disagreement_score":0.18936713,"about_ca_system_score_codex":0.00007333697,"about_ca_system_score_gemma":0.00022363312,"threshold_uncertainty_score":0.9998319},"labels":[],"label_agreement":null},{"id":"W2267584932","doi":"10.1111/dom.12642","title":"Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12‐month data from the <scp>OpT2mise</scp> randomized trial","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Medtronic; Novo Nordisk; Sanofi; Eli Lilly and Company","keywords":"Medicine; Insulin pump; Randomization; Randomized controlled trial; Type 2 diabetes; Insulin; Type 1 diabetes; Clinical endpoint; Diabetes mellitus; Internal medicine; Surgery; Anesthesia; Endocrinology","score_opus":0.031649223401205066,"score_gpt":0.2752478400027025,"score_spread":0.24359861660149745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2267584932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98855484,0.006712928,0.000031808555,0.0005494383,0.0002849673,0.00321345,0.00015690958,0.000060008035,0.00043563894],"genre_scores_gemma":[0.9960423,0.002040302,0.00019300144,0.00026051677,0.0003544261,0.00011100487,0.0003245078,0.00003623346,0.0006377073],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971126,0.0006363516,0.00055247295,0.000568377,0.000520469,0.000609783],"domain_scores_gemma":[0.9935488,0.004716977,0.00022923342,0.0011117151,0.00020995775,0.00018332282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019449713,0.00031217636,0.0013114589,0.00025900954,0.00015539653,0.000073753414,0.00057094166,0.00013517041,0.000059785038],"category_scores_gemma":[0.0035848476,0.0001529587,0.00013870743,0.0005811176,0.00061899953,0.0003041998,0.00042667304,0.0002933154,0.000014166244],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22677976,0.0052406043,0.67481375,0.00024948394,0.0040316205,0.0000148276995,0.002547075,0.000017939916,0.009108591,0.0004051116,0.0051296065,0.07166161],"study_design_scores_gemma":[0.6342271,0.00028969086,0.34998968,0.00020436192,0.0004321468,5.7352647e-8,0.00021947571,0.0009696775,0.0017020986,0.00033943087,0.011516562,0.00010973916],"about_ca_topic_score_codex":0.00018288313,"about_ca_topic_score_gemma":0.00012289506,"teacher_disagreement_score":0.4074473,"about_ca_system_score_codex":0.00002145292,"about_ca_system_score_gemma":0.00013926609,"threshold_uncertainty_score":0.62374747},"labels":[],"label_agreement":null},{"id":"W2291499225","doi":"10.1111/dom.12658","title":"Secular trends in antihyperglycaemic medication prescriptions in older adults with diabetes and chronic kidney disease: 2004–2013","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Seven Oaks General Hospital; Manitoba Health; University of Manitoba; Institute for Clinical Evaluative Sciences; Western University","funders":"Canadian Institutes of Health Research; Western University; Institute for Clinical Evaluative Sciences; London Health Sciences Centre; Lawson Health Research Institute","keywords":"Medicine; Gliclazide; Kidney disease; Metformin; Internal medicine; Diabetes mellitus; Sitagliptin; Rosiglitazone; Thiazolidinedione; Medical prescription; Type 2 diabetes; Glibenclamide; Pioglitazone; Dialysis; Renal function; Population; Saxagliptin; Nephrology; Endocrinology; Pharmacology","score_opus":0.00432910448264221,"score_gpt":0.20576289492310285,"score_spread":0.20143379044046064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2291499225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760706,0.019602675,0.000008253532,0.003410214,0.00009142675,0.0005519626,0.000044037915,0.000052779236,0.00016806982],"genre_scores_gemma":[0.9948549,0.0030282964,0.000098766184,0.00044604734,0.00009030033,0.00019661731,0.00019041914,0.000024315303,0.0010703402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849415,0.00006198783,0.0002402384,0.00048970064,0.00022916525,0.00048477575],"domain_scores_gemma":[0.9991475,0.00003605705,0.000067867804,0.00031286242,0.000036354693,0.0003993756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019441091,0.00025601956,0.00044557406,0.0004936523,0.000057007896,0.000027179993,0.00007450132,0.00008688506,0.00013055542],"category_scores_gemma":[0.000047022535,0.0001669797,0.000049573016,0.0003315729,0.00017440319,0.00031949766,0.00006772611,0.000106637286,0.00000921739],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055279186,0.0005729514,0.9339832,0.00033177706,0.00013433099,0.000015466287,0.00026406403,8.767825e-7,0.0018593529,0.00024903868,0.0020027286,0.060530953],"study_design_scores_gemma":[0.007662501,0.000097790755,0.9786819,0.0011802248,0.00037266727,4.0867258e-7,0.00003063079,0.00022927918,0.0007067028,0.00011806475,0.010693568,0.00022624356],"about_ca_topic_score_codex":0.00005080212,"about_ca_topic_score_gemma":0.0001200999,"teacher_disagreement_score":0.06030471,"about_ca_system_score_codex":0.000067020126,"about_ca_system_score_gemma":0.00004599455,"threshold_uncertainty_score":0.6809235},"labels":[],"label_agreement":null},{"id":"W2301357986","doi":"10.1111/dom.12661","title":"Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double‐blind randomized controlled trial ( <scp>BEGIN</scp> : <scp>ADD TO GLP</scp> ‐1 <scp>S</scp> tudy)","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novo Nordisk","keywords":"Liraglutide; Medicine; Placebo; Metformin; Insulin degludec; Type 2 diabetes; Internal medicine; Diabetes mellitus; Randomized controlled trial; Endocrinology; Insulin","score_opus":0.0085891965301117,"score_gpt":0.23521407583377166,"score_spread":0.22662487930365996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2301357986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.965433,0.0053492966,0.000026134156,0.00007986185,0.00037728963,0.02735892,0.00007281908,0.00012828542,0.0011744123],"genre_scores_gemma":[0.99026597,0.00066217914,0.000653979,0.00029236788,0.00021231812,0.0050030667,0.000102520666,0.00012206377,0.002685518],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9938281,0.0009151107,0.00145266,0.001255244,0.0009877755,0.0015610765],"domain_scores_gemma":[0.9867974,0.01026246,0.0007885063,0.0007351491,0.00044994833,0.0009665389],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002934568,0.0013104309,0.007229191,0.0013628701,0.00021771871,0.00017710461,0.00028840452,0.00032819502,0.000011980564],"category_scores_gemma":[0.0059033707,0.00069331547,0.00054056244,0.0010994809,0.0003200713,0.00047972167,0.00024360865,0.00025924837,0.000032237567],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7367414,0.005704085,0.2064125,0.0006761537,0.013992057,0.00006059951,0.0035956053,0.00003197199,0.0015935412,0.00059088756,0.0007405898,0.029860592],"study_design_scores_gemma":[0.92962164,0.012341154,0.029817985,0.00073675555,0.0075408802,6.5981084e-7,0.00016847317,0.000057251604,0.014592452,0.000056075838,0.0048837606,0.00018292008],"about_ca_topic_score_codex":0.00008763938,"about_ca_topic_score_gemma":0.00008808345,"teacher_disagreement_score":0.19288021,"about_ca_system_score_codex":0.00018978193,"about_ca_system_score_gemma":0.00018465068,"threshold_uncertainty_score":0.9999647},"labels":[],"label_agreement":null},{"id":"W2311186584","doi":"10.1111/dom.12666","title":"Long‐term maintenance of efficacy of dapagliflozin in patients with type 2 diabetes mellitus and cardiovascular disease","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; AstraZeneca (Canada); St. Michael's Hospital","funders":"National Institutes of Health; Servier; National Institute of General Medical Sciences; Intarcia Therapeutics; Sanofi; MannKind Corporation; AstraZeneca","keywords":"Dapagliflozin; Medicine; Type 2 Diabetes Mellitus; Disease; Diabetes mellitus; Term (time); Internal medicine; Type 2 diabetes; Intensive care medicine; Endocrinology","score_opus":0.005550549728598769,"score_gpt":0.19105456191078776,"score_spread":0.18550401218218898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2311186584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816356,0.017554795,0.0000061873834,0.000045207344,0.00006783291,0.0005636128,0.000032456224,0.00001501259,0.00007932011],"genre_scores_gemma":[0.9977124,0.0019430413,0.00013017481,0.00004783981,0.00002346374,0.0000145342265,0.000023793573,0.000017108396,0.00008765522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998811,0.000050624843,0.00023640419,0.00032283456,0.00027016088,0.0003089682],"domain_scores_gemma":[0.9991444,0.00006967538,0.000084591615,0.00040371495,0.00011701277,0.00018062723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021314697,0.00019477883,0.0006883311,0.00015580669,0.000022902594,0.000007603722,0.00006662637,0.00004612686,0.00001439768],"category_scores_gemma":[0.00009622805,0.00011742147,0.00010531327,0.00018397708,0.00022323945,0.00013262757,0.00008279321,0.00004744641,0.0000020107786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015418125,0.000583426,0.9443132,0.00035863748,0.00079042814,0.0000037775462,0.000058923608,0.000001061607,0.00020411206,0.00019384843,0.000015388094,0.053322986],"study_design_scores_gemma":[0.006894741,0.00020922265,0.9879102,0.00053534744,0.0012373729,3.0450533e-8,0.0000044433214,0.000003706983,0.0024333005,0.00007076576,0.00055959687,0.00014123513],"about_ca_topic_score_codex":0.00000827602,"about_ca_topic_score_gemma":0.0000019682714,"teacher_disagreement_score":0.053181753,"about_ca_system_score_codex":0.0000133731755,"about_ca_system_score_gemma":0.000021705766,"threshold_uncertainty_score":0.47883087},"labels":[],"label_agreement":null},{"id":"W2335878298","doi":"10.1111/dom.12640","title":"Low incidence of anti‐drug antibodies in patients with type 2 diabetes treated with once‐weekly glucagon‐like peptide‐1 receptor agonist dulaglutide","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Dulaglutide; Medicine; Agonist; Pharmacology; Internal medicine; Exenatide; Type 2 diabetes; Gastroenterology; Endocrinology; Receptor; Diabetes mellitus","score_opus":0.0069009306933684855,"score_gpt":0.22579742792270516,"score_spread":0.21889649722933668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335878298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966164,0.001936945,0.00000129958,0.00050062325,0.00008405318,0.00050107436,0.00013457186,0.00003880533,0.00018619238],"genre_scores_gemma":[0.9963979,0.0010745177,0.0005378248,0.00017427138,0.00008068887,0.00001575892,0.0000816446,0.00003466412,0.0016027385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767625,0.00011538732,0.00038792976,0.00051123265,0.00062143034,0.0006877749],"domain_scores_gemma":[0.99847335,0.00019294854,0.0001734235,0.00035114383,0.00052753836,0.00028159426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002938748,0.0003654922,0.00093340816,0.00034041292,0.00014565642,0.000031290692,0.00018464285,0.00010545572,0.000092372975],"category_scores_gemma":[0.00013188462,0.00019952326,0.0000752131,0.0006677999,0.0007262189,0.00030877354,0.0001278689,0.00022756484,0.0000300474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054124545,0.0005368588,0.9698153,0.00030593146,0.00018699441,0.000009864095,0.00015559688,9.0491255e-7,0.024619779,0.00008060575,0.00024780247,0.0034991226],"study_design_scores_gemma":[0.0027449746,0.0005279063,0.9023695,0.0011334823,0.00011941911,8.366821e-7,0.000037419326,0.0000084805815,0.0906082,0.00003808512,0.0021234357,0.0002882622],"about_ca_topic_score_codex":0.00020630262,"about_ca_topic_score_gemma":0.00007027697,"teacher_disagreement_score":0.0674458,"about_ca_system_score_codex":0.00003391063,"about_ca_system_score_gemma":0.00014929676,"threshold_uncertainty_score":0.81363225},"labels":[],"label_agreement":null},{"id":"W2336303226","doi":"10.1111/dom.12678","title":"Antiresorptive therapy and newly diagnosed diabetes in women: a historical cohort study","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; McGill University; University of Manitoba","funders":"World Health Organization; Amgen","keywords":"Medicine; Diabetes mellitus; Cohort; Internal medicine; Confidence interval; Cohort study; Body mass index; Osteoporosis; Hazard ratio; Bone mineral; Endocrinology","score_opus":0.017910708368926196,"score_gpt":0.2711527590035123,"score_spread":0.2532420506345861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336303226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857651,0.011190396,6.28068e-7,0.0014086571,0.00013350458,0.0013697091,0.000011002742,0.000043236054,0.000077758945],"genre_scores_gemma":[0.9916881,0.006282699,0.000053441294,0.0010779905,0.00013711426,0.0003335882,0.0000024089343,0.000022765962,0.00040190804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977644,0.00024740392,0.00032607772,0.0005138993,0.00037569558,0.0007724892],"domain_scores_gemma":[0.99861133,0.00039282843,0.00006385675,0.0002841303,0.000093251896,0.00055457465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001098811,0.00022725062,0.0008139278,0.00026557862,0.00012154117,0.000028790522,0.00008162113,0.00013273605,0.00005690066],"category_scores_gemma":[0.00036933646,0.000146586,0.000047336674,0.00028774198,0.00014800539,0.00016447324,0.000086869906,0.00024866444,0.000010558053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013284376,0.00090982125,0.93568426,0.000053181964,0.0000621266,0.000018539764,0.00091052183,8.385572e-9,0.003258457,0.000027903696,0.00026991247,0.058672428],"study_design_scores_gemma":[0.00693806,0.00061369827,0.98032624,0.00006772127,0.000030851825,6.6263334e-7,0.00015669296,0.000008631466,0.0007199296,0.00013681396,0.010825013,0.00017570348],"about_ca_topic_score_codex":0.00026464288,"about_ca_topic_score_gemma":0.000049059647,"teacher_disagreement_score":0.058496725,"about_ca_system_score_codex":0.00018853082,"about_ca_system_score_gemma":0.000094873176,"threshold_uncertainty_score":0.5977603},"labels":[],"label_agreement":null},{"id":"W2341277771","doi":"10.1111/dom.12679","title":"Gastrointestinal safety across the albiglutide development programme","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"GlaxoSmithKline","keywords":"Liraglutide; Placebo; Tolerability; Medicine; Nausea; Vomiting; Internal medicine; Gastroenterology; Adverse effect; Type 2 diabetes; Endocrinology; Diabetes mellitus","score_opus":0.013575770224160314,"score_gpt":0.23616941183591605,"score_spread":0.22259364161175574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341277771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99405223,0.0010891021,0.00017460423,0.002717787,0.00011720174,0.00057928433,0.000011959376,0.00010920952,0.0011486312],"genre_scores_gemma":[0.9895292,0.00016095635,0.00434456,0.0009026946,0.00015192058,0.000101016376,0.000020451082,0.000021024272,0.0047681546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984408,0.0000424461,0.00024423632,0.00031757503,0.00024402588,0.0007109281],"domain_scores_gemma":[0.99923253,0.00010310041,0.00007232253,0.00030021032,0.0000719169,0.00021994054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052834465,0.00022671832,0.00033389239,0.000041401803,0.0002960044,0.000052293184,0.0001193431,0.000030226342,0.000056240453],"category_scores_gemma":[0.0001128679,0.00010995037,0.000091799884,0.00012269121,0.0002111432,0.00012027364,0.00018598951,0.00008889306,0.00009865356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051920822,0.00039144908,0.5042367,0.00007980842,0.00027617687,0.00001841723,0.00034746266,1.138385e-7,0.0016463812,0.0031342076,0.00062671315,0.4891906],"study_design_scores_gemma":[0.0016712066,0.00006521131,0.7420104,0.00014431427,0.00015920562,0.000007931834,0.000066312976,0.0000039768174,0.00432939,0.0001844005,0.25122544,0.00013220923],"about_ca_topic_score_codex":0.000008835825,"about_ca_topic_score_gemma":0.000015810054,"teacher_disagreement_score":0.4890584,"about_ca_system_score_codex":0.000043296244,"about_ca_system_score_gemma":0.00004598174,"threshold_uncertainty_score":0.4483646},"labels":[],"label_agreement":null},{"id":"W2387599933","doi":"10.1111/dom.12684","title":"Efficacy and safety of titrated canagliflozin in patients with type 2 diabetes mellitus inadequately controlled on metformin and sitagliptin","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Golder Associates (Canada)","funders":"Janssen Research and Development; Roche; Novartis; Novo Nordisk; Sanofi; GlaxoSmithKline; Merck; Bristol-Myers Squibb; AstraZeneca; Takeda Pharmaceuticals U.S.A.; Amgen; Pfizer","keywords":"Canagliflozin; Sitagliptin; Metformin; Medicine; Sitagliptin Phosphate; Type 2 Diabetes Mellitus; Type 2 diabetes; Diabetes mellitus; Internal medicine; Endocrinology; Pharmacology","score_opus":0.006258163269643421,"score_gpt":0.20136252006855904,"score_spread":0.1951043567989156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2387599933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944307,0.0036974654,0.0000011684749,0.00017452426,0.00006078594,0.0011152914,0.000028106933,0.000025214582,0.000466695],"genre_scores_gemma":[0.99816555,0.001181995,0.00015680777,0.00018639452,0.000020894655,0.000025960491,0.000030364155,0.000019341509,0.00021269453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868435,0.00007514192,0.0003120402,0.00034174338,0.00021583101,0.00037090966],"domain_scores_gemma":[0.9991551,0.00024361935,0.00012268034,0.0001993774,0.00009878946,0.00018044339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031840024,0.0002609128,0.0009051968,0.00024336594,0.000053122996,0.000019239475,0.000049101673,0.00008639819,0.000024766476],"category_scores_gemma":[0.0001513195,0.00015105652,0.00003520433,0.00021382293,0.00016335378,0.00014539313,0.000056131965,0.000083459105,0.000003734107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023294764,0.0008249041,0.91418236,0.00017973907,0.0006910596,0.0000049397418,0.00016238772,7.64137e-7,0.0011040437,0.0015756424,0.0000486834,0.07889598],"study_design_scores_gemma":[0.033966165,0.00090235035,0.95896894,0.00031245372,0.00061085215,7.403663e-8,0.000016589373,0.00001933514,0.0033537277,0.000119849894,0.0015379867,0.00019167615],"about_ca_topic_score_codex":0.00004052009,"about_ca_topic_score_gemma":0.00004169342,"teacher_disagreement_score":0.078704305,"about_ca_system_score_codex":0.000026119302,"about_ca_system_score_gemma":0.000026760554,"threshold_uncertainty_score":0.61599064},"labels":[],"label_agreement":null},{"id":"W2388825372","doi":"10.1111/dom.12689","title":"Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global <scp>HAT</scp> study","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":274,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Science and Engineering Research Board; Novo Nordisk; National Institute for Health and Care Research; Boehringer Ingelheim; Medtronic; Sanofi; Medpace; GlaxoSmithKline; Bristol-Myers Squibb; AstraZeneca; Takeda Pharmaceuticals U.S.A.; Pfizer","keywords":"Medicine; Insulin; Type 2 diabetes; Type 1 diabetes; Internal medicine; Diabetes mellitus; Endocrinology","score_opus":0.009119883461574484,"score_gpt":0.23512112988095865,"score_spread":0.22600124641938416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2388825372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845802,0.013733609,6.206792e-7,0.00027360822,0.00020127739,0.0008495241,0.000080483886,0.000037826427,0.0002428415],"genre_scores_gemma":[0.9968149,0.0023239495,0.00003821219,0.00012480585,0.00010174174,0.00001999172,0.000025572353,0.000019504892,0.000531312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983235,0.00015894063,0.00026904474,0.00041630425,0.0003771847,0.00045505416],"domain_scores_gemma":[0.9986111,0.00056029565,0.00010300603,0.00031351068,0.00023408855,0.00017798801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000514032,0.00026413123,0.0006647795,0.00013458777,0.00010982081,0.00007344211,0.00014188334,0.00011169394,0.00002087045],"category_scores_gemma":[0.00048482188,0.00013658454,0.00002662817,0.00066864624,0.0004538765,0.00021547574,0.00022562128,0.00015964579,0.000007794953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007241026,0.0002782855,0.99560803,0.0001181754,0.00039471564,0.0000043266205,0.0007468481,3.0128166e-7,0.00045188091,0.00012484634,0.0003925972,0.0018075869],"study_design_scores_gemma":[0.0034025924,0.0005974747,0.98840743,0.00019108034,0.00047904032,2.4422184e-7,0.0006408781,0.000032297423,0.0015572765,0.00039008443,0.0042078015,0.000093800605],"about_ca_topic_score_codex":0.00016790809,"about_ca_topic_score_gemma":0.00025418305,"teacher_disagreement_score":0.012234701,"about_ca_system_score_codex":0.000020103045,"about_ca_system_score_gemma":0.000065291366,"threshold_uncertainty_score":0.5569756},"labels":[],"label_agreement":null},{"id":"W2463959854","doi":"10.1111/dom.12736","title":"Efficacy and safety of switching from sitagliptin to liraglutide in subjects with type 2 diabetes ( <scp>LIRA‐SWITCH</scp> ): a randomized, double‐blind, double‐dummy, active‐controlled 26‐week trial","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Novo Nordisk","keywords":"Liraglutide; Sitagliptin; Medicine; Clinical endpoint; Metformin; Type 2 diabetes; Sitagliptin Phosphate; Internal medicine; Weight loss; Randomized controlled trial; Urology; Endocrinology; Gastroenterology; Diabetes mellitus; Obesity","score_opus":0.014695607301590724,"score_gpt":0.2412439360185757,"score_spread":0.22654832871698496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463959854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875314,0.003929154,0.000038103954,0.000398737,0.00034767497,0.0066578477,0.000029376672,0.000118165226,0.0009495404],"genre_scores_gemma":[0.9966462,0.0009519903,0.0007389001,0.0003185185,0.00029572757,0.0004057955,0.000038312734,0.00007333353,0.0005311714],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966221,0.00027212908,0.0008739014,0.0008625114,0.00049961795,0.0008697541],"domain_scores_gemma":[0.9963986,0.002037008,0.0004008594,0.0005191916,0.00018438199,0.00045993342],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013605565,0.0006261665,0.003007867,0.00058926834,0.00014467831,0.0000909564,0.00019688878,0.00021702562,0.000029008548],"category_scores_gemma":[0.0006645652,0.00038199138,0.00025209106,0.0005328601,0.00020110597,0.0004024231,0.00023687408,0.00025406483,0.000024409594],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91364974,0.001988318,0.035506748,0.00020083446,0.0035073305,0.000023904393,0.0018166204,0.000008082551,0.023742769,0.0011702009,0.000086060485,0.01829938],"study_design_scores_gemma":[0.89146954,0.0008838964,0.076574646,0.0006318928,0.0026363975,3.5610813e-7,0.00012849766,0.00003064684,0.025666596,0.00036357468,0.0013531501,0.00026083316],"about_ca_topic_score_codex":0.00024223997,"about_ca_topic_score_gemma":0.00013804283,"teacher_disagreement_score":0.041067902,"about_ca_system_score_codex":0.00005932291,"about_ca_system_score_gemma":0.000099497774,"threshold_uncertainty_score":0.9998632},"labels":[],"label_agreement":null},{"id":"W2466620119","doi":"10.1111/dom.12687","title":"Similar efficacy and safety of once‐weekly dulaglutide in patients with type 2 diabetes aged ≥65 and &lt;65 years","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Dulaglutide; Type 2 diabetes; Medicine; Internal medicine; Diabetes mellitus; Gerontology; Exenatide; Endocrinology","score_opus":0.005353490245852348,"score_gpt":0.19682980196859595,"score_spread":0.1914763117227436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466620119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960153,0.0028068905,0.0000015707446,0.00019925678,0.00007700464,0.0006187294,0.00003131733,0.000029684037,0.0002202297],"genre_scores_gemma":[0.9978869,0.0011511669,0.00039211696,0.00019861119,0.00003280696,0.000011434089,0.000029989087,0.000022602686,0.00027440238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872446,0.000063013664,0.00025090517,0.0003634309,0.000223411,0.00037475768],"domain_scores_gemma":[0.9992717,0.00014222506,0.00009943509,0.0002463006,0.000064775464,0.00017557539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002477979,0.00023168635,0.0006149285,0.00018304966,0.000053445394,0.000019049488,0.000059976304,0.00008514533,0.000024651074],"category_scores_gemma":[0.000101246595,0.00015372144,0.000034924265,0.00019365877,0.00023119949,0.0001821036,0.000115457304,0.000084738866,0.000004012449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017184058,0.00039828563,0.9421974,0.00012699321,0.00023736335,0.000003506285,0.00017616569,3.0188457e-7,0.0014691413,0.00022517545,0.00010069072,0.054893177],"study_design_scores_gemma":[0.009491073,0.00042711743,0.9825702,0.0003163881,0.0004260821,8.050593e-8,0.000014885774,0.000005419926,0.0018356093,0.00012375902,0.0046004616,0.00018896737],"about_ca_topic_score_codex":0.000009309336,"about_ca_topic_score_gemma":0.000010821448,"teacher_disagreement_score":0.054704208,"about_ca_system_score_codex":0.000018035527,"about_ca_system_score_gemma":0.000018653687,"threshold_uncertainty_score":0.6268579},"labels":[],"label_agreement":null},{"id":"W2467997778","doi":"10.1111/dom.12739","title":"Glucocorticoid‐induced hyperglycaemia in respiratory disease: a systematic review and meta‐analysis","year":2016,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Medical Research Council Canada","keywords":"Glucocorticoid; Placebo; Relative risk; Medicine; Meta-analysis; Diabetes mellitus; Confidence interval; Internal medicine; Randomized controlled trial; Endocrinology; Pathology","score_opus":0.041734381447298144,"score_gpt":0.3250469359214884,"score_spread":0.2833125544741903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2467997778","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012616412,0.9941971,0.0000017692145,0.00018719317,0.000085786305,0.0038737291,0.00023404243,0.000042205127,0.000116569194],"genre_scores_gemma":[0.0007452706,0.995225,0.000016019792,0.0023043605,0.00006150263,0.0010162413,0.00007647972,0.000051994197,0.00050311774],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9960855,0.0005616566,0.0014225506,0.000923476,0.00040966648,0.00059713895],"domain_scores_gemma":[0.9974462,0.00050738256,0.00038297204,0.00089886086,0.00014203055,0.00062258047],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007233414,0.0007715561,0.012481515,0.0006013372,0.000083163744,0.000051254832,0.00019604152,0.00039390486,0.0001602532],"category_scores_gemma":[0.0006957031,0.00045852462,0.0020255316,0.00075157767,0.0001262956,0.00013544854,0.00016065342,0.00047991867,0.00004850242],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000987374,0.0001451324,0.00032541968,0.9373043,0.057214644,0.000052804025,0.00001732959,7.713407e-9,0.0000014264651,0.0003227993,0.000018072134,0.004588184],"study_design_scores_gemma":[0.00078958477,0.000047648784,0.0005181234,0.08819144,0.83629286,0.0000043206296,0.000002722103,0.0000018469947,3.8445157e-7,0.0000382654,0.073611766,0.0005010128],"about_ca_topic_score_codex":0.0000081175995,"about_ca_topic_score_gemma":0.0000035626747,"teacher_disagreement_score":0.84911287,"about_ca_system_score_codex":0.000047354595,"about_ca_system_score_gemma":0.00022242987,"threshold_uncertainty_score":0.9997867},"labels":[],"label_agreement":null},{"id":"W2494432242","doi":"10.1111/dom.12741","title":"One‐year efficacy and safety of saxagliptin add‐on in patients receiving dapagliflozin and metformin","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brampton Civic Hospital","funders":"AstraZeneca","keywords":"Saxagliptin; Dapagliflozin; Placebo; Metformin; Medicine; Internal medicine; Adverse effect; Glycated haemoglobin; Type 2 diabetes; Diabetes mellitus; Endocrinology; Sitagliptin; Insulin","score_opus":0.009020959823222884,"score_gpt":0.21245615479370644,"score_spread":0.20343519497048357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494432242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965214,0.0013816686,0.0000026979537,0.00019712867,0.00007589185,0.00054373953,0.000024859935,0.00002201688,0.0012306131],"genre_scores_gemma":[0.99732304,0.0016166454,0.0005325651,0.00015049068,0.00003888238,0.000014075427,0.000014142593,0.000015645312,0.00029452526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886006,0.000055767152,0.00026946375,0.0003176064,0.0002057281,0.0002913626],"domain_scores_gemma":[0.99934614,0.00017031947,0.000090820344,0.00020215545,0.00004495507,0.00014560689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003639281,0.00018081626,0.00052965037,0.00021510528,0.00004885773,0.000014568993,0.000046061043,0.000085215586,0.000029701063],"category_scores_gemma":[0.000199459,0.00012989204,0.00003744466,0.00012566372,0.000117804906,0.00015322935,0.000112383656,0.00008164793,0.000005716906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019076535,0.0006025818,0.7042328,0.00014392374,0.00015095434,9.3765146e-7,0.00025735,8.451382e-8,0.0010025564,0.0019457752,0.000072774725,0.2913995],"study_design_scores_gemma":[0.008444503,0.00030192555,0.9821463,0.0004362907,0.00025687148,6.8014884e-8,0.000025869267,0.0000036631668,0.0042567905,0.00024799202,0.0037370329,0.00014264257],"about_ca_topic_score_codex":0.000012874672,"about_ca_topic_score_gemma":0.000008638354,"teacher_disagreement_score":0.29125687,"about_ca_system_score_codex":0.0000199215,"about_ca_system_score_gemma":0.000010884143,"threshold_uncertainty_score":0.52968436},"labels":[],"label_agreement":null},{"id":"W2516863452","doi":"10.1111/dom.12786","title":"Sitagliptin and risk of fractures in type 2 diabetes: <scp>R</scp> esults from the <scp>TECOS</scp> trial","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"Merck Sharp and Dohme; Novo Nordisk; University of Alberta; National Institute for Health and Care Research; Novartis; Bayer; AstraZeneca; Endocrine Society; GlaxoSmithKline; Amgen","keywords":"Medicine; Sitagliptin; Type 2 diabetes; Internal medicine; Diabetes mellitus; Endocrinology","score_opus":0.013809678897011743,"score_gpt":0.271004348771971,"score_spread":0.25719466987495926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2516863452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9645971,0.033014443,0.000002144846,0.00044423222,0.0003723988,0.0009374192,0.00029028434,0.00003541892,0.0003065293],"genre_scores_gemma":[0.98409253,0.0139496345,0.00017110033,0.0007317104,0.00056072715,0.000044358203,0.000038079856,0.000030634114,0.00038122848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719125,0.00046205946,0.00055999326,0.00051280996,0.0004780915,0.000795796],"domain_scores_gemma":[0.99314135,0.0054608653,0.00025793677,0.00050915556,0.00018911755,0.000441596],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0016237561,0.00029427814,0.00091142766,0.00018277617,0.00018322996,0.00004606497,0.00019887918,0.00032578438,0.000029617218],"category_scores_gemma":[0.009468585,0.00016605215,0.00011741192,0.0003621009,0.0003388777,0.00017959374,0.00017092495,0.0005506769,0.000027584856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002995261,0.0003933011,0.9499234,0.0001695296,0.00020334224,0.000004889617,0.0015991157,4.2612922e-7,0.009125536,0.00007700675,0.006496057,0.031707883],"study_design_scores_gemma":[0.01788488,0.00031594705,0.9117244,0.00019661167,0.00023072526,3.7144196e-7,0.0002669123,0.000029328476,0.01568665,0.00081506296,0.052804638,0.000044462784],"about_ca_topic_score_codex":0.00051543966,"about_ca_topic_score_gemma":0.00021399552,"teacher_disagreement_score":0.04630858,"about_ca_system_score_codex":0.000021488546,"about_ca_system_score_gemma":0.00015630104,"threshold_uncertainty_score":0.9988751},"labels":[],"label_agreement":null},{"id":"W2517814663","doi":"10.1111/dom.12749","title":"Ezetimibe increases intestinal expression of the <scp>LDL</scp> receptor gene in dyslipidaemic men with insulin resistance","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Ezetimibe; Endocrinology; PCSK9; Internal medicine; LDL receptor; Insulin resistance; Cholesterol; Familial hypercholesterolemia; HMG-CoA reductase; Liver X receptor; Chemistry; Medicine; Insulin; Biology; Reductase; Lipoprotein; Biochemistry; Transcription factor; Nuclear receptor; Gene","score_opus":0.005997450683939614,"score_gpt":0.19873182551777488,"score_spread":0.19273437483383526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2517814663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881828,0.010337767,0.000052432446,0.00020867835,0.00005831827,0.0005046025,0.000028707449,0.000025796,0.00060093554],"genre_scores_gemma":[0.9957528,0.0014605543,0.0018166441,0.00018501279,0.00021517517,0.000049559065,0.0000057567177,0.000020690062,0.00049378054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998449,0.00022548913,0.00028708793,0.00031719086,0.00039430652,0.00032690878],"domain_scores_gemma":[0.9988856,0.00017556087,0.00014777711,0.00050989346,0.000121254685,0.00015994304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007204639,0.00018276501,0.00054803584,0.00009198644,0.00008872741,0.000010038854,0.00013825044,0.00009927893,0.000013063018],"category_scores_gemma":[0.0006364502,0.0000910396,0.00011008898,0.0002775759,0.00018755611,0.0001177965,0.00010748505,0.00017770726,0.0000035997698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102062986,0.00035895305,0.5863739,0.0004845002,0.000099755205,0.000006829962,0.00044046497,0.0000011830205,0.3988998,0.00025460724,0.0008828704,0.012095021],"study_design_scores_gemma":[0.002000575,0.000045072873,0.6753463,0.0010972654,0.000095040654,0.000004287457,0.000066388064,0.0000026299087,0.3141224,0.000116474934,0.0070539545,0.000049566846],"about_ca_topic_score_codex":0.00013084602,"about_ca_topic_score_gemma":0.000034879984,"teacher_disagreement_score":0.08897239,"about_ca_system_score_codex":0.000032925185,"about_ca_system_score_gemma":0.00012765217,"threshold_uncertainty_score":0.37124872},"labels":[],"label_agreement":null},{"id":"W2528138059","doi":"10.1111/dom.12805","title":"Glucagon‐like peptide‐1 receptor agonists compared with basal insulins for the treatment of type 2 diabetes mellitus: <scp>a</scp> systematic review and meta‐analysis","year":2016,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Boehringer Ingelheim; Amgen","keywords":"Dulaglutide; Exenatide; Medicine; Liraglutide; Internal medicine; Type 2 diabetes; Basal (medicine); Sitagliptin; Meta-analysis; Lixisenatide; Randomized controlled trial; Glucagon-like peptide 1 receptor; Diabetes mellitus; Endocrinology; Insulin; Receptor; Agonist","score_opus":0.03299279135512655,"score_gpt":0.2840780141662557,"score_spread":0.25108522281112916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528138059","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012308393,0.98803216,0.000012662788,0.00013646219,0.00014968203,0.009568711,0.0007339651,0.0000613353,0.00007419926],"genre_scores_gemma":[0.00014054164,0.99253404,0.00050723244,0.000390251,0.00010372362,0.0028323578,0.0006290057,0.00008999,0.0027728432],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9964088,0.000395464,0.001187218,0.0008814124,0.00042752383,0.0006995457],"domain_scores_gemma":[0.994898,0.0022066878,0.0010651948,0.001180219,0.00032682266,0.00032306297],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007795937,0.0011120776,0.0121187605,0.0004186264,0.00022816635,0.00009523713,0.00029173787,0.00023283239,0.000046576693],"category_scores_gemma":[0.000196874,0.000495762,0.0021364682,0.0008745973,0.0003196942,0.00012908729,0.000099731405,0.00013863404,0.000023525046],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000066211524,0.0007210476,0.00012041763,0.60200655,0.38601038,0.0000019968932,0.00015286492,1.8424768e-7,8.7719343e-7,0.00017253541,0.0006484476,0.010158086],"study_design_scores_gemma":[0.0007236694,0.00036441433,0.00007980431,0.016514486,0.58638054,4.5219156e-7,0.000022734424,0.0000050156677,0.00001732446,0.000013205624,0.395704,0.00017434104],"about_ca_topic_score_codex":0.000013204644,"about_ca_topic_score_gemma":0.000011691872,"teacher_disagreement_score":0.5854921,"about_ca_system_score_codex":0.000078497396,"about_ca_system_score_gemma":0.00012114117,"threshold_uncertainty_score":0.9997494},"labels":[],"label_agreement":null},{"id":"W2528767427","doi":"10.1111/dom.12789","title":"Glucagon in artificial pancreas systems: Potential benefits and safety profile of future chronic use","year":2016,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Cegep Edouard Montpetit; Montreal Children's Hospital; McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Novo Nordisk; Boehringer Ingelheim; Roche","keywords":"Medicine; Artificial pancreas; Safety profile; Pancreas; Intensive care medicine; Internal medicine; Diabetes mellitus; Endocrinology; Adverse effect; Type 1 diabetes","score_opus":0.020082468594124773,"score_gpt":0.25199060281501506,"score_spread":0.2319081342208903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528767427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15705006,0.8404303,0.0000024220953,0.000025158586,0.00075873866,0.0011195394,0.0004970218,0.000035066463,0.0000816769],"genre_scores_gemma":[0.0027980779,0.99503005,0.00005864309,0.00003248728,0.0014223416,0.00009503583,0.00022952218,0.000044779077,0.00028909434],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99757713,0.00026314872,0.00085076207,0.0005563035,0.00028204397,0.00047062],"domain_scores_gemma":[0.9986112,0.00022738749,0.00038869822,0.00039611515,0.00011513455,0.00026143366],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048950914,0.0004916923,0.0030390183,0.00038685836,0.00008315992,0.000051027222,0.000088868226,0.000569002,0.00007518455],"category_scores_gemma":[0.00020402376,0.0003355473,0.00028026217,0.00028850755,0.0001630085,0.00018753251,0.000098152916,0.00034303355,0.000021569278],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058232323,0.00019487474,0.0017749781,0.028294485,0.00042629222,0.000008928629,0.000041069623,4.819703e-7,0.00017766365,0.002695832,0.00012620132,0.96620095],"study_design_scores_gemma":[0.0017055074,0.00012461985,0.026946558,0.028666956,0.0031280215,0.000021321006,0.000029181898,0.00003367213,0.00015742783,0.000026311718,0.93864316,0.00051728525],"about_ca_topic_score_codex":0.000056656783,"about_ca_topic_score_gemma":0.0000053310137,"teacher_disagreement_score":0.9656837,"about_ca_system_score_codex":0.00006911994,"about_ca_system_score_gemma":0.00029181797,"threshold_uncertainty_score":0.99990964},"labels":[],"label_agreement":null},{"id":"W2529164329","doi":"10.1111/dom.12794","title":"Effect of vitamin D supplementation on oral glucose tolerance in individuals with low vitamin D status and increased risk for developing type 2 diabetes ( <scp>EVIDENCE</scp> ): A double‐blind, randomized, placebo‐controlled clinical trial","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada; Université de Montréal; Montreal Clinical Research Institute; University of Guelph; University of Toronto","funders":"Public Health Agency of Canada; Dairy Farmers of Canada","keywords":"Medicine; Internal medicine; Prediabetes; Glycated hemoglobin; Postprandial; Endocrinology; Type 2 diabetes; Insulin resistance; Placebo; Vitamin D and neurology; Impaired fasting glucose; Insulin; Diabetes mellitus; Glucose tolerance test; Impaired glucose tolerance","score_opus":0.024996536740296546,"score_gpt":0.33947994664678444,"score_spread":0.3144834099064879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529164329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98616236,0.0037740793,0.00004893839,0.00016821071,0.00019928311,0.009489189,0.00011801796,0.000029560586,0.000010365933],"genre_scores_gemma":[0.98967266,0.006968465,0.0012836836,0.00010435652,0.00020068283,0.0016328605,0.000048465547,0.000032757365,0.000056047687],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9951055,0.0019298773,0.0009960998,0.0006362923,0.0005589731,0.0007732499],"domain_scores_gemma":[0.97590524,0.022781592,0.0005067307,0.00027339192,0.00027719358,0.00025585206],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010168847,0.0004216518,0.0028257305,0.00041279735,0.00015982465,0.00005701171,0.00012368259,0.00019682686,0.0000055110145],"category_scores_gemma":[0.0180394,0.00023574667,0.00021741264,0.00035805986,0.000607663,0.00031804154,0.00011856045,0.00028818566,0.0000025437685],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4787071,0.00035966316,0.50268036,0.00067536713,0.0009943749,0.0000026490093,0.00034253855,0.0000012754493,0.0014453253,0.000070613074,0.00008636698,0.014634352],"study_design_scores_gemma":[0.73711973,0.0031171483,0.2218242,0.0011438391,0.0010625197,2.5795373e-7,0.000053637694,0.00008862537,0.03530247,0.00006909492,0.00008696824,0.00013148547],"about_ca_topic_score_codex":0.00006239154,"about_ca_topic_score_gemma":0.000059985414,"teacher_disagreement_score":0.28085616,"about_ca_system_score_codex":0.000052100782,"about_ca_system_score_gemma":0.00020714402,"threshold_uncertainty_score":0.99023205},"labels":[],"label_agreement":null},{"id":"W2544950685","doi":"10.1111/dom.12816","title":"Effects of once‐weekly dulaglutide on kidney function in patients with type 2 diabetes in phase <scp>II</scp> and <scp>III</scp> clinical trials","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Merck Sharp and Dohme; European Association for the Study of Diabetes; Novo Nordisk; Amgen","keywords":"Dulaglutide; Medicine; Insulin glargine; Renal function; Internal medicine; Placebo; Type 2 diabetes; Urology; Endocrinology; Exenatide; Gastroenterology; Diabetes mellitus","score_opus":0.01698268501004133,"score_gpt":0.2805988584911671,"score_spread":0.26361617348112576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544950685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99521697,0.0020713047,0.000004911375,0.000096210664,0.00050631794,0.0017124936,0.0000384711,0.000047892703,0.00030542436],"genre_scores_gemma":[0.99682444,0.0010816423,0.0001012606,0.00094465894,0.00015438654,0.000084482606,0.00008686619,0.000037403825,0.0006848328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969326,0.0005270618,0.0008691868,0.0006475171,0.00039462285,0.0006289823],"domain_scores_gemma":[0.9961018,0.002610753,0.000396965,0.00034533523,0.00012262848,0.00042254798],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019405159,0.00041258286,0.0016792327,0.0004747414,0.000079372956,0.000028072991,0.00010265014,0.00023520383,0.0000046864516],"category_scores_gemma":[0.0043974076,0.00026270453,0.00014606306,0.00041489344,0.00022327538,0.00028545794,0.00012987368,0.000228578,0.000012112782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001824228,0.003856134,0.94490856,0.00035395366,0.00049603754,0.0000070929013,0.0001901105,4.2329012e-7,0.0032234117,0.00031175616,0.0017222579,0.044747844],"study_design_scores_gemma":[0.035706695,0.0034371426,0.9238827,0.00088585785,0.001073814,5.5073954e-8,0.000037336464,0.000024761124,0.024003275,0.00030716023,0.010552486,0.00008871921],"about_ca_topic_score_codex":0.000020543368,"about_ca_topic_score_gemma":0.000012613225,"teacher_disagreement_score":0.044659123,"about_ca_system_score_codex":0.000040909094,"about_ca_system_score_gemma":0.00006292554,"threshold_uncertainty_score":0.99998254},"labels":[],"label_agreement":null},{"id":"W2548551915","doi":"10.1111/dom.12818","title":"Treatment with a novel agent combining docosahexaenoate and metformin increases protectin DX and IL‐6 production in skeletal muscle and reduces insulin resistance in obese diabetic <i>db/db</i> mice","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Montreal Heart Institute","funders":"","keywords":"Metformin; Insulin resistance; Internal medicine; Endocrinology; Insulin; Medicine; Skeletal muscle; Diabetes mellitus; Glucose clamp technique; Glucose uptake; Type 2 diabetes; Pancreatic hormone","score_opus":0.009844989439245503,"score_gpt":0.21901720320158327,"score_spread":0.20917221376233777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548551915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690661,0.02892674,0.0000060799593,0.00048654643,0.000058927963,0.0012969449,0.00006253695,0.000042132608,0.00005399368],"genre_scores_gemma":[0.98801285,0.010395909,0.00086051965,0.00006679151,0.0001224715,0.00029185557,0.000017114695,0.000025700652,0.0002067694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982609,0.00012089486,0.00038718755,0.0006134558,0.0002077456,0.00040977498],"domain_scores_gemma":[0.9991487,0.00013769328,0.00016102432,0.0002063778,0.000076127435,0.00027007362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004412656,0.00033677826,0.00068911613,0.00028938428,0.00014108626,0.000050797174,0.00004677412,0.000093429706,0.000004465717],"category_scores_gemma":[0.00033484746,0.00022295202,0.000033500957,0.00027648604,0.000336737,0.00046776488,0.000056953784,0.00011581592,7.287664e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079579203,0.0033177054,0.45969778,0.001592885,0.00035856137,0.00007226265,0.0062562274,0.000002231198,0.21198718,0.0010782446,0.000018775228,0.31482235],"study_design_scores_gemma":[0.007500859,0.00024108628,0.95334584,0.0008207543,0.00039258727,0.000020177882,0.00028187048,0.000020631465,0.02937658,0.00041281458,0.007240193,0.000346607],"about_ca_topic_score_codex":0.00037706987,"about_ca_topic_score_gemma":0.0006440143,"teacher_disagreement_score":0.49364805,"about_ca_system_score_codex":0.000041333464,"about_ca_system_score_gemma":0.00009114438,"threshold_uncertainty_score":0.90917194},"labels":[],"label_agreement":null},{"id":"W2550794647","doi":"10.1111/dom.12821","title":"Cardiovascular events and all‐cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: <scp>A B</scp> ayesian meta‐analysis of survival data","year":2016,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Simon Fraser University; MD Precision (Canada); Precision Nanosystems (Canada); University of British Columbia","funders":"","keywords":"Medicine; Meta-analysis; Internal medicine; Hazard ratio; Observational study; Placebo; Randomized controlled trial; Relative risk; Myocardial infarction; Stroke (engine); Confidence interval; Sitagliptin; Type 2 diabetes; Diabetes mellitus; Pharmacology; Insulin; Endocrinology; Metformin","score_opus":0.07167600119653196,"score_gpt":0.3062117333737652,"score_spread":0.23453573217723328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550794647","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0821276,0.91351146,0.000026478381,0.0000125827455,0.00007601527,0.0015451759,0.0022319844,0.00007698981,0.00039170886],"genre_scores_gemma":[0.00870005,0.9865076,0.00020046256,0.00006862027,0.00007694172,0.00012714743,0.00351383,0.00011697976,0.00068837684],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99556184,0.00064086355,0.00073559023,0.0013475886,0.0009961383,0.00071796356],"domain_scores_gemma":[0.995959,0.00051603734,0.0007062772,0.002236164,0.00019101625,0.0003915313],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015392507,0.0010081382,0.009429945,0.0006425189,0.00011183061,0.00006198437,0.00047213215,0.0003201504,0.000030369434],"category_scores_gemma":[0.00012587676,0.00057043676,0.0014528069,0.0010447041,0.00031733565,0.00028487088,0.00041676406,0.0002750584,0.000005090497],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009090304,0.00055725937,0.02020744,0.003777977,0.9626876,0.000024511362,0.00010899604,0.0000010622969,8.3375676e-7,0.000089169036,0.00007950828,0.012456564],"study_design_scores_gemma":[0.0016217205,0.000057682766,0.02646089,0.0013828295,0.6926346,0.0000011572935,0.00003622818,0.000009601746,0.000004612343,0.000009359825,0.27752417,0.00025718028],"about_ca_topic_score_codex":0.00023792432,"about_ca_topic_score_gemma":0.00014598003,"teacher_disagreement_score":0.27744466,"about_ca_system_score_codex":0.000045436173,"about_ca_system_score_gemma":0.00013246242,"threshold_uncertainty_score":0.99967474},"labels":[],"label_agreement":null},{"id":"W2560424376","doi":"10.1111/dom.12815","title":"Predictors of outcomes in patients with type 2 diabetes in the lixisenatide <scp>GetGoal</scp> clinical trials","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Boehringer Ingelheim; Novo Nordisk; Merck; Sanofi; Roche; GlaxoSmithKline; Janssen Pharmaceuticals; AstraZeneca","keywords":"Medicine; Lixisenatide; Type 2 diabetes; Internal medicine; Placebo; Basal insulin; Basal (medicine); Clinical endpoint; Diabetes mellitus; Insulin; Randomized controlled trial; Glycated hemoglobin; Endocrinology","score_opus":0.02459821376528614,"score_gpt":0.2894897659217755,"score_spread":0.26489155215648935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560424376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671024,0.0010369864,8.2687643e-7,0.00027125547,0.00030587832,0.0011398694,0.00003360683,0.000024830304,0.00047652292],"genre_scores_gemma":[0.9984275,0.0004160222,0.0001110453,0.0005111366,0.000083512816,0.00005422882,0.000029142113,0.000018638644,0.00034878217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747497,0.00057405373,0.0007927366,0.00034229178,0.0003909322,0.00042499226],"domain_scores_gemma":[0.996925,0.002196576,0.0002754404,0.00038595512,0.00009565554,0.00012135099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028908334,0.00025085278,0.0012850697,0.00026134972,0.000032583368,0.000019989864,0.00016532838,0.00012129946,0.000012874397],"category_scores_gemma":[0.0027167357,0.00011370584,0.00015604068,0.00034449447,0.0001848555,0.00017872902,0.00008127907,0.000149224,0.00000963654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028457187,0.001277271,0.9884448,0.000060776463,0.00038600093,0.0000021622545,0.00019501577,2.1925334e-7,0.00005459626,0.00023298823,0.00045068757,0.008867034],"study_design_scores_gemma":[0.007740492,0.00046996927,0.98623466,0.00017492194,0.00053512084,2.0709923e-8,0.000061378596,0.0000038934086,0.0006732502,0.00023183708,0.0038044082,0.00007006864],"about_ca_topic_score_codex":0.000010675585,"about_ca_topic_score_gemma":0.000023804729,"teacher_disagreement_score":0.008796965,"about_ca_system_score_codex":0.000018366736,"about_ca_system_score_gemma":0.000034510034,"threshold_uncertainty_score":0.463679},"labels":[],"label_agreement":null},{"id":"W2563073900","doi":"10.1111/dom.12851","title":"Comparison of exposure response relationship of atrasentan between <scp>N</scp> orth <scp>A</scp> merican and <scp>A</scp> sian populations","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"AbbVie","keywords":"Albuminuria; Pharmacodynamics; Placebo; Internal medicine; Medicine; Urology; Type 2 diabetes; Diabetic nephropathy; Endocrinology; Pharmacology; Chemistry; Diabetes mellitus; Pharmacokinetics; Pathology","score_opus":0.035551766309733314,"score_gpt":0.3031542375120466,"score_spread":0.2676024712023133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563073900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783882,0.01904299,0.00011749613,0.00013717402,0.0001289284,0.00065089896,0.0005099139,0.00006928409,0.0009551126],"genre_scores_gemma":[0.9963285,0.00044666303,0.0010092728,0.000070324466,0.000117240495,0.000033850385,0.00018372099,0.000047494206,0.00176297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704236,0.0004206844,0.00084279996,0.0005790007,0.00049906754,0.0006160971],"domain_scores_gemma":[0.99484485,0.0032749036,0.00058465055,0.00057558704,0.00020158412,0.00051839615],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059962214,0.0004445789,0.0013537148,0.00041837478,0.00030646953,0.00003192615,0.00016255109,0.00029360774,0.0000038057349],"category_scores_gemma":[0.0032707136,0.0003470799,0.00022930941,0.0005830737,0.00045987283,0.00029666696,0.00010761033,0.0002636992,0.000015206092],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013954241,0.000598942,0.98604524,0.000065282526,0.00030938044,0.000004923039,0.0024298255,0.0000030403191,0.006404806,0.00087318046,0.002450046,0.00080136396],"study_design_scores_gemma":[0.0037112338,0.00040820293,0.97248304,0.00009699363,0.0011494099,0.0000033117662,0.0017453015,0.000018553385,0.010835586,0.0011243541,0.008365346,0.0000586712],"about_ca_topic_score_codex":0.000112873495,"about_ca_topic_score_gemma":0.000053018957,"teacher_disagreement_score":0.018596327,"about_ca_system_score_codex":0.00003252761,"about_ca_system_score_gemma":0.00011643419,"threshold_uncertainty_score":0.99989814},"labels":[],"label_agreement":null},{"id":"W2563196695","doi":"10.1111/dom.12840","title":"Metformin in adults with type 1 diabetes: <scp>D</scp> esign and methods of <scp>REducing</scp> with <scp>MetfOrmin V</scp> ascular <scp>A</scp> dverse <scp>L</scp> esions ( <scp>REMOVAL</scp> ): <scp>A</scp> n international multicentre trial","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; St Joseph's Health Care","funders":"Steno Diabetes Center Copenhagen; Merck KGaA; British Heart Foundation; Juvenile Diabetes Research Foundation United Kingdom","keywords":"Metformin; Medicine; Pharmacology; Type 2 diabetes; Diabetes mellitus; Endocrinology","score_opus":0.01383300333938595,"score_gpt":0.27210012046824994,"score_spread":0.25826711712886397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563196695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9502326,0.023723833,0.0011495877,0.00015332815,0.002932271,0.0082290005,0.00080972596,0.000786202,0.011983443],"genre_scores_gemma":[0.7705753,0.03187928,0.06325817,0.0025715816,0.006813243,0.0029205997,0.002946339,0.0024013796,0.1166341],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.97566426,0.0028574122,0.004061789,0.005091177,0.0053372406,0.006988148],"domain_scores_gemma":[0.9554351,0.031503513,0.0029774094,0.003637139,0.0027462384,0.0037005895],"candidate_categories":["metaresearch","metaepi_narrow","sts","scholarly_communication","research_integrity"],"consensus_categories":["metaepi_narrow","sts","research_integrity"],"category_scores_codex":[0.0105761755,0.003965174,0.006568054,0.004924949,0.001341178,0.0010474393,0.0031915666,0.0023390893,0.00006633323],"category_scores_gemma":[0.05476113,0.0030532812,0.0016488702,0.005434324,0.0028169844,0.0037596477,0.0024917924,0.003523695,0.00037558386],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001063723,0.02725904,0.38343656,0.015844204,0.033611264,0.00311085,0.07952211,0.001151872,0.10156076,0.0068697757,0.22034813,0.12622169],"study_design_scores_gemma":[0.1039984,0.0055139433,0.09375241,0.006666877,0.00877838,0.00013308207,0.039273217,0.0063376315,0.13561592,0.0020941852,0.59718525,0.0006507177],"about_ca_topic_score_codex":0.00037114313,"about_ca_topic_score_gemma":0.00021299376,"teacher_disagreement_score":0.3768371,"about_ca_system_score_codex":0.0006157428,"about_ca_system_score_gemma":0.001393308,"threshold_uncertainty_score":0.99998957},"labels":[],"label_agreement":null},{"id":"W2563362161","doi":"10.1111/dom.12864","title":"The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Ion Transport and Channel Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Institutes of Health; Novo Nordisk; Kyowa Hakko Kirin; Boehringer Ingelheim; AstraZeneca; Amgen","keywords":"Medicine; Urology; Type 2 diabetes; Albuminuria; Placebo; Diabetic nephropathy; Metabolite; Diabetes mellitus; Population; Internal medicine; Renal function; Urine; Urinary system; Gastroenterology; Endocrinology; Pharmacology; Pathology","score_opus":0.0016736962902884887,"score_gpt":0.1643762295613279,"score_spread":0.16270253327103942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563362161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943998,0.0052535944,0.000002844688,0.00003487659,0.00011294028,0.00016560282,0.0000105735635,0.000003965612,0.000015825339],"genre_scores_gemma":[0.9986832,0.001094322,0.000021304386,0.000059341306,0.000053648513,0.0000083208515,0.000025200174,0.000009399094,0.000045236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993951,0.000047590336,0.000109156885,0.00018017167,0.00009212252,0.00017591173],"domain_scores_gemma":[0.9996628,0.00005212432,0.00005146438,0.00013805955,0.00004920399,0.000046311656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010071499,0.0001153676,0.00015401133,0.000035412457,0.00006428516,0.000008733187,0.000054879514,0.000063336585,0.000001191012],"category_scores_gemma":[0.000039111535,0.000061273415,0.000025468615,0.000063812004,0.00013552334,0.000008809938,0.000023597766,0.000032660726,4.890715e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008990921,0.00012199057,0.8868946,0.00004838422,0.00004334883,3.107618e-7,0.000035408702,2.7571832e-7,0.10478428,0.00027460037,0.0000145444055,0.007692355],"study_design_scores_gemma":[0.00088406936,0.0002931604,0.7945114,0.000037312224,0.00003243482,4.3392678e-8,0.000004928748,0.0000010349892,0.20276354,0.00014730361,0.0012440599,0.00008074601],"about_ca_topic_score_codex":0.000001423334,"about_ca_topic_score_gemma":0.0000030879553,"teacher_disagreement_score":0.09797926,"about_ca_system_score_codex":0.0000018968004,"about_ca_system_score_gemma":0.00000870826,"threshold_uncertainty_score":0.24986576},"labels":[],"label_agreement":null},{"id":"W2573794142","doi":"10.1111/dom.12873","title":"Dual role of interleukin‐1β in islet amyloid formation and its β‐cell toxicity: <scp>I</scp> mplications for type 2 diabetes and islet transplantation","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Islet; Downregulation and upregulation; Amyloid (mycology); Apoptosis; Cell biology; Transplantation; Chemistry; Endocrinology; Internal medicine; Biology; Insulin; Medicine; Biochemistry","score_opus":0.015709173806033722,"score_gpt":0.2499304910447204,"score_spread":0.23422131723868667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573794142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924882,0.0056820833,0.000026065645,0.00017107459,0.00008617533,0.0005375397,0.00013385892,0.000023950044,0.00085103506],"genre_scores_gemma":[0.99707246,0.0018593877,0.00034102105,0.0002667828,0.000087111825,0.00005919563,0.0001370733,0.000013712415,0.00016323834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990588,0.00003960354,0.00028487862,0.00024547544,0.00011752061,0.00025375144],"domain_scores_gemma":[0.9990353,0.00031173462,0.00018627237,0.00020684052,0.00013080698,0.00012906626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003071116,0.00016783415,0.0004473178,0.00017486939,0.00020124119,0.00006427842,0.00006231016,0.00012729876,0.0000050886683],"category_scores_gemma":[0.0005019249,0.00015533666,0.00004627733,0.000078359524,0.00011060193,0.00043791928,0.000037306192,0.00010907614,0.0000026978034],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051188563,0.00033771803,0.21972461,0.0016927685,0.00010474456,8.896307e-7,0.0035550534,0.0000023638293,0.7642837,0.0030047281,0.00026727704,0.0069749183],"study_design_scores_gemma":[0.0023898582,0.00015916607,0.48051783,0.00012734985,0.00032704262,0.0000021507433,0.00041279593,0.0017026922,0.5099796,0.0015643744,0.0027263423,0.00009078994],"about_ca_topic_score_codex":0.000013621493,"about_ca_topic_score_gemma":0.0000057059974,"teacher_disagreement_score":0.2607932,"about_ca_system_score_codex":0.0000096263975,"about_ca_system_score_gemma":0.000023812003,"threshold_uncertainty_score":0.6334445},"labels":[],"label_agreement":null},{"id":"W2574266291","doi":"10.1111/dom.12874","title":"Physician step prescription and monitoring to improve <scp>ARTERial</scp> health ( <scp>SMARTER</scp> ): A randomized controlled trial in patients with type 2 diabetes and hypertension","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Cardiovascular Health and Disease Prevention","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute; Jewish General Hospital; Concordia University; St Mary's Hospital Centre; McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research; McGill University; Heart and Stroke Foundation of Canada","keywords":"Medicine; Diabetes mellitus; Medical prescription; Type 2 diabetes; Randomized controlled trial; Internal medicine; Physical therapy; Emergency medicine; Endocrinology","score_opus":0.0074259383247465985,"score_gpt":0.23239505501288055,"score_spread":0.22496911668813394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574266291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98468107,0.008046241,0.000016253969,0.00007454149,0.0010657703,0.0060085887,0.000020199499,0.000035807283,0.00005153472],"genre_scores_gemma":[0.9975177,0.00080790353,0.0002279835,0.00041777952,0.00059023185,0.00030904816,0.000039785737,0.00002700076,0.00006257768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977168,0.00040117593,0.00047694668,0.000512606,0.00035467598,0.00053783215],"domain_scores_gemma":[0.9982442,0.00026639717,0.0003288812,0.00041505473,0.00018583819,0.0005595769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012768105,0.00030205052,0.0020953214,0.00018753052,0.00036601993,0.00018766984,0.00006566204,0.00012732173,5.012685e-7],"category_scores_gemma":[0.0015354054,0.00022798462,0.0001958783,0.00008456281,0.000114844675,0.00034183174,0.00009353532,0.00017980575,0.0000019970776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25731355,0.0023209124,0.6135282,0.0023082981,0.00211234,0.00001167024,0.0020863449,0.000002540475,0.010560126,0.000087577966,0.00035178068,0.10931669],"study_design_scores_gemma":[0.4357185,0.00021381442,0.5626291,0.00020808655,0.0005499309,1.9871479e-7,0.000052534942,0.0001093032,0.00019714922,0.000050648796,0.00022748762,0.00004324669],"about_ca_topic_score_codex":0.0001142279,"about_ca_topic_score_gemma":0.00001057285,"teacher_disagreement_score":0.17840497,"about_ca_system_score_codex":0.000027298482,"about_ca_system_score_gemma":0.00008846418,"threshold_uncertainty_score":0.9296943},"labels":[],"label_agreement":null},{"id":"W2574678721","doi":"10.1111/dom.12832","title":"Randomized clinical trial comparing the efficacy and safety of treatment with the once‐weekly dipeptidyl peptidase‐4 ( <scp>DPP</scp> ‐4) inhibitor omarigliptin or the once‐daily <scp>DPP</scp> ‐4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Sitagliptin; Medicine; Sitagliptin Phosphate; Metformin; Internal medicine; Randomized controlled trial; Dipeptidyl peptidase-4 inhibitor; Confidence interval; Dipeptidyl peptidase-4; Adverse effect; Type 2 diabetes; Gastroenterology; Saxagliptin; Diabetes mellitus; Pharmacology; Endocrinology; Insulin","score_opus":0.02663838770768699,"score_gpt":0.2781004863912154,"score_spread":0.25146209868352837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574678721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860342,0.0020799614,0.0000047665008,0.0005875176,0.0004403856,0.0098365275,0.000042185024,0.00006228322,0.0009121353],"genre_scores_gemma":[0.99504465,0.001256312,0.00019085094,0.0005598527,0.000553525,0.00070295803,0.00007611958,0.00007987304,0.0015358523],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99482876,0.0012404639,0.0013023118,0.00088113244,0.0007866375,0.000960704],"domain_scores_gemma":[0.98847073,0.008303623,0.0013598329,0.0013041884,0.00025751966,0.00030411052],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037392504,0.0009033512,0.003439342,0.00021610426,0.0009459894,0.0003702116,0.00054515054,0.00025391398,0.000009211879],"category_scores_gemma":[0.0021897731,0.00034077364,0.00043179115,0.0003176722,0.0014985438,0.00035588793,0.0002575305,0.0005968962,0.000010370356],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35915446,0.008398068,0.55629295,0.00022544061,0.008938799,0.00002450418,0.005335597,0.000051962204,0.00019440932,0.0009570899,0.0011576968,0.05926903],"study_design_scores_gemma":[0.63878626,0.0065586604,0.3393784,0.0004178834,0.0029420282,3.7703327e-7,0.00055656955,0.00036194807,0.0009797218,0.000052558215,0.009793146,0.00017245897],"about_ca_topic_score_codex":0.00013414944,"about_ca_topic_score_gemma":0.00018409213,"teacher_disagreement_score":0.2796318,"about_ca_system_score_codex":0.000108876455,"about_ca_system_score_gemma":0.00018973692,"threshold_uncertainty_score":0.99990445},"labels":[],"label_agreement":null},{"id":"W2577069570","doi":"10.1111/dom.12880","title":"Outpatient 60‐hour day‐and‐night glucose control with dual‐hormone artificial pancreas, single‐hormone artificial pancreas, or sensor‐augmented pump therapy in adults with type 1 diabetes: <scp>A</scp> n open‐label, randomised, crossover, controlled trial","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; Université de Montréal; McGill University Health Centre; Montreal Clinical Research Institute; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Artificial pancreas; Hormone; Medicine; Endocrinology; Internal medicine; Insulin; Diabetes mellitus; Glucagon; Pancreas; Crossover study; Type 2 diabetes; Hormone therapy; Type 1 diabetes; Pathology; Cancer","score_opus":0.028269055082034904,"score_gpt":0.27093403592543575,"score_spread":0.24266498084340085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577069570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97701675,0.008809564,0.000013424695,0.00049171306,0.0004927762,0.012114837,0.0001271393,0.00011165119,0.0008221527],"genre_scores_gemma":[0.9928594,0.002723714,0.00016277215,0.0006518618,0.00086135213,0.0009609119,0.00016384876,0.00012257001,0.0014935386],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99392664,0.0007460086,0.0011489097,0.001293117,0.0011981687,0.0016871729],"domain_scores_gemma":[0.99547535,0.0011395189,0.00085052307,0.0011761759,0.0005925832,0.0007658652],"candidate_categories":["metaepi_narrow","scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.0028115439,0.0009405042,0.003178463,0.00045907346,0.0010399515,0.001286266,0.0005778082,0.00040796187,0.000043593318],"category_scores_gemma":[0.0024163148,0.0005938485,0.00018445552,0.00045573048,0.00090476626,0.00086677744,0.00035318246,0.00079025485,0.000025742058],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89039016,0.010113079,0.031770423,0.00030092028,0.0039501344,0.00034838996,0.0015302043,0.000008669368,0.03360443,0.00029477553,0.0007856352,0.026903206],"study_design_scores_gemma":[0.84900624,0.0096385665,0.124513745,0.0005445192,0.0016123174,0.000002635952,0.00036912918,0.0016048272,0.0077179633,0.00018535859,0.004180347,0.0006243544],"about_ca_topic_score_codex":0.00021428474,"about_ca_topic_score_gemma":0.00021813413,"teacher_disagreement_score":0.09274332,"about_ca_system_score_codex":0.00007476726,"about_ca_system_score_gemma":0.00026769232,"threshold_uncertainty_score":0.9997505},"labels":[],"label_agreement":null},{"id":"W2582426955","doi":"10.1111/dom.12892","title":"Safety and efficacy of <scp>IDegLira</scp> titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: <scp>DUAL VI</scp> randomized clinical trial","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Novo Nordisk; European Foundation for the Study of Diabetes; American Diabetes Association","keywords":"Medicine; Type 2 diabetes; Metformin; Pioglitazone; Liraglutide; Internal medicine; Adverse effect; Diabetes mellitus; Randomized controlled trial; Gastroenterology; Insulin; Urology; Endocrinology","score_opus":0.01647658566892487,"score_gpt":0.2755543898933128,"score_spread":0.259077804224388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582426955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99058384,0.001817692,0.0000018011348,0.00012256305,0.0011869953,0.0035522955,0.00005168607,0.00007757293,0.0026055612],"genre_scores_gemma":[0.9972768,0.00091163674,0.00026843586,0.00027367944,0.00026045972,0.00006874166,0.00016701386,0.00006053131,0.00071271334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955838,0.00076186575,0.0011781256,0.0008959954,0.0006750616,0.0009051527],"domain_scores_gemma":[0.99298954,0.0045389384,0.0008620887,0.00087275315,0.00030738136,0.0004293182],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027384125,0.00064860866,0.0032072524,0.0003445883,0.00033388863,0.00017424488,0.0002920411,0.0003225541,0.000009053234],"category_scores_gemma":[0.00654163,0.00048190157,0.00034066552,0.00029982146,0.0008428763,0.00040021582,0.00023164558,0.00048449484,0.000021908258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20362072,0.008149672,0.7509609,0.00046475022,0.005783052,0.000027573526,0.00091467635,0.000015480418,0.00020998623,0.0010901567,0.0009413094,0.027821725],"study_design_scores_gemma":[0.4927921,0.002488068,0.49974743,0.00023687525,0.0021373825,4.0260396e-8,0.00007476576,0.0001404695,0.0005233582,0.00006460893,0.001687258,0.000107636],"about_ca_topic_score_codex":0.000060963728,"about_ca_topic_score_gemma":0.0000203559,"teacher_disagreement_score":0.28917137,"about_ca_system_score_codex":0.00004533161,"about_ca_system_score_gemma":0.00012458485,"threshold_uncertainty_score":0.99976325},"labels":[],"label_agreement":null},{"id":"W2583128854","doi":"10.1111/dom.12896","title":"Scriptaid enhances skeletal muscle insulin action and cardiac function in obese mice","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"National Health and Medical Research Council; Deakin University","keywords":"Skeletal muscle; Endocrinology; Internal medicine; Corepressor; Insulin; Cardiac function curve; Cardiac muscle; Glucose uptake; Beta oxidation; In vivo; Medicine; Metabolism; Biology; Gene expression; Heart failure; Biochemistry; Gene","score_opus":0.011553266496461776,"score_gpt":0.2606076476147208,"score_spread":0.24905438111825906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583128854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98379445,0.015166821,0.000010823535,0.0000813654,0.00047451153,0.0001595179,0.000022132992,0.000008689825,0.00028166384],"genre_scores_gemma":[0.9952369,0.0037539976,0.00007295605,0.00004580352,0.0003727744,0.00002637107,0.000038332146,0.000012817233,0.00044009768],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989947,0.00010143559,0.00013244101,0.0003693938,0.00013001199,0.0002720299],"domain_scores_gemma":[0.9994505,0.000010354503,0.00007118317,0.00030513172,0.00005844071,0.00010437481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003762833,0.00013807214,0.0002062777,0.000072905736,0.00032425974,0.00010153624,0.000120349236,0.00016295156,0.00000562337],"category_scores_gemma":[0.00020061259,0.00013983376,0.000053570628,0.000042833148,0.00020931107,0.00003828614,0.00016614741,0.00015825903,0.000008617235],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001823646,0.00005877336,0.013855199,0.000044135853,0.00002587127,8.458753e-7,0.00006434501,5.334726e-7,0.9533045,0.000050920935,0.00022147274,0.032355122],"study_design_scores_gemma":[0.00042486098,0.000048991547,0.59372836,0.000014379184,0.000020296076,3.2432314e-7,0.000044219003,0.000020627293,0.34735706,0.00005867598,0.058143392,0.00013877348],"about_ca_topic_score_codex":0.00019088238,"about_ca_topic_score_gemma":0.00016222213,"teacher_disagreement_score":0.6059475,"about_ca_system_score_codex":0.000009503088,"about_ca_system_score_gemma":0.000031729953,"threshold_uncertainty_score":0.57022554},"labels":[],"label_agreement":null},{"id":"W2586129535","doi":"10.1111/dom.12902","title":"Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon‐like peptide‐1 receptor agonists: <scp>H</scp> igher adherence and persistence with dulaglutide compared with once‐weekly exenatide and liraglutide","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Dulaglutide; Exenatide; Liraglutide; Medicine; Internal medicine; Glucagon-like peptide 1 receptor; Type 2 diabetes; Gastroenterology; Endocrinology; Insulin glargine; Diabetes mellitus; Urology; Agonist; Receptor","score_opus":0.013362450733565802,"score_gpt":0.2128715142048029,"score_spread":0.19950906347123712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586129535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99411213,0.0031294564,0.000003608835,0.00012905501,0.000060981267,0.0016427324,0.00009198084,0.000087332715,0.00074269524],"genre_scores_gemma":[0.9949468,0.0013087922,0.0014443614,0.00018593518,0.000048449296,0.00017950911,0.00023551224,0.00007213759,0.0015785495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971614,0.00009291639,0.00032819083,0.0010338561,0.0004916932,0.0008919282],"domain_scores_gemma":[0.99795854,0.00015274722,0.00036183203,0.00078958407,0.0002500774,0.00048719553],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014908549,0.0007780949,0.0012534007,0.0002249999,0.0005046076,0.00033665646,0.00019576278,0.0001232352,0.000015891224],"category_scores_gemma":[0.000043902222,0.00047155836,0.000053425694,0.0002310724,0.00070385257,0.000601462,0.00012775257,0.00021675858,0.000006864015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039565965,0.0009568383,0.9909485,0.0002436296,0.0010647401,0.000047372883,0.00082300254,0.0000041233125,0.00010162435,0.000045959612,0.000056758094,0.0053117755],"study_design_scores_gemma":[0.013594157,0.0049239346,0.9723275,0.0009425675,0.0016453259,0.0000027613492,0.0005439754,0.000062270636,0.0021502562,0.000011269139,0.003412828,0.00038317798],"about_ca_topic_score_codex":0.0005946967,"about_ca_topic_score_gemma":0.000801183,"teacher_disagreement_score":0.01862104,"about_ca_system_score_codex":0.00012317578,"about_ca_system_score_gemma":0.00008864522,"threshold_uncertainty_score":0.9997736},"labels":[],"label_agreement":null},{"id":"W2586360876","doi":"10.1111/dom.12858","title":"Chronic liraglutide therapy induces an enhanced endogenous glucagon‐like peptide‐1 secretory response in early type 2 diabetes","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Novo Nordisk","keywords":"Liraglutide; Incretin; Medicine; Internal medicine; Endocrinology; Glucagon-like peptide-1; Endogeny; Type 2 diabetes; Context (archaeology); Placebo; Glucagon; Diabetes mellitus; Hormone; Area under the curve; Glucagon-like peptide 1 receptor; Receptor; Agonist; Biology","score_opus":0.025454983720309386,"score_gpt":0.25834506315053946,"score_spread":0.23289007943023007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586360876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98061806,0.016238527,0.0000011591717,0.0002446302,0.0005841817,0.0008797513,0.00001634146,0.00011586837,0.0013014629],"genre_scores_gemma":[0.9950135,0.00259661,0.00016789688,0.0005668512,0.00042516846,0.00010883178,0.000052313164,0.00005457419,0.0010142792],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975709,0.00023764552,0.00034485036,0.00066569535,0.0003244332,0.00085651566],"domain_scores_gemma":[0.9981216,0.00012023813,0.00021897956,0.001087083,0.000111608664,0.00034046997],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008781017,0.00043429426,0.0008227553,0.00031725707,0.0004609665,0.00023623522,0.00037337426,0.00020235912,0.0000811589],"category_scores_gemma":[0.00018308595,0.00037902762,0.00013666472,0.00016224,0.00028610078,0.0007062661,0.0001898741,0.00030804359,0.00006097888],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084959564,0.0011052393,0.34816688,0.0001957626,0.00064592395,0.00007465577,0.0026244696,0.0000037755794,0.56470704,0.0003019411,0.00010477459,0.08121994],"study_design_scores_gemma":[0.003592033,0.0011089453,0.84886336,0.00012419814,0.00021078397,5.647847e-7,0.00006081671,0.000024187495,0.13532227,0.0002325468,0.010099105,0.00036119233],"about_ca_topic_score_codex":0.0001390604,"about_ca_topic_score_gemma":0.000054718097,"teacher_disagreement_score":0.5006965,"about_ca_system_score_codex":0.00009914591,"about_ca_system_score_gemma":0.00015604445,"threshold_uncertainty_score":0.9998662},"labels":[],"label_agreement":null},{"id":"W2588151434","doi":"10.1111/dom.12904","title":"Treatment with the glucagon receptor antagonist <scp>LY2409021</scp> increases ambulatory blood pressure in patients with type 2 diabetes","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Medicine; Internal medicine; Placebo; Blood pressure; Ambulatory blood pressure; Endocrinology; Type 2 diabetes; Glycemic; Glycated hemoglobin; Crossover study; Lipid profile; Mean arterial pressure; Ambulatory; Diabetes mellitus; Gastroenterology; Insulin; Heart rate","score_opus":0.00583972582482539,"score_gpt":0.20114962719925142,"score_spread":0.19530990137442603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588151434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98999107,0.007050048,1.905452e-7,0.00021458759,0.00013766582,0.0012146105,0.000065759676,0.00006839134,0.0012576611],"genre_scores_gemma":[0.99665266,0.0006325056,0.0001812275,0.00029825035,0.00015075158,0.00012946135,0.00016945135,0.000046386147,0.0017392829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981781,0.00008531524,0.00020784813,0.00053954765,0.00036669878,0.0006224787],"domain_scores_gemma":[0.9983875,0.00012323717,0.00023271683,0.0008872377,0.00013496223,0.00023430781],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017887497,0.00045154706,0.0007232915,0.00012784153,0.0005516142,0.00023069249,0.00023206357,0.00011081399,0.000023725033],"category_scores_gemma":[0.00008106616,0.0002486725,0.00008083547,0.00013996221,0.00038506635,0.00033767702,0.000138383,0.00016465802,0.000018908038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072467585,0.0019991372,0.98944443,0.00012080549,0.0016115707,0.000009053914,0.00021291133,0.0000014275665,0.00031554417,0.00012838036,0.00031340052,0.005770863],"study_design_scores_gemma":[0.0076263375,0.001314003,0.93967754,0.00014214353,0.003801634,2.8607457e-7,0.00007618334,0.000011653728,0.006774561,0.000019605488,0.04040045,0.00015559193],"about_ca_topic_score_codex":0.00016277684,"about_ca_topic_score_gemma":0.00005796997,"teacher_disagreement_score":0.049766887,"about_ca_system_score_codex":0.000026829332,"about_ca_system_score_gemma":0.00006555839,"threshold_uncertainty_score":0.99999654},"labels":[],"label_agreement":null},{"id":"W2588974371","doi":"10.1111/dom.12909","title":"Lipid‐lowering efficacy and safety of alirocumab in patients with or without diabetes: <scp>A</scp> sub‐analysis of <scp>ODYSSEY COMBO II</scp>","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Ezetimibe; PCSK9; Medicine; Statin; Internal medicine; Adverse effect; Diabetes mellitus; Gastroenterology; Urology; Pharmacology; Endocrinology; Cholesterol; Lipoprotein; LDL receptor","score_opus":0.008596369459351293,"score_gpt":0.23169539415642734,"score_spread":0.22309902469707604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588974371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956185,0.0028899387,0.000022220289,0.000023142218,0.00011712982,0.00094960956,0.000091559385,0.000027986673,0.000259896],"genre_scores_gemma":[0.9982558,0.0010269226,0.00027137966,0.00010954231,0.00010590899,0.000027898192,0.000062353465,0.000039707757,0.000100475394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735194,0.00013099486,0.0006396552,0.0005747459,0.00068374287,0.00061894604],"domain_scores_gemma":[0.9974131,0.00028328152,0.00053838803,0.0011398873,0.0002754202,0.00034994446],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00110876,0.0003787147,0.0022823552,0.00046205294,0.00034972024,0.00005193205,0.00024171968,0.00021642359,0.0000036341667],"category_scores_gemma":[0.0010844793,0.00027928088,0.000286526,0.0004972453,0.00036413627,0.00028479347,0.00027687734,0.00030965626,9.023591e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005296304,0.0006236415,0.98809224,0.0006943669,0.0026220328,0.0000025481406,0.0011063798,0.00001199096,0.0006536381,0.00005032474,0.000017028136,0.0060728267],"study_design_scores_gemma":[0.008122731,0.00038981345,0.97321314,0.0004374701,0.004194916,4.3213905e-7,0.00013171005,0.00015383011,0.0115105705,0.000013864089,0.0017436494,0.00008789388],"about_ca_topic_score_codex":0.00030478457,"about_ca_topic_score_gemma":0.00014823893,"teacher_disagreement_score":0.01487914,"about_ca_system_score_codex":0.000028169192,"about_ca_system_score_gemma":0.000100174155,"threshold_uncertainty_score":0.99996597},"labels":[],"label_agreement":null},{"id":"W2591690224","doi":"10.1111/dom.12930","title":"Lixisenatide reduces glycaemic variability in insulin‐treated patients with type 2 diabetes","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Sanofi","keywords":"Postprandial; Medicine; Lixisenatide; Internal medicine; Placebo; Diabetes mellitus; Insulin; Basal (medicine); Body mass index; Area under the curve; Type 2 diabetes; Endocrinology; Type 1 diabetes; Basal insulin","score_opus":0.009965807097266683,"score_gpt":0.24702719551059987,"score_spread":0.23706138841333319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591690224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99419546,0.0007691079,5.2760356e-7,0.00034639557,0.00019750033,0.0007495751,0.00001738411,0.00005711182,0.0036669204],"genre_scores_gemma":[0.99851006,0.00020593146,0.00023678274,0.0001807811,0.000110553156,0.00003208604,0.00008540003,0.000027147213,0.0006112727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805695,0.00014226152,0.00026662994,0.0005134528,0.000397219,0.00062350056],"domain_scores_gemma":[0.9985258,0.00013017814,0.00014789434,0.00070068956,0.0002561794,0.00023927947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008855553,0.00026512062,0.00062063005,0.00024093795,0.0003185442,0.00017350125,0.0002856376,0.00013868863,0.00006682951],"category_scores_gemma":[0.000942462,0.00019324906,0.000059745336,0.0002473476,0.00038631473,0.0004186528,0.00026699563,0.00033158783,0.000026758837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008821859,0.0005990913,0.97458273,0.00017137668,0.00013516906,0.000005009689,0.0000757627,6.288e-7,0.0007550442,0.00012647781,0.00012697418,0.023333486],"study_design_scores_gemma":[0.0030926976,0.00015931635,0.98807204,0.00017376085,0.00016800573,4.235064e-8,0.000012245376,0.00017871508,0.0053271833,0.0005275909,0.002054745,0.00023368117],"about_ca_topic_score_codex":0.00004750206,"about_ca_topic_score_gemma":0.0000151134245,"teacher_disagreement_score":0.023099804,"about_ca_system_score_codex":0.000032670137,"about_ca_system_score_gemma":0.00005265242,"threshold_uncertainty_score":0.7880468},"labels":[],"label_agreement":null},{"id":"W2600127085","doi":"10.1111/dom.12958","title":"Treatment with <scp>LY</scp> 2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Sitagliptin; Medicine; Internal medicine; Endocrinology; Placebo; Metformin; Glycated hemoglobin; Type 2 diabetes; Glucagon receptor; Blood pressure; Lipid profile; Glucagon-like peptide 1 receptor; Glucagon; Diabetes mellitus; Insulin; Receptor","score_opus":0.008540022634781116,"score_gpt":0.21006093675243936,"score_spread":0.20152091411765824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600127085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99341387,0.0030658655,7.725684e-7,0.00009204006,0.0001621533,0.0011901142,0.000065165776,0.00008054614,0.0019294994],"genre_scores_gemma":[0.9952893,0.001382416,0.0006829353,0.00026212868,0.00015873942,0.00012183919,0.00030647815,0.000052899566,0.0017432387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979747,0.00006896356,0.0002458905,0.0006244835,0.00036224214,0.0007237143],"domain_scores_gemma":[0.9984287,0.00010284889,0.00022564332,0.00076012634,0.0001530239,0.0003296662],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001278757,0.0005045653,0.000885938,0.00022078115,0.0003861523,0.00021393165,0.0001842476,0.00012348237,0.000037657952],"category_scores_gemma":[0.00009984486,0.0003317222,0.00008875435,0.00016669252,0.00028636437,0.00046943268,0.00013986429,0.00013997733,0.00005319862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011957338,0.0021769397,0.9805034,0.00013733347,0.0006474002,0.000022954533,0.00023917032,5.4268e-7,0.00022510135,0.0001429048,0.0003100025,0.015474695],"study_design_scores_gemma":[0.009203386,0.0020883027,0.94902384,0.00023513727,0.0010885245,3.1808463e-7,0.000059816462,0.00002579867,0.0065849996,0.00002738112,0.031460643,0.00020187067],"about_ca_topic_score_codex":0.0002763,"about_ca_topic_score_gemma":0.00010316787,"teacher_disagreement_score":0.03147956,"about_ca_system_score_codex":0.00009506092,"about_ca_system_score_gemma":0.00005399038,"threshold_uncertainty_score":0.99991345},"labels":[],"label_agreement":null},{"id":"W2604384839","doi":"10.1111/dom.12960","title":"Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus‐basal insulin regimens: <scp>A</scp> n analysis from the <scp>OpT2mise</scp> randomized trial","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Glycemic; Medicine; Type 1 diabetes; Insulin; Insulin pump; Diabetes mellitus; Randomized controlled trial; Internal medicine; Bolus (digestion); Type 2 diabetes; Basal (medicine); Univariate analysis; Endocrinology; Gastroenterology; Multivariate analysis; Anesthesia","score_opus":0.01044846833486708,"score_gpt":0.22614072643318736,"score_spread":0.2156922580983203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604384839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988287,0.004490442,0.000013446236,0.000117528696,0.00030490584,0.0063398182,0.0001134263,0.00011326361,0.0002201953],"genre_scores_gemma":[0.9975535,0.00037241302,0.000048091108,0.0005095866,0.00019031836,0.00025414227,0.00052981183,0.00009491444,0.00044720335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947913,0.0009379074,0.00081615534,0.0009756269,0.0012020858,0.0012769041],"domain_scores_gemma":[0.9923086,0.004549599,0.0010894855,0.0011228428,0.0005594476,0.00037000742],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019422912,0.0008430392,0.0036652107,0.00052416686,0.0007967231,0.00049360126,0.0006436454,0.0003844774,0.000013443643],"category_scores_gemma":[0.0053240275,0.0004351097,0.0005413951,0.0009615486,0.00061273057,0.00045667318,0.00018228803,0.0008390904,0.0000039254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.088953204,0.0011673738,0.8927586,0.000024476416,0.013571309,0.000025226886,0.00085822574,0.000027930986,0.00039050865,0.0000072155726,0.00008081968,0.0021351078],"study_design_scores_gemma":[0.48319814,0.0017272229,0.5084392,0.00015694546,0.004557939,2.370415e-8,0.00014183868,0.0011772761,0.00023268952,0.000070327915,0.0001659413,0.00013244462],"about_ca_topic_score_codex":0.00031677616,"about_ca_topic_score_gemma":0.0002713241,"teacher_disagreement_score":0.39424494,"about_ca_system_score_codex":0.00007831411,"about_ca_system_score_gemma":0.0001909904,"threshold_uncertainty_score":0.99981004},"labels":[],"label_agreement":null},{"id":"W2606062157","doi":"10.1111/dom.12980","title":"Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the <scp>LixiLan‐O</scp> trial testing a titratable fixed‐ratio combination of insulin glargine/lixisenatide ( <scp>iGlarLixi</scp> ) vs insulin glargine and lixisenatide monocomponents","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Sanofi","keywords":"Medicine; Lixisenatide; Insulin glargine; Glycated hemoglobin; Body mass index; Internal medicine; Diabetes mellitus; Type 2 diabetes; Endocrinology; Basal insulin","score_opus":0.03690419666737692,"score_gpt":0.32483341390899106,"score_spread":0.28792921724161413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606062157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526376,0.0012438473,0.00003342465,0.000358517,0.00022745355,0.0022459638,0.0001260605,0.000044581622,0.00045638482],"genre_scores_gemma":[0.9977266,0.00070456666,0.00051147194,0.00019055812,0.00021184406,0.00008983894,0.00026319566,0.000038182476,0.0002637511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956989,0.00067785586,0.0013958036,0.0006838229,0.0008262418,0.0007173375],"domain_scores_gemma":[0.99425375,0.0032071557,0.001022131,0.0007729642,0.00045693302,0.00028706845],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0045571746,0.00050483894,0.001534331,0.00062303693,0.00038458212,0.00029218118,0.00042868668,0.00033006986,0.000004442915],"category_scores_gemma":[0.013809547,0.0003617991,0.00022693838,0.00046448354,0.00052104733,0.0006941609,0.00029604055,0.00070877996,0.000003412367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029266268,0.0017968316,0.98553383,0.00034504005,0.00043868847,0.000011314435,0.0002950914,0.000018207573,0.0071741976,0.00029777805,0.00029091042,0.0035054332],"study_design_scores_gemma":[0.03172235,0.0013326647,0.9430735,0.0002635024,0.00031816136,7.087302e-7,0.00012298877,0.017980643,0.0040899147,0.00068051426,0.0003061774,0.00010887981],"about_ca_topic_score_codex":0.000280477,"about_ca_topic_score_gemma":0.000029476678,"teacher_disagreement_score":0.04246035,"about_ca_system_score_codex":0.000039027553,"about_ca_system_score_gemma":0.0001262371,"threshold_uncertainty_score":0.9998834},"labels":[],"label_agreement":null},{"id":"W2607405121","doi":"10.1111/dom.12983","title":"Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: outcomes from <scp>TECOS</scp>","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Merck","keywords":"Medicine; Sitagliptin; Kidney disease; Sitagliptin Phosphate; Internal medicine; Diabetes mellitus; Cohort; Adverse effect; Type 2 diabetes; Population; Surgery; Endocrinology","score_opus":0.006523128332024438,"score_gpt":0.21133195236320448,"score_spread":0.20480882403118006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607405121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933602,0.004818948,8.5596e-7,0.000193642,0.00018593266,0.00062308816,0.00019305992,0.00003095517,0.00059329305],"genre_scores_gemma":[0.998007,0.0006252405,0.00023891244,0.00032267475,0.00006441879,0.00002273274,0.00026995625,0.000025670151,0.00042340814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860984,0.00004183057,0.0002625616,0.00040620504,0.00026163334,0.00041794157],"domain_scores_gemma":[0.9986344,0.00011676885,0.0002042646,0.0005855797,0.00008463951,0.0003743415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017137268,0.00028581423,0.0007628295,0.00013701273,0.00016488029,0.0000675487,0.00014894748,0.00007941237,0.000032885517],"category_scores_gemma":[0.00041147723,0.00021323399,0.00006882167,0.00008030473,0.00022233052,0.00029114282,0.00021698963,0.00012263499,0.000008354631],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003287229,0.0004531475,0.9914636,0.0002107884,0.0004157107,0.0000031386317,0.00010068901,5.6453695e-7,0.00012817138,0.00016950084,0.00025556146,0.00676628],"study_design_scores_gemma":[0.0062116277,0.0001768144,0.9844892,0.00025978903,0.0008215444,8.763548e-9,0.000015002961,0.00003881077,0.00093274424,0.000239587,0.006705012,0.00010983651],"about_ca_topic_score_codex":0.0000381396,"about_ca_topic_score_gemma":0.000019824707,"teacher_disagreement_score":0.006974353,"about_ca_system_score_codex":0.00003120449,"about_ca_system_score_gemma":0.000056070996,"threshold_uncertainty_score":0.86954296},"labels":[],"label_agreement":null},{"id":"W2607581455","doi":"10.1111/dom.12986","title":"Efficacy and safety of lixisenatide in patients with type 2 diabetes and renal impairment","year":2017,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Sanofi","keywords":"Medicine; Lixisenatide; Type 2 diabetes; Internal medicine; Diabetes mellitus; Intensive care medicine; Endocrinology; Liraglutide","score_opus":0.017480152213805566,"score_gpt":0.2692898192023451,"score_spread":0.25180966698853957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607581455","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40035275,0.59812295,7.561675e-8,0.00001181628,0.00006167667,0.0012083125,0.000029850808,0.000012926105,0.00019964838],"genre_scores_gemma":[0.014648022,0.98446125,0.00022572477,0.00004479915,0.0000581436,0.000051678046,0.00022694665,0.000041564446,0.00024187806],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99822366,0.00009359769,0.00048172136,0.0005234411,0.00025983274,0.00041772885],"domain_scores_gemma":[0.9987352,0.00013253334,0.00038613647,0.0004511062,0.00007881045,0.00021622785],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033803852,0.0004951226,0.0024364481,0.00034143572,0.00010392329,0.00005411162,0.00011055986,0.00018750883,0.000010388087],"category_scores_gemma":[0.00008496057,0.00033573926,0.00010707151,0.00015245352,0.00024952003,0.00014212824,0.0002423343,0.00022683185,0.0000023791606],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072300245,0.0006761014,0.17496708,0.01049387,0.001024825,0.0000050569715,0.00008348792,5.538798e-8,7.247557e-7,0.00011301867,0.00006562449,0.81249785],"study_design_scores_gemma":[0.0046991254,0.00050049677,0.62650955,0.008621903,0.0036462226,2.5587295e-7,0.0000034672178,0.0000014743389,0.000008289939,0.000025131198,0.35568178,0.00030234168],"about_ca_topic_score_codex":0.000009067,"about_ca_topic_score_gemma":0.000003913052,"teacher_disagreement_score":0.8121955,"about_ca_system_score_codex":0.000031985495,"about_ca_system_score_gemma":0.00006339775,"threshold_uncertainty_score":0.99990946},"labels":[],"label_agreement":null},{"id":"W2611973976","doi":"10.1111/dom.12963","title":"Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Center for Advancing Translational Sciences; Novo Nordisk","keywords":"Medicine; Liraglutide; Randomized controlled trial; Phase (matter); Weight management; Internal medicine; Weight loss; Type 2 diabetes; Endocrinology; Diabetes mellitus; Obesity","score_opus":0.014177553145384573,"score_gpt":0.27153404159708555,"score_spread":0.257356488451701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611973976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9724301,0.0089677945,0.00032123647,0.0020908772,0.0006109298,0.008195249,0.00044871328,0.00009081514,0.0068442547],"genre_scores_gemma":[0.9772545,0.009392445,0.006004785,0.00091420475,0.0006760972,0.0007308977,0.00042712118,0.000052787385,0.0045471727],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99743545,0.00031206422,0.0008587009,0.00066284015,0.00027126874,0.00045965813],"domain_scores_gemma":[0.9969304,0.0012233446,0.0007553718,0.000732859,0.00009181254,0.00026620078],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028511425,0.00042215403,0.0034950331,0.00022244707,0.00059105916,0.0002578102,0.00016843995,0.00009549159,0.000025460247],"category_scores_gemma":[0.0011246637,0.00025787417,0.00044005262,0.00007179976,0.00025120613,0.0002592457,0.00013365195,0.000114362025,0.0000057490115],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8039005,0.0025170427,0.0064444207,0.0006195848,0.017918423,0.00009418904,0.0004917106,0.000001749221,0.00044987327,0.021399634,0.003037221,0.14312567],"study_design_scores_gemma":[0.89625347,0.0002445887,0.042971604,0.00015127708,0.016697047,6.316963e-7,0.000029930005,0.000510049,0.00034542056,0.002121356,0.04036409,0.00031053522],"about_ca_topic_score_codex":0.000037891066,"about_ca_topic_score_gemma":0.000008889847,"teacher_disagreement_score":0.14281513,"about_ca_system_score_codex":0.00001127819,"about_ca_system_score_gemma":0.000020186897,"threshold_uncertainty_score":0.99998736},"labels":[],"label_agreement":null},{"id":"W2621101635","doi":"10.1111/dom.13028","title":"Design and baseline characteristics of participants in the <scp>R</scp> esearching cardiovascular <scp>E</scp> vents with a <scp>W</scp> eekly <scp>IN</scp> cretin in <scp>D</scp> iabetes ( <scp>REWIND</scp> ) trial on the cardiovascular effects of dulaglutide","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Population Health Research Institute; Université Laval; University of Toronto; Hamilton Health Sciences; McMaster University","funders":"Regeneron Pharmaceuticals; Novo Nordisk; Sanofi; Servier; Amgen; Pfizer; AstraZeneca; Duke Clinical Research Institute; Eli Lilly and Company; Mylan; GlaxoSmithKline","keywords":"Medicine","score_opus":0.02342545171499733,"score_gpt":0.2439605460816667,"score_spread":0.22053509436666938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621101635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9563463,0.03253399,0.0002557303,0.00008462059,0.00086483004,0.008166528,0.00020211635,0.00015149459,0.0013944301],"genre_scores_gemma":[0.98815835,0.0066929194,0.0007309672,0.00049000187,0.0008514436,0.0013675217,0.00023758975,0.00030285094,0.0011683417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9834953,0.004302934,0.0023365146,0.002480443,0.0034163783,0.003968461],"domain_scores_gemma":[0.96824116,0.024658557,0.0015136687,0.003987082,0.0005734558,0.0010260583],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.014583191,0.0020781856,0.0056080665,0.0015403661,0.0009955913,0.00072339433,0.0019672767,0.00089377543,0.000002978238],"category_scores_gemma":[0.04681424,0.0015306331,0.0017128023,0.0015664313,0.0014262379,0.0010049734,0.0011194262,0.0021146773,0.00004367131],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032567972,0.0138634145,0.835164,0.011348385,0.032121412,0.0027225334,0.050023746,0.0025990906,0.012704688,0.0020413613,0.009693734,0.027391968],"study_design_scores_gemma":[0.047567107,0.0024255987,0.83556193,0.0035933366,0.009688823,0.000015733618,0.00699544,0.0025481693,0.04575433,0.000804141,0.044826496,0.00021892272],"about_ca_topic_score_codex":0.0005764492,"about_ca_topic_score_gemma":0.00008367435,"teacher_disagreement_score":0.047241427,"about_ca_system_score_codex":0.00022370186,"about_ca_system_score_gemma":0.0004274642,"threshold_uncertainty_score":0.999196},"labels":[],"label_agreement":null},{"id":"W2669035283","doi":"10.1111/dom.13040","title":"Glycemic Improvement with a Fixed‐dose combination of <scp>DPP</scp> ‐4 inhibitor + metformin in patients with Type 2 diabetes ( <scp>GIFT</scp> study)","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; LMC Diabetes & Endocrinology (Canada); Mount Sinai Hospital","funders":"","keywords":"Metformin; Medicine; Fixed-dose combination; Type 2 diabetes; Pill; Glycemic; Formulary; Diabetes mellitus; Internal medicine; Pharmacology; Endocrinology","score_opus":0.006730278868638191,"score_gpt":0.21396269146593078,"score_spread":0.20723241259729258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2669035283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952011,0.00096722925,0.0000018191399,0.000028089295,0.00025161656,0.0025445006,0.00003376709,0.000056575802,0.0009152813],"genre_scores_gemma":[0.99813837,0.00012314189,0.00036757503,0.00013863093,0.00006852165,0.00017236671,0.00014565974,0.000051824074,0.00079393975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749947,0.000065442204,0.00046754937,0.00060901954,0.0006606046,0.0006979335],"domain_scores_gemma":[0.99793863,0.00016226931,0.0005171499,0.00081114564,0.0003295574,0.00024122818],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041198957,0.00047985883,0.0010334096,0.00040034417,0.0002525767,0.00012995106,0.000267784,0.00012916065,0.00000602417],"category_scores_gemma":[0.00034744787,0.00035068882,0.0000869577,0.00030792435,0.00023035586,0.0006120858,0.0002729207,0.00023667526,0.000011359258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007242953,0.0043211426,0.9819737,0.0002992983,0.00071139453,0.000008299191,0.0007965949,0.0000015533964,0.00086537347,0.00013137392,0.00023107819,0.010587783],"study_design_scores_gemma":[0.017564366,0.0048402813,0.9591427,0.00026134762,0.0011596337,1.0984261e-7,0.00046219703,0.000044831373,0.014391603,0.00011471701,0.0019080584,0.00011018306],"about_ca_topic_score_codex":0.00007582659,"about_ca_topic_score_gemma":0.00006240741,"teacher_disagreement_score":0.022831008,"about_ca_system_score_codex":0.000066927176,"about_ca_system_score_gemma":0.000066133456,"threshold_uncertainty_score":0.9998945},"labels":[],"label_agreement":null},{"id":"W2715646815","doi":"10.1111/dom.13043","title":"Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the <scp>DUAL V</scp> randomized trial","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Novo Nordisk","keywords":"Liraglutide; Medicine; Insulin degludec; Type 2 diabetes; Insulin glargine; Internal medicine; Weight loss; Insulin; Body mass index; Post-hoc analysis; Basal (medicine); Diabetes mellitus; Endocrinology; Gastroenterology; Obesity","score_opus":0.00983911403288233,"score_gpt":0.2613156423722514,"score_spread":0.25147652833936907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2715646815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873763,0.0067677638,0.000018811043,0.00021902748,0.00035930544,0.0038246955,0.000040725838,0.000033738925,0.0013596469],"genre_scores_gemma":[0.9972613,0.0011960951,0.00011550939,0.00025229473,0.00024941223,0.00052186544,0.000028959323,0.000024133575,0.00035042738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764884,0.0004201858,0.00048813305,0.00045274917,0.00040173586,0.0005883464],"domain_scores_gemma":[0.9975575,0.0011940447,0.00037679504,0.0006241029,0.00009861382,0.00014892142],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025473752,0.00037827622,0.0016196318,0.00016141358,0.00038634296,0.00020826531,0.0002460246,0.00019504153,0.0000037263123],"category_scores_gemma":[0.0019205159,0.0002477126,0.00023847289,0.00014425813,0.0008313617,0.00034225063,0.00024307902,0.0003076446,0.00000399442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04991274,0.0014122921,0.9016668,0.000799505,0.0021020947,0.00010328427,0.009725532,0.0000019988536,0.0013994306,0.0057044784,0.00037739988,0.026794435],"study_design_scores_gemma":[0.3843557,0.00018940638,0.6079562,0.00007925634,0.00095202704,0.0000012012621,0.0005575351,0.000072191026,0.0023718518,0.0021582008,0.001219599,0.0000868371],"about_ca_topic_score_codex":0.00031158162,"about_ca_topic_score_gemma":0.00006784392,"teacher_disagreement_score":0.33444294,"about_ca_system_score_codex":0.000024031408,"about_ca_system_score_gemma":0.000038976592,"threshold_uncertainty_score":0.9999975},"labels":[],"label_agreement":null},{"id":"W2728705426","doi":"10.1111/dom.13052","title":"The challenges of achieving postprandial glucose control using closed‐loop systems in patients with type 1 diabetes","year":2017,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital; Université de Montréal; Montreal Clinical Research Institute","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; National Institutes of Health; Juvenile Diabetes Research Foundation International","keywords":"Medicine; Postprandial; Type 2 diabetes; Closed loop; Diabetes mellitus; Internal medicine; Endocrinology; Control engineering","score_opus":0.04845112612589183,"score_gpt":0.3107202422090482,"score_spread":0.2622691160831564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2728705426","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25990102,0.7375498,1.9314798e-7,0.000023472463,0.00042854366,0.0018355991,0.000038556504,0.000016015201,0.00020685646],"genre_scores_gemma":[0.07000033,0.92944753,0.000015339188,0.0000152389575,0.00026634967,0.00005649121,0.00005313024,0.00006244717,0.00008313287],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99697167,0.0004898323,0.00065812084,0.0005074503,0.00058987347,0.00078306795],"domain_scores_gemma":[0.9975919,0.00050171255,0.00065637607,0.0007942859,0.00027372385,0.00018196725],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015971517,0.0005127808,0.002948554,0.0004119158,0.00032985487,0.00016478663,0.00044403868,0.00032842328,0.0000038667417],"category_scores_gemma":[0.00042170807,0.00028914204,0.0002613514,0.00023655621,0.00038937473,0.00018698396,0.00022814679,0.00060354266,0.000006272449],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001087719,0.00040213365,0.08151912,0.026923023,0.0014906783,0.000005861584,0.00004955039,0.0000011245384,0.0000032106036,0.00054598396,0.000013245122,0.8889373],"study_design_scores_gemma":[0.0075228037,0.0009092706,0.35598806,0.036733534,0.007138536,5.005281e-7,0.000043137672,0.00014379814,0.00000493382,0.000042377458,0.5905918,0.0008812568],"about_ca_topic_score_codex":0.000019674819,"about_ca_topic_score_gemma":0.0000064990145,"teacher_disagreement_score":0.88805604,"about_ca_system_score_codex":0.00004219694,"about_ca_system_score_gemma":0.00017145234,"threshold_uncertainty_score":0.9999561},"labels":[],"label_agreement":null},{"id":"W2735625114","doi":"10.1111/dom.12935","title":"Improving glycaemic control in type 2 diabetes: <scp>S</scp> timulate insulin secretion or provide beta‐cell rest?","year":2017,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; European Commission; BC Children's Hospital; Canadian Diabetes Association","keywords":"Beta cell; Type 2 diabetes; Insulin; Medicine; Diabetes mellitus; Endocrinology; BETA (programming language); Internal medicine; Bioinformatics; Islet; Biology; Computer science","score_opus":0.032774083468979066,"score_gpt":0.28816430992586856,"score_spread":0.25539022645688947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735625114","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16211404,0.83364284,0.000005829799,0.000027166894,0.00088661705,0.0021523472,0.00012326213,0.00014302322,0.0009048952],"genre_scores_gemma":[0.0065878076,0.98748654,0.00023428517,0.0006049122,0.0007759735,0.00024908298,0.0004937298,0.00014129677,0.0034263986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99568075,0.0004550106,0.0011867458,0.0010974484,0.00045829435,0.0011217495],"domain_scores_gemma":[0.9957852,0.001305051,0.0010168753,0.0011039054,0.00022876452,0.00056022435],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012521113,0.0009872139,0.0046580075,0.0007217543,0.00029157047,0.0002223675,0.00038155643,0.0010205568,0.000056459165],"category_scores_gemma":[0.0033685442,0.0007424696,0.00054496503,0.0004946408,0.00024789997,0.00037726876,0.0001869338,0.0011842081,0.00020586184],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009190259,0.00079214084,0.012930108,0.0641233,0.0010016309,0.00009688094,0.000265745,0.0000026607172,0.0007780586,0.00010345443,0.0016016786,0.9182124],"study_design_scores_gemma":[0.0043463563,0.00025447586,0.0055003297,0.00920533,0.0049282326,0.0000057113066,0.000020438565,0.0006291952,0.00015327285,0.00005890025,0.9744863,0.00041145092],"about_ca_topic_score_codex":0.00007099021,"about_ca_topic_score_gemma":0.000009442721,"teacher_disagreement_score":0.97288465,"about_ca_system_score_codex":0.00012622366,"about_ca_system_score_gemma":0.00078139734,"threshold_uncertainty_score":0.99950266},"labels":[],"label_agreement":null},{"id":"W2738470483","doi":"10.1111/dom.13063","title":"Beyond glycaemic control: A cross‐over, double‐blinded, 24‐week intervention with liraglutide in type 1 diabetes","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Novo Nordisk","keywords":"Medicine; Liraglutide; Type 2 diabetes; Diabetes mellitus; Internal medicine; Endocrinology","score_opus":0.016842916185050797,"score_gpt":0.27087693168449756,"score_spread":0.25403401549944676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738470483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98867196,0.0066026733,0.0000081604,0.00038901728,0.00060024625,0.0008998694,0.00002189972,0.000080456244,0.0027256913],"genre_scores_gemma":[0.9965746,0.00050034106,0.00023694799,0.00059162313,0.00018576048,0.00009086758,0.00006324821,0.000038907026,0.0017177257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980956,0.000052059266,0.0003548294,0.00053837296,0.00030664008,0.00065253564],"domain_scores_gemma":[0.9986295,0.000056292334,0.00025933547,0.00070330687,0.00012517876,0.00022638982],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051141786,0.0003614371,0.0007954046,0.00026226928,0.0003002664,0.0003321502,0.00024268676,0.00015089952,0.00007610989],"category_scores_gemma":[0.000097523785,0.0002884792,0.00015426542,0.00015439896,0.0002950655,0.00062902196,0.00017484435,0.00026759182,0.000039254806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007176323,0.0009302559,0.9804415,0.00027264134,0.00053405255,0.000031767908,0.000111406014,0.000004572489,0.00083597563,0.0017632907,0.00026657,0.014090307],"study_design_scores_gemma":[0.025368912,0.0004627329,0.96063167,0.000303366,0.00079187605,8.9492823e-7,0.000023674553,0.00019685121,0.0033743854,0.0009930306,0.0075330683,0.00031955665],"about_ca_topic_score_codex":0.00015305096,"about_ca_topic_score_gemma":0.00016911217,"teacher_disagreement_score":0.02465128,"about_ca_system_score_codex":0.000048236907,"about_ca_system_score_gemma":0.00003735837,"threshold_uncertainty_score":0.9999567},"labels":[],"label_agreement":null},{"id":"W2738689849","doi":"10.1111/dom.13069","title":"Evaluation of the specific effects of intranasal glucagon on glucose production and lipid concentration in healthy men during a pancreatic clamp","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Diabetes Canada; University of Toronto","funders":"Canadian Diabetes Association","keywords":"Glucagon; Internal medicine; Endocrinology; Crossover study; Nasal administration; Chemistry; Glucose clamp technique; Triglyceride; Medicine; Placebo; Insulin; Pancreatic hormone; Cholesterol; Pharmacology; Insulin resistance","score_opus":0.014209217674613837,"score_gpt":0.25399865322804516,"score_spread":0.23978943555343132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738689849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939689,0.0035584632,9.376699e-7,0.0004515051,0.00028130395,0.0013902994,0.000002106467,0.000007578996,0.0003389267],"genre_scores_gemma":[0.99757224,0.0021703336,0.00003366686,0.000029277058,0.00010740629,0.00004605569,0.0000071987483,0.0000071720847,0.000026660451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989079,0.00015986401,0.00020587501,0.00021898093,0.00034750762,0.00015982901],"domain_scores_gemma":[0.9992773,0.000039506816,0.00020669738,0.00033666028,0.0000922536,0.00004757788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007538711,0.000116142444,0.00033445258,0.000070448885,0.00013018874,0.000020290487,0.00005584434,0.00004819107,0.000003393905],"category_scores_gemma":[0.0002983696,0.000084219035,0.00003924531,0.00006808726,0.00012706165,0.00014431293,0.000040106115,0.00007846596,4.694114e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004764322,0.0012719239,0.7169937,0.0022975951,0.0003835274,0.0000014708928,0.0019773603,0.00002348128,0.1876194,0.001866578,0.00003620307,0.08705233],"study_design_scores_gemma":[0.0026498297,0.00014143673,0.767453,0.0003493597,0.00051417755,1.6339811e-7,0.000029687806,0.00018708901,0.22835562,0.00021642155,0.000052969626,0.000050203475],"about_ca_topic_score_codex":0.000035315814,"about_ca_topic_score_gemma":0.000020924343,"teacher_disagreement_score":0.08700213,"about_ca_system_score_codex":0.000043232187,"about_ca_system_score_gemma":0.00003094262,"threshold_uncertainty_score":0.34343526},"labels":[],"label_agreement":null},{"id":"W2739009446","doi":"10.1111/dom.13064","title":"Insights into optimal basal insulin titration in type 2 diabetes: <scp>R</scp> esults of a quantitative survey","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Winnipeg Regional Health Authority","funders":"Sanofi","keywords":"Titration; Medicine; Basal insulin; Type 2 diabetes; Diabetes mellitus; Endocrinology; Chemistry","score_opus":0.03238971050280456,"score_gpt":0.3042466098995466,"score_spread":0.27185689939674207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739009446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916134,0.005289121,0.000010780869,0.00012129963,0.00028178148,0.00049587095,0.000017142322,0.000022798898,0.0021478422],"genre_scores_gemma":[0.99738705,0.00078132655,0.0008564319,0.00012921523,0.00008289204,0.000018719193,0.0001233251,0.000021979733,0.00059908186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981908,0.00022644937,0.00037450308,0.00039448106,0.00038569342,0.0004280517],"domain_scores_gemma":[0.9983341,0.000438417,0.00022272323,0.0004890912,0.00033679613,0.00017889032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011134594,0.0002218555,0.00067595637,0.00038186606,0.0002190533,0.000115346484,0.00026747995,0.00016495795,0.000012361556],"category_scores_gemma":[0.0034580813,0.00018764134,0.00007623402,0.00032545035,0.00036255983,0.0004888406,0.000237625,0.00029729898,0.00003370752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089284884,0.0008077996,0.9729974,0.00062573934,0.00029940024,0.000010639094,0.0023499003,0.000018684033,0.012281173,0.0029495598,0.0008046934,0.0067657214],"study_design_scores_gemma":[0.001998105,0.0002664953,0.9792426,0.00016637002,0.00008831575,2.3293001e-8,0.00013598979,0.0026607607,0.01209448,0.0008092184,0.0024425508,0.00009506679],"about_ca_topic_score_codex":0.00020783649,"about_ca_topic_score_gemma":0.00023124756,"teacher_disagreement_score":0.0066706543,"about_ca_system_score_codex":0.00001907764,"about_ca_system_score_gemma":0.00008814911,"threshold_uncertainty_score":0.7651792},"labels":[],"label_agreement":null},{"id":"W2746628081","doi":"10.1111/dom.13086","title":"Effect of once‐weekly dulaglutide on glycated haemoglobin ( <scp>HbA1c</scp> ) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline <scp>HbA1c</scp>","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Dulaglutide; Medicine; Internal medicine; Diabetes mellitus; Confidence interval; Glycated hemoglobin; Type 2 diabetes; Gastroenterology; Glycated haemoglobin; Adverse effect; Endocrinology; Liraglutide","score_opus":0.01035491514470968,"score_gpt":0.23737268121278995,"score_spread":0.22701776606808027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2746628081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99032784,0.007513498,0.000009783482,0.00008890743,0.00015653638,0.0012765336,0.00016036544,0.00004922085,0.00041729066],"genre_scores_gemma":[0.9978452,0.001025726,0.0003064149,0.00010594198,0.00006177183,0.00007914719,0.00036389608,0.0000380782,0.00017382846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974332,0.0002738356,0.0006975914,0.00061377365,0.0003981944,0.0005834457],"domain_scores_gemma":[0.9975178,0.00091685116,0.0006194171,0.0005484473,0.00013379127,0.00026366638],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009680193,0.0004660407,0.0011287729,0.0003507146,0.00032843216,0.000094721014,0.00014203964,0.00019326556,0.0000037131965],"category_scores_gemma":[0.0020249977,0.00040343046,0.0001220067,0.00021301192,0.00030370193,0.00037858367,0.00021696337,0.00022379876,0.0000021725623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020265015,0.00097442506,0.9021555,0.0010351698,0.00050297385,0.000010321432,0.0007431882,0.000014656352,0.06584504,0.00031618794,0.00032618764,0.028056072],"study_design_scores_gemma":[0.0053984323,0.0009317142,0.7133101,0.00039302558,0.0014008951,9.197664e-7,0.00012473056,0.0016028974,0.27591616,0.00016860847,0.00065124803,0.000101259975],"about_ca_topic_score_codex":0.00015630554,"about_ca_topic_score_gemma":0.000039026734,"teacher_disagreement_score":0.2100711,"about_ca_system_score_codex":0.00002688602,"about_ca_system_score_gemma":0.000026345026,"threshold_uncertainty_score":0.99984175},"labels":[],"label_agreement":null},{"id":"W2751490170","doi":"10.1111/dom.13008","title":"Monoacylglycerol signalling and ABHD6 in health and disease","year":2017,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Monoacylglycerol lipase; Signalling; Disease; Medicine; Biology; Cell biology; Internal medicine; Receptor","score_opus":0.05611425341355459,"score_gpt":0.36023134853831,"score_spread":0.30411709512475543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751490170","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021682974,0.9759004,0.000001202251,0.0010195106,0.00008740918,0.001147991,0.00008133496,0.000019590127,0.000059601087],"genre_scores_gemma":[0.0007652559,0.99698275,0.000038365204,0.00035318107,0.00025324288,0.00012072463,0.00007306255,0.000042447566,0.0013709796],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978595,0.00019710879,0.00047472454,0.0006291367,0.00026825228,0.00057132443],"domain_scores_gemma":[0.99783546,0.000040505394,0.00023054343,0.0003998221,0.00005156385,0.0014421002],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000853406,0.00039497772,0.0022959698,0.00036799375,0.0002664418,0.00017311703,0.00012532697,0.00020914388,0.00001429142],"category_scores_gemma":[0.00039246998,0.00031018394,0.00017973737,0.000120470286,0.00026271035,0.00011989861,0.00022487606,0.0006346607,0.0000034615264],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016279359,0.0000926033,0.0030571942,0.04038638,0.00008399782,0.000032744218,0.00011185778,3.361609e-8,6.835382e-7,0.00023038316,0.00067207345,0.95531577],"study_design_scores_gemma":[0.00076290057,0.00005616627,0.021971753,0.008271704,0.0004059763,0.000008239842,0.000014486626,0.000027914168,5.1215113e-7,0.00020632858,0.9680058,0.00026822218],"about_ca_topic_score_codex":0.00012573003,"about_ca_topic_score_gemma":0.000011909579,"teacher_disagreement_score":0.96733373,"about_ca_system_score_codex":0.000037738904,"about_ca_system_score_gemma":0.000772544,"threshold_uncertainty_score":0.99993503},"labels":[],"label_agreement":null},{"id":"W2752834631","doi":"10.1111/dom.13010","title":"Metabolomics applied to islet nutrient sensing mechanisms","year":2017,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Diabetes Canada; University of Alberta","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of General Medical Sciences; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Metabolomics; Islet; Insulin; Secretion; Computational biology; Biology; Bioinformatics; Chemistry; Computer science; Cell biology; Biochemistry; Endocrinology","score_opus":0.04656412140846029,"score_gpt":0.3038742621995362,"score_spread":0.25731014079107595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752834631","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022409784,0.99034834,0.0004084137,0.00008179721,0.0010843914,0.0017510642,0.00012879162,0.00014924185,0.0038069845],"genre_scores_gemma":[0.00016228185,0.9899267,0.006152325,0.0013047201,0.0007084555,0.00008829242,0.00022742517,0.00009667382,0.0013331171],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972343,0.00011755466,0.0006707428,0.00086755113,0.0003939709,0.0007158976],"domain_scores_gemma":[0.9974663,0.0001922558,0.00042738422,0.0010961429,0.00012217167,0.0006957114],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007224592,0.0007642465,0.004531034,0.00049145793,0.00038785822,0.00018090424,0.00023415488,0.0005516529,0.00006458814],"category_scores_gemma":[0.0004547096,0.00060625066,0.0006036937,0.00026003868,0.00012156676,0.000087734086,0.00027491612,0.0005431377,0.00031633658],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014950554,0.00014898038,0.000008796157,0.007994723,0.00080024626,0.0000129658165,0.00008038739,1.00560506e-7,0.00023934731,0.010491303,0.0012124621,0.97899574],"study_design_scores_gemma":[0.00076643034,0.000039071652,0.00012096831,0.0030973468,0.0066690613,0.000013324343,0.00001548356,0.000007471879,0.00073712517,0.0010629116,0.9868934,0.0005773705],"about_ca_topic_score_codex":0.000010534354,"about_ca_topic_score_gemma":5.260385e-7,"teacher_disagreement_score":0.985681,"about_ca_system_score_codex":0.00005450702,"about_ca_system_score_gemma":0.00022209488,"threshold_uncertainty_score":0.9996389},"labels":[],"label_agreement":null},{"id":"W2753333999","doi":"10.1111/dom.13104","title":"Metformin extended‐release versus immediate‐release: <scp>A</scp> n international, randomized, double‐blind, head‐to‐head trial in pharmacotherapy‐naïve patients with type 2 diabetes","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brampton Civic Hospital","funders":"AstraZeneca","keywords":"Metformin; Medicine; Type 2 diabetes; Randomized controlled trial; Placebo; Clinical endpoint; Internal medicine; Adverse effect; Diabetes mellitus; Pharmacotherapy; Gastroenterology; Endocrinology; Pharmacology","score_opus":0.023221334526631464,"score_gpt":0.3015745698871178,"score_spread":0.27835323536048634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753333999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872312,0.0033902207,0.000005027869,0.00038610073,0.0024916376,0.0039255763,0.00005603665,0.00008261179,0.002431598],"genre_scores_gemma":[0.9936295,0.0019816163,0.00046084746,0.00076915545,0.00061737903,0.0005843573,0.00033791637,0.000069137684,0.0015500967],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970682,0.00013102904,0.0005633752,0.0007229501,0.0006843923,0.00083002186],"domain_scores_gemma":[0.9977283,0.00041548823,0.00037160417,0.0006892695,0.00026837797,0.0005269948],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008442802,0.00055174244,0.0014189568,0.000538117,0.00028339608,0.00027400555,0.00042793385,0.00016513836,0.00009447043],"category_scores_gemma":[0.0007018603,0.0004211661,0.00024825035,0.0002499955,0.00026295305,0.0006646766,0.00022379989,0.00031131116,0.00009925149],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68343794,0.006972454,0.21176194,0.0003062579,0.005521867,0.00006891297,0.0010820846,0.000017853725,0.00058862666,0.001341195,0.0028108861,0.08608995],"study_design_scores_gemma":[0.8566434,0.0007308195,0.10538952,0.0001650243,0.0014628196,1.5065775e-7,0.000052838182,0.00013868336,0.0037524607,0.0001464469,0.031252597,0.00026524934],"about_ca_topic_score_codex":0.00010780378,"about_ca_topic_score_gemma":0.000056540393,"teacher_disagreement_score":0.17320542,"about_ca_system_score_codex":0.00008352778,"about_ca_system_score_gemma":0.00008256665,"threshold_uncertainty_score":0.999824},"labels":[],"label_agreement":null},{"id":"W2753736324","doi":"10.1111/dom.13001","title":"Recent new insights into the role of SNARE and associated proteins in insulin granule exocytosis","year":2017,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Exocytosis; Cell biology; Lipid bilayer fusion; Munc-18; SNARE complex; Biology; Granule (geology); Vesicle fusion; Secretion; Chemistry; Vesicle; Synaptic vesicle; Membrane; Biochemistry","score_opus":0.03377539440660406,"score_gpt":0.2831373104046554,"score_spread":0.24936191599805133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753736324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12502359,0.8728278,2.4641008e-7,0.00009137205,0.00013013525,0.0011605026,0.00002147821,0.000024010895,0.0007208288],"genre_scores_gemma":[0.0048694415,0.9941847,0.00007473837,0.00011697217,0.00014639858,0.00010901841,0.00012078412,0.000030044737,0.00034793926],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99817526,0.00027362868,0.0005734674,0.0004091482,0.00026423528,0.00030424944],"domain_scores_gemma":[0.998412,0.00022901171,0.00049249636,0.00052429206,0.00010825168,0.00023393072],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047362142,0.00039556285,0.002439229,0.00027305025,0.00018594161,0.000054171196,0.00018429795,0.00041370385,0.000037745962],"category_scores_gemma":[0.0012093895,0.0002471414,0.00021859042,0.00029712927,0.00020112834,0.00011062335,0.00015144995,0.00047131968,0.000008465832],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009298358,0.00017777916,0.0035681666,0.002493473,0.00027607614,0.0000020056498,0.0007331477,1.9835355e-8,0.000032582673,0.0001822514,0.00008213435,0.9924431],"study_design_scores_gemma":[0.001113218,0.00006069541,0.024844462,0.0060918476,0.0016308515,0.0000010616425,0.000051930867,0.000008648336,0.00026459876,0.0009807061,0.96471554,0.00023642514],"about_ca_topic_score_codex":0.00028972694,"about_ca_topic_score_gemma":0.00007862284,"teacher_disagreement_score":0.99220663,"about_ca_system_score_codex":0.00004385295,"about_ca_system_score_gemma":0.00032497602,"threshold_uncertainty_score":0.9999981},"labels":[],"label_agreement":null},{"id":"W2754397244","doi":"10.1111/dom.13112","title":"Insulin resistance and cardiovascular outcomes in the <scp>ORIGIN</scp> trial","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Sanofi","keywords":"Medicine; Insulin glargine; Insulin resistance; Insulin; Internal medicine; Hazard ratio; Myocardial infarction; Endocrinology; Randomization; Stroke (engine); Basal (medicine); Diabetes mellitus; Randomized controlled trial; Hypoglycemia; Confidence interval","score_opus":0.017958814643979578,"score_gpt":0.24971910115584622,"score_spread":0.23176028651186664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754397244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9341911,0.060899284,0.000010234709,0.00031718513,0.00046385318,0.0011509397,0.000025623549,0.000039966493,0.0029017858],"genre_scores_gemma":[0.9933424,0.0043475023,0.00029529692,0.00050413643,0.00068865524,0.00013389236,0.000011494219,0.00002848685,0.00064815383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976901,0.00027922887,0.0003226944,0.00054401567,0.0006362587,0.00052772433],"domain_scores_gemma":[0.9978129,0.00021840821,0.00012308038,0.001583013,0.00007735964,0.00018519997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025174038,0.00031307354,0.0013612363,0.00013531785,0.0005168222,0.00028711764,0.00034432116,0.00019747122,0.0000036238846],"category_scores_gemma":[0.0016297926,0.00021733982,0.00061124953,0.00011356675,0.00036977086,0.00029632403,0.00014307605,0.00041680364,0.000011089365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048910175,0.0011254395,0.6472249,0.0008996496,0.00573161,0.00025261714,0.0040569073,0.0000043860887,0.00012298881,0.003679288,0.0018226816,0.3345904],"study_design_scores_gemma":[0.018225476,0.000042223885,0.7585952,0.000057098678,0.00078332954,0.000002665405,0.00012214505,0.0000053275294,0.00027176534,0.00076394924,0.22104411,0.00008667242],"about_ca_topic_score_codex":0.0010586694,"about_ca_topic_score_gemma":0.00031457483,"teacher_disagreement_score":0.33450374,"about_ca_system_score_codex":0.000012241717,"about_ca_system_score_gemma":0.000053258984,"threshold_uncertainty_score":0.8862861},"labels":[],"label_agreement":null},{"id":"W2756174617","doi":"10.1111/dom.13114","title":"Efficacy and safety of alirocumab in insulin‐treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The <scp>ODYSSEY DM‐INSULIN</scp> randomized trial","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Internal medicine; Type 2 diabetes; Endocrinology; Placebo; Type 1 diabetes; Cholesterol; Insulin; Diabetes mellitus; PCSK9; Population; Apolipoprotein B; Lipoprotein; Apolipoprotein A1; LDL receptor","score_opus":0.010753474393634945,"score_gpt":0.23046606069594383,"score_spread":0.2197125863023089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756174617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690209,0.027395189,0.0000024213857,0.000108184286,0.00021572363,0.0028324684,0.000044163236,0.000040618554,0.00034029936],"genre_scores_gemma":[0.97863215,0.020306978,0.00036099806,0.00010399744,0.00015039467,0.00008933132,0.000070101385,0.00003555019,0.00025050077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976918,0.00041130974,0.0004889267,0.00053275976,0.00039615048,0.00047906986],"domain_scores_gemma":[0.9975565,0.0009025131,0.00038463643,0.000816306,0.00015108584,0.00018897033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018366093,0.00041079771,0.001976135,0.00020025147,0.00037719004,0.00015105642,0.0002024847,0.00018075934,0.000011361253],"category_scores_gemma":[0.00190476,0.00022938104,0.00016421231,0.00025401532,0.0006729702,0.00022699288,0.00026259696,0.00026045565,0.0000035708022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09400989,0.0016470168,0.81401926,0.0007088202,0.016949078,0.000042905776,0.002430718,0.00002461643,0.00023210798,0.0010231986,0.0002637467,0.06864861],"study_design_scores_gemma":[0.39325434,0.00046156635,0.5947263,0.00016732849,0.004884203,7.5530096e-7,0.00005745972,0.000048593327,0.0008965408,0.00020744136,0.005183242,0.000112230744],"about_ca_topic_score_codex":0.00027200763,"about_ca_topic_score_gemma":0.000030061743,"teacher_disagreement_score":0.29924443,"about_ca_system_score_codex":0.000015083306,"about_ca_system_score_gemma":0.000057282607,"threshold_uncertainty_score":0.93538874},"labels":[],"label_agreement":null},{"id":"W2765113122","doi":"10.1111/dom.13134","title":"Effects of common cold and concomitant administration of nasal decongestant on the pharmacokinetics and pharmacodynamics of nasal glucagon in otherwise healthy participants: <scp>A</scp> randomized clinical trial","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); GDI Integrated Facility Services (Canada)","funders":"Eli Lilly and Company","keywords":"Medicine; Nasal congestion; Decongestant; Concomitant; Nasal decongestant; Pharmacodynamics; Common cold; Pseudoephedrine; Anesthesia; Adverse effect; rhinorrhea; Mucous membrane of nose; Nausea; Pharmacokinetics; Nose; Internal medicine; Surgery; Pathology; Immunology","score_opus":0.031824790788710894,"score_gpt":0.3455311865108615,"score_spread":0.31370639572215064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765113122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99309903,0.0037526647,0.000003886108,0.00031023347,0.00030662506,0.0023464374,0.000038320002,0.000008625835,0.00013418437],"genre_scores_gemma":[0.99279934,0.006613916,0.00008127325,0.00030460244,0.00007302829,0.000076718134,0.000008047603,0.00001470098,0.00002835068],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99792725,0.0005269293,0.0007967525,0.0002548763,0.00021924695,0.00027494124],"domain_scores_gemma":[0.9955646,0.0032472129,0.00068727665,0.0002716651,0.000065600914,0.00016366302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023539069,0.00021233503,0.0014041954,0.000094756135,0.00008467728,0.00002706957,0.0001117932,0.00010529397,0.0000022951074],"category_scores_gemma":[0.0012265075,0.00014571947,0.00012794415,0.000055776913,0.0007194626,0.00010385098,0.00009150086,0.0001803928,2.6005551e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37852675,0.019098002,0.43235284,0.0074308277,0.005814918,0.000088221714,0.0038210838,0.000009041616,0.066900626,0.032859996,0.00039421284,0.052703485],"study_design_scores_gemma":[0.5813365,0.0024298101,0.2675173,0.000423209,0.0030286976,4.706003e-7,0.00014179577,0.0028625282,0.14116238,0.00041308522,0.0005647958,0.00011946588],"about_ca_topic_score_codex":0.000034131674,"about_ca_topic_score_gemma":0.000023113867,"teacher_disagreement_score":0.2028097,"about_ca_system_score_codex":0.000010039654,"about_ca_system_score_gemma":0.000056627832,"threshold_uncertainty_score":0.5942268},"labels":[],"label_agreement":null},{"id":"W2771026854","doi":"10.1111/dom.13163","title":"Systemic use of antibiotics and risk of diabetes in adults: <scp>A</scp> nested case‐control study of <scp>Alberta's Tomorrow Project</scp>","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Alberta Health; Alberta Cancer Foundation; University of Alberta","funders":"Alberta Cancer Foundation","keywords":"Medicine; Diabetes mellitus; Antibiotics; Odds ratio; Confounding; Nested case-control study; Logistic regression; Cohort study; Cohort; Internal medicine; Observational study; Environmental health; Endocrinology","score_opus":0.008924027519172439,"score_gpt":0.21627883491594938,"score_spread":0.20735480739677695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771026854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835818,0.014484768,0.0000039727065,0.000004232435,0.0003173635,0.0010807631,0.00045533167,0.000017143613,0.000054665496],"genre_scores_gemma":[0.99781376,0.0017377948,0.000053466752,0.000013249435,0.000027612208,0.0000024538303,0.0000134521315,0.000025285299,0.00031295308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974845,0.0005931204,0.0007918423,0.00050132745,0.00009086972,0.0005383458],"domain_scores_gemma":[0.99613976,0.0016988909,0.0011328363,0.00075053185,0.000225138,0.000052818945],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006518301,0.00035961976,0.001445709,0.00028881745,0.00029058068,0.000038637725,0.00032129616,0.0004210206,0.0000018862816],"category_scores_gemma":[0.002210177,0.0002961599,0.00012535868,0.00017792074,0.0007172899,0.00030096289,0.00020433753,0.00034475166,0.000002410505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017084894,0.0009138332,0.95679146,0.0008671849,0.0008481347,0.000016827806,0.0038328136,0.0000049427686,0.035984702,0.00011452276,0.000051939955,0.00055653206],"study_design_scores_gemma":[0.0047638332,0.0003289496,0.92265415,0.00065753097,0.0010939806,0.000016106631,0.0039971257,0.00009361033,0.06613407,0.000022155755,0.00014885582,0.00008962448],"about_ca_topic_score_codex":0.004041401,"about_ca_topic_score_gemma":0.002261553,"teacher_disagreement_score":0.034137323,"about_ca_system_score_codex":0.000007531214,"about_ca_system_score_gemma":0.000048728492,"threshold_uncertainty_score":0.99994904},"labels":[],"label_agreement":null},{"id":"W2774952602","doi":"10.1111/dom.13179","title":"Clinical correlates of hypoglycaemia over 4 years in people with type 2 diabetes starting insulin: An analysis from the CREDIT study","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Novo Nordisk; Sanofi","keywords":"Medicine; Insulin; Logistic regression; Diabetes mellitus; Regimen; Internal medicine; Observational study; Type 2 diabetes; Hypoglycemia; Body mass index; Univariate analysis; Type 1 diabetes; Prospective cohort study; Pediatrics; Endocrinology; Multivariate analysis","score_opus":0.023378684042730295,"score_gpt":0.31488547563110575,"score_spread":0.29150679158837545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774952602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99750227,0.0014776053,0.0000011599961,0.00011638999,0.00019011862,0.00052844326,0.000021654356,0.000020708778,0.00014162344],"genre_scores_gemma":[0.9990887,0.00020508129,0.00013285626,0.0001393928,0.00022522874,0.000013561278,0.000047979553,0.000018468058,0.00012872933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980704,0.00024237394,0.00042440792,0.00042972667,0.00044219708,0.0003908981],"domain_scores_gemma":[0.9981203,0.0004074301,0.00026717733,0.00091187644,0.00013006212,0.00016315271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016759246,0.00018131932,0.0008764653,0.0001936164,0.000210299,0.00013789891,0.00038868215,0.00010797419,0.00008735562],"category_scores_gemma":[0.00060938206,0.00011704129,0.00012288905,0.00045171488,0.0003370208,0.0002899361,0.00030895666,0.0004080347,0.0000066853513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008905236,0.00081653055,0.9879238,0.000024449875,0.0011496777,0.000007610913,0.00081315753,0.000012455225,0.00007914429,0.000023664452,0.000053682837,0.009006758],"study_design_scores_gemma":[0.0023495867,0.00038606406,0.99175316,0.00005562514,0.0019861492,1.2340597e-8,0.00052012724,0.0023551076,0.00007196449,0.00014692864,0.00023301698,0.00014226272],"about_ca_topic_score_codex":0.00055716175,"about_ca_topic_score_gemma":0.001022826,"teacher_disagreement_score":0.008864495,"about_ca_system_score_codex":0.0000100110465,"about_ca_system_score_gemma":0.000047530204,"threshold_uncertainty_score":0.47728053},"labels":[],"label_agreement":null},{"id":"W2782920834","doi":"10.1111/dom.13217","title":"<scp>DECLARE‐TIMI</scp> 58: Participants’ baseline characteristics","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"AstraZeneca","keywords":"Medicine; TIMI; Baseline (sea); Internal medicine; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.01928314700339614,"score_gpt":0.2485237473738867,"score_spread":0.22924060037049054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782920834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99188215,0.0017513889,0.0000872513,0.00034460786,0.0005669515,0.00046336325,0.000055935125,0.00016430757,0.0046840776],"genre_scores_gemma":[0.98743325,0.0006050386,0.0011694154,0.0030369328,0.0010081778,0.00005480465,0.00016950046,0.000038643837,0.0064842077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980564,0.000078435325,0.00033885034,0.00045464287,0.00028738388,0.00078430184],"domain_scores_gemma":[0.99864864,0.00014880257,0.00011874432,0.0004523864,0.0001936873,0.00043774373],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055649615,0.0003173366,0.0006707963,0.00016550442,0.00020879401,0.00008920599,0.000116934534,0.00012800998,0.00017285762],"category_scores_gemma":[0.00052698114,0.00026342724,0.0001258277,0.00023574448,0.000244912,0.00019557084,0.00015869856,0.00015614177,0.0003475588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049666105,0.0020784547,0.8845383,0.00048773107,0.0013600953,0.000064188185,0.0014038667,2.916219e-7,0.0071671815,0.00445772,0.0323397,0.06605283],"study_design_scores_gemma":[0.0013687036,0.00018032316,0.6508459,0.0000661419,0.0010714378,9.618046e-7,0.00005797672,0.0003644561,0.010194162,0.0002662794,0.33548033,0.00010336762],"about_ca_topic_score_codex":0.000009122701,"about_ca_topic_score_gemma":0.0000045512465,"teacher_disagreement_score":0.30314064,"about_ca_system_score_codex":0.00002295946,"about_ca_system_score_gemma":0.00003817133,"threshold_uncertainty_score":0.9999818},"labels":[],"label_agreement":null},{"id":"W2785139619","doi":"10.1111/dom.13172","title":"Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":294,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novo Nordisk; Novo Nordisk Fonden; Steno Diabetes Center Copenhagen","keywords":"Medicine; Semaglutide; Glycated haemoglobin; Diabetic retinopathy; Glycated hemoglobin; Ophthalmology; Diabetes mellitus; Internal medicine; Type 2 diabetes; Endocrinology","score_opus":0.007429259347866054,"score_gpt":0.2222728373629661,"score_spread":0.21484357801510004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785139619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918615,0.005041068,0.000001368302,0.00095812266,0.00019953185,0.00065062265,0.000011967461,0.0000212646,0.0012545224],"genre_scores_gemma":[0.99679,0.0023001016,0.0001995573,0.00007797187,0.000064921565,0.00003890612,0.000009591913,0.000011232757,0.00050771516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989784,0.00012099624,0.00023953641,0.00025897397,0.00015042824,0.0002517016],"domain_scores_gemma":[0.9990594,0.000081474,0.00023244994,0.0004937247,0.00005037875,0.00008259383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078845484,0.00016298275,0.0005432042,0.00011170386,0.0002326379,0.000054996755,0.000108202694,0.000070613394,0.000011446752],"category_scores_gemma":[0.00038576708,0.00010696038,0.00007650228,0.00008373943,0.00057124277,0.00011988855,0.00014948781,0.00014778349,0.0000039077986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015072212,0.00025689765,0.9610153,0.00019381898,0.00028003706,0.0000051207035,0.00062511803,0.0000012805009,0.001877324,0.0032330805,0.00013839558,0.03222291],"study_design_scores_gemma":[0.0055779936,0.000053893997,0.98067325,0.00010971795,0.0008777162,0.0000012067553,0.0000737934,0.00019182914,0.008686784,0.0026626003,0.0009873831,0.00010384983],"about_ca_topic_score_codex":0.0002740734,"about_ca_topic_score_gemma":0.0000179777,"teacher_disagreement_score":0.03211906,"about_ca_system_score_codex":0.000011306179,"about_ca_system_score_gemma":0.000013443569,"threshold_uncertainty_score":0.43617177},"labels":[],"label_agreement":null},{"id":"W2787959738","doi":"10.1111/dom.13257","title":"Alirocumab vs usual lipid‐lowering care as add‐on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM‐DYSLIPIDEMIA randomized trial","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Ezetimibe; Medicine; Internal medicine; Dyslipidemia; PCSK9; Population; Type 2 diabetes; Fenofibrate; Gastroenterology; Endocrinology; Clinical endpoint; Statin; Randomized controlled trial; Cholesterol; Diabetes mellitus; Apolipoprotein B; Lipoprotein; Apolipoprotein A1; LDL receptor","score_opus":0.009826980854002007,"score_gpt":0.25888975585096974,"score_spread":0.24906277499696772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787959738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863199,0.008571633,0.000008773968,0.00053891237,0.00068867457,0.0034831925,0.000027649947,0.000061917446,0.00029932882],"genre_scores_gemma":[0.99341536,0.00083910115,0.00037125847,0.0030005139,0.0018916117,0.00032534986,0.000036901987,0.000054118354,0.000065776614],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99680656,0.0006851265,0.0005204732,0.00063869584,0.0006428524,0.0007063199],"domain_scores_gemma":[0.99815136,0.0004942564,0.0001596958,0.0006019551,0.00023071842,0.00036199085],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029125814,0.00042670072,0.0017001985,0.00024081097,0.00032822482,0.00011816424,0.00016641572,0.00023595415,0.000050689625],"category_scores_gemma":[0.00085675047,0.00025560026,0.00019283826,0.00048253403,0.0003328059,0.00014754137,0.00011134798,0.00048939727,0.000016166625],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36379403,0.0009181004,0.16742168,0.0009978625,0.0036730603,0.000024124372,0.028327482,0.000019911957,0.0037689311,0.0012253547,0.0019033274,0.42792612],"study_design_scores_gemma":[0.6529739,0.0037090199,0.290916,0.00057890796,0.00078805146,0.0000041064127,0.001143068,0.000031255993,0.02114249,0.000245184,0.027772695,0.00069534866],"about_ca_topic_score_codex":0.00019153341,"about_ca_topic_score_gemma":0.00009492653,"teacher_disagreement_score":0.42723078,"about_ca_system_score_codex":0.00004270567,"about_ca_system_score_gemma":0.00018981747,"threshold_uncertainty_score":0.9999896},"labels":[],"label_agreement":null},{"id":"W2789501252","doi":"10.1111/dom.13278","title":"Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real‐world setting","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Diabetes Canada; McGill University Health Centre; Montreal Clinical Research Institute; University of Manitoba; Eli Lilly (Canada)","funders":"","keywords":"Medicine; Adverse effect; Continuous glucose monitoring; Type 2 diabetes; Prospective cohort study; Type 1 diabetes; Population; Glucagon; Diabetes mellitus; Internal medicine; Anesthesia; Pediatrics; Insulin; Endocrinology","score_opus":0.05040934713875908,"score_gpt":0.3324586729810634,"score_spread":0.28204932584230435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789501252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99469703,0.0005819808,0.000001962209,0.00020373872,0.000066602086,0.004331565,0.00001559427,0.000011262577,0.000090244655],"genre_scores_gemma":[0.99833107,0.00009067734,0.0006418605,0.00008020239,0.00010524596,0.00032991447,0.0000071917048,0.00001976313,0.0003940639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984901,0.00016707265,0.00030657384,0.0003212606,0.00031755448,0.0003974292],"domain_scores_gemma":[0.99854755,0.0006330366,0.00011577625,0.00032734798,0.00031602968,0.000060240087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095296244,0.00018393432,0.000513849,0.00023717168,0.00012357421,0.000034648554,0.00011603736,0.000037611142,0.0000063838957],"category_scores_gemma":[0.00026000393,0.00009397679,0.000050457198,0.0007343355,0.0001622778,0.00011509184,0.00007766955,0.00011159044,0.0000010013747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014564435,0.0010560334,0.96033144,0.00017353056,0.00028869061,0.000001017603,0.0077368813,0.00015157468,0.0010517285,0.00007754494,0.000025529336,0.027649578],"study_design_scores_gemma":[0.005138884,0.0046292455,0.96811914,0.00032951363,0.00029850245,4.2672728e-8,0.00096319197,0.013929542,0.0061849584,0.000117182855,0.00017250367,0.000117314245],"about_ca_topic_score_codex":0.0003415299,"about_ca_topic_score_gemma":0.0017313347,"teacher_disagreement_score":0.027532265,"about_ca_system_score_codex":0.00004540798,"about_ca_system_score_gemma":0.000064255946,"threshold_uncertainty_score":0.38322625},"labels":[],"label_agreement":null},{"id":"W2789883359","doi":"10.1111/dom.13225","title":"One‐year weight losses in the Tianjin Gestational Diabetes Mellitus Prevention Programme: A randomized clinical trial","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Cancer Centre; Dalhousie University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of General Medical Sciences; European Foundation for the Study of Diabetes","keywords":"Medicine; Weight loss; Overweight; Randomized controlled trial; Gestational diabetes; Waist; Obesity; Body mass index; Physical therapy; Weight management; Diabetes mellitus; Internal medicine; Pregnancy; Gestation; Endocrinology","score_opus":0.04090900994013091,"score_gpt":0.33869323593667217,"score_spread":0.29778422599654125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789883359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905796,0.002469012,0.00009681097,0.0023345214,0.00031947467,0.0031396516,0.000019584957,0.000039556104,0.0010017917],"genre_scores_gemma":[0.9922577,0.0013569037,0.002886309,0.0010902522,0.0011236808,0.00057073496,0.00022429267,0.000018651868,0.0004714827],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9962742,0.0013073429,0.00067146163,0.0004287906,0.00070683006,0.00061139214],"domain_scores_gemma":[0.99772173,0.0013474495,0.00015966348,0.00029431158,0.0002577372,0.00021909749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006102713,0.00020242382,0.00077657506,0.00022343572,0.00016000375,0.00012789067,0.0001827987,0.00012928656,0.00016331504],"category_scores_gemma":[0.0025120568,0.00014306164,0.0002698487,0.00036416893,0.00069938984,0.0002058639,0.00008700056,0.00032672693,0.00007523054],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1682329,0.015655108,0.27608645,0.001585245,0.0031040232,0.000023692777,0.0027291365,0.0000023739951,0.0004480783,0.12661996,0.006156937,0.3993561],"study_design_scores_gemma":[0.3173008,0.00071128935,0.63639426,0.00013150499,0.0005357136,2.8624254e-7,0.0001082195,0.00041221274,0.00028644854,0.02085947,0.023047201,0.00021258947],"about_ca_topic_score_codex":0.000019005165,"about_ca_topic_score_gemma":0.000024085937,"teacher_disagreement_score":0.39914352,"about_ca_system_score_codex":0.000019292827,"about_ca_system_score_gemma":0.00014120125,"threshold_uncertainty_score":0.5833884},"labels":[],"label_agreement":null},{"id":"W2789984616","doi":"10.1111/dom.13274","title":"Role of bicarbonate supplementation on urine uric acid crystals and diabetic tubulopathy in adults with type 1 diabetes","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Urine; Urine osmolality; Medicine; Internal medicine; Creatinine; Endocrinology; Sodium bicarbonate; Tubulopathy; Kidney disease; Type 1 diabetes; Microalbuminuria; Uric acid; Diabetes mellitus; Urology; Chemistry","score_opus":0.004463709535323452,"score_gpt":0.20985914966493777,"score_spread":0.2053954401296143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789984616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99338484,0.005234941,0.0000010988913,0.00016935122,0.00008150768,0.0005562481,0.00004050669,0.00003828002,0.00049323495],"genre_scores_gemma":[0.9981943,0.00055105245,0.000553787,0.00036256475,0.00015650764,0.00003551329,0.000068413305,0.000032418324,0.000045449608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983533,0.00008772479,0.00034098237,0.00044115997,0.00032576855,0.0004510362],"domain_scores_gemma":[0.99911094,0.00008893962,0.00014372713,0.00031109017,0.0001559816,0.00018935266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032927038,0.00027226235,0.00063063233,0.00032516164,0.00006922341,0.000019814284,0.00008548024,0.0001177382,0.000080629325],"category_scores_gemma":[0.00013474819,0.00021784513,0.000038734954,0.0004998613,0.00027372042,0.00015806561,0.00008415203,0.0001970142,0.000009091345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002670635,0.0004259783,0.85030985,0.00036696927,0.00014232397,0.0000052058144,0.0016654583,9.952688e-7,0.14043166,0.00016349007,0.00004497974,0.0061759977],"study_design_scores_gemma":[0.0032519777,0.0009231452,0.8049136,0.0003005124,0.0002887104,0.0000021308324,0.00018774191,0.00018870462,0.1887278,0.00031059812,0.00069366023,0.00021142031],"about_ca_topic_score_codex":0.000046325065,"about_ca_topic_score_gemma":0.000020485519,"teacher_disagreement_score":0.048296127,"about_ca_system_score_codex":0.000021061905,"about_ca_system_score_gemma":0.00004290131,"threshold_uncertainty_score":0.8883466},"labels":[],"label_agreement":null},{"id":"W2790059086","doi":"10.1111/dom.13235","title":"Effect of proprotein convertase subtilisin/kexin type 9 ( <scp>PCSK9</scp> ) monoclonal antibodies on new‐onset diabetes mellitus and glucose metabolism: <scp>A</scp> systematic review and meta‐analysis","year":2018,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Capital Health","keywords":"Medicine; PCSK9; Internal medicine; Alirocumab; Type 2 diabetes; Meta-analysis; Diabetes mellitus; Kexin; Publication bias; Subgroup analysis; Confidence interval; Gastroenterology; Endocrinology; Cholesterol; LDL receptor; Lipoprotein","score_opus":0.020657028541026294,"score_gpt":0.28550547619983746,"score_spread":0.26484844765881116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790059086","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10331809,0.88671994,0.000004854288,0.00003167934,0.00018587761,0.008945693,0.0006602062,0.000091246715,0.000042431515],"genre_scores_gemma":[0.00142159,0.995455,0.0003249898,0.0005149513,0.00031931518,0.00069648336,0.0005146947,0.00015119539,0.0006017833],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9903169,0.0033576384,0.0021028987,0.0017461161,0.0012603938,0.0012160174],"domain_scores_gemma":[0.99233115,0.0024697213,0.0015433816,0.0020317049,0.00050518935,0.0011188643],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.006637522,0.0018490567,0.022297392,0.0010303416,0.00032532774,0.00017983826,0.00042790704,0.0008385643,0.000024626423],"category_scores_gemma":[0.0043374086,0.0011799245,0.0037145973,0.0015582896,0.0006383666,0.0002745703,0.0003645833,0.0009560577,0.000039022118],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007851705,0.00018655274,0.00027113903,0.8586878,0.13049291,0.000018876548,0.00015107107,1.11783656e-7,0.000008787837,0.000094017894,0.00042521933,0.009655631],"study_design_scores_gemma":[0.0011791803,0.0006019315,0.0008763876,0.0380501,0.8593683,0.000038267535,0.000022295353,0.000012368164,0.0020116377,0.00005530388,0.09743987,0.00034433804],"about_ca_topic_score_codex":0.00021486876,"about_ca_topic_score_gemma":0.000015004636,"teacher_disagreement_score":0.8206377,"about_ca_system_score_codex":0.000044736815,"about_ca_system_score_gemma":0.00039738204,"threshold_uncertainty_score":0.9994254},"labels":[],"label_agreement":null},{"id":"W2790160447","doi":"10.1111/dom.13251","title":"Long‐term efficacy and safety of ertugliflozin monotherapy in patients with inadequately controlled T2DM despite diet and exercise: VERTIS MONO extension study","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Merck","keywords":"Extension (predicate logic); Term (time); Medicine; Physical therapy; Internal medicine; Computer science; Physics","score_opus":0.007645441871384784,"score_gpt":0.22841082766575554,"score_spread":0.22076538579437077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790160447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99264497,0.0045024306,0.000007726301,0.000069924135,0.00006742434,0.0026261904,0.000008976334,0.00002610665,0.00004626947],"genre_scores_gemma":[0.9977874,0.0016811594,0.0001680703,0.00015128903,0.000038100847,0.00005848526,0.000020303803,0.000023298346,0.00007189044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861103,0.000081078004,0.00033984642,0.00042205316,0.00023331965,0.0003126741],"domain_scores_gemma":[0.9992415,0.00008014123,0.00012537985,0.00027361207,0.000117572024,0.00016184032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030143923,0.00027738928,0.0009949548,0.00022085053,0.00009686142,0.000032874847,0.00005507139,0.000072019124,0.00001297287],"category_scores_gemma":[0.000040110648,0.00019593364,0.00003930323,0.00017581861,0.00019817242,0.00017307619,0.00009141029,0.00009018411,0.0000017695255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007484014,0.0017058146,0.911736,0.00008068094,0.00037084668,0.000006036204,0.0010035085,2.9151923e-7,0.00016094618,0.000025406931,0.000009819276,0.07741664],"study_design_scores_gemma":[0.05620108,0.0029303443,0.93894416,0.0002527557,0.0007427443,1.04522414e-7,0.000043654007,0.000048447746,0.0005084682,0.00003087911,0.00011408265,0.00018327622],"about_ca_topic_score_codex":0.00004517657,"about_ca_topic_score_gemma":0.000035202607,"teacher_disagreement_score":0.07723337,"about_ca_system_score_codex":0.000015646274,"about_ca_system_score_gemma":0.00001298228,"threshold_uncertainty_score":0.7989942},"labels":[],"label_agreement":null},{"id":"W2790892243","doi":"10.1111/dom.13293","title":"Rosiglitazone lowers resting and blood pressure response to exercise in men with type 2 diabetes: <scp>A</scp> 1‐year randomized study","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"GlaxoSmithKline","keywords":"Rosiglitazone; Internal medicine; Endocrinology; Medicine; Blood pressure; Agonist; Type 2 diabetes; Insulin resistance; Diastole; Diabetes mellitus; Insulin; Receptor","score_opus":0.0047547713575161795,"score_gpt":0.2151233258842722,"score_spread":0.210368554526756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790892243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915017,0.007008272,0.0000040833283,0.000029497802,0.000103849045,0.0011912233,0.000017835291,0.000030194487,0.00011332791],"genre_scores_gemma":[0.9983203,0.0003516797,0.00053697237,0.00010867163,0.00014165157,0.00012181141,0.000012849065,0.000040523548,0.00036558282],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978379,0.00054707425,0.0002748107,0.0006460924,0.00019560057,0.0004985328],"domain_scores_gemma":[0.99892795,0.00018322474,0.00009804849,0.0003677692,0.00017464937,0.00024834217],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014717472,0.0003077467,0.0006741722,0.00016891997,0.00015446513,0.000080951635,0.00017687345,0.00019158049,0.0000049413716],"category_scores_gemma":[0.0015890625,0.00025043965,0.00004480604,0.00033151457,0.00026880705,0.000023520535,0.00023392073,0.00017741225,0.0000047462418],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008696404,0.00047379956,0.2669294,0.00006152163,0.0005304802,0.000003687557,0.002293718,0.0000101586775,0.72042084,0.000005394766,0.00025843724,0.0003161737],"study_design_scores_gemma":[0.054460626,0.0011084415,0.14786056,0.00017894723,0.00085047237,0.0000012568526,0.0009783505,0.00005855244,0.7903987,0.00003532085,0.003721434,0.00034735032],"about_ca_topic_score_codex":0.00002423149,"about_ca_topic_score_gemma":0.0000130988365,"teacher_disagreement_score":0.11906884,"about_ca_system_score_codex":0.0000045249094,"about_ca_system_score_gemma":0.000058011796,"threshold_uncertainty_score":0.99999475},"labels":[],"label_agreement":null},{"id":"W2791007077","doi":"10.1111/dom.13236","title":"Two‐year trial of intermittent insulin therapy vs metformin for the preservation of β‐cell function after initial short‐term intensive insulin induction in early type 2 diabetes","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Metformin; Medicine; Insulin; Type 2 diabetes; Internal medicine; Randomized controlled trial; Diabetes mellitus; Endocrinology","score_opus":0.0340578647877229,"score_gpt":0.2946610893769653,"score_spread":0.2606032245892424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791007077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947401,0.0021357222,0.000032179178,0.00013374366,0.00083569717,0.0019224943,0.00001791692,0.000015854383,0.00016627816],"genre_scores_gemma":[0.99792147,0.0006902704,0.00015283923,0.00021922108,0.0006519585,0.00016998965,0.000045142486,0.00002225921,0.00012685911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984757,0.00012287381,0.00047690095,0.0002774447,0.00032299876,0.0003241278],"domain_scores_gemma":[0.9984904,0.00019659981,0.00016081381,0.0002972805,0.00078688096,0.00006800781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010070391,0.00018585326,0.0005161775,0.00035781454,0.000066021035,0.00003138349,0.00014399887,0.00013660945,0.00004185163],"category_scores_gemma":[0.00034155775,0.00012762663,0.00013375464,0.0004360963,0.00030881117,0.0003528063,0.00012315172,0.00022984584,0.000004035952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08079865,0.0025136457,0.5084631,0.0010009584,0.0011157438,0.0000020781297,0.004574532,0.000003872983,0.0620468,0.0008305467,0.00034876008,0.33830133],"study_design_scores_gemma":[0.023016568,0.003270339,0.8795409,0.00013365643,0.00030109673,6.354978e-8,0.00027251357,0.0004189848,0.09052846,0.0006401962,0.0017202735,0.0001569266],"about_ca_topic_score_codex":0.000034297438,"about_ca_topic_score_gemma":0.000014755051,"teacher_disagreement_score":0.37107787,"about_ca_system_score_codex":0.000016968625,"about_ca_system_score_gemma":0.000047956986,"threshold_uncertainty_score":0.5204463},"labels":[],"label_agreement":null},{"id":"W2791162071","doi":"10.1111/dom.13301","title":"Effects of the SGLT‐2 inhibitor dapagliflozin on glomerular and tubular injury markers","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Diabetes Canada; University of Toronto","funders":"Banting and Best Diabetes Centre, University of Toronto; Canadian Institutes of Health Research; University of Toronto; Nederlandse Organisatie voor Wetenschappelijk Onderzoek","keywords":"Dapagliflozin; Albuminuria; Urology; Medicine; Internal medicine; Excretion; Endocrinology; Urinary system; Placebo; Renal function; Diabetes mellitus; Type 2 diabetes; Pathology","score_opus":0.0032171069287916525,"score_gpt":0.20101722841888417,"score_spread":0.19780012149009252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791162071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941313,0.0030153508,0.0000017616061,0.00033308507,0.0004212576,0.00067516294,0.000009527595,0.00003135521,0.0013811807],"genre_scores_gemma":[0.9974994,0.00038102447,0.00015887077,0.0011232992,0.00022958902,0.000024631072,0.000004921039,0.00001717454,0.00056105695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989659,0.00007727098,0.00016622688,0.0002795213,0.0002345784,0.0002764808],"domain_scores_gemma":[0.9993629,0.00007611519,0.000074076845,0.00030420488,0.000052684558,0.00013004165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022407967,0.00019880474,0.00040244634,0.000107605476,0.0001247972,0.000021999007,0.00007952019,0.00008094781,0.0000178495],"category_scores_gemma":[0.00010595091,0.00013025802,0.00009193091,0.00018306256,0.00032591444,0.00007826638,0.00015064249,0.00010459437,0.000012564926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005620351,0.0024383971,0.6151953,0.0031976937,0.0025940484,0.000023718263,0.001127934,2.9345088e-7,0.19648175,0.0152184,0.010603559,0.1525569],"study_design_scores_gemma":[0.0016160576,0.00039414552,0.6944866,0.00023371351,0.00082588854,3.221743e-7,0.000015908347,0.000018356652,0.27001944,0.00039580482,0.031862993,0.00013076926],"about_ca_topic_score_codex":0.000010998813,"about_ca_topic_score_gemma":0.0000013953697,"teacher_disagreement_score":0.15242612,"about_ca_system_score_codex":0.000012361116,"about_ca_system_score_gemma":0.000014789864,"threshold_uncertainty_score":0.53117675},"labels":[],"label_agreement":null},{"id":"W2791740462","doi":"10.1111/dom.13137","title":"Efficacy of glucagon‐like peptide‐1 receptor agonists compared to dipeptidyl peptidase‐4 inhibitors for the management of type 2 diabetes: A meta‐analysis of randomized clinical trials","year":2018,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Incretin; Medicine; Glucagon-like peptide 1 receptor; Agonist; Exenatide; Type 2 diabetes; Dipeptidyl peptidase; Internal medicine; Dipeptidyl peptidase-4 inhibitor; Pharmacology; Dipeptidyl peptidase-4; Glucagon-like peptide-1; Adverse effect; Weight loss; Diabetes mellitus; Liraglutide; Alogliptin; Meta-analysis; Endocrinology; Receptor; Chemistry; Obesity; Biochemistry; Enzyme","score_opus":0.12533389312906065,"score_gpt":0.40361008164803713,"score_spread":0.2782761885189765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791740462","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024151405,0.9605386,0.0000648982,0.00007719437,0.0009318998,0.013328249,0.0007035823,0.000043346547,0.00016078522],"genre_scores_gemma":[0.003398812,0.9886506,0.0037163752,0.0001646988,0.0003665776,0.0015920746,0.0010155996,0.000095336,0.0009999229],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99006385,0.0024254543,0.0050019096,0.0010433568,0.0007775917,0.00068783306],"domain_scores_gemma":[0.9842121,0.009771766,0.0034675007,0.0015188089,0.0006527391,0.00037707406],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.017061055,0.0009958101,0.024411112,0.0011351531,0.00012893623,0.000048242462,0.00061770395,0.00040980513,0.00018881826],"category_scores_gemma":[0.001797985,0.0005747511,0.012419429,0.0019435957,0.0007836811,0.00008414525,0.0004747314,0.00027402176,0.00001732808],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003450466,0.0019478339,0.00016324995,0.028947966,0.815229,0.0000010704206,0.000236597,0.0000053971307,0.000008482448,0.0005870202,0.0032634167,0.14615948],"study_design_scores_gemma":[0.022161143,0.0002454254,0.00039984478,0.002615602,0.64112216,4.3795417e-8,0.000044778037,0.00004437441,0.00010920054,0.000022626598,0.3329,0.00033484548],"about_ca_topic_score_codex":0.000020546813,"about_ca_topic_score_gemma":0.0000056318877,"teacher_disagreement_score":0.32963657,"about_ca_system_score_codex":0.000039576877,"about_ca_system_score_gemma":0.00012868564,"threshold_uncertainty_score":0.9996704},"labels":[],"label_agreement":null},{"id":"W2792803451","doi":"10.1111/dom.13289","title":"Effects of intranasal insulin on endogenous glucose production in insulin‐resistant men","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Regulation of Appetite and Obesity","field":"Neuroscience","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Diabetes Canada; University of Toronto","funders":"Diabetes Canada","keywords":"Endogeny; Insulin; Nasal administration; Production (economics); Insulin resistance; Internal medicine; Endocrinology; Medicine; Economics; Pharmacology; Macroeconomics","score_opus":0.013039616732076015,"score_gpt":0.21678708344737418,"score_spread":0.20374746671529817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792803451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970951,0.00082462287,0.000005485325,0.00013183939,0.00034571972,0.00044360268,0.000009615609,0.00004211594,0.00110191],"genre_scores_gemma":[0.99829525,0.0010322684,0.00009078531,0.00024358496,0.00025406474,0.000013828837,0.0000023355092,0.00001296025,0.000054899472],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847454,0.00022148425,0.00027662248,0.00044824992,0.0002750595,0.00030407423],"domain_scores_gemma":[0.9993015,0.00018239407,0.00012325755,0.000239866,0.000059961294,0.00009304618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033496428,0.00017501853,0.0003399251,0.00022420319,0.00015249285,0.000027605438,0.00016272372,0.00009576518,0.000013912592],"category_scores_gemma":[0.00057214324,0.00015777224,0.00005150912,0.0004229424,0.00029038507,0.00020812853,0.00006295265,0.0001471479,0.000025942814],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013145407,0.00049423083,0.0030254254,0.00011896712,0.00000734857,0.0000048856245,0.00067263516,0.00000790299,0.9842972,0.0031198198,0.000021698026,0.0080984095],"study_design_scores_gemma":[0.00063093245,0.00012616756,0.30870935,0.000044809225,0.000016673674,5.5797585e-7,0.00000745297,0.00004964806,0.6881459,0.0008161189,0.0013426765,0.00010972606],"about_ca_topic_score_codex":0.00004771419,"about_ca_topic_score_gemma":0.000019778123,"teacher_disagreement_score":0.3056839,"about_ca_system_score_codex":0.000017563576,"about_ca_system_score_gemma":0.000028022361,"threshold_uncertainty_score":0.6433765},"labels":[],"label_agreement":null},{"id":"W2793672077","doi":"10.1111/dom.13245","title":"Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"AbbVie","keywords":"Medicine; Diabetic nephropathy; Clinical trial; Protocol (science); Urology; Sonar; Diabetes mellitus; Internal medicine; Alternative medicine; Endocrinology; Pathology; Artificial intelligence","score_opus":0.04565872220495022,"score_gpt":0.3243476603241468,"score_spread":0.2786889381191966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793672077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9071775,0.00019553832,0.00005893746,0.00019675189,0.00020516147,0.092045985,0.000053456628,0.000027534417,0.000039102226],"genre_scores_gemma":[0.9824278,0.000010331584,0.00090433017,0.0007798262,0.00072443695,0.015056058,0.0000074412897,0.000036986617,0.000052823376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969769,0.00047756202,0.0009231947,0.0005870477,0.0006044613,0.00043079755],"domain_scores_gemma":[0.99766904,0.0005024127,0.00038217977,0.00064238376,0.0003184154,0.0004855718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013204168,0.00033688606,0.0011564484,0.00014787055,0.00019531851,0.000038820803,0.00020519429,0.00013725538,0.000056995552],"category_scores_gemma":[0.00072246755,0.00021668481,0.000183567,0.0004897852,0.0007069389,0.00013235728,0.00019452703,0.00022032097,0.000004027588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28733093,0.038539875,0.6223376,0.0014351653,0.0017907725,0.000011070356,0.005112562,0.000009192926,0.024076162,0.00050579495,0.0020134766,0.01683743],"study_design_scores_gemma":[0.40310854,0.018710833,0.5589488,0.00032733253,0.002072736,0.0000016885834,0.00047097565,0.0001907362,0.012149881,0.00021293249,0.0034193373,0.00038615437],"about_ca_topic_score_codex":0.000031114425,"about_ca_topic_score_gemma":0.000017145303,"teacher_disagreement_score":0.11577763,"about_ca_system_score_codex":0.00001982057,"about_ca_system_score_gemma":0.00048362758,"threshold_uncertainty_score":0.883615},"labels":[],"label_agreement":null},{"id":"W2793793620","doi":"10.1111/dom.13252","title":"Dulaglutide 1.5 mg as an add‐on option for patients uncontrolled on insulin: Subgroup analysis by age, duration of diabetes and baseline glycated haemoglobin concentration","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"European Foundation for the Study of Diabetes; Eli Lilly and Company; American Diabetes Association","keywords":"Medicine; Dulaglutide; Subgroup analysis; Diabetes mellitus; Glycated haemoglobin; Internal medicine; Type 2 diabetes; Endocrinology; Meta-analysis; Liraglutide","score_opus":0.007338434889576477,"score_gpt":0.23898001209343775,"score_spread":0.23164157720386128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793793620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970799,0.0005983632,0.00013597595,0.00016262101,0.00015469763,0.0014658974,0.00019583845,0.0000548269,0.00015188388],"genre_scores_gemma":[0.99505615,0.00020048265,0.00042838714,0.0008122747,0.00014267654,0.00010668178,0.0030684439,0.000020560365,0.0001643432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829227,0.00013803858,0.00044854893,0.00048630085,0.00029365515,0.00034118467],"domain_scores_gemma":[0.99883986,0.00014335963,0.0002637679,0.00027881964,0.00027884683,0.00019533053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046615108,0.00028467216,0.00074860535,0.00025503436,0.00017460604,0.000058893504,0.000061832245,0.00013067794,0.000029451658],"category_scores_gemma":[0.00026303594,0.00023927857,0.00013556848,0.00038049853,0.00014971655,0.00026408362,0.000026782105,0.00007150831,0.0000051312077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027837346,0.007940829,0.79899335,0.000519945,0.005720684,0.0000029268278,0.0009721362,0.000035596404,0.055066686,0.0075351563,0.0020074095,0.11842154],"study_design_scores_gemma":[0.018190194,0.0046670623,0.8784622,0.00011896644,0.006062183,4.5477496e-8,0.000046786176,0.014009846,0.07414949,0.0010003708,0.002883908,0.00040897698],"about_ca_topic_score_codex":0.000024734729,"about_ca_topic_score_gemma":0.00002768795,"teacher_disagreement_score":0.11801256,"about_ca_system_score_codex":0.00003571789,"about_ca_system_score_gemma":0.000017158469,"threshold_uncertainty_score":0.9757497},"labels":[],"label_agreement":null},{"id":"W2794876887","doi":"10.1111/dom.13311","title":"Use of the waist‐to‐height ratio to predict cardiovascular risk in patients with diabetes: <scp>R</scp> esults from the <scp>ADVANCE‐ON</scp> study","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Japan Society for the Promotion of Science; National Health and Medical Research Council; Medical Research Council; Servier","keywords":"Waist-to-height ratio; Medicine; Hazard ratio; Waist; Body mass index; Waist–hip ratio; Internal medicine; Stroke (engine); Myocardial infarction; Confidence interval; Type 2 diabetes; Proportional hazards model; Diabetes mellitus; Demography; Obesity; Cardiology; Endocrinology","score_opus":0.008693423885560053,"score_gpt":0.19630004390657316,"score_spread":0.1876066200210131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794876887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900637,0.0035685168,0.00006378023,0.00005380485,0.00066318584,0.004683958,0.0006577673,0.000071510345,0.00017377615],"genre_scores_gemma":[0.9968693,0.00013938322,0.00045325648,0.0011543487,0.000744063,0.0002976662,0.000059544192,0.00008640946,0.00019599435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99484694,0.00091149984,0.000658055,0.0010724256,0.0015702217,0.0009408333],"domain_scores_gemma":[0.9952784,0.0010266502,0.00025502412,0.0024462151,0.0005422955,0.00045140318],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016432495,0.0006271874,0.0017109037,0.00024710016,0.00043306488,0.00013435887,0.00057182333,0.00019983403,0.000005257811],"category_scores_gemma":[0.004296406,0.00036552406,0.0006469153,0.0011817346,0.00039553,0.00033810176,0.00037146313,0.000604632,0.00004390487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032227683,0.0010792312,0.9673214,0.00004779768,0.002828971,0.0000033704723,0.0047378503,0.00025763226,0.000047566737,0.0000152101165,0.0014480408,0.02218068],"study_design_scores_gemma":[0.004653923,0.0008519824,0.9022599,0.0002927128,0.0021505284,1.3069112e-7,0.00045406749,0.00004483428,0.005820565,0.0000523706,0.083303675,0.00011532622],"about_ca_topic_score_codex":0.0021588693,"about_ca_topic_score_gemma":0.00070509914,"teacher_disagreement_score":0.08185564,"about_ca_system_score_codex":0.00005414884,"about_ca_system_score_gemma":0.0000942618,"threshold_uncertainty_score":0.99987966},"labels":[],"label_agreement":null},{"id":"W2795033409","doi":"10.1111/dom.13315","title":"Baseline characteristics and enrichment results from the <scp>SONAR</scp> trial","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"AbbVie","keywords":"Medicine; Baseline (sea); Fishery","score_opus":0.012679675476472616,"score_gpt":0.23919566503437067,"score_spread":0.22651598955789806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795033409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98862743,0.007795247,0.000009433112,0.0009796734,0.000509546,0.0005322238,0.00082627265,0.0000605971,0.0006595504],"genre_scores_gemma":[0.98895204,0.0013508799,0.00027746885,0.0046390016,0.003654919,0.000026829764,0.00047463767,0.000020644295,0.0006035914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983712,0.0001301167,0.0003668878,0.00044367232,0.00027309055,0.00041506192],"domain_scores_gemma":[0.9979283,0.0009512667,0.00013331768,0.00042283,0.00013956153,0.00042469465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069670234,0.00024107746,0.00051394047,0.000051092647,0.0002646951,0.00009170648,0.00010671466,0.00012607918,0.000049268474],"category_scores_gemma":[0.0020550413,0.00016249497,0.00009332059,0.00013676322,0.00031698658,0.00011320078,0.00014096414,0.00019298744,0.000045154946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006260724,0.0037218502,0.61201024,0.00044856,0.002072127,0.00006355659,0.008850854,1.687608e-7,0.017166944,0.0024990782,0.18721782,0.15968809],"study_design_scores_gemma":[0.026451157,0.00019480602,0.65331006,0.00008486874,0.0007827261,9.1610445e-7,0.0001116828,0.0002463732,0.0030174,0.00046380272,0.31525233,0.00008387914],"about_ca_topic_score_codex":0.00007284033,"about_ca_topic_score_gemma":0.000006083248,"teacher_disagreement_score":0.1596042,"about_ca_system_score_codex":0.000014992468,"about_ca_system_score_gemma":0.00012527885,"threshold_uncertainty_score":0.6626352},"labels":[],"label_agreement":null},{"id":"W2799866020","doi":"10.1111/dom.13359","title":"Hypothalamic arcuate nucleus glucokinase regulates insulin secretion and glucose homeostasis","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Nederlands Herseninstituut; Medical Research Council; Université de Lausanne; Rosetrees Trust; Medical Research Council Canada; Wellcome Trust","keywords":"Glucokinase; Internal medicine; Endocrinology; Arc (geometry); Arcuate nucleus; Glucose homeostasis; Insulin; Medicine; Homeostasis; Diabetes mellitus; Hypothalamus; Insulin resistance","score_opus":0.01026146709295816,"score_gpt":0.2214207674067677,"score_spread":0.21115930031380953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799866020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980742,0.016977917,0.000014654857,0.0003785018,0.0002736751,0.000292984,0.000039583614,0.00014072767,0.0011399955],"genre_scores_gemma":[0.99349725,0.0034594336,0.00096021156,0.0012431398,0.00041123724,0.000016611706,0.000056162797,0.000027703234,0.00032823472],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986135,0.00008109887,0.00025884746,0.0004282412,0.00021081393,0.00040751908],"domain_scores_gemma":[0.99899787,0.000108490436,0.00009365342,0.0003139922,0.00015315994,0.00033285253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034763303,0.00025646936,0.0005393945,0.00020719694,0.00023875627,0.000069197355,0.00005735026,0.0001603453,0.00016840968],"category_scores_gemma":[0.0003287033,0.00022104407,0.000077458106,0.00026057908,0.00043197192,0.00020440541,0.00008564374,0.00016265792,0.00008221748],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043180824,0.0008146697,0.26119918,0.0007131756,0.000632362,0.000030734685,0.001803838,5.64877e-7,0.45488223,0.0048160544,0.0014866898,0.27318868],"study_design_scores_gemma":[0.0023741215,0.00019763576,0.74687415,0.00010421391,0.00041764663,0.000012475236,0.000093024224,0.0006084025,0.2266968,0.001987795,0.020379914,0.00025383124],"about_ca_topic_score_codex":0.000035732217,"about_ca_topic_score_gemma":0.0000029876946,"teacher_disagreement_score":0.48567495,"about_ca_system_score_codex":0.0000183042,"about_ca_system_score_gemma":0.00003550611,"threshold_uncertainty_score":0.90139157},"labels":[],"label_agreement":null},{"id":"W2801318333","doi":"10.1111/dom.13337","title":"A practical approach and algorithm for intensifying beyond basal insulin in type 2 diabetes","year":2018,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; Credit Valley Hospital; Health Sciences Centre; McGill University; University of Toronto; Jewish General Hospital; McGill University Health Centre; Sunnybrook Health Science Centre; LMC Diabetes & Endocrinology (Canada)","funders":"Novo Nordisk; Sanofi; Merck; Boehringer Ingelheim; AstraZeneca","keywords":"Basal insulin; Type 2 diabetes; Basal (medicine); Insulin; Diabetes mellitus; Medicine; Intensive care medicine; Computer science; Process (computing); Risk analysis (engineering); Algorithm; Endocrinology","score_opus":0.049416641570814795,"score_gpt":0.32308235014969566,"score_spread":0.27366570857888084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801318333","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052467,0.99090743,0.00008678798,0.000092041766,0.00045140152,0.0025986175,0.000077865116,0.00006245701,0.00047672732],"genre_scores_gemma":[0.00008282547,0.9618256,0.035586912,0.0005058444,0.0005413026,0.00042119887,0.00058530417,0.00008522612,0.0003657481],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99740607,0.00014916545,0.0005919756,0.00087726186,0.0002330679,0.0007424376],"domain_scores_gemma":[0.99855,0.00037873414,0.00023856183,0.00038408214,0.00015819601,0.00029043926],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000843279,0.00064501906,0.002786046,0.0005014396,0.000118340715,0.00011415456,0.00011159016,0.00045222227,0.000012415515],"category_scores_gemma":[0.00039492932,0.00050376425,0.00028841832,0.00042377505,0.00024641215,0.00021174234,0.00028254432,0.00043112203,0.000017430219],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009288315,0.0005097139,0.00051382784,0.012472906,0.0008262653,0.000008103135,0.00007918811,8.789524e-9,7.1096207e-7,0.00045568057,0.0016583825,0.9834659],"study_design_scores_gemma":[0.0018396294,0.0002858894,0.0012565933,0.0031654346,0.0060951044,0.0000037761306,0.00003838074,0.00082938006,0.000011514946,0.00040759557,0.9855189,0.000547846],"about_ca_topic_score_codex":0.000006575677,"about_ca_topic_score_gemma":0.0000020505386,"teacher_disagreement_score":0.9838605,"about_ca_system_score_codex":0.000054537693,"about_ca_system_score_gemma":0.00013285443,"threshold_uncertainty_score":0.9997414},"labels":[],"label_agreement":null},{"id":"W2802498945","doi":"10.1111/dom.13346","title":"Time trends and geographical variation in prescribing of drugs for diabetes in England from 1998 to 2017","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Foundation; Medical Research Council; National Institute for Health and Care Research; Medical Research Council Canada; Wellcome Trust","keywords":"Medicine; Metformin; Medical prescription; Diabetes mellitus; Drug; Type 2 diabetes; Drug class; Clinical trial; Pharmacology; Internal medicine; Endocrinology","score_opus":0.008734570265024708,"score_gpt":0.22983335037809052,"score_spread":0.22109878011306583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802498945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975075,0.0011077836,0.000008760027,0.00043457857,0.00009400351,0.00046963847,0.000066279885,0.00001938158,0.00029207524],"genre_scores_gemma":[0.9979342,0.000082945066,0.0011961864,0.0002785308,0.00015112592,0.00007216239,0.00008565542,0.0000123444715,0.00018681481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989395,0.000044129793,0.00024848583,0.00033007975,0.00012708656,0.00031071244],"domain_scores_gemma":[0.99946433,0.00014305602,0.00006145054,0.00017690947,0.000036433466,0.00011783928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039086267,0.00015954372,0.00050103804,0.00048420712,0.000042821826,0.000024532703,0.000058493057,0.00009221188,0.000016221735],"category_scores_gemma":[0.00006332738,0.0001413437,0.000052733045,0.00027523568,0.00009636723,0.0001376237,0.000080729274,0.00006647319,0.000004007301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010597071,0.0004719559,0.9368724,0.00012400979,0.00020038223,0.0000010937357,0.0027969552,0.0000012148992,0.013320456,0.00040854965,0.00021922574,0.04547775],"study_design_scores_gemma":[0.003824889,0.00021816186,0.9777307,0.00013741874,0.00026995683,3.1677306e-8,0.000018071487,0.0010233726,0.004703825,0.0005808762,0.01135694,0.00013574903],"about_ca_topic_score_codex":0.00013085583,"about_ca_topic_score_gemma":0.00009417523,"teacher_disagreement_score":0.045342002,"about_ca_system_score_codex":0.000011235896,"about_ca_system_score_gemma":0.000008626258,"threshold_uncertainty_score":0.5763829},"labels":[],"label_agreement":null},{"id":"W2803237745","doi":"10.1111/dom.13370","title":"P465L‐PPARγ mutation confers partial resistance to the hypolipidaemic action of fibrates","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Northern British Columbia","funders":"FP7 Health; Wellcome; Medical Research Council; European Commission; Horizon 2020 Framework Programme; Wellcome Trust","keywords":"Internal medicine; Endocrinology; Insulin resistance; Very low-density lipoprotein; Steatosis; Fatty liver; Pathophysiology; Bezafibrate; Biology; Mutant; Lipoprotein; Gene; Medicine; Insulin; Cholesterol; Biochemistry; Disease","score_opus":0.010230307488901745,"score_gpt":0.24301585354469507,"score_spread":0.23278554605579332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803237745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977456,0.0010766266,0.00014625542,0.00027701407,0.0003575579,0.00018195793,0.000029223373,0.000012254368,0.00017353709],"genre_scores_gemma":[0.99838734,0.00018122527,0.00023557815,0.00035737324,0.0006156983,0.000022594048,0.000034005385,0.000012162298,0.00015400622],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99917644,0.00009915838,0.00015848847,0.00024549698,0.000104695486,0.00021570553],"domain_scores_gemma":[0.99948305,0.000016848804,0.000086993066,0.00021248436,0.00011987712,0.000080761776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002002672,0.00012442982,0.0001591884,0.000042512824,0.00014806048,0.000026316808,0.00012298179,0.00011171322,0.000016246942],"category_scores_gemma":[0.00013772186,0.00009709862,0.000045267407,0.00012925344,0.0001693499,0.000013325969,0.000064607295,0.00006842157,0.000010739584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057601326,0.000024960053,0.0060204198,0.00002119991,0.00005027387,7.0787436e-8,0.00017921235,0.000006666989,0.99124575,0.00014254224,0.00099448,0.0012568202],"study_design_scores_gemma":[0.00022252732,0.000060767685,0.0275507,0.0000131362685,0.000029652745,4.495185e-7,0.00006879277,0.000023906976,0.9253338,0.00007339715,0.046511788,0.000111077075],"about_ca_topic_score_codex":0.000011366952,"about_ca_topic_score_gemma":0.000045956305,"teacher_disagreement_score":0.06591195,"about_ca_system_score_codex":0.0000058167475,"about_ca_system_score_gemma":0.00003826066,"threshold_uncertainty_score":0.39595667},"labels":[],"label_agreement":null},{"id":"W2803567790","doi":"10.1111/dom.13374","title":"The effect of small doses of fructose and allulose on postprandial glucose metabolism in type 2 diabetes: A double‐blind, randomized, controlled, acute feeding, equivalence trial","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diet, Metabolism, and Disease","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Saskatchewan; St. Michael's Hospital","funders":"Banting and Best Diabetes Centre, University of Toronto; Canadian Institutes of Health Research","keywords":"Postprandial; Type 2 diabetes; Randomized controlled trial; Fructose; Medicine; Double blind; Internal medicine; Carbohydrate metabolism; Endocrinology; Diabetes mellitus; Food science; Chemistry; Placebo","score_opus":0.012708680500046518,"score_gpt":0.27247261180939797,"score_spread":0.25976393130935144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803567790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93563604,0.05749141,0.000002259979,0.00014611043,0.0015460415,0.0045643044,0.00006363227,0.000040283652,0.0005099031],"genre_scores_gemma":[0.98761684,0.010639102,0.00008871748,0.00028181472,0.0009457769,0.00026444363,0.000023677456,0.000043738288,0.000095885654],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99583125,0.0009266487,0.0012191164,0.00063463766,0.0006248816,0.0007634676],"domain_scores_gemma":[0.99549705,0.002425532,0.0006458541,0.00060706836,0.0003793217,0.00044514917],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004401611,0.00060494186,0.00412043,0.00047919588,0.00022113955,0.000094170646,0.00030839167,0.00028349253,0.00003834583],"category_scores_gemma":[0.0028128705,0.00035705054,0.0006607627,0.00052024634,0.00151738,0.0002276151,0.00019368353,0.00038270935,0.000008324478],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9783662,0.0005099947,0.005167861,0.00031751883,0.0013226161,0.000007666664,0.00069614704,6.7018993e-7,0.006947968,0.0018467227,0.000034320226,0.0047823116],"study_design_scores_gemma":[0.9293419,0.0027065494,0.020394774,0.00029585543,0.006254383,0.0000016780365,0.00006552914,0.00013380162,0.039025206,0.0006089726,0.0008075411,0.00036378953],"about_ca_topic_score_codex":0.000085240776,"about_ca_topic_score_gemma":0.000025295754,"teacher_disagreement_score":0.05198079,"about_ca_system_score_codex":0.000012419315,"about_ca_system_score_gemma":0.00014054305,"threshold_uncertainty_score":0.9998881},"labels":[],"label_agreement":null},{"id":"W2803715345","doi":"10.1111/dom.13384","title":"Efficacy and safety of alirocumab among individuals with diabetes mellitus and atherosclerotic cardiovascular disease in the ODYSSEY phase 3 trials","year":2018,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Ezetimibe; PCSK9; Medicine; Internal medicine; Placebo; Diabetes mellitus; Statin; Endocrinology; Lipoprotein; Cholesterol; LDL receptor; Apolipoprotein A1; Pathology","score_opus":0.03600435787991747,"score_gpt":0.29793487863960166,"score_spread":0.2619305207596842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803715345","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4123946,0.5841912,0.000005313482,0.000016207516,0.000052523537,0.0031508915,0.00016306783,0.000015177621,0.000011032612],"genre_scores_gemma":[0.04636231,0.9524457,0.00012049333,0.00008122728,0.00046915075,0.0002998308,0.00014497437,0.000066797635,0.000009539498],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942105,0.0022795848,0.0011397887,0.00087808823,0.00088144286,0.00061059877],"domain_scores_gemma":[0.9969535,0.00066548213,0.0004967727,0.0013012663,0.000105730316,0.00047723248],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008700439,0.0007052852,0.006367962,0.00030606156,0.00020309056,0.00009719095,0.00022157347,0.00035110692,0.000009193177],"category_scores_gemma":[0.00075383397,0.00039398336,0.001074062,0.00048317993,0.000672182,0.00015327438,0.00015147308,0.0005149733,0.0000016379254],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010017803,0.0006286564,0.010090772,0.034222122,0.008222922,0.00002383799,0.00071637117,7.0513835e-7,0.0000014353379,0.0001226738,0.000020100197,0.94585025],"study_design_scores_gemma":[0.01572987,0.00045577227,0.2160682,0.021315642,0.053697985,0.000012530116,0.000076034856,0.000008852788,0.000024634148,0.000106443,0.691646,0.0008580709],"about_ca_topic_score_codex":0.00009621533,"about_ca_topic_score_gemma":0.0000056783338,"teacher_disagreement_score":0.9449922,"about_ca_system_score_codex":0.000024409164,"about_ca_system_score_gemma":0.0002331674,"threshold_uncertainty_score":0.9998512},"labels":[],"label_agreement":null},{"id":"W2803721928","doi":"10.1111/dom.13351","title":"Empagliflozin as adjunct to insulin in Japanese participants with type 1 diabetes: Results of a 4‐week, double‐blind, randomized, placebo‐controlled phase 2 trial","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Boehringer Ingelheim Japan; Eli Lilly and Company","keywords":"Empagliflozin; Placebo; Medicine; Pharmacodynamics; Insulin; Internal medicine; Randomized controlled trial; Diabetes mellitus; Pharmacokinetics; Type 2 diabetes; Endocrinology","score_opus":0.03184946405653108,"score_gpt":0.3047898708028425,"score_spread":0.27294040674631137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803721928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98763657,0.0017048466,0.0000024754238,0.00044687674,0.00044990354,0.0072899517,0.00002863928,0.000059608697,0.0023811492],"genre_scores_gemma":[0.9962322,0.00021578057,0.00030923996,0.0007141277,0.00039112696,0.0007881459,0.00008064182,0.00004046613,0.0012282737],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99662954,0.00032516776,0.001001628,0.00066710095,0.0005090928,0.000867465],"domain_scores_gemma":[0.9978431,0.00046351092,0.000325308,0.0005808375,0.00029851365,0.0004887524],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023482994,0.0004761675,0.0026674261,0.00059780636,0.00009207305,0.000057991332,0.00017524304,0.0001656556,0.00008442261],"category_scores_gemma":[0.0012117635,0.00032438032,0.00023260464,0.0008205042,0.00035938175,0.0002143711,0.00013161861,0.00019540808,0.00010333826],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9869826,0.0035155413,0.0014025504,0.00011884401,0.0013993646,0.0000171809,0.0025145132,0.000005408565,0.0008703177,0.00019310607,0.00028922452,0.0026913425],"study_design_scores_gemma":[0.97754705,0.0044297567,0.0023309248,0.00029815428,0.0026489645,3.4351163e-7,0.00018038874,0.00031523395,0.009709613,0.00011855778,0.0020762181,0.00034478048],"about_ca_topic_score_codex":0.00017458622,"about_ca_topic_score_gemma":0.00014218835,"teacher_disagreement_score":0.009435543,"about_ca_system_score_codex":0.00003492562,"about_ca_system_score_gemma":0.00013324906,"threshold_uncertainty_score":0.99992085},"labels":[],"label_agreement":null},{"id":"W2804740558","doi":"10.1111/dom.13373","title":"Comparative efficacy and acceptability of antidiabetic agents for Alzheimer's disease and mild cognitive impairment: A systematic review and network meta‐analysis","year":2018,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Neurological Disorders and Treatments","field":"Neuroscience","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; Brain and Cognition Discovery Foundation; University Health Network","funders":"Allergan; China Scholarship Council; University of Toronto","keywords":"Medicine; Sitagliptin; Placebo; Metformin; Meta-analysis; Rosiglitazone; Pioglitazone; Randomized controlled trial; Liraglutide; Cochrane Library; Internal medicine; Linagliptin; MEDLINE; Pharmacology; Diabetes mellitus; Type 2 diabetes; Insulin; Endocrinology; Alternative medicine; Pathology","score_opus":0.12507677845945644,"score_gpt":0.36149428675023887,"score_spread":0.23641750829078242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804740558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023817299,0.9677711,0.0000037779002,0.000019918858,0.000038902916,0.0070860498,0.0012315676,0.00002136099,0.000009983403],"genre_scores_gemma":[0.057623453,0.9409325,0.000042114672,0.00048880395,0.000019809131,0.0008046434,0.00005735118,0.000021139584,0.000010159014],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9960121,0.0013584568,0.0008080715,0.0011498453,0.00021420198,0.00045734362],"domain_scores_gemma":[0.99634075,0.0021157318,0.00073174137,0.0003474717,0.00008556117,0.00037876575],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005869028,0.0006801244,0.0075198743,0.00014462777,0.00030580422,0.00009021422,0.00018101154,0.00013798813,0.000033571734],"category_scores_gemma":[0.00043377027,0.00043927916,0.0008483428,0.00058084057,0.0007185125,0.00015137628,0.00028880182,0.0001606995,0.000002133535],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005466754,0.0013315189,0.0013911814,0.8908369,0.10215766,0.000007313239,0.00019304443,3.1659647e-7,4.3008708e-7,0.00025617817,0.00006424933,0.0037065474],"study_design_scores_gemma":[0.00086243433,0.00018794788,0.013991502,0.009456274,0.9733967,0.0000010754358,0.0000050319295,0.000028874902,0.000011155958,0.00053777965,0.0010384294,0.00048279497],"about_ca_topic_score_codex":0.0000049237824,"about_ca_topic_score_gemma":0.0000019034969,"teacher_disagreement_score":0.8813806,"about_ca_system_score_codex":0.000004145894,"about_ca_system_score_gemma":0.000027812248,"threshold_uncertainty_score":0.9998059},"labels":[],"label_agreement":null},{"id":"W2807363782","doi":"10.1111/dom.13396","title":"Achieving glycaemic control without weight gain, hypoglycaemia, or gastrointestinal adverse events in type 2 diabetes in the SUSTAIN clinical trial programme","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Health Sciences Centre","funders":"Novo Nordisk","keywords":"Semaglutide; Medicine; Type 2 diabetes; Clinical endpoint; Sitagliptin; Placebo; Exenatide; Internal medicine; Adverse effect; Weight gain; Weight loss; Dulaglutide; Hypoglycemia; Gastroenterology; Diabetes mellitus; Clinical trial; Insulin; Endocrinology; Obesity; Liraglutide; Body weight","score_opus":0.02843823787394919,"score_gpt":0.3032648852547078,"score_spread":0.2748266473807586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807363782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467367,0.0008353067,0.000012213344,0.0007224063,0.0004733378,0.0027545323,0.000007456029,0.00006741618,0.00045367374],"genre_scores_gemma":[0.99568427,0.00018050736,0.0008988849,0.0016363331,0.000879488,0.00019391063,0.000043455067,0.000033482538,0.00044969804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99659586,0.0005774044,0.0007611044,0.0006056287,0.00039532885,0.0010646608],"domain_scores_gemma":[0.99840534,0.00052460097,0.00021260255,0.0004781348,0.0001370438,0.00024229377],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027394642,0.00039672275,0.0010060312,0.00028844495,0.00013285587,0.00003213688,0.00028007198,0.00014365067,0.000063385065],"category_scores_gemma":[0.0013013139,0.00025344803,0.00018914239,0.0005709778,0.00034215627,0.00022546724,0.00013039708,0.0004970008,0.00004180332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005601107,0.0016193305,0.9793972,0.00010252037,0.00014997428,0.000047355534,0.00020327454,7.2423825e-7,0.00010557469,0.00022143242,0.00022346602,0.012328037],"study_design_scores_gemma":[0.07092995,0.0025895673,0.9164817,0.00037840146,0.00070805417,0.000004624012,0.0002961723,0.00050784094,0.00007702169,0.0002375321,0.007478159,0.00031099157],"about_ca_topic_score_codex":0.000043566146,"about_ca_topic_score_gemma":0.00013363581,"teacher_disagreement_score":0.065328844,"about_ca_system_score_codex":0.000067908884,"about_ca_system_score_gemma":0.0001390266,"threshold_uncertainty_score":0.9999918},"labels":[],"label_agreement":null},{"id":"W2807732548","doi":"10.1111/dom.13413","title":"Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"National Institutes of Health; National Center for Advancing Translational Sciences; AstraZeneca","keywords":"Dapagliflozin; Medicine; Placebo; Renal function; Kidney disease; Type 2 diabetes; Internal medicine; Urology; Clinical endpoint; Adverse effect; Randomization; Diabetes mellitus; Gastroenterology; Randomized controlled trial; Endocrinology","score_opus":0.005970261016607593,"score_gpt":0.21811641055821412,"score_spread":0.21214614954160654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807732548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995755,0.0020728766,0.0000023243226,0.0001473662,0.00006806071,0.0018051161,0.000052235104,0.000021605652,0.000075380005],"genre_scores_gemma":[0.9990483,0.00026021877,0.000078330864,0.00030305452,0.00006161848,0.000041819363,0.00005677603,0.000019598707,0.00013031969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986299,0.00011379253,0.0002497642,0.00038788776,0.00025115183,0.00036750102],"domain_scores_gemma":[0.99912065,0.000058995334,0.00010131823,0.00031739136,0.000102801285,0.0002988137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029850015,0.00025627192,0.0005030337,0.00012244057,0.0001572216,0.000043488784,0.00007240355,0.00003892935,0.000031763364],"category_scores_gemma":[0.000056815094,0.00015843392,0.000028405086,0.00018153193,0.00033686374,0.000149905,0.00018313066,0.00010793418,0.0000024358671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008000066,0.0015689777,0.99080765,0.00017110199,0.0004895279,0.0000031742302,0.0008948505,0.0000038564913,0.00011622173,0.0001289306,0.00007098275,0.004944706],"study_design_scores_gemma":[0.01118509,0.0018221333,0.98387694,0.00015522272,0.00086983776,3.1034954e-8,0.00008428143,0.00028835752,0.0004976361,0.00005186409,0.0009986965,0.00016992966],"about_ca_topic_score_codex":0.000020285912,"about_ca_topic_score_gemma":0.00001844926,"teacher_disagreement_score":0.010385083,"about_ca_system_score_codex":0.000029395338,"about_ca_system_score_gemma":0.00006350319,"threshold_uncertainty_score":0.6460748},"labels":[],"label_agreement":null},{"id":"W2808271763","doi":"10.1111/dom.13353","title":"Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline <scp>BMI</scp> or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"ExxonMobil Research and Engineering Company; Novo Nordisk","keywords":"Semaglutide; Nausea; Weight loss; Vomiting; Medicine; Sitagliptin; Type 2 diabetes; Placebo; Internal medicine; Dulaglutide; Adverse effect; Gastroenterology; Exenatide; Liraglutide; Diabetes mellitus; Obesity; Endocrinology","score_opus":0.019855582552365737,"score_gpt":0.2665220678581215,"score_spread":0.24666648530575574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808271763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997003,0.0006632667,0.000009709606,0.00034521046,0.00012875433,0.0014375736,0.00002370604,0.000028733655,0.00036003697],"genre_scores_gemma":[0.99667984,0.0001131324,0.0013916269,0.0007877707,0.00024090291,0.00008964956,0.000042813168,0.00002727047,0.0006270159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972872,0.0005444849,0.0005901256,0.00045555973,0.00042387712,0.00069871533],"domain_scores_gemma":[0.99778664,0.0011420546,0.00023096478,0.00042148703,0.00022783331,0.00019100809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030944042,0.00034895024,0.0011094776,0.00049503805,0.00007354693,0.00001404786,0.00022940905,0.00007734519,0.000031931457],"category_scores_gemma":[0.0027145522,0.00020269227,0.00009442833,0.0010360522,0.00018571016,0.0001517625,0.00012648966,0.00020710615,0.000016088927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027428678,0.00095549197,0.9917781,0.00030758991,0.00017971412,0.00006272293,0.0011541208,0.000005895244,0.0023143818,0.00025831495,0.00057494256,0.002134463],"study_design_scores_gemma":[0.0049879686,0.001151854,0.96886545,0.00085164275,0.0005538309,0.0000038150083,0.0009874279,0.000050459515,0.018668486,0.000215476,0.0035263898,0.00013718323],"about_ca_topic_score_codex":0.000076529504,"about_ca_topic_score_gemma":0.0003503428,"teacher_disagreement_score":0.022912608,"about_ca_system_score_codex":0.00004202226,"about_ca_system_score_gemma":0.00012065409,"threshold_uncertainty_score":0.8265551},"labels":[],"label_agreement":null},{"id":"W2809389718","doi":"10.1111/dom.13445","title":"Impact of macronutrient content of meals on postprandial glucose control in the context of closed‐loop insulin delivery: <scp>A</scp> randomized cross‐over study","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Fonds de recherche du Québec – Nature et technologies; Canadian Institutes of Health Research","keywords":"Postprandial; Insulin; Medicine; Meal; Context (archaeology); Internal medicine; Endocrinology; Crossover study; Area under the curve; Carbohydrate; Bolus (digestion); Biology","score_opus":0.019508385797295462,"score_gpt":0.29934680326126195,"score_spread":0.2798384174639665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809389718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991303,0.0043417336,0.000004078009,0.00005187615,0.00015058629,0.0035197649,0.00013719768,0.00001028807,0.00048144473],"genre_scores_gemma":[0.99891883,0.000460047,0.0000102470685,0.0002955927,0.000116104704,0.00006334501,0.00001801578,0.00001729465,0.000100498764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967499,0.00085793476,0.0008446314,0.00032725782,0.0007439499,0.00047634318],"domain_scores_gemma":[0.99667364,0.0017565298,0.00042312723,0.00046093646,0.00055192027,0.00013381673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036750708,0.00027937014,0.0018434267,0.00040240202,0.00007536887,0.0000316477,0.000288211,0.00012295124,0.000041861174],"category_scores_gemma":[0.0015902207,0.00016091659,0.00045637312,0.00039360547,0.0009881954,0.00011416758,0.00011393753,0.00026270963,0.0000056410418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058858257,0.007403603,0.90179896,0.00031613265,0.002325314,0.000011189339,0.006488663,0.000004143254,0.015287366,0.0009832162,0.00023405431,0.006289098],"study_design_scores_gemma":[0.21127947,0.0034139967,0.7754595,0.00011176168,0.00060550583,1.6699983e-7,0.0007508912,0.00019728648,0.007867126,0.00011329705,0.00013648551,0.000064483094],"about_ca_topic_score_codex":0.00051925064,"about_ca_topic_score_gemma":0.000028974146,"teacher_disagreement_score":0.15242122,"about_ca_system_score_codex":0.00002364726,"about_ca_system_score_gemma":0.00007958569,"threshold_uncertainty_score":0.65619886},"labels":[],"label_agreement":null},{"id":"W2809681611","doi":"10.1111/dom.13377","title":"Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Canadian VIGOUR Centre; University of Alberta","funders":"Merck Sharp and Dohme; National Institute for Health and Care Research","keywords":"Medicine; Type 2 diabetes; Hazard ratio; Sitagliptin; Internal medicine; Aspirin; Diabetes mellitus; Myocardial infarction; Stroke (engine); Angina; Disease; Proportional hazards model; Confidence interval; Endocrinology","score_opus":0.007154820336780577,"score_gpt":0.19809272029479205,"score_spread":0.19093789995801147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809681611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903294,0.008566588,0.0000031986617,0.00004316033,0.00008377158,0.000620875,0.00003061153,0.0000242021,0.00029822488],"genre_scores_gemma":[0.9980736,0.00086902594,0.000515185,0.00009044524,0.000031339394,0.00003623195,0.00007150291,0.000014079211,0.00029860227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876845,0.000038916678,0.00021713797,0.00043122188,0.0002874327,0.0002568624],"domain_scores_gemma":[0.99930257,0.000040541312,0.00007042373,0.00036145395,0.00006472912,0.00016026675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017816773,0.00021622243,0.00071984873,0.00015460228,0.000056223937,0.000028488419,0.000050153907,0.00004372728,0.000020466188],"category_scores_gemma":[0.00003317702,0.00015080745,0.00005849329,0.00014413627,0.00022344304,0.00011507372,0.00014437118,0.000054736403,0.0000015954383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028954595,0.00028008706,0.9834855,0.00020137221,0.0017996774,0.000018029785,0.00013199895,8.780735e-8,0.00000805322,0.000060906463,0.000035156743,0.013950133],"study_design_scores_gemma":[0.0023320888,0.00011949403,0.9928231,0.0001203674,0.001921147,6.9479356e-8,0.00005123206,0.000024619696,0.00019773017,0.00031772736,0.0019287363,0.000163654],"about_ca_topic_score_codex":0.00004149308,"about_ca_topic_score_gemma":0.0000069235757,"teacher_disagreement_score":0.013786479,"about_ca_system_score_codex":0.000007515617,"about_ca_system_score_gemma":0.000008484304,"threshold_uncertainty_score":0.6149749},"labels":[],"label_agreement":null},{"id":"W2810651762","doi":"10.1111/dom.13448","title":"Acute vs cumulative benefits of metformin use in patients with type 2 diabetes and heart failure","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alliance for Canadian Health Outcomes Research in Diabetes; McGill University; University of Alberta; McGill University Health Centre","funders":"Government of Canada","keywords":"Metformin; Medicine; Exacerbation; Hazard ratio; Confidence interval; Diabetes mellitus; Proportional hazards model; Internal medicine; Heart failure; Type 2 diabetes; Population; Cumulative dose; Endocrinology; Environmental health","score_opus":0.009007983188584895,"score_gpt":0.21779254340710125,"score_spread":0.20878456021851635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810651762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99814427,0.00096414814,6.326212e-7,0.00008614211,0.00007414555,0.00057123555,0.000038651484,0.00002440762,0.00009638221],"genre_scores_gemma":[0.99713695,0.00011123863,0.0020906606,0.00036123558,0.00004513915,0.000014677428,0.000073401105,0.000019414485,0.00014728383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988974,0.000034032095,0.00020681122,0.00030583757,0.00021234753,0.00034362084],"domain_scores_gemma":[0.99930334,0.000063644875,0.00008477395,0.00022109944,0.00019222854,0.0001349363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014372962,0.00022123098,0.0006003384,0.00021899858,0.00006137375,0.000030157395,0.000048131827,0.000079703685,0.000023672575],"category_scores_gemma":[0.000050383573,0.00016252145,0.00003847725,0.00030321215,0.00020665138,0.00037927748,0.00009931454,0.0000891055,0.000005976705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010410298,0.00033261205,0.9949073,0.00007530914,0.00037659754,6.354229e-7,0.0002705593,5.987858e-7,0.0002235608,0.00045869162,0.0001994406,0.003050589],"study_design_scores_gemma":[0.0033911862,0.00086357107,0.9821106,0.00014951061,0.00067862106,9.9978145e-8,0.000021406639,0.000032218475,0.008605692,0.000096309486,0.0038842775,0.00016647267],"about_ca_topic_score_codex":0.000018596458,"about_ca_topic_score_gemma":0.000035420115,"teacher_disagreement_score":0.012796668,"about_ca_system_score_codex":0.000012524699,"about_ca_system_score_gemma":0.000014699208,"threshold_uncertainty_score":0.6627433},"labels":[],"label_agreement":null},{"id":"W2881018690","doi":"10.1111/dom.13460","title":"The effects of kisspeptin on β‐cell function, serum metabolites and appetite in humans","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Hypothalamic control of reproductive hormones","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Medical Research Council; Medical Research Council Canada; Biotechnology and Biological Sciences Research Council; Rosetrees Trust; Imperial College London; Diabetes UK; National Institute for Health and Care Research; Wellcome Trust","keywords":"Medicine; Kisspeptin; Appetite; Endocrinology; Internal medicine; Pharmacology; Function (biology); Hypothalamus; Genetics","score_opus":0.0036731325301247028,"score_gpt":0.20235299383027328,"score_spread":0.19867986130014859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2881018690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655853,0.032364327,0.0000067545534,0.00048796504,0.00029456103,0.00045859226,0.000004856131,0.000023981589,0.0007736771],"genre_scores_gemma":[0.9970356,0.0013937387,0.000096259464,0.000296859,0.00036780463,0.000020321788,0.0000022140266,0.000015965526,0.00077122985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881566,0.00012228668,0.00022913377,0.00035190265,0.00018628675,0.00029474328],"domain_scores_gemma":[0.9989889,0.00034109686,0.00009496074,0.00035464455,0.00012890282,0.0000914542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057911384,0.00018096068,0.00047482655,0.0001427204,0.00014733982,0.000023667068,0.00007038831,0.00007596704,0.0000104164865],"category_scores_gemma":[0.00045792255,0.00012246675,0.000061143124,0.00016629726,0.0003957366,0.00008754455,0.00006056298,0.00017761799,0.000012786582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020649517,0.0004001255,0.6219563,0.00047918936,0.0001964863,0.000003795782,0.00093709776,2.0401221e-7,0.33267483,0.006178791,0.00018964904,0.03677701],"study_design_scores_gemma":[0.0015926152,0.0002709627,0.8738416,0.000082155886,0.0002115143,7.292308e-7,0.00005342555,0.000011050048,0.10025835,0.0010575649,0.022518814,0.000101237296],"about_ca_topic_score_codex":0.000021598302,"about_ca_topic_score_gemma":0.000020476791,"teacher_disagreement_score":0.25188527,"about_ca_system_score_codex":0.0000070446454,"about_ca_system_score_gemma":0.000021344009,"threshold_uncertainty_score":0.49940494},"labels":[],"label_agreement":null},{"id":"W2883282832","doi":"10.1111/dom.13470","title":"Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild‐to‐moderate renal impairment","year":2018,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health; University of Alberta Hospital; University of Alberta; Alberta Health Services","funders":"Servier; GlaxoSmithKline; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Novo Nordisk; Valeant Pharmaceuticals International; Sanofi; American Diabetes Association","keywords":"Medicine; Insulin glargine; Type 2 diabetes; Type 1 diabetes; Internal medicine; Continuous glucose monitoring; Diabetes mellitus; Insulin; Endocrinology","score_opus":0.015610115476800567,"score_gpt":0.2655334214507449,"score_spread":0.2499233059739443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883282832","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42601898,0.57105535,0.0000061496276,0.00020186945,0.000094326264,0.0023572631,0.00011817877,0.000056399913,0.00009150449],"genre_scores_gemma":[0.017900985,0.9769756,0.0013547078,0.001006691,0.0006614346,0.00043247806,0.00025037906,0.00017544471,0.0012422488],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99592006,0.00021148846,0.00057424855,0.0013303439,0.0006886563,0.0012751921],"domain_scores_gemma":[0.9973409,0.00023664458,0.00023243982,0.00066626177,0.00036120592,0.0011625031],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00093058293,0.0009920894,0.0033111512,0.0007595324,0.00033420266,0.0002949595,0.00026769374,0.00034259594,0.0000488979],"category_scores_gemma":[0.000120026445,0.00064052356,0.00014395615,0.0009074763,0.00030497878,0.00020999784,0.00043024938,0.0006093162,0.00006067101],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013076991,0.000838824,0.021140521,0.029384162,0.0043752682,0.0000597514,0.0006927394,0.0000070610927,0.000091175076,0.00029333695,0.0036778718,0.9381316],"study_design_scores_gemma":[0.008340717,0.003957385,0.09632014,0.016234884,0.008072527,0.00001691989,0.00003847676,0.00016712626,0.00010037624,0.000064189386,0.86498225,0.0017050442],"about_ca_topic_score_codex":0.000020459282,"about_ca_topic_score_gemma":0.00005416761,"teacher_disagreement_score":0.9364265,"about_ca_system_score_codex":0.000056251596,"about_ca_system_score_gemma":0.00020800954,"threshold_uncertainty_score":0.9996046},"labels":[],"label_agreement":null},{"id":"W2887023054","doi":"10.1111/dom.13483","title":"3‐carboxy‐4‐methyl‐5‐propyl‐2‐furanpropanoic acid (CMPF) prevents high fat diet‐induced insulin resistance via maintenance of hepatic lipid homeostasis","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Insulin resistance; Internal medicine; Lipid metabolism; FGF21; Endocrinology; Fatty liver; Beta oxidation; Fatty acid; Lipid droplet; Chemistry; Fish oil; Lipotoxicity; Biology; Biochemistry; Insulin; Fibroblast growth factor; Medicine; Receptor","score_opus":0.008596861381035804,"score_gpt":0.2335609512493906,"score_spread":0.2249640898683548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887023054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938895,0.004622314,0.00018818081,0.0001071926,0.00033867653,0.00051478494,0.00014217019,0.000026943448,0.00017020048],"genre_scores_gemma":[0.99660325,0.00075878226,0.001346741,0.00012955189,0.00048945745,0.000056121018,0.000077665485,0.00005273196,0.00048571773],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99733394,0.00030799446,0.0004574421,0.0007429728,0.00040962786,0.00074803823],"domain_scores_gemma":[0.99838275,0.000039458788,0.0002297595,0.00075410376,0.0003531497,0.00024077605],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047747593,0.00036875613,0.00059447816,0.00013898495,0.00018975034,0.00004247355,0.0004775828,0.000289805,0.00005075735],"category_scores_gemma":[0.0003989876,0.0003335728,0.00015827414,0.00036487615,0.00047222574,0.000028664905,0.0004061978,0.00024313213,0.000029859824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029386536,0.00017611455,0.010791883,0.00028109734,0.0001591893,0.000001620988,0.00011255233,2.8293806e-7,0.98251766,0.00009797272,0.0003111898,0.0052565946],"study_design_scores_gemma":[0.0009999208,0.00046075953,0.1354209,0.00009877167,0.00006429846,6.767653e-7,0.000016279684,0.000022426566,0.8579022,0.00046867697,0.0042101145,0.00033491803],"about_ca_topic_score_codex":0.000095945536,"about_ca_topic_score_gemma":0.00011086336,"teacher_disagreement_score":0.12462902,"about_ca_system_score_codex":0.000020516607,"about_ca_system_score_gemma":0.00006941446,"threshold_uncertainty_score":0.9999116},"labels":[],"label_agreement":null},{"id":"W2889776606","doi":"10.1111/dom.13528","title":"The association of basal insulin treatment versus standard care with outcomes in anti‐GAD positive and negative subjects: A post‐hoc analysis of the ORIGIN trial","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Sanofi","keywords":"Insulin glargine; Medicine; Hazard ratio; Internal medicine; Confidence interval; Placebo; Incidence (geometry); Post-hoc analysis; Diabetes mellitus; Myocardial infarction; Randomized controlled trial; Stroke (engine); Gastroenterology; Insulin; Endocrinology; Hypoglycemia","score_opus":0.004122859864936471,"score_gpt":0.22987035766844277,"score_spread":0.2257474978035063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889776606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970151,0.0018801051,8.104344e-7,0.00011972419,0.000111859124,0.00030821175,0.00045581232,0.0000021453868,0.000106214145],"genre_scores_gemma":[0.9991094,0.0006809452,0.0000279699,0.000046406694,0.000031536234,0.000012582912,0.00005266486,0.0000062796553,0.00003220858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990907,0.00018031558,0.0001826971,0.00019393933,0.00015970768,0.0001926927],"domain_scores_gemma":[0.9991842,0.00014791111,0.00022985236,0.00015347482,0.00025310856,0.000031477404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022496376,0.00013560013,0.0003960326,0.00006075616,0.0001250306,0.000024204306,0.00008388541,0.000100397156,0.0000012355429],"category_scores_gemma":[0.00018879544,0.000075639364,0.0001215496,0.00030678295,0.00017873068,0.000008331079,0.000050540482,0.000050079216,9.147658e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006145517,0.00018971958,0.9789298,0.000012317047,0.0035664684,1.7527492e-7,0.0021246586,0.000010918878,0.004453453,0.00014296712,0.000008253306,0.0044157538],"study_design_scores_gemma":[0.01725401,0.001919309,0.9193829,0.000014356035,0.0012472984,9.974707e-9,0.0013609807,0.000015149195,0.058027368,0.000031571744,0.0006197676,0.00012725354],"about_ca_topic_score_codex":0.00025788773,"about_ca_topic_score_gemma":0.0032422943,"teacher_disagreement_score":0.059546873,"about_ca_system_score_codex":0.000031647105,"about_ca_system_score_gemma":0.000080417405,"threshold_uncertainty_score":0.30844837},"labels":[],"label_agreement":null},{"id":"W2889838690","doi":"10.1111/dom.13401","title":"Islet prohormone processing in health and disease","year":2018,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; BC Children's Hospital; Juvenile Diabetes Research Foundation International","keywords":"Proglucagon; Prohormone; Prohormone convertase; Proinsulin; Islet; Endocrinology; Enteroendocrine cell; Internal medicine; Amylin; Glucose homeostasis; Insulin; Glucagon; Biology; Type 2 diabetes; Hormone; Medicine; Insulin resistance; Diabetes mellitus; Glucagon-like peptide-1; Endocrine system","score_opus":0.029852731100373127,"score_gpt":0.3060687038235041,"score_spread":0.276215972723131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889838690","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015812023,0.9824601,0.0000027877936,0.00020863418,0.00012360892,0.0010344239,0.000041055966,0.000059558017,0.0002578132],"genre_scores_gemma":[0.00027593426,0.99694675,0.00031025533,0.0011736073,0.0003765895,0.00011662955,0.00016058615,0.00003884366,0.0006008228],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99806875,0.00016603227,0.00055101607,0.00054956943,0.00020005746,0.00046459807],"domain_scores_gemma":[0.9984301,0.00006857161,0.00025104804,0.00026893575,0.00005434037,0.00092700485],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005361787,0.00039801162,0.0021964724,0.00033461468,0.00012934614,0.00006144364,0.000063750296,0.00018677692,0.000022056136],"category_scores_gemma":[0.0005618954,0.00029995898,0.00014334107,0.00034137105,0.00019787627,0.0001217004,0.00008413311,0.0003242064,0.000018588587],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016859834,0.00022823359,0.004756587,0.0828036,0.000074617536,0.000008418502,0.00016280956,6.1269185e-9,0.000001199245,0.00018423551,0.0011865795,0.9105769],"study_design_scores_gemma":[0.0007203,0.00006498848,0.0073586125,0.017105464,0.00080467074,0.0000044529233,0.000014853519,0.000026257794,0.0000012136641,0.00022842434,0.97338974,0.00028102807],"about_ca_topic_score_codex":0.000012444814,"about_ca_topic_score_gemma":6.716075e-7,"teacher_disagreement_score":0.97220314,"about_ca_system_score_codex":0.00003760354,"about_ca_system_score_gemma":0.0006949116,"threshold_uncertainty_score":0.9999452},"labels":[],"label_agreement":null},{"id":"W2890415448","doi":"10.1111/dom.13522","title":"Glucagon‐like peptide‐1 receptor agonists for antipsychotic‐associated cardio‐metabolic risk factors: A systematic review and individual participant data meta‐analysis","year":2018,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Lundbeckfonden; Steno Diabetes Center Copenhagen","keywords":"Medicine; Glucagon-like peptide-1; Antipsychotic; Glucagon-like peptide 1 receptor; Meta-analysis; Pharmacology; Internal medicine; Diabetes mellitus; Endocrinology; Receptor; Schizophrenia (object-oriented programming); Type 2 diabetes; Agonist; Psychiatry","score_opus":0.14773646459709897,"score_gpt":0.3460003284333762,"score_spread":0.19826386383627723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890415448","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001090993,0.9805498,0.000012799871,0.000049747916,0.00035724125,0.009278816,0.008488541,0.00014422463,0.000027842098],"genre_scores_gemma":[0.00023135357,0.9851732,0.00055206724,0.00041338115,0.00021027187,0.0016352799,0.010808255,0.00012667092,0.0008495047],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.993228,0.00126068,0.001841249,0.0018374162,0.00069013686,0.0011425175],"domain_scores_gemma":[0.99395233,0.0008470851,0.001751189,0.0025392626,0.00027573013,0.00063440413],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.004035076,0.001424759,0.018367091,0.0007248296,0.00041086314,0.0003170418,0.0007654252,0.00048426838,0.00008099491],"category_scores_gemma":[0.0013197855,0.00094020367,0.0033830127,0.0013339213,0.0002755847,0.00035130844,0.00070281944,0.00043745193,0.000042910633],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003662938,0.0003792785,0.00032161147,0.41818503,0.5761231,0.0000022573195,0.00011506181,2.9900384e-8,7.881482e-8,0.000047556507,0.002381364,0.0024409648],"study_design_scores_gemma":[0.0005570688,0.00007762052,0.0007270044,0.021275392,0.66861606,9.0994837e-7,0.00001946545,0.000007730682,0.0000010578021,0.00001464423,0.3081373,0.0005657745],"about_ca_topic_score_codex":0.00006301151,"about_ca_topic_score_gemma":0.0000295817,"teacher_disagreement_score":0.39690962,"about_ca_system_score_codex":0.000029437597,"about_ca_system_score_gemma":0.00013904346,"threshold_uncertainty_score":0.9998502},"labels":[],"label_agreement":null},{"id":"W2891590598","doi":"10.1111/dom.13387","title":"Islet stress, degradation and autoimmunity","year":2018,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Nutrition, Metabolism and Diabetes","funders":"Diabetes Fonds; Juvenile Diabetes Research Foundation United States of America","keywords":"Endoplasmic-reticulum-associated protein degradation; Unfolded protein response; Endoplasmic reticulum; Proteasome; Autoimmunity; Protein degradation; Cell biology; Immune system; Biology; Ubiquitin; Inflammation; Context (archaeology); Translation (biology); Immunology; Biochemistry; Messenger RNA","score_opus":0.013411365750661654,"score_gpt":0.262544797419163,"score_spread":0.24913343166850133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891590598","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09405724,0.90483975,0.000008712455,0.000006921371,0.00017235216,0.00026117585,0.0003952372,0.00001476859,0.00024383028],"genre_scores_gemma":[0.0014365644,0.9962713,0.00013790757,0.00006607271,0.000359285,0.000044567758,0.0013173891,0.000030438961,0.00033646787],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998676,0.00018430167,0.0002701609,0.0004820913,0.00010590617,0.00028152595],"domain_scores_gemma":[0.9991583,0.000027183913,0.00017498808,0.00041224062,0.00005745493,0.00016979373],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017619366,0.00036024913,0.00075539167,0.00006615714,0.00017905315,0.00008353459,0.00016956638,0.0003495421,0.000014851725],"category_scores_gemma":[0.00011864863,0.00029667644,0.00018225225,0.000074506126,0.0002546649,0.000007977259,0.0002742453,0.00016243052,0.000008670522],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010957505,0.00023682784,0.003003816,0.014760222,0.0006809924,0.0000055074524,0.00004533582,1.8208338e-7,0.00022821815,0.00084653316,0.0034399831,0.97674143],"study_design_scores_gemma":[0.00022616623,0.000031662756,0.0016550169,0.0008569664,0.0007909194,0.000003632786,0.000006694689,0.000003862916,0.00040251852,0.00007529175,0.9955829,0.000364391],"about_ca_topic_score_codex":0.000019150511,"about_ca_topic_score_gemma":0.0000062290037,"teacher_disagreement_score":0.9921429,"about_ca_system_score_codex":0.0000045623233,"about_ca_system_score_gemma":0.00008002742,"threshold_uncertainty_score":0.99994856},"labels":[],"label_agreement":null},{"id":"W2893097539","doi":"10.1111/dom.13547","title":"Health‐related quality of life in people with type 2 diabetes participating in the LEADER trial","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Novo Nordisk","keywords":"Liraglutide; Medicine; Placebo; Quality of life (healthcare); EQ-5D; Visual analogue scale; Confidence interval; Physical therapy; Clinical trial; Type 2 diabetes; Internal medicine; Diabetes mellitus; Gerontology; Health related quality of life; Alternative medicine; Nursing; Endocrinology","score_opus":0.03952394011067687,"score_gpt":0.3006571993597987,"score_spread":0.2611332592491218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893097539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939979,0.0029751258,7.806815e-7,0.0014161364,0.00014028091,0.0009019535,0.0000042783563,0.000021604397,0.00054195215],"genre_scores_gemma":[0.9983136,0.000093280185,0.00013746505,0.0011272434,0.00009627165,0.00012711913,0.000021837526,0.0000120642435,0.0000710964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982046,0.00031383915,0.0005375822,0.00025149554,0.00025332923,0.00043918737],"domain_scores_gemma":[0.99917316,0.0001970372,0.00019424489,0.00026912248,0.000064972075,0.0001014332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015255967,0.00016470949,0.00079333683,0.00014952183,0.000068444424,0.00001980373,0.000089756366,0.00006698471,0.00004800856],"category_scores_gemma":[0.00029424045,0.00010496516,0.000050897288,0.00059296686,0.00016767238,0.00010729342,0.000044823617,0.000156795,0.000008154507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074021146,0.00079306256,0.98964024,0.0002271402,0.00013101356,9.03805e-7,0.0037233126,0.0000018981696,0.00009768575,0.00090660434,0.00014393292,0.0035939969],"study_design_scores_gemma":[0.01804115,0.0007388691,0.97923416,0.00011645255,0.000117821655,6.650523e-8,0.00043758252,0.00010139136,0.0003277199,0.00020060419,0.0005712817,0.000112921414],"about_ca_topic_score_codex":0.00045865536,"about_ca_topic_score_gemma":0.0008351889,"teacher_disagreement_score":0.01730094,"about_ca_system_score_codex":0.000018473685,"about_ca_system_score_gemma":0.00007448521,"threshold_uncertainty_score":0.4280355},"labels":[],"label_agreement":null},{"id":"W2894644761","doi":"10.1111/dom.13553","title":"Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ted Rogers Centre for Heart Research; University Health Network; University of Toronto; Toronto General Hospital; LMC Diabetes & Endocrinology (Canada); Heart and Stroke Foundation","funders":"Novo Nordisk","keywords":"Medicine; Semaglutide; Type 2 diabetes; Baseline (sea); Diabetes mellitus; Internal medicine; Endocrinology; Liraglutide","score_opus":0.011917956048650204,"score_gpt":0.20899184292867204,"score_spread":0.19707388688002184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894644761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99393,0.0021282455,0.00067067816,0.00011559562,0.000231205,0.0028434496,0.000046879526,0.000013472279,0.000020476722],"genre_scores_gemma":[0.9955474,0.00023281947,0.0034047898,0.0003849076,0.000113869224,0.00012629516,0.000119068056,0.000018880883,0.000051971656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988774,0.00009493771,0.00028137432,0.0002457277,0.00025179968,0.0002487609],"domain_scores_gemma":[0.9990687,0.00021329916,0.000095684976,0.00025197785,0.00029454587,0.00007583921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062176713,0.00017658444,0.00054051395,0.00009405966,0.00010203664,0.000020139329,0.00004942123,0.000055123626,0.000013826116],"category_scores_gemma":[0.00020735695,0.000110381014,0.00008302386,0.00016778067,0.00015870278,0.000080343714,0.00004979576,0.000062393745,0.000001534373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017806703,0.0025386466,0.7045637,0.00051878963,0.0046905912,0.0000022849324,0.0010466574,0.000063329164,0.00018283467,0.000723855,0.0011156668,0.266747],"study_design_scores_gemma":[0.03235404,0.0016560261,0.92726386,0.00009151121,0.0017918124,5.75224e-8,0.000025996316,0.0011923059,0.00094115234,0.00006767435,0.034438867,0.00017672895],"about_ca_topic_score_codex":0.000006615203,"about_ca_topic_score_gemma":0.0000025024885,"teacher_disagreement_score":0.26657027,"about_ca_system_score_codex":0.000015692121,"about_ca_system_score_gemma":0.000032674285,"threshold_uncertainty_score":0.4501207},"labels":[],"label_agreement":null},{"id":"W2894644940","doi":"10.1111/dom.13549","title":"Effect of selenium supplementation on changes in HbA1c: Results from a multiple‐dose, randomized controlled trial","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Selenium in Biological Systems","field":"Nursing","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Odense Universitetshospital; Kræftens Bekæmpelse","keywords":"Medicine; Selenium; Randomized controlled trial; Internal medicine","score_opus":0.011326318039326008,"score_gpt":0.26467763241626463,"score_spread":0.25335131437693864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894644940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99110115,0.00054976705,0.0000024155693,0.00024475768,0.0022631753,0.005389213,0.00017328924,0.00005230501,0.00022390594],"genre_scores_gemma":[0.99794775,0.00005319648,0.00010500776,0.0001708138,0.0010780478,0.00045527934,0.00015425292,0.000014390883,0.000021241767],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9951377,0.0029968724,0.0007759413,0.0004503837,0.0002751672,0.0003639394],"domain_scores_gemma":[0.9913419,0.007813197,0.0004488247,0.00023582879,0.000079785495,0.00008045782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040086387,0.00027872538,0.002149241,0.00018625321,0.00008804476,0.000036062585,0.0001455852,0.00022990168,0.00004171356],"category_scores_gemma":[0.0042849127,0.00018041045,0.00021872926,0.0001914419,0.00022809768,0.000077264696,0.00004042355,0.00016152041,0.000013473123],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93643856,0.0001918906,0.0053425604,0.000032932552,0.0001258447,1.9946128e-7,0.00079003687,8.987471e-7,0.05534239,0.000036371068,0.00008887681,0.0016094587],"study_design_scores_gemma":[0.72730535,0.00095625414,0.0151425395,0.00006580244,0.00024318526,4.984904e-8,0.000020327905,0.00044177278,0.2553175,0.000112150876,0.0002497674,0.00014529908],"about_ca_topic_score_codex":0.0008499001,"about_ca_topic_score_gemma":0.00026902035,"teacher_disagreement_score":0.2091332,"about_ca_system_score_codex":0.000023314853,"about_ca_system_score_gemma":0.0000065946238,"threshold_uncertainty_score":0.7356925},"labels":[],"label_agreement":null},{"id":"W2894980769","doi":"10.1111/dom.13552","title":"Personalized risk‐based screening for diabetic retinopathy: A multivariate approach versus the use of stratification rules","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Engineering and Physical Sciences Research Council; Medical Research Council Canada; Medical Research Council; National Institute for Health and Care Research","keywords":"Multivariate statistics; Confidence interval; Multivariate analysis; Diabetic retinopathy; Stratification (seeds); Risk stratification; Medicine; Diabetes mellitus; Artificial intelligence; Mathematics; Statistics; Internal medicine; Computer science","score_opus":0.07209137526660578,"score_gpt":0.2937419889729786,"score_spread":0.22165061370637282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894980769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99531287,0.0010157771,0.0023345312,0.000099323064,0.00008755289,0.00080690836,0.0002514371,0.000024398778,0.00006721454],"genre_scores_gemma":[0.9785866,0.000060056336,0.020777656,0.00008911714,0.00012209758,0.00009185876,0.00019505684,0.000015669399,0.00006187116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903345,0.00012515504,0.00019253526,0.00025644034,0.00017739841,0.00021504675],"domain_scores_gemma":[0.9989379,0.00032273604,0.00017182394,0.0002634322,0.0001955452,0.00010857814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023962141,0.00015036657,0.0003124884,0.000053610154,0.00023392407,0.000041234536,0.000062481166,0.00006308387,0.0000125277575],"category_scores_gemma":[0.00042688518,0.00009815228,0.0001459086,0.00010072753,0.00027868405,0.00009115874,0.00002002012,0.00007341641,0.0000022733077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0081868945,0.0031845607,0.8555199,0.0011799906,0.0022390636,0.000003270804,0.0026691605,0.000044517914,0.016099017,0.011725638,0.00029934107,0.09884868],"study_design_scores_gemma":[0.0055734394,0.00026230337,0.9636484,0.00006442037,0.0016878992,2.4443622e-7,0.00007788121,0.020933531,0.0057152756,0.00020981453,0.0017072225,0.00011957501],"about_ca_topic_score_codex":0.00008134465,"about_ca_topic_score_gemma":0.0000015674602,"teacher_disagreement_score":0.108128525,"about_ca_system_score_codex":0.0000071281593,"about_ca_system_score_gemma":0.000035861365,"threshold_uncertainty_score":0.40025342},"labels":[],"label_agreement":null},{"id":"W2895653157","doi":"10.1111/dom.13550","title":"Association between diabetic eye disease and other complications of diabetes: Implications for care. A systematic review","year":2018,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Bayer","keywords":"Medicine; Diabetes mellitus; Macrovascular disease; Diabetic retinopathy; Referral; Disease; Stroke (engine); Nephropathy; Intensive care medicine; Retinopathy; Type 2 diabetes; Internal medicine; Family medicine","score_opus":0.03245947634275809,"score_gpt":0.3370501022343341,"score_spread":0.30459062589157604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895653157","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040723174,0.9842779,0.000007661114,0.00016978353,0.000042750355,0.0068029193,0.0045379014,0.000036103447,0.000052688385],"genre_scores_gemma":[0.0011609308,0.9941264,0.00013702834,0.00032963447,0.00014143343,0.0026390569,0.0012757558,0.0000586159,0.00013116887],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9978411,0.00022540164,0.00087354047,0.0005068385,0.00020047731,0.0003525969],"domain_scores_gemma":[0.9970836,0.0005655715,0.00091870356,0.00066452706,0.00035670766,0.000410865],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034339947,0.00042875294,0.003359232,0.00015458089,0.00017512441,0.00003709931,0.00014680771,0.00018449774,0.0000068251443],"category_scores_gemma":[0.00070507365,0.00032102357,0.0006760852,0.00025386002,0.00011341799,0.00006245047,0.00007417085,0.00011536149,0.000012717417],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[8.6021845e-7,0.00013536414,0.11495118,0.87703776,0.0019012644,7.245936e-8,0.000022021835,1.723138e-9,3.1861924e-7,0.00020355488,0.0001287668,0.0056188423],"study_design_scores_gemma":[0.0005928231,0.00008300929,0.28596205,0.42905083,0.1448975,1.7207479e-7,0.000005336142,0.0000016275742,0.0000011487926,0.00038950352,0.13862064,0.00039535464],"about_ca_topic_score_codex":0.0000035384066,"about_ca_topic_score_gemma":6.0150666e-7,"teacher_disagreement_score":0.4479869,"about_ca_system_score_codex":0.00008324029,"about_ca_system_score_gemma":0.00013569534,"threshold_uncertainty_score":0.9999242},"labels":[],"label_agreement":null},{"id":"W2896703135","doi":"10.1111/dom.13556","title":"The relationships between markers of tubular injury and intrarenal haemodynamic function in adults with and without type 1 diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; University of Toronto; Juvenile Diabetes Research Foundation International","keywords":"Effective renal plasma flow; Medicine; Renal function; Internal medicine; Endocrinology; Tamm–Horsfall protein; Type 2 diabetes; Albuminuria; Type 1 diabetes; Lipocalin; Diabetes mellitus; Urology; Kidney; Renal blood flow","score_opus":0.012173041915362885,"score_gpt":0.22912827455064302,"score_spread":0.21695523263528013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896703135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926281,0.0059992373,1.8142077e-7,0.00025904528,0.00009369208,0.000751679,0.0001871882,0.000010961223,0.00006990213],"genre_scores_gemma":[0.9993005,0.0003242391,0.000029848323,0.00009197071,0.000105700914,0.000015395864,0.00010691338,0.000017513878,0.00000791641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982386,0.0003370846,0.0004281652,0.00037647746,0.0002414747,0.0003781938],"domain_scores_gemma":[0.99842626,0.000573212,0.00016542895,0.00038829463,0.00018835493,0.00025847295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011117511,0.00021550675,0.0005459025,0.00018636887,0.00025270422,0.00003626621,0.00010790749,0.00014254847,0.0000061412734],"category_scores_gemma":[0.0008929285,0.00013703288,0.000025694528,0.00051854405,0.0005769934,0.00015716493,0.00007320713,0.0003535815,0.0000010084138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005714674,0.000118061645,0.9937073,0.00007485175,0.00019271064,5.829556e-7,0.0013631245,8.6872734e-7,0.00011664547,0.00002867792,0.000054405125,0.0037712923],"study_design_scores_gemma":[0.0032927922,0.000767344,0.99287325,0.00045888912,0.00047888572,8.3385814e-8,0.00064099225,0.0004645632,0.00028769125,0.00041242468,0.0001740169,0.00014904047],"about_ca_topic_score_codex":0.011516805,"about_ca_topic_score_gemma":0.12992293,"teacher_disagreement_score":0.118406124,"about_ca_system_score_codex":0.00004247159,"about_ca_system_score_gemma":0.00024816053,"threshold_uncertainty_score":0.99506557},"labels":[],"label_agreement":null},{"id":"W2897347858","doi":"10.1111/dom.13412","title":"Implementing personalized medicine in diabetic kidney disease: Stakeholders' perspectives","year":2018,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Innovative Medicines Initiative; European Commission; European Federation of Pharmaceutical Industries and Associations","keywords":"Personalized medicine; Medicine; Precision medicine; Intensive care medicine; Disease; Alternative medicine; Health care; Clinical Practice; Diabetes mellitus; MEDLINE; Family medicine; Bioinformatics; Pathology","score_opus":0.04989399605290109,"score_gpt":0.3150990897770885,"score_spread":0.26520509372418744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897347858","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00580959,0.98889667,0.000002977621,0.00042961328,0.00032532233,0.0022119116,0.00015102387,0.00011435573,0.0020585405],"genre_scores_gemma":[0.00061026955,0.9934886,0.00017358239,0.00049524277,0.0008097748,0.00036518805,0.0008500228,0.00010109799,0.003106239],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959985,0.00028384055,0.0008169196,0.0011423526,0.0005267713,0.0012316251],"domain_scores_gemma":[0.9978259,0.000174976,0.00035829254,0.0006607009,0.00011776669,0.00086236704],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010423358,0.00088929903,0.003485061,0.0008717305,0.00021831243,0.00007462729,0.00024087795,0.00022783101,0.00072630093],"category_scores_gemma":[0.0004671279,0.0006678816,0.0005651589,0.000656019,0.00058743666,0.00018519883,0.00033842665,0.00041527755,0.00006210261],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051541596,0.0017573384,0.017112149,0.081234805,0.0045315456,0.00018534332,0.0032313976,2.5262413e-8,0.0000049137902,0.010002237,0.015400389,0.86648834],"study_design_scores_gemma":[0.0027438523,0.000102440565,0.0072644595,0.015880637,0.01002247,0.0000012865637,0.00039481645,0.0000062914824,0.0000014575877,0.00023321455,0.9627931,0.00055594457],"about_ca_topic_score_codex":0.00003462716,"about_ca_topic_score_gemma":0.000006984794,"teacher_disagreement_score":0.94739276,"about_ca_system_score_codex":0.0001579215,"about_ca_system_score_gemma":0.00025701473,"threshold_uncertainty_score":0.9995772},"labels":[],"label_agreement":null},{"id":"W2898326314","doi":"10.1111/dom.13565","title":"Day‐to‐day fasting self‐monitored blood glucose variability is associated with risk of hypoglycaemia in insulin‐treated patients with type 1 and type 2 diabetes: A post hoc analysis of the SWITCH Trials","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; European Foundation for the Study of Diabetes; American Diabetes Association; Novo Nordisk; Australian Diabetes Society; National Institute for Health and Care Research","keywords":"Medicine; Insulin degludec; Insulin glargine; Type 2 diabetes; Internal medicine; Population; Intermittent fasting; Post-hoc analysis; Endocrinology; Diabetes mellitus","score_opus":0.01045146279439519,"score_gpt":0.2432358781708654,"score_spread":0.2327844153764702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898326314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977912,0.00062088436,0.0000014752035,0.00005439441,0.00008544794,0.001130778,0.00019229611,0.00002962149,0.000093918905],"genre_scores_gemma":[0.99929225,0.00015246615,0.00022632362,0.00010684075,0.000049892384,0.000015088371,0.00008561095,0.000024615354,0.000046886536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969054,0.00093002454,0.0006017542,0.0004966226,0.0005854394,0.00048074557],"domain_scores_gemma":[0.99633104,0.0010594843,0.0005005463,0.00052557973,0.0013925981,0.00019073501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036213743,0.00028972237,0.0014916394,0.0005417448,0.00014197067,0.00003902543,0.00019570763,0.00016782209,0.000029416258],"category_scores_gemma":[0.0056680804,0.00016858995,0.00011062301,0.0040956535,0.00030456312,0.00012778695,0.0002157444,0.00026855833,0.0000014471381],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003794588,0.0010668533,0.98670745,0.00013667815,0.0048746094,8.1364016e-7,0.0011126397,0.0000043590985,0.0024004432,0.0000066231323,0.000014161317,0.0032959406],"study_design_scores_gemma":[0.004519723,0.001206436,0.9745579,0.00028567237,0.00949522,1.7753319e-8,0.000055176046,0.00048268706,0.009138398,0.000022865073,0.00004582265,0.00019011853],"about_ca_topic_score_codex":0.00008802735,"about_ca_topic_score_gemma":0.000113120834,"teacher_disagreement_score":0.012149557,"about_ca_system_score_codex":0.000028554457,"about_ca_system_score_gemma":0.000117082935,"threshold_uncertainty_score":0.68748987},"labels":[],"label_agreement":null},{"id":"W2899757702","doi":"10.1111/dom.13578","title":"Hypoglycaemia as a function of HbA1c in type 2 diabetes: Insulin glargine 300 U/mL in a patient‐level pooled analysis of EDITION 1, 2 and 3","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Sanofi","keywords":"Insulin glargine; Medicine; Type 2 diabetes; Insulin; Internal medicine; Diabetes mellitus; Endocrinology","score_opus":0.013394377525270841,"score_gpt":0.2520523750613682,"score_spread":0.23865799753609734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899757702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486476,0.00391121,0.00000772265,0.00012325238,0.00015561367,0.00038198283,0.0000352825,0.000013455282,0.0005067187],"genre_scores_gemma":[0.9987947,0.0004943068,0.00014045661,0.0001979581,0.00009080194,0.00001698059,0.00012348221,0.000012555672,0.00012880759],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984456,0.00011483807,0.00043155788,0.00032154948,0.00033865112,0.00034784357],"domain_scores_gemma":[0.9991708,0.00010014518,0.00014626455,0.00023074939,0.00023991366,0.00011214805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006317488,0.0001675962,0.0007766329,0.0014042587,0.00003754513,0.000015422831,0.00007113198,0.00013973411,0.00013105976],"category_scores_gemma":[0.000333247,0.0001474527,0.0000858592,0.002069405,0.00024325922,0.00018671839,0.000118306336,0.00018058685,0.0000057667175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003377768,0.0008713341,0.88892794,0.0005069294,0.0012548489,0.000004869144,0.0008173617,0.000007808828,0.019417413,0.00048488047,0.00014531905,0.087223545],"study_design_scores_gemma":[0.0021203705,0.0004926672,0.98590773,0.00015859457,0.0014621317,5.826059e-8,0.00012041475,0.0019198587,0.006039378,0.0006259819,0.0010196468,0.00013317804],"about_ca_topic_score_codex":0.000102580336,"about_ca_topic_score_gemma":0.000113143295,"teacher_disagreement_score":0.09697981,"about_ca_system_score_codex":0.000020575717,"about_ca_system_score_gemma":0.00004225085,"threshold_uncertainty_score":0.60129464},"labels":[],"label_agreement":null},{"id":"W2900447792","doi":"10.1111/dom.13573","title":"CANadian CAnagliflozin REgistry: Effectiveness and safety of canagliflozin in the treatment of type 2 diabetes mellitus in Canadian clinical practice","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada); Mount Sinai Hospital; University of Waterloo; McGill University Health Centre; University of British Columbia; Diabetes Canada; University of Toronto; University of Manitoba","funders":"Mitsubishi Tanabe Pharma Corporation; European Foundation for the Study of Diabetes; Diabetes Canada; Janssen Research and Development; American Diabetes Association","keywords":"Canagliflozin; Medicine; Glycated hemoglobin; Clinical endpoint; Type 2 Diabetes Mellitus; Regimen; Internal medicine; Weight loss; Diabetes mellitus; Adverse effect; Type 2 diabetes; Body mass index; Blood pressure; Renal function; Weight change; Surgery; Endocrinology; Clinical trial; Obesity","score_opus":0.012931836768372841,"score_gpt":0.2841871140611043,"score_spread":0.27125527729273147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900447792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824577,0.012045362,2.1765365e-7,0.0011346597,0.0002642086,0.0010717993,0.00008161999,0.00000693225,0.0029374838],"genre_scores_gemma":[0.9940614,0.0048706173,0.0001800175,0.00061043154,0.00010964946,0.000040971107,0.000048207872,0.000017005339,0.000061659695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977872,0.00044352066,0.0005007587,0.00039347642,0.00020190381,0.0006731734],"domain_scores_gemma":[0.9982034,0.0005591703,0.00014367378,0.00044647534,0.000165358,0.00048193472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001632579,0.0002568551,0.00085635216,0.00046191073,0.00009097597,0.00002294679,0.00013582232,0.000162274,0.000018607234],"category_scores_gemma":[0.00047658978,0.00019177499,0.00007822045,0.0005914261,0.00033672783,0.00012735353,0.000025573618,0.00014034855,0.0000032849584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010865579,0.0005038819,0.9618491,0.00016980406,0.00035874476,0.000042002706,0.0009373037,0.000001393554,0.00003961297,0.0017916255,0.0001430426,0.034054838],"study_design_scores_gemma":[0.002295808,0.00068451697,0.8737331,0.00014942946,0.00056159863,9.562567e-7,0.00026297878,0.000066671426,0.00051661074,0.00013225069,0.12144841,0.00014765834],"about_ca_topic_score_codex":0.89615417,"about_ca_topic_score_gemma":0.9636694,"teacher_disagreement_score":0.12130537,"about_ca_system_score_codex":0.00030275105,"about_ca_system_score_gemma":0.0007197115,"threshold_uncertainty_score":0.7820357},"labels":[],"label_agreement":null},{"id":"W2900763157","doi":"10.1111/dom.13580","title":"Insulin glargine/lixisenatide fixed‐ratio combination improves glycaemic variability and control without increasing hypoglycaemia","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Sanofi","keywords":"Lixisenatide; Insulin glargine; Medicine; Internal medicine; Hypoglycemia; Endocrinology; Glycated haemoglobin; Basal insulin; Type 2 diabetes; Diabetes mellitus; Exenatide","score_opus":0.007540714160374208,"score_gpt":0.24378613251231127,"score_spread":0.23624541835193705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900763157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427325,0.001275817,0.0003639205,0.0008351799,0.00024483868,0.00092580623,0.000018747114,0.00011120843,0.0019512192],"genre_scores_gemma":[0.9967134,0.0001762187,0.0012110131,0.000826221,0.0004237572,0.000038216258,0.000049070655,0.000027635942,0.0005344454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978984,0.00030585032,0.00034425923,0.00052981905,0.00038837802,0.0005333162],"domain_scores_gemma":[0.9985861,0.00030771643,0.000123346,0.00036080673,0.00032185542,0.00030016925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019602661,0.00027697944,0.0006256239,0.00024165961,0.0003342836,0.00015281561,0.000121990386,0.00017340605,0.000041877833],"category_scores_gemma":[0.0011258654,0.00023285067,0.0000727168,0.0002887022,0.0005654247,0.00038907438,0.00016863862,0.00031224187,0.000018110379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000365718,0.0005397306,0.83030826,0.00051831984,0.00033538142,0.000004756877,0.00039445751,3.3187854e-7,0.11937702,0.0046159555,0.00025225896,0.0432878],"study_design_scores_gemma":[0.0060622315,0.0002490948,0.96812683,0.00009446517,0.00041636315,0.0000023916903,0.00004437355,0.007100131,0.010426911,0.0030247283,0.0041681477,0.00028433054],"about_ca_topic_score_codex":0.00005798786,"about_ca_topic_score_gemma":0.0000073122637,"teacher_disagreement_score":0.13781856,"about_ca_system_score_codex":0.000035276902,"about_ca_system_score_gemma":0.00006471225,"threshold_uncertainty_score":0.94953746},"labels":[],"label_agreement":null},{"id":"W2901294588","doi":"10.1111/dom.13588","title":"Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real‐world studies","year":2018,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"NIHR Leicester Biomedical Research Centre; Novo Nordisk; National Institute for Health and Care Research","keywords":"Medicine; Real world data; Real world evidence; Internal medicine; Data science","score_opus":0.09797833499607542,"score_gpt":0.4307543182501102,"score_spread":0.3327759832540348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901294588","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25229853,0.7395093,4.7603524e-7,0.0001746236,0.0004150509,0.0064410814,0.00010955158,0.00004216083,0.0010092607],"genre_scores_gemma":[0.072353646,0.92149377,0.00006592082,0.00031180755,0.000664223,0.00043459397,0.00005652488,0.00008883884,0.0045306906],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99535125,0.00097097363,0.00082378753,0.00082946726,0.0011735446,0.00085096486],"domain_scores_gemma":[0.99701196,0.00033667037,0.0004562029,0.0015791649,0.00038757248,0.00022840624],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025780522,0.0007102239,0.0037322647,0.00024869636,0.00060366624,0.00011530149,0.0009844708,0.000115177645,0.000025427726],"category_scores_gemma":[0.0002832849,0.00031022506,0.0003586991,0.0018415442,0.00045478554,0.00010208722,0.0019187711,0.000668348,0.000035382986],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000628353,0.0076787597,0.8594951,0.0100892605,0.008867401,0.000017603392,0.0024888583,5.909279e-7,3.0071467e-7,0.00036418077,0.012438829,0.098496266],"study_design_scores_gemma":[0.0013398987,0.0007397388,0.21965043,0.0029021,0.010229235,3.601243e-7,0.0025678403,0.000003031416,0.000004086117,0.000020236945,0.7622123,0.00033075397],"about_ca_topic_score_codex":0.00005942112,"about_ca_topic_score_gemma":0.0010174578,"teacher_disagreement_score":0.74977344,"about_ca_system_score_codex":0.000060079892,"about_ca_system_score_gemma":0.00015770092,"threshold_uncertainty_score":0.999935},"labels":[],"label_agreement":null},{"id":"W2901474773","doi":"10.1111/dom.13595","title":"Identification of autoimmune type 1 diabetes and multiple organ‐specific autoantibodies in adult‐onset non‐insulin‐requiring diabetes in China: A population‐based multicentre nationwide survey","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"National Natural Science Foundation of China","keywords":"Autoantibody; Medicine; Internal medicine; Type 1 diabetes; Diabetes mellitus; Odds ratio; Population; Glutamate decarboxylase; Immunology; Endocrinology; Antibody; Biology","score_opus":0.005816497401431077,"score_gpt":0.22151566020856475,"score_spread":0.21569916280713367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901474773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956145,0.0030801753,0.0000049957234,0.000053449057,0.00020174362,0.00031874972,0.0007028928,0.000016248023,0.0000072008916],"genre_scores_gemma":[0.9967257,0.0006172833,0.00012323534,0.00008990106,0.000044781642,0.000013719828,0.0023470507,0.000023401666,0.000014967688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981949,0.00021179768,0.0005326814,0.0004655888,0.00015763399,0.0004374507],"domain_scores_gemma":[0.9990397,0.0001109776,0.00025733045,0.0002741954,0.000248039,0.0000697769],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007455721,0.0002494464,0.00043990047,0.00025138207,0.0001388611,0.00006331365,0.0001621364,0.00020464872,0.0000075359208],"category_scores_gemma":[0.0010074972,0.00025901577,0.00005576779,0.00046620978,0.00017857314,0.000042617638,0.00011608472,0.00012261973,0.000002836798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019052559,0.0001891023,0.85575384,0.00006765121,0.00004033387,1.3490019e-7,0.00014503002,0.00005753979,0.14279774,0.00000882869,0.000054405362,0.0008663107],"study_design_scores_gemma":[0.0013969745,0.00004591089,0.9023687,0.00007111306,0.000027222084,2.6617604e-8,0.00005011811,0.0054346872,0.09016796,0.0000666363,0.00011490615,0.00025569505],"about_ca_topic_score_codex":0.00033601787,"about_ca_topic_score_gemma":0.0011760398,"teacher_disagreement_score":0.052629784,"about_ca_system_score_codex":0.000014541533,"about_ca_system_score_gemma":0.000036107802,"threshold_uncertainty_score":0.99998623},"labels":[],"label_agreement":null},{"id":"W2904088434","doi":"10.1111/dom.13603","title":"Adherence, persistence, glycaemic control and costs among patients with type 2 diabetes initiating dulaglutide compared with liraglutide or exenatide once weekly at 12‐month follow‐up in a real‐world setting in the United States","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Exenatide; Dulaglutide; Liraglutide; Medicine; Discontinuation; Type 2 diabetes; Internal medicine; Endocrinology; Diabetes mellitus","score_opus":0.014719400181179777,"score_gpt":0.22701795383515339,"score_spread":0.2122985536539736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904088434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99647385,0.00048471545,0.0000017610437,0.00019788717,0.00008765151,0.0016030562,0.00004325606,0.000062074236,0.0010457485],"genre_scores_gemma":[0.99710387,0.00020098157,0.00042781938,0.0013173352,0.000056270856,0.00013023044,0.00030424455,0.000036989575,0.0004222858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975015,0.000265481,0.0004378186,0.0005638744,0.0004383502,0.0007930018],"domain_scores_gemma":[0.99842113,0.0005601779,0.00026933113,0.00034018623,0.0002200275,0.00018913907],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005933013,0.00043439894,0.00081734307,0.00052431144,0.0002922588,0.00011316527,0.00017620334,0.00007616942,0.000017763601],"category_scores_gemma":[0.00016901443,0.00026376394,0.00004633494,0.0010843936,0.00042188895,0.00035737694,0.0001222991,0.00027112727,0.0000039785054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006546648,0.00029120446,0.99416935,0.0001242183,0.00026392034,0.00002565983,0.0023418004,0.000011660668,0.00006661721,0.00004476531,0.00019600215,0.001810131],"study_design_scores_gemma":[0.012137591,0.001019836,0.9802919,0.0011261554,0.00058898696,5.0133036e-7,0.0011881134,0.002185128,0.00022818992,0.000028043176,0.0008499583,0.0003556209],"about_ca_topic_score_codex":0.0010545213,"about_ca_topic_score_gemma":0.011758856,"teacher_disagreement_score":0.013877479,"about_ca_system_score_codex":0.00015634595,"about_ca_system_score_gemma":0.000059728773,"threshold_uncertainty_score":0.99998146},"labels":[],"label_agreement":null},{"id":"W2905361067","doi":"10.1111/dom.13613","title":"The effects of incretin‐based therapies on β‐cell function and insulin resistance in type 2 diabetes: A systematic review and network meta‐analysis combining 360 trials","year":2018,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"China Scholarship Council; Cambridge Trust; National Natural Science Foundation of China; National Institute for Health and Care Research","keywords":"Medicine; Incretin; Insulin resistance; Type 2 diabetes; Internal medicine; Placebo; Meta-analysis; Subgroup analysis; Cochrane Library; Lixisenatide; Insulin; Randomized controlled trial; Diabetes mellitus; Confidence interval; Sitagliptin; Exenatide; Gastroenterology; Endocrinology; Pathology","score_opus":0.034934140937823266,"score_gpt":0.2901301820123201,"score_spread":0.25519604107449684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905361067","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031630856,0.9914487,0.0000019412457,0.00005811861,0.00016929331,0.0050249933,0.000018406952,0.000027868216,0.00008758189],"genre_scores_gemma":[0.002256942,0.99589634,0.000117229865,0.0005498655,0.000069726804,0.00074798375,0.0000890426,0.000038427097,0.00023445586],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9950722,0.0023407824,0.0012902198,0.0005679109,0.00030851946,0.00042037218],"domain_scores_gemma":[0.99322516,0.004700337,0.0011907445,0.00064445205,0.000112030175,0.00012727648],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0051994184,0.0006171634,0.010003415,0.00036662634,0.00017499876,0.0000809426,0.00014431887,0.00021294631,0.0000098477485],"category_scores_gemma":[0.0011641433,0.00033779972,0.0008972006,0.0010865126,0.00019584465,0.00006812313,0.00010127406,0.00025864187,0.0000037848436],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032820397,0.00018320291,0.00029585787,0.91848004,0.07412792,0.0000018705799,0.000058766178,1.1686104e-7,6.9028334e-7,0.00035953187,0.00021031855,0.0062488485],"study_design_scores_gemma":[0.0012353753,0.0003549896,0.001249029,0.13107122,0.82105815,6.547768e-8,0.000009654721,0.000007263774,0.0000064320666,0.00025034795,0.04442321,0.0003342804],"about_ca_topic_score_codex":0.00000502254,"about_ca_topic_score_gemma":0.000018277451,"teacher_disagreement_score":0.7874088,"about_ca_system_score_codex":0.000023818564,"about_ca_system_score_gemma":0.000047533846,"threshold_uncertainty_score":0.9999074},"labels":[],"label_agreement":null},{"id":"W2905455723","doi":"10.1111/dom.13617","title":"Stability of insulin and C‐peptide measurement with long‐term frozen storage of serum: Implications for diabetes research studies","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Concordance; Insulin; Analyte; Reproducibility; Diabetes mellitus; C-peptide; Peptide; Concordance correlation coefficient; Confidence interval; Internal medicine; Medicine; Chemistry; Endocrinology; Chromatography; Biochemistry; Mathematics; Statistics","score_opus":0.12108253350561021,"score_gpt":0.3616008749532017,"score_spread":0.2405183414475915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905455723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98690665,0.0103976615,0.00003193628,0.0008126083,0.000050496343,0.0014212193,0.00010911299,0.000021791462,0.00024851292],"genre_scores_gemma":[0.99812067,0.00070689013,0.0007249438,0.0000640211,0.00010755474,0.0001297549,0.00001277196,0.000020797983,0.000112581285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979596,0.00017221722,0.0003543602,0.00041848436,0.0005730941,0.0005222596],"domain_scores_gemma":[0.9967766,0.000321531,0.00012617347,0.0004813736,0.0021122177,0.00018212464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033232467,0.00018377042,0.00070927496,0.0002908566,0.00023445034,0.000026189236,0.00015379002,0.00007830134,0.000019636222],"category_scores_gemma":[0.0006853368,0.00013307622,0.00007034727,0.0004188133,0.001471049,0.00015238357,0.00026097213,0.000177445,0.0000013949626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094567404,0.00046964866,0.9544415,0.0024411392,0.0007109545,2.7729573e-7,0.00069757254,1.393206e-7,0.022006398,0.0006373569,0.00022903451,0.018271435],"study_design_scores_gemma":[0.0017160143,0.0007139639,0.9365387,0.00028874126,0.00033149545,7.511345e-8,0.00020308568,0.000027684686,0.058315396,0.0011273947,0.0006141033,0.0001233728],"about_ca_topic_score_codex":0.0000097676175,"about_ca_topic_score_gemma":0.00005862415,"teacher_disagreement_score":0.036308996,"about_ca_system_score_codex":0.000034565655,"about_ca_system_score_gemma":0.00008858372,"threshold_uncertainty_score":0.5426691},"labels":[],"label_agreement":null},{"id":"W2911886982","doi":"10.1111/dom.13666","title":"Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add‐on to sodium‐glucose co‐transporter‐2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Novo Nordisk","keywords":"Medicine; Insulin glargine; Type 2 diabetes; Liraglutide; Insulin; Clinical endpoint; Internal medicine; Adverse effect; Diabetes mellitus; Gastroenterology; Hazard ratio; Randomized controlled trial; Confidence interval; Endocrinology","score_opus":0.014451675164902306,"score_gpt":0.2782371434809578,"score_spread":0.2637854683160555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911886982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863709,0.004552842,0.0000021079256,0.00034855184,0.0011477462,0.0069044945,0.000038087892,0.00008440463,0.00055086403],"genre_scores_gemma":[0.9956104,0.0019377978,0.00031253102,0.0009708724,0.00037386856,0.00029721623,0.00017891549,0.00006298648,0.00025539537],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962554,0.0005077132,0.0011486245,0.000792939,0.0005799261,0.0007153841],"domain_scores_gemma":[0.9969969,0.001498791,0.00028315876,0.00064016954,0.00017761298,0.00040336477],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020687648,0.00056885846,0.0032103136,0.00048479013,0.000066119355,0.000053029948,0.00021282818,0.0002527576,0.0002230908],"category_scores_gemma":[0.0007498544,0.00040318177,0.00046533323,0.00066678907,0.0002006001,0.00017785894,0.000066907276,0.00037588185,0.00011975893],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8383845,0.004700161,0.1294372,0.00016064837,0.001848461,0.000017786351,0.0007244141,0.000016709313,0.0018044501,0.00029368847,0.00009394722,0.02251802],"study_design_scores_gemma":[0.7504256,0.0056513734,0.22937538,0.00024810687,0.0009965806,1.4177563e-7,0.000055914206,0.000093332936,0.00759255,0.0000315913,0.005146799,0.00038263967],"about_ca_topic_score_codex":0.00008570497,"about_ca_topic_score_gemma":0.00006942727,"teacher_disagreement_score":0.09993819,"about_ca_system_score_codex":0.000048440736,"about_ca_system_score_gemma":0.00020222056,"threshold_uncertainty_score":0.999842},"labels":[],"label_agreement":null},{"id":"W2912391401","doi":"10.1111/dom.13656","title":"Association between allopurinol and cardiovascular outcomes and all‐cause mortality in diabetes: A retrospective, population‐based cohort study","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Institute for Clinical Evaluative Sciences; Women's College Hospital","funders":"Department of Medicine, University of Toronto; Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Allopurinol; Hazard ratio; Interquartile range; Internal medicine; Proportional hazards model; Population; Retrospective cohort study; Diabetes mellitus; Cumulative incidence; Myocardial infarction; Stroke (engine); Cohort; Surgery; Confidence interval; Endocrinology","score_opus":0.01298370599253307,"score_gpt":0.251498737171857,"score_spread":0.23851503117932393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912391401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954512,0.0020890913,0.0000024964365,0.00013342916,0.00013063668,0.0019665183,0.00005083239,0.00007566624,0.00010011786],"genre_scores_gemma":[0.9990476,0.00018654925,0.00012477687,0.00024948482,0.00008947449,0.00007239835,0.000081457685,0.00003086422,0.00011741614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973722,0.00027126347,0.0004252591,0.0007203226,0.0007358001,0.00047515982],"domain_scores_gemma":[0.9987793,0.00018042568,0.00015653583,0.00057289476,0.00010063249,0.00021020141],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016772308,0.00032453897,0.0014741733,0.0002353684,0.000094753916,0.000065467444,0.00008003171,0.0002369306,0.000012413197],"category_scores_gemma":[0.00041028985,0.0002954107,0.0001529166,0.0002792828,0.000041743762,0.0002771023,0.00012562885,0.0003688369,0.0000105558565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000044408644,0.00022990498,0.99368167,0.00011215363,0.0053958045,0.0000049730234,0.00022890036,0.0000036716137,0.00008783938,0.000015301273,0.000009683655,0.00022563021],"study_design_scores_gemma":[0.0036540318,0.00008031793,0.98939663,0.00003480705,0.005999494,3.4706136e-7,0.000078125784,0.00009933946,0.00011732821,0.000093135466,0.00015228304,0.00029413067],"about_ca_topic_score_codex":0.0008934667,"about_ca_topic_score_gemma":0.00006230432,"teacher_disagreement_score":0.0042850366,"about_ca_system_score_codex":0.00013125407,"about_ca_system_score_gemma":0.000028605667,"threshold_uncertainty_score":0.9999498},"labels":[],"label_agreement":null},{"id":"W2912733453","doi":"10.1111/dom.13649","title":"Generalizability of glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Eli Lilly and Company","keywords":"Population; Medicine; Generalizability theory; Clinical trial; Type 2 diabetes; Internal medicine; Myocardial infarction; Population study; Diabetes mellitus; Demography; Endocrinology; Statistics; Environmental health","score_opus":0.027593446234962127,"score_gpt":0.2704935831468206,"score_spread":0.24290013691185847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912733453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917515,0.004194018,0.000003991698,0.0012880006,0.0005444404,0.0020046895,0.00005081532,0.000031421587,0.00013112758],"genre_scores_gemma":[0.995248,0.00058177084,0.00024881764,0.0026834824,0.00013624295,0.000080415484,0.00059424416,0.000020982598,0.0004059985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738425,0.0007703838,0.0006174622,0.00037673858,0.0004536699,0.00039751935],"domain_scores_gemma":[0.9984778,0.00033867845,0.00016020917,0.00079820555,0.00012763505,0.00009743818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039677266,0.00026501442,0.0011524685,0.00021481716,0.00009722075,0.00006684496,0.00021407985,0.00009020975,0.000075573385],"category_scores_gemma":[0.0003853293,0.00014831818,0.00037306247,0.00057438127,0.000065092834,0.00011848066,0.00011402508,0.00015486215,0.00003901664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054088912,0.000307178,0.9910158,0.00027234704,0.0008704139,7.600185e-7,0.0008485022,0.00049244746,0.00070573424,0.0008795477,0.0013304228,0.0032227407],"study_design_scores_gemma":[0.001629813,0.00014468138,0.85279506,0.000045950324,0.0009733665,9.681021e-8,0.00015483082,0.00022793343,0.0009765828,0.00028702253,0.142598,0.00016665814],"about_ca_topic_score_codex":0.0007101541,"about_ca_topic_score_gemma":0.000029355459,"teacher_disagreement_score":0.14126758,"about_ca_system_score_codex":0.00004150237,"about_ca_system_score_gemma":0.000017725746,"threshold_uncertainty_score":0.604824},"labels":[],"label_agreement":null},{"id":"W2913495096","doi":"10.1111/dom.13665","title":"Association between uric acid, renal haemodynamics and arterial stiffness over the natural history of type 1 diabetes","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Lunenfeld-Tanenbaum Research Institute; Health Sciences Centre; Mount Sinai Hospital; Sunnybrook Health Science Centre; University Health Network; Toronto General Hospital; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Juvenile Diabetes Research Foundation Canada","keywords":"Internal medicine; Arterial stiffness; Effective renal plasma flow; Medicine; Pulse wave velocity; Aldosterone; Renal function; Cardiology; Plasma renin activity; Hemodynamics; Uric acid; Diabetes mellitus; Endocrinology; Renin–angiotensin system; Renal blood flow; Blood pressure","score_opus":0.006673999725667458,"score_gpt":0.2039932729642124,"score_spread":0.19731927323854495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913495096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98714393,0.010749628,0.0000017525364,0.00021110929,0.001276872,0.0003373129,0.000036168276,0.00003351762,0.00020968019],"genre_scores_gemma":[0.9973508,0.00020841906,0.00008596535,0.00033463305,0.000433661,0.000006031155,0.00007118412,0.000021370954,0.0014879172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864167,0.00010779877,0.00026540976,0.00028549842,0.00036459442,0.00033505377],"domain_scores_gemma":[0.9990082,0.00022334674,0.00023374775,0.00029423056,0.0001363084,0.00010417231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045066897,0.00020290307,0.00060935976,0.000119744116,0.000059906302,0.000021401913,0.00011212087,0.00020387357,0.0000712421],"category_scores_gemma":[0.00024687982,0.00014935635,0.000081975035,0.00017921496,0.00012387514,0.00018529677,0.00010883808,0.00034170313,0.000013231781],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004388355,0.00008094198,0.9059612,0.00020816729,0.00060856587,9.715649e-7,0.0007354176,8.8217797e-7,0.0865277,0.00019402138,0.0011031901,0.0045350413],"study_design_scores_gemma":[0.001491304,0.00004117673,0.98184615,0.000044977092,0.0010232582,7.7119404e-7,0.000021791924,0.0005141328,0.0018360425,0.00016945838,0.01284237,0.00016858503],"about_ca_topic_score_codex":0.000022446106,"about_ca_topic_score_gemma":0.0000019791385,"teacher_disagreement_score":0.08469166,"about_ca_system_score_codex":0.00014140706,"about_ca_system_score_gemma":0.00009674903,"threshold_uncertainty_score":0.6090575},"labels":[],"label_agreement":null},{"id":"W2913976280","doi":"10.1111/dom.13661","title":"Intranasal glucagon acutely increases energy expenditure without inducing hyperglycaemia in overweight/obese adults","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Regulation of Appetite and Obesity","field":"Neuroscience","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Diabetes Canada; University of Toronto","funders":"Banting and Best Diabetes Centre, University of Toronto","keywords":"Overweight; Medicine; Resting energy expenditure; Crossover study; Appetite; Internal medicine; Endocrinology; Glucagon; Placebo; Nasal administration; Insulin; Adverse effect; Energy expenditure; Obesity; Pharmacology","score_opus":0.007308227490843986,"score_gpt":0.21075641737255282,"score_spread":0.20344818988170885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913976280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99692196,0.0009701561,0.000010327082,0.000114136135,0.00039847274,0.00023996465,0.000028969613,0.00008627911,0.0012297174],"genre_scores_gemma":[0.99713445,0.0008681277,0.00012992069,0.0012097997,0.00023980287,0.000015855885,0.000020367856,0.00002751684,0.00035416716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778765,0.00022215296,0.00032595856,0.0007408277,0.00038295213,0.0005404279],"domain_scores_gemma":[0.99901456,0.00019889565,0.00013604513,0.00039816415,0.000036724556,0.00021560266],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023590274,0.00031979647,0.0005356869,0.00025762053,0.00015984749,0.00011341188,0.0003067618,0.00023247868,0.00017600913],"category_scores_gemma":[0.00014594205,0.00028675704,0.00009658547,0.00032414144,0.00012103738,0.00076416886,0.00017172997,0.0002976042,0.000058426333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002155938,0.0006441055,0.6299136,0.00014490847,0.000026796972,0.000031459636,0.0011042448,0.000059078302,0.34653234,0.01312813,0.00022112126,0.007978564],"study_design_scores_gemma":[0.0015153635,0.000049033286,0.55232626,0.00013608817,0.000024790115,0.000005338098,0.00006772338,0.0005952601,0.43098092,0.0008700886,0.013043121,0.0003860203],"about_ca_topic_score_codex":0.00048571016,"about_ca_topic_score_gemma":0.00011498858,"teacher_disagreement_score":0.08444859,"about_ca_system_score_codex":0.000027954846,"about_ca_system_score_gemma":0.00005023767,"threshold_uncertainty_score":0.99995846},"labels":[],"label_agreement":null},{"id":"W2914178425","doi":"10.1111/dom.13644","title":"Dimorphic autoantigenic and protective effects of Reg2 peptide in the treatment of diabetic β‐cell loss","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Natural Sciences and Engineering Research Council of Canada; National Natural Science Foundation of China; Canadian Diabetes Association","keywords":"Medicine; Islet; Internal medicine; Endocrinology; Diabetes mellitus; Antibody; CD8; Streptozocin; Streptozotocin; Insulin; Immune system; Immunology","score_opus":0.0052837459271437865,"score_gpt":0.204439386754619,"score_spread":0.19915564082747522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914178425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854094,0.012640128,0.0000025730462,0.000087238535,0.00009877782,0.001225501,0.000007744162,0.00001217694,0.0005164777],"genre_scores_gemma":[0.9982903,0.0011208327,0.0001011449,0.00011446487,0.00003383616,0.00006692,0.000005702774,0.0000101361065,0.00025669023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900573,0.00014205235,0.00022641936,0.00022953357,0.00017195095,0.00022433445],"domain_scores_gemma":[0.999075,0.00041457888,0.00011215395,0.00027662812,0.000048526734,0.00007312043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023171885,0.00017037937,0.0006600988,0.00013598274,0.00003191309,0.000007987738,0.00005145596,0.00008269262,0.000021191094],"category_scores_gemma":[0.00009641926,0.00010748209,0.00009440896,0.0002057917,0.00015716637,0.000058785958,0.000018617317,0.00009255207,0.0000069471516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060519986,0.0010964363,0.9039343,0.0013929731,0.0001351895,0.0000051050174,0.0025728883,0.000001461749,0.08794659,0.00037148534,0.000015208039,0.0024678342],"study_design_scores_gemma":[0.0029811503,0.0006582382,0.806914,0.0001523474,0.00030409024,0.0000012308845,0.00011302937,0.00007040143,0.18785521,0.0004025651,0.00046192738,0.00008583555],"about_ca_topic_score_codex":0.00007178385,"about_ca_topic_score_gemma":0.000002260203,"teacher_disagreement_score":0.099908635,"about_ca_system_score_codex":0.000013727462,"about_ca_system_score_gemma":0.00003572165,"threshold_uncertainty_score":0.43829924},"labels":[],"label_agreement":null},{"id":"W2914902752","doi":"10.1111/dom.13642","title":"Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. John’s Health Sciences Centre","funders":"Amgen","keywords":"Medicine; Metformin; Type 2 diabetes; Kidney disease; Internal medicine; Diabetes mellitus; Disease; Endocrinology","score_opus":0.005217562185070648,"score_gpt":0.18397353790726192,"score_spread":0.17875597572219126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914902752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98386407,0.014816544,5.5363387e-7,0.00004506616,0.00012138505,0.0010298378,0.000024974388,0.000029916704,0.000067626104],"genre_scores_gemma":[0.9976116,0.0013563465,0.00013738444,0.00035765313,0.00003823602,0.000032348576,0.0001338955,0.000025619891,0.00030692676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867606,0.000052319854,0.00015818187,0.00044514396,0.0002663918,0.0004019271],"domain_scores_gemma":[0.99909973,0.000037013204,0.000042806536,0.00035064755,0.00006167251,0.0004081177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020705361,0.00025629852,0.0006062634,0.00017705749,0.000054907116,0.000039832954,0.000046633766,0.00006126721,0.000025991256],"category_scores_gemma":[0.00007009993,0.00019349476,0.00007075723,0.00018225909,0.00007296963,0.00043067322,0.00012637323,0.000105105486,0.000011158714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005281549,0.00023978838,0.99097246,0.0003890421,0.00066532893,0.000003301419,0.00005418067,0.0000017768753,0.000037895443,0.000111797235,0.000045053213,0.0074265697],"study_design_scores_gemma":[0.0058984226,0.00023647735,0.98198646,0.0002173003,0.0012170137,8.988098e-8,0.000009238848,0.000075059164,0.00018916588,0.00008172848,0.009863688,0.00022533035],"about_ca_topic_score_codex":0.000015748858,"about_ca_topic_score_gemma":0.000002919613,"teacher_disagreement_score":0.013747493,"about_ca_system_score_codex":0.000027485316,"about_ca_system_score_gemma":0.000040382223,"threshold_uncertainty_score":0.78904873},"labels":[],"label_agreement":null},{"id":"W2915555967","doi":"10.1111/dom.13677","title":"Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10)","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institutes of Health; Novo Nordisk","keywords":"Liraglutide; Medicine; Mace; Insulin glargine; Hazard ratio; Insulin degludec; Internal medicine; Type 2 diabetes; Diabetes mellitus; Insulin; Proportional hazards model; Endocrinology; Myocardial infarction; Confidence interval; Percutaneous coronary intervention","score_opus":0.009402614858056152,"score_gpt":0.20513423684962048,"score_spread":0.19573162199156433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915555967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99739194,0.0015120842,0.0000030301026,0.000014855615,0.00003088645,0.00086513354,0.000050564417,0.000028247803,0.000103265214],"genre_scores_gemma":[0.99885166,0.0002591778,0.0001260029,0.00008916484,0.000011399182,0.000026930016,0.0002325564,0.000028097389,0.00037498714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819976,0.0001401168,0.0003130375,0.00049144856,0.00046009614,0.0003955463],"domain_scores_gemma":[0.9989647,0.000071120434,0.00016124862,0.0004315145,0.00021282348,0.00015859118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037510024,0.0003251057,0.001170397,0.000265796,0.000047735175,0.0000309774,0.00006638727,0.00010976044,0.000029642926],"category_scores_gemma":[0.000085957196,0.00023000083,0.00016247432,0.0005453483,0.000099236866,0.0003156265,0.0000732638,0.00012347188,0.0000044971853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020997929,0.00094451086,0.9920303,0.00011860638,0.0056291013,0.000012586922,0.0000734958,0.000036074845,0.00003450012,0.000013168207,0.000008833591,0.00088884565],"study_design_scores_gemma":[0.00862613,0.00047324348,0.9841616,0.00024844642,0.0046433215,1.0707736e-7,0.000015842166,0.00021317785,0.0011300786,0.000017026283,0.00022019228,0.00025081294],"about_ca_topic_score_codex":0.000514754,"about_ca_topic_score_gemma":0.00016644406,"teacher_disagreement_score":0.008416151,"about_ca_system_score_codex":0.0000427992,"about_ca_system_score_gemma":0.000031039523,"threshold_uncertainty_score":0.9379162},"labels":[],"label_agreement":null},{"id":"W2916549936","doi":"10.1111/dom.13675","title":"Fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Cilag; Esperion Therapeutics; Servier; Sanofi; Kowa Company; Novo Nordisk; Medicines Company; European Foundation for the Study of Diabetes; AstraZeneca; Eli Lilly and Company; Amgen; Pfizer; Steno Diabetes Center Copenhagen; American Diabetes Association","keywords":"Medicine; Insulin degludec; Liraglutide; Basal insulin; Type 2 diabetes; Internal medicine; Diabetes mellitus; Basal (medicine); Insulin; Endocrinology","score_opus":0.003049679341641157,"score_gpt":0.17336434118006108,"score_spread":0.17031466183841992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916549936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99235874,0.0053133327,0.000003196331,0.000047620186,0.00019004483,0.001577563,0.000027843911,0.000032420645,0.00044922662],"genre_scores_gemma":[0.9983239,0.0008004075,0.00031974103,0.0002223405,0.000030438843,0.000043128683,0.000116321666,0.000029193556,0.000114536015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982382,0.0001630412,0.00035110512,0.00045889095,0.00041829122,0.0003704424],"domain_scores_gemma":[0.9989679,0.00015021401,0.0001819528,0.00039669508,0.00017057669,0.00013265824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005669933,0.000308676,0.0009866371,0.00032581037,0.00006260333,0.000035570876,0.00007835152,0.00012200587,0.000013688215],"category_scores_gemma":[0.00018025705,0.00023979253,0.00013165928,0.00032638776,0.0001007199,0.00022764613,0.00008043847,0.00019375025,0.000009263559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048628755,0.00077930465,0.9661684,0.0002331884,0.001179697,0.0000013743194,0.00012134273,0.000031829415,0.00033523695,0.00021549824,0.00003109973,0.030416736],"study_design_scores_gemma":[0.018199189,0.0012866437,0.97551656,0.00017045604,0.0009958863,2.675225e-8,0.000035333516,0.000482419,0.0022987386,0.00018949845,0.0005883174,0.00023691816],"about_ca_topic_score_codex":0.00007018397,"about_ca_topic_score_gemma":0.000012449782,"teacher_disagreement_score":0.030179817,"about_ca_system_score_codex":0.00003898588,"about_ca_system_score_gemma":0.000036456186,"threshold_uncertainty_score":0.97784555},"labels":[],"label_agreement":null},{"id":"W2917974791","doi":"10.1111/dom.13674","title":"Effects of basal insulin glargine and omega‐3 on lower limb arterial disease outcome in patients with dysglycaemia: An analysis of the Outcome Reduction with an Initial Glargine INtervention (ORIGIN) trial","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute; Hamilton General Hospital; Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; Hazard ratio; Insulin glargine; Internal medicine; Placebo; Randomized controlled trial; Diabetes mellitus; Incidence (geometry); Type 2 diabetes; Confidence interval; Endocrinology","score_opus":0.006510270591356861,"score_gpt":0.24503217935952357,"score_spread":0.2385219087681667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917974791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979247,0.00007065237,0.000009119642,0.00007129008,0.00039183354,0.0014369745,0.00006979161,0.000016574919,0.000009085931],"genre_scores_gemma":[0.9994096,0.000006393067,0.000058718324,0.00016502973,0.00011207489,0.000036863712,0.00016677483,0.000017904982,0.000026653035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982995,0.0002110982,0.00044908974,0.00040217026,0.00041541818,0.00022271708],"domain_scores_gemma":[0.9990242,0.000030407879,0.00024468487,0.00040847485,0.00009085841,0.00020137712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002642792,0.00024153176,0.0008018715,0.0003677631,0.00004001072,0.00002686363,0.000097514596,0.000067988454,0.000021054162],"category_scores_gemma":[0.000048762075,0.0001524733,0.00013822934,0.00045817325,0.0001230975,0.00035667347,0.000060743234,0.00015857244,7.401269e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046733685,0.0036333376,0.94674104,0.00041707713,0.00046788633,0.000004365004,0.00010103806,0.000053267653,0.00032963965,0.000072372735,0.0000010433472,0.0014452483],"study_design_scores_gemma":[0.047943365,0.0029328994,0.94505024,0.00012757386,0.0027985787,7.585487e-8,0.000028495417,0.0005685003,0.0003443149,0.000019350518,0.000025467476,0.00016114303],"about_ca_topic_score_codex":0.000044727265,"about_ca_topic_score_gemma":0.000023050608,"teacher_disagreement_score":0.0023306925,"about_ca_system_score_codex":0.00003303961,"about_ca_system_score_gemma":0.000022875463,"threshold_uncertainty_score":0.62176806},"labels":[],"label_agreement":null},{"id":"W2918318471","doi":"10.1111/dom.13680","title":"Randomised study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Primary results of the BERSON clinical trial","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"Amgen","keywords":"Evolocumab; Medicine; Placebo; Atorvastatin; Internal medicine; Statin; Type 2 diabetes; PCSK9; Gastroenterology; Diabetes mellitus; Cholesterol; Endocrinology; Lipoprotein; Apolipoprotein A1","score_opus":0.014141394061538503,"score_gpt":0.2587694760928445,"score_spread":0.244628082031306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918318471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99534976,0.00085969234,1.0854e-7,0.000023133322,0.00030152017,0.00327491,0.00001895746,0.000006302431,0.00016560922],"genre_scores_gemma":[0.99953234,0.00010692092,0.000055633685,0.00012847631,0.000095290285,0.000017253227,0.000016502561,0.000013494846,0.00003408224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783635,0.0004926924,0.00058937486,0.00032628977,0.0005395096,0.00021576679],"domain_scores_gemma":[0.9986567,0.00029516715,0.00027235228,0.00054934766,0.00013564606,0.000090806585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020120814,0.00015846995,0.0010825066,0.00007935153,0.000040671745,0.000009162388,0.00007858574,0.00010599137,0.000004786876],"category_scores_gemma":[0.00028574336,0.00009259692,0.00011000439,0.00021692744,0.00010670507,0.00007077434,0.00006741452,0.0002662933,8.39287e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043536533,0.0017063082,0.9441722,0.00027163883,0.0003050132,3.6522363e-7,0.00048195975,0.0000019107881,0.00005546767,0.000010626789,0.000022328804,0.009435643],"study_design_scores_gemma":[0.2564027,0.0026337325,0.7400653,0.00013112307,0.00026603145,3.6853e-8,0.00012128213,0.0000073726187,0.00018179146,0.0000065987947,0.0001113318,0.00007270471],"about_ca_topic_score_codex":0.000074436604,"about_ca_topic_score_gemma":0.000013808404,"teacher_disagreement_score":0.21286617,"about_ca_system_score_codex":0.000015892583,"about_ca_system_score_gemma":0.00009288112,"threshold_uncertainty_score":0.37759927},"labels":[],"label_agreement":null},{"id":"W2919371810","doi":"10.1111/dom.13687","title":"Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010–2017","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIHR Exeter Clinical Research Facility; Medical Research Council; National Institute for Health and Care Research; Medical Research Council Canada; Department of Health and Social Care; Wellcome Trust","keywords":"Medicine; Discontinuation; Type 2 diabetes; Metformin; Medical prescription; Blood pressure; Weight loss; Diabetes mellitus; Population; Internal medicine; Confidence interval; Endocrinology; Pharmacology; Obesity","score_opus":0.012478294501780693,"score_gpt":0.23634766540505767,"score_spread":0.22386937090327697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919371810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98838645,0.009913473,2.829948e-7,0.000021663369,0.00010215254,0.00036105126,0.00058745284,0.000024508661,0.00060294376],"genre_scores_gemma":[0.9970527,0.0009274164,0.00016769918,0.000025499636,0.000019627452,0.00000588762,0.0010598684,0.000017876933,0.0007233969],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983327,0.00017640393,0.0003522648,0.0005340542,0.0002786126,0.00032597064],"domain_scores_gemma":[0.99851286,0.00020569278,0.0002591375,0.00079875306,0.0001152513,0.00010831775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061136665,0.00025097525,0.0012919063,0.0010118616,0.000041954638,0.000019199706,0.00017180211,0.00011661106,0.00007158546],"category_scores_gemma":[0.00010208471,0.00021111882,0.00013006951,0.0009067806,0.00015751536,0.00028638556,0.00031748426,0.00016000734,0.0000041062453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019695963,0.00021276814,0.9849832,0.00023145489,0.0022582335,0.0000012853537,0.0018919243,0.00000602067,0.0059678596,0.00002244157,0.00012283257,0.0041049905],"study_design_scores_gemma":[0.0017474025,0.00023638087,0.9867385,0.0001324006,0.006075317,3.8560618e-8,0.0003056094,0.0006468715,0.003454622,0.000017946337,0.00046728746,0.00017762509],"about_ca_topic_score_codex":0.00018523994,"about_ca_topic_score_gemma":0.000017898305,"teacher_disagreement_score":0.008986057,"about_ca_system_score_codex":0.000054335917,"about_ca_system_score_gemma":0.000036246187,"threshold_uncertainty_score":0.86091757},"labels":[],"label_agreement":null},{"id":"W2919787870","doi":"10.1111/dom.13682","title":"Trial design and baseline data for LIRA‐PRIME: A randomized trial investigating the efficacy of liraglutide in controlling glycaemia in type 2 diabetes in a primary care setting","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GRi Simulations (Canada); Surrey Memorial Hospital","funders":"Novo Nordisk; American Diabetes Association","keywords":"Medicine; Liraglutide; Clinical endpoint; Randomized controlled trial; Type 2 diabetes; Metformin; Overweight; Internal medicine; Diabetes mellitus; Glycated hemoglobin; Pediatrics; Insulin; Obesity; Endocrinology","score_opus":0.02199204367663652,"score_gpt":0.26251990096163225,"score_spread":0.24052785728499573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919787870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97561544,0.014104849,0.000025781645,0.00021869935,0.0002771355,0.009655585,0.000028316497,0.000020136711,0.000054025404],"genre_scores_gemma":[0.9942483,0.00042553328,0.004094172,0.00039662156,0.00018957803,0.00028016965,0.00031102673,0.000026952215,0.000027658922],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973188,0.0006735543,0.0008067834,0.0005186021,0.00021857496,0.0004636989],"domain_scores_gemma":[0.99517184,0.003945939,0.00024189045,0.00048604477,0.000068026566,0.00008628119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005343049,0.0002750575,0.0016074756,0.0003012673,0.000051602605,0.000045087967,0.00019890274,0.0001291421,0.0000038680605],"category_scores_gemma":[0.003215324,0.00019644338,0.00010651715,0.00034340174,0.00014610992,0.00019666235,0.00022698875,0.00024922017,8.704265e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82166684,0.0010282886,0.12553734,0.0017086599,0.00059013977,0.0000056724543,0.0023016615,0.00024325833,0.00517934,0.000315808,0.00004634356,0.041376635],"study_design_scores_gemma":[0.94820416,0.0004201592,0.019203467,0.0006952749,0.0007245733,8.087613e-8,0.0001566019,0.028688366,0.0012693666,0.0002785851,0.00015482226,0.00020456042],"about_ca_topic_score_codex":0.000076744276,"about_ca_topic_score_gemma":0.000028233791,"teacher_disagreement_score":0.1265373,"about_ca_system_score_codex":0.00004472197,"about_ca_system_score_gemma":0.00014520834,"threshold_uncertainty_score":0.80107284},"labels":[],"label_agreement":null},{"id":"W2921421880","doi":"10.1111/dom.13699","title":"Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7)","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"National Institutes of Health; Novo Nordisk","keywords":"Insulin degludec; Insulin glargine; Medicine; Insulin; Diabetes mellitus; Endocrinology; Internal medicine; Pediatrics; Hypoglycemia","score_opus":0.007635116727159678,"score_gpt":0.21004748691954406,"score_spread":0.20241237019238437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921421880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99025166,0.0076471684,0.0000017230611,0.000057203888,0.00036943986,0.0011090394,0.00019491858,0.000040605268,0.000328256],"genre_scores_gemma":[0.9969029,0.0014276005,0.0005689697,0.0001128132,0.00009775825,0.000009287934,0.00039766738,0.000047172576,0.00043582375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725854,0.0001837559,0.000499235,0.0006953288,0.0007346544,0.00062845537],"domain_scores_gemma":[0.99840945,0.00029829674,0.00014823805,0.0006895912,0.00020531345,0.00024908406],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008026418,0.00035106283,0.0011807089,0.0003381526,0.00006789308,0.000047470712,0.00020165638,0.00023481925,0.00007849657],"category_scores_gemma":[0.0003839596,0.00026844535,0.00014098593,0.0006977395,0.00019393286,0.00027449048,0.00028887278,0.00044420484,0.000028946084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008902172,0.0006888646,0.9288175,0.00045449156,0.001809265,0.000029297662,0.0004844737,0.000065167296,0.0003676269,0.000021492659,0.00013618566,0.058223445],"study_design_scores_gemma":[0.031546544,0.0005513019,0.957698,0.0003769846,0.00053145055,8.936792e-8,0.00004143977,0.00015158812,0.00060849293,0.000023020382,0.0081279185,0.00034317782],"about_ca_topic_score_codex":0.00014611846,"about_ca_topic_score_gemma":0.000053310796,"teacher_disagreement_score":0.057880268,"about_ca_system_score_codex":0.000041285486,"about_ca_system_score_gemma":0.00008810186,"threshold_uncertainty_score":0.99997675},"labels":[],"label_agreement":null},{"id":"W2921562138","doi":"10.1111/dom.13698","title":"Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; St. Michael's Hospital","funders":"Novo Nordisk","keywords":"Semaglutide; Liraglutide; Medicine; Diabetes mellitus; Mace; Internal medicine; Type 2 diabetes; Post-hoc analysis; Lixisenatide; Diabetic nephropathy; Endocrinology; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.0253702906421352,"score_gpt":0.3092381997192483,"score_spread":0.2838679090771131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921562138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98725635,0.011367609,0.000002713471,0.0002951675,0.000085833846,0.00082531106,0.00007382721,0.000009346322,0.00008384117],"genre_scores_gemma":[0.9982096,0.0011993119,0.00020158748,0.00014141481,0.0000450202,0.00000812544,0.00003065458,0.000010681363,0.00015361857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997932,0.00042446575,0.0008285778,0.0003329613,0.00024956468,0.00023244311],"domain_scores_gemma":[0.99798286,0.00091832795,0.00048145937,0.0003304366,0.00016546626,0.000121432124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024168533,0.0002014109,0.0017816349,0.00028902205,0.000049616137,0.000019367331,0.00006382836,0.00012109563,0.000014187749],"category_scores_gemma":[0.00086031435,0.00013104212,0.00032330482,0.00039063313,0.00040172174,0.000096545366,0.00016423351,0.000114478265,3.2717134e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009640308,0.00024498897,0.9653987,0.0005397273,0.003910949,4.1497773e-7,0.0004922354,0.000003442475,0.008027407,0.0006422102,0.000030987394,0.0206125],"study_design_scores_gemma":[0.003655626,0.00029732252,0.97610235,0.00011634866,0.011671758,1.7219311e-7,0.00029711364,0.0004206444,0.006940181,0.00009376303,0.00029084217,0.00011384999],"about_ca_topic_score_codex":0.000026594293,"about_ca_topic_score_gemma":0.000011154325,"teacher_disagreement_score":0.020498652,"about_ca_system_score_codex":0.0000064151427,"about_ca_system_score_gemma":0.000033838376,"threshold_uncertainty_score":0.53437424},"labels":[],"label_agreement":null},{"id":"W2921595130","doi":"10.1111/dom.13692","title":"Sodium glucose cotransporter (SGLT)‐2 inhibitors: Do we need them for glucose‐lowering, for cardiorenal protection or both?","year":2019,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Colorado Clinical and Translational Sciences Institute; Canadian Institutes of Health Research; National Institutes of Health; Novo Nordisk Fonden; University of Toronto; National Institute of Diabetes and Digestive and Kidney Diseases; University of Colorado; ZonMw; Fondation Leducq; University Health Network; Horizon Pharmaceuticals; Diabetes Canada; Eli Lilly and Company; AstraZeneca; Canadian Diabetes Association; International Society for Pediatric and Adolescent Diabetes; Novo Nordisk; Thrasher Research Fund; Sanofi","keywords":"Cotransporter; Medicine; Internal medicine; Endocrinology; Sodium; Chemistry","score_opus":0.044988646982151256,"score_gpt":0.28159246317917935,"score_spread":0.23660381619702808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921595130","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051919427,0.97844124,0.00028943192,0.00012115441,0.0016631186,0.013459764,0.00045435646,0.00018816383,0.00019084896],"genre_scores_gemma":[0.0006724336,0.9877948,0.00088293984,0.00013521888,0.0016221902,0.0042788577,0.0008342858,0.00018184901,0.0035974316],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99684966,0.00006618303,0.0008101865,0.0010103626,0.0003638532,0.0008997668],"domain_scores_gemma":[0.9982609,0.00017760294,0.0004483724,0.00066133257,0.00015863888,0.00029314889],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058471406,0.00096058095,0.0036105986,0.00036256746,0.00021424145,0.00015470771,0.0002139901,0.0005871513,0.000061656385],"category_scores_gemma":[0.00006244854,0.00066375436,0.0015405506,0.00026268818,0.00009070783,0.00022963484,0.00009210177,0.00034319342,0.000054946857],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017608295,0.00045495338,0.00011548314,0.0600845,0.0026187813,0.000006835221,0.00011457693,1.846856e-7,0.000045091674,0.00026872443,0.0017172769,0.9343975],"study_design_scores_gemma":[0.004023696,0.0004491545,0.00016013882,0.007718786,0.017058251,0.0000050047443,0.00002822793,0.000012534274,0.0011471249,0.0001682529,0.9685252,0.00070365635],"about_ca_topic_score_codex":0.000010932692,"about_ca_topic_score_gemma":0.0000037926916,"teacher_disagreement_score":0.9668079,"about_ca_system_score_codex":0.000106137864,"about_ca_system_score_gemma":0.00020160327,"threshold_uncertainty_score":0.9995814},"labels":[],"label_agreement":null},{"id":"W2921878115","doi":"10.1111/dom.13695","title":"Gastrin analogue administration adds no significant glycaemic benefit to a glucagon‐like peptide‐1 receptor agonist acutely or after washout of both analogues","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"OPKO Health (Canada)","funders":"Eli Lilly and Company","keywords":"Placebo; Medicine; Tolerability; Gastrin; Nausea; Agonist; Internal medicine; Adverse effect; Vomiting; Insulin; Endocrinology; Gastroenterology; Receptor","score_opus":0.009621001642796896,"score_gpt":0.23406959652495235,"score_spread":0.22444859488215546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921878115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564934,0.00080004585,0.000016893457,0.00030729623,0.0004370941,0.0012529931,0.00031047533,0.00007625841,0.0011495928],"genre_scores_gemma":[0.98748535,0.00041593643,0.002228246,0.001037449,0.00020321688,0.00014474476,0.0005487154,0.000038629336,0.007897742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786085,0.000053497763,0.0004954621,0.00061153714,0.0003890878,0.00058955536],"domain_scores_gemma":[0.9986448,0.00007733818,0.00017675608,0.00052886177,0.00017650549,0.00039569134],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003169443,0.00039696353,0.0009175067,0.00030065468,0.000073405165,0.000072766634,0.00016333156,0.00014427316,0.0005623931],"category_scores_gemma":[0.00006275305,0.0003106728,0.00020479049,0.00037233616,0.00010090635,0.0002268177,0.00013549635,0.0001561662,0.00032263008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036034533,0.002665274,0.87184167,0.0016288782,0.002193658,0.00006998533,0.0011220719,0.000009960455,0.08365975,0.001678961,0.0092148855,0.022311421],"study_design_scores_gemma":[0.0032698351,0.002150038,0.8692387,0.00038148064,0.0013775202,0.0000022036957,0.00017985822,0.00006643828,0.02532846,0.000068639725,0.097400285,0.000536564],"about_ca_topic_score_codex":0.0000728715,"about_ca_topic_score_gemma":0.00008099167,"teacher_disagreement_score":0.08818541,"about_ca_system_score_codex":0.00005307134,"about_ca_system_score_gemma":0.00010344,"threshold_uncertainty_score":0.99993455},"labels":[],"label_agreement":null},{"id":"W2928618472","doi":"10.1111/dom.13732","title":"Reporting of hypoglycaemia in clinical trials of basal insulins: A need for consensus","year":2019,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Sanofi","keywords":"Medicine; Intensive care medicine; Randomized controlled trial; Continuous glucose monitoring; Basal insulin; Hypoglycemia; Adverse effect; Clinical trial; Clinical Practice; Gold standard (test); Diabetes mellitus; Insulin; Type 2 diabetes; Internal medicine; Type 1 diabetes; Physical therapy; Endocrinology","score_opus":0.35035989989894034,"score_gpt":0.5040464253399498,"score_spread":0.15368652544100947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2928618472","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09846124,0.89664084,0.0000034015716,0.000050107938,0.0005161282,0.0037727961,0.00015036429,0.000013790825,0.00039133904],"genre_scores_gemma":[0.0015133474,0.9959892,0.00097356725,0.00006301147,0.00036470024,0.00010706136,0.0001842956,0.000049950435,0.0007548899],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98975587,0.0010558137,0.0077517363,0.00055773585,0.0003878078,0.0004910133],"domain_scores_gemma":[0.9876923,0.004685479,0.0065621086,0.0005896736,0.00029354577,0.0001768756],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.02773785,0.00037394126,0.010419262,0.000730074,0.000028014265,0.000017632945,0.00020015457,0.0006011079,0.00002153968],"category_scores_gemma":[0.035490476,0.00026681513,0.0017270104,0.00049469987,0.00027578286,0.00004167385,0.00021470459,0.0006000727,0.0000044362077],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007873363,0.0004573743,0.014511794,0.08986606,0.0009785676,0.0000075623548,0.000028177688,1.5639576e-7,0.000016571475,0.00031792515,0.00052729866,0.89320976],"study_design_scores_gemma":[0.0059273764,0.00034425504,0.023340771,0.02365179,0.008185475,0.0000010991572,0.000044993474,0.00010064572,0.000090272464,0.00041686653,0.9374758,0.00042067678],"about_ca_topic_score_codex":0.000014754423,"about_ca_topic_score_gemma":0.0000018720897,"teacher_disagreement_score":0.9369485,"about_ca_system_score_codex":0.000017543385,"about_ca_system_score_gemma":0.0005135667,"threshold_uncertainty_score":0.9999784},"labels":[],"label_agreement":null},{"id":"W2929722478","doi":"10.1111/dom.13726","title":"First assessment of the performance of an implantable continuous glucose monitoring system through 180 days in a primarily adolescent population with type 1 diabetes","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Merck Canada; Gilead Sciences; European Foundation for the Study of Diabetes; AstraZeneca; Eli Lilly and Company; Amgen; Pfizer; Novo Nordisk; Valeant Pharmaceuticals International; Sanofi; American Diabetes Association","keywords":"Medicine; Continuous glucose monitoring; Type 2 diabetes; Population; Type 1 diabetes; Internal medicine; Diabetes mellitus; Endocrinology; Environmental health","score_opus":0.00903000549003959,"score_gpt":0.24710264616660313,"score_spread":0.23807264067656353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2929722478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970609,0.0010641923,0.0000011101052,0.000017218788,0.00026298437,0.000849022,0.000008700477,0.000019340388,0.00071655586],"genre_scores_gemma":[0.9992068,0.00016213824,0.0004067835,0.000020173578,0.000058923102,0.000015365935,0.000021994752,0.000016205167,0.00009161105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986497,0.00007829862,0.00028830513,0.00023826734,0.0004055835,0.00033980442],"domain_scores_gemma":[0.9992414,0.000041664032,0.00017045935,0.0003645774,0.0001231552,0.000058730104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049865403,0.00015405566,0.0005728605,0.00010941791,0.00007215208,0.000024007077,0.00015004822,0.000069431495,0.0000050451295],"category_scores_gemma":[0.000014797201,0.00009874153,0.000046214984,0.00034905123,0.0000660453,0.00027818236,0.0001251348,0.00019247082,0.0000015128679],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043833625,0.0002778692,0.98882914,0.0027368988,0.00007388395,4.294657e-7,0.00012323378,0.00011370809,0.006231679,0.00025952625,0.0000056387653,0.0013041424],"study_design_scores_gemma":[0.0013807102,0.00027018067,0.9723439,0.00135158,0.00014305467,2.624613e-7,0.00014138693,0.0038254426,0.020217754,0.000007646829,0.0002103688,0.000107678665],"about_ca_topic_score_codex":0.0000922574,"about_ca_topic_score_gemma":0.000010900342,"teacher_disagreement_score":0.016485222,"about_ca_system_score_codex":0.000046552464,"about_ca_system_score_gemma":0.000044269855,"threshold_uncertainty_score":0.4026563},"labels":[],"label_agreement":null},{"id":"W2932567006","doi":"10.1111/dom.13729","title":"Baseline nocturnal glucose change: A predictor of the treatment effect of bolus intensification in insulin‐treated type 2 diabetes","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Zafgen; Abbott Diabetes Care; Dexcom; Novo Nordisk; Sanofi; MannKind Corporation; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Internal medicine; Type 2 diabetes; Bolus (digestion); Diabetes mellitus; Insulin; Nocturnal; Endocrinology; Cardiology","score_opus":0.013117985935490897,"score_gpt":0.25184387476242776,"score_spread":0.23872588882693685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2932567006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897558,0.008145091,2.9527115e-7,0.00024177083,0.00026185613,0.00140577,0.000027665908,0.000017005284,0.0001447502],"genre_scores_gemma":[0.9980443,0.0012503249,0.000025287463,0.00011502379,0.0000964237,0.00004407236,0.000056069206,0.000015677502,0.00035279014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862945,0.00022672037,0.00030546077,0.00024672726,0.00028796762,0.00030370086],"domain_scores_gemma":[0.9990211,0.00019526626,0.00014074321,0.00038006116,0.00017339143,0.000089428446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006812488,0.0001942742,0.0006713839,0.00025357932,0.000030954205,0.0000108726435,0.00012599277,0.00010260966,0.000054516557],"category_scores_gemma":[0.00024504468,0.00010847522,0.00013044753,0.00055351935,0.00012817976,0.00009572267,0.00008389346,0.0001555847,0.000010448048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015972777,0.00044594903,0.9373806,0.0005148199,0.0001817791,7.713092e-7,0.00025418124,0.0000019134468,0.029741867,0.000041744355,0.00003355427,0.031243058],"study_design_scores_gemma":[0.0030025525,0.0006934222,0.8387535,0.00023738026,0.00030230053,8.8313946e-8,0.00001583312,0.0015706654,0.15360625,0.000026587079,0.0017116887,0.00007970743],"about_ca_topic_score_codex":0.00005718485,"about_ca_topic_score_gemma":0.000007857484,"teacher_disagreement_score":0.12386438,"about_ca_system_score_codex":0.000030171925,"about_ca_system_score_gemma":0.000028196833,"threshold_uncertainty_score":0.44234914},"labels":[],"label_agreement":null},{"id":"W2933543441","doi":"10.1111/dom.13730","title":"Short‐term cost‐utility of degludec versus glargine U100 for patients with type 2 diabetes at high risk of hypoglycaemia and cardiovascular events: A Canadian setting (DEVOTE 9)","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital; University of Manitoba","funders":"Canadian Society of Endocrinology and Metabolism; Novo Nordisk; Diabetes Canada","keywords":"Insulin degludec; Medicine; Insulin glargine; Diabetes mellitus; Continuous glucose monitoring; Type 2 diabetes; Pediatrics; Quartile; Stroke (engine); Internal medicine; Intensive care medicine; Type 1 diabetes; Endocrinology; Confidence interval","score_opus":0.007903825763419092,"score_gpt":0.21875281386762596,"score_spread":0.21084898810420688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2933543441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99351525,0.0038954169,0.0000041291855,0.000029285586,0.00024861254,0.0017634413,0.00034293538,0.000016505242,0.00018439528],"genre_scores_gemma":[0.9986656,0.00033676374,0.0004537383,0.00003107761,0.000054552198,0.0000320699,0.0002547116,0.000030361922,0.00014118006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980807,0.00010186882,0.0002987995,0.00044586044,0.0004597267,0.00061309576],"domain_scores_gemma":[0.9984498,0.00020052568,0.00011201564,0.00050420966,0.00038986263,0.0003435804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082379126,0.00024991372,0.00089245185,0.00024906397,0.00012861926,0.000016102134,0.00013365058,0.00013496078,0.00004648503],"category_scores_gemma":[0.00025216074,0.00019835655,0.00017789069,0.0002712566,0.0001686558,0.00015154522,0.00015349858,0.00017439768,0.0000031823145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029963395,0.00012940798,0.9704083,0.0008487144,0.0015793053,7.102179e-7,0.000062584215,0.0000054446655,0.00020550429,0.000026190095,0.00007183915,0.026362324],"study_design_scores_gemma":[0.0059728315,0.00039409613,0.98551714,0.00015966188,0.001500825,5.4520264e-8,0.000023853356,0.00031676947,0.0022220525,0.00004488234,0.00364466,0.00020317138],"about_ca_topic_score_codex":0.0011000679,"about_ca_topic_score_gemma":0.00064495933,"teacher_disagreement_score":0.026159154,"about_ca_system_score_codex":0.00003808645,"about_ca_system_score_gemma":0.000080870625,"threshold_uncertainty_score":0.8088745},"labels":[],"label_agreement":null},{"id":"W2936097160","doi":"10.1111/dom.13751","title":"Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: A multicentre, randomized controlled trial using continuous glucose monitoring","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"Sanofi","keywords":"Medicine; Insulin glargine; Morning; Randomized controlled trial; Type 2 diabetes; Insulin; Diabetes mellitus; Internal medicine; Endocrinology","score_opus":0.01267882740177082,"score_gpt":0.24844079432213162,"score_spread":0.2357619669203608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936097160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880073,0.0047776983,0.000007160885,0.000018840907,0.0006704377,0.006340385,0.000024646488,0.0000381928,0.000115314666],"genre_scores_gemma":[0.99820787,0.0009935295,0.00034447797,0.00002128846,0.00015190928,0.00005619026,0.00009609874,0.000044491055,0.00008414673],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996713,0.00057819113,0.0009916397,0.00047779107,0.0006297953,0.00060962536],"domain_scores_gemma":[0.9966298,0.0011390578,0.00056485436,0.00033894714,0.001122652,0.00020470226],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015981807,0.0004068389,0.0027582035,0.0007324346,0.00009539525,0.000043464777,0.00013830367,0.00020666067,0.000025559788],"category_scores_gemma":[0.0030520328,0.0003060264,0.00012335843,0.001422547,0.00025866702,0.00028365676,0.00017400621,0.00045054135,0.0000024995554],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70636797,0.0012468533,0.27988142,0.00065008743,0.0012636795,0.0000028679433,0.0008021593,0.00022579233,0.002469976,0.00006501013,0.0000016898038,0.0070225266],"study_design_scores_gemma":[0.8314177,0.0010784816,0.15628706,0.0009177412,0.0012347462,9.915556e-8,0.00022748431,0.00629549,0.0021939317,0.0000069998664,0.000071504335,0.0002687652],"about_ca_topic_score_codex":0.0001133393,"about_ca_topic_score_gemma":0.000007709523,"teacher_disagreement_score":0.12504975,"about_ca_system_score_codex":0.000047312064,"about_ca_system_score_gemma":0.0001360257,"threshold_uncertainty_score":0.9999392},"labels":[],"label_agreement":null},{"id":"W2939788581","doi":"10.1111/dom.13646","title":"Residual cardiovascular risk among people with diabetes","year":2019,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; University Health Network","funders":"","keywords":"Residual risk; Medicine; Diabetes mellitus; Disease; Type 2 diabetes; Atherosclerotic cardiovascular disease; Cardiovascular health; Environmental health; Internal medicine; Intensive care medicine; Endocrinology","score_opus":0.014250612439845042,"score_gpt":0.23154158952086837,"score_spread":0.21729097708102332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939788581","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.151115,0.8440673,0.000010800657,0.000009946168,0.00053093303,0.0031775432,0.00030469152,0.00021835684,0.0005654638],"genre_scores_gemma":[0.0025912086,0.9933068,0.00042112145,0.000080940794,0.001572495,0.00052682066,0.0005753779,0.0002989136,0.00062632415],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936438,0.00092932803,0.00089918805,0.0017337026,0.0013623443,0.0014316298],"domain_scores_gemma":[0.9955843,0.0003025848,0.000546711,0.0026059132,0.0002709711,0.00068951264],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0021493486,0.001440833,0.009891645,0.00063730066,0.00034968677,0.00022215782,0.00045147,0.0010073489,0.000064955144],"category_scores_gemma":[0.0003520884,0.0010474295,0.003988884,0.00088749157,0.00042468676,0.00034946037,0.00033580483,0.0016407553,0.00021739038],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000079207375,0.00016366091,0.019569146,0.027173743,0.015598434,0.00002707973,0.00010781443,0.000004071034,1.3504447e-7,0.000022143668,0.00030678412,0.93701905],"study_design_scores_gemma":[0.0015836325,0.00014447415,0.1323968,0.0073992694,0.056515682,0.00000983967,0.000021814925,0.000005287094,0.00002305279,0.000025239835,0.80077386,0.0011010701],"about_ca_topic_score_codex":0.0013770129,"about_ca_topic_score_gemma":0.00017368974,"teacher_disagreement_score":0.935918,"about_ca_system_score_codex":0.00007909971,"about_ca_system_score_gemma":0.00040462252,"threshold_uncertainty_score":0.9998341},"labels":[],"label_agreement":null},{"id":"W2942519534","doi":"10.1111/dom.13754","title":"Acute kidney injury with sodium‐glucose co‐transporter‐2 inhibitors: A meta‐analysis of cardiovascular outcome trials","year":2019,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Acute kidney injury; Kidney disease; Hazard ratio; Internal medicine; Placebo; Randomized controlled trial; Meta-analysis; Type 2 diabetes; Diabetes mellitus; Intensive care medicine; Adverse effect; Relative risk; Confidence interval; Endocrinology; Pathology","score_opus":0.0784109921710881,"score_gpt":0.33839555872688576,"score_spread":0.25998456655579766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942519534","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033949171,0.9894518,0.0000216966,0.000035153793,0.00027758186,0.0036697036,0.0027384881,0.00008880954,0.00032180262],"genre_scores_gemma":[0.0006752567,0.99387985,0.00037305173,0.00030028453,0.00019544731,0.0004542937,0.003151862,0.00010463467,0.0008653309],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99471873,0.00063719647,0.0019070168,0.0011123121,0.00093340274,0.000691352],"domain_scores_gemma":[0.99636114,0.00023196901,0.0010842918,0.0016105582,0.00017717599,0.00053489546],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.002628972,0.0011812423,0.023900313,0.001662019,0.00008446395,0.000074837466,0.0003003883,0.0004975978,0.00019518864],"category_scores_gemma":[0.00009932601,0.0007201964,0.012833336,0.0014478633,0.00018953612,0.0002214717,0.00011486359,0.00042866607,0.000038148788],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040407464,0.00045514575,0.0009952196,0.020880103,0.87686443,0.000035115525,0.00006376463,5.782574e-7,0.0000029793491,0.00009449849,0.00029382313,0.10027394],"study_design_scores_gemma":[0.001011578,0.00010436194,0.00028714436,0.0006263435,0.5252005,7.0146785e-7,0.0000036105391,0.0000012032816,0.000096952244,0.0000041035883,0.47231105,0.00035244582],"about_ca_topic_score_codex":0.000040400737,"about_ca_topic_score_gemma":0.0000017299958,"teacher_disagreement_score":0.47201723,"about_ca_system_score_codex":0.000048181188,"about_ca_system_score_gemma":0.00023479035,"threshold_uncertainty_score":0.9995249},"labels":[],"label_agreement":null},{"id":"W2943127375","doi":"10.1111/dom.13762","title":"Weight loss enhances cardiac energy metabolism and function in heart failure associated with obesity","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; Heart and Stroke Foundation of Canada","keywords":"Heart failure; Internal medicine; Medicine; Endocrinology; Weight loss; Cardiac function curve; Ventricle; Muscle hypertrophy; Beta oxidation; Cardiac hypertrophy; Obesity; Metabolism","score_opus":0.0036187875414610826,"score_gpt":0.18304957692986853,"score_spread":0.17943078938840745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943127375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869145,0.011422969,0.000030887306,0.000273529,0.0006994167,0.0003203241,0.000023752551,0.00008209262,0.00023249407],"genre_scores_gemma":[0.9963285,0.0019498674,0.00008487372,0.00048126935,0.00023128123,0.000022226755,0.00008116107,0.00002807379,0.00079279306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982082,0.00021807523,0.00023672896,0.00052722014,0.0003935193,0.000416221],"domain_scores_gemma":[0.9991614,0.000085461004,0.00008341539,0.000309714,0.00012545983,0.00023454888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000510939,0.0003030869,0.0010511078,0.00023931672,0.00011971989,0.000048872622,0.000047313,0.00024958537,0.00008111781],"category_scores_gemma":[0.000057899106,0.0002279318,0.0002288184,0.00041511632,0.00013150158,0.00028428654,0.000056205645,0.00031083828,0.000015782261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007448772,0.00015680592,0.9916049,0.000057672118,0.00059220876,0.0000038944045,0.00014008285,0.0000030909619,0.00463207,0.00072053645,0.0003934878,0.001620713],"study_design_scores_gemma":[0.002003941,0.00006133059,0.8389483,0.00007682759,0.0006313242,0.000004235979,0.00007839253,0.000023533348,0.0079448465,0.00009419099,0.1498857,0.00024739048],"about_ca_topic_score_codex":0.00023847091,"about_ca_topic_score_gemma":0.00013011605,"teacher_disagreement_score":0.15265666,"about_ca_system_score_codex":0.000029529972,"about_ca_system_score_gemma":0.00005946896,"threshold_uncertainty_score":0.9294789},"labels":[],"label_agreement":null},{"id":"W2943453646","doi":"10.1111/dom.13755","title":"Response of 1,5‐anhydroglucitol level to intensive glucose‐ and blood‐pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Servier; National Health and Medical Research Council; National Institutes of Health; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Hazard ratio; Internal medicine; Confidence interval; Blood pressure; Diabetes mellitus; Glycated hemoglobin; Type 2 diabetes; Proportional hazards model; Endocrinology","score_opus":0.030216539972744108,"score_gpt":0.307938708642132,"score_spread":0.2777221686693879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943453646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805302,0.017140716,0.00001588511,0.0005530654,0.00019472714,0.001430644,0.000092492526,0.00001560342,0.000026657799],"genre_scores_gemma":[0.9980435,0.00056925276,0.0003929095,0.0005839766,0.0000786431,0.00005440019,0.000008412484,0.0000150304995,0.00025390167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983284,0.00037657513,0.00043088463,0.00034364717,0.00027806565,0.00024244271],"domain_scores_gemma":[0.9985987,0.0006154874,0.00014510205,0.0003195392,0.00019743119,0.00012376954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022135614,0.00017745356,0.000960047,0.00014907902,0.00006529186,0.000034849763,0.0000966305,0.000117366595,0.000005573462],"category_scores_gemma":[0.0020667978,0.00012173112,0.00023050925,0.00018270021,0.00009052539,0.00015433913,0.00010108952,0.0002773227,0.0000029132418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057197716,0.0010507733,0.95741975,0.0005589124,0.002931996,0.000018393355,0.0028294132,0.000009903446,0.001387499,0.00034149765,0.000047899866,0.027684169],"study_design_scores_gemma":[0.016692521,0.00056494353,0.976246,0.00028027198,0.0014112422,0.0000035528242,0.00034203526,0.000015071927,0.0023326287,0.000046132296,0.0019208321,0.00014474604],"about_ca_topic_score_codex":0.0002123268,"about_ca_topic_score_gemma":0.00013901861,"teacher_disagreement_score":0.027539423,"about_ca_system_score_codex":0.000004693709,"about_ca_system_score_gemma":0.000038213595,"threshold_uncertainty_score":0.49640512},"labels":[],"label_agreement":null},{"id":"W2945166916","doi":"10.1111/dom.13611","title":"A safety update on sodium glucose co‐transporter 2 inhibitors","year":2019,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Canagliflozin; Medicine; Empagliflozin; Dapagliflozin; Randomized controlled trial; Incidence (geometry); Internal medicine; Adverse effect; Diabetes mellitus; Observational study; Acute kidney injury; Placebo; Amputation; Surgery; Type 2 diabetes; Endocrinology; Pathology","score_opus":0.020074418725650908,"score_gpt":0.27450870267141614,"score_spread":0.2544342839457652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945166916","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0054208287,0.98582757,0.0000019061013,0.00011316746,0.00091730914,0.002372652,0.0002764237,0.00014123757,0.0049288934],"genre_scores_gemma":[0.00031933546,0.99237275,0.00008846089,0.0010737398,0.0005249018,0.00013478904,0.0019261992,0.000104187304,0.0034556254],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997126,0.00012341866,0.0007062845,0.00088099315,0.00043474082,0.0007286008],"domain_scores_gemma":[0.9984019,0.00010188539,0.00030130954,0.00079467235,0.00005174206,0.00034853388],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040403823,0.0008752049,0.0034689414,0.0004621414,0.00012835926,0.00007621978,0.00019514073,0.00044878141,0.00021263096],"category_scores_gemma":[0.000021303505,0.00064007053,0.0009001477,0.00028031194,0.0001199132,0.00014315899,0.00009473944,0.0005321187,0.0011155319],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028729179,0.0006218547,0.0006575271,0.019680947,0.0017551493,0.000040484916,0.000045021803,7.2609055e-8,0.0000016597717,0.0012312876,0.0032880658,0.9726492],"study_design_scores_gemma":[0.0016502531,0.00013899765,0.002359013,0.006189189,0.011000312,0.0000018455257,0.000004628119,0.0000013454421,0.00006890018,0.000043185482,0.9779763,0.0005660278],"about_ca_topic_score_codex":0.0000055874843,"about_ca_topic_score_gemma":0.0000013062895,"teacher_disagreement_score":0.97468823,"about_ca_system_score_codex":0.00007703426,"about_ca_system_score_gemma":0.00011490011,"threshold_uncertainty_score":0.9996622},"labels":[],"label_agreement":null},{"id":"W2945971750","doi":"10.1111/dom.13789","title":"Authors' reply to: “The role of long‐term effects of allopurinol on cardiovascular outcomes and all‐cause mortality in diabetes”","year":2019,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Institute for Clinical Evaluative Sciences; Women's College Hospital","funders":"","keywords":"Medicine; Diabetes mellitus; Endocrinology","score_opus":0.0073494023102385255,"score_gpt":0.22618286081185815,"score_spread":0.21883345850161962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945971750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98023796,0.015519516,0.0000021022006,0.0025939946,0.0005012496,0.0009747578,0.00012872371,0.000011554868,0.000030154213],"genre_scores_gemma":[0.9616909,0.0015695834,0.000034401965,0.035655923,0.00050909864,0.00011807462,0.00023561782,0.000069527916,0.00011688687],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972811,0.00045683264,0.00046581897,0.00081708253,0.00042562163,0.0005535468],"domain_scores_gemma":[0.99824274,0.00011348023,0.00024041551,0.0012045328,0.00009347966,0.00010536981],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005753901,0.00051386474,0.0013154955,0.00019075454,0.000048395184,0.000031331594,0.00040323296,0.0008253766,0.0000031942159],"category_scores_gemma":[0.00030096184,0.0003976543,0.0004003585,0.00014252076,0.00017126686,0.000012055587,0.00037863944,0.0007154749,0.000003306379],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019541842,0.00015274827,0.8753517,0.0010465162,0.0053235814,0.000011100661,0.00014639273,0.000012554079,0.111226805,0.0000066900766,0.004310835,0.0023915262],"study_design_scores_gemma":[0.0005274522,0.000106330466,0.41456297,0.000112441616,0.00065453735,5.490105e-7,0.0000034214995,0.0000017877203,0.5077028,0.000016441516,0.075984634,0.00032658098],"about_ca_topic_score_codex":0.000066801345,"about_ca_topic_score_gemma":0.0000075789308,"teacher_disagreement_score":0.46078873,"about_ca_system_score_codex":0.000014087375,"about_ca_system_score_gemma":0.000049375514,"threshold_uncertainty_score":0.99984753},"labels":[],"label_agreement":null},{"id":"W2950136952","doi":"10.1111/dom.13811","title":"Sodium‐glucose co‐transporter inhibitors, their role in type 1 diabetes treatment and a risk mitigation strategy for preventing diabetic ketoacidosis: The STOP DKA Protocol","year":2019,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Manitoba Health; Lunenfeld-Tanenbaum Research Institute; Health Sciences Centre; St Joseph's Health Care; University of Toronto; Western University; Sunnybrook Health Science Centre; LMC Diabetes & Endocrinology (Canada)","funders":"Sanofi; AstraZeneca","keywords":"Medicine; Empagliflozin; Diabetic ketoacidosis; Dapagliflozin; Diabetes mellitus; Type 2 diabetes; Type 1 diabetes; Insulin; Canagliflozin; Intensive care medicine; Internal medicine; Endocrinology","score_opus":0.026315365111541193,"score_gpt":0.2924846575457922,"score_spread":0.266169292434251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950136952","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21613047,0.7125768,9.274593e-7,0.000030848503,0.00014269703,0.07075869,0.00021512675,0.000056597954,0.000087816756],"genre_scores_gemma":[0.010296124,0.9043425,0.000100356265,0.00007102667,0.0003477388,0.08347059,0.0007834717,0.000114556744,0.00047364802],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968748,0.00034936232,0.0008425834,0.0008866929,0.00022678764,0.0008197637],"domain_scores_gemma":[0.998194,0.00037528397,0.000555223,0.00059006724,0.0000854615,0.00019999863],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008303476,0.00090131763,0.0025527633,0.00033530247,0.00023115432,0.00017507336,0.00017470775,0.00037913542,0.000019889068],"category_scores_gemma":[0.0000533274,0.0005453233,0.0005432427,0.00033450953,0.00016165237,0.00023091948,0.000077377284,0.00036198506,0.000014234293],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030774005,0.0007381808,0.042975076,0.016025424,0.0016474952,0.0000017888943,0.00039713085,9.2759075e-7,0.000024063753,0.000075963646,0.00007598935,0.9380072],"study_design_scores_gemma":[0.0054710153,0.0009759724,0.036077153,0.0080536725,0.013581984,9.519915e-7,0.00014732599,0.0001254458,0.0010943371,0.00043530585,0.9331916,0.0008452379],"about_ca_topic_score_codex":0.000029818124,"about_ca_topic_score_gemma":0.000025405,"teacher_disagreement_score":0.9371619,"about_ca_system_score_codex":0.000110786,"about_ca_system_score_gemma":0.00016937812,"threshold_uncertainty_score":0.99969983},"labels":[],"label_agreement":null},{"id":"W2954115740","doi":"10.1111/dom.13820","title":"Sodium glucose cotransporter 2 inhibitors and risk of genital mycotic and urinary tract infection: A population‐based study of older women and men with diabetes","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Ontario Drug Policy Research Network; Institute for Clinical Evaluative Sciences; Women's College Hospital; University of Toronto","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Dapagliflozin; Hazard ratio; Diabetes mellitus; Internal medicine; Cohort study; Population; Incidence (geometry); Urinary system; Cohort; Retrospective cohort study; Confidence interval; Type 2 diabetes; Endocrinology","score_opus":0.0042578219873595285,"score_gpt":0.1978892058495821,"score_spread":0.1936313838622226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954115740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963212,0.0022803103,0.0000010647428,0.000022510247,0.00004783842,0.0011924072,0.000025488855,0.000025984224,0.00008317933],"genre_scores_gemma":[0.99934906,0.00028904228,0.00009299748,0.000037186328,0.00003071181,0.000047507412,0.000029703517,0.000019667435,0.00010415417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988435,0.00006823125,0.00027581854,0.00034024977,0.00021267617,0.0002595439],"domain_scores_gemma":[0.9993377,0.00007785973,0.00016799576,0.00020119583,0.000057662357,0.00015759155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025156696,0.00024031108,0.0006742923,0.00022512044,0.00007198699,0.000024235609,0.000026999824,0.00007017745,0.000024163008],"category_scores_gemma":[0.0000109332805,0.00018358216,0.000038853857,0.00015171159,0.000093500115,0.00022654941,0.00004461545,0.00010581611,5.8318557e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008103254,0.0018895157,0.9923081,0.0006775555,0.00059836195,0.000003640824,0.0017163384,0.0000028629456,0.00050406915,0.00001440234,0.0000040654986,0.0022000943],"study_design_scores_gemma":[0.0069513577,0.0019455475,0.9872481,0.000103617516,0.0015132511,8.788373e-7,0.0003506399,0.000129543,0.0014594237,0.000058287576,0.00005837974,0.00018092262],"about_ca_topic_score_codex":0.000104048886,"about_ca_topic_score_gemma":0.0000117259015,"teacher_disagreement_score":0.006870325,"about_ca_system_score_codex":0.000013225687,"about_ca_system_score_gemma":0.000013198252,"threshold_uncertainty_score":0.7486263},"labels":[],"label_agreement":null},{"id":"W2954462466","doi":"10.1111/dom.13824","title":"Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"Novo Nordisk; Sanofi; Pfizer; Janssen Pharmaceuticals; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Diabetes mellitus; Weight management; Type 2 diabetes; Randomized controlled trial; Internal medicine; Body mass index; Overweight; Endocrinology","score_opus":0.003699516871405874,"score_gpt":0.22044988878038713,"score_spread":0.21675037190898125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954462466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98560727,0.0035139685,0.00000700534,0.00023638972,0.00014831685,0.006421016,0.0000132663645,0.0000912331,0.003961524],"genre_scores_gemma":[0.99445236,0.0011042755,0.0007611071,0.00048536205,0.000056347762,0.00044926206,0.000060529754,0.000041387837,0.002589365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749535,0.0001988697,0.00049152016,0.0007591029,0.00042595188,0.00062919816],"domain_scores_gemma":[0.99892807,0.00012564693,0.0001502774,0.00048815215,0.00006254078,0.00024531246],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00090591004,0.000468918,0.0016441399,0.0004365285,0.00014575123,0.000057245015,0.00011557733,0.0000807572,0.00007766631],"category_scores_gemma":[0.00003014996,0.0003269677,0.00011209069,0.00033462778,0.00016047679,0.00028091465,0.00026474404,0.00020315242,0.000020696938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01622398,0.006495199,0.9551837,0.0009415852,0.0024624802,0.000066481276,0.0019787308,0.0000015201466,0.00011820507,0.0017841794,0.00007358997,0.0146703655],"study_design_scores_gemma":[0.4674903,0.0015316462,0.521309,0.00071733055,0.0024453434,8.495695e-7,0.00050460617,0.00084736786,0.00029881988,0.00019140319,0.004208162,0.00045515996],"about_ca_topic_score_codex":0.000031744356,"about_ca_topic_score_gemma":0.0000226025,"teacher_disagreement_score":0.45126632,"about_ca_system_score_codex":0.000037648362,"about_ca_system_score_gemma":0.000017771545,"threshold_uncertainty_score":0.9999182},"labels":[],"label_agreement":null},{"id":"W2954546034","doi":"10.1111/dom.13826","title":"Long‐term efficacy and safety of combined insulin and glucagon‐like peptide‐1 therapy: Evidence from the LEADER trial","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Novo Nordisk","keywords":"Medicine; Term (time); Insulin; Glucagon-like peptide-1; Internal medicine; Intensive care medicine; Endocrinology; Type 2 diabetes; Diabetes mellitus","score_opus":0.02133313376193959,"score_gpt":0.2495910649470088,"score_spread":0.2282579311850692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954546034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9586148,0.038541913,0.0000031446875,0.00078031694,0.00028932752,0.001593745,0.000020007923,0.000029986833,0.00012671622],"genre_scores_gemma":[0.98598456,0.012360548,0.00010552961,0.0007809321,0.00014364326,0.000024725798,0.00003783842,0.000017172215,0.00054504606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987411,0.000111411086,0.0002809736,0.00037221427,0.00022913433,0.0002651492],"domain_scores_gemma":[0.99878544,0.00052675145,0.00012310676,0.0003861555,0.000051723582,0.00012679992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003959887,0.00023604972,0.0006386095,0.00006143244,0.000096212476,0.000053632073,0.00010703924,0.00009208728,0.00008043258],"category_scores_gemma":[0.000083014915,0.00015072167,0.00007932331,0.00011506989,0.00021637787,0.00019079517,0.00014779471,0.00014589907,0.000011605637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007134684,0.000699139,0.91772175,0.00019067498,0.00079149235,0.0000032848322,0.0017487003,4.4936604e-7,0.004311029,0.000351473,0.000247355,0.0668],"study_design_scores_gemma":[0.043295942,0.0005553603,0.94980633,0.0002613801,0.0005926978,2.6749984e-7,0.00006470426,0.000020297308,0.0020890825,0.00010999728,0.00305295,0.00015096091],"about_ca_topic_score_codex":0.00006635174,"about_ca_topic_score_gemma":0.0000078735775,"teacher_disagreement_score":0.066649035,"about_ca_system_score_codex":0.000008365834,"about_ca_system_score_gemma":0.000024529918,"threshold_uncertainty_score":0.6146251},"labels":[],"label_agreement":null},{"id":"W2956359130","doi":"10.1111/dom.13831","title":"Renal hyperfiltration defined by high estimated glomerular filtration rate: A risk factor for cardiovascular disease and mortality","year":2019,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"Koç Üniversitesi Translasyonel Tıp Araştırma Merkezi; Ministerio de Fomento","keywords":"Glomerular hyperfiltration; Renal function; Medicine; Kidney disease; Diabetes mellitus; Nephron; Risk factor; Disease; Internal medicine; Intensive care medicine; Endocrinology; Diabetic nephropathy","score_opus":0.034576305812519345,"score_gpt":0.28683598987509923,"score_spread":0.25225968406257987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956359130","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1679617,0.82046384,0.00009973706,0.00001744332,0.00022899885,0.0024338223,0.008702553,0.00008480319,0.000007090596],"genre_scores_gemma":[0.0075105564,0.98417896,0.00031649013,0.0001181968,0.0003660863,0.00036980683,0.006977441,0.00007644394,0.00008601969],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997204,0.00032999262,0.00062007696,0.0009600948,0.00036695568,0.00051886],"domain_scores_gemma":[0.9977145,0.00031931303,0.00032747403,0.000762002,0.00015388893,0.00072279805],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005766067,0.00067797943,0.002829696,0.00016097593,0.00022672705,0.00013362878,0.000105512125,0.00040003666,0.000055923963],"category_scores_gemma":[0.000879735,0.00055525306,0.0011923522,0.00023074425,0.00013682162,0.00025883634,0.000060687264,0.00031576602,0.000014937356],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009716018,0.0007358512,0.012891581,0.08385609,0.014493166,0.0000132749765,0.000061738254,0.000008244811,0.00017526255,0.0004022257,0.0015353366,0.8857301],"study_design_scores_gemma":[0.004475764,0.00015018617,0.08649351,0.004973607,0.106515884,0.0000040905798,0.0000054062316,0.00066745694,0.00015795918,0.00053910975,0.79476845,0.0012485872],"about_ca_topic_score_codex":0.00006621047,"about_ca_topic_score_gemma":0.0000013135163,"teacher_disagreement_score":0.8844815,"about_ca_system_score_codex":0.00005980002,"about_ca_system_score_gemma":0.0005432374,"threshold_uncertainty_score":0.9996899},"labels":[],"label_agreement":null},{"id":"W2965202731","doi":"10.1111/dom.13852","title":"Dapagliflozin vs non‐SGLT‐2i treatment is associated with lower healthcare costs in type 2 diabetes patients similar to participants in the DECLARE‐TIMI 58 trial: A nationwide observational study","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca","keywords":"Dapagliflozin; Medicine; Propensity score matching; Population; Observational study; Type 2 diabetes; TIMI; Internal medicine; Diabetes mellitus; Inclusion and exclusion criteria; Emergency medicine; Endocrinology; Environmental health; Myocardial infarction; Alternative medicine","score_opus":0.04937953159987543,"score_gpt":0.29813904196884766,"score_spread":0.24875951036897223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965202731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99112296,0.00041361802,1.7655138e-7,0.0021280346,0.00030559747,0.005817413,0.000054348322,0.00003275431,0.0001250678],"genre_scores_gemma":[0.9936608,0.00007998388,0.000050482635,0.0049538636,0.000051445728,0.00060085754,0.00027623208,0.00003122229,0.00029511485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973855,0.0002790567,0.00046515648,0.00055533095,0.0006082212,0.00070673844],"domain_scores_gemma":[0.9987548,0.00025994546,0.00014413465,0.00042079456,0.00021990617,0.00020039668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073823566,0.00036134492,0.0008443983,0.00030058922,0.000104269406,0.000074473835,0.0001547173,0.00010969976,0.00005303186],"category_scores_gemma":[0.000244799,0.00024206129,0.000077837525,0.00083906,0.000034106455,0.00021590391,0.00007566528,0.00014960376,0.00003473207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011523401,0.005890877,0.98820573,0.00003596722,0.00038969915,0.000010671869,0.0024112242,0.0000140965085,0.000017816255,0.000045203597,0.00031573363,0.0015106571],"study_design_scores_gemma":[0.035941504,0.004128502,0.956259,0.00017687524,0.00043846434,2.4767896e-8,0.0003650625,0.00022547592,0.00011924345,0.00004199188,0.0020648164,0.00023904149],"about_ca_topic_score_codex":0.00015817954,"about_ca_topic_score_gemma":0.0011641819,"teacher_disagreement_score":0.034789167,"about_ca_system_score_codex":0.00026625546,"about_ca_system_score_gemma":0.00011226314,"threshold_uncertainty_score":0.98709726},"labels":[],"label_agreement":null},{"id":"W2965229115","doi":"10.1111/dom.13839","title":"Glucagon‐like peptide‐2 mobilizes lipids from the intestine by a systemic nitric oxide‐independent mechanism","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Diabetes Canada; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Chylomicron; Internal medicine; Endocrinology; Nitric oxide; Triglyceride; Omega-N-Methylarginine; Medicine; Chemistry; Lipoprotein; Nitric oxide synthase; Very low-density lipoprotein; Cholesterol","score_opus":0.006032439116310421,"score_gpt":0.19833749693419228,"score_spread":0.19230505781788185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965229115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813553,0.01487769,0.000036506524,0.00035400744,0.0005842302,0.0014593184,0.00007669945,0.00016461937,0.0010916328],"genre_scores_gemma":[0.98923326,0.0010631757,0.00028506524,0.0017693199,0.00024084795,0.00014058585,0.0002036691,0.0000447858,0.0070193005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783975,0.0001262848,0.00038337984,0.00062404847,0.00046497298,0.0005615681],"domain_scores_gemma":[0.9985073,0.00028480554,0.00015996555,0.00070604135,0.00010079837,0.00024105003],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004828305,0.0004103876,0.0007838046,0.00012353026,0.000152463,0.00011109645,0.00026554332,0.00014804743,0.00023472076],"category_scores_gemma":[0.00008756566,0.00027404676,0.00020133694,0.00027366608,0.00008056285,0.00019336543,0.00027735403,0.00028942683,0.00039623887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013707297,0.0016803448,0.73944116,0.0007028512,0.0026550498,0.00002657363,0.00084665715,0.0000058064857,0.21577735,0.008612248,0.019118957,0.010995912],"study_design_scores_gemma":[0.010244249,0.00041936085,0.8557158,0.0008764971,0.0045469888,0.000013005167,0.0013369198,0.0008093156,0.0364101,0.0050989375,0.08341721,0.001111634],"about_ca_topic_score_codex":0.0002514913,"about_ca_topic_score_gemma":0.000006580225,"teacher_disagreement_score":0.17936726,"about_ca_system_score_codex":0.00005546293,"about_ca_system_score_gemma":0.000038752572,"threshold_uncertainty_score":0.99997115},"labels":[],"label_agreement":null},{"id":"W2971769159","doi":"10.1111/dom.13874","title":"Cardiovascular outcomes trials in type 2 diabetes: Time to include young adults","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Public Health Ontario; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Type 2 diabetes; Medicine; Diabetes mellitus; Internal medicine; Pediatrics; Gerontology; Endocrinology","score_opus":0.011434455576190002,"score_gpt":0.24030736058747618,"score_spread":0.22887290501128618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971769159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857494,0.008521557,0.0000012687457,0.0003887525,0.00049977616,0.0018358533,0.000019421339,0.00009017006,0.0028937727],"genre_scores_gemma":[0.9930037,0.00040821484,0.0004330015,0.0014218495,0.00014032784,0.000093865296,0.0000828115,0.000039176393,0.0043770485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976453,0.00023992751,0.00052600505,0.00055396254,0.0004304226,0.00060436974],"domain_scores_gemma":[0.9987106,0.00020706472,0.000092239345,0.0006349072,0.000089021,0.0002661746],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021252993,0.00033999528,0.0021549289,0.00040011946,0.00005356889,0.000057053443,0.00014138337,0.00013457511,0.00036301732],"category_scores_gemma":[0.0005889989,0.00026782512,0.00046297457,0.00043635917,0.00003399856,0.0001876007,0.0002157235,0.0001523727,0.0014557758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007155698,0.00039887498,0.9657881,0.00028021232,0.0018232217,0.000010902816,0.00036629662,0.000014832068,0.001158696,0.00013395945,0.00086798694,0.029085347],"study_design_scores_gemma":[0.0043899943,0.00018307561,0.92537606,0.00020711782,0.0011184963,2.3127775e-7,0.00003704682,0.000091326576,0.0017847485,0.00008912715,0.06640793,0.00031485295],"about_ca_topic_score_codex":0.000048699,"about_ca_topic_score_gemma":0.0000068680188,"teacher_disagreement_score":0.06553994,"about_ca_system_score_codex":0.000049940583,"about_ca_system_score_gemma":0.000030180228,"threshold_uncertainty_score":0.9999774},"labels":[],"label_agreement":null},{"id":"W2972107819","doi":"10.1111/dom.13876","title":"Effects of sodium‐glucose co‐transporter‐2 inhibitors in type 2 diabetes in women versus men","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Medicine; Empagliflozin; Type 2 diabetes; Diabetes mellitus; Internal medicine; Dapagliflozin; Adverse effect; Canagliflozin; Placebo; Endocrinology","score_opus":0.004777926649296908,"score_gpt":0.21199667970781733,"score_spread":0.20721875305852042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972107819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899805,0.006501722,9.495045e-8,0.00006878465,0.00043109467,0.0010023495,0.0000065945223,0.000034697754,0.001974171],"genre_scores_gemma":[0.99811596,0.0011848712,0.000053280648,0.00018406361,0.000054027347,0.000071998285,0.00003830086,0.000024126017,0.00027337926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998405,0.00006628933,0.00034199265,0.00036373115,0.00024110096,0.0005818807],"domain_scores_gemma":[0.9993033,0.00016083155,0.00009117583,0.0002537186,0.00003687533,0.00015409772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003684855,0.0002577329,0.00083136704,0.00040351102,0.000020220199,0.000015795582,0.000097554555,0.00012684918,0.000058230165],"category_scores_gemma":[0.00004754303,0.00023120629,0.00008011794,0.0004103766,0.000077683355,0.00019276995,0.00005410602,0.00016908195,0.00003987596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031411607,0.00095556624,0.9613387,0.0012166529,0.00027111932,0.00001723777,0.0010584996,0.0000019300358,0.021140378,0.00027574133,0.00011462379,0.013295432],"study_design_scores_gemma":[0.009851614,0.0004134838,0.89158213,0.00026877373,0.00019722627,3.9287226e-8,0.00012793473,0.000053887583,0.09328603,0.00015781568,0.00385025,0.00021078275],"about_ca_topic_score_codex":0.00004038003,"about_ca_topic_score_gemma":0.000011353382,"teacher_disagreement_score":0.072145656,"about_ca_system_score_codex":0.00006817087,"about_ca_system_score_gemma":0.00003451965,"threshold_uncertainty_score":0.9428319},"labels":[],"label_agreement":null},{"id":"W2979521390","doi":"10.1111/dom.13893","title":"Comparative cardiovascular and hypoglycaemic safety of glimepiride in type 2 diabetes: A population‐based cohort study","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Boehringer Ingelheim Stiftung","keywords":"Glimepiride; Medicine; Hazard ratio; Incidence (geometry); Type 2 diabetes; Internal medicine; Myocardial infarction; Stroke (engine); Gliclazide; Diabetes mellitus; Proportional hazards model; Population; Confidence interval; Cohort study; Cardiology; Endocrinology; Insulin","score_opus":0.011605204755857614,"score_gpt":0.23999813862626526,"score_spread":0.22839293387040766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979521390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888518,0.008263598,0.0000016366988,0.000034737903,0.00014110765,0.002112383,0.0000126996065,0.00003087363,0.00055118604],"genre_scores_gemma":[0.99913573,0.00022251606,0.0002020624,0.00013512229,0.000027919414,0.0000452842,0.000082706254,0.000015351787,0.0001333339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985202,0.00013587104,0.00033004352,0.00041336138,0.0003049062,0.00029564052],"domain_scores_gemma":[0.99921334,0.000097906996,0.000089360285,0.00040947628,0.000081807695,0.00010808902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059838314,0.00023016968,0.0012273351,0.0002566308,0.000044583663,0.000017320563,0.00006457232,0.0000694117,0.000034850207],"category_scores_gemma":[0.00003727479,0.00019958592,0.0001272928,0.0003385625,0.000057657795,0.00013089724,0.000080786114,0.00012001726,0.000012310437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005677709,0.00055801217,0.9958968,0.00018462606,0.0011135172,0.0000027763476,0.00025970404,0.00006192821,0.00028999374,0.0000842112,0.000015728721,0.0014759],"study_design_scores_gemma":[0.0042675743,0.00026164076,0.9910983,0.000100089754,0.0013459843,1.2734401e-7,0.00013890637,0.0004713395,0.0008942399,0.000058165122,0.001184826,0.00017882536],"about_ca_topic_score_codex":0.00014519905,"about_ca_topic_score_gemma":0.000022074651,"teacher_disagreement_score":0.0102839265,"about_ca_system_score_codex":0.00003526263,"about_ca_system_score_gemma":0.000025485982,"threshold_uncertainty_score":0.8138878},"labels":[],"label_agreement":null},{"id":"W2982015658","doi":"10.1111/dom.13901","title":"Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT study","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto","funders":"Genentech; HLS Therapeutics; Ipsen; Novo Nordisk; Intarcia Therapeutics; Sanofi; GlaxoSmithKline; Roche Diabetes Care; Servier; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Insulin degludec; Insulin glargine; Titration; Insulin; Medicine; Hypoglycemia; Internal medicine; Endocrinology; Chemistry; Inorganic chemistry","score_opus":0.008804360340932764,"score_gpt":0.21409659241442822,"score_spread":0.20529223207349545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982015658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99640393,0.0017850357,0.000011173768,0.00022547827,0.00004565858,0.001281595,0.00004007894,0.000022334618,0.00018471545],"genre_scores_gemma":[0.99895525,0.00031627814,0.000027470966,0.00015662216,0.00006406029,0.00004506007,0.000029207236,0.000022327622,0.0003837188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984228,0.00021956471,0.00026052914,0.00037364033,0.00041530968,0.0003081541],"domain_scores_gemma":[0.9989418,0.00012585665,0.00015105213,0.00031919582,0.00033754704,0.00012458133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045354143,0.00023041676,0.00058876193,0.0002810453,0.00015379013,0.000067648965,0.000100204365,0.000099594516,0.000028407094],"category_scores_gemma":[0.00010193872,0.00015064247,0.000041335014,0.00079466595,0.00018174079,0.00032884182,0.00012379607,0.00027911025,0.0000020915998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057719974,0.00026907705,0.9866605,0.0003567559,0.00069262646,0.000006803074,0.0012368553,0.000011917135,0.006467797,0.00009476778,0.000006548867,0.0036191694],"study_design_scores_gemma":[0.0066359336,0.0001912553,0.98309517,0.0001287858,0.0012871956,0.0000011018312,0.000727014,0.0007017334,0.006770948,0.000049515977,0.00023582527,0.00017552682],"about_ca_topic_score_codex":0.00008633851,"about_ca_topic_score_gemma":0.0001482641,"teacher_disagreement_score":0.006058734,"about_ca_system_score_codex":0.00002102047,"about_ca_system_score_gemma":0.0000652899,"threshold_uncertainty_score":0.6143022},"labels":[],"label_agreement":null},{"id":"W2993540759","doi":"10.1111/dom.13938","title":"Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose‐lowering therapy?","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Manitoba; University of Toronto; Lunenfeld-Tanenbaum Research Institute; St. Michael's Hospital","funders":"Boehringer Ingelheim; Eli Lilly and Company","keywords":"Empagliflozin; Medicine; Baseline (sea); Internal medicine; Cardiology; Diabetes mellitus; Type 2 diabetes; Endocrinology","score_opus":0.00789071885382023,"score_gpt":0.20363925178007017,"score_spread":0.19574853292624994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993540759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.919058,0.07953996,0.000004571287,0.0003399247,0.00013429021,0.00062472833,0.00004772934,0.000032708318,0.00021806771],"genre_scores_gemma":[0.9896763,0.0081321,0.0001018587,0.0016706819,0.000068244226,0.000029572706,0.00003493615,0.000019456582,0.00026687243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988846,0.00005719513,0.00020218798,0.00030713793,0.00026998075,0.00027885672],"domain_scores_gemma":[0.9991484,0.00006210153,0.00010730583,0.0004411106,0.000074745534,0.00016631812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051053456,0.00021186355,0.00062122574,0.00007815413,0.000077406665,0.000030090714,0.000091902664,0.000071215734,0.000035861325],"category_scores_gemma":[0.00008309016,0.00013950714,0.00016993277,0.00015566322,0.00009246443,0.00012682866,0.00010182655,0.00010726863,0.000007639127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049745107,0.0003364631,0.90668637,0.00047335646,0.0026345449,0.000002848227,0.00036868232,0.000026514088,0.017983373,0.00028478823,0.0009539251,0.07019938],"study_design_scores_gemma":[0.0035750456,0.00009591983,0.8384235,0.00018568808,0.00094608316,7.8533884e-7,0.00011250853,0.00009618122,0.058363724,0.000050214752,0.09793904,0.00021129289],"about_ca_topic_score_codex":0.000036278805,"about_ca_topic_score_gemma":0.0000011167945,"teacher_disagreement_score":0.09698511,"about_ca_system_score_codex":0.000007690649,"about_ca_system_score_gemma":0.000013593027,"threshold_uncertainty_score":0.5688936},"labels":[],"label_agreement":null},{"id":"W2995051978","doi":"10.1111/dom.13943","title":"Comparative effects of lifestyle modification, metformin and exenatide/glargine combination therapy on daily glycaemic fluctuation in the setting of near‐normoglycaemia","year":2019,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Banting and Best Diabetes Centre, University of Toronto; Canadian Institutes of Health Research","keywords":"Mount; Medicine; Exenatide; Diabetes mellitus; Metformin; Family medicine; Gerontology; Library science; History; Type 2 diabetes; Engineering; Endocrinology","score_opus":0.012862102025733136,"score_gpt":0.24962455513296092,"score_spread":0.2367624531072278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995051978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97996485,0.0050511807,0.000010429057,0.012304686,0.0001503781,0.0021608842,0.000025098247,0.000017232083,0.00031524722],"genre_scores_gemma":[0.97203255,0.0018173102,0.00028506777,0.024418807,0.00015898197,0.00014976933,0.00083807186,0.000027261707,0.0002721967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821377,0.00025604924,0.0004429682,0.0003671275,0.00045172567,0.0002683363],"domain_scores_gemma":[0.99813646,0.0008362444,0.00045096586,0.00039826374,0.00014774116,0.000030353667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006108508,0.00033710874,0.0010555807,0.00033484664,0.000072175324,0.00003741602,0.0001455093,0.0002680767,0.0000048665133],"category_scores_gemma":[0.000102821905,0.0002370296,0.000100652825,0.00030339777,0.00014375758,0.00018752395,0.00004461231,0.00047448333,0.0000039913452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010180383,0.008796736,0.45196518,0.031700216,0.008139756,0.00009926467,0.071797304,0.00015146035,0.038825933,0.017722731,0.22172238,0.148061],"study_design_scores_gemma":[0.0077978694,0.00078811747,0.9228035,0.00087436405,0.0011418583,0.0000015683946,0.00012706085,0.0013241624,0.025033562,0.0008342881,0.038885266,0.0003883536],"about_ca_topic_score_codex":0.00005505416,"about_ca_topic_score_gemma":0.0000029712012,"teacher_disagreement_score":0.47083837,"about_ca_system_score_codex":0.000029888313,"about_ca_system_score_gemma":0.00004266226,"threshold_uncertainty_score":0.96657866},"labels":[],"label_agreement":null},{"id":"W2996036402","doi":"10.1111/dom.13946","title":"The importance of the initial period of basal insulin titration in people with diabetes","year":2019,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Health Sciences Centre; Winnipeg Regional Health Authority","funders":"Department of Health and Social Care; National Institute for Health and Care Research; Sanofi","keywords":"Basal insulin; Basal (medicine); Period (music); Titration; Insulin; Diabetes mellitus; Endocrinology; Medicine; Chemistry; Type 2 diabetes; Art; Inorganic chemistry","score_opus":0.026442326779344324,"score_gpt":0.3023705261040479,"score_spread":0.2759281993247036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996036402","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28928688,0.70866823,2.6137278e-7,0.00009918071,0.00015055996,0.0011818844,0.00003161548,0.0000058583323,0.00057551067],"genre_scores_gemma":[0.038367413,0.9605892,0.00003323237,0.000075274154,0.0001397201,0.00009956062,0.000063741754,0.000037071142,0.00059482077],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980028,0.00024457244,0.00057731336,0.00030224153,0.00048350805,0.00038951106],"domain_scores_gemma":[0.9985416,0.0002760433,0.00042577318,0.00056801643,0.00012578303,0.00006280474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093108614,0.00028449923,0.0016005329,0.00018284847,0.00009578754,0.000037600512,0.00032965574,0.00018612466,0.000023298238],"category_scores_gemma":[0.00020299673,0.00013561318,0.00027239873,0.000673449,0.0003405019,0.000101156955,0.00021447218,0.00047576247,0.000004902451],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003571836,0.00041340615,0.42491725,0.041383144,0.0007444662,0.0000021874475,0.00028771732,0.0000010424209,0.000020237865,0.0016967049,0.0001944475,0.53030366],"study_design_scores_gemma":[0.001734549,0.0002254967,0.5196142,0.010181078,0.002517594,4.429081e-7,0.000078231016,0.000076261815,0.00021278065,0.00021636677,0.464752,0.0003909772],"about_ca_topic_score_codex":0.000007720235,"about_ca_topic_score_gemma":0.00007529994,"teacher_disagreement_score":0.5299127,"about_ca_system_score_codex":0.00002043212,"about_ca_system_score_gemma":0.000296652,"threshold_uncertainty_score":0.5530145},"labels":[],"label_agreement":null},{"id":"W2996554586","doi":"10.1111/dom.13945","title":"Low‐dose empagliflozin as adjunct‐to‐insulin therapy in type 1 diabetes: A valid modelling and simulation analysis to confirm efficacy","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Boehringer Ingelheim (Canada); Mount Sinai Hospital","funders":"Boehringer Ingelheim; Eli Lilly and Company","keywords":"Empagliflozin; Medicine; Insulin; Population; Diabetes mellitus; Placebo; Type 2 diabetes; Type 1 diabetes; Internal medicine; Endocrinology","score_opus":0.026340575980382454,"score_gpt":0.3030969097098147,"score_spread":0.2767563337294322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996554586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99457204,0.002754825,0.00011696908,0.0004913541,0.00015439118,0.0014998772,0.000008888423,0.000048720674,0.00035291153],"genre_scores_gemma":[0.99630624,0.00060084386,0.0003823957,0.0016380805,0.0001082287,0.00002835854,0.000056679077,0.000032788274,0.0008463559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779534,0.00013069889,0.00035189823,0.00063749263,0.00044918343,0.0006353638],"domain_scores_gemma":[0.99863315,0.00025762097,0.00006280389,0.00043135224,0.00018729303,0.00042776405],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008922193,0.00029146115,0.00087435794,0.0010921981,0.00008598798,0.00011883599,0.00014460238,0.00014456498,0.00016763114],"category_scores_gemma":[0.00018292603,0.00024817284,0.0001317604,0.0018140215,0.00005279669,0.00017742053,0.00015673015,0.00025344468,0.00020186907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006553853,0.0013665536,0.7240305,0.00041431325,0.0021382081,0.000011320723,0.0031068157,0.16355106,0.008983705,0.00040537937,0.0001007993,0.09523597],"study_design_scores_gemma":[0.0041739554,0.00053042406,0.7855352,0.0001554027,0.0006546149,4.847789e-8,0.00008408793,0.19659626,0.0038971726,0.0002729771,0.007657498,0.00044231347],"about_ca_topic_score_codex":0.000050845003,"about_ca_topic_score_gemma":0.000010117625,"teacher_disagreement_score":0.09479366,"about_ca_system_score_codex":0.000024477931,"about_ca_system_score_gemma":0.000040866802,"threshold_uncertainty_score":0.9999971},"labels":[],"label_agreement":null},{"id":"W2998275298","doi":"10.1111/dom.13955","title":"Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ted Rogers Centre for Heart Research; Toronto General Hospital","funders":"Novo Nordisk; Steno Diabetes Center Copenhagen","keywords":"Semaglutide; Medicine; Type 2 diabetes; Diabetes mellitus; Internal medicine; Cardiology; Intensive care medicine; Endocrinology; Liraglutide","score_opus":0.01189550944405662,"score_gpt":0.22508104765261885,"score_spread":0.21318553820856223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998275298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8826075,0.11582862,0.000011203789,0.0003461684,0.00018490884,0.0007533319,0.000025429106,0.00009759483,0.0001452065],"genre_scores_gemma":[0.98991245,0.008626434,0.0004680508,0.0005279449,0.00024337893,0.000056216635,0.000048649857,0.000043851076,0.000073019066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747556,0.00021972015,0.0003385422,0.00074156537,0.00046634107,0.00075826043],"domain_scores_gemma":[0.99890834,0.00008880705,0.00007789529,0.00044590296,0.000090278445,0.0003887594],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009692151,0.00038775755,0.0012659399,0.00013607845,0.00020525507,0.000053420194,0.00012312061,0.00014546883,0.000011303938],"category_scores_gemma":[0.00038773174,0.00035042164,0.00046126483,0.0005150799,0.00011978248,0.00021953456,0.00029560548,0.0003025892,0.000018120985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051518346,0.00025964936,0.89157605,0.00079770386,0.0068245707,0.000059598606,0.0020453306,0.0002581471,0.00083753385,0.000076406126,0.00015332353,0.09706018],"study_design_scores_gemma":[0.004480548,0.00016017622,0.9425772,0.00016451892,0.003679534,0.0000011537039,0.00039280707,0.0006269977,0.005569321,0.0002487963,0.041596044,0.0005029184],"about_ca_topic_score_codex":0.000085757056,"about_ca_topic_score_gemma":0.0000027731337,"teacher_disagreement_score":0.107304916,"about_ca_system_score_codex":0.000037488986,"about_ca_system_score_gemma":0.000030404422,"threshold_uncertainty_score":0.9998948},"labels":[],"label_agreement":null},{"id":"W3004835181","doi":"10.1111/dom.13991","title":"Association between uric acid levels and cardio‐renal outcomes and death in patients with type 2 diabetes: A subanalysis of EMPA‐REG OUTCOME","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; Lunenfeld-Tanenbaum Research Institute; St. Michael's Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Eli Lilly and Company","keywords":"Empagliflozin; Medicine; Hazard ratio; Mace; Internal medicine; Uric acid; Type 2 diabetes; Placebo; Diabetic nephropathy; Confidence interval; Diabetes mellitus; Cardiology; Endocrinology; Myocardial infarction; Kidney; Percutaneous coronary intervention","score_opus":0.017860684801858918,"score_gpt":0.23375872892902466,"score_spread":0.21589804412716573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004835181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969426,0.002072893,0.000008960361,0.0004226184,0.000032340195,0.0003464124,0.000110135,0.000028607505,0.00003547645],"genre_scores_gemma":[0.9988162,0.00007064135,0.0003664269,0.00053156744,0.000070113136,0.000008016796,0.000057372283,0.000023047929,0.000056616853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820185,0.000119805205,0.00043147677,0.00040733902,0.0004617558,0.00037779543],"domain_scores_gemma":[0.998952,0.00016651292,0.00024066737,0.0001957934,0.00016041163,0.0002846309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040117805,0.0002745192,0.0013307796,0.00019776852,0.00006602907,0.000028260465,0.00007783928,0.00017988587,0.000012482824],"category_scores_gemma":[0.0005596083,0.00021248563,0.00009053837,0.0005085258,0.000060454422,0.00020455361,0.00010976463,0.00027452374,0.0000026280356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023116923,0.00007481597,0.9967317,0.00016846508,0.0010375446,0.0000017176116,0.0005718054,0.0000013910847,0.00030689323,0.000008762057,0.000011157539,0.0010626054],"study_design_scores_gemma":[0.003054005,0.00017280683,0.99194986,0.00003916291,0.0028158007,1.215723e-7,0.00003249631,0.000034346263,0.0014757832,0.000030309266,0.0001798502,0.0002154692],"about_ca_topic_score_codex":0.000042744887,"about_ca_topic_score_gemma":0.000005898076,"teacher_disagreement_score":0.0047818767,"about_ca_system_score_codex":0.00004279577,"about_ca_system_score_gemma":0.00003554027,"threshold_uncertainty_score":0.86649126},"labels":[],"label_agreement":null},{"id":"W3006085306","doi":"10.1111/dom.13997","title":"Efficacy and safety of dual add‐on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52‐week, randomized, active‐controlled trial","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca; American Diabetes Association","keywords":"Saxagliptin; Medicine; Dapagliflozin; Glimepiride; Metformin; Type 2 diabetes; Pharmacology; Fixed-dose combination; Diabetes mellitus; Internal medicine; Urology; Endocrinology; Sitagliptin","score_opus":0.014505288255022824,"score_gpt":0.22342156750597997,"score_spread":0.20891627925095715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006085306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881605,0.0018792247,0.0000010714473,0.000272984,0.00017497872,0.008539888,0.00023198903,0.00003604088,0.0007033216],"genre_scores_gemma":[0.9981101,0.000523764,0.00030820287,0.00035509316,0.00012433728,0.00022759229,0.00024415992,0.000038734215,0.000068013906],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970629,0.00038841483,0.00086145964,0.0006220709,0.00059903704,0.00046611877],"domain_scores_gemma":[0.9964416,0.0021286062,0.00062643667,0.00035558201,0.00019589548,0.00025185966],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006925852,0.00050929846,0.0036016705,0.0002672414,0.00007223795,0.000033458728,0.00010944153,0.00013282022,0.00003362671],"category_scores_gemma":[0.0009376013,0.0003073527,0.00020574787,0.00037889497,0.0002542348,0.00019181399,0.000062979096,0.00024005068,0.0000026721139],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98255754,0.002801265,0.0022613632,0.000058824455,0.0043187332,0.0000065094796,0.000857519,0.00003920571,0.00033368377,0.00018327059,0.000042082735,0.0065399953],"study_design_scores_gemma":[0.92190814,0.013019183,0.05770471,0.00025445415,0.002422605,1.8505782e-8,0.00008284934,0.00022732963,0.003719399,0.000022683922,0.0003638421,0.0002748138],"about_ca_topic_score_codex":0.00007003136,"about_ca_topic_score_gemma":0.000018160197,"teacher_disagreement_score":0.060649432,"about_ca_system_score_codex":0.000039400235,"about_ca_system_score_gemma":0.00009839386,"threshold_uncertainty_score":0.99993783},"labels":[],"label_agreement":null},{"id":"W3008335290","doi":"10.1111/dom.14011","title":"Cardiovascular and renal benefits of dapagliflozin in patients with short and long‐standing type 2 diabetes: Analysis from the DECLARE‐TIMI 58 trial","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; LMC Diabetes & Endocrinology (Canada); Mount Sinai Hospital","funders":"","keywords":"Medicine; Dapagliflozin; Diabetes mellitus; Internal medicine; Myocardial infarction; Mace; Type 2 diabetes; Hazard ratio; Stroke (engine); Cardiology; TIMI; Percutaneous coronary intervention; Endocrinology; Confidence interval","score_opus":0.01415808740807647,"score_gpt":0.20265518379180927,"score_spread":0.1884970963837328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008335290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748844,0.02400966,0.000014887209,0.00016350983,0.00005399288,0.00074793777,0.00006474412,0.000018581699,0.00004229096],"genre_scores_gemma":[0.9980064,0.0010390728,0.0002380402,0.0004059664,0.00010038961,0.00001923567,0.00016682365,0.000016534927,0.0000075100033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985598,0.000092793576,0.00026965188,0.000436041,0.00035778462,0.00028393365],"domain_scores_gemma":[0.99927914,0.00011062003,0.00006740962,0.000285462,0.00007622882,0.00018115046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030389146,0.0002343325,0.0009565386,0.00014420223,0.000080537844,0.000048098053,0.00007940903,0.00008107641,0.000018887506],"category_scores_gemma":[0.00008594621,0.00015483802,0.00014591363,0.0006062643,0.00012501839,0.00014063985,0.0001322419,0.00013346366,6.3259847e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007809669,0.00015974307,0.98394114,0.00006253304,0.004875265,0.0000024294739,0.00038041075,0.00003975568,0.000027281078,0.000041824318,0.000030946492,0.0096577145],"study_design_scores_gemma":[0.0149690965,0.00037555993,0.97327125,0.00007956741,0.009475249,2.1336781e-8,0.00004906815,0.00019194989,0.00044759092,0.00002126906,0.00095416204,0.00016519167],"about_ca_topic_score_codex":0.000036982805,"about_ca_topic_score_gemma":0.000031819014,"teacher_disagreement_score":0.023122031,"about_ca_system_score_codex":0.000012657208,"about_ca_system_score_gemma":0.00001522798,"threshold_uncertainty_score":0.63141114},"labels":[],"label_agreement":null},{"id":"W3009238663","doi":"10.1111/dom.14017","title":"Can the cardiovascular risk reductions observed with empagliflozin in the EMPA‐REG OUTCOME trial be explained by concomitant changes seen in conventional cardiovascular risk factor levels?","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; Lunenfeld-Tanenbaum Research Institute; St. Michael's Hospital","funders":"National Institute for Health and Care Research","keywords":"Empagliflozin; Medicine; Internal medicine; Cardiology; Myocardial infarction; Risk factor; Heart failure; Type 2 diabetes; Diabetes mellitus; Relative risk; Hazard ratio; Confidence interval; Endocrinology","score_opus":0.05443718887107603,"score_gpt":0.23978317151922038,"score_spread":0.18534598264814434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009238663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738516,0.016525451,0.000019835392,0.006155267,0.00021275206,0.0024414088,0.0006684257,0.0000512008,0.00007405493],"genre_scores_gemma":[0.9962759,0.0015436949,0.00008773918,0.0010569302,0.00034426904,0.00041534583,0.0001427746,0.00003088361,0.00010243201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969286,0.0008526257,0.00040807662,0.00057714945,0.0007187956,0.0005147961],"domain_scores_gemma":[0.99875945,0.00019983487,0.0001479742,0.0006342886,0.00006835795,0.00019007205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001406931,0.00038505418,0.0011772689,0.00011927497,0.00026703867,0.00008392495,0.00025443605,0.000120369965,0.00003657094],"category_scores_gemma":[0.00027473483,0.00022281158,0.00062773895,0.00051795895,0.00020322467,0.00013548222,0.00009989773,0.0005072065,0.000004622949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020154049,0.0012898243,0.9453124,0.00036377888,0.020240067,0.00012481443,0.011358212,0.0003094103,0.0001902778,0.00056493556,0.0016675338,0.016563334],"study_design_scores_gemma":[0.03904348,0.00038955445,0.8881257,0.0000498261,0.005498312,0.0000015802793,0.0022071763,0.000097004515,0.00053704454,0.00008456084,0.0635992,0.00036656737],"about_ca_topic_score_codex":0.0008732135,"about_ca_topic_score_gemma":0.00042212737,"teacher_disagreement_score":0.061931666,"about_ca_system_score_codex":0.000058918045,"about_ca_system_score_gemma":0.000054813274,"threshold_uncertainty_score":0.90859926},"labels":[],"label_agreement":null},{"id":"W3010351291","doi":"10.1111/dom.14020","title":"Efficacy and safety of once‐monthly efpeglenatide in patients with type 2 diabetes: Results of a phase 2 placebo‐controlled, 16‐week randomized dose‐finding study","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"Sanofi","keywords":"Placebo; Medicine; Type 2 diabetes; Adverse effect; Clinical endpoint; Metformin; Internal medicine; Randomized controlled trial; Diabetes mellitus; Randomization; Gastroenterology; Endocrinology; Insulin","score_opus":0.012231868217493709,"score_gpt":0.24304934158717661,"score_spread":0.23081747336968292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010351291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99197763,0.0019264322,0.0000019555055,0.00014561703,0.000068945206,0.005039927,0.00006701391,0.000030274125,0.00074219925],"genre_scores_gemma":[0.9991061,0.00019989803,0.00023267545,0.00015091726,0.000034345918,0.00008095699,0.00011325305,0.00002424476,0.000057629008],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99764776,0.00030092677,0.0008265719,0.00046593056,0.00038962133,0.00036921428],"domain_scores_gemma":[0.9983603,0.00061400456,0.00040254748,0.00025370912,0.00015315162,0.00021629193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008585207,0.00033129152,0.0022882237,0.00025678735,0.00005973558,0.00002114481,0.000099005236,0.0000728871,0.00001292968],"category_scores_gemma":[0.0008057096,0.00023150683,0.00011595169,0.00041979525,0.00020095482,0.00016302375,0.00011689341,0.00016026001,0.000001643829],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.52720433,0.011112869,0.43528703,0.0006364555,0.003777297,0.000011121444,0.005121208,0.000034332486,0.0004885343,0.00015301436,0.00008391124,0.016089883],"study_design_scores_gemma":[0.6812639,0.0025077579,0.31217372,0.00023048604,0.0020798284,1.5584376e-8,0.00019282791,0.00032361955,0.00081503065,0.000018990177,0.00021517235,0.00017861584],"about_ca_topic_score_codex":0.000033332723,"about_ca_topic_score_gemma":0.000009957026,"teacher_disagreement_score":0.1540596,"about_ca_system_score_codex":0.000023094242,"about_ca_system_score_gemma":0.00003269908,"threshold_uncertainty_score":0.94405746},"labels":[],"label_agreement":null},{"id":"W3010648955","doi":"10.1111/dom.14032","title":"Pharmacokinetic and dose‐finding studies on efpeglenatide in patients with type 2 diabetes","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Medicine; Dosing; Pharmacokinetics; Placebo; Postprandial; Pharmacodynamics; Type 2 diabetes; Diabetes mellitus; Anesthesia; Urology; Internal medicine; Endocrinology","score_opus":0.019440194938486713,"score_gpt":0.2527941115982972,"score_spread":0.23335391665981048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010648955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99303776,0.0051611317,1.7455963e-7,0.00063660933,0.0001281217,0.0005831054,0.0000074209224,0.0000495055,0.00039615878],"genre_scores_gemma":[0.9962846,0.0007009919,0.00018734811,0.0025951015,0.000074896125,0.000026777692,0.000029847391,0.00002143847,0.00007901191],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885535,0.00004204329,0.0001890955,0.00036630794,0.00021599038,0.00033120075],"domain_scores_gemma":[0.9994907,0.00007915205,0.00006528502,0.000115698414,0.000064648164,0.00018456625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118577445,0.0002396949,0.0005312822,0.0001481462,0.000071408474,0.000028784487,0.0000497177,0.000041526717,0.000014333967],"category_scores_gemma":[0.0000981497,0.00017439314,0.000030024252,0.0002805897,0.00009445592,0.00012590416,0.00009543968,0.00014053247,0.00001300081],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009842387,0.00030694704,0.98354214,0.00031625805,0.00043860122,0.0000065001555,0.0006741095,0.000006143688,0.00034403533,0.00023032018,0.00019088744,0.01384564],"study_design_scores_gemma":[0.0052446607,0.00067271397,0.9869139,0.00017796936,0.0005331272,3.2399882e-8,0.00007782491,0.000104652325,0.0033252756,0.000069102905,0.0026811298,0.00019957918],"about_ca_topic_score_codex":0.0000016776951,"about_ca_topic_score_gemma":0.0000012194215,"teacher_disagreement_score":0.013646061,"about_ca_system_score_codex":0.00001876,"about_ca_system_score_gemma":0.000009915533,"threshold_uncertainty_score":0.7111546},"labels":[],"label_agreement":null},{"id":"W3011497856","doi":"10.1111/dom.14026","title":"Glucose and protein metabolic responses to an energy‐ but not protein‐ restricted diet in type 2 diabetes","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Muscle metabolism and nutrition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Type 2 diabetes; Internal medicine; Endocrinology; Diabetes mellitus","score_opus":0.01207265938748419,"score_gpt":0.2212107678357456,"score_spread":0.2091381084482614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011497856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98112565,0.017301818,0.000022671577,0.00064883986,0.00008203429,0.0006194877,0.00012831033,0.00004016042,0.000031001753],"genre_scores_gemma":[0.99426943,0.0016762802,0.0012005965,0.0019560214,0.0004442099,0.00016947603,0.00014704262,0.0000378799,0.00009903639],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99786586,0.0003958692,0.00031612642,0.00072829885,0.00019463731,0.00049923913],"domain_scores_gemma":[0.9989831,0.000019947509,0.00008518773,0.0003402999,0.00011447201,0.00045698156],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030434688,0.00031970732,0.00050083984,0.00016242146,0.00012963534,0.000092051996,0.00021478347,0.00023188531,0.000010675954],"category_scores_gemma":[0.00044776953,0.00031165572,0.00005931014,0.0003882669,0.00010528323,0.0000408146,0.0002417136,0.0001610636,0.000005105443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006444109,0.00014781945,0.00686527,0.000069033435,0.000035810994,0.0000031758238,0.00010977676,0.0000012408667,0.98412657,0.00073272246,0.00008291567,0.0071812626],"study_design_scores_gemma":[0.000988568,0.00041333374,0.27131337,0.000025303048,0.000045331086,3.2144445e-7,0.000025175694,0.000053819018,0.6621801,0.00017801503,0.06443313,0.0003434923],"about_ca_topic_score_codex":0.000076227436,"about_ca_topic_score_gemma":0.000033021173,"teacher_disagreement_score":0.3219464,"about_ca_system_score_codex":0.0000035602116,"about_ca_system_score_gemma":0.00005308883,"threshold_uncertainty_score":0.99993354},"labels":[],"label_agreement":null},{"id":"W3013330267","doi":"10.1111/dom.14015","title":"Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: <i>Post hoc</i> analysis of the EMPA‐REG OUTCOME trial","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; McGill University; University of Toronto; McGill University Health Centre; St. Michael's Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of General Medical Sciences","keywords":"Empagliflozin; Medicine; Internal medicine; Myocardial infarction; Post-hoc analysis; Placebo; Diabetes mellitus; Heart failure; Cardiology; Type 2 diabetes; Hazard ratio; Confidence interval; Endocrinology","score_opus":0.017965382220222717,"score_gpt":0.2772640766944761,"score_spread":0.2592986944742534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013330267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99182856,0.0013874287,0.000019564579,0.0027673955,0.00017646574,0.0029044813,0.00089264446,0.000020892148,0.0000025737093],"genre_scores_gemma":[0.99830186,0.00028282302,0.00025718368,0.00045412805,0.00015244019,0.00031259898,0.00021025263,0.000021318683,0.000007410263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978132,0.00026286338,0.0007180852,0.00048057624,0.00031607298,0.00040916726],"domain_scores_gemma":[0.9985491,0.0003657915,0.00042066077,0.00037278768,0.00018554351,0.00010608816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011913248,0.0003005736,0.0014149955,0.00019650478,0.00021147315,0.00006050692,0.00014769248,0.00016428929,0.0000048002835],"category_scores_gemma":[0.0008225667,0.00019409142,0.00058452995,0.0012412242,0.00029468947,0.0002531159,0.00013250677,0.00019239544,2.3603357e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005396788,0.0002486127,0.99182713,0.00025494845,0.0023674956,6.474172e-8,0.0025200492,0.00018954645,0.0012602465,0.00010105661,0.0002103099,0.00048088422],"study_design_scores_gemma":[0.010778936,0.0004598209,0.9696386,0.00004324528,0.008433319,2.318239e-8,0.0013805837,0.00081209047,0.006754344,0.00026835196,0.0012479177,0.0001828117],"about_ca_topic_score_codex":0.000457751,"about_ca_topic_score_gemma":0.0011155829,"teacher_disagreement_score":0.02218855,"about_ca_system_score_codex":0.000027749149,"about_ca_system_score_gemma":0.00004247375,"threshold_uncertainty_score":0.79148185},"labels":[],"label_agreement":null},{"id":"W3014351387","doi":"10.1111/dom.14043","title":"Differential glycaemic control with basal insulin glargine 300 <scp>U/mL</scp> versus degludec 100 <scp>U/mL</scp> according to kidney function in type 2 diabetes: A subanalysis from the <scp>BRIGHT</scp> trial","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Sanofi","keywords":"Insulin degludec; Medicine; Renal function; Insulin glargine; Internal medicine; Urology; Diabetes mellitus; Type 2 diabetes; Confidence interval; Endocrinology; Kidney disease; Gastroenterology; Randomized controlled trial; Type 1 diabetes","score_opus":0.014324296476900424,"score_gpt":0.22038638604777686,"score_spread":0.20606208957087643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014351387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884522,0.0047371103,0.00032129695,0.0009139665,0.0016425863,0.0027462158,0.00028145782,0.00028350338,0.00062167423],"genre_scores_gemma":[0.9886366,0.00066644856,0.00029751824,0.006262274,0.0021583869,0.00035902055,0.00094485877,0.00013781246,0.0005370719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944259,0.00046322803,0.00095536676,0.0015103414,0.0010567555,0.00158842],"domain_scores_gemma":[0.99488515,0.0022481845,0.0004391704,0.00088880194,0.0002737693,0.0012649363],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00064016256,0.0010600834,0.0022158863,0.00054262805,0.00041222075,0.00040838777,0.0005847655,0.00040619282,0.00007554275],"category_scores_gemma":[0.0030304787,0.00077461073,0.00050523813,0.0018838929,0.00021493937,0.0005515242,0.00037052511,0.0008088755,0.00018814133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006546162,0.003933531,0.884629,0.0006267429,0.015626002,0.000149539,0.0058929278,0.00023841402,0.023411317,0.00077779975,0.04016674,0.018001815],"study_design_scores_gemma":[0.17713413,0.0040448513,0.6037848,0.00047903394,0.018473966,7.5513793e-7,0.0023486284,0.004307356,0.013798397,0.00035930736,0.1748771,0.00039163674],"about_ca_topic_score_codex":0.0002663262,"about_ca_topic_score_gemma":0.00012038059,"teacher_disagreement_score":0.28084418,"about_ca_system_score_codex":0.00015399608,"about_ca_system_score_gemma":0.00022583296,"threshold_uncertainty_score":0.9994705},"labels":[],"label_agreement":null},{"id":"W3014409190","doi":"10.1111/dom.14041","title":"Safety of dapagliflozin in a broad population of patients with type 2 diabetes: Analyses from the DECLARE‐TIMI 58 study","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Agence Nationale de la Recherche; AstraZeneca","keywords":"Dapagliflozin; Medicine; Placebo; Type 2 diabetes; Adverse effect; Internal medicine; Diabetic ketoacidosis; Diabetes mellitus; Population; Renal function; Urology; Endocrinology; Insulin","score_opus":0.021327916295630935,"score_gpt":0.25585816195749583,"score_spread":0.2345302456618649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014409190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99683636,0.0018480083,0.0000037242792,0.00015276988,0.00005057581,0.0009232246,0.000068194124,0.000018118539,0.00009901229],"genre_scores_gemma":[0.9989148,0.000093576586,0.00025040322,0.00039718093,0.00003860958,0.000014500299,0.00026312133,0.000014491767,0.000013337925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998723,0.00011994915,0.0003613762,0.00027775537,0.00031364805,0.0002042961],"domain_scores_gemma":[0.99923784,0.0001153459,0.00017470896,0.00026968637,0.0001108925,0.00009153855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016797059,0.0001851182,0.0006732085,0.00009033153,0.00004370485,0.000012571845,0.00010832169,0.00004877229,0.000044611064],"category_scores_gemma":[0.00012407829,0.00011634393,0.00006604625,0.00049831875,0.00006397384,0.00012346658,0.00009369896,0.00010040299,0.0000022488723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017233679,0.0009746295,0.9925068,0.00007018045,0.00062665174,9.105386e-7,0.0010124993,0.000021917052,0.00028685224,0.000027947295,0.000054169617,0.0042451257],"study_design_scores_gemma":[0.0038409925,0.00048238185,0.99216574,0.000081437756,0.0013609817,3.41183e-9,0.00024526106,0.0001460342,0.0011016787,0.000043205306,0.00042358236,0.000108694956],"about_ca_topic_score_codex":0.00026319755,"about_ca_topic_score_gemma":0.000083179126,"teacher_disagreement_score":0.0041364306,"about_ca_system_score_codex":0.00001311369,"about_ca_system_score_gemma":0.000017030177,"threshold_uncertainty_score":0.4744368},"labels":[],"label_agreement":null},{"id":"W3014701587","doi":"10.1111/dom.13965","title":"What have we learned about renal protection from the cardiovascular outcome trials and observational analyses with SGLT2 inhibitors?","year":2020,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Diabetes Canada; University of Toronto","funders":"","keywords":"Medicine; Empagliflozin; Canagliflozin; Clinical trial; Intensive care medicine; Internal medicine; Albuminuria; Clinical endpoint; Type 2 diabetes; Renal function; Diabetes mellitus; Endocrinology","score_opus":0.23986227727852943,"score_gpt":0.36642641467798515,"score_spread":0.1265641373994557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014701587","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006412497,0.98869056,0.000035585897,0.0011065311,0.00035978964,0.0031850648,0.00010089028,0.000072646886,0.000036442078],"genre_scores_gemma":[0.00038820325,0.99617666,0.00030858198,0.00037758023,0.0011936802,0.00051124446,0.000602349,0.000055807523,0.00038589526],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99660087,0.0007656745,0.00084019813,0.000809461,0.00063135615,0.0003524429],"domain_scores_gemma":[0.9981732,0.00045335345,0.0005039357,0.0005455675,0.00010336262,0.00022059203],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013205601,0.0006575701,0.004598699,0.00016366046,0.00024796117,0.00041148585,0.00014291397,0.0002748949,0.000032057407],"category_scores_gemma":[0.0003875974,0.00035184473,0.0011569256,0.0003400529,0.00016929959,0.0004007466,0.00017554493,0.00048657655,0.000015154484],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003081478,0.00009773382,0.0020557607,0.004049161,0.013046518,0.00001923686,0.00016444731,0.0000014829408,0.0000057907814,0.00008099444,0.00022587585,0.98022217],"study_design_scores_gemma":[0.0016002811,0.00009514063,0.010254538,0.0059570954,0.04034224,0.000002413231,0.00008275676,0.000013815434,0.000035687015,0.00012349528,0.94113827,0.00035426326],"about_ca_topic_score_codex":0.0001033613,"about_ca_topic_score_gemma":0.0000141290975,"teacher_disagreement_score":0.97986794,"about_ca_system_score_codex":0.000048208538,"about_ca_system_score_gemma":0.00010676628,"threshold_uncertainty_score":0.99989337},"labels":[],"label_agreement":null},{"id":"W3014973577","doi":"10.1111/dom.14050","title":"Effect of liraglutide on food consumption, appetite sensations and eating behaviours in overweight people with type 1 diabetes","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Novo Nordisk","keywords":"Liraglutide; Appetite; Medicine; Overweight; Crossover study; Placebo; Type 2 diabetes; Internal medicine; Endocrinology; Insulin; Diabetes mellitus; Obesity","score_opus":0.0086374462452065,"score_gpt":0.22145787819047297,"score_spread":0.21282043194526648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014973577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966103,0.0022035835,0.0000018096548,0.00027661206,0.000044486445,0.0006031284,0.000025453308,0.000051868024,0.0001827515],"genre_scores_gemma":[0.99889845,0.00027336122,0.00028649718,0.00036161827,0.000042158983,0.000028527676,0.000060154864,0.000017485403,0.000031726573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903935,0.000080342375,0.00018029286,0.0002818495,0.00016854242,0.0002496445],"domain_scores_gemma":[0.99941623,0.00017566627,0.00008119009,0.00013843064,0.000039055718,0.00014941512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019229553,0.00019722576,0.00052006164,0.00012870242,0.00006346376,0.00002226243,0.000036415513,0.000056741334,0.000018897545],"category_scores_gemma":[0.00008986719,0.00015021699,0.000041506115,0.00023498254,0.00008267971,0.00009588098,0.00005011313,0.00011954447,0.000005113845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006015069,0.00013856072,0.99385417,0.00048633534,0.00016188879,0.0000024878432,0.00042565737,0.000005927806,0.0011578783,0.00038379923,0.00004164013,0.0032815328],"study_design_scores_gemma":[0.0025084573,0.002006048,0.9775228,0.00033354713,0.00065456063,2.878858e-7,0.000026726693,0.00037723713,0.01609318,0.00002355359,0.00030528352,0.00014831405],"about_ca_topic_score_codex":0.000012182374,"about_ca_topic_score_gemma":0.00002077043,"teacher_disagreement_score":0.016331337,"about_ca_system_score_codex":0.0000109689445,"about_ca_system_score_gemma":0.000012715017,"threshold_uncertainty_score":0.61256707},"labels":[],"label_agreement":null},{"id":"W3021285140","doi":"10.1111/dom.14082","title":"Sodium‐glucose co‐transporter‐2 inhibitors and the risk of urosepsis: A multi‐site, prevalent new‐user cohort study","year":2020,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland; Saskatchewan Health Quality Council; University of Manitoba; Manitoba Health; Health Sciences Centre; Institut National d'Excellence en Santé et en Services Sociaux; University of Calgary; McGill University Health Centre; Institute for Clinical Evaluative Sciences; McGill University; Jewish General Hospital; Sunnybrook Health Science Centre; Sinai Health System; University of Toronto; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Dapagliflozin; Medicine; Empagliflozin; Hazard ratio; Internal medicine; Proportional hazards model; Confidence interval; Type 2 diabetes; Canagliflozin; Cohort; Diabetes mellitus; Endocrinology","score_opus":0.017826730922764,"score_gpt":0.28436987930530844,"score_spread":0.26654314838254445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021285140","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24484639,0.75001913,0.0000026799512,0.00006195512,0.00020390583,0.0043324083,0.0004565203,0.000043188382,0.00003379763],"genre_scores_gemma":[0.0123169,0.98609316,0.00015471983,0.00019500553,0.0002976196,0.00024354388,0.00018612614,0.0000771777,0.0004357352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99657845,0.0005900057,0.0010206011,0.0008623487,0.00051916414,0.00042945135],"domain_scores_gemma":[0.99769205,0.00024193853,0.00068644277,0.00068901014,0.000089993264,0.0006005905],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008585268,0.0007861767,0.004401641,0.00018365344,0.0001953812,0.000054047996,0.00019731873,0.00031680326,0.000025697696],"category_scores_gemma":[0.00022009124,0.00045254207,0.0008003187,0.00032357182,0.00033051192,0.000103052706,0.00013926135,0.00066842727,0.000016227694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112849244,0.0015043933,0.7930913,0.00745648,0.005304809,0.00002719368,0.0018358853,5.5264938e-8,0.0000019983836,0.000027399024,0.00027967198,0.19035797],"study_design_scores_gemma":[0.00663423,0.00015370273,0.48157683,0.0015729287,0.036671072,0.000008349602,0.000060583443,0.000005469253,0.000018247441,0.000009252885,0.472989,0.00030033768],"about_ca_topic_score_codex":0.00036835772,"about_ca_topic_score_gemma":0.000010450298,"teacher_disagreement_score":0.47270933,"about_ca_system_score_codex":0.000026838026,"about_ca_system_score_gemma":0.00023427763,"threshold_uncertainty_score":0.99979264},"labels":[],"label_agreement":null},{"id":"W3021290569","doi":"10.1111/dom.14079","title":"The effect of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the <scp>LEADER</scp> and <scp>SUSTAIN</scp> 6 trials","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Sun Pharma; Novo Nordisk; Valeant Pharmaceuticals International; American Heart Association; Sanofi; HLS Therapeutics; Amgen; AstraZeneca; Eli Lilly and Company","keywords":"Semaglutide; Liraglutide; Mace; Medicine; Diabetic nephropathy; Internal medicine; Nephropathy; Blood pressure; Type 2 diabetes; Diabetes mellitus; Dulaglutide; Endocrinology; Placebo; Cardiology","score_opus":0.011967852273858442,"score_gpt":0.245136943228653,"score_spread":0.23316909095479457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021290569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92612743,0.07149113,0.000011748355,0.00045184352,0.00013885867,0.0014042843,0.000245127,0.00004141662,0.000088147564],"genre_scores_gemma":[0.9927067,0.0054624653,0.000106360705,0.00044245424,0.00014730041,0.00008336724,0.000061784114,0.00003705192,0.0009524745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996341,0.0009692228,0.00074524997,0.0007020398,0.0006211233,0.0006214017],"domain_scores_gemma":[0.9947472,0.0036076715,0.00045020663,0.00069438294,0.00015942544,0.00034107213],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035082945,0.00053535553,0.002684917,0.00015950858,0.00044685614,0.00013050824,0.00020942187,0.0001858863,0.0000029884184],"category_scores_gemma":[0.004618466,0.0002981707,0.0007741868,0.0006853534,0.00065033656,0.00012141476,0.00038087773,0.00029055757,8.541615e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010274411,0.00033997945,0.8965578,0.002761592,0.07189921,0.000015312544,0.0063468223,0.00016025595,0.005221589,0.00040731195,0.0019083924,0.014278994],"study_design_scores_gemma":[0.008237212,0.00079391897,0.746097,0.00017027924,0.08754302,0.0000016018902,0.0019411953,0.0004934661,0.07283845,0.000071609145,0.08166637,0.000145872],"about_ca_topic_score_codex":0.00011124383,"about_ca_topic_score_gemma":0.000027439597,"teacher_disagreement_score":0.15046078,"about_ca_system_score_codex":0.00000957112,"about_ca_system_score_gemma":0.000037954364,"threshold_uncertainty_score":0.9999471},"labels":[],"label_agreement":null},{"id":"W3021808388","doi":"10.1111/dom.14077","title":"<scp>iGlarLixi</scp> effectively reduces residual hyperglycaemia in patients with type 2 diabetes on basal insulin: A post hoc analysis from the <scp>LixiLan‐L</scp> study","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Type 2 diabetes; Lixisenatide; Basal insulin; Metformin; Medicine; Insulin glargine; Basal (medicine); Internal medicine; Insulin; Endocrinology; Diabetes mellitus; Gastroenterology","score_opus":0.00812366234545442,"score_gpt":0.20665570532734998,"score_spread":0.19853204298189556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021808388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930127,0.0037824968,6.8392774e-7,0.0003500658,0.00018661207,0.0018768327,0.00017273476,0.00011687307,0.0005009796],"genre_scores_gemma":[0.9955765,0.00019151915,0.00013117131,0.0029332603,0.00031329307,0.000121445395,0.00051856996,0.000057415575,0.00015680071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99661183,0.0004229148,0.000439798,0.0009938114,0.0007720395,0.0007595931],"domain_scores_gemma":[0.99743354,0.0011842095,0.00022323294,0.00055303297,0.0002284487,0.00037752415],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045966156,0.0006007116,0.0013054713,0.00035961994,0.00024020721,0.00016986646,0.00032856333,0.00016624619,0.000014097113],"category_scores_gemma":[0.0009723058,0.00039412186,0.0001937205,0.0015945606,0.00016434673,0.0002737516,0.00025897074,0.00048181033,0.000056565477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010953825,0.0020861537,0.98543847,0.00004752321,0.0038807455,0.000020495983,0.0038920052,0.000018830724,0.00031073808,0.00002962081,0.0012940862,0.0028718042],"study_design_scores_gemma":[0.0070048887,0.003186478,0.9777996,0.00007918668,0.0051106946,2.6262207e-8,0.0014219702,0.00006574074,0.002338383,0.000041622,0.0028372512,0.00011417479],"about_ca_topic_score_codex":0.00011101521,"about_ca_topic_score_gemma":0.00006922749,"teacher_disagreement_score":0.0076388745,"about_ca_system_score_codex":0.000053058433,"about_ca_system_score_gemma":0.00006138462,"threshold_uncertainty_score":0.99985105},"labels":[],"label_agreement":null},{"id":"W3025648277","doi":"10.1111/dom.14084","title":"Goal achievement of <scp>HbA1c</scp> and <scp>LDL‐</scp> cholesterol in a randomized trial comparing colesevelam with ezetimibe: <scp>GOAL‐RCT</scp>","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada); Mount Sinai Hospital","funders":"","keywords":"Ezetimibe; Medicine; Internal medicine; Gastroenterology; Randomized controlled trial; Type 2 diabetes; Discontinuation; Cholesterol; Statin; Endocrinology; Diabetes mellitus","score_opus":0.01245808594523028,"score_gpt":0.2262069639989136,"score_spread":0.2137488780536833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025648277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98038286,0.013056685,0.0002771758,0.00025829163,0.00025376957,0.0047298907,0.000047400918,0.00010553999,0.0008884015],"genre_scores_gemma":[0.9936613,0.0022784579,0.0010363181,0.0015319452,0.00075281947,0.00033088116,0.00007882422,0.00008148138,0.00024800518],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9948347,0.0008234198,0.0011802354,0.0009909709,0.001111177,0.0010594748],"domain_scores_gemma":[0.99678254,0.0009674961,0.0005059047,0.00063639716,0.00021867437,0.0008889576],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029293806,0.0006860478,0.0039248513,0.00032337641,0.00023395859,0.00013120232,0.00027392438,0.00035746468,0.0000037810266],"category_scores_gemma":[0.001882714,0.0005481431,0.00054967275,0.00063431385,0.0004973978,0.00030246892,0.00030796445,0.00087722734,0.000009212106],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04228784,0.007717908,0.8234743,0.014149667,0.012870747,0.0003445316,0.042845365,0.0003954764,0.020174649,0.0038146826,0.0040575056,0.027867354],"study_design_scores_gemma":[0.59383565,0.00076347933,0.37590915,0.00056821073,0.0019932925,0.000016555972,0.0011782378,0.0009500875,0.010682846,0.00011944273,0.01386107,0.00012200784],"about_ca_topic_score_codex":0.00034067553,"about_ca_topic_score_gemma":0.00007853064,"teacher_disagreement_score":0.55154777,"about_ca_system_score_codex":0.00004256382,"about_ca_system_score_gemma":0.00025897534,"threshold_uncertainty_score":0.999697},"labels":[],"label_agreement":null},{"id":"W3028818452","doi":"10.1111/dom.14103","title":"Sex‐specific associations between cardiovascular risk factors and myocardial infarction in patients with type 2 diabetes: The <scp>ADVANCE‐ON</scp> study","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Health and Medical Research Council; Medical Research Council; Servier; University of New South Wales","keywords":"Medicine; Hazard ratio; Internal medicine; Body mass index; Myocardial infarction; Diabetes mellitus; Proportional hazards model; Blood pressure; Type 2 diabetes; Relative risk; Cohort; Cohort study; Risk factor; Confidence interval; Demography; Endocrinology","score_opus":0.017986675731275714,"score_gpt":0.24065019938256754,"score_spread":0.22266352365129183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028818452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959629,0.0017515504,0.000009129264,0.00027914788,0.0001539888,0.0014385842,0.00021334007,0.00005752674,0.00013380137],"genre_scores_gemma":[0.99794847,0.00067863445,0.000036175294,0.0007270737,0.00039513523,0.000041213916,0.00012202292,0.000034514294,0.000016765072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739504,0.000536289,0.00029150868,0.0005281427,0.00079037226,0.00045866688],"domain_scores_gemma":[0.99846524,0.00052861124,0.000110977286,0.000384838,0.00022240548,0.0002879458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077401253,0.00028600782,0.00088790245,0.00016844583,0.0003501517,0.00008476067,0.00011710314,0.00013452832,0.000004566243],"category_scores_gemma":[0.00076283276,0.00019243188,0.00018779759,0.0007389142,0.00016283819,0.00020650514,0.00012571414,0.0007257184,0.000013960558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001161096,0.00016710297,0.99286497,0.0000127848425,0.0019263115,9.93348e-7,0.0017425424,0.000049872215,0.000012228379,0.000009346788,0.00041805796,0.00278417],"study_design_scores_gemma":[0.0025149735,0.0005183273,0.96470475,0.000011199861,0.0007950854,3.9993772e-8,0.0005518333,0.000017170038,0.00012887802,0.000025357667,0.030641474,0.00009088588],"about_ca_topic_score_codex":0.00010193719,"about_ca_topic_score_gemma":0.0000029172925,"teacher_disagreement_score":0.030223416,"about_ca_system_score_codex":0.000054031745,"about_ca_system_score_gemma":0.000039663264,"threshold_uncertainty_score":0.78471446},"labels":[],"label_agreement":null},{"id":"W3031038558","doi":"10.1111/dom.14102","title":"Positioning sulphonylureas in a modern treatment algorithm for patients with type 2 diabetes: Expert opinion from a European consensus panel","year":2020,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Merck Sharp and Dohme; TrigoCare International; Hebrew University of Jerusalem; Mylan; KU Leuven; Teva Pharmaceutical Industries; Novo Nordisk; Sanofi; Servier; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Type 2 diabetes; Medicine; Metformin; Intensive care medicine; Expert opinion; Diabetes mellitus; Diabetes treatment; Endocrinology","score_opus":0.03341292104257114,"score_gpt":0.27084942317275323,"score_spread":0.23743650213018208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031038558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017124003,0.97796965,0.000029934945,0.000055412263,0.00036904193,0.0034574135,0.0006927135,0.00010841025,0.00019344255],"genre_scores_gemma":[0.00073429657,0.9856082,0.0054981518,0.0002989095,0.00045744004,0.00047493866,0.0066751293,0.00014906781,0.00010382554],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99742013,0.0002244896,0.0005558098,0.00092672254,0.00026498013,0.0006078937],"domain_scores_gemma":[0.99863666,0.00022828438,0.00028653274,0.00040862392,0.00011513314,0.0003247764],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014395642,0.0008028009,0.002584594,0.00026949102,0.00012541018,0.00009583673,0.00013247847,0.00019323934,0.000013418637],"category_scores_gemma":[0.000045120658,0.00058057794,0.000350894,0.00030562902,0.000086422944,0.00008805883,0.00010993461,0.00019920857,0.000023616536],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030322273,0.0009234516,0.00227768,0.0012520091,0.0016203993,0.000021091439,0.00030926848,2.1312269e-7,0.0000012665638,0.000013602815,0.00014793052,0.9934028],"study_design_scores_gemma":[0.006966258,0.0009857718,0.010225613,0.007409195,0.004168049,5.9003327e-7,0.000031919768,0.0003560053,0.000009819113,0.00006288151,0.9690506,0.00073333667],"about_ca_topic_score_codex":0.00005405785,"about_ca_topic_score_gemma":0.0000047176545,"teacher_disagreement_score":0.9926694,"about_ca_system_score_codex":0.00017193829,"about_ca_system_score_gemma":0.000118711665,"threshold_uncertainty_score":0.99966455},"labels":[],"label_agreement":null},{"id":"W3033072901","doi":"10.1111/dom.14111","title":"Chronic glucokinase activator treatment activates liver Carbohydrate response element binding protein and improves hepatocyte <scp>ATP</scp> homeostasis during substrate challenge","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Cholesterol and Lipid Metabolism","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council Canada","keywords":"Carbohydrate-responsive element-binding protein; Glucokinase; Internal medicine; Endocrinology; Glucose homeostasis; Hepatocyte; Homeostasis; Medicine; Cell biology; Biochemistry; Biology; Transcription factor; Gene; Insulin resistance; In vitro; Insulin","score_opus":0.01643195933039404,"score_gpt":0.2234258433639886,"score_spread":0.20699388403359456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033072901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723528,0.024547825,0.000001989721,0.0010960107,0.00013471248,0.0015489728,0.00010941703,0.00017380374,0.000034456934],"genre_scores_gemma":[0.990918,0.0071778153,0.00012663721,0.0002091903,0.0008504477,0.0002493291,0.000033406923,0.00007452688,0.00036064835],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971579,0.0002861356,0.00043789993,0.0008981973,0.00035160934,0.00086825725],"domain_scores_gemma":[0.9982973,0.00017455015,0.00022791645,0.0003827462,0.000081927275,0.00083558745],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040598973,0.0006263546,0.0010822555,0.00024471254,0.00035593,0.00014652542,0.00012422082,0.00021544508,0.000019630714],"category_scores_gemma":[0.0002360063,0.0005218023,0.00019152494,0.00032865195,0.00017516919,0.00045468067,0.00018813876,0.00037297516,0.00001666804],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003774467,0.0002828156,0.0060176402,0.0006405076,0.0004434364,0.00006691658,0.0032960656,0.0000010554756,0.97426,0.0000884873,0.000006298177,0.014519334],"study_design_scores_gemma":[0.0047509708,0.00055166706,0.21237265,0.00015911668,0.00052034913,0.000004554047,0.00034169492,0.00016612683,0.75571704,0.000013308929,0.025172723,0.0002297806],"about_ca_topic_score_codex":0.00007852514,"about_ca_topic_score_gemma":0.000011415141,"teacher_disagreement_score":0.21854293,"about_ca_system_score_codex":0.00013616121,"about_ca_system_score_gemma":0.00015234495,"threshold_uncertainty_score":0.9997234},"labels":[],"label_agreement":null},{"id":"W3034401538","doi":"10.1111/dom.14117","title":"Semaglutide once weekly in people with type 2 diabetes: Real‐world analysis of the Canadian <scp>LMC</scp> diabetes registry ( <scp>SPARE</scp> study)","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Semaglutide; Medicine; Exenatide; Type 2 diabetes; Internal medicine; Liraglutide; Diabetes mellitus; Retrospective cohort study; Glucagon-like peptide 1 receptor; Cohort; Endocrinology; Agonist","score_opus":0.011871058071430296,"score_gpt":0.22199252926547053,"score_spread":0.21012147119404023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034401538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98987144,0.002898778,8.1500673e-7,0.00079161645,0.00018396637,0.0014698579,0.0001134619,0.00009201498,0.0045780446],"genre_scores_gemma":[0.9949094,0.00025944517,0.00017015683,0.0019304318,0.00013566564,0.00011706445,0.00013747907,0.00006262627,0.0022777484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99621713,0.0002644587,0.000654562,0.0009225644,0.0007325409,0.0012087133],"domain_scores_gemma":[0.9970242,0.00058866036,0.00038581682,0.0009836059,0.00023727244,0.0007804881],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006358048,0.0006015415,0.0018192565,0.0008602716,0.00032205987,0.00013009112,0.0005076384,0.000167013,0.000023992405],"category_scores_gemma":[0.00085994496,0.00044730646,0.00030522502,0.0049738265,0.00027372566,0.00021928057,0.0002766611,0.00048792062,0.000016815404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000045923352,0.0005182697,0.9902513,0.00027430878,0.0031477977,0.000017608183,0.00245319,0.00015015987,0.0004074305,0.00019926995,0.002003023,0.0005730623],"study_design_scores_gemma":[0.001786449,0.00031371496,0.9697601,0.00016285374,0.007548463,1.0109031e-7,0.0013902332,0.00085332786,0.002535051,0.000039245704,0.015473709,0.00013674109],"about_ca_topic_score_codex":0.012551006,"about_ca_topic_score_gemma":0.1925005,"teacher_disagreement_score":0.17994949,"about_ca_system_score_codex":0.0001637998,"about_ca_system_score_gemma":0.00033398275,"threshold_uncertainty_score":0.9997979},"labels":[],"label_agreement":null},{"id":"W3035236623","doi":"10.1111/dom.14044","title":"Postprandial hyperglycaemia following insulin suspensions by the artificial pancreas: Implications for bolus calculators","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital; McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Postprandial; Insulin; Medicine; Bolus (digestion); Artificial pancreas; Internal medicine; Meal; Diabetes mellitus; Endocrinology; Regular insulin; Type 1 diabetes; Hypoglycemia","score_opus":0.02744931408699795,"score_gpt":0.2776482186697307,"score_spread":0.25019890458273275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035236623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971639,0.004020703,0.00013270947,0.02237494,0.00019688853,0.0010871842,0.000080980164,0.00007725562,0.0003903617],"genre_scores_gemma":[0.9948737,0.00013293256,0.00021737575,0.0037651705,0.0004917742,0.00010503473,0.00017378875,0.00002724244,0.00021296277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863404,0.0000688146,0.0002469714,0.00035760252,0.00021512594,0.000477438],"domain_scores_gemma":[0.99904644,0.00022224346,0.00005439162,0.00025342806,0.00008704601,0.0003364383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039491567,0.0001810188,0.00041868293,0.00006398166,0.00049914035,0.000092612376,0.00016345951,0.00010415129,0.000024690677],"category_scores_gemma":[0.0005159028,0.00012631361,0.0002405809,0.0003344454,0.000120120865,0.00011545718,0.00013101935,0.00022871899,0.000021990078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090913597,0.0011725104,0.51147926,0.00052855065,0.0022045637,0.0000126441355,0.0018684864,0.000011783789,0.16620135,0.03722759,0.072174385,0.20620972],"study_design_scores_gemma":[0.0036316505,0.00028813278,0.7387934,0.00004892104,0.0015204502,8.8273003e-7,0.00022021846,0.0012476345,0.0066981204,0.00263139,0.24449268,0.00042652874],"about_ca_topic_score_codex":0.000017585575,"about_ca_topic_score_gemma":0.0000044610806,"teacher_disagreement_score":0.22731411,"about_ca_system_score_codex":0.000012012735,"about_ca_system_score_gemma":0.000054507134,"threshold_uncertainty_score":0.51509196},"labels":[],"label_agreement":null},{"id":"W3036174462","doi":"10.1111/dom.14118","title":"γ‐aminobutyric acid stimulates β‐cell proliferation through the <scp>mTORC1</scp> / <scp>p70S6K</scp> pathway, an effect amplified by <scp>Ly49</scp> , a novel γ‐aminobutyric acid type A receptor positive allosteric modulator","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Cell growth; mTORC1; Receptor; Cell biology; PI3K/AKT/mTOR pathway; Aminobutyric acid; Cell; Chemistry; Endocrinology; Internal medicine; Signal transduction; Biology; Biochemistry; Medicine","score_opus":0.014909305773513138,"score_gpt":0.22535702520054504,"score_spread":0.21044771942703192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036174462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760317,0.01657326,0.0008256594,0.00024013525,0.00086894573,0.0026627895,0.0006080024,0.0005021109,0.0016873976],"genre_scores_gemma":[0.98727834,0.0006204609,0.0011668422,0.0056102504,0.0011936858,0.00029001152,0.0014135516,0.00018028117,0.002246557],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9941697,0.00068538217,0.000971974,0.0015920837,0.001046202,0.0015346318],"domain_scores_gemma":[0.99448895,0.002267744,0.00058463553,0.0009447224,0.0005788575,0.0011350894],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00083153386,0.0012274834,0.0019248208,0.00025321488,0.0007735452,0.00044034063,0.0005334685,0.0006954062,0.00004559097],"category_scores_gemma":[0.0046954253,0.0009381062,0.0004274069,0.0014457831,0.00040298232,0.0010161019,0.00031625837,0.0010021261,0.00032298896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000613387,0.0013136665,0.055205755,0.000728395,0.00079597515,0.000014102697,0.009327946,0.000074633914,0.9132211,0.00032598194,0.017624844,0.0013062119],"study_design_scores_gemma":[0.007709473,0.0027542568,0.08634205,0.00019947981,0.0019338162,0.000018786419,0.0016525066,0.006245317,0.8352417,0.00015941418,0.05745845,0.00028478942],"about_ca_topic_score_codex":0.000063041756,"about_ca_topic_score_gemma":0.0000024386004,"teacher_disagreement_score":0.07797949,"about_ca_system_score_codex":0.00010822222,"about_ca_system_score_gemma":0.0002553314,"threshold_uncertainty_score":0.999307},"labels":[],"label_agreement":null},{"id":"W3038205043","doi":"10.1111/dom.14123","title":"The effect of referral to an open‐group behavioural weight‐management programme on the relative risk of normoglycaemia, non‐diabetic hyperglycaemia and type 2 diabetes: Secondary analysis of the <scp>WRAP</scp> trial","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Education","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council Canada; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Relative risk; Body mass index; Diabetes mellitus; Confidence interval; Type 2 diabetes; Internal medicine; Weight management; Randomized controlled trial; Overweight; Endocrinology","score_opus":0.018876471789053214,"score_gpt":0.25316372148879035,"score_spread":0.23428724969973713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038205043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994233,0.001069608,0.0000031035,0.00053963345,0.00032958065,0.0029175214,0.000053438882,0.000017645181,0.0008364526],"genre_scores_gemma":[0.9985995,0.00023699505,0.00014901898,0.00043602745,0.00010044971,0.00015628898,0.00006595699,0.000025173065,0.00023057993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975198,0.00056683953,0.0005586809,0.00045326754,0.0004512138,0.0004502231],"domain_scores_gemma":[0.9975792,0.0008613159,0.0004938771,0.00069849077,0.00013562209,0.00023150128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018105189,0.0003114202,0.0009974381,0.0001999904,0.0002907985,0.00008196021,0.0005768419,0.00011406912,0.000016303802],"category_scores_gemma":[0.00068640546,0.00016303874,0.00025627774,0.0014867787,0.0003538628,0.00021930061,0.00045205274,0.00038071733,0.0000024053595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010327139,0.0005345999,0.95298856,0.00041341642,0.0049214605,7.634091e-7,0.0031534496,0.000012938684,0.0017492556,0.00221184,0.00093668577,0.032044314],"study_design_scores_gemma":[0.006829979,0.002906208,0.9664841,0.0001044434,0.011646335,4.4912102e-8,0.00048618563,0.0004758077,0.008349953,0.00018347509,0.0024297526,0.00010371333],"about_ca_topic_score_codex":0.000073889816,"about_ca_topic_score_gemma":0.000029334065,"teacher_disagreement_score":0.0319406,"about_ca_system_score_codex":0.000022214766,"about_ca_system_score_gemma":0.000035719524,"threshold_uncertainty_score":0.66485274},"labels":[],"label_agreement":null},{"id":"W3039898484","doi":"10.1111/dom.14127","title":"Sotagliflozin added to optimized insulin therapy leads to <scp>HbA1c</scp> reduction without weight gain in adults with type 1 diabetes: A pooled analysis of <scp>inTandem1</scp> and <scp>inTandem2</scp>","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Placebo; Medicine; Insulin; Ketoacidosis; Internal medicine; Weight gain; Weight loss; Diabetes mellitus; Type 1 diabetes; Clinical trial; Gastroenterology; Body weight; Type 2 diabetes; Endocrinology; Obesity; Pathology","score_opus":0.013861662298813521,"score_gpt":0.2512247156702229,"score_spread":0.2373630533714094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039898484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867599,0.0085719,0.0001480882,0.00075200596,0.00018417205,0.002388312,0.000069517526,0.00016126425,0.00096483383],"genre_scores_gemma":[0.98925346,0.0034389659,0.0031872557,0.0020228026,0.00035652486,0.00019837297,0.00021272007,0.0001094802,0.0012204077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947658,0.00049951026,0.00092659413,0.0013870718,0.0010634661,0.0013575469],"domain_scores_gemma":[0.99646103,0.0007473899,0.00033399664,0.00068590307,0.0005489638,0.0012226963],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016054667,0.0007653786,0.0024512308,0.0017415184,0.00021453277,0.00017388778,0.00042975682,0.0003957916,0.000031939362],"category_scores_gemma":[0.0022561098,0.0006169622,0.00029424767,0.0049871705,0.00034168857,0.0004217316,0.00036049666,0.00077024754,0.000034099827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006227335,0.0018414767,0.85942966,0.0013157532,0.008808817,0.000049030197,0.02060589,0.0011918872,0.07682922,0.00027245845,0.007572337,0.021460723],"study_design_scores_gemma":[0.021169214,0.0031780533,0.8435516,0.0010624662,0.006403682,0.0000018272062,0.0049395533,0.012100382,0.08892133,0.00019482196,0.018107101,0.000370014],"about_ca_topic_score_codex":0.000054168755,"about_ca_topic_score_gemma":0.000044182252,"teacher_disagreement_score":0.02109071,"about_ca_system_score_codex":0.00006565208,"about_ca_system_score_gemma":0.00014735346,"threshold_uncertainty_score":0.9996282},"labels":[],"label_agreement":null},{"id":"W3041938457","doi":"10.1111/dom.14140","title":"Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the <scp>LEADER</scp> and <scp>SUSTAIN</scp> 6 clinical trials","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; Lunenfeld-Tanenbaum Research Institute; St. Michael's Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Semaglutide; Medicine; Liraglutide; Type 2 diabetes; Hazard ratio; Internal medicine; Empagliflozin; Placebo; Disease; Diabetes mellitus; Macrovascular disease; Adverse effect; Clinical trial; Confidence interval; Surgery; Cardiology; Endocrinology; Pathology","score_opus":0.05417518927297947,"score_gpt":0.3188147998343146,"score_spread":0.2646396105613351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041938457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9543929,0.04273443,0.0000038013334,0.000618692,0.0002502635,0.0015045926,0.0002840521,0.000061147315,0.0001501316],"genre_scores_gemma":[0.99096185,0.0061905473,0.0001289911,0.0018165321,0.00039744924,0.000042458814,0.00026020478,0.00004686469,0.00015508021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99567235,0.0011205343,0.0011095153,0.00086161855,0.0005604514,0.00067555526],"domain_scores_gemma":[0.99369913,0.004251861,0.00033258428,0.0009061903,0.00013542951,0.0006747734],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035858501,0.00051095546,0.002656663,0.0001565641,0.000113618626,0.00008873386,0.00024521438,0.00018952816,0.0000062581908],"category_scores_gemma":[0.015941428,0.0003211868,0.0014128109,0.00042602845,0.00028381072,0.00016347239,0.00024225403,0.00041602796,0.00002017492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069623915,0.00078933866,0.9766267,0.0002106088,0.00753605,0.00004330506,0.0010669868,0.00004094943,0.00020399144,0.00007880268,0.0034800225,0.009853644],"study_design_scores_gemma":[0.008976284,0.00040856123,0.96065843,0.000145773,0.0047244495,9.374076e-8,0.00040961907,0.00018397695,0.00066107325,0.00022076236,0.0235295,0.00008147828],"about_ca_topic_score_codex":0.0001273408,"about_ca_topic_score_gemma":0.0000047685858,"teacher_disagreement_score":0.03656898,"about_ca_system_score_codex":0.00003378734,"about_ca_system_score_gemma":0.00011271363,"threshold_uncertainty_score":0.999924},"labels":[],"label_agreement":null},{"id":"W3046517060","doi":"10.1111/dom.14158","title":"Consistent effects of empagliflozin on cardiovascular and kidney outcomes irrespective of diabetic kidney disease categories: Insights from the <scp>EMPA‐REG OUTCOME</scp> trial","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Empagliflozin; Medicine; Albuminuria; Renal function; Kidney disease; Internal medicine; Creatinine; Urology; Diabetes mellitus; Post-hoc analysis; Population; Type 2 diabetes; Endocrinology","score_opus":0.013615514011522918,"score_gpt":0.22350527547802146,"score_spread":0.20988976146649854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046517060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98318535,0.012724149,0.000010052206,0.0010640094,0.00045644204,0.0020429962,0.00020408344,0.00005141454,0.00026148563],"genre_scores_gemma":[0.994409,0.0006582808,0.000081884355,0.0042800144,0.00020930203,0.00011511213,0.000105517,0.000031753734,0.000109095774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977079,0.00029039007,0.0004968794,0.0005687241,0.00058280997,0.00035327085],"domain_scores_gemma":[0.99708045,0.0010673837,0.00021255059,0.00059356145,0.00011300618,0.0009330332],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022193453,0.00042427852,0.0016294216,0.00011422808,0.00012336265,0.000038996117,0.00016747108,0.00010473878,0.000009467985],"category_scores_gemma":[0.0034482477,0.00027130236,0.00058898306,0.0002547456,0.00036745484,0.00011539611,0.00020806602,0.00020426138,0.0000074415075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009771335,0.0015334614,0.9703271,0.002104489,0.010493976,0.000060076323,0.005065858,0.00000588396,0.001042632,0.0034237409,0.0027325512,0.0022331355],"study_design_scores_gemma":[0.034082614,0.0007056677,0.9273242,0.00024502174,0.009671242,7.9897376e-8,0.0002976507,0.00005131522,0.010204374,0.0008992689,0.016361635,0.00015697717],"about_ca_topic_score_codex":0.000096026924,"about_ca_topic_score_gemma":0.0000018136304,"teacher_disagreement_score":0.043002907,"about_ca_system_score_codex":0.000023400095,"about_ca_system_score_gemma":0.00009841635,"threshold_uncertainty_score":0.9999739},"labels":[],"label_agreement":null},{"id":"W3046544717","doi":"10.1111/dom.14164","title":"Cardiometabolic risk factor control in black and white people in the United States initiating sodium‐glucose co‐transporter‐2 inhibitors: A real‐world study","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; Toronto General Hospital; St. Michael's Hospital","funders":"","keywords":"Medicine; Body mass index; Internal medicine; Type 2 diabetes; Odds ratio; Confidence interval; Diabetes mellitus; Blood pressure; Endocrinology; Triglyceride; Cholesterol","score_opus":0.013923173439054394,"score_gpt":0.24194294683143033,"score_spread":0.22801977339237595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046544717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544555,0.0010964806,0.0000062549657,0.00092155824,0.00005822539,0.0020075764,0.00017569543,0.00006573736,0.00022293178],"genre_scores_gemma":[0.9952739,0.002135173,0.000034944413,0.0020900592,0.00015503025,0.000116860734,0.00014914549,0.00002891061,0.000015998254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977016,0.00042480393,0.00049928034,0.0005007675,0.000349252,0.0005243356],"domain_scores_gemma":[0.9990719,0.00023197994,0.00015271835,0.00026830594,0.000054133885,0.00022093627],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071571476,0.00036141602,0.0010155475,0.0005754336,0.00011386594,0.00011232626,0.00012722585,0.00006941396,0.000019904039],"category_scores_gemma":[0.00008935249,0.00026637354,0.00010025925,0.00126424,0.00010698829,0.0002265291,0.000057474626,0.00038752158,0.000006794611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007701185,0.0006769909,0.96869886,0.00015588813,0.00031270666,0.000048127935,0.027511647,0.000026096464,0.000094037016,0.00003153112,0.0000465723,0.0023205334],"study_design_scores_gemma":[0.008333892,0.00025252262,0.9812883,0.00005745849,0.00090693706,2.4659954e-7,0.005615685,0.001181129,0.00015439562,0.000052016716,0.0019094852,0.0002479474],"about_ca_topic_score_codex":0.001474425,"about_ca_topic_score_gemma":0.0012420482,"teacher_disagreement_score":0.021895962,"about_ca_system_score_codex":0.000021783533,"about_ca_system_score_gemma":0.000024509876,"threshold_uncertainty_score":0.99997884},"labels":[],"label_agreement":null},{"id":"W3046891294","doi":"10.1111/dom.14160","title":"Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the <scp>LEADER</scp> and <scp>SUSTAIN</scp> 6 trials","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; St. Michael's Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; Novo Nordisk","keywords":"Semaglutide; Liraglutide; Medicine; Type 2 diabetes; Dulaglutide; Body mass index; Internal medicine; Lixisenatide; Placebo; Glucagon-like peptide 1 receptor; Overweight; Diabetes mellitus; Myocardial infarction; Glucagon-like peptide-1; Endocrinology; Receptor; Agonist","score_opus":0.013947813844310757,"score_gpt":0.24224426339219243,"score_spread":0.22829644954788167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046891294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658842,0.03151638,0.0000042172333,0.00034692266,0.0002766135,0.0016655192,0.0001102137,0.000046724857,0.0001492244],"genre_scores_gemma":[0.9942015,0.004243728,0.00017571097,0.0006241037,0.00013316248,0.000065464206,0.000042608368,0.000046039808,0.000467693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99652517,0.00055688113,0.00084173644,0.0007677425,0.0005574668,0.00075099943],"domain_scores_gemma":[0.9966143,0.0019485994,0.00042280735,0.00049993687,0.00015937355,0.00035498827],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018103225,0.0005531008,0.0023654425,0.0001936087,0.00019321349,0.00009250903,0.00017992886,0.0002541513,0.000001019505],"category_scores_gemma":[0.004985674,0.00039066095,0.00032960047,0.0005142483,0.0005849626,0.00018524477,0.00036437338,0.00035821053,0.0000018300808],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001377183,0.0004969835,0.95150787,0.0048871282,0.004490419,0.00003130803,0.0077880733,0.000031824973,0.020593803,0.0004010768,0.0016983775,0.007935399],"study_design_scores_gemma":[0.009338338,0.0004831378,0.8801148,0.00039765637,0.0019521591,6.148992e-7,0.0014734084,0.00008663392,0.08579885,0.0002936402,0.019937087,0.00012368806],"about_ca_topic_score_codex":0.000107812055,"about_ca_topic_score_gemma":0.000017454706,"teacher_disagreement_score":0.0713931,"about_ca_system_score_codex":0.000032424825,"about_ca_system_score_gemma":0.00006855882,"threshold_uncertainty_score":0.9998545},"labels":[],"label_agreement":null},{"id":"W3081300539","doi":"10.1111/dom.14179","title":"Cardiorenal outcomes with dapagliflozin by baseline glucose‐lowering agents: Post hoc analyses from <scp>DECLARE‐TIMI</scp> 58","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"AstraZeneca; Bristol-Myers Squibb","keywords":"Dapagliflozin; Medicine; TIMI; Post-hoc analysis; Baseline (sea); Internal medicine; Endocrinology; Type 2 diabetes; Diabetes mellitus; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.02102524981586148,"score_gpt":0.2515692520510866,"score_spread":0.23054400223522512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081300539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803068,0.015950589,0.00029678075,0.0012015639,0.00016965566,0.00055864424,0.00048432837,0.00020996522,0.0008216666],"genre_scores_gemma":[0.9863691,0.0013293915,0.001977412,0.007829788,0.00033997206,0.00005262208,0.0013181291,0.000067474626,0.00071611925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99760145,0.00009291782,0.0003811901,0.0007441799,0.0005410142,0.0006392663],"domain_scores_gemma":[0.9984312,0.00022118079,0.00014604484,0.00043626418,0.00013635124,0.00062892656],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021435836,0.00052921515,0.0012320604,0.00015040748,0.00017408264,0.00013407253,0.00019523264,0.0001275018,0.00011120624],"category_scores_gemma":[0.00026570554,0.0003934031,0.00027817363,0.00036645288,0.0001253657,0.00031759893,0.00020195896,0.0002494096,0.00006484807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020699106,0.0014064468,0.883466,0.00046360595,0.010452869,0.00025693802,0.0018759442,0.00006265289,0.03982001,0.00011483678,0.03511578,0.026757894],"study_design_scores_gemma":[0.0076301536,0.0005861239,0.7252916,0.00015951891,0.0069991765,0.0000011392663,0.00066048146,0.00061499386,0.070545316,0.00004675054,0.18704718,0.00041757495],"about_ca_topic_score_codex":0.00011644886,"about_ca_topic_score_gemma":0.0000150649785,"teacher_disagreement_score":0.15817444,"about_ca_system_score_codex":0.000033465545,"about_ca_system_score_gemma":0.000042005162,"threshold_uncertainty_score":0.99985176},"labels":[],"label_agreement":null},{"id":"W3083189092","doi":"10.1111/dom.14181","title":"Peri‐transplant glycaemic control as a predictor of pancreas transplant survival","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council Canada; Medical Research Council; Royal College of Surgeons of Edinburgh","keywords":"Medicine; Confidence interval; Perioperative; Internal medicine; Area under the curve; Transplantation; Diabetes mellitus; Pancreas transplantation; Proportional hazards model; Urology; Surgery; Gastroenterology; Endocrinology; Kidney transplantation","score_opus":0.01239356902055796,"score_gpt":0.23086371399839406,"score_spread":0.2184701449778361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083189092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944813,0.002663462,0.00023233764,0.0006766007,0.00013401272,0.00043844356,0.0007870004,0.000060994196,0.0005258189],"genre_scores_gemma":[0.99634564,0.0020462314,0.00017013405,0.0010549837,0.00012502896,0.000017920685,0.00015491381,0.000019849133,0.00006527116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998709,0.00007422312,0.00032784833,0.00029569984,0.00030747967,0.00028572715],"domain_scores_gemma":[0.9992261,0.000110956906,0.00008094992,0.00013681919,0.000059252794,0.0003859277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011285433,0.00023227786,0.00077901233,0.000057850168,0.00006321246,0.00001369718,0.00007769243,0.00010380805,0.00011437082],"category_scores_gemma":[0.000022585315,0.00017775492,0.00019647751,0.00012486172,0.00009643899,0.00009049335,0.000006291914,0.00015369095,0.000019524323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090104906,0.0002619272,0.9671935,0.0009858306,0.000857538,0.000098597906,0.0019093722,0.0000035859669,0.025773518,0.0014937595,0.000008665145,0.000512648],"study_design_scores_gemma":[0.009854048,0.00030553364,0.9689354,0.0003070864,0.0020819195,0.000024418168,0.000044374872,0.00021900551,0.016686678,0.00008690027,0.0012597739,0.00019486212],"about_ca_topic_score_codex":0.00007612162,"about_ca_topic_score_gemma":0.0000033843128,"teacher_disagreement_score":0.00908684,"about_ca_system_score_codex":0.000006012905,"about_ca_system_score_gemma":0.00005520819,"threshold_uncertainty_score":0.7248635},"labels":[],"label_agreement":null},{"id":"W3091408760","doi":"10.1111/dom.14204","title":"Differential effects of L‐ and D‐phenylalanine on pancreatic and gastrointestinal hormone release in humans: A randomized crossover study","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Muscle metabolism and nutrition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIHR Imperial Biomedical Research Centre; Biotechnology and Biological Sciences Research Council; Medical Research Council; Medical Research Council Canada; National Institute for Health and Care Research; Imperial College Healthcare NHS Trust; H2020 European Research Council; Imperial College London; Diabetes UK","keywords":"Medicine; Crossover study; Randomized controlled trial; Internal medicine; Gastroenterology; Endocrinology; Placebo; Pathology; Alternative medicine","score_opus":0.0052432918155434225,"score_gpt":0.20771271072459072,"score_spread":0.2024694189090473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091408760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99328965,0.0058684093,0.00005914767,0.00004109833,0.000030262267,0.000670102,0.00001776456,0.0000073761526,0.000016164258],"genre_scores_gemma":[0.99818075,0.0013107003,0.0001498163,0.00013865902,0.00012904943,0.000041731626,0.000026294334,0.000012061683,0.0000109420935],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99888945,0.00023137145,0.00023945012,0.00034728515,0.00010770845,0.00018476756],"domain_scores_gemma":[0.99955964,0.000075734635,0.00008612651,0.00012330376,0.000027927368,0.00012727438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001497405,0.0001849732,0.00062745827,0.000052191626,0.000051365976,0.00002722932,0.00005453252,0.000055370205,0.0000035316598],"category_scores_gemma":[0.00034027887,0.000156361,0.00005454164,0.000063732776,0.00015745364,0.000008899681,0.00009524448,0.00010015329,3.3915188e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017400369,0.001109618,0.19243202,0.00059625256,0.0001569798,0.000013102447,0.00073495624,0.0000017378461,0.7844553,0.00034879622,0.00005735752,0.002693507],"study_design_scores_gemma":[0.08728188,0.00065314973,0.8837068,0.00007146141,0.00026116404,0.0000014614112,0.000042172807,0.00014341227,0.027391933,0.0001911537,0.00006700001,0.00018842366],"about_ca_topic_score_codex":0.000031715113,"about_ca_topic_score_gemma":0.000006408793,"teacher_disagreement_score":0.7570634,"about_ca_system_score_codex":0.0000012355852,"about_ca_system_score_gemma":0.00000739666,"threshold_uncertainty_score":0.63762164},"labels":[],"label_agreement":null},{"id":"W3092361090","doi":"10.1111/dom.14223","title":"Design and baseline characteristics of the <scp>AMPLITUDE‐O</scp> cardiovascular outcomes trial of efpeglenatide, a weekly glucagon‐like peptide‐1 receptor agonist","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Internal medicine; Placebo; Adverse effect; Diabetes mellitus; Renal function; Glucagon-like peptide 1 receptor; Stroke (engine); Myocardial infarction; Type 2 diabetes; Kidney disease; Agonist; Endocrinology; Receptor; Pathology","score_opus":0.017930540110283284,"score_gpt":0.21955812251201745,"score_spread":0.20162758240173417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092361090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919595,0.004722987,0.00041567665,0.0006584945,0.00036757073,0.0015776019,0.000087311455,0.00003975504,0.00017106156],"genre_scores_gemma":[0.99343485,0.0016305652,0.0029455582,0.0009982394,0.00021995518,0.00007071133,0.00005947258,0.0000354039,0.0006052758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797714,0.000253173,0.0005311973,0.00040205292,0.00050502067,0.0003313919],"domain_scores_gemma":[0.9984685,0.00038142048,0.00025769716,0.0005001457,0.00016758584,0.00022465581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008670337,0.00031035035,0.0013642746,0.00008793951,0.00010783487,0.000039341,0.00016995957,0.00011039103,0.000013257405],"category_scores_gemma":[0.00083537225,0.00021380183,0.00043496068,0.00025135462,0.00023592751,0.00010756404,0.00022069667,0.00016536383,0.000005097443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026643435,0.005467412,0.77405834,0.006597257,0.025417,0.000033128013,0.007007328,0.000043797365,0.038345817,0.0033866023,0.012516277,0.12446271],"study_design_scores_gemma":[0.04232004,0.0009014849,0.7810914,0.0002186645,0.00752577,8.8973275e-7,0.00025524123,0.00034796822,0.025677446,0.00015487493,0.14127313,0.00023311374],"about_ca_topic_score_codex":0.000022425558,"about_ca_topic_score_gemma":6.059274e-7,"teacher_disagreement_score":0.12875685,"about_ca_system_score_codex":0.000012908088,"about_ca_system_score_gemma":0.000058541475,"threshold_uncertainty_score":0.8718586},"labels":[],"label_agreement":null},{"id":"W3101372907","doi":"10.1111/dom.14254","title":"Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase‐4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: A subgroup analysis of the randomized <scp>CAROLINA</scp> trial","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Boehringer Ingelheim","keywords":"Linagliptin; Glimepiride; Medicine; Hazard ratio; Type 2 diabetes; Mace; Internal medicine; Clinical endpoint; Diabetes mellitus; Randomized controlled trial; Lower risk; Dipeptidyl peptidase-4 inhibitor; Adverse effect; Myocardial infarction; Confidence interval; Endocrinology; Percutaneous coronary intervention","score_opus":0.006807630801666101,"score_gpt":0.19952963826545225,"score_spread":0.19272200746378615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3101372907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897677,0.0054197945,0.000037321082,0.00090516114,0.00006445712,0.0035080472,0.00003526847,0.00005282309,0.00020944477],"genre_scores_gemma":[0.99797076,0.0003696364,0.00022891599,0.00085539743,0.0000990664,0.00023811574,0.00007847729,0.000038176007,0.000121428675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970939,0.0004453587,0.0005161949,0.0006458274,0.0007400553,0.00055863097],"domain_scores_gemma":[0.9978163,0.0007225144,0.00030712597,0.00071495457,0.00019727349,0.00024178094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010391878,0.00052954734,0.003097561,0.00025432845,0.00019040056,0.00007713148,0.00021676396,0.000111236826,0.000008729931],"category_scores_gemma":[0.00024053387,0.00024120064,0.0005686876,0.0019171544,0.0005535449,0.00016930125,0.0001847361,0.0003199134,0.0000014336288],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019092804,0.0005650906,0.95136905,0.0003480659,0.021952145,0.0000131057295,0.00546282,0.0004113449,0.00008810001,0.00013755025,0.00012045848,0.0004394856],"study_design_scores_gemma":[0.23003839,0.00040768756,0.7406622,0.00014858207,0.025450831,5.184671e-7,0.00069833384,0.0006713306,0.00052841305,0.0000081432045,0.0012268629,0.00015869038],"about_ca_topic_score_codex":0.0001452013,"about_ca_topic_score_gemma":0.00041307523,"teacher_disagreement_score":0.21094558,"about_ca_system_score_codex":0.000025783911,"about_ca_system_score_gemma":0.00008024877,"threshold_uncertainty_score":0.9835877},"labels":[],"label_agreement":null},{"id":"W3106244848","doi":"10.1111/dom.14252","title":"Inter‐individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the <scp>SONAR</scp> trial","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Relypsa; National Institutes of Health; Servier; Novo Nordisk Fonden; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Duke Clinical Research Institute; Novo Nordisk; Novo Nordisk UK Research Foundation; Eli Lilly and Company; AstraZeneca; CSL Behring; Gilead Sciences; Sanofi; Amgen; Pfizer; GlaxoSmithKline","keywords":"Medicine; Post-hoc analysis; Post hoc; Sonar; Pharmacology; Internal medicine; Oceanography; Geology","score_opus":0.01942790409123715,"score_gpt":0.23874052931698814,"score_spread":0.21931262522575098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106244848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958219,0.00073805323,0.000042680993,0.00093430385,0.0001436571,0.0016564153,0.00058051327,0.000034262986,0.00004819385],"genre_scores_gemma":[0.998418,0.00011210882,0.00007783551,0.00093111047,0.00014489767,0.000119662735,0.0001673983,0.000014231211,0.000014773041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960631,0.0017478407,0.0007240452,0.00068412704,0.00038199525,0.0003988615],"domain_scores_gemma":[0.9980253,0.00071283925,0.0002158317,0.00045203025,0.00012192833,0.00047205095],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.003496627,0.00027580856,0.00097022334,0.00031700198,0.00010459534,0.00004753545,0.00014882955,0.0002363475,0.000035621593],"category_scores_gemma":[0.009816691,0.00022038199,0.00031987397,0.0014301839,0.00024524226,0.00024906258,0.00018334926,0.0003934305,8.5543263e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027638404,0.0010848864,0.97091466,0.0007077481,0.00066459726,0.000005131537,0.003797013,0.000005373941,0.0164685,0.00017806311,0.00009004924,0.0033201636],"study_design_scores_gemma":[0.016553449,0.00044648675,0.9706965,0.0001700326,0.0026440911,6.291511e-7,0.00071519165,0.0023006906,0.005388258,0.0004021729,0.0005713267,0.00011115277],"about_ca_topic_score_codex":0.00013890021,"about_ca_topic_score_gemma":0.000069493784,"teacher_disagreement_score":0.013789608,"about_ca_system_score_codex":0.000068888236,"about_ca_system_score_gemma":0.00036100092,"threshold_uncertainty_score":0.99852407},"labels":[],"label_agreement":null},{"id":"W3106995227","doi":"10.1111/dom.14269","title":"Proportion of newly diagnosed diabetes in <scp>COVID</scp> ‐19 patients: A systematic review and meta‐analysis","year":2020,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":256,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Meta-analysis; Diabetes mellitus; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Medicine; Internal medicine; Virology; Disease; Endocrinology; Infectious disease (medical specialty)","score_opus":0.05036164860493033,"score_gpt":0.37291857437089015,"score_spread":0.32255692576595985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106995227","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00193277,0.99042654,0.0000052039645,0.00022519607,0.00003498472,0.0069931145,0.00032231212,0.000046377914,0.000013508048],"genre_scores_gemma":[0.00078151864,0.9953682,0.000091829475,0.0018050505,0.00004600994,0.001519621,0.00023388834,0.000045661483,0.00010826436],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9937269,0.0013611013,0.00233762,0.0010266675,0.00091062527,0.00063706154],"domain_scores_gemma":[0.98549235,0.0111932475,0.0013910257,0.0007817652,0.00041465755,0.0007269645],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0027484854,0.0007644768,0.01775338,0.0007872101,0.00009573861,0.000044764714,0.00029619332,0.00034483257,0.000027365335],"category_scores_gemma":[0.096637994,0.00049841445,0.0022579024,0.0023589612,0.0003328403,0.00015702816,0.000503328,0.00074494845,0.000011115559],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[9.18413e-7,0.00033931725,0.010021889,0.92295206,0.063063525,0.000011978446,0.00009336796,1.8760657e-7,1.7832247e-7,0.000028451086,0.0000842918,0.0034038348],"study_design_scores_gemma":[0.000738829,0.00013713616,0.006007968,0.04838314,0.85814035,1.4756407e-7,0.000012898688,0.000017278417,8.4774484e-7,0.000079434314,0.08626966,0.00021232342],"about_ca_topic_score_codex":0.00005155493,"about_ca_topic_score_gemma":0.000013866237,"teacher_disagreement_score":0.87456894,"about_ca_system_score_codex":0.00008333074,"about_ca_system_score_gemma":0.00037502963,"threshold_uncertainty_score":0.99974674},"labels":[],"label_agreement":null},{"id":"W3108090279","doi":"10.1111/dom.14283","title":"Prediction of heart failure outcomes in patients with type 2 diabetes mellitus: Validation of the Thrombolysis in Myocardial Infarction Risk Score for Heart Failure in Diabetes ( <scp> TRS‐HF <sub>DM</sub> </scp> ) in patients in the <scp>ACCORD</scp> trial","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; St. Michael's Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Myocardial infarction; Cardiology; Diabetes mellitus; Thrombolysis; Framingham Risk Score; Creatinine; Clinical endpoint; Randomized controlled trial; Endocrinology; Disease","score_opus":0.0097584222737263,"score_gpt":0.20343287014692,"score_spread":0.19367444787319368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108090279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942771,0.00039993032,0.0000015447526,0.0003644608,0.0002877532,0.0044449796,0.0001852073,0.000024882094,0.000014119553],"genre_scores_gemma":[0.9985103,0.00013358303,0.00012863179,0.00035298965,0.00008796841,0.00035772467,0.00038643766,0.00003845339,0.00000392963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964996,0.0005848588,0.0009712328,0.0006012918,0.00068625185,0.00065675343],"domain_scores_gemma":[0.9982032,0.0006706627,0.00042395736,0.00041872272,0.0001782836,0.00010517502],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010823208,0.00044033356,0.001398536,0.00064666156,0.000078664365,0.000049549635,0.00022436693,0.00026400955,0.0000019423762],"category_scores_gemma":[0.0013825775,0.00030350528,0.00024378396,0.0016673055,0.00015484128,0.0005096067,0.0001264975,0.00046310067,0.0000018596205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017280584,0.0016995927,0.99362403,0.0002639978,0.0002195906,1.8419297e-7,0.0019654161,0.00021104034,0.00066221895,0.00002112095,0.00030058666,0.0008594097],"study_design_scores_gemma":[0.029711904,0.0011138696,0.9561414,0.00027802036,0.0004537811,1.0642745e-8,0.0005273962,0.00017603615,0.010738257,0.00019128993,0.00058440014,0.00008362257],"about_ca_topic_score_codex":0.00012811083,"about_ca_topic_score_gemma":0.00032922454,"teacher_disagreement_score":0.037482623,"about_ca_system_score_codex":0.00009372466,"about_ca_system_score_gemma":0.00007029957,"threshold_uncertainty_score":0.9999417},"labels":[],"label_agreement":null},{"id":"W3108268477","doi":"10.1111/dom.14284","title":"Extended‐release naltrexone/bupropion and liver health: Pooled, post hoc analysis from four randomized controlled trials","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Bausch Health (Canada); LMC Diabetes & Endocrinology (Canada)","funders":"Orexigen Therapeutics","keywords":"Medicine; Post-hoc analysis; Weight loss; Internal medicine; Placebo; Overweight; Fatty liver; Bupropion; Gastroenterology; Body mass index; Obesity; Disease; Pathology","score_opus":0.022868737944642118,"score_gpt":0.2616724228823353,"score_spread":0.23880368493769316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108268477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84567136,0.14535251,0.00005123102,0.0060878247,0.000092179165,0.0022356082,0.00041274074,0.00006170664,0.00003481669],"genre_scores_gemma":[0.9646586,0.025714144,0.00049300963,0.008116593,0.00036969857,0.00021777347,0.00036181492,0.000021080354,0.00004727281],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99629897,0.0013869014,0.0009398301,0.0006250534,0.00037817028,0.0003710487],"domain_scores_gemma":[0.99633336,0.0017785409,0.0004984948,0.00025653534,0.00017529113,0.0009577668],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001517842,0.0003894966,0.0061498317,0.00022645653,0.00018645258,0.00010267262,0.00006825296,0.00012017144,0.00033447726],"category_scores_gemma":[0.0018900419,0.00024867564,0.0013828466,0.0002965948,0.00012603049,0.00014353429,0.0000725506,0.00016560222,0.000024168825],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4527254,0.00637709,0.18308885,0.0014168508,0.16901693,0.00055623165,0.0079829125,0.000015676369,0.0042379755,0.0032925068,0.0022523247,0.16903724],"study_design_scores_gemma":[0.43161675,0.00031139606,0.497201,0.00011309529,0.06585275,0.0000011564305,0.000154502,0.0027521858,0.00070985244,0.00030203885,0.0006515798,0.0003336979],"about_ca_topic_score_codex":0.00055415387,"about_ca_topic_score_gemma":0.000021425807,"teacher_disagreement_score":0.31411216,"about_ca_system_score_codex":0.000022812092,"about_ca_system_score_gemma":0.00011717812,"threshold_uncertainty_score":0.99999654},"labels":[],"label_agreement":null},{"id":"W3108278357","doi":"10.1111/dom.14275","title":"Genetically determined lean mass and dietary response","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Public Health Ontario; Diabetes Canada; University of Toronto; University Health Network","funders":"","keywords":"Weight loss; Lean body mass; Obesity; Preference; Food preference; Biology; Medicine; Physiology; Endocrinology; Body weight; Food science","score_opus":0.009817217134228194,"score_gpt":0.21388366514919424,"score_spread":0.20406644801496604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108278357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98520845,0.013593175,0.00012449615,0.0007002902,0.00006995153,0.00014233775,0.00007521256,0.000018906509,0.00006716806],"genre_scores_gemma":[0.9931254,0.0018327628,0.0015805729,0.0029331923,0.0003546257,0.00001106265,0.0000619024,0.00001813934,0.00008236248],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999007,0.00009758272,0.00015225967,0.00039824803,0.000093971015,0.00025094082],"domain_scores_gemma":[0.9993108,0.000021708172,0.0000351063,0.0001880159,0.00005205525,0.00039231175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014382262,0.00016934692,0.00019911614,0.000027441933,0.000106927575,0.000039500894,0.00010097933,0.00011497618,0.000013149379],"category_scores_gemma":[0.00018463618,0.00017083842,0.0000649171,0.00005080448,0.0001622059,0.000005482016,0.00011342294,0.00006281167,0.0000048073375],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045752333,0.00006578868,0.043238293,0.0000743,0.00005080915,0.0000059065137,0.00009914013,0.0000022539346,0.951639,0.000045588684,0.0006596949,0.003661729],"study_design_scores_gemma":[0.0019296436,0.00036366095,0.68595964,0.0000119358,0.00017911085,0.0000024159654,0.000058893787,0.0002208208,0.26022604,0.00093285897,0.049653497,0.00046150223],"about_ca_topic_score_codex":0.0000018713334,"about_ca_topic_score_gemma":0.0000016103944,"teacher_disagreement_score":0.6914129,"about_ca_system_score_codex":0.0000015243166,"about_ca_system_score_gemma":0.00003245954,"threshold_uncertainty_score":0.6966589},"labels":[],"label_agreement":null},{"id":"W3110989969","doi":"10.1111/dom.14296","title":"Effects of <b>da</b> pagliflozin on prevention of major clinical events and recovery in patients with <b>re</b> spiratory failure because of COVID‐ <b>19</b> : Design and rationale for the DARE‐19 study","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Dapagliflozin; Medicine; Kidney disease; Internal medicine; Clinical endpoint; Placebo; Respiratory failure; Population; Clinical trial; Intensive care medicine; Acute kidney injury; Type 2 diabetes; Diabetes mellitus; Pathology; Endocrinology","score_opus":0.029813648003676117,"score_gpt":0.27801396143111434,"score_spread":0.24820031342743823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110989969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936273,0.0015413979,0.00031884396,0.00028574085,0.000044732293,0.004133987,0.000035089826,0.0000089859395,0.00000393014],"genre_scores_gemma":[0.9983911,0.0001691614,0.00083308364,0.00038936557,0.000027496946,0.00012654725,0.000027130614,0.000013623439,0.00002251024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867827,0.00024082584,0.00039795134,0.00029730296,0.00024038962,0.00014525584],"domain_scores_gemma":[0.9985667,0.000794693,0.0002517932,0.00015717642,0.00008067685,0.00014896657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006723365,0.00016659546,0.00060785766,0.000100760975,0.000052589814,0.000008726529,0.00006149907,0.00006534817,0.000004797283],"category_scores_gemma":[0.00047548866,0.00011264005,0.00006743907,0.0001450067,0.00011330374,0.00011256966,0.00006865254,0.00008470905,2.3105119e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011776167,0.0027474666,0.9830264,0.0013753123,0.0006297082,0.000001381308,0.000805705,0.000021551385,0.00023524705,0.00014591866,0.00021207113,0.009621658],"study_design_scores_gemma":[0.014441192,0.004438441,0.9768544,0.00014866705,0.0014789149,2.9550737e-8,0.00021126492,0.000064178676,0.001634999,0.00032982777,0.0002963331,0.0001017757],"about_ca_topic_score_codex":0.000009798622,"about_ca_topic_score_gemma":0.000010768922,"teacher_disagreement_score":0.013263576,"about_ca_system_score_codex":0.000010236935,"about_ca_system_score_gemma":0.00005803019,"threshold_uncertainty_score":0.45933282},"labels":[],"label_agreement":null},{"id":"W3112981338","doi":"10.1111/dom.14300","title":"Sodium‐glucose co‐transporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors and the risk of heart failure: A nationwide cohort study of older adults with diabetes mellitus","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Sinai Health System; University of Toronto","funders":"Institute of Chemical and Engineering Sciences; Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Hazard ratio; Diabetic ketoacidosis; Internal medicine; Diabetes mellitus; Confidence interval; Cohort study; Rate ratio; Heart failure; Cohort; Endocrinology","score_opus":0.0051031615147639105,"score_gpt":0.2022933258319656,"score_spread":0.19719016431720168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112981338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99162614,0.0044414974,0.0000036546417,0.0007015864,0.000116562216,0.0028815726,0.00006605431,0.000059967897,0.00010295054],"genre_scores_gemma":[0.99850005,0.0005936069,0.00023287069,0.00024215301,0.00014073499,0.00016471974,0.000070386195,0.000035565092,0.000019898127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763024,0.0002019355,0.00057837315,0.00056501024,0.00062345667,0.00040098303],"domain_scores_gemma":[0.99851143,0.00030232104,0.0003434533,0.0003780295,0.00018732925,0.00027743474],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058911,0.00040324565,0.0012007117,0.00016429376,0.00016372999,0.000038859816,0.00012159592,0.00010143291,0.000021854885],"category_scores_gemma":[0.00011731296,0.0002597561,0.00017611857,0.00040947442,0.00051006826,0.00022766765,0.0000862856,0.0002517997,0.0000032209496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086005434,0.0011290477,0.9878976,0.00048630615,0.0017635196,0.000003443993,0.005360141,0.000004634669,0.00040378617,0.000108771805,0.00029808725,0.001684647],"study_design_scores_gemma":[0.026602697,0.0011855407,0.9409497,0.00025239552,0.0041702013,1.773989e-7,0.0024329727,0.00010275268,0.023010643,0.000022713297,0.0010004814,0.00026975077],"about_ca_topic_score_codex":0.00012383464,"about_ca_topic_score_gemma":0.00007038125,"teacher_disagreement_score":0.046947885,"about_ca_system_score_codex":0.00001219254,"about_ca_system_score_gemma":0.00003395838,"threshold_uncertainty_score":0.99998546},"labels":[],"label_agreement":null},{"id":"W3113276992","doi":"10.1111/dom.14294","title":"A retrospective observational population‐based study to assess the prevalence and burden of illness of type 2 diabetes with an estimated glomerular filtration rate &lt; 90 mL/min/1.73 m <sup>2</sup> in Ontario, Canada","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Renal function; Type 2 diabetes; Kidney disease; Population; Retrospective cohort study; Creatinine; Internal medicine; Diabetes mellitus; Dialysis; Health care; Emergency medicine; Environmental health; Endocrinology","score_opus":0.026243111032516787,"score_gpt":0.2519217443805053,"score_spread":0.22567863334798852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113276992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777114,0.0006945379,0.0000043693562,0.00041437396,0.00002997174,0.00092383224,0.00013370867,0.00001609315,0.000011948518],"genre_scores_gemma":[0.99883413,0.000010543798,0.00029910926,0.0005540386,0.000044333752,0.000035866757,0.00018878175,0.00001485906,0.00001836068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985035,0.00016742296,0.00033579246,0.00036740382,0.00038961408,0.00023624358],"domain_scores_gemma":[0.9989081,0.00014226523,0.00014333896,0.00024714417,0.00030345077,0.00025572203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034395437,0.00020181024,0.0005628534,0.00007717704,0.00009503441,0.00002648867,0.000110777895,0.00004767114,0.00007356154],"category_scores_gemma":[0.00049520086,0.00015189826,0.000028490427,0.00050554646,0.00006806078,0.00021805633,0.00004674624,0.00015264272,2.6421682e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013562846,0.00024834755,0.9935374,0.00035505262,0.00010696053,0.0000026634918,0.0023083703,0.0016493524,0.0014563128,0.00006843775,0.000027122393,0.00010431509],"study_design_scores_gemma":[0.0016556057,0.00044116925,0.98059106,0.00017443475,0.0004427664,1.1646292e-7,0.00043311116,0.013928306,0.0020513157,0.000061240804,0.000048835238,0.00017202983],"about_ca_topic_score_codex":0.14230505,"about_ca_topic_score_gemma":0.11049314,"teacher_disagreement_score":0.03181191,"about_ca_system_score_codex":0.00008835662,"about_ca_system_score_gemma":0.00087104936,"threshold_uncertainty_score":0.90573806},"labels":[],"label_agreement":null},{"id":"W3116633224","doi":"10.1111/dom.14308","title":"The cost‐effectiveness of dapagliflozin in treating high‐risk patients with type 2 diabetes mellitus: An economic evaluation using data from the DECLARE‐TIMI 58 trial","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Dapagliflozin; Medicine; TIMI; Myocardial infarction; Placebo; Population; Unstable angina; Quality-adjusted life year; Stroke (engine); Heart failure; Internal medicine; Intensive care medicine; Cost effectiveness; Emergency medicine; Type 2 diabetes; Diabetes mellitus; Environmental health; Thrombolysis; Risk analysis (engineering); Alternative medicine","score_opus":0.045958767042678206,"score_gpt":0.2840855385992422,"score_spread":0.23812677155656398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116633224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99345475,0.003605389,0.000012675841,0.0000817384,0.00023897426,0.0023226133,0.00023110415,0.000020154717,0.000032604596],"genre_scores_gemma":[0.99773043,0.00040606677,0.00036311115,0.00012393006,0.00018805091,0.00005725188,0.0011062833,0.000023202627,0.0000016839257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790114,0.0007295516,0.00031840004,0.00046628006,0.00029307822,0.0002915541],"domain_scores_gemma":[0.99815625,0.000780148,0.00023404538,0.00061828684,0.00010166044,0.000109582084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014730404,0.00022250107,0.0005380167,0.000048144775,0.00019723889,0.00007991879,0.00027334533,0.00006722412,0.0000240437],"category_scores_gemma":[0.00037923746,0.00012907074,0.000044552653,0.00019201069,0.00012197152,0.0003636772,0.00018843696,0.00014792291,0.0000041232474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002299502,0.0003609147,0.94207233,0.00005614128,0.0006222485,4.3826432e-7,0.00032621005,0.0002835733,0.00018078556,0.00008654062,0.000027485747,0.053683836],"study_design_scores_gemma":[0.02823527,0.0004857524,0.9450004,0.0001297125,0.0023723745,1.10583285e-8,0.00012644206,0.021057023,0.00151888,0.00024450955,0.00066449505,0.00016512486],"about_ca_topic_score_codex":0.00042759866,"about_ca_topic_score_gemma":0.00015342126,"teacher_disagreement_score":0.053518713,"about_ca_system_score_codex":0.000058051653,"about_ca_system_score_gemma":0.00008884759,"threshold_uncertainty_score":0.52633524},"labels":[],"label_agreement":null},{"id":"W3120931056","doi":"10.1111/dom.14316","title":"Essential diabetes medicines and health outcomes in 127 countries","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Queen's University; St. Michael's Hospital","funders":"St. Michael's Hospital Foundation; Canadian Institutes of Health Research; Ontario SPOR SUPPORT Unit","keywords":"Medicine; Diabetes mellitus; Per capita; Population; Interquartile range; Gross domestic product; Confidence interval; Environmental health; Internal medicine; Demography; Endocrinology","score_opus":0.026657386207932794,"score_gpt":0.2758455092691804,"score_spread":0.2491881230612476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120931056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93761075,0.044703193,0.000007794626,0.015974171,0.00042806,0.000116237934,0.00020556846,0.000018836316,0.00093538966],"genre_scores_gemma":[0.9759914,0.010193529,0.00013020223,0.013295509,0.0001609463,0.0000146600005,0.000022409735,0.000015515758,0.0001758226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985624,0.00003044889,0.00051282113,0.0003976686,0.000030585525,0.00046606926],"domain_scores_gemma":[0.9993331,0.00010158888,0.00015215247,0.00017723849,0.000021132988,0.00021481214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000686597,0.00018140674,0.0008338776,0.00017597186,0.000120163066,0.00010831741,0.00009332459,0.00008829806,0.00014658533],"category_scores_gemma":[0.00010980504,0.00019475973,0.000063920656,0.00013931545,0.00014906743,0.00022855392,0.00012222919,0.00016547639,0.000037387756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000011310408,0.00007220057,0.8831957,0.000096563555,0.000051583673,0.0000015541885,0.00027278822,0.0000013211273,0.000023591625,0.11516418,0.00036193858,0.0007574635],"study_design_scores_gemma":[0.00093093555,0.000012121723,0.87510276,0.000019750789,0.0000121086705,5.780046e-7,0.000027935615,0.00054119894,0.000549837,0.03509187,0.08748537,0.00022554398],"about_ca_topic_score_codex":0.00015807031,"about_ca_topic_score_gemma":0.00013990054,"teacher_disagreement_score":0.08712343,"about_ca_system_score_codex":0.000023476969,"about_ca_system_score_gemma":0.000041554384,"threshold_uncertainty_score":0.79420716},"labels":[],"label_agreement":null},{"id":"W3125150772","doi":"10.1111/dom.14326","title":"Impact of polyvascular disease with and without co‐existent kidney dysfunction on cardiovascular outcomes in diabetes: A post hoc analysis of <scp>EMPA‐REG OUTCOME</scp>","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; Lunenfeld-Tanenbaum Research Institute; St. Michael's Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Empagliflozin; Medicine; Internal medicine; Mace; Hazard ratio; Cardiology; Type 2 diabetes; Heart failure; Post-hoc analysis; Population; Diabetes mellitus; Proportional hazards model; Placebo; Confidence interval; Myocardial infarction; Endocrinology; Conventional PCI; Pathology","score_opus":0.01055226278675396,"score_gpt":0.249620035423218,"score_spread":0.23906777263646406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125150772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98909247,0.009643082,0.0000089983405,0.000092132956,0.00005669268,0.0006125594,0.0002460224,0.000031349435,0.00021669724],"genre_scores_gemma":[0.9979418,0.0007334645,0.00015672662,0.00037744947,0.000024973757,0.000049674753,0.0003938959,0.000030781623,0.000291224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763876,0.00016902824,0.00048576022,0.0005992327,0.00063335994,0.0004738648],"domain_scores_gemma":[0.9981768,0.00011882234,0.00019139837,0.0007684028,0.00022189588,0.0005226584],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045964125,0.00041814402,0.0021597636,0.0007777427,0.000064036336,0.00003642745,0.000081263635,0.00009981987,0.000018690165],"category_scores_gemma":[0.00038481326,0.00029750867,0.0010959444,0.00089722703,0.00018013222,0.00016873066,0.00008942983,0.00015224723,0.0000021454287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007730903,0.0011883306,0.97196704,0.00047789054,0.023097409,0.00002410675,0.00021458027,0.00014140301,0.00051155104,0.000107598455,0.00001893995,0.0021738256],"study_design_scores_gemma":[0.004964014,0.00053952466,0.9693892,0.00018537826,0.022480393,3.4310398e-7,0.0001368665,0.00021417231,0.0013808336,0.000018041575,0.0005438555,0.00014736278],"about_ca_topic_score_codex":0.00012395676,"about_ca_topic_score_gemma":0.000021680444,"teacher_disagreement_score":0.008909617,"about_ca_system_score_codex":0.000061767336,"about_ca_system_score_gemma":0.000106309686,"threshold_uncertainty_score":0.9999477},"labels":[],"label_agreement":null},{"id":"W3126647711","doi":"10.1111/dom.14335","title":"Reducing the need for carbohydrate counting in type 1 diabetes using closed‐loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non‐inferiority, crossover pilot trial","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; McGill University; Sinai Health System; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Diabetes Canada","keywords":"Empagliflozin; Medicine; Insulin; Meal; Crossover study; Type 2 diabetes; Diabetes mellitus; Internal medicine; Endocrinology; Placebo","score_opus":0.025204139370200652,"score_gpt":0.28779470572282884,"score_spread":0.2625905663526282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126647711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818186,0.012453295,0.000008941106,0.00047843746,0.0008988705,0.0040622232,0.000025070953,0.00009946993,0.00015505185],"genre_scores_gemma":[0.99705184,0.00082288217,0.00033718234,0.00053430966,0.00072158076,0.00022344533,0.000056275283,0.000044455206,0.00020801826],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99675685,0.0005682373,0.00082698936,0.0005742955,0.00042520525,0.00084840663],"domain_scores_gemma":[0.99738157,0.0013752453,0.00025247445,0.00033171856,0.00047468068,0.00018429066],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004083454,0.0003732022,0.002226476,0.00031224405,0.00045464459,0.00044136998,0.00013721045,0.00018819633,0.000027921003],"category_scores_gemma":[0.00271597,0.00026358097,0.00028542397,0.0006662186,0.00040950842,0.0002778288,0.00027335572,0.00040751905,0.0000034742984],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6075609,0.002845508,0.088961706,0.002537281,0.005288505,0.00009710738,0.0020615354,0.00035478597,0.26791015,0.0021552604,0.0005336767,0.019693611],"study_design_scores_gemma":[0.7309541,0.00025120718,0.030713856,0.00042601273,0.002540483,0.0000010094145,0.00023806431,0.22651602,0.006551617,0.00086833455,0.00042756592,0.0005116872],"about_ca_topic_score_codex":0.00019538731,"about_ca_topic_score_gemma":0.000037923448,"teacher_disagreement_score":0.26135856,"about_ca_system_score_codex":0.000039396895,"about_ca_system_score_gemma":0.00026786394,"threshold_uncertainty_score":0.99998164},"labels":[],"label_agreement":null},{"id":"W3127915609","doi":"10.1111/dom.14339","title":"The comparative effects of intensive glucose lowering in diabetes patients aged below or above 65 years: Results from the <scp>ADVANCE</scp> trial","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Health and Medical Research Council","keywords":"Medicine; Diabetes mellitus; Hazard ratio; Internal medicine; Confidence interval; Randomized controlled trial; Proportional hazards model; Relative risk; Clinical trial; Type 2 diabetes; Endocrinology","score_opus":0.012246029300390374,"score_gpt":0.24313643000418003,"score_spread":0.23089040070378966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127915609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865155,0.010667564,0.0000017113125,0.00016842312,0.00089813146,0.0013946304,0.00010183654,0.000027378588,0.00022477226],"genre_scores_gemma":[0.99615383,0.0017390072,0.0001460662,0.00089818804,0.00020530782,0.000108867105,0.00019932337,0.00002004496,0.00052939326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803275,0.00024246374,0.00046711325,0.00043367187,0.00034513662,0.00047887614],"domain_scores_gemma":[0.9954965,0.003359753,0.00023771152,0.0004865449,0.00030482965,0.00011466263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037980673,0.00028029748,0.0008365668,0.00006604554,0.00015204381,0.000072772586,0.00017408379,0.000090655005,0.0000037955206],"category_scores_gemma":[0.0032316,0.0001653173,0.00015271989,0.0003758729,0.00022242281,0.00016730627,0.00024327163,0.00023900879,0.00000765497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009782263,0.009414349,0.71024436,0.0010780493,0.009066386,0.00035505148,0.05287589,0.000046163506,0.026757954,0.0010347969,0.020947544,0.15839723],"study_design_scores_gemma":[0.044571765,0.00039922367,0.85404783,0.00044296865,0.0006934561,6.884724e-8,0.0010908376,0.000039282455,0.08367215,0.0004021221,0.014539872,0.00010041076],"about_ca_topic_score_codex":0.000047137524,"about_ca_topic_score_gemma":0.00016636506,"teacher_disagreement_score":0.15829681,"about_ca_system_score_codex":0.000033491448,"about_ca_system_score_gemma":0.00005238542,"threshold_uncertainty_score":0.6741444},"labels":[],"label_agreement":null},{"id":"W3128318125","doi":"10.1111/dom.14344","title":"Associations between attainment of incentivized primary care indicators and incident sight‐threatening diabetic retinopathy in England: A population‐based historical cohort study","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Global Challenges Research Fund; Moorfields Eye Hospital NHS Foundation Trust; Medical Research Council; National Institute for Health and Care Research; UK Research and Innovation","keywords":"Medicine; Diabetic retinopathy; Diabetes mellitus; Hazard ratio; Cohort; Type 2 diabetes; Cohort study; Concordance; Proportional hazards model; Demography; Quality and Outcomes Framework; Population; Propensity score matching; Educational attainment; Internal medicine; Primary care; Pediatrics; Confidence interval; Family medicine; Environmental health; Endocrinology","score_opus":0.019089989668730795,"score_gpt":0.31122246976242973,"score_spread":0.29213248009369897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128318125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929638,0.0047684424,0.000008589256,0.00040313773,0.00032782732,0.0011500326,0.00017474062,0.00003953948,0.00016387425],"genre_scores_gemma":[0.99783003,0.00022656642,0.00025145346,0.00076644844,0.00012135222,0.00013918376,0.00057962735,0.000019741872,0.00006559645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99636483,0.0013595775,0.00090671686,0.00043550425,0.0004480482,0.00048532852],"domain_scores_gemma":[0.9979831,0.000923201,0.00044380716,0.00027309798,0.00017412122,0.0002026692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013827984,0.00021219612,0.001141155,0.00034428734,0.0005027322,0.000013243114,0.00010385793,0.00022175495,0.00002778342],"category_scores_gemma":[0.00028707084,0.00020517946,0.00007255574,0.00048002688,0.000032809097,0.00013535314,0.0002486961,0.0005309743,0.000001668066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009993359,0.00019605928,0.99040323,0.0003810653,0.00005643292,0.0000058000574,0.0053319023,5.1709077e-7,0.000044159504,0.000027023321,0.000026523816,0.0035173055],"study_design_scores_gemma":[0.0026916764,0.00004293923,0.9942841,0.00008024446,0.00025135017,4.6327976e-8,0.00036665055,0.0000037314305,0.000077494005,0.00011812022,0.0018988235,0.00018480707],"about_ca_topic_score_codex":0.001546006,"about_ca_topic_score_gemma":0.00064357783,"teacher_disagreement_score":0.004965252,"about_ca_system_score_codex":0.0013310981,"about_ca_system_score_gemma":0.0005758667,"threshold_uncertainty_score":0.8366975},"labels":[],"label_agreement":null},{"id":"W3129758593","doi":"10.1111/dom.14290","title":"Obesity as a <scp>multisystem</scp> disease: Trends in obesity rates and <scp>obesity‐related</scp> complications","year":2021,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":408,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; Diabetes Canada; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Obesity; Prediabetes; Weight loss; Type 2 diabetes; Disease; Body mass index; Diabetes mellitus; Comorbidity; Gerontology; Intensive care medicine; Internal medicine; Endocrinology","score_opus":0.025957243631668188,"score_gpt":0.30073740944117444,"score_spread":0.27478016580950626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129758593","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2888678,0.70753545,0.000004424285,0.00008610892,0.00067743653,0.00120882,0.00042490158,0.00019572259,0.0009993536],"genre_scores_gemma":[0.020094115,0.9701718,0.00019006469,0.00043372807,0.00048401346,0.00031323617,0.0019201337,0.0001493293,0.006243599],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99251044,0.0014209136,0.00185189,0.002002282,0.0007638847,0.0014506083],"domain_scores_gemma":[0.99207723,0.0037509294,0.0009189989,0.0014654032,0.00029953005,0.0014878862],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0017253258,0.0015390465,0.006532199,0.0015073228,0.0006798035,0.00030719367,0.00050807744,0.0012996914,0.00007185037],"category_scores_gemma":[0.002385883,0.0013666059,0.0013931297,0.002417641,0.00043853722,0.00045434348,0.00065336487,0.0018136825,0.000146049],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000049159094,0.0032696167,0.69803476,0.027210835,0.0022820325,0.00052088837,0.0010143637,0.0000014925826,0.000008070437,0.006887491,0.0049893064,0.2557762],"study_design_scores_gemma":[0.0010026086,0.000025551632,0.49055746,0.0045871986,0.0047489917,0.000070643546,0.00010077897,0.000028287704,0.000011810145,0.00025552785,0.49835628,0.00025484097],"about_ca_topic_score_codex":0.00022863918,"about_ca_topic_score_gemma":0.000053357606,"teacher_disagreement_score":0.493367,"about_ca_system_score_codex":0.00016767236,"about_ca_system_score_gemma":0.00061383226,"threshold_uncertainty_score":0.99999684},"labels":[],"label_agreement":null},{"id":"W3129981552","doi":"10.1111/dom.14352","title":"Dapagliflozin effects on lung fluid volumes in patients with heart failure and reduced ejection fraction: Results from the <scp>DEFINE‐HF</scp> trial","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; Ted Rogers Centre for Heart Research; University Health Network","funders":"Novo Nordisk; Eisai; Sanofi; AstraZeneca; GlaxoSmithKline; Amgen","keywords":"Dapagliflozin; Ejection fraction; Placebo; Heart failure; Medicine; Randomized controlled trial; Cardiology; Internal medicine; Urology; Endocrinology; Diabetes mellitus","score_opus":0.005336022667569256,"score_gpt":0.20323578025193384,"score_spread":0.1978997575843646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129981552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99512905,0.0018790577,0.0000019263014,0.0009953661,0.0004604381,0.0010686248,0.000046084668,0.00005064802,0.00036881366],"genre_scores_gemma":[0.9972336,0.00016836404,0.00029845795,0.0009742018,0.00041545872,0.00007186913,0.000404855,0.000021649286,0.0004115332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983984,0.00018599605,0.0002427337,0.0005100614,0.00034786292,0.0003149137],"domain_scores_gemma":[0.9988111,0.00053443457,0.00009110114,0.00034985683,0.000089774265,0.00012369054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002788696,0.00025202328,0.0005149735,0.0001011542,0.00017128157,0.00009934498,0.00004793678,0.0001276593,0.000008306311],"category_scores_gemma":[0.00045576197,0.000172702,0.00006924973,0.00028254546,0.000059858972,0.00019292816,0.00006815352,0.00025178085,0.0000091141],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001736578,0.0013149043,0.9700186,0.00012660008,0.0005947022,0.0000151384,0.00039193803,0.0000037761727,0.0015190211,0.00014883984,0.015682379,0.008447516],"study_design_scores_gemma":[0.04121406,0.00044521334,0.9217166,0.00020981753,0.0006208478,2.0059426e-7,0.000107331274,0.000043986158,0.0074316813,0.00007397348,0.028054837,0.00008147431],"about_ca_topic_score_codex":0.00007958779,"about_ca_topic_score_gemma":0.000043290827,"teacher_disagreement_score":0.048302032,"about_ca_system_score_codex":0.000037110574,"about_ca_system_score_gemma":0.00003542724,"threshold_uncertainty_score":0.7042583},"labels":[],"label_agreement":null},{"id":"W3130138560","doi":"10.1111/dom.14350","title":"Metformin and carotid intima‐media thickness in never‐smokers with type <scp>1</scp> diabetes: The <scp>REMOVAL</scp> trial","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; St Joseph's Health Care","funders":"Novo Nordisk; Juvenile Diabetes Research Foundation Australia; University of Glasgow; Steno Diabetes Center Copenhagen; Astellas Pharma; Mylan; Insulet Corporation; National Health and Medical Research Council; Leona M. and Harry B. Helmsley Charitable Trust; Juvenile Diabetes Research Foundation United States of America; Merck KGaA; Sanofi; GlaxoSmithKline; Amgen; Pfizer; NHS Greater Glasgow and Clyde; European Foundation for the Study of Diabetes; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Metformin; Type 2 diabetes; Internal medicine; Diabetes mellitus; Endocrinology","score_opus":0.015960868952204336,"score_gpt":0.24489024886294186,"score_spread":0.22892937991073753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130138560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97983044,0.0137893595,0.000006661232,0.00040109784,0.00068024365,0.0012864337,0.000020888074,0.00007924385,0.0039056104],"genre_scores_gemma":[0.98370135,0.0033282016,0.00107987,0.002461373,0.0009199074,0.00018012627,0.00018571629,0.00011075373,0.008032683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99642146,0.00037209466,0.000456188,0.00076662,0.0008238282,0.0011598292],"domain_scores_gemma":[0.99669075,0.001765869,0.00015030813,0.000651455,0.00032706955,0.00041456355],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001902838,0.00047026458,0.0010670687,0.00039188287,0.00028964138,0.00026079378,0.00029871336,0.0002772024,0.000027525473],"category_scores_gemma":[0.003016103,0.0003138673,0.00014704339,0.0013775206,0.00057613297,0.0005255734,0.0004596294,0.0008728465,0.000029687384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030562046,0.0017446523,0.9344129,0.0021127993,0.0017063199,0.0003966923,0.0071616536,0.000021880369,0.0071085137,0.0045668106,0.010077147,0.030384993],"study_design_scores_gemma":[0.03492066,0.0005375247,0.7824513,0.0004724493,0.001462436,0.00001443242,0.0042064455,0.00046892682,0.013999703,0.0014796357,0.15975136,0.00023515886],"about_ca_topic_score_codex":0.000033437842,"about_ca_topic_score_gemma":0.000055546938,"teacher_disagreement_score":0.15196164,"about_ca_system_score_codex":0.00003638151,"about_ca_system_score_gemma":0.0002418385,"threshold_uncertainty_score":0.99993134},"labels":[],"label_agreement":null},{"id":"W3131254615","doi":"10.1111/dom.14360","title":"Applying <scp>REWIND</scp> cardiovascular disease criteria to <scp>SUSTAIN</scp> 6 and <scp>PIONEER</scp> 6: An exploratory analysis of cardiovascular outcomes with semaglutide","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ted Rogers Centre for Heart Research; University of Toronto; Toronto General Hospital; St. Michael's Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Novo Nordisk","keywords":"Semaglutide; Mace; Hazard ratio; Medicine; Dulaglutide; Placebo; Internal medicine; Subgroup analysis; Type 2 diabetes; Confidence interval; Pooled analysis; Lower risk; Diabetes mellitus; Endocrinology; Exenatide; Myocardial infarction; Liraglutide","score_opus":0.013043416719402885,"score_gpt":0.23010970592467944,"score_spread":0.21706628920527657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131254615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92791665,0.06879306,0.0006861809,0.000048544636,0.00021104109,0.0015872037,0.00016745001,0.00017417606,0.00041569976],"genre_scores_gemma":[0.99120826,0.002629685,0.0023986176,0.0009115841,0.00023384255,0.0007465473,0.000497697,0.00012471713,0.0012490278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99487525,0.0004706615,0.0006551171,0.001486363,0.0013364663,0.001176129],"domain_scores_gemma":[0.995371,0.0004785667,0.00018911128,0.0020051748,0.00056660164,0.0013895541],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013826228,0.0008359609,0.0032122293,0.0010271593,0.0003679791,0.00024311687,0.00026276204,0.00020911766,0.000007882232],"category_scores_gemma":[0.0011327505,0.0007258201,0.0015085785,0.0018995109,0.00024900163,0.00055631367,0.00047544343,0.00028853363,0.0000108272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000121790945,0.0015879824,0.8582968,0.001970603,0.1121637,0.0007846805,0.0049716593,0.0028583126,0.0014016606,0.0006506634,0.0012978683,0.014003892],"study_design_scores_gemma":[0.0031987117,0.0001529265,0.75417596,0.00016526002,0.06985142,0.0000030591339,0.005427996,0.0005382115,0.005003575,0.00011161609,0.16120586,0.00016538096],"about_ca_topic_score_codex":0.000103101054,"about_ca_topic_score_gemma":0.000024476187,"teacher_disagreement_score":0.15990798,"about_ca_system_score_codex":0.00007620922,"about_ca_system_score_gemma":0.00016703957,"threshold_uncertainty_score":0.9995193},"labels":[],"label_agreement":null},{"id":"W3131978373","doi":"10.1111/dom.14351","title":"Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the <scp>ADVANCE</scp> trial","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Health and Medical Research Council; Medical Research Council; Servier; University of New South Wales","keywords":"Medicine; Post-hoc analysis; Renal function; Hazard ratio; Internal medicine; Type 2 diabetes; Proportional hazards model; Diabetes mellitus; Diabetic nephropathy; Creatinine; Nephropathy; Clinical trial; Confidence interval; Endocrinology","score_opus":0.011647337123727654,"score_gpt":0.27963635289626565,"score_spread":0.267989015772538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131978373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98374146,0.014084614,0.000017792805,0.00066831923,0.000195111,0.00075602566,0.0004793313,0.000020599175,0.000036763464],"genre_scores_gemma":[0.99533993,0.0027090088,0.00030061544,0.001116053,0.00012713051,0.000058670343,0.0003125555,0.0000129301125,0.000023088354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958546,0.0020616918,0.00089209864,0.00054885005,0.00026319266,0.00037957614],"domain_scores_gemma":[0.9899622,0.008708952,0.00030067118,0.00066224934,0.00016962604,0.00019626465],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004180155,0.00026111392,0.0015151673,0.00011869233,0.00011383041,0.00006113415,0.0001395277,0.00018696097,0.000039312017],"category_scores_gemma":[0.016095944,0.00015607962,0.0004224623,0.00090620073,0.0005297784,0.00017999744,0.00012923432,0.00042567175,0.0000022721513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004620708,0.0006229858,0.9951513,0.000059089172,0.0012030668,0.0000039334695,0.00035765098,0.000019103654,0.0003409334,0.00020760305,0.000023865283,0.0015483875],"study_design_scores_gemma":[0.035973143,0.00006509573,0.9519083,0.000060872637,0.004660179,7.304557e-8,0.00021051348,0.0031431003,0.00079062267,0.002929954,0.00018310038,0.00007506382],"about_ca_topic_score_codex":0.00033128052,"about_ca_topic_score_gemma":0.0003414253,"teacher_disagreement_score":0.04324303,"about_ca_system_score_codex":0.000021903139,"about_ca_system_score_gemma":0.00023343827,"threshold_uncertainty_score":0.9921919},"labels":[],"label_agreement":null},{"id":"W3134146806","doi":"10.1111/dom.14372","title":"Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Sanofi","keywords":"Insulin glargine; Insulin degludec; Medicine; Type 2 diabetes; Confidence interval; Post-hoc analysis; Incidence (geometry); Internal medicine; Population; Hazard ratio; Diabetes mellitus; Endocrinology","score_opus":0.0135104133642412,"score_gpt":0.2568153891177615,"score_spread":0.24330497575352028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134146806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97110814,0.025704013,0.000009509931,0.0013886399,0.000101281315,0.0013023271,0.00003153667,0.000025378495,0.0003291926],"genre_scores_gemma":[0.9935476,0.0047105844,0.00013989715,0.00090615434,0.00020953134,0.000118867945,0.000033928358,0.0000255589,0.0003078708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972305,0.0005309516,0.00042031234,0.0005846127,0.0004504109,0.00078319083],"domain_scores_gemma":[0.9987491,0.00044448156,0.00010820112,0.00036269464,0.00009017677,0.0002453499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016670608,0.0003011553,0.00084979634,0.00028366892,0.00015624444,0.00015161013,0.00013941305,0.00017493358,0.000043063028],"category_scores_gemma":[0.0004913479,0.00019622436,0.000059155886,0.000663673,0.0003126501,0.00022324361,0.0001448241,0.0006500474,0.000006424233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049394546,0.0014964106,0.9189356,0.00037841304,0.00033623615,0.00030939156,0.001874999,0.0000060314096,0.0009465907,0.00066598516,0.00023837792,0.06987253],"study_design_scores_gemma":[0.07725073,0.00020746043,0.91415155,0.00017098749,0.00042542536,0.0000037162679,0.00024422686,0.0008308322,0.00060708623,0.0005348115,0.0053285826,0.00024460236],"about_ca_topic_score_codex":0.00013248652,"about_ca_topic_score_gemma":0.00031978785,"teacher_disagreement_score":0.072311275,"about_ca_system_score_codex":0.000020164707,"about_ca_system_score_gemma":0.00010485193,"threshold_uncertainty_score":0.80017966},"labels":[],"label_agreement":null},{"id":"W3135935417","doi":"10.1111/dom.14382","title":"The J‐shaped relationship between body mass index and mortality in patients with <scp>COVID</scp> ‐19: A dose‐response meta‐analysis","year":2021,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Funnel plot; Body mass index; Coronavirus disease 2019 (COVID-19); Meta-analysis; Publication bias; Demography; Index (typography); Statistics; Plot (graphics); Medicine; Mathematics; Internal medicine; Computer science; Sociology","score_opus":0.0949946134359526,"score_gpt":0.4066922413542328,"score_spread":0.3116976279182802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135935417","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18227072,0.81567854,0.000029196897,0.00012593993,0.000033813893,0.0014942018,0.00031998925,0.000033469605,0.000014141977],"genre_scores_gemma":[0.13389575,0.86451066,0.00007114012,0.00026396944,0.00009952606,0.00036589496,0.00032160035,0.000045317167,0.00042614754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9930255,0.0029640624,0.001093541,0.0010769821,0.0010638285,0.0007760859],"domain_scores_gemma":[0.94012773,0.057150237,0.00053861685,0.0010806671,0.00033451317,0.00076821615],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0057055326,0.00067105755,0.0058954763,0.00068590976,0.0005047162,0.00016993165,0.00030164677,0.00047668404,0.00001598518],"category_scores_gemma":[0.059360955,0.0003888257,0.0012425033,0.002311101,0.0006156826,0.00014675726,0.00050688366,0.0014450802,0.0000054576717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026533551,0.0001564713,0.936751,0.0043410864,0.053089187,0.000015626696,0.00007614674,8.0347996e-7,4.1166132e-8,0.00006979562,0.000013739683,0.005459567],"study_design_scores_gemma":[0.00089819095,0.000055275294,0.6751561,0.00029213147,0.1599992,6.6321306e-8,0.0000133024205,0.000008435725,6.148527e-8,0.00016254853,0.16328707,0.00012758994],"about_ca_topic_score_codex":0.00013974831,"about_ca_topic_score_gemma":0.00006946115,"teacher_disagreement_score":0.2615949,"about_ca_system_score_codex":0.00010919184,"about_ca_system_score_gemma":0.00084825826,"threshold_uncertainty_score":0.99985635},"labels":[],"label_agreement":null},{"id":"W3136693186","doi":"10.1111/dom.14386","title":"The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the <scp>CREDENCE</scp> trial","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Mitsubishi Tanabe Pharma Corporation","keywords":"Canagliflozin; Medicine; Hazard ratio; Heart failure; Internal medicine; Empagliflozin; Proportional hazards model; Renal function; Type 2 diabetes; Diabetes mellitus; Kidney disease; Cardiology; Confidence interval; Endocrinology","score_opus":0.00925961364996951,"score_gpt":0.2186879114533947,"score_spread":0.20942829780342517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136693186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785761,0.0202205,0.000007479933,0.0002720831,0.00021789449,0.00057642086,0.000068386165,0.000010718099,0.000050421382],"genre_scores_gemma":[0.9972306,0.0018474407,0.00005681916,0.0003175125,0.000081328624,0.000053465734,0.000051498115,0.000010862763,0.00035049245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984199,0.00029266527,0.00031317642,0.00029504162,0.00038039632,0.0002988559],"domain_scores_gemma":[0.99838644,0.0006891102,0.00011993829,0.00056354806,0.000112918715,0.00012804508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007194556,0.00018655082,0.0009935274,0.00008082555,0.00014798842,0.00003447641,0.00008681893,0.00006772612,0.0000048931265],"category_scores_gemma":[0.0010511448,0.0001084749,0.00043977168,0.00042486688,0.00014239547,0.000041163956,0.0001078308,0.00011350173,7.034803e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034194253,0.0023314697,0.8753283,0.0016017075,0.061806794,0.00003687685,0.0011986444,0.000025940946,0.02374889,0.0031755203,0.009101954,0.021301983],"study_design_scores_gemma":[0.008835378,0.00025187657,0.8306175,0.00016522793,0.03514922,4.0437985e-7,0.00019089521,0.00024749467,0.058189664,0.000056889818,0.06621679,0.00007866993],"about_ca_topic_score_codex":0.00010241541,"about_ca_topic_score_gemma":0.000041274303,"teacher_disagreement_score":0.057114832,"about_ca_system_score_codex":0.000009325528,"about_ca_system_score_gemma":0.000045735083,"threshold_uncertainty_score":0.4423478},"labels":[],"label_agreement":null},{"id":"W3146265631","doi":"10.1111/dom.14391","title":"Sex differences in risk factors for cognitive decline and dementia, including death as a competing risk, in individuals with diabetes: Results from the <scp>ADVANCE</scp> trial","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Health and Medical Research Council; Medical Research Council; Servier; University of New South Wales","keywords":"Dementia; Odds ratio; Medicine; Diabetes mellitus; Waist; Internal medicine; Risk factor; Waist–hip ratio; Stroke (engine); Type 2 diabetes; Gerontology; Body mass index; Disease; Endocrinology","score_opus":0.029541246103450942,"score_gpt":0.29729966411366665,"score_spread":0.2677584180102157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3146265631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916413,0.0055358475,0.000059396614,0.0001094758,0.000076843586,0.001559375,0.00085311383,0.000021592818,0.00014305861],"genre_scores_gemma":[0.99640566,0.0019896638,0.00055134005,0.00029065926,0.00015677986,0.00018025377,0.0003531648,0.000021334256,0.00005116872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969921,0.0007347048,0.0004908391,0.0006590197,0.00047019465,0.0006531585],"domain_scores_gemma":[0.9916863,0.007500023,0.00026844777,0.00017302162,0.0001829486,0.00018926532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020031054,0.00030628004,0.00080238865,0.00016582302,0.00036766744,0.0001610945,0.0001167473,0.000117506985,0.0000108731065],"category_scores_gemma":[0.006851521,0.00020716547,0.00008205635,0.00038265958,0.00020015253,0.0002153922,0.00030267838,0.0005406622,0.0000012737493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003825625,0.00043527895,0.98960245,0.000043894295,0.00046072048,0.000008605961,0.0035052968,6.200203e-7,0.0001774598,0.000020790936,0.0000046708246,0.0053576417],"study_design_scores_gemma":[0.046381224,0.00040969768,0.93537563,0.00042097605,0.0008465443,3.6388866e-7,0.0066377036,0.00018291468,0.007883442,0.0014123616,0.00033416084,0.00011499486],"about_ca_topic_score_codex":0.00048536877,"about_ca_topic_score_gemma":0.0005370386,"teacher_disagreement_score":0.054226838,"about_ca_system_score_codex":0.000017874421,"about_ca_system_score_gemma":0.00012221023,"threshold_uncertainty_score":0.8447963},"labels":[],"label_agreement":null},{"id":"W3154836626","doi":"10.1111/dom.14401","title":"Prevalence and progression of chronic kidney disease among patients with type <scp>2</scp> diabetes: Insights from the <scp>DISCOVER</scp> study","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"AstraZeneca","keywords":"Interquartile range; Kidney disease; Renal function; Medicine; Creatinine; Internal medicine; Type 2 diabetes; Diabetes mellitus; Urology; Stage (stratigraphy); Observational study; Gastroenterology; Endocrinology; Biology","score_opus":0.005908242942561242,"score_gpt":0.21395183185815883,"score_spread":0.2080435889155976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154836626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700727,0.027568154,0.0000016490844,0.000037164635,0.00022905874,0.0016233987,0.00012353761,0.00005037291,0.00029398376],"genre_scores_gemma":[0.99706876,0.0011275803,0.000078395926,0.00034920088,0.00014032098,0.0001090694,0.00030280295,0.00003572754,0.00078813394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782133,0.00019756902,0.00030833212,0.0006483678,0.0005646741,0.0004597476],"domain_scores_gemma":[0.9980496,0.0003914529,0.0002143848,0.00062618434,0.00023703098,0.0004813183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016292353,0.00037450626,0.0006338638,0.000087836714,0.0002196781,0.0001061492,0.00016210724,0.00008061335,0.000013641443],"category_scores_gemma":[0.00066574663,0.00023086384,0.00008429999,0.00037063364,0.0002913078,0.00037400963,0.00034162754,0.00019221427,0.000006511122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008240428,0.0023196128,0.99234045,0.0005067881,0.00071797933,0.0000149051875,0.0010959153,0.0000014167766,0.00022715957,0.00008115658,0.00079604547,0.0018903093],"study_design_scores_gemma":[0.00386091,0.00060768565,0.9841221,0.00073546584,0.0026698457,4.4575874e-8,0.00030503795,0.0000779298,0.002437314,0.0001828056,0.0049330657,0.00006776927],"about_ca_topic_score_codex":0.000018712068,"about_ca_topic_score_gemma":0.000013683869,"teacher_disagreement_score":0.026996087,"about_ca_system_score_codex":0.000029557623,"about_ca_system_score_gemma":0.0001585414,"threshold_uncertainty_score":0.9414354},"labels":[],"label_agreement":null},{"id":"W3157339478","doi":"10.1111/dom.14421","title":"Short‐term intensive insulin as induction and maintenance therapy for the preservation of beta‐cell function in early type 2 diabetes ( <scp>RESET‐IT Main</scp> ): A 2‐year randomized controlled trial","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; McMaster University; University of Toronto; St. Michael's Hospital; Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Randomized controlled trial; Insulin; Type 2 diabetes; Insulin resistance; Diabetes mellitus; Internal medicine; Type 1 diabetes; Endocrinology","score_opus":0.015840925882715986,"score_gpt":0.24326886958923857,"score_spread":0.22742794370652258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157339478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789613,0.015323475,0.000079452955,0.00060317985,0.0007612835,0.0039514136,0.000019801633,0.000026780073,0.0002733535],"genre_scores_gemma":[0.9917232,0.005182321,0.00013916472,0.0010892897,0.0002961576,0.00059366715,0.00007409946,0.000023661025,0.0008784357],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979753,0.0003949178,0.0006262982,0.00038232427,0.00027240824,0.000348789],"domain_scores_gemma":[0.9959266,0.0026463487,0.00024690057,0.00027891496,0.00078420946,0.000117001146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015947245,0.00025670923,0.0015663976,0.00018356508,0.00012173983,0.00006388195,0.00006819722,0.00020358592,0.000021011061],"category_scores_gemma":[0.00534101,0.00016809971,0.00026717808,0.00035056594,0.00023793151,0.00025483334,0.000048224247,0.0002532773,0.0000025753898],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66857725,0.0016372595,0.18440194,0.00070119655,0.003225378,0.000006075823,0.0043836236,0.000019759305,0.11914329,0.004695877,0.0022648554,0.010943488],"study_design_scores_gemma":[0.70017016,0.0005831531,0.2687705,0.00013994044,0.0011229292,9.4875753e-7,0.0007742309,0.00075838447,0.023507085,0.0023371058,0.0017205172,0.00011509503],"about_ca_topic_score_codex":0.00003050582,"about_ca_topic_score_gemma":0.0000057081047,"teacher_disagreement_score":0.095636204,"about_ca_system_score_codex":0.000018202012,"about_ca_system_score_gemma":0.00012076567,"threshold_uncertainty_score":0.6854907},"labels":[],"label_agreement":null},{"id":"W3157970388","doi":"10.1111/dom.14415","title":"Effect of empagliflozin on cardiorenal outcomes and mortality according to body mass index: A subgroup analysis of the <scp>EMPA‐REG OUTCOME</scp> trial with a focus on Asia","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Empagliflozin; Medicine; Hazard ratio; Body mass index; Internal medicine; Proportional hazards model; Diabetes mellitus; Placebo; Diabetic nephropathy; Type 2 diabetes; Heart failure; Nephropathy; Cardiology; Confidence interval; Endocrinology","score_opus":0.010290191231539795,"score_gpt":0.26770079108212314,"score_spread":0.25741059985058334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157970388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974024,0.0003378486,0.000012594803,0.00012013366,0.00016545554,0.0010714303,0.00006833078,0.000023900724,0.0007978471],"genre_scores_gemma":[0.9992613,0.00003347606,0.00006577978,0.00021413261,0.000058877267,0.00007293109,0.000025300616,0.00001917077,0.00024902067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978467,0.00031174236,0.00041077912,0.00047547885,0.00059457886,0.00036070083],"domain_scores_gemma":[0.9983279,0.0005708539,0.00020781421,0.0006077377,0.00009048929,0.00019522093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008079002,0.0003448653,0.0017752128,0.0003709833,0.000091909955,0.000039734565,0.000119560325,0.00010055634,0.000005440163],"category_scores_gemma":[0.00047079037,0.0001993411,0.00049398915,0.00093963835,0.00010733178,0.00007379734,0.00014239457,0.00017867722,0.000001296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000541519,0.00036281705,0.988307,0.00019719351,0.0062763467,0.00001371066,0.00013122369,0.000027499973,0.00080946885,0.00045470876,0.000018551906,0.0028599505],"study_design_scores_gemma":[0.013294427,0.0011827276,0.9381574,0.00009966612,0.014139715,2.1431971e-7,0.00011671282,0.000054215754,0.032696452,0.000049504106,0.00012538877,0.000083574945],"about_ca_topic_score_codex":0.00007525109,"about_ca_topic_score_gemma":0.000044622764,"teacher_disagreement_score":0.050149605,"about_ca_system_score_codex":0.000029404633,"about_ca_system_score_gemma":0.00003107684,"threshold_uncertainty_score":0.8128894},"labels":[],"label_agreement":null},{"id":"W3159368165","doi":"10.1111/dom.14416","title":"Patient‐reported outcomes in adults with type 1 diabetes in global real‐world clinical practice: The <scp>SAGE</scp> study","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Manitoba","funders":"Sanofi","keywords":"Medicine; Worry; Diabetes mellitus; Hypoglycemia; Distress; Type 1 diabetes; Insulin; Observational study; Type 2 diabetes; Glycemic; Quality of life (healthcare); Diabetes management; Anxiety; Internal medicine; Clinical psychology; Psychiatry; Endocrinology; Nursing","score_opus":0.020961073199652302,"score_gpt":0.33468884320982034,"score_spread":0.31372777001016805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159368165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98904014,0.002706721,3.0679854e-7,0.0007108179,0.00036575668,0.001447732,0.000009559912,0.000050058046,0.0056689274],"genre_scores_gemma":[0.9963605,0.00063616346,0.0002167146,0.0011165667,0.00010693089,0.000081348546,0.000039784394,0.000024245164,0.0014177492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99639654,0.0007094307,0.0007393242,0.00066461996,0.0007460384,0.00074402813],"domain_scores_gemma":[0.9974637,0.001129338,0.00021953417,0.00064424815,0.0003138415,0.00022931158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018810802,0.00030152986,0.0009434349,0.00020635914,0.00011828564,0.00011442607,0.00017356224,0.00011947624,0.000024987623],"category_scores_gemma":[0.0032734922,0.00018902351,0.000109503766,0.0016845021,0.00020697158,0.0003042388,0.00034676128,0.0006544231,0.000016909262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047198264,0.003449236,0.9754896,0.00010365593,0.00050231145,0.0003483768,0.00059444597,0.0000024506992,0.000010847463,0.00013643129,0.00029983738,0.019015614],"study_design_scores_gemma":[0.004403733,0.00039953552,0.9814483,0.00016975265,0.00041464117,8.3070114e-7,0.0027471203,0.000099040626,0.000073591174,0.00014287636,0.009999979,0.000100610814],"about_ca_topic_score_codex":0.00017276652,"about_ca_topic_score_gemma":0.001318754,"teacher_disagreement_score":0.018915003,"about_ca_system_score_codex":0.00004213125,"about_ca_system_score_gemma":0.00016976862,"threshold_uncertainty_score":0.77081555},"labels":[],"label_agreement":null},{"id":"W3159474548","doi":"10.1111/dom.14411","title":"Renal haemodynamic response to sodium‐glucose cotransporter‐2 inhibition does not depend on protein intake: An analysis of three randomized controlled trials","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Department of Medicine, University of Toronto; Diabetes Canada","keywords":"Dapagliflozin; Tubuloglomerular feedback; Renal function; Urology; Medicine; Internal medicine; Endocrinology; Placebo; Creatinine; Blood pressure; Chemistry; Cardiology; Diabetes mellitus; Type 2 diabetes; Pathology","score_opus":0.01623434562228844,"score_gpt":0.2629193872096659,"score_spread":0.24668504158737747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159474548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932224,0.000848005,0.00041251493,0.0010087984,0.00013399376,0.003994337,0.00020300898,0.000061702995,0.000115218],"genre_scores_gemma":[0.9964521,0.00016464318,0.0009908982,0.0007416233,0.0000836835,0.00055716705,0.00045646925,0.000023572638,0.00052986667],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99571455,0.0015742918,0.0012079468,0.00059021194,0.0005394208,0.0003736102],"domain_scores_gemma":[0.9974689,0.0009991223,0.0004425025,0.0005363381,0.00025774052,0.00029540548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064637004,0.000375306,0.005477259,0.0008962566,0.00010302088,0.00007150112,0.00007979736,0.00014659186,0.00018641539],"category_scores_gemma":[0.001879845,0.00023494134,0.0012227256,0.000603295,0.000104419996,0.00016948092,0.000047457143,0.0001481693,0.0000061742526],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3627544,0.0026485021,0.004241615,0.00021229225,0.020266123,0.0001260811,0.00075993413,0.000098971985,0.59152466,0.0038996118,0.000012033362,0.013455794],"study_design_scores_gemma":[0.31053662,0.00042931535,0.16731109,0.00029391728,0.042827733,4.6251955e-7,0.000103906736,0.0021770578,0.4747905,0.00094487134,0.0002128858,0.0003716431],"about_ca_topic_score_codex":0.000053143463,"about_ca_topic_score_gemma":0.00043618664,"teacher_disagreement_score":0.16306947,"about_ca_system_score_codex":0.000038973787,"about_ca_system_score_gemma":0.000083942956,"threshold_uncertainty_score":0.958063},"labels":[],"label_agreement":null},{"id":"W3163402894","doi":"10.1111/dom.14443","title":"Potential kidney protection with liraglutide and semaglutide: Exploratory mediation analysis","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Center for Advancing Translational Sciences; Canadian Institutes of Health Research; National Institute of Diabetes and Digestive and Kidney Diseases; Novo Nordisk","keywords":"Liraglutide; Semaglutide; Medicine; Mediation; Exploratory analysis; Type 2 diabetes; Endocrinology; Diabetes mellitus","score_opus":0.006874194599851394,"score_gpt":0.20026230806813572,"score_spread":0.19338811346828433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163402894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944964,0.0029076098,0.0005539418,0.0011514529,0.00010961253,0.00038133594,0.000016610651,0.00008032456,0.0003027273],"genre_scores_gemma":[0.99617624,0.0006285839,0.0012208835,0.0008706507,0.00014615383,0.00007871394,0.00017400997,0.00001636441,0.0006883677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882406,0.00007727197,0.00017192082,0.00040103306,0.0002577045,0.00026802835],"domain_scores_gemma":[0.9992435,0.000015482154,0.00007933892,0.00023464592,0.00014085128,0.0002861649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020634386,0.00019324668,0.00046360499,0.00025202343,0.0001489145,0.00006956157,0.000027967228,0.00007791673,0.000055986206],"category_scores_gemma":[0.00007647942,0.00015714008,0.00009121941,0.0005930568,0.00007945401,0.000193739,0.00006850443,0.00011500548,0.0000072584144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014658476,0.001219632,0.90560365,0.0008595593,0.009695893,0.00018978439,0.0010748772,0.00007121302,0.02764767,0.0015823655,0.0008483292,0.051060457],"study_design_scores_gemma":[0.002438986,0.00011813277,0.95954347,0.000051558884,0.00724599,0.00000433672,0.00018358688,0.0011540969,0.017661802,0.00025596775,0.011084911,0.00025717117],"about_ca_topic_score_codex":0.000015304226,"about_ca_topic_score_gemma":0.000021837288,"teacher_disagreement_score":0.053939827,"about_ca_system_score_codex":0.000020549092,"about_ca_system_score_gemma":0.00006133568,"threshold_uncertainty_score":0.6407986},"labels":[],"label_agreement":null},{"id":"W3164661689","doi":"10.1111/dom.14447","title":"Alleviating carbohydrate counting with a <scp>FiASP‐plus‐pramlintide closed‐loop</scp> delivery system (artificial pancreas): Feasibility and pilot studies","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; McGill University; McGill University Health Centre","funders":"Breakthrough T1D Canada; Canada Research Chairs; Juvenile Diabetes Research Foundation United Kingdom; Juvenile Diabetes Research Foundation International","keywords":"SMA*; Medicine; Placebo; Psychological intervention; Bolus (digestion); Internal medicine; Nursing","score_opus":0.035123969872938025,"score_gpt":0.25256989133994434,"score_spread":0.2174459214670063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164661689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95164925,0.04681082,0.000021562111,0.0001660177,0.00046249523,0.00047731196,0.000028455228,0.00016641784,0.00021767634],"genre_scores_gemma":[0.9961417,0.0014403507,0.0010541048,0.00056679983,0.00051524723,0.000035268786,0.000028704604,0.00003479072,0.00018306717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731165,0.00034448653,0.00056303665,0.0007697161,0.00038262876,0.0006284966],"domain_scores_gemma":[0.99726665,0.001277416,0.00025565023,0.00041542723,0.00050941244,0.0002754313],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015680875,0.00039134885,0.0013703337,0.00012653593,0.0004855962,0.0001193748,0.00007323057,0.00014248495,0.0000041336493],"category_scores_gemma":[0.0017108171,0.00031085583,0.00012947647,0.00043682678,0.00022721302,0.00027246735,0.00020168141,0.00038123076,0.000005335833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090005866,0.00025758732,0.98036575,0.0020039666,0.0010538249,0.00020135476,0.0014741302,0.000008204626,0.009019401,0.001811857,0.00010086611,0.0036130745],"study_design_scores_gemma":[0.0025831705,0.00015700623,0.971853,0.0006326075,0.0023227283,0.00006680602,0.0059495596,0.00073706656,0.01418602,0.0002772068,0.000940696,0.0002941351],"about_ca_topic_score_codex":0.00015767085,"about_ca_topic_score_gemma":0.00009223468,"teacher_disagreement_score":0.045370467,"about_ca_system_score_codex":0.00007039235,"about_ca_system_score_gemma":0.00023580091,"threshold_uncertainty_score":0.9999344},"labels":[],"label_agreement":null},{"id":"W3166262312","doi":"10.1111/dom.14472","title":"Using machine learning to predict severe hypoglycaemia in hospital","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Public Health; Centre for Global Health Research; Sinai Health System; Public Health Ontario; University of Toronto","funders":"Canadian Institutes of Health Research; Canadian HIV Trials Network, Canadian Institutes of Health Research","keywords":"Medicine; Decile; Logistic regression; Lasso (programming language); Machine learning; Artificial intelligence; Retrospective cohort study; Psychological intervention; Cohort; Emergency medicine; Internal medicine; Statistics; Nursing","score_opus":0.012322720445825502,"score_gpt":0.25226130083368975,"score_spread":0.23993858038786425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166262312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99374247,0.00397768,0.000032176704,0.00075665803,0.00031771866,0.00025287407,0.00002930577,0.00004588993,0.0008452507],"genre_scores_gemma":[0.9959018,0.0002606006,0.0020236531,0.0010421295,0.00017385694,0.000013981752,0.000054473287,0.000020978267,0.0005084763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856204,0.000073414456,0.00027965134,0.00039804474,0.0002356668,0.00045119747],"domain_scores_gemma":[0.99922895,0.00007110915,0.000032957312,0.00018881902,0.00014088834,0.00033725487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016098339,0.0002002546,0.0005519912,0.00012217464,0.000117412084,0.00003984973,0.000060003553,0.00014663859,0.000100060846],"category_scores_gemma":[0.00049030123,0.00018775188,0.00010211326,0.000295583,0.0000520273,0.0001144238,0.00012455748,0.00037886834,0.000013963113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087079075,0.0004728647,0.9804091,0.00012814841,0.00008367127,0.00017453141,0.0007795713,0.00003214319,0.012099762,0.00036909318,0.000052621443,0.0053114267],"study_design_scores_gemma":[0.010327628,0.0005676742,0.90998536,0.0005860757,0.00063450844,0.00007792379,0.0004260633,0.006739443,0.008397045,0.00081378577,0.06063361,0.00081086624],"about_ca_topic_score_codex":0.00008446232,"about_ca_topic_score_gemma":0.000017486407,"teacher_disagreement_score":0.070423715,"about_ca_system_score_codex":0.00003109537,"about_ca_system_score_gemma":0.00008435252,"threshold_uncertainty_score":0.76562995},"labels":[],"label_agreement":null},{"id":"W3168679049","doi":"10.1111/dom.14468","title":"Use of once‐weekly semaglutide in patients with type <scp>2</scp> diabetes in routine clinical practice: Results from the <scp>SURE C</scp> anada multicentre, prospective, observational study","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Boniface Hospital; Nova Scotia Health Authority; Western University; Montreal Clinical Research Institute; Professional Engineers Ontario; McGill University Health Centre","funders":"Novo Nordisk","keywords":"Semaglutide; Medicine; Type 2 diabetes; Internal medicine; Clinical endpoint; Observational study; Confidence interval; Prospective cohort study; Waist; Glucagon-like peptide 1 receptor; Diabetes mellitus; Clinical trial; Agonist; Endocrinology; Obesity; Liraglutide","score_opus":0.040906573998949064,"score_gpt":0.2858680078196724,"score_spread":0.24496143382072336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168679049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995513,0.001445469,5.406688e-7,0.00027970521,0.00026499786,0.0019141586,0.0002154454,0.00003330432,0.0003333514],"genre_scores_gemma":[0.9955326,0.00027574514,0.0018367949,0.0009323077,0.00012398715,0.000057085723,0.0005202431,0.00003348821,0.00068777014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964106,0.00060386775,0.00090192124,0.00078800385,0.00073237077,0.00056322094],"domain_scores_gemma":[0.99291,0.0052707456,0.00044107033,0.00061641436,0.00058034505,0.00018141237],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00096968975,0.00036842143,0.0009819217,0.00013030942,0.00010333631,0.00008701755,0.00016409736,0.00014480168,0.000005436377],"category_scores_gemma":[0.012644883,0.0002631284,0.000099694,0.0009114305,0.00015210138,0.00047974312,0.00023804288,0.00046527316,0.000006311255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008529972,0.006722507,0.98848736,0.000044922555,0.00071480457,0.000036628237,0.0012534953,0.000034357166,0.000049898,0.000110583394,0.0010589614,0.0014011773],"study_design_scores_gemma":[0.013525079,0.00044219848,0.9726804,0.00020485788,0.00096525304,9.659954e-8,0.0013466261,0.00025993315,0.0006374045,0.000075718446,0.009789557,0.00007289239],"about_ca_topic_score_codex":0.00048730112,"about_ca_topic_score_gemma":0.0010337892,"teacher_disagreement_score":0.015806982,"about_ca_system_score_codex":0.00006524544,"about_ca_system_score_gemma":0.00018552701,"threshold_uncertainty_score":0.9999821},"labels":[],"label_agreement":null},{"id":"W3173855870","doi":"10.1111/dom.14474","title":"Comparative effectiveness and safety of sodium‐glucose cotransporter‐2 inhibitors versus metformin in patients with type 2 diabetes: An observational study using data from routine care","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sinai Health System; University of Toronto","funders":"National Institute on Aging; Canadian Institutes of Health Research","keywords":"Medicine; Metformin; Internal medicine; Hazard ratio; Diabetic ketoacidosis; Diabetes mellitus; Type 2 diabetes; Dapagliflozin; Propensity score matching; Lactic acidosis; Myocardial infarction; Stroke (engine); Confidence interval; Endocrinology; Insulin","score_opus":0.06893482035059344,"score_gpt":0.3041577007592252,"score_spread":0.23522288040863176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173855870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99514407,0.0032897613,0.000003374152,0.0000054596076,0.00018073802,0.0009790867,0.0003531476,0.000016561837,0.000027800705],"genre_scores_gemma":[0.9957376,0.00006286966,0.00079913693,0.000031467745,0.00004139421,0.000013319404,0.0032953701,0.000015765729,0.000003060199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984887,0.00017060363,0.00029385588,0.00051146274,0.00029395326,0.0002414066],"domain_scores_gemma":[0.99892735,0.00015422373,0.00011197088,0.0004320639,0.00025574668,0.00011865602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024686637,0.00024120789,0.0008186387,0.00010506761,0.00007989703,0.000026762733,0.000094509895,0.00006073753,0.000015149544],"category_scores_gemma":[0.000035147794,0.00020082059,0.000028127755,0.00032266433,0.00009370974,0.00046743485,0.00015229,0.00011243394,5.736698e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007591807,0.0016763697,0.9925335,0.00016095457,0.00069348444,0.00000726329,0.0015564974,0.000009224553,0.00055221986,0.000023961116,0.0000016459221,0.002025715],"study_design_scores_gemma":[0.014172555,0.0006174895,0.9745682,0.00020201913,0.0014256282,2.9007312e-8,0.0013667821,0.00020578783,0.007142861,0.000014574159,0.00009236393,0.00019174263],"about_ca_topic_score_codex":0.00012800851,"about_ca_topic_score_gemma":0.000244157,"teacher_disagreement_score":0.017965315,"about_ca_system_score_codex":0.000040893105,"about_ca_system_score_gemma":0.00007726993,"threshold_uncertainty_score":0.81892264},"labels":[],"label_agreement":null},{"id":"W3176966268","doi":"10.1111/dom.14479","title":"Impact of pregnancy on the trajectories of cardiovascular risk factors in women with and without gestational diabetes","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Work & Health; Institute for Clinical Evaluative Sciences; Mount Sinai Hospital; Health Sciences Centre; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Pregnancy; Gestational diabetes; Medicine; Obstetrics; Diabetes mellitus; Population; Gestation; Endocrinology; Internal medicine; Biology; Environmental health","score_opus":0.011348405558671702,"score_gpt":0.24361852812219556,"score_spread":0.23227012256352386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176966268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926194,0.0067511434,0.0000058021137,0.000050964558,0.00001556589,0.0003271807,0.000117597345,0.0000062395643,0.00010609918],"genre_scores_gemma":[0.9977466,0.0019525122,0.00014684688,0.000022391236,0.0000128860365,0.000046067107,0.000025934549,0.000010400301,0.000036387133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987585,0.00015992869,0.0001760229,0.00021488128,0.00040858408,0.00028206795],"domain_scores_gemma":[0.99915427,0.00025378913,0.00007514413,0.00021634444,0.00018634721,0.00011409126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032551071,0.00014410929,0.00048767947,0.00012594355,0.000052859537,0.00001619686,0.000049056365,0.000038673832,0.00003062728],"category_scores_gemma":[0.00035311683,0.00008511783,0.00009718782,0.0002596174,0.00019945583,0.00008928873,0.00004266622,0.0001477656,3.1806834e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045037916,0.00021873256,0.992306,0.00028522837,0.0012594871,0.0000018405566,0.00091602624,0.00015400445,0.0010094673,0.0005738391,0.0000070751244,0.0032232385],"study_design_scores_gemma":[0.0011438029,0.00028385565,0.98902667,0.00024162939,0.00019763595,1.7961968e-7,0.00031037096,0.000054052645,0.007992338,0.0005590768,0.000106408006,0.000083963954],"about_ca_topic_score_codex":0.000101012956,"about_ca_topic_score_gemma":0.0000075695334,"teacher_disagreement_score":0.0069828713,"about_ca_system_score_codex":0.000022889264,"about_ca_system_score_gemma":0.00010451544,"threshold_uncertainty_score":0.34710044},"labels":[],"label_agreement":null},{"id":"W3181430803","doi":"10.1111/dom.14494","title":"The modifying effects of adiposity on the cardiovascular safety of sulphonylureas","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; McGill University; Partners Healthcare","keywords":"Medicine; Internal medicine; Endocrinology; Pharmacology","score_opus":0.006655463016191803,"score_gpt":0.19336421319014394,"score_spread":0.18670875017395214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181430803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8751525,0.122844025,0.00006701771,0.00025070435,0.00030370915,0.00054891984,0.000017877424,0.00002145529,0.00079375494],"genre_scores_gemma":[0.99360055,0.00564655,0.00012766565,0.00023771364,0.0001995361,0.00003279175,0.000011740373,0.000021848973,0.000121605044],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978999,0.00047123805,0.00032073195,0.0003236414,0.0006318967,0.0003525891],"domain_scores_gemma":[0.9977139,0.0006645795,0.000111213085,0.0011134322,0.0002686713,0.00012815715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014882728,0.00021951208,0.0010196164,0.000052949606,0.00030500712,0.00002663063,0.00017125795,0.00012522563,0.0000084275225],"category_scores_gemma":[0.00093625946,0.00012896341,0.0010646515,0.00030762726,0.00032081883,0.000058513782,0.00012923974,0.0003019155,0.00000416007],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026626996,0.0010779202,0.028140867,0.0037574824,0.02378075,0.000084132414,0.0016648475,0.00014883612,0.017313207,0.016565278,0.00046984767,0.90673053],"study_design_scores_gemma":[0.0014771773,0.00005809558,0.62686723,0.00028422495,0.0024929557,0.000005032737,0.00007382868,0.00004147499,0.33011517,0.00047560953,0.037965607,0.00014360789],"about_ca_topic_score_codex":0.0005297433,"about_ca_topic_score_gemma":0.000028766297,"teacher_disagreement_score":0.90658695,"about_ca_system_score_codex":0.000014756695,"about_ca_system_score_gemma":0.00008885079,"threshold_uncertainty_score":0.5258975},"labels":[],"label_agreement":null},{"id":"W3181897787","doi":"10.1111/dom.14489","title":"Changes in plasma and urine metabolites associated with empagliflozin in patients with type 1 diabetes","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ted Rogers Centre for Heart Research; Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University Health Network; University of Toronto; Toronto General Hospital; Diabetes Canada","funders":"","keywords":"Empagliflozin; Metabolite; Type 2 diabetes; Urine; Internal medicine; Endocrinology; Diabetes mellitus; Chemistry; Medicine; Pharmacology","score_opus":0.006488083987414294,"score_gpt":0.1940352688528273,"score_spread":0.187547184865413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181897787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939014,0.0048015453,1.3618117e-7,0.00030731192,0.000071271745,0.00049747893,0.000026037358,0.000043095402,0.0003517623],"genre_scores_gemma":[0.9977752,0.000590493,0.0003175918,0.00049828604,0.000033093365,0.000050419472,0.00026253113,0.000030287707,0.00044212065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845,0.00009217126,0.00019940932,0.0004609106,0.00026854532,0.0005289691],"domain_scores_gemma":[0.99928886,0.00010107181,0.00008102615,0.00022138255,0.0001435025,0.00016415834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022782078,0.00029970563,0.0007745275,0.00029288328,0.000055367484,0.0000557905,0.000051428902,0.0000958277,0.000039362843],"category_scores_gemma":[0.00014170533,0.00022154268,0.000027037704,0.0006721438,0.00010671256,0.00018384014,0.00010189775,0.00017471342,0.0000032732166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067601955,0.00094656437,0.99307185,0.00011299283,0.0003934237,0.000026030342,0.00021500143,0.0000015765971,0.00025148096,0.00017451071,0.00002861578,0.004710365],"study_design_scores_gemma":[0.007357585,0.0003344312,0.9836139,0.00030076504,0.0005786686,2.0150331e-7,0.00006467905,0.00004897527,0.005743171,0.000071637485,0.0016252317,0.00026071855],"about_ca_topic_score_codex":0.000015784413,"about_ca_topic_score_gemma":0.0005883523,"teacher_disagreement_score":0.0094579,"about_ca_system_score_codex":0.00003148284,"about_ca_system_score_gemma":0.000039429353,"threshold_uncertainty_score":0.9034248},"labels":[],"label_agreement":null},{"id":"W3186539542","doi":"10.1111/dom.14504","title":"Effect of insulin degludec versus insulin glargine <scp>U100</scp> on time in range: <scp>SWITCH PRO</scp> , a crossover study of basal insulin‐treated adults with type 2 diabetes and risk factors for hypoglycaemia","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Novo Nordisk","keywords":"Insulin degludec; Insulin glargine; Medicine; Internal medicine; Crossover study; Diabetes mellitus; Insulin; Endocrinology; Type 2 diabetes; Placebo","score_opus":0.009979427910325139,"score_gpt":0.2555264918040429,"score_spread":0.24554706389371778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186539542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98856866,0.0076549333,0.000001119257,0.000014780649,0.00017537364,0.0031283998,0.0001806153,0.00005760247,0.00021849392],"genre_scores_gemma":[0.9975625,0.0012059899,0.00012780789,0.000033977583,0.00010468505,0.00015025462,0.00022682817,0.00007621253,0.0005117269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99641716,0.00048996584,0.00062949857,0.00085814996,0.0007351231,0.00087008945],"domain_scores_gemma":[0.99504536,0.0032058225,0.00034507207,0.00055721385,0.0005244864,0.00032203863],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012248954,0.0005861934,0.0017222494,0.00057103514,0.00015351006,0.000076372286,0.00022257496,0.0003008048,0.000012719972],"category_scores_gemma":[0.004194817,0.00043232468,0.00015509033,0.0013121864,0.00027865643,0.00023771521,0.000269069,0.00056371064,0.000008085806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018208487,0.002846335,0.9769577,0.0016577196,0.0012907509,0.000025723008,0.0021993874,0.000026614045,0.003250438,0.000013506167,0.00020345507,0.009707533],"study_design_scores_gemma":[0.04396267,0.0075314185,0.8640967,0.0004698329,0.0013300373,2.2772375e-7,0.0006047023,0.0009827536,0.080095865,0.00002739143,0.0007536025,0.00014477521],"about_ca_topic_score_codex":0.000115652176,"about_ca_topic_score_gemma":0.000076221666,"teacher_disagreement_score":0.11286096,"about_ca_system_score_codex":0.000039911676,"about_ca_system_score_gemma":0.00011029946,"threshold_uncertainty_score":0.99981284},"labels":[],"label_agreement":null},{"id":"W3189855140","doi":"10.1111/dom.14513","title":"Efficacy and safety of sotagliflozin in patients with type <scp>2</scp> diabetes and severe renal impairment","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Placebo; Medicine; Renal function; Internal medicine; Clinical endpoint; Gastroenterology; Diabetes mellitus; Blood pressure; Confidence interval; Kidney disease; Type 2 diabetes; Adverse effect; Type 1 diabetes; Randomized controlled trial; Urology; Endocrinology; Pathology","score_opus":0.004508049062991897,"score_gpt":0.1942720261216524,"score_spread":0.1897639770586605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3189855140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99246705,0.0062825037,8.0085357e-7,0.000073585245,0.0000676811,0.0005547928,0.00002750235,0.000023061062,0.00050303363],"genre_scores_gemma":[0.9976456,0.00088615075,0.00059722306,0.0002614151,0.00003369014,0.000014213338,0.000115403345,0.000019376052,0.00042689423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869734,0.00006491198,0.00025413977,0.00038155686,0.0002307069,0.0003713293],"domain_scores_gemma":[0.9992274,0.00015488127,0.00008871207,0.00022264424,0.00011760548,0.00018877303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019703335,0.00023719294,0.00061475753,0.00013727395,0.00006625824,0.000031713003,0.00004121504,0.0000819331,0.000013697957],"category_scores_gemma":[0.00012421716,0.00018669262,0.00003712205,0.00026524864,0.00013106957,0.00013897086,0.00015562179,0.00012242343,0.0000020516832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060401133,0.000874349,0.9883029,0.00029545178,0.0003795393,0.000007691363,0.00037920926,0.0000020514171,0.0005243775,0.0002346628,0.00017740155,0.008761981],"study_design_scores_gemma":[0.008789589,0.00043941362,0.98134804,0.00024784036,0.000560448,4.2568595e-7,0.000085772335,0.000021586735,0.00371004,0.00010105506,0.004596948,0.000098865414],"about_ca_topic_score_codex":0.000006217503,"about_ca_topic_score_gemma":0.0000073535202,"teacher_disagreement_score":0.008729187,"about_ca_system_score_codex":0.000017683937,"about_ca_system_score_gemma":0.00003736889,"threshold_uncertainty_score":0.7613104},"labels":[],"label_agreement":null},{"id":"W3197785709","doi":"10.1111/dom.14535","title":"Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the <scp>EMPA‐REG OUTCOME</scp> trial","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; Lunenfeld-Tanenbaum Research Institute; St. Michael's Hospital","funders":"Eli Lilly and Company","keywords":"Empagliflozin; Medicine; Insulin; Placebo; Internal medicine; Diabetes mellitus; Type 2 diabetes; Endocrinology","score_opus":0.011845454628464088,"score_gpt":0.21517571711972322,"score_spread":0.20333026249125913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197785709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99219745,0.006306121,0.0000020892537,0.000083985135,0.0002015046,0.0011186305,0.000032510583,0.0000224178,0.00003529869],"genre_scores_gemma":[0.99819624,0.00067506253,0.000096686745,0.0005077754,0.00008028503,0.00006624632,0.00028956245,0.000018762583,0.0000693865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986088,0.00016917783,0.00026340864,0.00037248334,0.00034895926,0.00023716284],"domain_scores_gemma":[0.9987351,0.0005620165,0.00008486188,0.0003403785,0.00015904332,0.000118620235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027845358,0.0002104535,0.0006074045,0.00010843495,0.000069260146,0.000040038212,0.000061614955,0.00007378897,0.0000060382595],"category_scores_gemma":[0.0012604039,0.00013112256,0.000101820246,0.0003325015,0.000081616876,0.00013414201,0.000073374875,0.00013313582,0.000004330923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006195168,0.0007618319,0.9903357,0.00022923296,0.00082145963,0.000008166504,0.00040937762,0.0000034730306,0.00013155858,0.000097714925,0.000091878916,0.0064900885],"study_design_scores_gemma":[0.022031497,0.00037282566,0.97003627,0.0002246812,0.0018865056,2.0538492e-8,0.000076404045,0.00003030498,0.0038695936,0.00009271501,0.0013108071,0.00006835057],"about_ca_topic_score_codex":0.0000143976995,"about_ca_topic_score_gemma":0.00000517888,"teacher_disagreement_score":0.021411981,"about_ca_system_score_codex":0.000020321953,"about_ca_system_score_gemma":0.000036952617,"threshold_uncertainty_score":0.5347023},"labels":[],"label_agreement":null},{"id":"W3199001556","doi":"10.1111/dom.14551","title":"Gastrointestinal tolerability of once‐weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada); McMaster University; York University","funders":"","keywords":"Semaglutide; Weight loss; Tolerability; Overweight; Adverse effect; Medicine; Obesity; Weight management; Gastrointestinal system; Anti obesity; Internal medicine; Endocrinology; Diabetes mellitus; Type 2 diabetes","score_opus":0.013496819939861935,"score_gpt":0.23526608980532987,"score_spread":0.22176926986546794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199001556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695593,0.0009914965,0.000052806972,0.0009148807,0.00002961095,0.0007075561,0.000044471682,0.000028446297,0.0002747743],"genre_scores_gemma":[0.9933242,0.00012650306,0.0057761637,0.00012169694,0.00007744359,0.00003378195,0.000056368255,0.000018094184,0.00046572732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980313,0.00023906869,0.00044308492,0.0005222307,0.00033098538,0.00043329128],"domain_scores_gemma":[0.99825275,0.0008293446,0.00018742484,0.00035267373,0.00015047647,0.0002273498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062812486,0.0003146793,0.000827667,0.00012995141,0.00014678262,0.000019289253,0.00008781957,0.000045857854,0.000029984267],"category_scores_gemma":[0.0005633465,0.00020019048,0.00008281971,0.00033831145,0.000534493,0.00019152767,0.00022500432,0.0003001358,0.0000023251207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005746557,0.00044150415,0.9954285,0.0005983328,0.00009100435,0.0000838617,0.0002815233,0.0000018117643,0.000036800684,0.0016263623,0.000018303195,0.0008173553],"study_design_scores_gemma":[0.009971759,0.00031325393,0.98498213,0.0016636853,0.0006684856,0.00009160819,0.00020428636,0.00013351155,0.00026987933,0.0014115935,0.000110079614,0.00017971217],"about_ca_topic_score_codex":0.00009107394,"about_ca_topic_score_gemma":0.00014424641,"teacher_disagreement_score":0.01044634,"about_ca_system_score_codex":0.000034480483,"about_ca_system_score_gemma":0.00009970338,"threshold_uncertainty_score":0.8163531},"labels":[],"label_agreement":null},{"id":"W3199091208","doi":"10.1111/dom.14552","title":"The ongoing evolution of basal insulin therapy over 100 years and its promise for the future","year":2021,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Context (archaeology); Insulin; Insulin degludec; Basal (medicine); Insulin glargine; Basal insulin; Medicine; Endocrinology; Bioinformatics; Internal medicine; Biology; Diabetes mellitus; Type 2 diabetes; Hypoglycemia","score_opus":0.02892116287858056,"score_gpt":0.31707443446232536,"score_spread":0.2881532715837448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199091208","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022047888,0.975001,0.0000026818225,0.00023599692,0.00038382923,0.002203497,0.00004622238,0.000013208578,0.00006570222],"genre_scores_gemma":[0.00063166086,0.9968568,0.000036418947,0.000074354146,0.0008249063,0.00019767408,0.00004523928,0.00003408955,0.0012988553],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99849576,0.0001844608,0.0003195955,0.00032180193,0.00031369546,0.00036471835],"domain_scores_gemma":[0.9986775,0.0005689789,0.00018324144,0.00034009386,0.00013711321,0.000093108196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011539195,0.000256469,0.0010744288,0.00012094076,0.00026387235,0.000092591545,0.00019894486,0.00021202455,0.00002000524],"category_scores_gemma":[0.00017181433,0.00012954237,0.00033424827,0.00031250442,0.00014658699,0.0000765528,0.00017732904,0.0003694536,0.0000022347879],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014412218,0.000081125916,0.00025512543,0.005252925,0.0006542977,0.000001076097,0.00006451048,5.27781e-8,0.0000074606332,0.0023037966,0.0008120837,0.99055314],"study_design_scores_gemma":[0.00088882976,0.000052768995,0.018827427,0.0017101291,0.0011099023,3.5376723e-7,0.00004532333,0.00006271299,0.000014228551,0.00013363447,0.9770143,0.00014037918],"about_ca_topic_score_codex":0.0000037893312,"about_ca_topic_score_gemma":0.0000034910013,"teacher_disagreement_score":0.9904128,"about_ca_system_score_codex":0.000021159782,"about_ca_system_score_gemma":0.00017176659,"threshold_uncertainty_score":0.52825844},"labels":[],"label_agreement":null},{"id":"W3199674324","doi":"10.1111/dom.14559","title":"Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the <scp>EMPA‐REG OUTCOME</scp> trial","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute","funders":"Boehringer Ingelheim; Eli Lilly and Company","keywords":"Empagliflozin; Medicine; EMPA; Post-hoc analysis; Uric acid; Type 2 diabetes; Diabetes mellitus; Gout; Internal medicine; Pharmacology; Endocrinology; Chemistry","score_opus":0.011980052104121532,"score_gpt":0.24204910675745814,"score_spread":0.2300690546533366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199674324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95996755,0.03774227,0.0000041214944,0.000548935,0.00048812057,0.00072383886,0.0001767926,0.000049814815,0.00029857157],"genre_scores_gemma":[0.99561137,0.0010108686,0.0004036232,0.0019246865,0.0002753823,0.00006063241,0.00008206762,0.000043779826,0.000587608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961681,0.0004932289,0.0009717244,0.00082000374,0.00072704523,0.0008199212],"domain_scores_gemma":[0.9973793,0.0005522649,0.00037366766,0.0010050819,0.0003036031,0.00038609363],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011361155,0.0005058119,0.002306547,0.0007473001,0.00017814057,0.000077974015,0.00030667646,0.0003719309,0.00006132646],"category_scores_gemma":[0.0025802006,0.00037574847,0.00065213925,0.0032085464,0.00034107364,0.0002686419,0.00045434758,0.0006637802,0.000008265145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001831796,0.0009413684,0.9542185,0.00031414258,0.0035331452,0.00003084362,0.0025437481,0.000011479832,0.034538697,0.00041712308,0.00017186222,0.0030959162],"study_design_scores_gemma":[0.015511273,0.00009815287,0.94413966,0.000065557266,0.011239257,0.000004042594,0.0005764635,0.000192873,0.021408113,0.00014703724,0.0064423466,0.00017522476],"about_ca_topic_score_codex":0.00007670958,"about_ca_topic_score_gemma":0.000088968416,"teacher_disagreement_score":0.0367314,"about_ca_system_score_codex":0.000039682185,"about_ca_system_score_gemma":0.0001942397,"threshold_uncertainty_score":0.99986947},"labels":[],"label_agreement":null},{"id":"W3203632442","doi":"10.1111/dom.14564","title":"Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine <scp>U300</scp> in people with type 2 diabetes: A post hoc analysis of the <scp>CONCLUDE</scp> trial","year":2021,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; LMC Diabetes & Endocrinology (Canada)","funders":"Novo Nordisk; National Institute for Health and Care Research","keywords":"Insulin degludec; Medicine; Insulin glargine; Internal medicine; Type 2 diabetes; Renal function; Insulin; Endocrinology; Diabetes mellitus; Kidney disease; Lixisenatide; Post-hoc analysis; Basal insulin","score_opus":0.01522354404536465,"score_gpt":0.25493959651881537,"score_spread":0.2397160524734507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203632442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98630846,0.0065674814,0.0000017685056,0.0039118454,0.00046011948,0.0017077771,0.000432393,0.00002046109,0.0005897209],"genre_scores_gemma":[0.97790337,0.0034665016,0.00004554762,0.014379214,0.00093703356,0.000066227214,0.0017815664,0.00010821064,0.0013123436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956592,0.00075292727,0.0009088988,0.00073134026,0.0011624598,0.0007851768],"domain_scores_gemma":[0.9939366,0.0033088136,0.0007839768,0.0010934048,0.0006238521,0.00025335714],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014855401,0.00061689503,0.0024672465,0.0011775336,0.0001448873,0.000067609784,0.00046493317,0.0006196862,0.000059330163],"category_scores_gemma":[0.0051683243,0.00035049798,0.0007391245,0.0037410408,0.00054744334,0.00013321578,0.00042652295,0.0015485261,0.0000029126688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017007273,0.005949107,0.79282767,0.0060851355,0.061744746,0.00004989262,0.004896929,0.0004097419,0.006430697,0.00036839326,0.087786585,0.016443841],"study_design_scores_gemma":[0.034405254,0.0027947398,0.91167504,0.0006361535,0.009361262,1.9454514e-7,0.00018654251,0.00032540812,0.00070076465,0.000016445692,0.0397781,0.00012011839],"about_ca_topic_score_codex":0.00019340993,"about_ca_topic_score_gemma":0.00008525275,"teacher_disagreement_score":0.11884736,"about_ca_system_score_codex":0.00007588586,"about_ca_system_score_gemma":0.0005684703,"threshold_uncertainty_score":0.9998947},"labels":[],"label_agreement":null},{"id":"W3212829511","doi":"10.1111/dom.14591","title":"Restrictive versus liberal transfusion in patients with diabetes undergoing cardiac surgery: An o <scp>pen‐label,</scp> randomized, blinded outcome evaluation trial","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Blood transfusion and management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Libin Cardiovascular Institute of Alberta; Kingston General Hospital; University of Calgary; Centre Hospitalier de l’Université de Montréal; The Quebec Population Health Research Network; Health Sciences Centre; Mount Sinai Hospital; University of Toronto; St. Michael's Hospital","funders":"Health Research Council of New Zealand; National Health and Medical Research Council; Canadian Institutes of Health Research; National Institutes of Health; Canadian Blood Services","keywords":"Medicine; Diabetes mellitus; Randomized controlled trial; Internal medicine; Surgery; Blood transfusion; Stroke (engine); Myocardial infarction; Dialysis; Intensive care unit","score_opus":0.029934372663176,"score_gpt":0.2716096901452942,"score_spread":0.24167531748211818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212829511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99264616,0.0018138207,0.000017261431,0.00023423803,0.0013130549,0.0032785754,0.00002816982,0.00007338211,0.00059536914],"genre_scores_gemma":[0.99738115,0.00091157586,0.00034367995,0.00038641924,0.00019226175,0.00024253858,0.0003945479,0.000039670125,0.00010818544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99612075,0.0011641982,0.0006168207,0.0006690104,0.0008853608,0.00054387486],"domain_scores_gemma":[0.9974505,0.0013642106,0.00015300329,0.00039594193,0.00035294,0.0002834149],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021885072,0.0003558661,0.0016071674,0.00039008734,0.00017935589,0.00009404295,0.00007862082,0.00020169282,0.000032870354],"category_scores_gemma":[0.0012096652,0.00029217708,0.00027086932,0.0006649311,0.00011386102,0.0004251934,0.000052039675,0.00034579556,0.0000047446197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.080727234,0.0040532527,0.88051164,0.00034486738,0.0015091181,0.000016222433,0.0015480139,0.000019677376,0.00035037863,0.0006390779,0.00018345013,0.030097079],"study_design_scores_gemma":[0.46706098,0.0002773268,0.5280809,0.00010091622,0.0021638304,6.694829e-8,0.00017867946,0.00020543506,0.001307026,0.00016968901,0.00030782068,0.00014736425],"about_ca_topic_score_codex":0.000040897863,"about_ca_topic_score_gemma":0.000108084205,"teacher_disagreement_score":0.38633376,"about_ca_system_score_codex":0.000059211205,"about_ca_system_score_gemma":0.0002379972,"threshold_uncertainty_score":0.99995303},"labels":[],"label_agreement":null},{"id":"W4200582462","doi":"10.1111/dom.14629","title":"Pushing the limits of insulin delivery 100 years later: A case study of a race across Canada","year":2021,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"York University","funders":"","keywords":"Race (biology); Insulin delivery; Insulin; Medicine; Demography; Sociology; Internal medicine; Gender studies; Endocrinology; Diabetes mellitus; Type 1 diabetes","score_opus":0.026244466748680813,"score_gpt":0.2752432618423576,"score_spread":0.24899879509367678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200582462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97519016,0.008997007,1.8343754e-7,0.0143955685,0.0003496256,0.0008588056,0.000118994925,0.000012847527,0.00007678109],"genre_scores_gemma":[0.96786165,0.00050190825,0.000026160049,0.029251087,0.00060670986,0.000033888187,0.00009114926,0.000042721087,0.0015847483],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973732,0.0003250372,0.00047106267,0.00043242032,0.00081431976,0.0005839395],"domain_scores_gemma":[0.9983393,0.0003573073,0.0002590151,0.0006476735,0.00029361702,0.0001030624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074473926,0.00029297473,0.0010956699,0.00011527569,0.00014601981,0.00006708772,0.00028701083,0.00027661576,0.00003803322],"category_scores_gemma":[0.00017244552,0.00021513847,0.00015160508,0.0004225127,0.00017759298,0.000086632455,0.00043835497,0.0012335008,0.0000013790882],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012858983,0.0029802828,0.3427982,0.010097705,0.008816071,0.04192303,0.02039643,0.000027244554,0.0012268567,0.000012437268,0.4560067,0.11558643],"study_design_scores_gemma":[0.0049806465,0.00036582537,0.3536646,0.0007829635,0.0027447422,0.000056629,0.0072309948,0.00010760129,0.0018940833,0.000017731567,0.6274869,0.00066729815],"about_ca_topic_score_codex":0.1137036,"about_ca_topic_score_gemma":0.070043385,"teacher_disagreement_score":0.17148015,"about_ca_system_score_codex":0.00003105706,"about_ca_system_score_gemma":0.00026342407,"threshold_uncertainty_score":0.9469259},"labels":[],"label_agreement":null},{"id":"W4200603578","doi":"10.1111/dom.14622","title":"Trends in basal insulin prescribing in older adults with chronic kidney disease in Ontario, Canada: A population‐based analysis from 2010 to 2020","year":2021,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St Joseph's Health Care; Lawson Health Research Institute; Western University","funders":"Schulich School of Medicine and Dentistry; Western University; Ontario Ministry of Health and Long-Term Care; Academic Medical Organization of Southwestern Ontario; Lawson Health Research Institute","keywords":"Medicine; Insulin glargine; Kidney disease; Insulin degludec; Medical prescription; Diabetes mellitus; Internal medicine; Population; Type 2 diabetes; Intensive care medicine; Endocrinology; Pharmacology; Environmental health","score_opus":0.005974535116680456,"score_gpt":0.19893583274309798,"score_spread":0.19296129762641753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200603578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996069,0.0019197318,0.0000050979074,0.0013469264,0.00009876917,0.00037174587,0.00010214156,0.000013830299,0.00007277179],"genre_scores_gemma":[0.9951072,0.000029686556,0.00040361375,0.0015384445,0.000041883945,0.000094466624,0.0021712822,0.000014951871,0.0005984792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983705,0.00007782277,0.00030668417,0.0005485898,0.00028363866,0.00041274147],"domain_scores_gemma":[0.9991152,0.000038687496,0.00005339412,0.00032110006,0.000038978866,0.00043259875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011592999,0.00023284816,0.0006530028,0.000644582,0.000033115324,0.00003431664,0.00006857226,0.000058278285,0.00051983155],"category_scores_gemma":[0.000061047715,0.00021263614,0.000077450684,0.0015211892,0.000014181053,0.00013082643,0.00006798042,0.00019936662,0.0000015797874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001369022,0.0005204888,0.9940035,0.0000539491,0.00023877138,0.00019514344,0.0003564576,0.0006279952,0.000021699032,0.000010789955,0.00031997316,0.003514357],"study_design_scores_gemma":[0.0059972657,0.00002799988,0.9890877,0.00037175292,0.0009333391,2.5954472e-8,0.00003358229,0.0022494057,0.00015477424,0.000014021245,0.0009097057,0.00022043801],"about_ca_topic_score_codex":0.91314965,"about_ca_topic_score_gemma":0.99620324,"teacher_disagreement_score":0.08305359,"about_ca_system_score_codex":0.0004812565,"about_ca_system_score_gemma":0.00069885503,"threshold_uncertainty_score":0.867105},"labels":[],"label_agreement":null},{"id":"W4205144121","doi":"10.1111/dom.14637","title":"<scp>Glucagon‐like peptide</scp> ‐1 receptor agonists as adjunctive treatment for type 1 diabetes: Renewed opportunities through tailored approaches?","year":2022,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Type 2 diabetes; Type 1 diabetes; Glucagon-like peptide-1; Narrative review; Adjunctive treatment; Diabetes mellitus; Intensive care medicine; Internal medicine; Endocrinology","score_opus":0.18476293404873256,"score_gpt":0.3183659521337006,"score_spread":0.13360301808496805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205144121","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011629241,0.9701374,0.0000039673323,0.00010142816,0.0018942547,0.0066223987,0.0008329053,0.00030635938,0.008472026],"genre_scores_gemma":[0.00007071307,0.9451338,0.0011526446,0.00065176794,0.00075952336,0.005057913,0.012471495,0.00027004135,0.034432087],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947583,0.00043154933,0.0010454981,0.0016438054,0.00064819056,0.0014726258],"domain_scores_gemma":[0.99632734,0.00094293384,0.0008093246,0.0011703776,0.00016987903,0.0005801645],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0006298644,0.0016654205,0.0050892546,0.0005346887,0.0006542911,0.00021603155,0.00041971428,0.00056520663,0.00032074374],"category_scores_gemma":[0.0003531109,0.0013338763,0.0015379982,0.00062241533,0.00033692986,0.00037634617,0.0004311298,0.00048664634,0.00010093189],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049665443,0.0026100564,0.00023810394,0.018775025,0.0124312695,0.00003645555,0.0014425117,9.957084e-7,0.0000054914726,0.0038477783,0.028750554,0.9318121],"study_design_scores_gemma":[0.0028663583,0.0015510597,0.00010848636,0.0016908512,0.018891033,0.0000030007718,0.00073042116,0.000010150929,0.00008579664,0.00043200186,0.9730594,0.0005714157],"about_ca_topic_score_codex":0.000040079423,"about_ca_topic_score_gemma":0.000006330298,"teacher_disagreement_score":0.9443089,"about_ca_system_score_codex":0.00051751593,"about_ca_system_score_gemma":0.00066120306,"threshold_uncertainty_score":0.9996093},"labels":[],"label_agreement":null},{"id":"W4205306193","doi":"10.1111/dom.14000","title":"Cover Image, Volume 22, Issue 3","year":2020,"lang":"en","type":"paratext","venue":"Diabetes Obesity and Metabolism","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ted Rogers Centre for Heart Research; Toronto General Hospital","funders":"","keywords":"Cover (algebra); Semaglutide; Type 2 diabetes; Front cover; Image (mathematics); Volume (thermodynamics); Medicine; Computer science; Artificial intelligence; Diabetes mellitus; Engineering; Physics; Mechanical engineering; Endocrinology","score_opus":0.005847285509191481,"score_gpt":0.22723898418700145,"score_spread":0.22139169867780997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205306193","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.105007954,0.8383056,0.00012281768,0.00013790005,0.0046409597,0.00054705783,0.0016711367,0.000038805185,0.049527753],"genre_scores_gemma":[0.010190656,0.66520184,0.0009397798,0.011138026,0.015241759,0.00022715984,0.005611162,0.00030453093,0.2911451],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967821,0.00022590155,0.0004962334,0.0012612711,0.00037056737,0.00086388405],"domain_scores_gemma":[0.9981925,0.00001955076,0.0003015813,0.00077441323,0.00022637386,0.00048561284],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00027746937,0.00080294645,0.0012461336,0.0001162147,0.00021568313,0.00020612722,0.0005695403,0.00093697157,0.006460613],"category_scores_gemma":[0.00014048441,0.0007997408,0.0003994554,0.00020528854,0.00031686155,0.00002157553,0.0004906775,0.00057156046,0.009056932],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024476934,0.00008929376,0.00011726281,0.00036460167,0.00036000408,0.0000025110628,0.000052293715,0.0000048051434,0.013502191,0.000030153573,0.96395844,0.021493983],"study_design_scores_gemma":[0.0008413008,0.00006997299,0.0013461778,0.000048054564,0.0003738657,0.00000119692,0.000014232737,0.000022316575,0.04857529,0.00005463272,0.9477597,0.00089328625],"about_ca_topic_score_codex":0.000032721666,"about_ca_topic_score_gemma":0.0000033786143,"teacher_disagreement_score":0.24161732,"about_ca_system_score_codex":0.0000143324605,"about_ca_system_score_gemma":0.0002272889,"threshold_uncertainty_score":0.9994453},"labels":[],"label_agreement":null},{"id":"W4205423256","doi":"10.1111/dom.14652","title":"<scp>ZT</scp> ‐01: A novel somatostatin receptor 2 antagonist for restoring the glucagon response to hypoglycaemia in type 1 diabetes","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"iCo Therapeutics (Canada); York University","funders":"Leona M. and Harry B. Helmsley Charitable Trust; Juvenile Diabetes Research Foundation International","keywords":"Glucagon; Type 1 diabetes; Somatostatin; Antagonist; Receptor antagonist; Hypoglycemia; Glucagon-like peptide 1 receptor","score_opus":0.02058933680820301,"score_gpt":0.2716529716777969,"score_spread":0.2510636348695939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205423256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99074155,0.0034516063,0.000011166177,0.0027527902,0.00077120296,0.0017097164,0.00012811253,0.00007716821,0.00035670615],"genre_scores_gemma":[0.98721755,0.0001575387,0.0015830528,0.0022110604,0.0003604627,0.00074379775,0.0001214057,0.0000766786,0.007528476],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972214,0.00030481673,0.00037229058,0.00055718306,0.00058722764,0.0009570775],"domain_scores_gemma":[0.9977303,0.0012715502,0.00010409806,0.00050408236,0.000116447074,0.00027352653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032106957,0.00028138293,0.00057597476,0.0004706551,0.0006708972,0.00012790841,0.0003705721,0.000083633975,0.000047292597],"category_scores_gemma":[0.0021362556,0.00022658371,0.00012918237,0.0010357286,0.00013577992,0.00014401562,0.0005943875,0.0004998607,0.000025476967],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015963076,0.0018819174,0.35997918,0.001033158,0.0005592331,0.000020718833,0.006336385,0.00014422952,0.5513344,0.0031139364,0.04815569,0.025844863],"study_design_scores_gemma":[0.002708096,0.0004735053,0.3541696,0.00007839078,0.00013379593,5.4227536e-7,0.0010303576,0.00048652597,0.0172485,0.00024780148,0.6232645,0.00015835298],"about_ca_topic_score_codex":0.000022610835,"about_ca_topic_score_gemma":0.000008803327,"teacher_disagreement_score":0.5751088,"about_ca_system_score_codex":0.00010748793,"about_ca_system_score_gemma":0.00013414636,"threshold_uncertainty_score":0.92398155},"labels":[],"label_agreement":null},{"id":"W4206145164","doi":"10.1111/dom.14634","title":"Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the <scp>REWIND</scp> randomized trial","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université Laval; Population Health Research Institute; Hamilton Health Sciences; University of Toronto; St. Michael's Hospital; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Eli Lilly and Company","keywords":"Dulaglutide; Medicine; Atrial fibrillation; Post-hoc analysis; Internal medicine; Heart failure; Placebo; Atrial flutter; Cardiology; Stroke (engine); Randomized controlled trial; Diabetes mellitus; Type 2 diabetes; Exenatide; Endocrinology","score_opus":0.0062953249637689975,"score_gpt":0.20741575548699737,"score_spread":0.20112043052322837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206145164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927126,0.004074068,0.0000025254237,0.00022972956,0.000328279,0.0024581086,0.000106125495,0.000037376798,0.000051176445],"genre_scores_gemma":[0.997237,0.0002649639,0.00014615779,0.00089146366,0.0003243128,0.00008884626,0.00076046825,0.000023720893,0.00026303323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767,0.0004947896,0.00042324926,0.0004750452,0.00052743824,0.00040946816],"domain_scores_gemma":[0.99821556,0.000990431,0.00022437106,0.00034312383,0.000092370334,0.00013414191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008886047,0.00029341047,0.00119772,0.00033511824,0.0002678502,0.000099923294,0.0001096683,0.00006945318,0.000109049004],"category_scores_gemma":[0.00047238657,0.00017528933,0.0002665203,0.000815077,0.00012961235,0.00017904006,0.00025923227,0.0001962786,0.0000045310917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056791823,0.00020565726,0.9343372,0.00002255588,0.003420095,0.0000049653677,0.00096887356,0.000070308786,0.000018141815,0.00004022689,0.00018486819,0.0039353105],"study_design_scores_gemma":[0.32429478,0.00056410895,0.6647271,0.00001777078,0.0061527337,5.101351e-8,0.00011276557,0.0003258349,0.00001840479,0.00007242523,0.0036320721,0.00008198286],"about_ca_topic_score_codex":0.00015646819,"about_ca_topic_score_gemma":0.00008603033,"teacher_disagreement_score":0.26961008,"about_ca_system_score_codex":0.000056590467,"about_ca_system_score_gemma":0.00005301707,"threshold_uncertainty_score":0.7148091},"labels":[],"label_agreement":null},{"id":"W4206528639","doi":"10.1111/dom.14645","title":"Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: A post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Prediabetes; Placebo; Medicine; Internal medicine; Diabetes mellitus; Gastroenterology; Impaired fasting glucose; Type 2 diabetes; Post-hoc analysis; Endocrinology; Impaired glucose tolerance","score_opus":0.0415527206936868,"score_gpt":0.32807263884282367,"score_spread":0.28651991814913685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206528639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96664184,0.02897818,0.0000073798215,0.00007837808,0.00016755336,0.0014227679,0.00266371,0.000032889584,0.0000072948405],"genre_scores_gemma":[0.99392927,0.0011337098,0.0007613159,0.00044691455,0.00008157024,0.00003477749,0.0035670002,0.000032411415,0.000013044161],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963155,0.0007948563,0.0010290231,0.0008969851,0.00046199778,0.00050168607],"domain_scores_gemma":[0.99722296,0.0010316686,0.000527684,0.00078023167,0.00013813998,0.00029929343],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024531165,0.00039035192,0.0025424769,0.0006240999,0.00016271407,0.000059383634,0.00023486953,0.00013386415,0.00009736962],"category_scores_gemma":[0.0006984443,0.00031612662,0.00013979987,0.0008788212,0.00024902125,0.00030156202,0.00055403623,0.0003420397,8.325677e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001839643,0.0025395977,0.95004195,0.00010083206,0.007720016,0.0000065637137,0.00017819593,0.000010721324,0.0016033563,0.00001851422,0.00005388279,0.035886712],"study_design_scores_gemma":[0.037496667,0.0017866316,0.9245165,0.00007976056,0.030217327,9.8857925e-8,0.00006311762,0.003982447,0.00026354904,0.000034549932,0.0012383441,0.00032100733],"about_ca_topic_score_codex":0.000082842234,"about_ca_topic_score_gemma":0.000031449737,"teacher_disagreement_score":0.035657022,"about_ca_system_score_codex":0.000035732006,"about_ca_system_score_gemma":0.000079728095,"threshold_uncertainty_score":0.9999291},"labels":[],"label_agreement":null},{"id":"W4211100132","doi":"10.1111/dom.14666","title":"Effects of glucagon‐like peptide‐1 receptor agonists on cardiovascular and renal outcomes: A <scp>meta‐analysis</scp> and <scp>meta‐regression</scp> analysis","year":2022,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Mace; Medicine; Internal medicine; Meta-analysis; Myocardial infarction; Meta-regression; Hazard ratio; Semaglutide; Weight loss; Endocrinology; Diabetes mellitus; Type 2 diabetes; Obesity; Liraglutide; Confidence interval","score_opus":0.030950195687448515,"score_gpt":0.275676389128329,"score_spread":0.24472619344088048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211100132","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.056523647,0.93994135,0.000018758581,0.000018973726,0.00026312086,0.0023617372,0.00032160745,0.00010605625,0.00044475406],"genre_scores_gemma":[0.0015776688,0.991012,0.000523495,0.00030861536,0.00013880251,0.0010586986,0.001118885,0.000118079006,0.0041437894],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9931073,0.0012573258,0.0012488632,0.0019473309,0.0014041339,0.0010350394],"domain_scores_gemma":[0.99336493,0.0032314386,0.0009783693,0.0015277658,0.00013719262,0.0007602885],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.0018517021,0.0017453778,0.016632667,0.0026900866,0.00045557923,0.00018462882,0.0003969991,0.0005300058,0.00009808997],"category_scores_gemma":[0.00072111667,0.0011378614,0.011428425,0.0030473752,0.00037534747,0.00021113455,0.0007642218,0.00080818334,0.000015735432],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003826195,0.0007555154,0.0027019698,0.016847275,0.9176542,0.00007104457,0.00024394576,0.000010426441,0.000006311666,0.00014262243,0.0006894145,0.060873456],"study_design_scores_gemma":[0.00083740545,0.00013562074,0.0070497897,0.0002740805,0.520652,0.0000012630777,0.000033718417,0.000006995857,0.000056197034,0.00002086329,0.47078,0.00015204649],"about_ca_topic_score_codex":0.000112659705,"about_ca_topic_score_gemma":0.000013422922,"teacher_disagreement_score":0.47009057,"about_ca_system_score_codex":0.000078883684,"about_ca_system_score_gemma":0.00010255046,"threshold_uncertainty_score":0.99952924},"labels":[],"label_agreement":null},{"id":"W4213199527","doi":"10.1111/dom.14670","title":"Effects of empagliflozin on markers of liver steatosis and fibrosis and their relationship to cardiorenal outcomes","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Eurostars; Bundesministerium für Bildung und Forschung; European Regional Development Fund; Bundesministerium für Gesundheit; Boehringer Ingelheim","keywords":"Empagliflozin; Steatosis; Medicine; Internal medicine; Fatty liver; Fibrosis; Type 2 diabetes; Diabetes mellitus; Gastroenterology; Placebo; Disease; Endocrinology; Pathology","score_opus":0.007884611794065365,"score_gpt":0.2119760811619748,"score_spread":0.20409146936790945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213199527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913402,0.007720629,0.000001106964,0.00016818212,0.00004785289,0.0004769241,0.00017840977,0.000009887552,0.00005680264],"genre_scores_gemma":[0.99904394,0.00041040522,0.00012863618,0.00025785377,0.000014363793,0.00008326167,0.000014236392,0.000009595363,0.00003771721],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921113,0.00012800006,0.0001476758,0.00021230362,0.00016698263,0.0001339224],"domain_scores_gemma":[0.99905646,0.00054628536,0.000058217138,0.00014076543,0.0000317693,0.00016652525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000164802,0.00014025798,0.00048999605,0.00014216908,0.000114567534,0.000007965685,0.000032505635,0.00003217831,0.000014663085],"category_scores_gemma":[0.0000892595,0.000104679646,0.00010052443,0.000120151795,0.000065191234,0.000042252315,0.000109521985,0.00007804078,5.723429e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010847249,0.0003528508,0.99278295,0.0003391793,0.0003868844,0.0000032834682,0.0008403514,0.000002080528,0.0007879256,0.000375136,0.00011520371,0.0039057117],"study_design_scores_gemma":[0.0013675049,0.00040567754,0.98413664,0.00007866207,0.00082645443,6.8489265e-7,0.00013382013,0.000013714738,0.012595078,0.00008204548,0.0002720214,0.000087702625],"about_ca_topic_score_codex":0.00006789861,"about_ca_topic_score_gemma":0.0000017429178,"teacher_disagreement_score":0.011807152,"about_ca_system_score_codex":0.0000134432885,"about_ca_system_score_gemma":0.00001674095,"threshold_uncertainty_score":0.4268712},"labels":[],"label_agreement":null},{"id":"W4214893005","doi":"10.1111/dom.14677","title":"The differential effects of ertugliflozin on glucosuria and natriuresis biomarkers: Prespecified analyses from <scp>VERTIS CV</scp>","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Merck KGaA; Pfizer","keywords":"Natriuresis; Renal function; Medicine; Placebo; Internal medicine; Kidney disease; Albuminuria; Endocrinology; Uric acid; Diabetes mellitus; Urology; Confidence interval; Gastroenterology; Cardiology; Pathology","score_opus":0.012070645568670666,"score_gpt":0.23946648804927426,"score_spread":0.2273958424806036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214893005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972391,0.02550985,0.0000068479953,0.00020001463,0.00045684382,0.00067846786,0.00008416404,0.00004673094,0.000626064],"genre_scores_gemma":[0.9958541,0.0026684033,0.000090439215,0.00030155212,0.00013311098,0.00011957548,0.00008674559,0.000022537593,0.0007235635],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982593,0.0002481366,0.0002713876,0.00040985196,0.00044804282,0.00036330317],"domain_scores_gemma":[0.99801093,0.0012226291,0.00014697091,0.0003902707,0.000039125105,0.00019008943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020415192,0.0002656636,0.0005966922,0.00018834707,0.000404417,0.000067644585,0.00015722537,0.00006219221,0.00004376537],"category_scores_gemma":[0.000329393,0.00018536879,0.00017635681,0.0002458601,0.00015178476,0.00007331125,0.00031957007,0.00016342552,0.000003369916],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010229341,0.005574812,0.31324524,0.0012911059,0.023019683,0.00013839046,0.0025140643,0.000012549972,0.37096924,0.008356632,0.03811059,0.23574476],"study_design_scores_gemma":[0.0035786387,0.00033709226,0.8415831,0.000055661767,0.002015304,3.0512817e-7,0.00014965766,0.000114231596,0.108285524,0.0007256198,0.043055482,0.00009937983],"about_ca_topic_score_codex":0.000098354416,"about_ca_topic_score_gemma":0.00000822777,"teacher_disagreement_score":0.5283379,"about_ca_system_score_codex":0.000024762205,"about_ca_system_score_gemma":0.000021591082,"threshold_uncertainty_score":0.75591195},"labels":[],"label_agreement":null},{"id":"W4220670177","doi":"10.1111/dom.14687","title":"Efficacy of lower doses of pioglitazone after stroke or transient ischaemic attack in patients with insulin resistance","year":2022,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Western University","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Pioglitazone; Medicine; Stroke (engine); Diabetes mellitus; Insulin resistance; Adverse effect; Internal medicine; Placebo; Hazard ratio; Heart failure; Insulin; Myocardial infarction; Type 2 diabetes; Cardiology; Endocrinology; Confidence interval","score_opus":0.017495620797651955,"score_gpt":0.26119936239177355,"score_spread":0.2437037415941216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220670177","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44067612,0.55770266,0.0000010841399,0.00000422584,0.000083299055,0.0011920457,0.00029330264,0.0000070774277,0.000040152274],"genre_scores_gemma":[0.046766788,0.952333,0.0002336472,0.000044357555,0.00008085084,0.00018438841,0.00013849273,0.000051088675,0.00016740747],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997292,0.00029187126,0.0008215576,0.0005002965,0.0007210138,0.00037329004],"domain_scores_gemma":[0.9985682,0.000117881726,0.00035032237,0.0007031589,0.00010193063,0.00015854572],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006274081,0.00040099514,0.0033200893,0.00032655144,0.00004154021,0.0000065043932,0.00014593652,0.00020630473,0.00013905687],"category_scores_gemma":[0.00010064465,0.00026211873,0.00057926995,0.0005506707,0.00014813087,0.000072215305,0.0000814924,0.00049726,0.0000013682527],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029105681,0.0033468483,0.009799376,0.09749089,0.0021066011,0.00006362646,0.0005926835,0.0000013151976,0.0000018897547,0.000035063604,0.000052944226,0.8835982],"study_design_scores_gemma":[0.0050348043,0.00039648608,0.18859334,0.00827792,0.0027946576,0.0000014464418,0.000017466376,1.7228805e-7,0.000011988744,0.0000014840246,0.7945778,0.00029247496],"about_ca_topic_score_codex":0.0000403218,"about_ca_topic_score_gemma":0.000034345394,"teacher_disagreement_score":0.8833057,"about_ca_system_score_codex":0.00005502279,"about_ca_system_score_gemma":0.00032509083,"threshold_uncertainty_score":0.99998313},"labels":[],"label_agreement":null},{"id":"W4220688079","doi":"10.1111/dom.14699","title":"Efficacy, safety, tolerability, and noninferiority phase 3 study of glucagon as a ready‐to‐use room temperature liquid stable formulation versus a lyophilised formulation for the biochemical recovery and symptomatic relief of insulin‐induced severe hypoglycaemia in adults with type 1 diabetes","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Medicine; Tolerability; Family medicine; Pharmacology; Adverse effect","score_opus":0.017156926855270944,"score_gpt":0.2787632229340698,"score_spread":0.2616062960787989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220688079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995101,0.0008706894,0.000001209293,0.00013933952,0.00009545071,0.003679378,0.00007579934,0.000020828908,0.000016319229],"genre_scores_gemma":[0.99928546,0.00013491769,0.00014697386,0.000057442285,0.00003661937,0.0001455655,0.0001439757,0.000022175796,0.00002686864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825543,0.00013829768,0.00044824416,0.00041285346,0.00041416642,0.0003309951],"domain_scores_gemma":[0.9983484,0.00077552063,0.000168687,0.00034833114,0.00023056989,0.00012847655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087616366,0.00022151202,0.0006694455,0.00025820066,0.00022237633,0.000044199624,0.000110739384,0.000100818506,0.000008075326],"category_scores_gemma":[0.00064512365,0.0001630168,0.000046825564,0.000600718,0.000048878763,0.0002758722,0.00028323734,0.0002734707,1.8530616e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14548127,0.015141929,0.5919898,0.006099172,0.0018109763,0.000008201431,0.015672924,0.0006687528,0.19137114,0.00070368993,0.00012905237,0.030923082],"study_design_scores_gemma":[0.041596875,0.018530333,0.9154341,0.0004241591,0.00078232196,8.3325733e-7,0.0012229132,0.004932116,0.016322602,0.00016122246,0.0002241661,0.00036831206],"about_ca_topic_score_codex":0.00009735941,"about_ca_topic_score_gemma":0.000032126743,"teacher_disagreement_score":0.32344434,"about_ca_system_score_codex":0.000050309616,"about_ca_system_score_gemma":0.000082640945,"threshold_uncertainty_score":0.6647632},"labels":[],"label_agreement":null},{"id":"W4220706492","doi":"10.1111/dom.14698","title":"Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Manitoba Health","funders":"AstraZeneca Pharma Poland; AstraZeneca","keywords":"Medicine; Observational study; Multinational corporation; Type 2 diabetes; Disease; Diabetes mellitus; Health care; Intensive care medicine; Internal medicine; Endocrinology; Economic growth; Finance","score_opus":0.053073966119162624,"score_gpt":0.29522077216829157,"score_spread":0.24214680604912894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220706492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99125856,0.006476744,0.000004625492,0.0002435294,0.00004153492,0.0016558396,0.00028400857,0.000027097632,0.000008039237],"genre_scores_gemma":[0.9981306,0.00019670476,0.00009097471,0.00033144528,0.000019843443,0.0003520835,0.00079365174,0.000018755498,0.00006590631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998105,0.00020748546,0.0002620726,0.00034921727,0.00077872217,0.0002975306],"domain_scores_gemma":[0.9991655,0.000105897554,0.00015523519,0.0002030684,0.00023343474,0.00013690416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085225626,0.00019213425,0.000551478,0.00015796216,0.0002515292,0.000036195102,0.00006594491,0.00003213177,0.000017470045],"category_scores_gemma":[0.00012177296,0.00015812244,0.00004699572,0.00043433657,0.000119757184,0.00018888207,0.00015698042,0.00013179485,3.067693e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008856638,0.0010498221,0.99433315,0.00014511065,0.0010610091,0.000011203352,0.0017393826,0.0003681793,0.000006429435,0.00021086134,0.000019135729,0.0009671355],"study_design_scores_gemma":[0.00505844,0.00048285688,0.98964614,0.00011556029,0.0008524047,1.9962079e-7,0.0007426107,0.0003101181,0.00004805437,0.000048343074,0.0025377066,0.00015758612],"about_ca_topic_score_codex":0.00010782529,"about_ca_topic_score_gemma":0.00016805124,"teacher_disagreement_score":0.0068720537,"about_ca_system_score_codex":0.000084462816,"about_ca_system_score_gemma":0.00012324998,"threshold_uncertainty_score":0.6448046},"labels":[],"label_agreement":null},{"id":"W4220790895","doi":"10.1111/dom.14691","title":"Cardiorenal outcomes with ertugliflozin assessed according to baseline glucose‐lowering agent: An analysis from <scp>VERTIS CV</scp>","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Merck KGaA","keywords":"Medicine; Hazard ratio; Metformin; Mace; Internal medicine; Myocardial infarction; Diabetes mellitus; Type 2 diabetes; Confidence interval; Placebo; Stroke (engine); Insulin; Endocrinology; Percutaneous coronary intervention","score_opus":0.010409421984768243,"score_gpt":0.2339835748773109,"score_spread":0.22357415289254265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220790895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951688,0.0020410728,0.0008582861,0.00024038965,0.00027698424,0.00060837413,0.0002443436,0.00017766144,0.000384077],"genre_scores_gemma":[0.9939418,0.00013434683,0.0021061376,0.001977132,0.00017304615,0.000207847,0.00078286364,0.00004822863,0.0006286321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973762,0.00016791321,0.0003479815,0.0007795291,0.0006817839,0.0006466031],"domain_scores_gemma":[0.99840856,0.00022115083,0.00012278548,0.0006487585,0.000086974636,0.0005117945],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059693924,0.00041804343,0.0012285518,0.0006223427,0.0004220233,0.00013918403,0.0002319714,0.000059379683,0.00012153507],"category_scores_gemma":[0.00012452666,0.00034892792,0.00032113676,0.0010842958,0.000044570894,0.0003008861,0.0003917246,0.00023898603,0.000014861028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003213522,0.00066463015,0.9763497,0.0000376766,0.0054136207,0.00008548417,0.00057108083,0.00068950956,0.0035622565,0.00008214831,0.00023081938,0.012280951],"study_design_scores_gemma":[0.0023661724,0.0002475064,0.9567767,0.000024873536,0.008059536,7.461346e-7,0.0011129449,0.0014851264,0.006829246,0.00004063371,0.022837138,0.00021939525],"about_ca_topic_score_codex":0.0004492481,"about_ca_topic_score_gemma":0.00008694027,"teacher_disagreement_score":0.022606319,"about_ca_system_score_codex":0.00009716885,"about_ca_system_score_gemma":0.000042114112,"threshold_uncertainty_score":0.9998963},"labels":[],"label_agreement":null},{"id":"W4220949041","doi":"10.1111/dom.14700","title":"Cardiovascular efficacy of liraglutide and semaglutide in individuals with diabetes and peripheral artery disease","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Semaglutide; Liraglutide; Mace; Medicine; Hazard ratio; Type 2 diabetes; Internal medicine; Myocardial infarction; Placebo; Empagliflozin; Diabetes mellitus; Confidence interval; Gastroenterology; Surgery; Endocrinology; Percutaneous coronary intervention","score_opus":0.006453551494449718,"score_gpt":0.1985013044114067,"score_spread":0.192047752916957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220949041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9634762,0.03530276,0.0000023729233,0.0002287018,0.00005082773,0.0007116611,0.000058033933,0.00003223533,0.00013723079],"genre_scores_gemma":[0.9983088,0.00051123736,0.0004247576,0.00036948494,0.000042319396,0.0001303744,0.00005124771,0.000023891356,0.00013791835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843526,0.0001376342,0.00023470524,0.0004388323,0.00036121646,0.0003923329],"domain_scores_gemma":[0.9992523,0.00008263408,0.000070738366,0.00031655323,0.000026818021,0.00025093206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000485718,0.0002474649,0.0007619434,0.00023645887,0.00014683556,0.000033401342,0.00006672548,0.000033943423,0.00003234555],"category_scores_gemma":[0.00004463467,0.00020906678,0.000114250906,0.00022453876,0.00020574432,0.00011695989,0.0002685501,0.00016662973,4.6059233e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004054647,0.0004364748,0.9828992,0.00031537435,0.00096381904,0.000027801372,0.0005439796,0.000047300473,0.00016564497,0.00026955357,0.00004434548,0.014245945],"study_design_scores_gemma":[0.0047001685,0.0001962232,0.9846961,0.00008785518,0.0015789777,0.0000014828155,0.00017410958,0.00017975943,0.00028288495,0.00020526818,0.0076777916,0.00021940659],"about_ca_topic_score_codex":0.000019444156,"about_ca_topic_score_gemma":0.0000029918467,"teacher_disagreement_score":0.03483259,"about_ca_system_score_codex":0.000022705546,"about_ca_system_score_gemma":0.000034326473,"threshold_uncertainty_score":0.8525496},"labels":[],"label_agreement":null},{"id":"W4224218205","doi":"10.1111/dom.14725","title":"Weight regain and cardiometabolic effects after withdrawal of semaglutide: The <scp>STEP</scp> 1 trial extension","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":921,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; York University","funders":"Novo Nordisk; National Institute for Health and Care Research","keywords":"Semaglutide; Medicine; Placebo; Weight loss; Body mass index; Randomized controlled trial; Internal medicine; Physical therapy; Diabetes mellitus; Obesity; Type 2 diabetes; Endocrinology","score_opus":0.005126095142822623,"score_gpt":0.20570540382778232,"score_spread":0.2005793086849597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224218205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.962288,0.034658436,0.0000073557853,0.00022789245,0.00062238367,0.0014727118,0.000028061726,0.00004789494,0.0006472416],"genre_scores_gemma":[0.9959238,0.00072303077,0.00025114682,0.0008502105,0.00027556007,0.00039983133,0.00002786609,0.000029412136,0.0015191417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980699,0.00030215707,0.0002883507,0.0004299586,0.00048170687,0.0004279576],"domain_scores_gemma":[0.99884504,0.000317493,0.00014063931,0.00047052818,0.000058996582,0.00016727785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079274736,0.00027839685,0.0008365853,0.0002442577,0.00028755047,0.000036684844,0.000114121496,0.00006303848,0.000019917856],"category_scores_gemma":[0.00016160471,0.00019073095,0.00019302731,0.00040246482,0.00020069948,0.000091371454,0.00042417113,0.0002382965,0.000004124277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047471756,0.004453789,0.66686255,0.0033720005,0.008098166,0.00041268347,0.0065089283,0.000020790381,0.02216901,0.0155421095,0.026076036,0.24173675],"study_design_scores_gemma":[0.028561125,0.0006605579,0.76623297,0.00006904605,0.0031479434,0.000007686556,0.00022744898,0.00014193126,0.004798244,0.00051105156,0.19550768,0.00013431927],"about_ca_topic_score_codex":0.000031372765,"about_ca_topic_score_gemma":0.000002708498,"teacher_disagreement_score":0.24160244,"about_ca_system_score_codex":0.00001972313,"about_ca_system_score_gemma":0.000032343505,"threshold_uncertainty_score":0.77777827},"labels":[],"label_agreement":null},{"id":"W4225003979","doi":"10.1111/dom.14729","title":"Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from <scp>DAPASALT</scp> and <scp>DIAMOND</scp>","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of British Columbia; University Health Network","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; AstraZeneca; Juvenile Diabetes Research Foundation United States of America; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Boettcher Foundation; American Heart Association","keywords":"Dapagliflozin; Medicine; Kidney disease; Internal medicine; Endocrinology; Renal function; Albuminuria; Urology; Creatinine; Diabetes mellitus; Aldosterone; Excretion; Type 2 diabetes","score_opus":0.0035316257272561143,"score_gpt":0.18532639046903926,"score_spread":0.18179476474178313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225003979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844307,0.011678218,0.0000032299092,0.00004917815,0.0003140595,0.002161858,0.0011160229,0.00008221823,0.0001645154],"genre_scores_gemma":[0.9961446,0.0009265011,0.00011386569,0.00047338175,0.000085476255,0.00026287782,0.0011789766,0.00007174193,0.0007425692],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967461,0.0002796577,0.0005202966,0.0009296263,0.00064543565,0.0008788407],"domain_scores_gemma":[0.99759454,0.00061274454,0.00034129687,0.00053801603,0.00008217161,0.0008312473],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038317105,0.00054394256,0.0011660568,0.00044810597,0.00020769902,0.00007154157,0.00015252556,0.0001101452,0.0000036186066],"category_scores_gemma":[0.0006146436,0.00047355957,0.0000904587,0.00039325113,0.0002626089,0.00025608044,0.00038478556,0.00037824342,0.000003883474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101841106,0.0011568542,0.9918087,0.0013479558,0.00054620055,0.000020077097,0.0010593752,0.000050859508,0.00036702678,0.00011982716,0.00061871903,0.00280256],"study_design_scores_gemma":[0.01689286,0.0010619164,0.9726652,0.00075482304,0.0015355739,1.5164972e-7,0.00013399794,0.0019831269,0.0004741629,0.00016760906,0.004186755,0.00014384733],"about_ca_topic_score_codex":0.00016984636,"about_ca_topic_score_gemma":0.000021159041,"teacher_disagreement_score":0.019143527,"about_ca_system_score_codex":0.00020867199,"about_ca_system_score_gemma":0.00017919939,"threshold_uncertainty_score":0.9997716},"labels":[],"label_agreement":null},{"id":"W4226335524","doi":"10.1111/dom.14703","title":"Healthcare costs and hospitalizations in <scp>US</scp> patients with type 2 diabetes and cardiovascular disease: A retrospective database study ( <scp>OFFSET</scp> )","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novo Nordisk; International Business Machines Corporation","keywords":"Medicine; Disease; Type 2 diabetes; Health care; Offset (computer science); Retrospective cohort study; Diabetes mellitus; Medical emergency; Emergency medicine; Internal medicine; Endocrinology","score_opus":0.006169460079034918,"score_gpt":0.21041075406453347,"score_spread":0.20424129398549856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226335524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9636274,0.03314107,0.0000016300784,0.00006866668,0.00019106788,0.0023709154,0.00039774895,0.00007385801,0.00012762309],"genre_scores_gemma":[0.9965918,0.001398243,0.000084736304,0.00041541728,0.000060457114,0.00037921485,0.00083808316,0.000046767997,0.00018526202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974344,0.00025564554,0.0002701319,0.00082137005,0.0006446874,0.00057378056],"domain_scores_gemma":[0.9985916,0.00014695407,0.000102939055,0.00056025607,0.0001717686,0.00042646634],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047556832,0.00036830985,0.0008034573,0.0003335627,0.00044603177,0.00008820902,0.0001050944,0.000050271545,0.000006564947],"category_scores_gemma":[0.0003308013,0.00032670575,0.000082445324,0.00070263527,0.00013866217,0.00030563126,0.00046065316,0.0002700218,0.0000021362807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009497009,0.001462103,0.99371916,0.00019660362,0.001074529,0.000030355535,0.001104464,0.000007985508,0.000006654432,0.00030951318,0.00038185745,0.0016972661],"study_design_scores_gemma":[0.0048073432,0.00075076113,0.9814397,0.00008085114,0.0017635218,3.1002725e-7,0.0014919363,0.00009195385,0.000025901632,0.000103942555,0.009345208,0.000098567354],"about_ca_topic_score_codex":0.00011236413,"about_ca_topic_score_gemma":0.00004140815,"teacher_disagreement_score":0.0329644,"about_ca_system_score_codex":0.000099349265,"about_ca_system_score_gemma":0.000056312972,"threshold_uncertainty_score":0.9999185},"labels":[],"label_agreement":null},{"id":"W4280488682","doi":"10.1111/dom.14775","title":"Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: An adjusted indirect treatment comparison","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; University of Toronto","funders":"Eli Lilly and Company","keywords":"Medicine; Semaglutide; Type 2 diabetes; Internal medicine; Diabetes mellitus; Endocrinology; Liraglutide","score_opus":0.01808116998617759,"score_gpt":0.24334209779018834,"score_spread":0.22526092780401075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280488682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99546975,0.0027703538,2.00507e-7,0.00004001822,0.00017369677,0.0010173139,0.000062042796,0.00005473846,0.0004119025],"genre_scores_gemma":[0.9986073,0.00010542565,0.00029618887,0.00008998382,0.00003241515,0.00008844758,0.0004971544,0.000031208132,0.00025190893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826205,0.00016244652,0.00032946756,0.0004536784,0.00035442066,0.00043794222],"domain_scores_gemma":[0.99907166,0.00013448621,0.00016720736,0.00034901928,0.000074097115,0.0002035335],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021458465,0.00031338964,0.000893153,0.00032728844,0.00014569928,0.000022883485,0.00009091855,0.000057213132,0.00014807138],"category_scores_gemma":[0.000048043727,0.00025524967,0.000062520776,0.00045287245,0.00010903905,0.00012385407,0.00014406709,0.00014036059,0.0000048640627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010298566,0.00337158,0.9645594,0.00009781976,0.00058649376,0.0000044100034,0.00072308234,0.00003149604,0.0001362741,0.000046976813,0.00010566175,0.029306952],"study_design_scores_gemma":[0.018775871,0.0039229654,0.9680959,0.000051089963,0.0011925105,7.445768e-8,0.00016303356,0.0003009067,0.0012971386,0.000011384785,0.0059469314,0.0002422013],"about_ca_topic_score_codex":0.000080538295,"about_ca_topic_score_gemma":0.000077260025,"teacher_disagreement_score":0.02906475,"about_ca_system_score_codex":0.00009861144,"about_ca_system_score_gemma":0.000044812183,"threshold_uncertainty_score":0.99999},"labels":[],"label_agreement":null},{"id":"W4280523671","doi":"10.1111/dom.14760","title":"Efficacy and safety outcomes of dulaglutide by baseline <scp>HbA1c</scp> : A post hoc analysis of the <scp>REWIND</scp> trial","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Eli Lilly and Company","keywords":"Dulaglutide; Medicine; Post-hoc analysis; Baseline (sea); Subgroup analysis; Body mass index; Internal medicine; Proportional hazards model; Placebo; Diabetes mellitus; Type 2 diabetes; Liraglutide; Confidence interval; Endocrinology","score_opus":0.00729499682094312,"score_gpt":0.2230150266327257,"score_spread":0.2157200298117826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280523671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890148,0.007872544,0.0000099183935,0.0003373085,0.0002898389,0.0012212783,0.00070282735,0.000040072326,0.0005113894],"genre_scores_gemma":[0.995038,0.0006532392,0.00014550464,0.0008642568,0.00006294632,0.000069142174,0.0003576937,0.0000272545,0.0027820098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742943,0.00034089474,0.0006370576,0.00048225533,0.0006362542,0.00047410539],"domain_scores_gemma":[0.9975347,0.0011336786,0.00039905266,0.00061299105,0.000117259886,0.00020234556],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001135485,0.0003437235,0.0014746742,0.0004418411,0.00029230842,0.000027193397,0.00024494575,0.00008839355,0.0000490116],"category_scores_gemma":[0.0009215679,0.00024710654,0.00050015684,0.0010916388,0.0002251734,0.00010881761,0.00052135356,0.00024210622,0.0000016400822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074602006,0.0056139096,0.9341063,0.00042135565,0.019807108,0.000010792755,0.0031247775,0.000114770235,0.00846273,0.0020099792,0.0073616677,0.018220603],"study_design_scores_gemma":[0.026816314,0.0005451488,0.8931045,0.000024670542,0.01460393,3.9774628e-7,0.0005261532,0.0002541885,0.0030371784,0.00006601499,0.060958337,0.00006314685],"about_ca_topic_score_codex":0.00009096497,"about_ca_topic_score_gemma":0.000016586511,"teacher_disagreement_score":0.053596668,"about_ca_system_score_codex":0.000033024407,"about_ca_system_score_gemma":0.000056159282,"threshold_uncertainty_score":0.9999981},"labels":[],"label_agreement":null},{"id":"W4281295175","doi":"10.1111/dom.14769","title":"Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Heart, Lung, and Blood Institute; Merck; National Institutes of Health; Pfizer","keywords":"Medicine; Internal medicine; Diabetes mellitus; Microalbuminuria; Glycated hemoglobin; Kidney disease; Type 2 Diabetes Mellitus; Renal function; Type 2 diabetes; Endocrinology","score_opus":0.0029302933040736517,"score_gpt":0.18838291019564649,"score_spread":0.18545261689157283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281295175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961871,0.0020195553,3.077279e-7,0.00043347335,0.00030165882,0.00081878423,0.000055245244,0.000054778404,0.00012910915],"genre_scores_gemma":[0.9972854,0.0001019081,0.00030185876,0.0018064986,0.000042908614,0.00009191811,0.00016296098,0.000031538453,0.000174992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984394,0.00010981366,0.00021242637,0.0003809968,0.0004644707,0.0003928922],"domain_scores_gemma":[0.9990253,0.00017281849,0.00011171423,0.00029434057,0.00006993534,0.00032591692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021360356,0.00029012174,0.00075395853,0.00023674298,0.00017921672,0.000023246004,0.00008204696,0.00005834399,0.000069118156],"category_scores_gemma":[0.0001260639,0.00021395828,0.00008329183,0.0002725208,0.00013395243,0.00012392898,0.0001755775,0.00018797688,0.000003843513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041681295,0.0005411954,0.9935137,0.0003150709,0.00054251176,0.0000027794224,0.00014024386,0.0000013893532,0.00015088514,0.00023543516,0.0018024468,0.0027126344],"study_design_scores_gemma":[0.0036311343,0.00087363477,0.9694606,0.000083086255,0.000837399,6.923587e-8,0.000032642543,0.000013655016,0.004254583,0.00007701768,0.020524256,0.00021192657],"about_ca_topic_score_codex":0.000017844188,"about_ca_topic_score_gemma":0.000003141379,"teacher_disagreement_score":0.02405313,"about_ca_system_score_codex":0.00002440805,"about_ca_system_score_gemma":0.000028844423,"threshold_uncertainty_score":0.8724965},"labels":[],"label_agreement":null},{"id":"W4281611212","doi":"10.1111/dom.14787","title":"Comparing a daily versus weekly titration algorithm in people with type 2 diabetes switching from basal insulin to <scp>iGlarLixi</scp> in the <scp>LixiLan ONE CAN</scp> randomized trial","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sanofi (Canada); McGill University Health Centre; Western University; St. Michael's Hospital; University of Toronto; Brampton Civic Hospital; McMaster University","funders":"Sanofi","keywords":"Basal insulin; Randomized controlled trial; Type 2 diabetes; Basal (medicine); Insulin; Algorithm; Computer science; Medicine; Diabetes mellitus; Gerontology; Internal medicine; Endocrinology","score_opus":0.020393817961443548,"score_gpt":0.24649940607671617,"score_spread":0.22610558811527262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281611212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919133,0.002480585,0.00004559492,0.00054284174,0.0006143567,0.0027611412,0.000035022465,0.000054477303,0.0015526429],"genre_scores_gemma":[0.99629146,0.00015914894,0.0008027754,0.0009178575,0.0004653772,0.0005483917,0.00031803118,0.00004103026,0.0004559346],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960488,0.0009650547,0.00054399896,0.0006131233,0.0009860365,0.00084297935],"domain_scores_gemma":[0.9968452,0.0022495172,0.00016537504,0.000424689,0.000092399016,0.00022285624],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033167358,0.0003469202,0.0013286093,0.0006106215,0.00033670373,0.00022554689,0.00040303613,0.000108939945,0.000027061675],"category_scores_gemma":[0.0013192197,0.0002660704,0.00013545192,0.0013160694,0.00009246299,0.00023583353,0.00035975646,0.0009261014,0.000016212096],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059474032,0.0077611464,0.80447674,0.00068072765,0.0031776454,0.00016261663,0.06187475,0.0010110316,0.0084866,0.0015524565,0.0051391604,0.046203103],"study_design_scores_gemma":[0.5193025,0.00091972377,0.4539795,0.00014357422,0.0006820428,2.676256e-7,0.004373972,0.011842495,0.0008877687,0.00065922,0.007041453,0.00016747304],"about_ca_topic_score_codex":0.0011240803,"about_ca_topic_score_gemma":0.0010381145,"teacher_disagreement_score":0.45982847,"about_ca_system_score_codex":0.00009054532,"about_ca_system_score_gemma":0.0001463172,"threshold_uncertainty_score":0.99997914},"labels":[],"label_agreement":null},{"id":"W4281734667","doi":"10.1111/dom.14792","title":"<scp>Long‐term</scp> clinical outcomes of oral antidiabetic drugs as <scp>fixed‐dose</scp> combinations: A nationwide retrospective cohort study","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Health Insurance Service; Ministry of Food and Drug Safety","keywords":"Medicine; Discontinuation; Hazard ratio; Internal medicine; Propensity score matching; Retrospective cohort study; Stroke (engine); Myocardial infarction; Proportional hazards model; Cohort; Confidence interval; Pill; Type 2 diabetes; Diabetes mellitus; Fixed-dose combination; Pharmacology","score_opus":0.022716543079221187,"score_gpt":0.3172238390351476,"score_spread":0.29450729595592645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281734667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99259686,0.0016468982,0.000022000451,0.0002673941,0.00075551285,0.0018787828,0.00006720493,0.000111860165,0.002653469],"genre_scores_gemma":[0.9899441,0.00041179496,0.00018380942,0.0015134492,0.000088837005,0.0004166586,0.000121715006,0.00003284859,0.0072868103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960202,0.0005886485,0.0009418204,0.000725009,0.001235522,0.0004888028],"domain_scores_gemma":[0.99689084,0.0009954382,0.00055665866,0.00069818663,0.0004968754,0.00036202],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024136424,0.000331546,0.0013805547,0.00032177079,0.00045954707,0.000047106347,0.0003767738,0.00012638916,0.0001896926],"category_scores_gemma":[0.003419368,0.00031279091,0.00027054932,0.00079536584,0.00034079846,0.00023010586,0.00031111832,0.0007165065,0.000119487726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000039015713,0.0031638425,0.990457,0.000058757727,0.0005663068,0.0000095370315,0.0011403474,9.678866e-7,0.00008466094,0.0013333681,0.0023397165,0.0008415807],"study_design_scores_gemma":[0.004224604,0.00048685103,0.9868685,0.000037230624,0.0007731844,0.0000039466754,0.001656604,0.000069393325,0.00040132468,0.0014267943,0.0039724107,0.00007914685],"about_ca_topic_score_codex":0.00007870788,"about_ca_topic_score_gemma":0.000006084047,"teacher_disagreement_score":0.004633341,"about_ca_system_score_codex":0.000058549656,"about_ca_system_score_gemma":0.00024854037,"threshold_uncertainty_score":0.9999324},"labels":[],"label_agreement":null},{"id":"W4281817250","doi":"10.1111/dom.14794","title":"In vivo and in vitro characterization of <scp>GL0034</scp> , a novel long‐acting <scp>glucagon‐like peptide</scp> ‐1 receptor agonist","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Medical Research Council; European Commission; Engineering and Physical Sciences Research Council; European Foundation for the Study of Diabetes; Innovative Medicines Initiative; Imperial College London; Wellcome Trust; Steno Diabetes Center Copenhagen; National Institute for Health and Care Research; Society for Endocrinology; Medical Research Council Canada; Diabetes UK; Juvenile Diabetes Research Foundation International; British Society for Neuroendocrinology; Horizon 2020 Framework Programme; Academy of Medical Sciences","keywords":"Agonist; Medicine; In vitro; In vivo; Receptor; Pharmacology; Internal medicine; Biochemistry; Biology; Biotechnology","score_opus":0.009129238576364142,"score_gpt":0.21480356351233348,"score_spread":0.20567432493596935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281817250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99585366,0.0015638524,0.000019295701,0.00015566341,0.00043598306,0.0008548874,0.00016889138,0.000047629583,0.0009001144],"genre_scores_gemma":[0.9937185,0.0006188016,0.0005212324,0.0008293351,0.00012913479,0.00018431271,0.00031675067,0.000044049062,0.0036378691],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997878,0.000121416655,0.0005014601,0.0005441017,0.00036949018,0.0005855248],"domain_scores_gemma":[0.9989842,0.00024466825,0.00027262757,0.00028347567,0.000059598882,0.00015540727],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006801207,0.00032675973,0.0008181902,0.00054621673,0.00018087977,0.00005916208,0.00012996916,0.00010116981,0.000042018524],"category_scores_gemma":[0.00024616285,0.00033796404,0.00010310248,0.00061237835,0.00010938331,0.00036961422,0.00032656363,0.0003290563,0.0000052171526],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003101812,0.0016047583,0.22503357,0.0005031265,0.0002301929,0.000021890055,0.002904947,0.00000634054,0.7644425,0.00034380477,0.0004931518,0.00438468],"study_design_scores_gemma":[0.0051343995,0.00017797029,0.68212956,0.00012806967,0.00040452837,0.000003268223,0.0011880818,0.00035139074,0.20934086,0.00009188347,0.10092456,0.00012541832],"about_ca_topic_score_codex":0.00008737684,"about_ca_topic_score_gemma":0.000019842833,"teacher_disagreement_score":0.5551017,"about_ca_system_score_codex":0.000082831684,"about_ca_system_score_gemma":0.00005156672,"threshold_uncertainty_score":0.99990726},"labels":[],"label_agreement":null},{"id":"W4283260230","doi":"10.1111/dom.14802","title":"The association of <scp>long‐acting</scp> insulin analogue use versus neutral protamine Hagedorn insulin use and the risk of major adverse cardiovascular events among individuals with type 2 diabetes: A <scp>population‐based</scp> cohort study","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Mace; Medicine; Insulin; Hazard ratio; Type 2 diabetes; Internal medicine; Diabetes mellitus; NPH insulin; Myocardial infarction; Population; Endocrinology; Protamine; Proportional hazards model; Cohort; Insulin glargine; Confidence interval; Percutaneous coronary intervention","score_opus":0.01259803569458863,"score_gpt":0.22803143163550596,"score_spread":0.21543339594091732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283260230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926397,0.0027528515,0.0000048160405,0.00003418175,0.00024199327,0.0040741707,0.00017243027,0.00004019904,0.00003965735],"genre_scores_gemma":[0.99819726,0.00047288032,0.000099978155,0.000046069636,0.00008319911,0.00036137356,0.00021169556,0.00004280747,0.0004847373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99497443,0.001846206,0.00059315196,0.0005198436,0.001440812,0.0006255292],"domain_scores_gemma":[0.99465096,0.0033092855,0.0007084526,0.000719394,0.00044033103,0.00017158627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064264783,0.00033682,0.0010674137,0.00034840283,0.00077531696,0.000112027476,0.00030247736,0.00011834986,0.0000043287114],"category_scores_gemma":[0.005666045,0.00021565467,0.00029716687,0.0011604778,0.00029598782,0.0004381919,0.0004299414,0.00072941894,0.0000015007731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009119633,0.0005992536,0.99092543,0.00015155307,0.005605542,0.0000041576222,0.0008978316,0.00060718704,0.000013994398,0.00003377142,0.00009730035,0.000972758],"study_design_scores_gemma":[0.011293038,0.0005101322,0.97969687,0.00005344725,0.004875661,1.1773845e-7,0.0009464106,0.00064572465,0.00023613377,0.000039534247,0.0016259113,0.00007703311],"about_ca_topic_score_codex":0.00067923754,"about_ca_topic_score_gemma":0.00018652296,"teacher_disagreement_score":0.011228599,"about_ca_system_score_codex":0.000078313315,"about_ca_system_score_gemma":0.000087881606,"threshold_uncertainty_score":0.8794142},"labels":[],"label_agreement":null},{"id":"W4285589669","doi":"10.1111/dom.14817","title":"<scp>TOTUM</scp> ‐63, a plant‐based polyphenol‐rich extract, improves glycaemic control in subjects with prediabetes or early stage newly‐diagnosed type 2 diabetes in a randomized, double‐blind, placebo‐controlled trial","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Phytochemicals and Antioxidant Activities","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Prediabetes; Postprandial; Placebo; Glycemic; Internal medicine; Overweight; Tolerability; Type 2 diabetes; Body mass index; Waist; Gastroenterology; Diabetes mellitus; Randomized controlled trial; Endocrinology; Insulin; Adverse effect","score_opus":0.011754197695622087,"score_gpt":0.23174321875289136,"score_spread":0.21998902105726928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285589669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98408717,0.0062885247,0.0000043034993,0.00019151975,0.00039337765,0.008338212,0.00028835508,0.00013903149,0.00026950488],"genre_scores_gemma":[0.9941119,0.00029981992,0.00013359592,0.00074846414,0.00035018637,0.0035503784,0.0001592277,0.00008300958,0.00056342816],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99532104,0.0008111954,0.0010016055,0.00088718353,0.0007006145,0.0012783426],"domain_scores_gemma":[0.9937643,0.004823251,0.0005305275,0.00044616262,0.00009412974,0.0003416181],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017917766,0.0007175296,0.0035970565,0.00084494933,0.00024406538,0.00015039688,0.00029826112,0.00025507755,0.000049964194],"category_scores_gemma":[0.0012118459,0.00052940944,0.0003443489,0.00094671245,0.00034075967,0.0003817153,0.0001256847,0.0011061813,0.0000025638742],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86564463,0.002050361,0.07549367,0.00032838437,0.00065418874,0.00013113649,0.00094959734,0.00005810093,0.054296326,0.00007217632,0.00009111661,0.00023028975],"study_design_scores_gemma":[0.9593372,0.0011778445,0.016833559,0.00022921666,0.00087047473,0.0000026989312,0.0004049805,0.0033479694,0.01692622,0.00011637132,0.000378853,0.00037464194],"about_ca_topic_score_codex":0.0002082323,"about_ca_topic_score_gemma":0.00016947364,"teacher_disagreement_score":0.09369252,"about_ca_system_score_codex":0.00007298292,"about_ca_system_score_gemma":0.00053419673,"threshold_uncertainty_score":0.99971575},"labels":[],"label_agreement":null},{"id":"W4287307425","doi":"10.1111/dom.14823","title":"The <scp>Real‐World</scp> Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Patients with Type 2 Diabetes ( <scp>TROPHIES</scp> ): Patient disposition, clinical characteristics and treatment persistence at 12 months","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"Eli Lilly and Company; American Diabetes Association","keywords":"Medicine; Liraglutide; Dulaglutide; Observational study; Type 2 diabetes; Persistence (discontinuity); Internal medicine; Diabetes mellitus; Endocrinology","score_opus":0.020050611484245643,"score_gpt":0.24656024290133,"score_spread":0.22650963141708436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287307425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950103,0.0018556883,3.4250775e-7,0.00015113178,0.0001262297,0.0026321504,0.00012321894,0.000030145637,0.000070794056],"genre_scores_gemma":[0.9977255,0.00079317606,0.00014139185,0.00029102288,0.000027527092,0.00032260333,0.00020306332,0.000029597479,0.00046614205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974639,0.00031651332,0.00061053206,0.00057311147,0.0005323312,0.00050361094],"domain_scores_gemma":[0.99815327,0.000691332,0.00044946081,0.00033450482,0.00016361888,0.00020778735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047943584,0.00036852297,0.0010031712,0.00017855135,0.00066364114,0.000049355647,0.000089319874,0.000038228784,0.0000022706797],"category_scores_gemma":[0.000148092,0.0002302355,0.00006453519,0.00034700288,0.00028579353,0.00015128904,0.0002658175,0.00018194037,5.7774315e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007491634,0.0034118104,0.9885796,0.0000659129,0.0008511639,0.000005370111,0.0026686203,0.00000767836,0.0000047409258,0.00017941157,0.000064546875,0.0040862574],"study_design_scores_gemma":[0.0062388643,0.0063263085,0.9834096,0.000059971266,0.00069842034,2.6593847e-7,0.0017355679,0.00005943753,0.000023458162,0.00003954188,0.0013378512,0.00007071135],"about_ca_topic_score_codex":0.00013149796,"about_ca_topic_score_gemma":0.00038557462,"teacher_disagreement_score":0.0061639477,"about_ca_system_score_codex":0.00019598355,"about_ca_system_score_gemma":0.000078093915,"threshold_uncertainty_score":0.9388731},"labels":[],"label_agreement":null},{"id":"W4292332601","doi":"10.1111/dom.14844","title":"<scp>iGlarLixi</scp> versus basal plus <scp>Rapid‐Acting</scp> insulin in adults with type 2 diabetes advancing from basal insulin therapy: The <scp>SoliSimplify Real‐World</scp> study","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Sanofi","keywords":"Medicine; Type 2 diabetes; Basal insulin; Confidence interval; Regimen; Observational study; Propensity score matching; Odds ratio; Basal (medicine); Internal medicine; Insulin; Diabetes mellitus; Endocrinology","score_opus":0.016820505435864087,"score_gpt":0.2597489733641618,"score_spread":0.24292846792829773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292332601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692524,0.020130828,0.0000037876573,0.00023637424,0.0015849654,0.0032140103,0.00016582648,0.00028134786,0.005130478],"genre_scores_gemma":[0.9901915,0.0034473778,0.00026837303,0.0014928329,0.0010378269,0.0005808759,0.00040109496,0.00020765563,0.0023724341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9916676,0.0013603655,0.0010111051,0.00164137,0.001946061,0.0023734423],"domain_scores_gemma":[0.9917159,0.0053025885,0.00053107855,0.0013912093,0.0003757674,0.0006834509],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00333775,0.0010135866,0.0018274372,0.001106966,0.0011838393,0.00035838157,0.001117351,0.0002583898,0.00009191613],"category_scores_gemma":[0.0027822112,0.0007684346,0.0002914566,0.0029774439,0.00042088688,0.00066539797,0.0013511039,0.0023895416,0.0000626573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003675333,0.0037690322,0.9328782,0.00040793503,0.0022803105,0.0001939541,0.019779377,0.00034463694,0.001216353,0.00024385848,0.010573989,0.027944833],"study_design_scores_gemma":[0.021009566,0.002209268,0.8490415,0.00024156256,0.0006624759,5.0716864e-7,0.02095053,0.002094362,0.0020481695,0.00050210435,0.10103662,0.00020331262],"about_ca_topic_score_codex":0.00086495455,"about_ca_topic_score_gemma":0.0006820114,"teacher_disagreement_score":0.09046263,"about_ca_system_score_codex":0.0002497261,"about_ca_system_score_gemma":0.0004082399,"threshold_uncertainty_score":0.99991196},"labels":[],"label_agreement":null},{"id":"W4292696070","doi":"10.1111/dom.14825","title":"Hypoglycaemia events with <scp>iGlarLixi</scp> versus premix biphasic insulin aspart 30 ( <scp>BIAsp</scp> 30) in people with type 2 diabetes advancing from basal insulin: An analysis of the <scp>SoliMix</scp> trial","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Sanofi","keywords":"Medicine; Internal medicine; Incidence (geometry); Type 2 diabetes; Insulin aspart; Endocrinology; Logistic regression; Diabetes mellitus; Basal (medicine); Insulin; Basal insulin; Mathematics","score_opus":0.013486987864835407,"score_gpt":0.2444401437915788,"score_spread":0.2309531559267434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292696070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98901016,0.0067420336,0.000012121228,0.00007443304,0.00092455244,0.0020418188,0.0002661874,0.000117166994,0.0008115367],"genre_scores_gemma":[0.9961218,0.000590338,0.00036459934,0.000412991,0.00040655315,0.00030070727,0.00059377815,0.00011947873,0.0010897466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99316835,0.0009838273,0.00091238366,0.0013110618,0.0019702779,0.0016541173],"domain_scores_gemma":[0.9948447,0.0022076992,0.000638439,0.0013432506,0.0003646518,0.00060128863],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020478214,0.0007631625,0.0021259345,0.0012210816,0.00059486687,0.0001420887,0.0009588188,0.00028241152,0.00010528352],"category_scores_gemma":[0.0022923953,0.0005670535,0.00038952686,0.004558206,0.00035430898,0.00060846837,0.0009290434,0.0013341579,0.000019378202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005611688,0.0018693623,0.9826156,0.00025919284,0.0038464991,0.000027006701,0.0038191173,0.0013552847,0.0020179346,0.00008759479,0.0008698928,0.0026713302],"study_design_scores_gemma":[0.035570323,0.0019784085,0.93429726,0.00017121343,0.005318101,4.1240898e-7,0.003675692,0.004695703,0.004590605,0.00019631517,0.0093513075,0.00015468073],"about_ca_topic_score_codex":0.00032626398,"about_ca_topic_score_gemma":0.0004928344,"teacher_disagreement_score":0.04831838,"about_ca_system_score_codex":0.00017707718,"about_ca_system_score_gemma":0.00042767293,"threshold_uncertainty_score":0.9996781},"labels":[],"label_agreement":null},{"id":"W4294397820","doi":"10.1111/dom.14856","title":"All‐cause and cardiorenal mortality in 6 million adults with and without type 2 diabetes: A comparative, trend analysis in Canada, Spain, and the <scp>UK</scp>","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences","funders":"National Institute for Health and Care Research; AstraZeneca","keywords":"Medicine; Type 2 diabetes; Cardiorenal syndrome; Diabetes mellitus; Gerontology; Demography; Environmental health; Internal medicine; Heart failure; Endocrinology","score_opus":0.012604358336796368,"score_gpt":0.22554937734763986,"score_spread":0.21294501901084348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294397820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95668095,0.042190902,0.0000020197187,0.00008546072,0.000060291968,0.00072150375,0.00011499598,0.000014664022,0.0001292152],"genre_scores_gemma":[0.9970383,0.0021108044,0.0000719171,0.00044102155,0.000056423713,0.00012394744,0.00010284997,0.000018566298,0.000036180358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744666,0.00056895806,0.0003445953,0.0006040735,0.00052319723,0.0005124965],"domain_scores_gemma":[0.99895304,0.00021599185,0.00012167884,0.000385862,0.00006233987,0.00026110228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012698236,0.0003323479,0.0015739268,0.0003550467,0.00020271032,0.000058620233,0.00009455156,0.00006757671,0.000008190244],"category_scores_gemma":[0.00010650379,0.00023826791,0.000115324794,0.0009405841,0.00037072104,0.0001167864,0.00017481134,0.0004509918,1.7698945e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082289866,0.00006952007,0.9902481,0.00011691398,0.0026975982,0.000022185992,0.002462206,0.000095542455,0.000017275843,0.00003977351,0.00004677845,0.0041018045],"study_design_scores_gemma":[0.006307432,0.00008747685,0.9830836,0.00006289779,0.003518005,0.0000055297637,0.0019300969,0.0019681833,0.00011889988,0.00004547993,0.002724333,0.00014805904],"about_ca_topic_score_codex":0.3815815,"about_ca_topic_score_gemma":0.6972978,"teacher_disagreement_score":0.31571633,"about_ca_system_score_codex":0.00006599166,"about_ca_system_score_gemma":0.00016078858,"threshold_uncertainty_score":0.97162837},"labels":[],"label_agreement":null},{"id":"W4295024043","doi":"10.1111/dom.14867","title":"External validation and extension of the <scp>TIMI</scp> risk score for heart failure in diabetes for patients with recent acute coronary syndrome: An analysis of the <scp>EXAMINE</scp> trial","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Acute coronary syndrome; Internal medicine; TIMI; Cardiology; Heart failure; Myocardial infarction; Type 2 diabetes; Creatinine; Framingham Risk Score; Confidence interval; Atrial fibrillation; Diabetes mellitus; Clinical endpoint; Natriuretic peptide; Randomized controlled trial; Thrombolysis; Endocrinology; Disease","score_opus":0.010888144472666407,"score_gpt":0.22904266183587868,"score_spread":0.21815451736321229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295024043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99532306,0.00050206,0.000025103593,0.00020658236,0.000189189,0.0033079865,0.0004299275,0.0000135163755,0.0000025586558],"genre_scores_gemma":[0.9976924,0.00014188816,0.0012182448,0.00017202212,0.000030665196,0.0003522065,0.0002665288,0.000021314185,0.0001047388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817693,0.00027722836,0.00038521935,0.00040115815,0.00043311343,0.0003263254],"domain_scores_gemma":[0.998532,0.0004515096,0.00032124665,0.00042668186,0.0001694589,0.00009907805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007530523,0.00022484473,0.0007553611,0.00024800366,0.00029070931,0.000022366443,0.00013663016,0.00007179533,0.0000071176123],"category_scores_gemma":[0.0003233222,0.00013634586,0.00021397449,0.0006123415,0.00011927747,0.0001554882,0.00018426504,0.0001584241,1.1957954e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015930671,0.00093152275,0.9945579,0.000101650636,0.0009408681,4.942356e-7,0.00045141228,0.000088208755,0.0009472678,0.000049713162,0.00040063972,0.0013709972],"study_design_scores_gemma":[0.014431293,0.0011443371,0.97090816,0.000061574596,0.0060405927,6.2689617e-7,0.0002359253,0.00070524274,0.0025883857,0.00014393561,0.003701095,0.000038797465],"about_ca_topic_score_codex":0.000032297532,"about_ca_topic_score_gemma":0.000040326628,"teacher_disagreement_score":0.023649724,"about_ca_system_score_codex":0.000033740955,"about_ca_system_score_gemma":0.00004423257,"threshold_uncertainty_score":0.55600226},"labels":[],"label_agreement":null},{"id":"W4295079843","doi":"10.1111/dom.14866","title":"Cross‐sectional association of metrics derived from continuous glucose monitoring with cognitive performance in older adults with type 2 diabetes","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Japan Society for the Promotion of Science; National Center for Geriatrics and Gerontology","keywords":"Memory span; Trail Making Test; Montreal Cognitive Assessment; Cognition; Type 2 diabetes; Verbal fluency test; Medicine; Confounding; Cognitive test; Audiology; Effects of sleep deprivation on cognitive performance; Psychology; Diabetes mellitus; Internal medicine; Neuropsychology; Cognitive impairment; Psychiatry; Endocrinology; Working memory","score_opus":0.007217876421667732,"score_gpt":0.24215188303362248,"score_spread":0.23493400661195474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295079843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99668425,0.0024331186,0.0000048796683,0.000016027092,0.0001181723,0.0005059633,0.000074750606,0.000019811543,0.00014301042],"genre_scores_gemma":[0.99898803,0.00033638623,0.00012438514,0.000058595684,0.00007664633,0.00010449632,0.0001263055,0.000015560046,0.00016959016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998394,0.00011899115,0.00020035551,0.00028843223,0.00065815175,0.00034003065],"domain_scores_gemma":[0.9989545,0.0002399738,0.00014995376,0.00008366761,0.00048108544,0.00009083146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047769622,0.00014388682,0.00035752312,0.00024959858,0.0001688265,0.000034192915,0.000060843537,0.00005347954,0.0001471158],"category_scores_gemma":[0.00016601065,0.00012021406,0.000035045567,0.00062583113,0.00007597798,0.0001867272,0.000086539825,0.00032328308,0.0000022507918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055452087,0.0005085508,0.99144167,0.00010235451,0.0002814784,0.0000060902935,0.0004897487,0.00000410461,0.0025510206,0.0000018858974,0.000001670375,0.0040568877],"study_design_scores_gemma":[0.0057181455,0.0005641227,0.9209395,0.00017181195,0.00020301092,6.7491715e-7,0.0004871972,0.00011679773,0.07161437,0.0000057765487,0.000047934667,0.00013064053],"about_ca_topic_score_codex":0.00006271591,"about_ca_topic_score_gemma":0.000006892661,"teacher_disagreement_score":0.07050217,"about_ca_system_score_codex":0.00007219052,"about_ca_system_score_gemma":0.00008594228,"threshold_uncertainty_score":0.49021873},"labels":[],"label_agreement":null},{"id":"W4295084553","doi":"10.1111/dom.14862","title":"Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the <scp>FIGHT</scp> trial","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Heart, Lung, and Blood Institute; Fundação para a Ciência e a Tecnologia","keywords":"Medicine; Ejection fraction; Liraglutide; Heart failure; Lightheadedness; Internal medicine; Placebo; Post-hoc analysis; Cardiology; Rate ratio; Hazard ratio; Myocardial infarction; Confidence interval; Diabetes mellitus; Type 2 diabetes; Endocrinology","score_opus":0.005161291033091831,"score_gpt":0.20780536470486644,"score_spread":0.20264407367177462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295084553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981809,0.0003780381,0.000004255938,0.00016408843,0.000113330934,0.0008911584,0.000072434224,0.000017428449,0.00017833977],"genre_scores_gemma":[0.9989285,0.000060790706,0.0003217377,0.00013831133,0.00003975587,0.00010320143,0.00006755216,0.000012673652,0.00032747482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985749,0.00022234813,0.00026406907,0.00028224904,0.00043458442,0.0002218218],"domain_scores_gemma":[0.99909747,0.00010311787,0.00029854785,0.00034270526,0.00009116354,0.00006702815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040009833,0.00017005535,0.0006665436,0.00045281617,0.0001524236,0.000004064067,0.00008444806,0.000044804256,0.00004359061],"category_scores_gemma":[0.00006854946,0.00010890004,0.0002015302,0.0014603416,0.000071757204,0.00012578524,0.000089607696,0.00021946104,8.523546e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013129187,0.0011521504,0.99142605,0.00006387492,0.00329773,0.0000024411538,0.00043702236,0.00042788172,0.0013011724,0.0000782786,0.00017875177,0.00032170827],"study_design_scores_gemma":[0.015870813,0.0009653759,0.96438,0.000043071523,0.008208713,5.8611795e-7,0.0009786589,0.000117251286,0.003074186,0.000027351463,0.0062795333,0.00005442479],"about_ca_topic_score_codex":0.00020119429,"about_ca_topic_score_gemma":0.00016606135,"teacher_disagreement_score":0.027046034,"about_ca_system_score_codex":0.0000475599,"about_ca_system_score_gemma":0.000058937054,"threshold_uncertainty_score":0.4440815},"labels":[],"label_agreement":null},{"id":"W4295419496","doi":"10.1111/dom.14872","title":"Ethnicity and risks of severe <scp>COVID</scp> ‐19 outcomes associated with glucose‐lowering medications: A cohort study","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"NIHR Leicester Biomedical Research Centre; Medical Research Council; University of Oxford; National Institute for Health and Care Research; UK Research and Innovation; Public Health England; Department of Health and Social Care; Cancer Research UK; Wellcome Trust","keywords":"Medicine; Metformin; Pandemic; Diabetes mellitus; Ethnic group; Cohort; Cohort study; Type 2 diabetes; Population; Internal medicine; Observational study; Insulin; Coronavirus disease 2019 (COVID-19); Disease; Endocrinology; Environmental health; Infectious disease (medical specialty)","score_opus":0.023701621004731468,"score_gpt":0.2798515955079793,"score_spread":0.25614997450324783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295419496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940718,0.00342489,0.000008502984,0.000113241884,0.00009856338,0.0014703474,0.00006956403,0.00009274059,0.000650357],"genre_scores_gemma":[0.9977506,0.00033353362,0.000107019965,0.0005476397,0.00001960884,0.00029911206,0.00009336089,0.000021806274,0.00082732615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825275,0.00016284357,0.00029042014,0.00041003758,0.0005526975,0.0003312519],"domain_scores_gemma":[0.9987898,0.00035973563,0.00020923009,0.0003281909,0.00007569941,0.00023734619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010030033,0.00023674675,0.00076916144,0.00019670225,0.0003247984,0.000023979748,0.00011456982,0.000053071064,0.000044469216],"category_scores_gemma":[0.00043676211,0.00018977204,0.00007376139,0.00035235102,0.00013305525,0.00011389967,0.00030643828,0.00023539575,0.0000013453192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008148112,0.0014732684,0.99336797,0.00007656632,0.0019522491,0.000012347177,0.0014144116,0.00001107461,0.00007814928,0.00011592222,0.00017083167,0.0013190414],"study_design_scores_gemma":[0.0035446237,0.00036144714,0.9893635,0.000026204305,0.002654749,0.0000011650993,0.00123524,0.00004302334,0.0001258027,0.00014470352,0.0024079627,0.00009160062],"about_ca_topic_score_codex":0.00021031454,"about_ca_topic_score_gemma":0.00005039039,"teacher_disagreement_score":0.0040045124,"about_ca_system_score_codex":0.00006224544,"about_ca_system_score_gemma":0.00006253166,"threshold_uncertainty_score":0.7738679},"labels":[],"label_agreement":null},{"id":"W4295907355","doi":"10.1111/dom.14871","title":"Rationale and design of the phase 3a development programme ( <scp>ONWARDS</scp> 1–6 trials) investigating once‐weekly insulin icodec in diabetes","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada); Mount Sinai Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Novo Nordisk","keywords":"Diabetes mellitus; Insulin; Phase (matter); Medicine; Internal medicine; Endocrinology; Chemistry","score_opus":0.07775272463722106,"score_gpt":0.30364494058981084,"score_spread":0.2258922159525898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295907355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913874,0.0054717716,0.000036552876,0.00057376316,0.00015703695,0.0021498096,0.000029573504,0.000032624605,0.00016142483],"genre_scores_gemma":[0.9941139,0.00016280856,0.0035940837,0.0006070361,0.000102269325,0.00055928883,0.00007298306,0.000026863354,0.0007607471],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99683964,0.00083113206,0.0006520442,0.00039672919,0.00070322613,0.00057722715],"domain_scores_gemma":[0.99825764,0.00092201994,0.0002706571,0.00025036512,0.00010034712,0.00019894498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053682597,0.00023144657,0.0007849573,0.00031065044,0.00039680643,0.00007078964,0.00022503712,0.00007330372,0.000038621583],"category_scores_gemma":[0.0025307513,0.00017091529,0.00009812106,0.00070690515,0.00029015387,0.00015298737,0.00053352927,0.0004268929,0.0000019091226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052699397,0.0023035388,0.7058093,0.0011390835,0.0006651481,0.000008373671,0.006241548,0.00020102398,0.051598877,0.0020398607,0.0014827573,0.2284578],"study_design_scores_gemma":[0.014099961,0.00045316006,0.8146328,0.00027082104,0.00047996454,8.8486524e-7,0.0014505186,0.0068654353,0.07474455,0.0036316891,0.08308517,0.00028507746],"about_ca_topic_score_codex":0.000010970737,"about_ca_topic_score_gemma":0.00000434622,"teacher_disagreement_score":0.2281727,"about_ca_system_score_codex":0.000045248635,"about_ca_system_score_gemma":0.00027354903,"threshold_uncertainty_score":0.6969723},"labels":[],"label_agreement":null},{"id":"W4302292984","doi":"10.1111/dom.14890","title":"Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: <scp>STEP</scp> 1 and 4 exploratory analyses","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Novo Nordisk","keywords":"Medicine; Overweight; Semaglutide; Obesity; Internal medicine; Gerontology; Type 2 diabetes; Endocrinology; Diabetes mellitus; Liraglutide","score_opus":0.014075579139428468,"score_gpt":0.23548500658293253,"score_spread":0.22140942744350406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302292984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837478,0.014440296,0.0000066989533,0.000041597727,0.00019974489,0.00096015213,0.00012692441,0.00011555224,0.00036124137],"genre_scores_gemma":[0.99485266,0.0030094527,0.00042197763,0.0003267087,0.00013121517,0.00024340663,0.000108716944,0.000050836665,0.00085500476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737906,0.00026572714,0.00036085086,0.00075228536,0.0005376716,0.00070440857],"domain_scores_gemma":[0.99862236,0.00029429235,0.00020906156,0.00046339474,0.0000639161,0.00034696946],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004687308,0.0004895877,0.0011980821,0.0007404014,0.00041953745,0.00007886272,0.00014552534,0.000085374704,0.000030432511],"category_scores_gemma":[0.00017468921,0.00035086466,0.00015040788,0.0009442136,0.00018429704,0.00030874938,0.0003949241,0.00039417922,0.0000042874426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008531907,0.0007597912,0.9867438,0.00031775047,0.0011018893,0.0000785446,0.00213735,0.000014330423,0.00078164117,0.0001437141,0.00047151188,0.0073643723],"study_design_scores_gemma":[0.0043914164,0.00044708353,0.95575154,0.00008200607,0.0020194203,0.0000034665154,0.0039020292,0.00016744561,0.0036715704,0.00007888303,0.029256385,0.00022874345],"about_ca_topic_score_codex":0.00041029224,"about_ca_topic_score_gemma":0.00013496309,"teacher_disagreement_score":0.030992236,"about_ca_system_score_codex":0.000064187996,"about_ca_system_score_gemma":0.00007900414,"threshold_uncertainty_score":0.9998943},"labels":[],"label_agreement":null},{"id":"W4306166068","doi":"10.1111/dom.14893","title":"Sodium‐glucose co‐transporter‐2 inhibitors in type 2 diabetes: Are clinical trial benefits for heart failure reflected in real‐world clinical practice? A systematic review and meta‐analysis of observational studies","year":2022,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Oxford; National Institute for Health and Care Research","keywords":"Observational study; Meta-analysis; Medicine; Type 2 diabetes; Clinical trial; Systematic review; Randomized controlled trial; Internal medicine; Diabetes mellitus; Heart failure; Clinical Practice; MEDLINE; Intensive care medicine; Physical therapy; Endocrinology","score_opus":0.26656893213608385,"score_gpt":0.4697742417022192,"score_spread":0.20320530956613536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306166068","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015122656,0.973232,1.3346217e-7,0.00057211076,0.00031267258,0.010296242,0.0004065805,0.000037003636,0.00002060395],"genre_scores_gemma":[0.00024343368,0.99305636,0.00072553963,0.0014108709,0.00014186639,0.0027866706,0.0014513744,0.000057291945,0.0001265798],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.991334,0.0019765415,0.0044552553,0.00110542,0.0005884049,0.000540342],"domain_scores_gemma":[0.99040806,0.006142005,0.0021688803,0.00071562757,0.0003396293,0.00022581799],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.008124824,0.0007589816,0.018386882,0.0012301034,0.00009628175,0.000037758855,0.00021960969,0.0003533099,0.000049535356],"category_scores_gemma":[0.004263914,0.0005614546,0.0026171587,0.0025950437,0.00019833988,0.0002515202,0.00016695782,0.00073232857,0.00000203845],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042455937,0.0027276734,0.013215341,0.7434776,0.23276152,0.000014611108,0.00010207782,6.7360986e-7,6.546017e-8,0.00033594106,0.00096019247,0.005979769],"study_design_scores_gemma":[0.0065524178,0.0004553028,0.007262256,0.026792074,0.74726516,3.122189e-7,0.00006587905,0.000004962073,4.329864e-7,0.000024909517,0.21117103,0.0004052607],"about_ca_topic_score_codex":0.000015982107,"about_ca_topic_score_gemma":0.00028682305,"teacher_disagreement_score":0.7166855,"about_ca_system_score_codex":0.00009008491,"about_ca_system_score_gemma":0.00023092183,"threshold_uncertainty_score":0.9996837},"labels":[],"label_agreement":null},{"id":"W4306167352","doi":"10.1111/dom.14891","title":"Effect of faecal microbial transplant via colonoscopy in patients with severe obesity and insulin resistance: A randomized double‐blind, placebo‐controlled Phase 2 trial","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Toronto Western Hospital; Princess Margaret Cancer Centre; University Health Network; University of Toronto; Toronto General Hospital; Public Health Ontario","funders":"Banting and Best Diabetes Centre, University of Toronto; Canadian Institutes of Health Research","keywords":"Insulin resistance; Internal medicine; Medicine; Gastroenterology; Randomized controlled trial; Endocrinology; Insulin","score_opus":0.003674056461495466,"score_gpt":0.23014525126230398,"score_spread":0.22647119480080852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306167352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992654,0.0031218948,0.000020607196,0.000030282674,0.00018131068,0.0036817628,0.00027985853,0.000007710161,0.000022537293],"genre_scores_gemma":[0.99875474,0.0002896828,0.000095507836,0.000099296805,0.0000666609,0.00026245636,0.0003546014,0.000017389093,0.00005965305],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976853,0.00091901916,0.00044746272,0.00044166934,0.00015930171,0.00034725026],"domain_scores_gemma":[0.9992954,0.00012715923,0.00022000141,0.0001908383,0.00004927156,0.000117290896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014020071,0.00027104846,0.001226098,0.00011440175,0.00021196011,0.000020489915,0.00012818463,0.00015343218,0.00001590154],"category_scores_gemma":[0.00004519349,0.00021541123,0.00014267271,0.00012898709,0.00018104084,0.0000104363535,0.00009152382,0.00024385951,3.9685145e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9581078,0.00085322425,0.007474643,0.00018557826,0.00019553919,0.0000019869835,0.00022044026,0.000005262037,0.03269245,0.00002501706,0.0000343929,0.00020362785],"study_design_scores_gemma":[0.96963274,0.0020261996,0.005546918,0.000026678996,0.00036089856,0.000001195635,0.000007550486,0.0000147627825,0.021495149,0.000015455247,0.0006267352,0.00024574075],"about_ca_topic_score_codex":0.000045696826,"about_ca_topic_score_gemma":0.00007141293,"teacher_disagreement_score":0.011524879,"about_ca_system_score_codex":0.0000156978,"about_ca_system_score_gemma":0.00009381193,"threshold_uncertainty_score":0.8784215},"labels":[],"label_agreement":null},{"id":"W4307773091","doi":"10.1111/dom.14911","title":"Weight management in young adults with type 1 diabetes: The advancing care for type 1 diabetes and obesity network sequential multiple assignment randomized trial pilot results","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Nutrition Obesity Research Center, University of Alabama at Birmingham","keywords":"Medicine; Overweight; Weight loss; Body mass index; Type 2 diabetes; Randomized controlled trial; Obesity; Randomization; Diabetes mellitus; Placebo; Internal medicine; Type 1 diabetes; Endocrinology","score_opus":0.01488480251892933,"score_gpt":0.25579600854514506,"score_spread":0.24091120602621574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307773091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780047,0.011918949,0.000018626486,0.0003570158,0.0011709114,0.007656659,0.00006445737,0.00007364823,0.0007350324],"genre_scores_gemma":[0.9945592,0.0011706046,0.0008639313,0.00040616625,0.000552376,0.0012637655,0.00038196842,0.0000572215,0.0007447407],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99604475,0.00065835065,0.00060001336,0.0008036138,0.00073817326,0.0011550662],"domain_scores_gemma":[0.9980578,0.0007849065,0.00023341905,0.00050716347,0.00018671247,0.00023002207],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031977715,0.0004264829,0.0012112891,0.0002681868,0.000851941,0.00012791457,0.00028640367,0.000082082726,0.00004534341],"category_scores_gemma":[0.00035128757,0.00029214748,0.00015759596,0.0007009303,0.00029701367,0.00018989357,0.0006350131,0.00050028815,0.0000030528836],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6679414,0.0022312033,0.28610247,0.0031573838,0.0034725098,0.000048306098,0.004562885,0.0011064642,0.0005058324,0.0014293528,0.0037300058,0.025712218],"study_design_scores_gemma":[0.8772976,0.0031030267,0.08074905,0.0005033815,0.0022331341,6.117965e-7,0.0016945532,0.0083075,0.0005765505,0.0006729123,0.024033265,0.0008284083],"about_ca_topic_score_codex":0.000039429768,"about_ca_topic_score_gemma":0.00011724851,"teacher_disagreement_score":0.20935623,"about_ca_system_score_codex":0.00011196774,"about_ca_system_score_gemma":0.000067571855,"threshold_uncertainty_score":0.9999531},"labels":[],"label_agreement":null},{"id":"W4309244284","doi":"10.1111/dom.14923","title":"Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from <scp>VERTIS CV</scp> , a randomized trial of the <scp>sodium‐glucose cotransporter‐2</scp> inhibitor ertugliflozin","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"European Association for the Study of Diabetes; Pfizer; European Foundation for the Study of Diabetes; American Heart Association","keywords":"Medicine; Internal medicine; Hazard ratio; Steatosis; Mace; Gastroenterology; Heart failure; Quartile; Placebo; Kidney disease; Type 2 diabetes; Fatty liver; Diabetes mellitus; Confidence interval; Cardiology; Endocrinology; Disease; Pathology; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.011506921221839063,"score_gpt":0.21801209467513286,"score_spread":0.2065051734532938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309244284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87861425,0.11760577,9.929644e-7,0.000036408976,0.000108778724,0.0018186792,0.0017881086,0.000018630966,0.000008404058],"genre_scores_gemma":[0.99139136,0.007670239,0.00007090931,0.00015382776,0.000049544105,0.00039751956,0.00020966453,0.0000344887,0.000022474247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967321,0.0007787657,0.0005971216,0.000606288,0.0008916004,0.0003941251],"domain_scores_gemma":[0.9974088,0.0013430614,0.0003278204,0.0005049639,0.00009342416,0.00032191185],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006952487,0.00043003386,0.0023272142,0.00022715578,0.0001941223,0.00004955499,0.00016763186,0.00010427653,0.00001177702],"category_scores_gemma":[0.0003523303,0.00027850358,0.00063575583,0.00044568267,0.0005018521,0.00017849119,0.00020347218,0.00022608973,3.7145435e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017603388,0.0010402945,0.98494095,0.0002530238,0.0076483763,0.000008262307,0.0019097168,0.000017853377,0.0016835167,0.00000927656,0.00009038169,0.0006380231],"study_design_scores_gemma":[0.16170363,0.00021890155,0.80948406,0.00020578965,0.010837895,3.4887796e-7,0.00030951414,0.00003762503,0.016684413,0.000045913624,0.00039376997,0.00007815768],"about_ca_topic_score_codex":0.0007077795,"about_ca_topic_score_gemma":0.000014232281,"teacher_disagreement_score":0.1754569,"about_ca_system_score_codex":0.000028825405,"about_ca_system_score_gemma":0.00010558895,"threshold_uncertainty_score":0.99996674},"labels":[],"label_agreement":null},{"id":"W4311480480","doi":"10.1111/dom.14943","title":"Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once‐weekly glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist tirzepatide: A <i>post hoc</i> analysis of the <scp>SURPASS</scp> ‐1 to ‐5 studies","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; University of Toronto","funders":"Eli Lilly and Company; American Diabetes Association","keywords":"Semaglutide; Type 2 diabetes; Medicine; Weight loss; Internal medicine; Glucagon-like peptide 1 receptor; Placebo; Basal insulin; Basal (medicine); Hypoglycemia; Exenatide; Clinical endpoint; Endocrinology; Post-hoc analysis; Randomized controlled trial; Diabetes mellitus; Insulin; Agonist; Obesity; Liraglutide; Receptor","score_opus":0.00725095975743336,"score_gpt":0.21771508767922182,"score_spread":0.21046412792178845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311480480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97309166,0.023888636,0.0000029408493,0.0013191766,0.0001370868,0.0013052827,0.00015807798,0.000025595791,0.00007154793],"genre_scores_gemma":[0.99438727,0.0028597987,0.0006207715,0.001075938,0.00003999055,0.00023229879,0.00006843162,0.000037444017,0.0006780512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735785,0.00025829606,0.00048423177,0.00063251547,0.0007072007,0.0005599264],"domain_scores_gemma":[0.9983307,0.00028819445,0.00038448203,0.0005912871,0.00022097229,0.00018437738],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006018782,0.0004559624,0.001325124,0.0004097011,0.00035708208,0.000043192187,0.0002674038,0.00006158329,0.000011006872],"category_scores_gemma":[0.00009229715,0.0002611046,0.00012467889,0.001431939,0.00053123274,0.00013898649,0.0006539812,0.00031577965,0.0000010583801],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025264628,0.0005915022,0.9800617,0.00030557878,0.005084711,0.0000066873927,0.003494504,0.0000977229,0.0067699,0.00022544133,0.00038711648,0.0027224955],"study_design_scores_gemma":[0.0036471558,0.0017308507,0.9614456,0.00017815942,0.006421248,0.0000014697549,0.0026889916,0.00008188939,0.012547168,0.000037760885,0.011019852,0.0001998439],"about_ca_topic_score_codex":0.00018239478,"about_ca_topic_score_gemma":0.0005393966,"teacher_disagreement_score":0.021295622,"about_ca_system_score_codex":0.00009378026,"about_ca_system_score_gemma":0.000093736,"threshold_uncertainty_score":0.99998415},"labels":[],"label_agreement":null},{"id":"W4312093562","doi":"10.1111/dom.14949","title":"<scp>IMpact</scp> of flash glucose Monitoring in <scp>pEople</scp> with type 2 Diabetes Inadequately controlled with non‐insulin Antihyperglycaemic <scp>ThErapy</scp> ( <scp>IMMEDIATE</scp> ): A randomized controlled trial","year":2022,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Abbott Diabetes Care","keywords":"Medicine; Randomized controlled trial; Type 2 diabetes; Diabetes mellitus; Insulin; Internal medicine; Blood Glucose Self-Monitoring; Diabetes management; Endocrinology; Glycemic; Continuous glucose monitoring","score_opus":0.010410676465415282,"score_gpt":0.24652758766846175,"score_spread":0.23611691120304648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312093562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94565946,0.03666893,0.0000094512125,0.00007655666,0.0013311693,0.014101551,0.0003586355,0.0002391704,0.0015550622],"genre_scores_gemma":[0.98331124,0.0067489604,0.00025064274,0.00030595728,0.0010057705,0.0033714909,0.0006978111,0.00025851413,0.004049616],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9875732,0.0024037096,0.0023859832,0.0016972891,0.0028236434,0.003116161],"domain_scores_gemma":[0.97950244,0.015510153,0.0016436648,0.001276365,0.0009404264,0.0011269402],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0077856104,0.0016861283,0.009281242,0.002333081,0.00069796667,0.00038810764,0.0010844201,0.0005833727,0.000038840637],"category_scores_gemma":[0.010524501,0.0011725223,0.0013259082,0.0033669625,0.00088848284,0.000747908,0.0006614822,0.0021329275,0.00004378438],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24990414,0.01652788,0.6053614,0.002772203,0.02617643,0.00056663225,0.01875715,0.0018185162,0.05691468,0.000444595,0.012890362,0.007865994],"study_design_scores_gemma":[0.8962404,0.0045223325,0.0648807,0.0004136915,0.0031466088,0.0000051803713,0.0033033695,0.0020702244,0.014457574,0.00025850127,0.010491325,0.00021006845],"about_ca_topic_score_codex":0.00018063953,"about_ca_topic_score_gemma":0.000046479723,"teacher_disagreement_score":0.64633626,"about_ca_system_score_codex":0.00020787257,"about_ca_system_score_gemma":0.00081557996,"threshold_uncertainty_score":0.99958855},"labels":[],"label_agreement":null},{"id":"W4313454138","doi":"10.1111/dom.14965","title":"Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the <scp>VERTIS CV</scp> population with type 2 diabetes and atherosclerotic cardiovascular disease","year":2023,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"Pfizer; American Diabetes Association","keywords":"Medicine; Type 2 diabetes; Residual risk; Internal medicine; Atherosclerotic cardiovascular disease; Population; Diabetes mellitus; Type 2 Diabetes Mellitus; Insulin resistance; Post-hoc analysis; Endocrinology; Obesity; Disease; Environmental health","score_opus":0.014742287592752942,"score_gpt":0.2366771745231051,"score_spread":0.22193488693035215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313454138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9060393,0.08091571,0.00015784385,0.0055621276,0.00074451166,0.0060179774,0.0004544072,0.00010227426,0.0000058720084],"genre_scores_gemma":[0.91947407,0.029330919,0.0013889358,0.022446316,0.017814811,0.0039318297,0.0048156017,0.00046156364,0.00033595267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949347,0.0008388165,0.0005649556,0.0013871295,0.0013072786,0.00096714153],"domain_scores_gemma":[0.99712926,0.0003213075,0.0001990786,0.0017456369,0.00034613427,0.00025857493],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0042087426,0.00065108406,0.0020167204,0.00025072292,0.00052783976,0.00016706594,0.00021774367,0.00066749606,0.0000017813129],"category_scores_gemma":[0.00082853285,0.0004690103,0.0016656022,0.0004196831,0.00022105694,0.0001533235,0.00009993773,0.0011091763,0.000003211673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009766689,0.0019046294,0.33500633,0.060759354,0.11405152,0.0006752596,0.0054399045,0.0054994486,0.0003422448,0.0002770499,0.24049713,0.23457047],"study_design_scores_gemma":[0.0038579805,0.00027538984,0.75309426,0.00038329815,0.014361552,0.0000132774985,0.00012474411,0.00023656256,0.000096020645,0.0010240235,0.22620896,0.00032393407],"about_ca_topic_score_codex":0.00067527423,"about_ca_topic_score_gemma":0.000016613953,"teacher_disagreement_score":0.41808793,"about_ca_system_score_codex":0.000086291366,"about_ca_system_score_gemma":0.00017833612,"threshold_uncertainty_score":0.9997762},"labels":[],"label_agreement":null},{"id":"W4313455221","doi":"10.1111/dom.14966","title":"Lifestyle intervention for the prevention of type 2 diabetes in women with prior gestational diabetes: A systematic review and meta‐analysis","year":2023,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Gestational diabetes; Medicine; Type 2 diabetes; Meta-analysis; Diabetes mellitus; Intervention (counseling); Obstetrics; Pregnancy; Gestation; Internal medicine; Endocrinology; Psychiatry","score_opus":0.04338813503796039,"score_gpt":0.34015320911502867,"score_spread":0.29676507407706826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313455221","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006338813,0.9861225,0.000018837436,0.00016981004,0.000028483253,0.0070574083,0.00023262684,0.000025856265,0.0000056800636],"genre_scores_gemma":[0.00066978385,0.99192053,0.00023416535,0.00020462589,0.000024783785,0.0057224273,0.0004381746,0.000045419787,0.0007400786],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99704576,0.0004955299,0.000992329,0.00049158797,0.00047361373,0.0005012033],"domain_scores_gemma":[0.99705374,0.0014158093,0.0006370637,0.00040288645,0.00032575268,0.00016473322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026966932,0.00041013106,0.004774544,0.00070649944,0.00009626144,0.000059857935,0.00018955207,0.0001252187,0.0000432061],"category_scores_gemma":[0.0008784405,0.00023724273,0.0007476486,0.0014655502,0.00014127954,0.00014735742,0.00013602468,0.00024299478,0.0000057580423],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008606635,0.00018662501,0.0001901346,0.90543234,0.0862881,7.743293e-7,0.00005772072,0.0000022764152,4.2011771e-7,0.00019188972,0.000043660162,0.007597462],"study_design_scores_gemma":[0.00091249397,0.00041248935,0.009460065,0.084295064,0.89306486,4.6689144e-7,0.00007662282,0.00020400631,0.0000022922181,0.00037833673,0.01081167,0.00038163795],"about_ca_topic_score_codex":0.000009444995,"about_ca_topic_score_gemma":0.00002245786,"teacher_disagreement_score":0.82113725,"about_ca_system_score_codex":0.000051344174,"about_ca_system_score_gemma":0.00012207306,"threshold_uncertainty_score":0.96744776},"labels":[],"label_agreement":null},{"id":"W4315752826","doi":"10.1111/dom.14973","title":"Patient perspectives and experiences with basal insulin titration in type 2 diabetes in the United States: A cross‐sectional survey","year":2023,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Sanofi","keywords":"Medicine; Cross-sectional study; Type 2 diabetes; Basal insulin; Basal (medicine); Diabetes mellitus; Family medicine; Endocrinology; Pathology","score_opus":0.019274948283101334,"score_gpt":0.252886190038437,"score_spread":0.23361124175533565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315752826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988113,0.0033795668,3.7202875e-7,0.007315181,0.00020946993,0.00080436526,0.000067146386,0.000041447085,0.0000694763],"genre_scores_gemma":[0.95205045,0.001356254,0.000039838313,0.043210343,0.0003082658,0.00033831142,0.0024293452,0.00004100204,0.00022618368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979342,0.0003386412,0.00030477086,0.0005498585,0.0004210414,0.00045144025],"domain_scores_gemma":[0.999079,0.0003825041,0.000117974996,0.00022737219,0.00013770726,0.00005545153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061974366,0.0003433953,0.00052254763,0.00058964634,0.00011383654,0.00018768564,0.00010138091,0.0002464732,0.00002451612],"category_scores_gemma":[0.00014128257,0.0002256521,0.000044603046,0.0008413762,0.00028639304,0.00017156405,0.00007036634,0.0006210363,0.0000071388636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006077958,0.00026287846,0.9747559,0.00020035397,0.00019785854,0.000057032823,0.015478745,0.000009321655,0.000003378778,0.000027945067,0.008583176,0.00036264557],"study_design_scores_gemma":[0.001169823,0.00034100199,0.9800784,0.00012497384,0.000096001924,4.747488e-7,0.00439991,0.00022628382,0.000028703276,0.000090802976,0.013187315,0.00025629022],"about_ca_topic_score_codex":0.0005188494,"about_ca_topic_score_gemma":0.0003337756,"teacher_disagreement_score":0.03606252,"about_ca_system_score_codex":0.00004897752,"about_ca_system_score_gemma":0.00005354734,"threshold_uncertainty_score":0.9201825},"labels":[],"label_agreement":null},{"id":"W4317871404","doi":"10.1111/dom.14987","title":"Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetes","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Placebo; Tolerability; Medicine; Nausea; Adverse effect; Vomiting; Type 1 diabetes; Insulin; Internal medicine; Diabetes mellitus; Type 2 diabetes; Anesthesia; Endocrinology","score_opus":0.02025264063125084,"score_gpt":0.2784638522499135,"score_spread":0.2582112116186627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317871404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943823,0.0042456705,0.0000037720863,0.00022606259,0.000040461913,0.0008620809,0.0001275101,0.000021680455,0.000090467125],"genre_scores_gemma":[0.9954068,0.003457387,0.00018444982,0.000040827646,0.000025527437,0.000038736256,0.0002698021,0.000014408577,0.0005620614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988646,0.00006741171,0.0002715408,0.0002516301,0.00022162266,0.00032321337],"domain_scores_gemma":[0.99872684,0.0007205001,0.00009632804,0.000254962,0.00012222728,0.000079115205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005742734,0.00016672496,0.0007923726,0.0006415889,0.00007058728,0.000018881117,0.00008928342,0.0000744897,0.00002157516],"category_scores_gemma":[0.00013433775,0.000092922266,0.00010769522,0.0020466275,0.00021212077,0.000060179715,0.000050357758,0.00007903934,0.0000010502517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014984315,0.0004095154,0.9308353,0.00021483334,0.0033496777,8.951712e-7,0.0007833658,0.00010829488,0.0010707537,0.00020435803,0.000063781816,0.062809356],"study_design_scores_gemma":[0.0029792879,0.00050340436,0.97719675,0.00007431734,0.0034143352,3.383584e-8,0.00023037786,0.0025181384,0.002935178,0.00005862524,0.009987926,0.00010164606],"about_ca_topic_score_codex":0.000034527642,"about_ca_topic_score_gemma":0.000034780744,"teacher_disagreement_score":0.062707715,"about_ca_system_score_codex":0.000014631454,"about_ca_system_score_gemma":0.000036143985,"threshold_uncertainty_score":0.378926},"labels":[],"label_agreement":null},{"id":"W4318168210","doi":"10.1111/dom.14990","title":"Safety and tolerability of semaglutide across the <scp>SUSTAIN</scp> and <scp>PIONEER</scp> phase <scp>IIIa</scp> clinical trial programmes","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ted Rogers Centre for Heart Research; University of Toronto","funders":"Novo Nordisk; Steno Diabetes Center Copenhagen","keywords":"Semaglutide; Medicine; Tolerability; Placebo; Adverse effect; Dulaglutide; Internal medicine; Clinical trial; Diabetes mellitus; Type 2 diabetes; Pharmacology; Exenatide; Endocrinology; Liraglutide","score_opus":0.02576372130846005,"score_gpt":0.327358820115485,"score_spread":0.30159509880702495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318168210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98532116,0.009191479,0.000021524518,0.00039002384,0.0006702547,0.0031954779,0.00019705211,0.00027354874,0.00073949003],"genre_scores_gemma":[0.9875181,0.0060938816,0.00037709685,0.00063728506,0.00065207883,0.00024301968,0.00022926554,0.00006887158,0.004180427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99525285,0.00047214903,0.001238811,0.0010534124,0.000631961,0.0013508315],"domain_scores_gemma":[0.994031,0.003758249,0.00046139353,0.00084491813,0.0002586564,0.0006458003],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004211858,0.0006296865,0.001845003,0.00020853916,0.0005889589,0.00021853727,0.00027567745,0.00037527306,0.000004200611],"category_scores_gemma":[0.0048884964,0.00045435474,0.00040552433,0.00076961843,0.0012006921,0.000288977,0.0006854952,0.00055201654,0.000018133791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004870557,0.0067948014,0.7284037,0.0023403962,0.0034846321,0.00009248519,0.009957737,0.000009928801,0.00080665515,0.003876057,0.015018377,0.22872819],"study_design_scores_gemma":[0.047329452,0.0012489869,0.6561965,0.00012636128,0.0019444716,0.0000036199142,0.004198906,0.00047553072,0.0019072556,0.0015967399,0.28488418,0.00008801138],"about_ca_topic_score_codex":0.00006528309,"about_ca_topic_score_gemma":0.000026876587,"teacher_disagreement_score":0.2698658,"about_ca_system_score_codex":0.00003416459,"about_ca_system_score_gemma":0.00010702406,"threshold_uncertainty_score":0.99979085},"labels":[],"label_agreement":null},{"id":"W4318754175","doi":"10.1111/dom.14997","title":"Glucagon‐like peptide 1 receptor agonists in patients with type 2 diabetes with and without chronic heart failure: A meta‐analysis of randomized placebo‐controlled outcome trials","year":2023,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Fundação para a Ciência e a Tecnologia","keywords":"Medicine; Internal medicine; Hazard ratio; Heart failure; Placebo; Type 2 diabetes; Randomized controlled trial; Diabetes mellitus; Confidence interval; Meta-analysis; Endocrinology; Pathology","score_opus":0.03912709330418561,"score_gpt":0.3085626076375541,"score_spread":0.2694355143333685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318754175","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15562585,0.83471096,0.0000014940082,0.000068721725,0.00013793426,0.009156255,0.00018078019,0.000083877305,0.000034128996],"genre_scores_gemma":[0.007471492,0.9853548,0.0011205615,0.0001633846,0.00011946962,0.0026930526,0.0014442377,0.00017835038,0.0014546898],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9935504,0.0016759423,0.002180338,0.0010594147,0.0007252513,0.0008086094],"domain_scores_gemma":[0.995227,0.0019223292,0.0015304289,0.00074066786,0.00025217934,0.00032740057],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.004543639,0.0011869238,0.029426621,0.0018309148,0.00010713455,0.00011736714,0.0001929315,0.00035007324,0.00011453861],"category_scores_gemma":[0.0007540062,0.00064292795,0.0026414243,0.0018681136,0.00038923434,0.00019059727,0.00017410328,0.00042143808,0.000016794227],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016003715,0.0010423884,0.07152537,0.02214981,0.8763078,0.0000041803005,0.0001589513,0.0000072711427,0.0000023306511,0.00013079247,0.00022308055,0.012444303],"study_design_scores_gemma":[0.18218733,0.0004228067,0.006771306,0.0021108733,0.7508198,1.3115601e-7,0.000012715542,0.00002262235,0.0000060306315,0.000010429557,0.057002854,0.00063306757],"about_ca_topic_score_codex":0.00004255573,"about_ca_topic_score_gemma":0.00013787307,"teacher_disagreement_score":0.16618362,"about_ca_system_score_codex":0.000091362475,"about_ca_system_score_gemma":0.00021699611,"threshold_uncertainty_score":0.9996022},"labels":[],"label_agreement":null},{"id":"W4318755799","doi":"10.1111/dom.15000","title":"Sulphonylureas versus metformin and the risk of ventricular arrhythmias among people with type 2 diabetes: A population‐based cohort study","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé; Faculty of Medicine and Health, University of Sydney; McGill University","keywords":"Metformin; Medicine; Hazard ratio; Type 2 diabetes; Internal medicine; Confidence interval; Cohort; Proportional hazards model; Cohort study; Propensity score matching; Population; Diabetes mellitus; Combination therapy; Relative risk; Lower risk; Endocrinology; Insulin","score_opus":0.007082311232602926,"score_gpt":0.21893171097360017,"score_spread":0.21184939974099726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318755799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99556816,0.0019906668,0.0000027533,0.00008855345,0.0001789601,0.0019405452,0.00001819044,0.000085464555,0.00012668139],"genre_scores_gemma":[0.9989496,0.00032629856,0.00011412919,0.00004956473,0.00006512819,0.00016960209,0.00013321584,0.000023698514,0.00016877253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985087,0.00015869946,0.00025280484,0.000341444,0.00039427594,0.0003440625],"domain_scores_gemma":[0.9988619,0.0003276502,0.00017538361,0.00039756572,0.00010584701,0.00013162142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009326629,0.00024141681,0.0007485996,0.00023260029,0.00018456856,0.000040556402,0.000076091346,0.000060446426,0.000020339081],"category_scores_gemma":[0.00022035686,0.00014415881,0.000099052006,0.0008383615,0.0001491457,0.00012490754,0.00009304119,0.00012997487,0.00000777522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022599277,0.00024312975,0.99595076,0.00009521165,0.0014010594,0.000013564433,0.00031300817,0.000038052924,0.0000044465623,0.00016182443,0.00006288632,0.0014900493],"study_design_scores_gemma":[0.009910437,0.00033803895,0.98267794,0.000047679998,0.0047671027,2.5524525e-7,0.000263747,0.0011340713,0.00022740864,0.00009789459,0.000380374,0.00015502886],"about_ca_topic_score_codex":0.00039825487,"about_ca_topic_score_gemma":0.00013842617,"teacher_disagreement_score":0.013272813,"about_ca_system_score_codex":0.000018037248,"about_ca_system_score_gemma":0.00002402981,"threshold_uncertainty_score":0.58786255},"labels":[],"label_agreement":null},{"id":"W4319059252","doi":"10.1111/dom.15002","title":"Effects of somatostatin receptor type 2 antagonism during insulin‐induced hypoglycaemia in male rats with prediabetes","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"iCo Therapeutics (Canada); York University","funders":"Breakthrough T1D Canada; Canadian Glycomics Network; Natural Sciences and Engineering Research Council of Canada","keywords":"Internal medicine; Endocrinology; Glucagon; Medicine; Insulin; Prediabetes; Type 2 diabetes; Somatostatin; Streptozotocin; Diabetes mellitus","score_opus":0.008441693927555779,"score_gpt":0.23518134370661758,"score_spread":0.2267396497790618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319059252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966139,0.0016468009,3.5517022e-7,0.00017134924,0.00022843627,0.00087111857,0.0000146882185,0.00010776195,0.00034556733],"genre_scores_gemma":[0.9972606,0.00080171303,0.0002342738,0.00006870263,0.00011966436,0.00005831517,0.0000727474,0.000038483147,0.0013455078],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998168,0.000107823,0.00029224006,0.00038933795,0.0003999457,0.0006426796],"domain_scores_gemma":[0.99912924,0.00021761378,0.00009607899,0.0002560286,0.00011111957,0.00018989887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041491733,0.0002379364,0.00065107434,0.00054908084,0.00009270292,0.00003436767,0.0001343196,0.00013116983,0.000034619126],"category_scores_gemma":[0.00024231574,0.00018955836,0.00006101054,0.001157678,0.0001386468,0.00019185717,0.00017749022,0.00028796043,0.000058756465],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019401025,0.0003163914,0.4350801,0.0028458808,0.00019033311,0.00005768042,0.0005076547,0.000003225534,0.5547946,0.00014485518,0.00024960237,0.0056156255],"study_design_scores_gemma":[0.0023575777,0.0001988257,0.6144973,0.00027666683,0.00009314347,4.2018502e-7,0.00006185982,0.00011122624,0.38176334,0.000079587124,0.0004095238,0.00015053777],"about_ca_topic_score_codex":0.000013443229,"about_ca_topic_score_gemma":0.0000030843917,"teacher_disagreement_score":0.17941716,"about_ca_system_score_codex":0.000018496727,"about_ca_system_score_gemma":0.000062653744,"threshold_uncertainty_score":0.77299654},"labels":[],"label_agreement":null},{"id":"W4319460681","doi":"10.1111/dom.15009","title":"Comparative efficacy of <scp>sodium‐glucose</scp> co‐transporter‐2 inhibitors, <scp>glucagon‐like</scp> peptide‐1 receptor agonists and non‐steroidal mineralocorticoid receptor antagonists in chronic kidney disease and type 2 diabetes: A systematic review and network <scp>meta‐analysis</scp>","year":2023,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Mace; Internal medicine; Type 2 diabetes; Kidney disease; Mineralocorticoid receptor; Glucagon-like peptide 1 receptor; Myocardial infarction; Endocrinology; Gastroenterology; Diabetes mellitus; Percutaneous coronary intervention; Receptor","score_opus":0.026744199475365646,"score_gpt":0.28922584845590626,"score_spread":0.2624816489805406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319460681","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2039371,0.7866764,0.0000022468348,0.000043569995,0.0003680087,0.0078878,0.00087765383,0.00013668906,0.00007050431],"genre_scores_gemma":[0.005005419,0.985443,0.00023497942,0.00059573544,0.00045670252,0.0014572446,0.0045747366,0.00020827597,0.002023918],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99089146,0.0011513577,0.0030428036,0.00220263,0.00089760195,0.0018141476],"domain_scores_gemma":[0.9919747,0.0025056875,0.0020293484,0.0013387491,0.00030504016,0.0018464718],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0020585377,0.0021725437,0.015941761,0.001206752,0.00033987555,0.00032426443,0.00046767632,0.0006296232,0.000017589178],"category_scores_gemma":[0.0010992083,0.0017290729,0.0016832774,0.002635575,0.0008033293,0.0004433304,0.00044618413,0.0009285501,0.00006002992],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010233589,0.0010498605,0.0111769475,0.88092214,0.090001464,0.0000697944,0.0010296279,0.0000041597514,0.00010414675,0.00005773718,0.014061606,0.001512289],"study_design_scores_gemma":[0.0039555402,0.00063002226,0.017845202,0.12475388,0.61734414,0.0000052966157,0.00016296969,0.000089926034,0.0001458903,0.00003536798,0.23447672,0.0005550734],"about_ca_topic_score_codex":0.000045525547,"about_ca_topic_score_gemma":0.000052292766,"teacher_disagreement_score":0.75616825,"about_ca_system_score_codex":0.00020071577,"about_ca_system_score_gemma":0.0005326693,"threshold_uncertainty_score":0.9991015},"labels":[],"label_agreement":null},{"id":"W4320494607","doi":"10.1111/dom.15011","title":"A cross‐sectional study of the prevalence and clinical management of atherosclerotic cardiovascular diseases in patients with type 2 diabetes across the Middle East and Africa ( <scp>PACT‐MEA</scp> ): Study design and rationale","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novo Nordisk","keywords":"Medicine; Reimbursement; Cross-sectional study; Guideline; Type 2 diabetes; Observational study; Family medicine; Epidemiology; Pact; Disease management; Diabetes mellitus; Disease; Health care; Internal medicine; Pathology","score_opus":0.03878253715765891,"score_gpt":0.25464470283110024,"score_spread":0.21586216567344133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320494607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98619336,0.01038916,0.000002958715,0.000006038297,0.00010610715,0.0032234804,0.000052685868,0.000019281371,0.0000069210882],"genre_scores_gemma":[0.9989237,0.0007483866,0.00004345928,0.000015070745,0.0000456808,0.00012766928,0.0000058112114,0.000020393281,0.00006978806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975945,0.00054346863,0.0003981588,0.00047950994,0.00067430025,0.00031007716],"domain_scores_gemma":[0.99874514,0.00032833524,0.00013371595,0.00050234486,0.00017315325,0.00011728388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018352434,0.00021752073,0.0007210035,0.00007462561,0.00024380875,0.000064944295,0.00013398212,0.00006604106,0.0000016970126],"category_scores_gemma":[0.0002671847,0.0001317451,0.0001501503,0.00045535265,0.0004885436,0.00013423838,0.00029122198,0.00017483156,6.130003e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042781492,0.0013286545,0.9881546,0.00048548277,0.0019887704,0.0000017689763,0.0029208178,0.000077831406,0.0000035899798,0.0000044685216,0.000004752757,0.0049864897],"study_design_scores_gemma":[0.0052510877,0.0006414181,0.99033505,0.00014886018,0.001687009,2.7956457e-7,0.0016187689,0.00009126805,0.00002136747,0.00004980291,0.00007407716,0.0000810094],"about_ca_topic_score_codex":0.000081447484,"about_ca_topic_score_gemma":0.00002272132,"teacher_disagreement_score":0.012730374,"about_ca_system_score_codex":0.000008833095,"about_ca_system_score_gemma":0.000026168616,"threshold_uncertainty_score":0.5372409},"labels":[],"label_agreement":null},{"id":"W4320709102","doi":"10.1111/dom.15019","title":"Efficacy and safety of sotagliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; University of Toronto; Diabetes Canada; Heart and Stroke Foundation of Canada; Department of Medicine, University of Toronto; Sanofi","keywords":"Albuminuria; Medicine; Placebo; Renal function; Internal medicine; Kidney disease; Creatinine; Diabetes mellitus; Type 2 diabetes; Urology; Gastroenterology; Clinical trial; Endocrinology; Pathology","score_opus":0.005905114787099368,"score_gpt":0.21212779298316764,"score_spread":0.20622267819606827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320709102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949997,0.0037587895,3.4828898e-7,0.00017588855,0.00007580632,0.0007367907,0.00008200706,0.000051343406,0.00011930523],"genre_scores_gemma":[0.9974924,0.0014678629,0.00006345489,0.00021917131,0.000035588426,0.000021210546,0.00023671189,0.000021644306,0.00044198762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886024,0.00004199087,0.00020162195,0.0003321845,0.00019741643,0.0003665397],"domain_scores_gemma":[0.99924517,0.00007014192,0.00006954844,0.00021754157,0.00005101609,0.0003466065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019216428,0.00020749141,0.00048349163,0.0002342206,0.000064170956,0.000023173705,0.00004545617,0.00005045158,0.000024262466],"category_scores_gemma":[0.00011237083,0.00016067331,0.000028219467,0.00035915707,0.00016458199,0.00014019296,0.00013496872,0.0000904267,0.000005838306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001842091,0.00032263604,0.9873956,0.00064424606,0.00020380953,0.000004494064,0.00013165819,0.0000027692158,0.00017629692,0.00034999495,0.0001625276,0.0104217455],"study_design_scores_gemma":[0.007822927,0.00029415896,0.983989,0.00025128148,0.000441439,1.3724508e-8,0.000016291298,0.00012261275,0.00036219426,0.00006582868,0.006471812,0.00016244239],"about_ca_topic_score_codex":0.0000076128545,"about_ca_topic_score_gemma":0.0000039164324,"teacher_disagreement_score":0.010259303,"about_ca_system_score_codex":0.000018953087,"about_ca_system_score_gemma":0.00004982738,"threshold_uncertainty_score":0.65520674},"labels":[],"label_agreement":null},{"id":"W4321499324","doi":"10.1111/dom.15025","title":"Use of the <scp>FreeStyle Libre</scp> system and diabetes treatment progression in <scp>T2DM</scp> : Results from a retrospective cohort study using a <scp>Canadian</scp> private payer claims database","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"Abbott Diabetes Care","keywords":"Medicine; Diabetes mellitus; Retrospective cohort study; Cohort; Internal medicine; Database; Demography; Endocrinology","score_opus":0.03040760601775555,"score_gpt":0.26918374932032846,"score_spread":0.2387761433025729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321499324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990708,0.002469541,0.0000010697441,0.000077964636,0.00040836557,0.0046829614,0.0010801384,0.00017522684,0.00039674566],"genre_scores_gemma":[0.99636185,0.0006386222,0.000266959,0.00008955052,0.0002500465,0.00026952455,0.00041400452,0.00009275642,0.0016167103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99455565,0.000691025,0.0008558878,0.0013020542,0.0010902988,0.0015050623],"domain_scores_gemma":[0.9956279,0.0017443742,0.00041415266,0.0012742213,0.00023951798,0.00069986016],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001978892,0.0006558555,0.0015247996,0.00092919084,0.00050055614,0.00031394482,0.00040796457,0.0002909763,0.0000025540264],"category_scores_gemma":[0.0024913668,0.00045674722,0.00021179138,0.0019075299,0.00039992091,0.00064374413,0.0008395792,0.0005808823,0.000019583145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007655151,0.00079331116,0.98874795,0.0003329386,0.0008000376,0.00007962875,0.0024220364,0.000014832104,0.004163908,0.00012723032,0.0011134378,0.0013970322],"study_design_scores_gemma":[0.004216146,0.00034406877,0.97502697,0.0010022387,0.0010163632,7.0705164e-7,0.0021021233,0.0037823291,0.0066490932,0.00013153223,0.005649392,0.000079049845],"about_ca_topic_score_codex":0.0046500405,"about_ca_topic_score_gemma":0.0019542729,"teacher_disagreement_score":0.013720996,"about_ca_system_score_codex":0.0002781032,"about_ca_system_score_gemma":0.00022128386,"threshold_uncertainty_score":0.9997884},"labels":[],"label_agreement":null},{"id":"W4321499386","doi":"10.1111/dom.15026","title":"Association between residual islet beta‐cell function and achieving the target of time in range in inpatients with type 2 diabetes undergoing antidiabetic treatment: An observation study","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Natural Science Foundation of Shandong Province; National Natural Science Foundation of China","keywords":"Medicine; Insulin; Internal medicine; tar (computing); Diabetes mellitus; Logistic regression; Confounding; Type 2 diabetes; Endocrinology; Islet; Type 1 diabetes","score_opus":0.017127201436341492,"score_gpt":0.2306486240206104,"score_spread":0.2135214225842689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321499386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979546,0.00087768055,8.625881e-7,0.00018298444,0.000076247845,0.0007597744,0.000021486881,0.00005045354,0.00007587826],"genre_scores_gemma":[0.9990569,0.00023201508,0.00007859538,0.000093875766,0.00008726535,0.000037595615,0.00018983775,0.000021049054,0.00020289901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835235,0.00034703838,0.00034814372,0.0003198019,0.0002937473,0.00033893014],"domain_scores_gemma":[0.99885297,0.0005886967,0.00018742876,0.00020148205,0.000087081164,0.00008233365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095301034,0.00020594355,0.0006079813,0.00033795726,0.00011528541,0.000035180386,0.00005028158,0.0001115015,0.000013416415],"category_scores_gemma":[0.00022616597,0.00014730616,0.000030188532,0.0008484657,0.00005035194,0.00030525096,0.000038113045,0.0001528585,0.0000076030997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005378515,0.00041439245,0.99292177,0.000102301,0.00016281629,9.104471e-7,0.0011510848,0.00002438414,0.0043578185,0.0000052570304,0.000015670888,0.0007898227],"study_design_scores_gemma":[0.0042207465,0.0010476265,0.98986757,0.00011020394,0.000595364,4.2950788e-8,0.00044630695,0.00045103027,0.0029430662,0.00012090075,0.000058221474,0.0001389223],"about_ca_topic_score_codex":0.00010398675,"about_ca_topic_score_gemma":0.000053756543,"teacher_disagreement_score":0.004166961,"about_ca_system_score_codex":0.00006130698,"about_ca_system_score_gemma":0.000051774125,"threshold_uncertainty_score":0.60069704},"labels":[],"label_agreement":null},{"id":"W4328048371","doi":"10.1111/dom.15057","title":"Cardiovascular and kidney outcomes with canagliflozin according to type 2 diabetes treatment targets at baseline: Data from the <scp>CANVAS</scp> programme and <scp>CREDENCE</scp>","year":2023,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Hospital; University of Manitoba; NOSM University; McGill University Health Centre","funders":"Janssen Canada; Mitsubishi Tanabe Pharma Corporation","keywords":"Canagliflozin; Medicine; Empagliflozin; Internal medicine; Type 2 diabetes; Nephropathy; Type 2 Diabetes Mellitus; Diabetes mellitus; Diabetic nephropathy; Creatinine; Post-hoc analysis; Kidney disease; Endocrinology","score_opus":0.031398394816738076,"score_gpt":0.2413543484380646,"score_spread":0.20995595362132652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4328048371","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9039095,0.058147036,0.00000821559,0.03091393,0.0008578248,0.0033798069,0.002292193,0.0003065059,0.0001849771],"genre_scores_gemma":[0.097453706,0.073150806,0.008816058,0.6832999,0.015503477,0.0038424607,0.069209315,0.0017238109,0.04700046],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99450684,0.00033089277,0.00053781446,0.0020018215,0.00096634985,0.0016562879],"domain_scores_gemma":[0.99465597,0.0018111342,0.00024442354,0.002241946,0.00017557919,0.0008709777],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010018789,0.0012688374,0.0025098117,0.00033787097,0.0005557697,0.00045035413,0.0005897686,0.00052465644,0.0000125855595],"category_scores_gemma":[0.0014202435,0.00080134446,0.00031635366,0.000526677,0.0003073415,0.000316404,0.0014282966,0.0006806331,0.00006560411],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000044413746,0.00013660153,0.5608813,0.0004611766,0.010804211,0.00021790556,0.00045746335,0.0000022203715,0.000048024343,0.000008320548,0.41645235,0.010525968],"study_design_scores_gemma":[0.0022627984,0.0002946233,0.1952863,0.0003618917,0.01085804,0.0000024649296,0.0003000315,0.00009512547,0.0002862994,0.000040416006,0.7900139,0.00019813099],"about_ca_topic_score_codex":0.0020781583,"about_ca_topic_score_gemma":0.000432112,"teacher_disagreement_score":0.8064558,"about_ca_system_score_codex":0.00015692909,"about_ca_system_score_gemma":0.00019560261,"threshold_uncertainty_score":0.99944377},"labels":[],"label_agreement":null},{"id":"W4353021269","doi":"10.1111/dom.15058","title":"Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of <scp>SOUL</scp> , a randomized trial","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Novo Nordisk","keywords":"Semaglutide; Medicine; Type 2 diabetes; Randomized controlled trial; Kidney disease; Disease; Diabetes mellitus; Internal medicine; Physical therapy; Endocrinology","score_opus":0.011004047311891228,"score_gpt":0.22011931855942451,"score_spread":0.2091152712475333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353021269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96825814,0.027129311,0.00004464584,0.000062123065,0.00013125878,0.0042128093,0.00009916138,0.000058113426,0.0000044346343],"genre_scores_gemma":[0.9895139,0.009160538,0.00043151123,0.00013705489,0.000070991395,0.00038135765,0.00013509158,0.00005084964,0.00011873042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997158,0.00070860755,0.00047741496,0.0005921176,0.00056640856,0.0004974379],"domain_scores_gemma":[0.99725467,0.0014330272,0.00016625552,0.00049542834,0.00009556523,0.0005550469],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023087026,0.00044252162,0.00276498,0.0004338856,0.000076017954,0.000057858964,0.00008401824,0.00009689508,0.0000030800052],"category_scores_gemma":[0.003230186,0.0002999853,0.00035736457,0.00046272486,0.00038321177,0.0001464336,0.00015266264,0.00014292689,0.0000011936548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038132984,0.0021777907,0.8819379,0.013301203,0.033471774,0.00019406233,0.0009589414,0.00021047301,0.0007176339,0.00026697974,0.00021041665,0.028419843],"study_design_scores_gemma":[0.28406268,0.000536019,0.6965424,0.0007801822,0.015108157,2.1457402e-7,0.00001965513,0.001093345,0.00081191974,0.00011298682,0.00075133436,0.00018113074],"about_ca_topic_score_codex":0.00002277306,"about_ca_topic_score_gemma":7.583735e-7,"teacher_disagreement_score":0.2459297,"about_ca_system_score_codex":0.000021426433,"about_ca_system_score_gemma":0.00012595445,"threshold_uncertainty_score":0.9999452},"labels":[],"label_agreement":null},{"id":"W4361190342","doi":"10.1111/dom.15065","title":"Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: Integrated analysis from the <scp>CANVAS</scp> Program and <scp>CREDENCE</scp> trial","year":2023,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec; University of British Columbia","funders":"","keywords":"Medicine; Kidney disease; Diabetology; Library science; George (robot); Family medicine; Internal medicine; Diabetes mellitus; History; Art history; Endocrinology","score_opus":0.005120574803165702,"score_gpt":0.20186903255608327,"score_spread":0.19674845775291758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361190342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839161,0.0077635576,0.000004078552,0.0014596569,0.0003095758,0.00531358,0.0011349476,0.000086953325,0.000011540992],"genre_scores_gemma":[0.9609013,0.0032640495,0.00018788183,0.019394381,0.0018629342,0.002091368,0.011200788,0.00023964273,0.00085763936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961023,0.00047239437,0.0004396416,0.0012157374,0.0009785112,0.00079143164],"domain_scores_gemma":[0.9975423,0.0003776009,0.0002896999,0.0007206428,0.00012877988,0.0009409706],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033015077,0.00088051695,0.0020873095,0.00046032577,0.0001829519,0.00016005414,0.00019117848,0.00029557216,0.0000043115147],"category_scores_gemma":[0.0005633181,0.00054822606,0.0003161227,0.0007056299,0.00048212954,0.00019004525,0.00018596346,0.00066050846,0.0000011471293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092861394,0.0007140824,0.9655694,0.0017626185,0.016562667,0.00011033913,0.0003364308,0.0000071663144,0.000006181472,0.0000053080407,0.011080444,0.0029167654],"study_design_scores_gemma":[0.04088303,0.0009786304,0.8751115,0.0013614475,0.031561114,1.3938586e-7,0.000027954642,0.00012924,0.000020039988,0.000027808755,0.049734432,0.00016463282],"about_ca_topic_score_codex":0.001048034,"about_ca_topic_score_gemma":0.00015639086,"teacher_disagreement_score":0.09045786,"about_ca_system_score_codex":0.00009886133,"about_ca_system_score_gemma":0.00035498402,"threshold_uncertainty_score":0.9996969},"labels":[],"label_agreement":null},{"id":"W4361191084","doi":"10.1111/dom.15063","title":"Ultra rapid lispro showed greater reduction in postprandial glucose versus Humalog in children, adolescents and adults with type 1 diabetes mellitus","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Eli Lilly and Company","keywords":"Insulin lispro; Postprandial; Medicine; Tolerability; Crossover study; Type 1 diabetes; Meal; Internal medicine; Diabetes mellitus; Bolus (digestion); Endocrinology; Insulin; Adverse effect; Placebo","score_opus":0.011533707238199057,"score_gpt":0.2382628710976963,"score_spread":0.22672916385949726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361191084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99252325,0.0057280017,9.965088e-8,0.00024038996,0.0002981397,0.00094518973,0.000013272812,0.000083201,0.00016842375],"genre_scores_gemma":[0.99613005,0.0032529589,0.000032476037,0.00006945563,0.00019469453,0.00004361066,0.0001338464,0.000032311473,0.000110605804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799746,0.00011363479,0.00025886262,0.0005618453,0.00034039127,0.0007278324],"domain_scores_gemma":[0.9993645,0.000038547012,0.00005569122,0.00025166306,0.00008706536,0.0002025185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005583072,0.00027095468,0.000533929,0.0008915289,0.000101137804,0.00007496253,0.00010289506,0.00015356363,0.000027224423],"category_scores_gemma":[0.00010584773,0.00021627577,0.0000459626,0.0012302768,0.00020999822,0.00026029474,0.00009419436,0.00035939898,0.000028891141],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014043942,0.0002586154,0.9652954,0.0003320214,0.0001316214,0.000015323983,0.00052024546,0.0000027575168,0.0021940842,0.000027868822,0.000054495933,0.029763177],"study_design_scores_gemma":[0.010127652,0.00054504786,0.9832941,0.0005400067,0.00014184843,7.226069e-7,0.00013078735,0.00010409133,0.0046027196,0.000055780147,0.00020658261,0.00025066058],"about_ca_topic_score_codex":0.00003538757,"about_ca_topic_score_gemma":0.00002136767,"teacher_disagreement_score":0.029512517,"about_ca_system_score_codex":0.000025472324,"about_ca_system_score_gemma":0.000031629428,"threshold_uncertainty_score":0.881947},"labels":[],"label_agreement":null},{"id":"W4362601025","doi":"10.1111/dom.15081","title":"Semaglutide reduces the risk of major adverse cardiovascular events consistently across baseline triglyceride levels in patients with type 2 diabetes: Post hoc analyses of the <scp>SUSTAIN</scp> 6 and <scp>PIONEER</scp> 6 trials","year":2023,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novo Nordisk","keywords":"Semaglutide; Post-hoc analysis; Type 2 diabetes; Medicine; Triglyceride; Diabetes mellitus; Adverse effect; Internal medicine; Baseline (sea); Post hoc; Endocrinology; Cholesterol; Liraglutide; Biology","score_opus":0.024800301952432297,"score_gpt":0.2642104988669024,"score_spread":0.2394101969144701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362601025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739447,0.019072847,0.0000014091562,0.0014981343,0.00057295803,0.0029955767,0.0018231203,0.000050233026,0.00004101885],"genre_scores_gemma":[0.9787587,0.0043757115,0.00020349008,0.011654954,0.00071023963,0.0002449711,0.0011371821,0.00019363323,0.002721108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99389815,0.0016121189,0.0013133025,0.0008957846,0.001252627,0.0010279856],"domain_scores_gemma":[0.9932774,0.0032938884,0.0013092101,0.0012457672,0.0007014959,0.0001722865],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0038076304,0.0008440306,0.0034672972,0.0004756377,0.00028550596,0.00005613032,0.00043895986,0.00050925877,0.0000066316256],"category_scores_gemma":[0.0060519073,0.0004727539,0.0010843279,0.0011555346,0.00062600814,0.00017229091,0.00047856604,0.0009009514,0.0000058169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008444538,0.00085814233,0.9221317,0.0031370593,0.029554222,0.000051093484,0.0016662349,0.00011876385,0.0004978854,0.000008887167,0.036524218,0.0053673047],"study_design_scores_gemma":[0.00821256,0.00037450815,0.9191238,0.0009231804,0.018642088,5.152147e-7,0.00094518013,0.000021607786,0.0048800507,0.00007016673,0.04664753,0.00015876703],"about_ca_topic_score_codex":0.00022679858,"about_ca_topic_score_gemma":0.000031460364,"teacher_disagreement_score":0.014697136,"about_ca_system_score_codex":0.00006626187,"about_ca_system_score_gemma":0.00017436121,"threshold_uncertainty_score":0.9997724},"labels":[],"label_agreement":null},{"id":"W4364352053","doi":"10.1111/dom.15083","title":"Control of human pancreatic beta cell kinome by glucagon‐like peptide‐1 receptor biased agonism","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Medical Research Council; Diabetes UK; UK Research and Innovation; European Foundation for the Study of Diabetes; Eli Lilly and Company","keywords":"Kinome; Agonist; Medicine; Glucagon-like peptide 1 receptor; Receptor; Glucagon-like peptide-1; Internal medicine; Beta cell; Endocrinology; BETA (programming language); Beta adrenergic receptor kinase; Pharmacology; Cell biology; Kinase; G protein-coupled receptor; Biology; Diabetes mellitus; Type 2 diabetes","score_opus":0.010038426379119572,"score_gpt":0.22407242030774752,"score_spread":0.21403399392862793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4364352053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99204457,0.0043181055,0.000010498426,0.0004672684,0.00026830053,0.0008170751,0.00018094297,0.00019392685,0.001699299],"genre_scores_gemma":[0.98989415,0.0006334437,0.00012845374,0.0006876699,0.00012955401,0.00009721243,0.0006024905,0.00004308659,0.007783937],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981232,0.00009216631,0.00040965906,0.00044407047,0.00033949572,0.0005913994],"domain_scores_gemma":[0.9988801,0.00012925905,0.00017758396,0.00045187783,0.00008402191,0.0002771971],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041545118,0.00032842794,0.0009581334,0.00029185548,0.0001615483,0.000040812552,0.0001449801,0.00012875278,0.0001799781],"category_scores_gemma":[0.00003293863,0.00028714864,0.00021951419,0.00039748085,0.00022167647,0.0001402886,0.00009578076,0.00014641033,0.0001591594],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008766804,0.0020556701,0.33021206,0.0016838573,0.0019231354,0.000023568604,0.0007759301,0.000003567384,0.6100326,0.003756109,0.04234766,0.0070981695],"study_design_scores_gemma":[0.013746827,0.0007084703,0.6199957,0.00024267675,0.004132939,4.3048945e-7,0.00030068852,0.00017091044,0.22117619,0.00048168268,0.13833186,0.0007116295],"about_ca_topic_score_codex":0.000101765785,"about_ca_topic_score_gemma":0.000003331651,"teacher_disagreement_score":0.38885644,"about_ca_system_score_codex":0.000023665843,"about_ca_system_score_gemma":0.000028290622,"threshold_uncertainty_score":0.99995804},"labels":[],"label_agreement":null},{"id":"W4365443628","doi":"10.1111/dom.15088","title":"Neutrophil to lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes: Post hoc analysis of the <scp>SUSTAIN</scp> 6 and <scp>PIONEER</scp> 6 cardiovascular outcomes trials","year":2023,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ted Rogers Centre for Heart Research; University of Toronto; St. Michael's Hospital","funders":"Novo Nordisk; Steno Diabetes Center Copenhagen","keywords":"Medicine; Post-hoc analysis; Type 2 diabetes; Post hoc; Diabetes mellitus; Lymphocyte; Internal medicine; Immunology; Endocrinology","score_opus":0.012677140490507957,"score_gpt":0.22541870464936944,"score_spread":0.21274156415886147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365443628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9447457,0.048275698,0.000008387549,0.0021925068,0.00079466857,0.0032178452,0.0006040466,0.00012433986,0.000036770805],"genre_scores_gemma":[0.9112231,0.012260614,0.0004391933,0.06673217,0.0028753409,0.0018314571,0.0025002523,0.00065243477,0.0014854331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99210155,0.0018059091,0.0013218432,0.001417735,0.002098725,0.0012542201],"domain_scores_gemma":[0.9942099,0.001739657,0.0005788235,0.002234788,0.0007983172,0.00043854452],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004089064,0.0010583214,0.0063319593,0.0018478443,0.00028067705,0.00010173053,0.00058396236,0.0010281779,0.0000053004414],"category_scores_gemma":[0.0053229732,0.000753236,0.003082115,0.0036398035,0.00030283764,0.00021996745,0.0005829125,0.00091959635,0.000010286578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033176828,0.00013849341,0.905981,0.0022781254,0.07696358,0.00013984766,0.001156219,0.00043496786,0.00009411881,0.00000572403,0.011751682,0.0010230467],"study_design_scores_gemma":[0.0034202496,0.00011842383,0.87442553,0.00045533857,0.056588158,0.0000024364167,0.00026805745,0.000099419296,0.00046389317,0.000021691909,0.063940905,0.00019592234],"about_ca_topic_score_codex":0.00018873489,"about_ca_topic_score_gemma":0.000053046024,"teacher_disagreement_score":0.06453966,"about_ca_system_score_codex":0.0001961322,"about_ca_system_score_gemma":0.0005236548,"threshold_uncertainty_score":0.9994919},"labels":[],"label_agreement":null},{"id":"W4365483438","doi":"10.1111/dom.15092","title":"Lower risk of cardiovascular events and death associated with initiation of sodium‐glucose cotransporter‐2 inhibitors versus sulphonylureas: Analysis from the <scp>CVD‐REAL</scp> 2 study","year":2023,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"Taipei Veterans General Hospital; Syddansk Universitet; Saint Luke's Health System; Novo Nordisk Fonden; AstraZeneca","keywords":"Medicine; Family medicine; Advisory committee; Management","score_opus":0.01354308518714901,"score_gpt":0.21625870016536491,"score_spread":0.2027156149782159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365483438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99040145,0.005998476,0.0000056831245,0.00055016775,0.00036882775,0.0014192061,0.0011034233,0.000065455046,0.00008732621],"genre_scores_gemma":[0.9895767,0.004944485,0.000032045442,0.0014430436,0.00042780963,0.00010125881,0.0032309094,0.000069843765,0.00017387736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99686253,0.00043473605,0.0005378865,0.00069049955,0.001020526,0.00045380305],"domain_scores_gemma":[0.9972949,0.0009309242,0.00062048977,0.00077799585,0.00026308824,0.00011261159],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008546203,0.0005432643,0.0021021727,0.0004519505,0.0001348431,0.00003527804,0.00018078047,0.00040626954,0.00000814413],"category_scores_gemma":[0.0002305882,0.00037301626,0.00072682404,0.00090032077,0.00014036952,0.00013055139,0.00010645491,0.00058213447,0.000002656151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042677526,0.00068742974,0.90260667,0.00015873858,0.0910865,0.000076877586,0.001135378,0.000016592558,0.000012062858,0.000002858652,0.0034086236,0.00076561986],"study_design_scores_gemma":[0.0056265257,0.0003993043,0.8643763,0.00019712679,0.12344358,5.886876e-8,0.00030532986,0.000023408633,0.00034668137,0.000038614664,0.0051077353,0.00013534862],"about_ca_topic_score_codex":0.0021157223,"about_ca_topic_score_gemma":0.0002987429,"teacher_disagreement_score":0.038230356,"about_ca_system_score_codex":0.000043681997,"about_ca_system_score_gemma":0.000054507917,"threshold_uncertainty_score":0.99987215},"labels":[],"label_agreement":null},{"id":"W4367843752","doi":"10.1111/dom.15115","title":"Cover Image","year":2023,"lang":"en","type":"paratext","venue":"Diabetes Obesity and Metabolism","topic":"Diet and metabolism studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cover (algebra); Medicine; Diabetes mellitus; Baseline (sea); Kidney disease; Front cover; Internal medicine; Political science; Engineering; Endocrinology","score_opus":0.014515633190999523,"score_gpt":0.26260200572308634,"score_spread":0.24808637253208682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367843752","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34176764,0.101795994,0.000013535796,0.0009801328,0.01236889,0.0010717462,0.0008764353,0.00029964314,0.54082596],"genre_scores_gemma":[0.009300501,0.06948928,0.0005110917,0.0021886467,0.00409862,0.00013954216,0.00093657104,0.00019599998,0.91313976],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99759966,0.000071988274,0.0004108183,0.0007036671,0.00044257735,0.0007712965],"domain_scores_gemma":[0.99862874,0.00011953302,0.00017437057,0.0005101737,0.0002207043,0.00034650476],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00034985604,0.0006074184,0.0018618623,0.000359777,0.0002224885,0.000097899814,0.00015838305,0.00048447997,0.0018859454],"category_scores_gemma":[0.0002107692,0.0005076619,0.00037517754,0.00037580033,0.0003142618,0.00014922865,0.00033435613,0.0006639545,0.038142104],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020908918,0.00013422305,0.00041124385,0.00091822795,0.0006350401,0.000019448036,0.00022717634,2.0183552e-7,0.0012439314,0.00021976467,0.99304837,0.003121458],"study_design_scores_gemma":[0.0010872559,0.000031676303,0.14768589,0.00023823006,0.0013334448,0.0000013653251,0.000036516256,0.00000535776,0.00093232415,0.00014081497,0.84807116,0.00043600146],"about_ca_topic_score_codex":0.000039153114,"about_ca_topic_score_gemma":0.0000024001977,"teacher_disagreement_score":0.37231377,"about_ca_system_score_codex":0.000018743824,"about_ca_system_score_gemma":0.00013204661,"threshold_uncertainty_score":0.9997375},"labels":[],"label_agreement":null},{"id":"W4376121968","doi":"10.1111/dom.15091","title":"<scp>The sodium‐glucose cotransporter‐2</scp> inhibitor canagliflozin does not increase risk of non‐genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the <scp>CANVAS</scp> Program and <scp>CREDENCE</scp> randomized double‐blind trials","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Janssen Research and Development","keywords":"Canagliflozin; Medicine; Hazard ratio; Placebo; Internal medicine; Proportional hazards model; Post-hoc analysis; Diabetes mellitus; Confidence interval; Type 2 diabetes; Urology; Surgery; Endocrinology; Pathology","score_opus":0.009550942729889354,"score_gpt":0.24690151203213107,"score_spread":0.23735056930224172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376121968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97590584,0.017320089,0.000014378427,0.00021569434,0.0002567276,0.005270411,0.0007725979,0.00016526054,0.00007903301],"genre_scores_gemma":[0.98412806,0.012513469,0.0002853905,0.0002672784,0.00030772528,0.0009853407,0.0010000735,0.000067381305,0.00044528831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952169,0.00097344257,0.0011619941,0.0009542887,0.0007043308,0.0009890113],"domain_scores_gemma":[0.99000186,0.007712255,0.0007208773,0.00073298905,0.00034258762,0.0004894281],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0039126715,0.00076812896,0.0031115087,0.0008537426,0.0005050628,0.0003502316,0.0002874422,0.0002982349,0.00001270119],"category_scores_gemma":[0.0025299815,0.00043125174,0.00047137242,0.0024153641,0.00080393575,0.00040196456,0.00023168387,0.0005092308,0.000011238715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020196263,0.0019477176,0.9396886,0.0005441219,0.019184433,0.000044262175,0.013009661,0.00006254696,0.0053248904,0.0001330101,0.00071311806,0.017327974],"study_design_scores_gemma":[0.12718202,0.00089869683,0.7891243,0.00027918242,0.045078438,0.0000017254234,0.00411312,0.0011369841,0.02602023,0.00043719163,0.0055462066,0.00018190515],"about_ca_topic_score_codex":0.007244038,"about_ca_topic_score_gemma":0.012384278,"teacher_disagreement_score":0.15056434,"about_ca_system_score_codex":0.00004018958,"about_ca_system_score_gemma":0.00018623732,"threshold_uncertainty_score":0.9998139},"labels":[],"label_agreement":null},{"id":"W4376132684","doi":"10.1111/dom.15106","title":"Long‐acting insulin analogues and the risk of diabetic retinopathy among patients with type 2 diabetes: A population‐based cohort study","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; McGill University","keywords":"Medicine; Insulin; NPH insulin; Hazard ratio; Internal medicine; Type 2 diabetes; Diabetes mellitus; Insulin glargine; Population; Insulin detemir; Proportional hazards model; Endocrinology; Cohort; Confidence interval","score_opus":0.006036240404913996,"score_gpt":0.220107993074998,"score_spread":0.21407175267008402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376132684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99718696,0.0011863504,8.3466745e-7,0.000025007646,0.000078410325,0.0013685898,0.000060254628,0.00005302457,0.00004055704],"genre_scores_gemma":[0.9992986,0.00021839474,0.000037048616,0.00005858025,0.000034062155,0.00006115966,0.00024327879,0.000022861463,0.000026030351],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998484,0.00026440033,0.00027966726,0.00032954954,0.00036060123,0.0002817905],"domain_scores_gemma":[0.99886066,0.0002849576,0.00022709054,0.00030176586,0.00017209728,0.00015345967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052668166,0.00021234686,0.00062565296,0.00015240592,0.00021361584,0.000035218876,0.000063794265,0.000055057826,0.00001088761],"category_scores_gemma":[0.00042704152,0.0001245859,0.00007876544,0.0005243011,0.00019438966,0.00009779704,0.00006482587,0.00014311279,0.0000042774946],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017762232,0.00048058154,0.9969988,0.00011144433,0.0004697075,0.000004063933,0.00024876365,0.000008919372,0.0000029733749,0.000007584753,0.000005077037,0.0014844604],"study_design_scores_gemma":[0.005550683,0.0003208349,0.99067694,0.000118923046,0.0023701682,5.2442115e-8,0.00009732253,0.000590791,0.00004941438,0.00009071774,0.0000059459903,0.00012822445],"about_ca_topic_score_codex":0.00031212656,"about_ca_topic_score_gemma":0.000028911183,"teacher_disagreement_score":0.0063218796,"about_ca_system_score_codex":0.000011038976,"about_ca_system_score_gemma":0.000021072217,"threshold_uncertainty_score":0.50804657},"labels":[],"label_agreement":null},{"id":"W4376613148","doi":"10.1111/dom.15112","title":"Kidney protection with canagliflozin: A combined analysis of the randomized <scp>CANVAS</scp> program and <scp>CREDENCE</scp> trials","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University of British Columbia; University Health Network","funders":"Janssen Research and Development; Mitsubishi Tanabe Pharma Corporation; American Society of Nephrology","keywords":"Canagliflozin; Medicine; Albuminuria; Renal function; Kidney disease; Empagliflozin; Internal medicine; Population; Urology; Creatinine; Kidney; Type 2 diabetes; Diabetes mellitus; Endocrinology","score_opus":0.019082076094144345,"score_gpt":0.25315936492035485,"score_spread":0.2340772888262105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376613148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916136,0.0015165005,0.000020400184,0.00046429876,0.000201366,0.0051047388,0.000077192475,0.00020296419,0.0007989141],"genre_scores_gemma":[0.99263436,0.0011267186,0.00038304942,0.00045298666,0.00010314898,0.0013021973,0.00019896342,0.000034757595,0.0037638252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972516,0.0005821638,0.00060215266,0.00050045655,0.00052861846,0.0005350425],"domain_scores_gemma":[0.99766034,0.00089419103,0.00045707688,0.000471574,0.00017706455,0.00033973804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002621721,0.00036524987,0.00232784,0.00063519797,0.0002354487,0.00010514521,0.00014429283,0.00013898294,0.000009089492],"category_scores_gemma":[0.0030808025,0.00021323978,0.00048981415,0.002134498,0.00039527979,0.00015280464,0.00015394657,0.00018950703,0.0000049704217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029568244,0.004450837,0.7672881,0.003764335,0.10217845,0.000056109675,0.009466478,0.00018383916,0.011706514,0.0074549643,0.017600605,0.072892964],"study_design_scores_gemma":[0.11640453,0.00063162716,0.7704717,0.00038045496,0.05812088,0.0000013934708,0.0009251216,0.0047463933,0.012664708,0.000848504,0.034658954,0.00014573109],"about_ca_topic_score_codex":0.0003585095,"about_ca_topic_score_gemma":0.00010646956,"teacher_disagreement_score":0.1134477,"about_ca_system_score_codex":0.000024843212,"about_ca_system_score_gemma":0.00010328521,"threshold_uncertainty_score":0.86956656},"labels":[],"label_agreement":null},{"id":"W4377223615","doi":"10.1111/dom.15122","title":"Stabilization of kidney function and reduction in heart failure events with sodium‐glucose co‐transporter 2 inhibitors: A meta‐analysis and meta‐regression analysis","year":2023,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Japan Society for the Promotion of Science","keywords":"Medicine; Renal function; Hazard ratio; Internal medicine; Meta-analysis; Meta-regression; Confidence interval; Heart failure; Diabetes mellitus; Type 2 diabetes; Placebo; Kidney disease; Blood pressure; Cardiology; Randomized controlled trial; Proportional hazards model; Endocrinology; Pathology","score_opus":0.029766468517735373,"score_gpt":0.28738270151207396,"score_spread":0.25761623299433856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377223615","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.048741408,0.94909596,0.000053238004,0.00019296262,0.000069802554,0.0015840132,0.00019537387,0.000058109803,0.000009136554],"genre_scores_gemma":[0.019659795,0.97687465,0.00045728465,0.00008677898,0.00008638814,0.0003619505,0.0021543812,0.00005292043,0.00026587164],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9974246,0.00028414963,0.0007247566,0.00081517966,0.00042461255,0.00032672257],"domain_scores_gemma":[0.99866796,0.000076465556,0.00044340693,0.00038756212,0.00010648534,0.00031810266],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006874691,0.0006189827,0.005569126,0.0021865522,0.000089766036,0.000044019005,0.000054609292,0.00028737387,0.00006795933],"category_scores_gemma":[0.00003391197,0.00038026556,0.0012588426,0.0028741702,0.00012591221,0.00029782107,0.00005732684,0.0002302602,0.0000019615813],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079274374,0.00079182134,0.044998176,0.025570186,0.9110447,0.0000057412394,0.00025277768,0.000008383073,0.000038899812,0.00008731703,0.00025759346,0.016865091],"study_design_scores_gemma":[0.00081405276,0.00011774808,0.019126015,0.0005402766,0.9258539,7.0099213e-7,0.000046248308,0.000018536473,0.00009674838,0.00006192731,0.053015146,0.00030870776],"about_ca_topic_score_codex":0.00011226896,"about_ca_topic_score_gemma":0.000119754026,"teacher_disagreement_score":0.052757554,"about_ca_system_score_codex":0.000028740687,"about_ca_system_score_gemma":0.000067284556,"threshold_uncertainty_score":0.99986494},"labels":[],"label_agreement":null},{"id":"W4378348677","doi":"10.1111/dom.15099","title":"Safety, tolerability, pharmacodynamics and pharmacokinetics of the soluble guanylyl cyclase activator <scp>BI</scp> 685509 in patients with diabetic kidney disease: A randomized trial","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Department of Medicine, University of Toronto; Canadian Institutes of Health Research; Kidney Foundation of Canada; University of Toronto; Diabetes Canada; Boehringer Ingelheim","keywords":"Placebo; Medicine; Renal function; Albuminuria; Internal medicine; Kidney disease; Tolerability; Creatinine; Pharmacodynamics; Urology; Endocrinology; Gastroenterology; Adverse effect; Pharmacokinetics; Pharmacology; Pathology","score_opus":0.004590596198653822,"score_gpt":0.21367781500390212,"score_spread":0.2090872188052483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378348677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997127,0.00081640197,0.00004687709,0.00008578756,0.00046907985,0.0012380395,0.00017305916,0.00001629891,0.000027454838],"genre_scores_gemma":[0.9983284,0.00083235244,0.00008577295,0.00024979824,0.00011830305,0.00007485921,0.00015530628,0.000028435185,0.00012677345],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982226,0.00033246857,0.0003791461,0.00041660687,0.00026604833,0.00038312742],"domain_scores_gemma":[0.9990514,0.00014644225,0.00017973971,0.00027586814,0.00009153762,0.00025499272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007238727,0.0002560195,0.0005889083,0.0000827141,0.00013184908,0.000038579165,0.00019549314,0.00011400487,0.000011225324],"category_scores_gemma":[0.0005435809,0.00018015063,0.00014408251,0.00025808424,0.00024341737,0.000017662192,0.00029344435,0.00016221235,7.6126105e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10808254,0.0028338074,0.40086967,0.0010078346,0.0012547928,0.000004698085,0.0010000772,0.00072389754,0.47655478,0.00081797445,0.0013283379,0.0055216076],"study_design_scores_gemma":[0.66987735,0.000217758,0.12858899,0.00013948855,0.0007101868,2.231684e-7,0.000047523485,0.0035013163,0.18986575,0.0011053976,0.00557788,0.00036810228],"about_ca_topic_score_codex":0.000010623365,"about_ca_topic_score_gemma":0.000002356636,"teacher_disagreement_score":0.5617948,"about_ca_system_score_codex":0.000008433754,"about_ca_system_score_gemma":0.000089996975,"threshold_uncertainty_score":0.73463297},"labels":[],"label_agreement":null},{"id":"W4378639993","doi":"10.1111/dom.15140","title":"Relationship between body weight change and glycaemic control with tirzepatide treatment in people with type 2 diabetes: A post hoc assessment of the <scp>SURPASS</scp> clinical trial programme","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Eli Lilly and Company; American Diabetes Association","keywords":"Post-hoc analysis; Post hoc; Weight loss; Body weight; Weight change; Type 2 diabetes; Medicine; Clinical trial; Obesity; Diabetes mellitus; Internal medicine; Endocrinology","score_opus":0.04520161446501675,"score_gpt":0.29709012449393574,"score_spread":0.251888510028919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378639993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924963,0.0031935654,0.000004192624,0.00030110317,0.00019441757,0.0035593573,0.00009438467,0.00007725188,0.000079432],"genre_scores_gemma":[0.99769205,0.00054109114,0.0002715509,0.00014805987,0.00049704954,0.000556597,0.00013833916,0.000044607903,0.00011067639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973291,0.0005149904,0.0005230692,0.00051816885,0.00050022284,0.0006144573],"domain_scores_gemma":[0.99766815,0.0010914182,0.0002531692,0.00054989615,0.00016679478,0.0002706035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015166802,0.00034124358,0.0014345617,0.0002302492,0.0001520685,0.000048620346,0.00012261876,0.00021553207,0.0000030942458],"category_scores_gemma":[0.0005250591,0.00020284539,0.00024901162,0.00084668695,0.00028196562,0.00016189036,0.00006977036,0.00036809128,0.00000398383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026293175,0.0003871622,0.9778403,0.00016031461,0.0007042466,0.0000061983665,0.00043788354,7.4433507e-7,0.000016975497,0.000060911443,0.000020585172,0.020101741],"study_design_scores_gemma":[0.037126005,0.0024669543,0.95418614,0.000190507,0.0020873293,0.0000012852573,0.00011445159,0.00012380324,0.000098290046,0.00004548148,0.0034442935,0.000115479794],"about_ca_topic_score_codex":0.0007216275,"about_ca_topic_score_gemma":0.00088895235,"teacher_disagreement_score":0.036863074,"about_ca_system_score_codex":0.000048313756,"about_ca_system_score_gemma":0.0002448597,"threshold_uncertainty_score":0.8271795},"labels":[],"label_agreement":null},{"id":"W4378640039","doi":"10.1111/dom.15119","title":"The association between anthropometric indicators of obesity and cardiac reverse remodelling with empagliflozin in patients with type 2 diabetes and coronary artery disease","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McMaster University; University of British Columbia; St. Michael's Hospital","funders":"University of Toronto; Boehringer Ingelheim","keywords":"Empagliflozin; Medicine; Internal medicine; Cardiology; Type 2 diabetes; Waist; Body mass index; Coronary artery disease; Diabetes mellitus; Placebo; Anthropometry; Obesity; Endocrinology","score_opus":0.006149460745457394,"score_gpt":0.20428899293108377,"score_spread":0.19813953218562638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378640039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953547,0.0036500134,9.053583e-7,0.00011496507,0.000077153054,0.00066930364,0.000056246598,0.000038621834,0.00003805781],"genre_scores_gemma":[0.9969089,0.0026166004,0.00007636791,0.00004367066,0.00003784984,0.000018489472,0.00013772414,0.000019656352,0.0001407091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986376,0.00009662437,0.00021457831,0.00031744328,0.00036098118,0.00037275118],"domain_scores_gemma":[0.999091,0.00026239807,0.00015758241,0.00020959262,0.00008397802,0.00019539603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051570125,0.00020270613,0.0005301562,0.00043192654,0.00017682159,0.000039227427,0.000053924006,0.00007134461,0.0000019746797],"category_scores_gemma":[0.000101923935,0.00013346669,0.000036195826,0.0010304332,0.00017523208,0.00018741196,0.000096583644,0.00013404529,0.0000022267043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065924294,0.00016869591,0.99139774,0.00016143767,0.0005359444,0.0000030418682,0.00016953207,0.0000022864592,0.0000074068817,0.00005079531,0.00007707141,0.0073601333],"study_design_scores_gemma":[0.0018764018,0.00027002074,0.995475,0.0001307069,0.0011793505,1.4691988e-8,0.00008404745,0.000047074653,0.00009201361,0.000096129006,0.0005947632,0.00015446961],"about_ca_topic_score_codex":0.000011940066,"about_ca_topic_score_gemma":0.0000037669452,"teacher_disagreement_score":0.0072056637,"about_ca_system_score_codex":0.000039629795,"about_ca_system_score_gemma":0.00003140212,"threshold_uncertainty_score":0.54426134},"labels":[],"label_agreement":null},{"id":"W4381598155","doi":"10.1111/dom.15148","title":"Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; York University","funders":"Eli Lilly and Company","keywords":"Semaglutide; Medicine; Regimen; Body weight; Weight loss; Weight change; Internal medicine; Propensity score matching; Mean difference; Obesity; Animal science; Confidence interval; Endocrinology; Diabetes mellitus; Type 2 diabetes; Liraglutide; Biology","score_opus":0.03178952701191406,"score_gpt":0.2765193998934975,"score_spread":0.24472987288158343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381598155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99055994,0.006363478,0.000016638178,0.00035653258,0.00010308898,0.0020605987,0.00012622164,0.00014405487,0.00026945028],"genre_scores_gemma":[0.99321014,0.0025489747,0.0008759204,0.00010240106,0.00012307154,0.00043767347,0.00034708908,0.000038191243,0.0023165552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841666,0.00007370126,0.00031281196,0.00046463785,0.00024060093,0.00049155677],"domain_scores_gemma":[0.9987431,0.0003251706,0.00015465902,0.00045845518,0.00008919999,0.00022940828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022261545,0.00039050583,0.0010755843,0.00021499474,0.00028250727,0.00005658685,0.000085083,0.00007555603,0.000030140935],"category_scores_gemma":[0.000017908253,0.00022727378,0.0001456197,0.0003121292,0.00020330123,0.00010164646,0.000041078645,0.000046126348,0.000012518458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047369231,0.0041979863,0.8640124,0.00031718786,0.003268273,0.000014707069,0.0036394817,0.000047459598,0.0010325628,0.0005027901,0.0008744906,0.12161892],"study_design_scores_gemma":[0.008031061,0.003454494,0.89273006,0.000075590026,0.004232175,0.0000011797356,0.00056148507,0.004113061,0.012738231,0.00014040555,0.0736476,0.00027463541],"about_ca_topic_score_codex":0.00017744652,"about_ca_topic_score_gemma":0.00029004968,"teacher_disagreement_score":0.12134428,"about_ca_system_score_codex":0.0000620014,"about_ca_system_score_gemma":0.000041070198,"threshold_uncertainty_score":0.9267956},"labels":[],"label_agreement":null},{"id":"W4382363273","doi":"10.1111/dom.15073","title":"Baseline determinants of remission of type 2 diabetes in response to short‐term insulin‐based therapy: The pivotal role of beta‐cell function","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Banting and Best Diabetes Centre, University of Toronto; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Medicine; Internal medicine; Type 2 diabetes; Insulin glargine; Insulin resistance; Insulin; Diabetes mellitus; Endocrinology; Body mass index; Exenatide","score_opus":0.0135811436169266,"score_gpt":0.24927126617245227,"score_spread":0.23569012255552566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382363273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954191,0.0035413092,0.000001462842,0.00014060186,0.00012513444,0.00062154606,0.000032260003,0.000027322394,0.00009126429],"genre_scores_gemma":[0.99896175,0.00050512375,0.000102797516,0.00014674001,0.000034320805,0.000028775456,0.00004479095,0.00001928126,0.00015643756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985844,0.00018945233,0.00042262356,0.0002459603,0.000276368,0.00028121468],"domain_scores_gemma":[0.9990045,0.00027795593,0.00012898487,0.00036352672,0.0001252557,0.0000998098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011829634,0.00018359764,0.0005965623,0.0003881968,0.00004061467,0.0000067497986,0.000112261405,0.00008629957,0.000026650907],"category_scores_gemma":[0.00015207005,0.0001268528,0.0001110433,0.00072738127,0.0000882539,0.00006991615,0.00009061423,0.00008985483,0.0000048648335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077720056,0.00052198704,0.6404324,0.0002030815,0.00006828816,0.0000016062057,0.00026792058,0.000019227413,0.30912423,0.000010680377,0.00006979089,0.048503563],"study_design_scores_gemma":[0.0012319767,0.0004998247,0.6970791,0.00015263497,0.00018552555,2.7516023e-8,0.0000751344,0.000931315,0.2982432,0.000044610402,0.0014760663,0.000080564256],"about_ca_topic_score_codex":0.000019767516,"about_ca_topic_score_gemma":0.000007643258,"teacher_disagreement_score":0.056646697,"about_ca_system_score_codex":0.000011310875,"about_ca_system_score_gemma":0.00004873928,"threshold_uncertainty_score":0.5172907},"labels":[],"label_agreement":null},{"id":"W4382918428","doi":"10.1111/dom.15196","title":"Contemporary trends in the utilization of second‐line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Food and Drug Administration; Novo Nordisk; McGill University; Brigham and Women's Hospital; Pfizer; National Institute on Aging; U.S. Food and Drug Administration; Patient-Centered Outcomes Research Institute; Bristol-Myers Squibb","keywords":"Metformin; Medicine; Type 2 diabetes; Internal medicine; Diabetes mellitus; First line; Pharmacology; Endocrinology","score_opus":0.09025694862777887,"score_gpt":0.3301188495014631,"score_spread":0.2398619008736842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382918428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990809,0.0039695334,0.0000016711912,0.004001939,0.00008418212,0.0009003144,0.0000395398,0.00003190196,0.00016188396],"genre_scores_gemma":[0.99387604,0.0016519539,0.000017126853,0.003201082,0.000049827857,0.00015806289,0.000896628,0.000010759187,0.00013851745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875206,0.00037229713,0.00026375143,0.00018726052,0.00016364623,0.00026100542],"domain_scores_gemma":[0.99865425,0.0009910605,0.00009291701,0.00016706214,0.00006437761,0.000030320145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015328366,0.00016917243,0.00039633084,0.00046691336,0.00010630907,0.00004323297,0.00014798486,0.00006172749,0.000024069544],"category_scores_gemma":[0.000098809185,0.00007715309,0.00006388911,0.0015057495,0.00028297876,0.00008029762,0.000056045265,0.000137288,8.786939e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001200366,0.0020355107,0.888654,0.0007872901,0.0017944217,0.000020555108,0.023868222,0.0001227547,0.002675745,0.033735793,0.016970018,0.0281353],"study_design_scores_gemma":[0.0088181,0.00028630657,0.90509,0.000057564077,0.00051465037,2.1755885e-7,0.0021830052,0.008529871,0.0010723987,0.0025991502,0.07070778,0.00014095756],"about_ca_topic_score_codex":0.00008610023,"about_ca_topic_score_gemma":0.00003036409,"teacher_disagreement_score":0.053737767,"about_ca_system_score_codex":0.0000057962775,"about_ca_system_score_gemma":0.000010621927,"threshold_uncertainty_score":0.31462115},"labels":[],"label_agreement":null},{"id":"W4383301637","doi":"10.1111/dom.15201","title":"Cost‐effectiveness of canagliflozin and dapagliflozin for treatment of patients with chronic kidney disease and type 2 diabetes","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Memorial University of Newfoundland","funders":"","keywords":"Canagliflozin; Dapagliflozin; Medicine; Kidney disease; Type 2 diabetes; Diabetes mellitus; Intensive care medicine; Disease; Internal medicine; Endocrinology","score_opus":0.013360940474585125,"score_gpt":0.24448621324006434,"score_spread":0.2311252727654792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383301637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918924,0.005519757,0.000003486656,0.00007796267,0.000100593636,0.001968975,0.00037041065,0.000035813555,0.000030587624],"genre_scores_gemma":[0.997318,0.0015729262,0.00012310542,0.00004980361,0.00003976862,0.00021095987,0.00053210376,0.000025541867,0.00012774671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989475,0.000055984983,0.00018194281,0.0003307079,0.00015643233,0.00032745567],"domain_scores_gemma":[0.9990537,0.00018557713,0.00009182649,0.00021349435,0.00012605733,0.00032931595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017945959,0.0002336836,0.0006814541,0.00019289271,0.00007082312,0.000014560834,0.00003697895,0.00004969197,0.000006314837],"category_scores_gemma":[0.00008090086,0.00017035118,0.00005896294,0.00024493548,0.00018328699,0.00009888515,0.000054490545,0.000023956589,9.420967e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033475118,0.00053611957,0.97870046,0.002243628,0.00087179895,0.0000016767948,0.00011331831,0.0000032967623,0.0007653124,0.00047135237,0.00010562177,0.015852652],"study_design_scores_gemma":[0.0074963593,0.0012432146,0.9768563,0.0002760089,0.0019961689,2.6755277e-8,0.000014587265,0.00020222695,0.0063337404,0.00021692249,0.005204913,0.0001595626],"about_ca_topic_score_codex":0.00003664026,"about_ca_topic_score_gemma":0.000011929003,"teacher_disagreement_score":0.015693089,"about_ca_system_score_codex":0.000037085523,"about_ca_system_score_gemma":0.000078045916,"threshold_uncertainty_score":0.6946719},"labels":[],"label_agreement":null},{"id":"W4383303146","doi":"10.1111/dom.15186","title":"Development and validation of a real‐world model to predict 1‐year Level 3 (severe) hypoglycaemia risk in adults with diabetes (the <scp>iNPHORM</scp> study, United States)","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Sanofi","keywords":"Medicine; Diabetes mellitus; Gerontology; Pediatrics; Environmental health; Endocrinology","score_opus":0.024060529435662184,"score_gpt":0.2568736959968429,"score_spread":0.23281316656118073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383303146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997404,0.00016703212,0.0000137286925,0.00013827339,0.000042173884,0.0017381032,0.00007475425,0.00008129129,0.0003406354],"genre_scores_gemma":[0.9960493,0.00043936828,0.0010384023,0.00013573114,0.00004115893,0.0001835664,0.000226924,0.000036736456,0.001848844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764574,0.00016619604,0.00041640058,0.00047975933,0.00065369345,0.00063822715],"domain_scores_gemma":[0.9987283,0.00033659508,0.00013556115,0.00035787534,0.00019186691,0.00024985007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016329058,0.0002773623,0.0005752292,0.0010744726,0.0001879836,0.00006164457,0.00018830385,0.00007192524,0.0000041619164],"category_scores_gemma":[0.00026828152,0.00019047938,0.000040557235,0.0020269533,0.00013875739,0.00016855192,0.00033758668,0.0003134887,0.000014291242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061758714,0.00040928155,0.9807866,0.0004238403,0.00030677507,0.000005312585,0.008175036,0.0010721901,0.00019863642,0.000106839376,0.00069597317,0.007757713],"study_design_scores_gemma":[0.0034497706,0.00021420619,0.9753538,0.00030143964,0.00024904736,6.33914e-8,0.0022884766,0.012587808,0.003183054,0.00024065883,0.002014816,0.000116852425],"about_ca_topic_score_codex":0.00013026348,"about_ca_topic_score_gemma":0.00023485019,"teacher_disagreement_score":0.011515617,"about_ca_system_score_codex":0.000033348442,"about_ca_system_score_gemma":0.000079518184,"threshold_uncertainty_score":0.77675235},"labels":[],"label_agreement":null},{"id":"W4383710102","doi":"10.1111/dom.15211","title":"A model‐based approach to predict individual weight loss with semaglutide in people with overweight or obesity","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; York University","funders":"Novo Nordisk","keywords":"Semaglutide; Overweight; Weight loss; Medicine; Obesity; Demographics; Population; Dosing; Internal medicine; Diabetes mellitus; Type 2 diabetes; Demography; Endocrinology; Environmental health; Liraglutide","score_opus":0.014379455177132398,"score_gpt":0.22045006541803472,"score_spread":0.2060706102409023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383710102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949746,0.00027250178,0.00049369375,0.00047321978,0.00005055168,0.0015026401,0.00009796184,0.00025213553,0.0018826548],"genre_scores_gemma":[0.9893547,0.00009355942,0.006741535,0.0011251456,0.0000875415,0.00037497302,0.0002876988,0.00005320507,0.0018816298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997552,0.000065126755,0.00026088246,0.0007018274,0.0006199058,0.0008002769],"domain_scores_gemma":[0.9989082,0.00007568012,0.000076117285,0.00046425767,0.000072664036,0.00040305714],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043410412,0.0004188486,0.0008304912,0.0005691395,0.00014170606,0.00006893395,0.00017644504,0.00011651652,0.000023019025],"category_scores_gemma":[0.000031870582,0.0002673262,0.00007328249,0.0014155017,0.00010875993,0.00019094256,0.00016814322,0.00022064496,0.000029488163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044935208,0.0016637747,0.990009,0.0005156346,0.00047110725,0.00008268105,0.0011175903,0.0014765633,0.000060604256,0.0009817625,0.0013982577,0.0017736759],"study_design_scores_gemma":[0.006192062,0.00044944588,0.96840143,0.00023157778,0.0009778547,0.0000029672242,0.00010853313,0.018296253,0.0009895413,0.00012066856,0.0038037328,0.00042591905],"about_ca_topic_score_codex":0.000057941525,"about_ca_topic_score_gemma":0.00019294325,"teacher_disagreement_score":0.021607552,"about_ca_system_score_codex":0.000052376097,"about_ca_system_score_gemma":0.00015857989,"threshold_uncertainty_score":0.9999779},"labels":[],"label_agreement":null},{"id":"W4383711165","doi":"10.1111/dom.15203","title":"Effect of sotagliflozin on albuminuria in patients with type 2 diabetes and chronic kidney disease","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"Department of Medicine, University of Toronto; Canadian Institutes of Health Research; Boston VA Research Institute; University of Toronto; Kidney Foundation of Canada; Heart and Stroke Foundation of Canada; Bristol-Myers Squibb","keywords":"Medicine; Albuminuria; Hazard ratio; Renal function; Kidney disease; Internal medicine; Type 2 diabetes; Clinical endpoint; Diabetes mellitus; Microalbuminuria; Dapagliflozin; Creatinine; Randomized controlled trial; Confidence interval; Urology; Endocrinology","score_opus":0.0035999479209241183,"score_gpt":0.20997615246005044,"score_spread":0.20637620453912633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383711165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972441,0.0014602118,5.4132304e-8,0.00013864112,0.00013839302,0.000780247,0.000033881694,0.000055801487,0.00014865352],"genre_scores_gemma":[0.9988829,0.00026994778,0.000014430111,0.00022667511,0.000051195155,0.000048094065,0.00020326774,0.00002380871,0.0002796619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884146,0.00007951413,0.0001628144,0.00031950916,0.00022791851,0.0003687767],"domain_scores_gemma":[0.99927086,0.00010006313,0.000059192855,0.00023999954,0.000037425638,0.00029245688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026303044,0.0002287274,0.00052264356,0.0002682313,0.000045683013,0.000017971699,0.000051722047,0.00005298066,0.00001930921],"category_scores_gemma":[0.00013755113,0.00016094181,0.000046973197,0.00037907477,0.0000920409,0.00009691366,0.00007616956,0.0000933694,0.00002219092],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022575892,0.00029078493,0.9815113,0.00081487,0.00019758467,0.000005597182,0.0000551747,0.0000025380532,0.00024860236,0.00012262276,0.0005447786,0.015980368],"study_design_scores_gemma":[0.0059841983,0.0014790607,0.9844608,0.00036072562,0.0005992515,1.017966e-8,0.0000038125024,0.000091704365,0.004980636,0.00005342151,0.0018330769,0.00015334297],"about_ca_topic_score_codex":0.0000040129503,"about_ca_topic_score_gemma":0.0000016774902,"teacher_disagreement_score":0.015827024,"about_ca_system_score_codex":0.000023872697,"about_ca_system_score_gemma":0.000032820008,"threshold_uncertainty_score":0.6563017},"labels":[],"label_agreement":null},{"id":"W4383998664","doi":"10.1111/dom.15202","title":"Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: A report from the <scp>GARFIELD‐AF</scp> registry","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Internal medicine; Atrial fibrillation; Diabetes mellitus; Hazard ratio; Stroke (engine); Population; Proportional hazards model; Gastroenterology; Endocrinology; Confidence interval","score_opus":0.02280272397524157,"score_gpt":0.2761064568922203,"score_spread":0.2533037329169787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383998664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99707675,0.0006489093,0.000030130745,0.0007698007,0.0004799231,0.00076372316,0.00003615227,0.00011670275,0.00007789775],"genre_scores_gemma":[0.997015,0.00013596671,0.00018630033,0.00016818364,0.0012579624,0.0000033112512,0.0005111419,0.000022237733,0.00069991377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833965,0.00010249883,0.00039111509,0.00037883795,0.00041115895,0.00037673468],"domain_scores_gemma":[0.99833715,0.00085865444,0.00021515418,0.00038804012,0.000102219536,0.00009877552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004976971,0.00020743292,0.0005040935,0.00009259877,0.00020310715,0.00010824658,0.00008640048,0.000141496,0.000015444442],"category_scores_gemma":[0.0013331459,0.00014456101,0.00012211026,0.0006147089,0.000100538586,0.00020176491,0.0001067994,0.00014653035,0.000024495204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038741626,0.000006502484,0.9934833,0.000027770575,0.00010549369,0.000018707939,0.0005041819,0.00014665406,0.000037692404,0.00007302768,0.0006323687,0.004925531],"study_design_scores_gemma":[0.0035826697,0.000041676598,0.97638845,0.000061403516,0.00024248473,3.9408633e-7,0.00014013804,0.0002660889,0.00012925205,0.00022774027,0.018839715,0.00008000753],"about_ca_topic_score_codex":0.00016577911,"about_ca_topic_score_gemma":0.00006504338,"teacher_disagreement_score":0.018207347,"about_ca_system_score_codex":0.000016033573,"about_ca_system_score_gemma":0.00003607403,"threshold_uncertainty_score":0.5895027},"labels":[],"label_agreement":null},{"id":"W4385331114","doi":"10.1111/dom.15221","title":"Safety of sodium‐glucose co‐transporter‐2 inhibitors on amputation across categories of baseline cardiovascular disease and diuretics use in patients with type 2 diabetes","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Research Foundation of Korea; Ministry of Food and Drug Safety","keywords":"Medicine; Hazard ratio; Amputation; Cohort; Type 2 diabetes; Internal medicine; Retrospective cohort study; Propensity score matching; Cohort study; Diabetes mellitus; Proportional hazards model; Confidence interval; Surgery; Endocrinology","score_opus":0.008389640401609506,"score_gpt":0.21497732013791918,"score_spread":0.20658767973630968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385331114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720854,0.0017531617,0.000005584372,0.000035643512,0.00009845114,0.0006406245,0.00021027535,0.00003612598,0.000011595731],"genre_scores_gemma":[0.9978822,0.0010765989,0.000083614716,0.00006377567,0.00002993467,0.000017599672,0.0007887518,0.000023025177,0.000034515575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862057,0.000068249035,0.0003163937,0.00031040062,0.0003760865,0.00030830107],"domain_scores_gemma":[0.99920887,0.00010362275,0.00009891047,0.00028526137,0.0001509916,0.00015233901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041643516,0.0002168522,0.0006422358,0.0001968343,0.000056053075,0.000018515126,0.000042703163,0.00006396699,0.0000033907731],"category_scores_gemma":[0.00009907602,0.00017097077,0.00010041086,0.00042051577,0.00020275648,0.00018116225,0.000040320603,0.00008595278,0.0000017503635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030811253,0.000473658,0.9892365,0.0005471858,0.0006757505,0.0000059886966,0.0004872421,0.000111378,0.000113913375,0.000116283554,0.000023829383,0.007900187],"study_design_scores_gemma":[0.0039957743,0.00027500515,0.9874751,0.0002038384,0.0010467584,1.3855804e-8,0.000066984605,0.00015602694,0.005832954,0.00007810222,0.00071288587,0.00015657127],"about_ca_topic_score_codex":0.000031650638,"about_ca_topic_score_gemma":0.000008907284,"teacher_disagreement_score":0.007743615,"about_ca_system_score_codex":0.0000140167185,"about_ca_system_score_gemma":0.00002327857,"threshold_uncertainty_score":0.69719857},"labels":[],"label_agreement":null},{"id":"W4385752248","doi":"10.1111/dom.15241","title":"Post‐initiation predictors of discontinuation of the sodium‐glucose cotransporter‐2 inhibitors: A comparative cohort study from the United Kingdom","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université Laval; Health Sciences Centre; University of Waterloo; Sunnybrook Health Science Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Discontinuation; Cohort; Medicine; Cotransporter; Cohort study; Internal medicine; Sodium; Chemistry","score_opus":0.022532548089796562,"score_gpt":0.25419073524909547,"score_spread":0.2316581871592989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385752248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970502,0.0002537218,0.0000033849176,0.00030917564,0.000308151,0.0017712031,0.0001608828,0.000046033034,0.000097248914],"genre_scores_gemma":[0.99903023,0.00006450535,0.000012790256,0.00013363517,0.00010362262,0.00006906511,0.00050820335,0.000010397983,0.00006755518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870515,0.00017131481,0.00035573286,0.00021467976,0.00037846685,0.00017464388],"domain_scores_gemma":[0.9990292,0.00019851055,0.00023744804,0.0003213419,0.0001651712,0.000048328664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000439321,0.00016191622,0.0004660249,0.0001334518,0.000112556365,0.00001829095,0.000116860676,0.00004842249,0.000013884286],"category_scores_gemma":[0.000065502165,0.000092263515,0.000115304036,0.00057540037,0.00016173469,0.00012211785,0.0000752734,0.000102664824,0.0000035419248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035760528,0.00065557944,0.9897756,0.00002956798,0.00073242583,8.010863e-7,0.004943866,0.0000070045835,0.0031225216,0.00025658828,0.00017272028,0.0002675639],"study_design_scores_gemma":[0.0017973364,0.00015424608,0.9739925,0.00010625569,0.0018265733,3.1252657e-8,0.0012321103,0.0001499237,0.019963613,0.00008983169,0.000608904,0.00007861936],"about_ca_topic_score_codex":0.0005831982,"about_ca_topic_score_gemma":0.00010565803,"teacher_disagreement_score":0.016841091,"about_ca_system_score_codex":0.000011975339,"about_ca_system_score_gemma":0.000024997422,"threshold_uncertainty_score":0.37623972},"labels":[],"label_agreement":null},{"id":"W4385827492","doi":"10.1111/dom.15234","title":"Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Professional Engineers Ontario; Western University; Ottawa Hospital; University of Ottawa; Hamilton Health Sciences; McGill University; University of Calgary; Impact; LMC Diabetes & Endocrinology (Canada); McMaster University; Population Health Research Institute","funders":"Obesity Canada; Canadian Institutes of Health Research; Bayer Canada; National Institutes of Health; HLS Therapeutics; Bausch Health; Mitacs; Novo Nordisk; Dexcom; Insulet Corporation; Diabetes Canada; University of Calgary; Kowa Company; Sanofi; Hamilton Health Sciences; GlaxoSmithKline; McMaster University; Lawson Foundation; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Alberta Health Services; Pfizer","keywords":"Medicine; Metformin; Diabetes mellitus; Type 2 diabetes; Insulin glargine; Internal medicine; Hazard ratio; Lixisenatide; Confidence interval; Insulin; Endocrinology; Liraglutide","score_opus":0.022017787339578987,"score_gpt":0.2561282778115219,"score_spread":0.23411049047194293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385827492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98362935,0.011876458,0.000007721283,0.00022260043,0.0004287558,0.0033343278,0.000024828032,0.00014072318,0.00033524606],"genre_scores_gemma":[0.9961032,0.0017273454,0.0006425638,0.00015218345,0.00014836545,0.00034359738,0.000290156,0.0000398233,0.00055272813],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973158,0.00035386084,0.0008756177,0.00061612646,0.00035218656,0.00048635903],"domain_scores_gemma":[0.9981301,0.00058499316,0.00039874783,0.00034712872,0.00020065035,0.0003383762],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025603906,0.0003970667,0.0018357824,0.00057153404,0.00018016541,0.00008110812,0.00009379334,0.0001794635,0.0000045636966],"category_scores_gemma":[0.0031325638,0.00030831067,0.00034693588,0.00045142075,0.00015545638,0.00046709998,0.00022201835,0.00021705855,0.0000024652147],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44164765,0.007907164,0.1114151,0.004133882,0.020629536,0.00016927303,0.023888351,0.000023501345,0.03257744,0.0071711377,0.002015633,0.34842134],"study_design_scores_gemma":[0.9281725,0.0010316487,0.04638503,0.00057075446,0.0047268188,9.793632e-7,0.0015704256,0.0053530885,0.0087467935,0.0008333661,0.002174558,0.000434005],"about_ca_topic_score_codex":0.000028188791,"about_ca_topic_score_gemma":0.0000043588284,"teacher_disagreement_score":0.48652488,"about_ca_system_score_codex":0.000013136712,"about_ca_system_score_gemma":0.000027707018,"threshold_uncertainty_score":0.9999369},"labels":[],"label_agreement":null},{"id":"W4386084393","doi":"10.1111/dom.15243","title":"Impact of sarcosine on diabetic retinopathy: Findings based on weighted gene co‐expression network analysis and machine learning techniques","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Manitoba Health","funders":"Zhejiang University; Anhui Medical University; Natural Science Foundation of Zhejiang Province; National Natural Science Foundation of China; Wenzhou Medical University","keywords":"Sarcosine; Odds ratio; Internal medicine; Medicine; Diabetic retinopathy; Logistic regression; Confidence interval; Interquartile range; Body mass index; Diabetes mellitus; Endocrinology; Bioinformatics; Oncology; Genetics; Biology","score_opus":0.009477936432036555,"score_gpt":0.2664616575259388,"score_spread":0.2569837210939023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386084393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980701,0.0011473706,0.000022242972,0.000065858774,0.000023860099,0.00030725286,0.00012462176,0.000113371825,0.00012527507],"genre_scores_gemma":[0.99771947,0.0008914246,0.00047846496,0.00010722985,0.00006552256,0.000021314194,0.0006044437,0.000023836415,0.00008827815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986551,0.00013714179,0.00022900826,0.0003575746,0.00028095642,0.00034025963],"domain_scores_gemma":[0.99916977,0.00018506582,0.00011587743,0.00023810632,0.000059418748,0.00023176226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003017349,0.00024614017,0.0006862642,0.0004635182,0.00016695117,0.000024919158,0.000050402952,0.00010140622,0.00005253894],"category_scores_gemma":[0.000104120285,0.00017419954,0.000252717,0.00085254986,0.00007735395,0.0000455706,0.00004130968,0.00018342987,0.0000055973146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024168968,0.00027245705,0.9796838,0.000077826146,0.0003931342,0.00001920537,0.000033275985,0.00007519896,0.016156012,0.000014921506,0.000058812508,0.0029736569],"study_design_scores_gemma":[0.0009943048,0.0006509712,0.9291549,0.00021216788,0.0014512168,3.8400054e-7,0.0000022579231,0.0060047433,0.061191633,0.000080216065,0.00011944255,0.0001378],"about_ca_topic_score_codex":0.000050998126,"about_ca_topic_score_gemma":6.697095e-7,"teacher_disagreement_score":0.050528947,"about_ca_system_score_codex":0.00002092235,"about_ca_system_score_gemma":0.000021535645,"threshold_uncertainty_score":0.71036506},"labels":[],"label_agreement":null},{"id":"W4386703896","doi":"10.1111/dom.15268","title":"Severe (level 3) hypoglycaemia occurrence in a real‐world cohort of adults with type 1 or 2 diabetes mellitus ( <scp>iNPHORM</scp> , United States)","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Center for Advancing Translational Sciences; Sanofi","keywords":"Medicine; Type 1 diabetes; Incidence (geometry); Type 2 Diabetes Mellitus; Diabetes mellitus; Epidemiology; Internal medicine; Prospective cohort study; Pediatrics; Demography; Endocrinology","score_opus":0.024700575008834137,"score_gpt":0.2713769618219571,"score_spread":0.24667638681312296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386703896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951813,0.0016846827,0.00000148399,0.00012090223,0.00016879846,0.0010381321,0.00023292947,0.00015233798,0.0014194158],"genre_scores_gemma":[0.98271435,0.0077734953,0.00035904022,0.00033590823,0.00009514825,0.00009734633,0.0013579025,0.000049069564,0.0072177164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99706805,0.00014797301,0.00047054325,0.00059775007,0.00069818035,0.0010175204],"domain_scores_gemma":[0.99800825,0.000628438,0.00016346184,0.00049506954,0.00036283463,0.00034195147],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010062307,0.00036913407,0.0009455979,0.0013603449,0.00011499614,0.00005433243,0.00027134392,0.00014210287,0.000058368558],"category_scores_gemma":[0.0004904989,0.0002648988,0.00008209713,0.0043703816,0.00032336917,0.00022691501,0.00026151948,0.0004519875,0.00006279211],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015284047,0.00035656264,0.98126155,0.0014167207,0.0003629857,0.000050985476,0.0009050395,0.000041781026,0.00047301763,0.00018573093,0.0055408617,0.009251949],"study_design_scores_gemma":[0.0031151427,0.00030972032,0.9662858,0.0007201941,0.00032067532,5.2470523e-7,0.00051809254,0.0019365806,0.0032444643,0.00020617252,0.023142401,0.00020023348],"about_ca_topic_score_codex":0.00022248724,"about_ca_topic_score_gemma":0.0002467383,"teacher_disagreement_score":0.017601538,"about_ca_system_score_codex":0.00003551445,"about_ca_system_score_gemma":0.00014469385,"threshold_uncertainty_score":0.99998033},"labels":[],"label_agreement":null},{"id":"W4387033838","doi":"10.1111/dom.15240","title":"Patient and physician perspectives and experiences of basal insulin titration in type 2 diabetes in the United States: Cross‐sectional surveys","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Sanofi","keywords":"Medicine; Basal insulin; Observational study; Pharmacy; Cross-sectional study; Family medicine; Type 2 diabetes; Diabetes mellitus; Internal medicine","score_opus":0.01432211689660374,"score_gpt":0.2712706262229241,"score_spread":0.25694850932632035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387033838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971598,0.002302593,8.632932e-7,0.00014033286,0.00009406871,0.00020986957,0.000019001778,0.000011105381,0.00006236561],"genre_scores_gemma":[0.99851847,0.0010012863,0.000014784233,0.00031035865,0.000035406425,0.000030619696,0.00007581109,0.0000051651327,0.000008115934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990536,0.0001754372,0.00021071908,0.00020220526,0.0001648252,0.00019319545],"domain_scores_gemma":[0.9995099,0.00022380512,0.000037485795,0.00007806608,0.00009904697,0.0000517258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046317079,0.000105204264,0.00024861822,0.00018435445,0.00007263626,0.000032506814,0.0000346652,0.0000662279,0.0000070781703],"category_scores_gemma":[0.00018672626,0.00007579978,0.000023452836,0.00043605999,0.0002498826,0.000107557215,0.000031170457,0.00013044353,8.3493893e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051886684,0.00019093408,0.95656973,0.00006854221,0.000022265749,0.000002686569,0.040236294,0.0000065946356,0.0004972794,0.0003901869,0.000010454773,0.001953143],"study_design_scores_gemma":[0.0012039074,0.00020513916,0.98012584,0.000044993183,0.000019396262,2.6826643e-7,0.015469827,0.001765003,0.00032952498,0.0006135875,0.0001382592,0.00008422655],"about_ca_topic_score_codex":0.00013785688,"about_ca_topic_score_gemma":0.000027068527,"teacher_disagreement_score":0.02476647,"about_ca_system_score_codex":0.000006735019,"about_ca_system_score_gemma":0.000019511675,"threshold_uncertainty_score":0.30910254},"labels":[],"label_agreement":null},{"id":"W4387357825","doi":"10.1111/dom.15301","title":"Breaking a feedback loop: A reassessment of an investigator initiated <scp>OS‐AID</scp> study","year":2023,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Context-Aware Activity Recognition Systems","field":"Computer Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Medical Research Council","keywords":"Gateway (web page); Computer science; Loop (graph theory); World Wide Web; Combinatorics; Mathematics","score_opus":0.04574036661001977,"score_gpt":0.2687548718851961,"score_spread":0.22301450527517633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387357825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98768026,0.000549339,0.00048221942,0.0071809404,0.0016221491,0.0014018731,0.0002287726,0.0006129986,0.00024143531],"genre_scores_gemma":[0.88881016,0.00007627962,0.0015759723,0.10515637,0.002476001,0.00047749636,0.00035078984,0.00018810501,0.00088879874],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99431604,0.0014891946,0.0008746397,0.0013797206,0.0010803534,0.0008600713],"domain_scores_gemma":[0.99571013,0.0011996983,0.000852729,0.0013773979,0.00046422312,0.00039583555],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015673089,0.00069589214,0.0016088601,0.00076767226,0.0002504507,0.00061033026,0.0014182297,0.0006597188,0.000006917807],"category_scores_gemma":[0.0006885521,0.00070059614,0.00023818518,0.0012110205,0.00019136186,0.0013248706,0.0009595478,0.0013489965,0.00007166794],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012684499,0.0053437855,0.17258947,0.004673959,0.0059368764,0.002073662,0.026109714,0.000008906747,0.0033174595,0.0008848354,0.59302783,0.1860208],"study_design_scores_gemma":[0.0044118655,0.00066146255,0.6484157,0.0013137426,0.0011396792,0.000047144913,0.00089961843,0.0021921678,0.003511563,0.003346097,0.33265698,0.0014039597],"about_ca_topic_score_codex":0.00055945345,"about_ca_topic_score_gemma":0.000081870596,"teacher_disagreement_score":0.47582623,"about_ca_system_score_codex":0.000055140583,"about_ca_system_score_gemma":0.0003909772,"threshold_uncertainty_score":0.9995445},"labels":[],"label_agreement":null},{"id":"W4387563674","doi":"10.1111/dom.15309","title":"Proportion of participants with type 2 diabetes achieving a metabolic composite endpoint with once‐weekly semaglutide treatment versus comparators: Post hoc pooled analysis from <scp>SUSTAIN</scp> 1‐5, 7‐10 and <scp>SUSTAIN</scp> China","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"FSD Pharma (Canada)","funders":"Novo Nordisk","keywords":"Semaglutide; Medicine; Post-hoc analysis; Type 2 diabetes; Internal medicine; Clinical endpoint; Placebo; Logistic regression; Covariate; Randomized controlled trial; Diabetes mellitus; Endocrinology; Mathematics; Statistics","score_opus":0.014177814722031596,"score_gpt":0.24719868808648404,"score_spread":0.23302087336445246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387563674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98590094,0.011495263,0.000015566637,0.00016800941,0.00012294504,0.0015340362,0.00022760591,0.0002699775,0.000265678],"genre_scores_gemma":[0.9950668,0.0013478973,0.0008635404,0.00011870662,0.00013339776,0.00017946362,0.0011866373,0.00007732997,0.0010262189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99600106,0.00025244508,0.00068385125,0.0010152967,0.0007336826,0.0013136864],"domain_scores_gemma":[0.9971841,0.0005271546,0.0005416274,0.0007265772,0.0003914309,0.0006291251],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049931067,0.00081530574,0.0022321595,0.00090138917,0.0003445218,0.00017207555,0.00018090068,0.00017323966,0.000020417197],"category_scores_gemma":[0.00023372483,0.0005816881,0.00028006904,0.002105068,0.00039626757,0.00035711974,0.00017952741,0.00023203134,0.000023724875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040443512,0.001583898,0.9570363,0.00047210683,0.022708116,0.000107806096,0.003816706,0.00027939075,0.007978672,0.00042260092,0.00022182647,0.0049681305],"study_design_scores_gemma":[0.0075627565,0.0021257354,0.9308031,0.00017522262,0.030107662,5.888165e-7,0.002239219,0.001301238,0.020392524,0.00006556292,0.005017476,0.00020887199],"about_ca_topic_score_codex":0.00027727694,"about_ca_topic_score_gemma":0.00015907036,"teacher_disagreement_score":0.026233168,"about_ca_system_score_codex":0.000100584344,"about_ca_system_score_gemma":0.00015342883,"threshold_uncertainty_score":0.9996635},"labels":[],"label_agreement":null},{"id":"W4387600391","doi":"10.1111/dom.15315","title":"Time trends towards earlier puberty in boys and girls with type 1 diabetes: Insights from the German Diabetes Prospective Follow‐up (DPV) registry, 2000 to 2021","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kirkland and District Hospital","funders":"","keywords":"Medicine; Type 1 diabetes; Diabetes mellitus; Body mass index; Type 2 diabetes; Prospective cohort study; Pediatrics; Population; Internal medicine; Endocrinology; Environmental health","score_opus":0.004603337045971016,"score_gpt":0.20816750624274769,"score_spread":0.20356416919677667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387600391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913272,0.006271786,5.80273e-7,0.0007364974,0.00021326903,0.0003538455,0.00019641794,0.000038267128,0.0008621307],"genre_scores_gemma":[0.9942983,0.00061709184,0.000049930844,0.000985306,0.00024489692,0.00010556153,0.0004736872,0.000049596092,0.0031756505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997822,0.00015549592,0.00026406563,0.0007738255,0.00025200847,0.00073259795],"domain_scores_gemma":[0.9989936,0.000069606634,0.00010879247,0.00048441108,0.000113071794,0.00023054899],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029188904,0.00039409852,0.00053650385,0.00014548209,0.00022566959,0.00016531022,0.00029250357,0.00026060053,0.000053190863],"category_scores_gemma":[0.00017529259,0.00028453322,0.00009873786,0.00083627127,0.00022043301,0.000035785397,0.00030096347,0.00022759361,0.00004671328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113376496,0.00030099862,0.8401163,0.00005133855,0.00087700115,0.0000075202197,0.0029253718,0.000032171512,0.10360993,0.00008852171,0.019770151,0.032107323],"study_design_scores_gemma":[0.0014120843,0.000203362,0.92537737,0.00006423814,0.00015692573,1.0898478e-7,0.00015473178,0.00014872514,0.023333872,0.0005183794,0.048072908,0.00055727764],"about_ca_topic_score_codex":0.00011387846,"about_ca_topic_score_gemma":0.00025747248,"teacher_disagreement_score":0.085261084,"about_ca_system_score_codex":0.000020437194,"about_ca_system_score_gemma":0.00008893709,"threshold_uncertainty_score":0.99996066},"labels":[],"label_agreement":null},{"id":"W4387764698","doi":"10.1111/dom.15333","title":"Gastrointestinal adverse events and weight reduction in people with type 2 diabetes treated with tirzepatide in the <scp>SURPASS</scp> clinical trials","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"European Foundation for the Study of Diabetes; Eli Lilly and Company","keywords":"Medicine; Nausea; Placebo; Adverse effect; Vomiting; Weight change; Weight loss; Semaglutide; Internal medicine; Type 2 diabetes; Gastroenterology; Clinical trial; Diabetes mellitus; Liraglutide; Obesity; Endocrinology","score_opus":0.03167783784088358,"score_gpt":0.2967542691922431,"score_spread":0.26507643135135955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387764698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813783,0.00041931547,0.0000050059675,0.0004438163,0.000059704056,0.0007450269,0.0000126074765,0.00006362831,0.000113092785],"genre_scores_gemma":[0.9985066,0.00024312988,0.00075287634,0.00014107276,0.00009448594,0.00005108893,0.000069433714,0.000020159925,0.00012117645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99752975,0.00070052315,0.0005406351,0.00044987025,0.00028722695,0.00049198273],"domain_scores_gemma":[0.9982307,0.0010388477,0.00018139734,0.00024845637,0.0001175338,0.00018307722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030137545,0.00026011313,0.0008679215,0.00034477387,0.00009673946,0.000020393181,0.0000904322,0.00006923581,0.000007010875],"category_scores_gemma":[0.0027605265,0.00016004322,0.00007125063,0.0012946433,0.00020416251,0.000177834,0.000043128075,0.0004308229,0.000010834393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012318532,0.00035246767,0.9975915,0.00009886231,0.00004301038,0.00002969468,0.00034215752,0.000015524716,0.00029962993,0.000024064813,0.00011831288,0.0009615771],"study_design_scores_gemma":[0.0038641775,0.00070528284,0.9923351,0.000488525,0.00029113214,0.000050610586,0.0012297003,0.00044230907,0.000131371,0.00022237006,0.00017141958,0.00006804365],"about_ca_topic_score_codex":0.00010904344,"about_ca_topic_score_gemma":0.00025820837,"teacher_disagreement_score":0.0052564545,"about_ca_system_score_codex":0.000014934776,"about_ca_system_score_gemma":0.0000868721,"threshold_uncertainty_score":0.65263724},"labels":[],"label_agreement":null},{"id":"W4387865855","doi":"10.1111/dom.15331","title":"Diabetes, antidiabetic medications and risk of dementia: A systematic umbrella review and meta‐analysis","year":2023,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Université de Montréal; Université de Sherbrooke; McGill University Health Centre","funders":"McGill University Health Centre; McGill University","keywords":"Medicine; Metformin; Pioglitazone; Dementia; Cochrane Library; Meta-analysis; Internal medicine; Type 2 diabetes; Diabetes mellitus; CINAHL; Cohort study; Relative risk; Pharmacology; Endocrinology; Insulin; Confidence interval; Psychiatry; Disease; Psychological intervention","score_opus":0.04235189374697281,"score_gpt":0.3084662030670428,"score_spread":0.26611430932007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387865855","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014767131,0.9936942,0.000004691517,0.00012750365,0.00006553973,0.0040337583,0.00041338304,0.00009370488,0.00009054193],"genre_scores_gemma":[0.00025671854,0.9971474,0.00029257097,0.0002235336,0.000037383885,0.00097326894,0.0003708501,0.00007333837,0.00062496756],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9959882,0.0006724288,0.0014052894,0.0008898931,0.00047576491,0.00056841125],"domain_scores_gemma":[0.9965413,0.00083937886,0.0011550962,0.0009181423,0.00014005475,0.00040600466],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001972136,0.0008107423,0.01156267,0.0009593554,0.0001792015,0.00006270635,0.00020528652,0.0002840438,0.000068484274],"category_scores_gemma":[0.0003574407,0.00055632804,0.0015686341,0.0015857236,0.00030803008,0.000116538155,0.00037848495,0.00033715306,0.000024437299],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[2.826576e-7,0.00012897675,0.0013965149,0.59868354,0.39269146,0.0000027743868,0.00002600025,3.6201566e-8,1.6644651e-7,0.00017175825,0.00014605903,0.006752439],"study_design_scores_gemma":[0.00034491403,0.00004800916,0.0023730164,0.024435632,0.93194807,0.0000011087081,0.000009950492,0.000013201296,0.0000023748644,0.00008183543,0.040356036,0.00038588382],"about_ca_topic_score_codex":0.000034349698,"about_ca_topic_score_gemma":0.0000117106465,"teacher_disagreement_score":0.5742479,"about_ca_system_score_codex":0.00001832094,"about_ca_system_score_gemma":0.00006899911,"threshold_uncertainty_score":0.9996888},"labels":[],"label_agreement":null},{"id":"W4387950612","doi":"10.1111/dom.15340","title":"Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes: Insights from the <scp>CANVAS</scp> Program and <scp>CREDENCE</scp> trial","year":2023,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Paul's Hospital; University of British Columbia; St. Michael's Hospital; McGill University Health Centre","funders":"Janssen Canada; Janssen Research and Development; McGill University Health Centre; Language Literacy and Culture, University of Maryland, Baltimore County","keywords":"Canagliflozin; Credence; Type 2 diabetes; Empagliflozin; Heart failure; Medicine; Diabetes mellitus; Clinical trial; Pharmacology; Internal medicine; Endocrinology; Computer science","score_opus":0.013380282846031787,"score_gpt":0.22747753760283193,"score_spread":0.21409725475680014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387950612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852944,0.008203705,0.0000037890054,0.0012513828,0.00030239634,0.0040274835,0.00084631646,0.000047639234,0.000022871065],"genre_scores_gemma":[0.9420645,0.0022983823,0.011841918,0.027042313,0.0023107622,0.0022651358,0.010722011,0.00048491213,0.0009700452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972386,0.00014526017,0.00056518405,0.0007221467,0.00068529404,0.00064354634],"domain_scores_gemma":[0.9968424,0.0019711978,0.00025914473,0.0005417789,0.000224679,0.00016083791],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036646012,0.00055847305,0.0021364475,0.0002814044,0.00011410698,0.00007937041,0.00016814537,0.0004213198,0.0000024717724],"category_scores_gemma":[0.00063587166,0.0003680466,0.00027202538,0.00030784286,0.00036589566,0.00013235095,0.00019178585,0.00049448,0.0000013940333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008876526,0.00063871505,0.9120467,0.002266676,0.008751211,0.00001788889,0.00090643513,0.0000047901303,0.00002334014,0.00017371005,0.06835878,0.006723048],"study_design_scores_gemma":[0.018693466,0.0010893501,0.8025984,0.00053438474,0.0059091058,9.773133e-8,0.00016617813,0.00004321218,0.000129753,0.0005731214,0.17014726,0.00011563463],"about_ca_topic_score_codex":0.0004845145,"about_ca_topic_score_gemma":0.00017836438,"teacher_disagreement_score":0.10944821,"about_ca_system_score_codex":0.0000292724,"about_ca_system_score_gemma":0.00007713487,"threshold_uncertainty_score":0.99987715},"labels":[],"label_agreement":null},{"id":"W4388538144","doi":"10.1111/dom.15353","title":"Effects of <scp>CB1R</scp> inverse agonist, <scp>INV</scp> ‐202, in patients with features of metabolic syndrome. A randomized, placebo‐controlled, double‐blind phase 1b study","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Inversago Pharma (Canada)","funders":"American Diabetes Association","keywords":"Placebo; Medicine; Tolerability; Waist; Internal medicine; Gastroenterology; Confidence interval; Pharmacodynamics; Area under the curve; Body mass index; Metabolic syndrome; Adverse effect; Pharmacokinetics; Endocrinology; Obesity; Pathology","score_opus":0.008409374410353864,"score_gpt":0.2591078960781044,"score_spread":0.25069852166775053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388538144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981463,0.009256989,0.0000024787507,0.000080362566,0.00025906332,0.008379325,0.00008396711,0.000065942426,0.00040885102],"genre_scores_gemma":[0.9933215,0.00082463486,0.000042390187,0.00011920455,0.00009796483,0.001024541,0.000093628696,0.00006760343,0.004408535],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99528563,0.0007670744,0.00092961435,0.0007463032,0.0012753112,0.0009960615],"domain_scores_gemma":[0.9969503,0.00096477295,0.00046763223,0.00060164504,0.000495308,0.000520325],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002633308,0.0005824068,0.0038389666,0.0013781863,0.00016086771,0.00007239888,0.00030473003,0.00025775065,0.0000099446315],"category_scores_gemma":[0.002442133,0.000417117,0.00048120372,0.0018095395,0.0005774435,0.00024227466,0.00025720632,0.00065556273,0.000012742899],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20502648,0.053025603,0.6608719,0.008515183,0.01295031,0.0007771599,0.022450991,0.000101137724,0.007966682,0.0017772616,0.020642258,0.005895011],"study_design_scores_gemma":[0.5720525,0.00075117283,0.41588247,0.0001683901,0.0017271949,0.0000026470632,0.00072101655,0.00006177521,0.0071193106,0.000054606957,0.0013748809,0.00008406415],"about_ca_topic_score_codex":0.0003267378,"about_ca_topic_score_gemma":0.00006401035,"teacher_disagreement_score":0.36702603,"about_ca_system_score_codex":0.000025640893,"about_ca_system_score_gemma":0.00026765358,"threshold_uncertainty_score":0.99982804},"labels":[],"label_agreement":null},{"id":"W4388946741","doi":"10.1111/dom.15362","title":"Obesity attenuates acute phosphate excretion after an oral challenge in females: A sex‐specific effect of obesity on phosphate handling","year":2023,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Southeastern Ontario Academic Medical Organization; Canadian Institutes of Health Research","keywords":"Gateway (web page); Obesity; Table (database); Computer science; Medicine; Psychology; World Wide Web; Database; Internal medicine","score_opus":0.019590036974337796,"score_gpt":0.26804462252378053,"score_spread":0.24845458554944272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388946741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9511308,0.04148704,0.0000038890926,0.0047034924,0.00058666867,0.0015009763,0.00033561722,0.00015093484,0.000100594865],"genre_scores_gemma":[0.96889716,0.01581191,0.000081620434,0.01154848,0.0007685668,0.00033181737,0.0015269642,0.00015785686,0.000875617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99572915,0.00049702986,0.00069942797,0.001320948,0.0006978571,0.0010555917],"domain_scores_gemma":[0.9981397,0.00028571108,0.00035116408,0.00084054045,0.00011734693,0.0002655585],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00082682894,0.0010207096,0.002543171,0.00055700034,0.0001856765,0.00008334411,0.00025173512,0.0010791763,0.00003421448],"category_scores_gemma":[0.000055700297,0.0008522665,0.00044812952,0.00046277145,0.00025395083,0.00030627867,0.0001593938,0.0014101072,0.00013625645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014438315,0.002573884,0.96366674,0.0018524991,0.0019295196,0.0026973407,0.0018704596,0.000008296626,0.0006451321,0.000040744628,0.016497012,0.0067745354],"study_design_scores_gemma":[0.010041224,0.0017964488,0.9446617,0.0009626671,0.002273609,0.000007934545,0.00004368756,0.00016943054,0.014897475,0.00045347383,0.023540797,0.0011515854],"about_ca_topic_score_codex":0.00022207024,"about_ca_topic_score_gemma":0.000049925773,"teacher_disagreement_score":0.02567513,"about_ca_system_score_codex":0.000094369345,"about_ca_system_score_gemma":0.000060332277,"threshold_uncertainty_score":0.9993928},"labels":[],"label_agreement":null},{"id":"W4388982295","doi":"10.1111/dom.15361","title":"<scp>S</scp> odium‐glucose co‐transporter‐2 inhibitors are associated with kidney benefits at all degrees of albuminuria: A retrospective cohort study of adults with diabetes","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"University of Alberta; Government of Alberta","keywords":"Albuminuria; Medicine; Renal function; Kidney disease; Diabetes mellitus; Internal medicine; Retrospective cohort study; Urology; Cohort; Endocrinology","score_opus":0.00805353841563022,"score_gpt":0.21127396958394334,"score_spread":0.20322043116831312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388982295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99343634,0.0029949206,1.6973691e-7,0.000059687325,0.00011707388,0.0018665142,0.0011573819,0.00019209152,0.0001758031],"genre_scores_gemma":[0.9980075,0.00036491817,0.000025991558,0.00021514233,0.0001059399,0.00016394377,0.0008437215,0.00008136748,0.00019149388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964812,0.00013940023,0.00064931536,0.00083481945,0.0010262368,0.00086902897],"domain_scores_gemma":[0.9970266,0.0003729674,0.0006329724,0.00059581484,0.00055436144,0.0008172911],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005819847,0.0005695823,0.0018908167,0.00039682453,0.00016799828,0.00002557154,0.0001875427,0.00024580292,0.000027720314],"category_scores_gemma":[0.00085827557,0.0004358549,0.00019825801,0.0010150711,0.00038837545,0.00023978823,0.0001011851,0.00030706672,0.000008104408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011994844,0.002188875,0.98732156,0.00055324094,0.0024128314,0.000034120716,0.0034847981,0.00001577599,0.0019008341,0.000016266275,0.001852289,0.00009948153],"study_design_scores_gemma":[0.009481353,0.001276958,0.94385064,0.0013560314,0.003214997,7.3125676e-7,0.0017084989,0.000080104735,0.038614124,0.000016315178,0.00015975379,0.00024051612],"about_ca_topic_score_codex":0.00011088819,"about_ca_topic_score_gemma":0.0002916478,"teacher_disagreement_score":0.043470923,"about_ca_system_score_codex":0.00010079348,"about_ca_system_score_gemma":0.00023441177,"threshold_uncertainty_score":0.9998093},"labels":[],"label_agreement":null},{"id":"W4389097078","doi":"10.1111/dom.15385","title":"Insulin, hypoglycaemia and dementia: A causal mediation analysis showcasing challenges and potential opportunities","year":2023,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Manitoba Health; Women's College Hospital; University of Toronto; University of Waterloo","funders":"Alzheimer Society Research Program; Alzheimer's Society","keywords":"Medicine; Dementia; Mediation; Insulin; Internal medicine; Disease","score_opus":0.03982752714907278,"score_gpt":0.269136602795444,"score_spread":0.2293090756463712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389097078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83602554,0.06139888,0.00002495062,0.10121278,0.00025971045,0.0005225549,0.00014624596,0.00010261116,0.00030674008],"genre_scores_gemma":[0.6849522,0.23644799,0.0002491736,0.07006965,0.0035632523,0.00016188926,0.002429713,0.00011867691,0.0020074472],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971845,0.0002644213,0.0003856544,0.0007411015,0.0007558421,0.0006684801],"domain_scores_gemma":[0.99885166,0.00019978336,0.00017027499,0.00025520497,0.00024420608,0.00027889237],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075923244,0.00043987914,0.0010822859,0.0010905424,0.00025461605,0.00018106442,0.00008758666,0.0005828068,0.00006447602],"category_scores_gemma":[0.0001473255,0.00040267577,0.00017573418,0.00029298107,0.00033764483,0.00023222392,0.0002898626,0.0009448174,0.0000067673454],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023291667,0.0006448176,0.32394254,0.009508427,0.044526454,0.004247044,0.0038279705,0.0000011703089,0.0019335552,0.0004930934,0.09882393,0.5118181],"study_design_scores_gemma":[0.0016108934,0.00014602969,0.8992374,0.00013158355,0.012774988,0.000019643538,0.00043892692,0.00023968675,0.00017700564,0.000589101,0.08415857,0.00047618983],"about_ca_topic_score_codex":0.00003454007,"about_ca_topic_score_gemma":0.000019888103,"teacher_disagreement_score":0.57529485,"about_ca_system_score_codex":0.000018615581,"about_ca_system_score_gemma":0.00008979954,"threshold_uncertainty_score":0.9998425},"labels":[],"label_agreement":null},{"id":"W4389109661","doi":"10.1111/dom.15381","title":"A comment on tirzepatide versus glucagon‐like peptide‐1 receptor agonists and heart rate with regard to ‘Impact of a dual glucose‐dependent insulinotropic peptide/glucagon‐like peptide‐1 receptor agonist tirzepatide on heart rate among patients with type 2 diabetes: A systematic review and pairwise and network meta‐analysis’","year":2023,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Diabetes mellitus; Type 2 diabetes; Receptor; Agonist; Medicine; Internal medicine; Chemistry; Endocrinology","score_opus":0.029839198786723593,"score_gpt":0.28017882106944203,"score_spread":0.25033962228271844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389109661","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38002175,0.60996336,0.0000011859045,0.00028767047,0.00025204284,0.008783976,0.0005197801,0.00013474702,0.00003549438],"genre_scores_gemma":[0.010088377,0.9804367,0.0008183727,0.00303702,0.00017648077,0.0022858914,0.0019066302,0.0003288673,0.00092164846],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9916519,0.0018255654,0.0019486328,0.0020658858,0.0010668132,0.0014412298],"domain_scores_gemma":[0.9937607,0.001436423,0.0014692345,0.0016059441,0.00049193954,0.0012357458],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0022232456,0.0021259133,0.012201963,0.0009834042,0.00046848104,0.00034686213,0.00029401138,0.0003862475,0.000067653986],"category_scores_gemma":[0.00042870612,0.0013789453,0.0012711002,0.0020056306,0.00045112814,0.00030698846,0.0004826257,0.0007750842,0.00007426668],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016668375,0.0028109364,0.042582523,0.589534,0.34461433,0.0000606781,0.00067797105,0.00006160207,0.000010447386,0.00011381539,0.014008795,0.0038580806],"study_design_scores_gemma":[0.008227383,0.011326687,0.07854255,0.14552492,0.67203146,0.0000033131141,0.00008908453,0.000039516806,0.000031374144,0.00001401759,0.08140097,0.0027687128],"about_ca_topic_score_codex":0.00020912867,"about_ca_topic_score_gemma":0.00017462045,"teacher_disagreement_score":0.44400907,"about_ca_system_score_codex":0.0003015614,"about_ca_system_score_gemma":0.0002440239,"threshold_uncertainty_score":0.9991482},"labels":[],"label_agreement":null},{"id":"W4389180501","doi":"10.1111/dom.15367","title":"Incretin‐based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta‐analysis of observational studies","year":2023,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"McGill University","keywords":"Medicine; Incretin; Meta-analysis; Type 2 diabetes; Observational study; Internal medicine; Confidence interval; Diabetic retinopathy; Cochrane Library; Diabetes mellitus; Retinopathy; Relative risk; Endocrinology","score_opus":0.06251447739997212,"score_gpt":0.31274015845991415,"score_spread":0.25022568105994203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389180501","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04842354,0.9463409,4.3745308e-7,0.0001314236,0.000032693955,0.004599906,0.00040811845,0.00003690114,0.000026071735],"genre_scores_gemma":[0.0023489883,0.9953566,0.0002047423,0.0003291966,0.000017567385,0.0010677127,0.00035500535,0.00005190583,0.00026824287],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9957285,0.0012317278,0.0013593759,0.00060426455,0.000705023,0.00037110236],"domain_scores_gemma":[0.99371123,0.0031080393,0.0018368057,0.00072525087,0.00047413856,0.00014452336],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0043419697,0.00069775747,0.0131941,0.00065259496,0.0001370993,0.00004232053,0.00020545423,0.00016696392,0.000017465527],"category_scores_gemma":[0.0015072104,0.00034653093,0.0010421651,0.0019052423,0.0009542285,0.00010300158,0.00028392745,0.0002815662,0.0000020076316],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000048333827,0.00008057359,0.013694252,0.6664013,0.318812,0.0000010985984,0.00022928874,5.00497e-7,5.8449135e-8,0.00026018402,0.000040855964,0.00047498697],"study_design_scores_gemma":[0.00088130054,0.00010160287,0.012593255,0.055910453,0.92878467,1.5826463e-7,0.00007171341,0.000027216862,0.0000031031882,0.00008679709,0.0012514992,0.00028824405],"about_ca_topic_score_codex":0.000019200515,"about_ca_topic_score_gemma":0.0000075123125,"teacher_disagreement_score":0.6104909,"about_ca_system_score_codex":0.00001824827,"about_ca_system_score_gemma":0.0000768179,"threshold_uncertainty_score":0.9998987},"labels":[],"label_agreement":null},{"id":"W4389609315","doi":"10.1111/dom.15396","title":"Once‐weekly semaglutide reduces the risk of cardiovascular events in people with type 2 diabetes and polyvascular disease: A post hoc analysis","year":2023,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital","funders":"Novo Nordisk","keywords":"Semaglutide; Medicine; Type 2 diabetes; Internal medicine; Post-hoc analysis; Population; Placebo; Myocardial infarction; Physical therapy; Stroke (engine); Cardiology; Diabetes mellitus; Endocrinology; Liraglutide; Pathology","score_opus":0.0060700517841647175,"score_gpt":0.20066669162208325,"score_spread":0.19459663983791853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389609315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9018945,0.0818917,0.0000011550687,0.014643036,0.00016068584,0.0010802872,0.00023181678,0.00006137923,0.000035461086],"genre_scores_gemma":[0.94645697,0.027565535,0.00018266222,0.020544589,0.0009002064,0.00032841408,0.0018604334,0.0001714474,0.0019897404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99673665,0.0004098739,0.00043356387,0.0008540324,0.0008467217,0.0007191784],"domain_scores_gemma":[0.9980002,0.00031740137,0.00027034982,0.0010349447,0.00018150898,0.00019557055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008376263,0.0005986898,0.0021150808,0.0008020683,0.0001603547,0.000048715006,0.0002422192,0.000278629,0.000018297711],"category_scores_gemma":[0.00020397763,0.00038605827,0.00082003203,0.0016300341,0.00025725266,0.00011174831,0.00024786292,0.00068558636,0.000009010583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008657451,0.0002703377,0.93099254,0.0014499617,0.054135203,0.00010220656,0.00050372595,0.000114468006,0.000036839163,0.000012694581,0.0073539168,0.0049415156],"study_design_scores_gemma":[0.0014196642,0.0001864552,0.88910043,0.00034440818,0.06007778,3.4507866e-7,0.000088012406,0.00011975375,0.00011851038,0.00008362559,0.04806669,0.00039433967],"about_ca_topic_score_codex":0.00054742914,"about_ca_topic_score_gemma":0.00009509778,"teacher_disagreement_score":0.05432616,"about_ca_system_score_codex":0.00004104546,"about_ca_system_score_gemma":0.00009611457,"threshold_uncertainty_score":0.99985915},"labels":[],"label_agreement":null},{"id":"W4390005477","doi":"10.1111/dom.15417","title":"Cardiovascular and renal outcomes with varying degrees of kidney disease in high‐risk people with type 2 diabetes: An epidemiological analysis of data from the AMPLITUDE‐O trial","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Hazard ratio; Renal function; Kidney disease; Albuminuria; Internal medicine; Diabetes mellitus; Confidence interval; Mace; Type 2 diabetes; Proportional hazards model; Creatinine; Urology; Endocrinology; Myocardial infarction","score_opus":0.03638020386393328,"score_gpt":0.281562740278508,"score_spread":0.2451825364145747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390005477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98926914,0.008232665,0.000018671855,0.00022208384,0.00004525811,0.0005131545,0.0016541097,0.000038950922,0.000005944224],"genre_scores_gemma":[0.9953929,0.0014490903,0.00048205716,0.0002946584,0.000096312855,0.000029861618,0.0022324896,0.000017837736,0.0000048002203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768233,0.0004356182,0.00043046995,0.0006461393,0.00041865997,0.00038679584],"domain_scores_gemma":[0.99677414,0.0011046972,0.00019252839,0.0012238822,0.00009783557,0.00060691865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013709886,0.0002706837,0.0017535872,0.00024480693,0.0000982886,0.00002544583,0.00027232763,0.00009349139,0.000036027264],"category_scores_gemma":[0.0022107558,0.00014647968,0.00021166795,0.0012187222,0.00030716756,0.00024597766,0.00024957315,0.00020029784,0.0000010718145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001413785,0.0002715798,0.99110276,0.00011119722,0.0054791016,0.000006527606,0.0001983067,0.00040529415,0.00008115663,0.00004466871,0.00007414895,0.00081148674],"study_design_scores_gemma":[0.011614489,0.00018896163,0.9657953,0.00012611703,0.016151853,4.2857383e-8,0.0000651648,0.0054932344,0.000060711744,0.0001616398,0.00016107442,0.00018142106],"about_ca_topic_score_codex":0.0015309597,"about_ca_topic_score_gemma":0.00018381447,"teacher_disagreement_score":0.025307456,"about_ca_system_score_codex":0.000009869431,"about_ca_system_score_gemma":0.00024476895,"threshold_uncertainty_score":0.59732676},"labels":[],"label_agreement":null},{"id":"W4390016542","doi":"10.1111/dom.15415","title":"Impact of the diagnosis of gestational diabetes on maternal physical activity after pregnancy","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; St. Michael's Hospital; University of Toronto; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Gestational diabetes; Pregnancy; Medicine; Obstetrics; Body mass index; Prospective cohort study; Cohort study; Physical activity; Type 2 diabetes; Diabetes mellitus; Gestation; Gynecology; Endocrinology; Internal medicine; Physical therapy","score_opus":0.016389985540266026,"score_gpt":0.2970005244234828,"score_spread":0.28061053888321674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390016542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985622,0.00026496174,8.5772706e-7,0.00027414862,0.000063770625,0.00040181263,0.0002663429,0.00002012563,0.00014574207],"genre_scores_gemma":[0.9992137,0.00023641855,0.000028797322,0.000047406484,0.000053113916,0.00015369005,0.000021792595,0.000012565065,0.00023249985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876064,0.0000862562,0.00013349642,0.00019860949,0.00050451176,0.0003164574],"domain_scores_gemma":[0.9991918,0.00024802834,0.00009092376,0.00022402935,0.00012733761,0.00011786233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014497018,0.00014258706,0.0003404338,0.0001594197,0.000052593547,0.000013438553,0.00010102233,0.00004029172,0.00005738815],"category_scores_gemma":[0.00018845702,0.00009057585,0.00023444495,0.0003420662,0.00017188511,0.000105241605,0.00012755733,0.00013314396,0.000014859623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040384846,0.0005624562,0.97823584,0.00040556246,0.0002377239,0.0000017651805,0.0001227615,0.00003398327,0.004946426,0.0005572727,0.0002079872,0.014647853],"study_design_scores_gemma":[0.000601172,0.00016845486,0.957871,0.0002841442,0.00011039539,6.679459e-8,0.0000053376607,0.00041321776,0.039399568,0.0009938612,0.00007897958,0.00007377705],"about_ca_topic_score_codex":0.00003186586,"about_ca_topic_score_gemma":0.000001511264,"teacher_disagreement_score":0.034453142,"about_ca_system_score_codex":0.000018289373,"about_ca_system_score_gemma":0.000056049434,"threshold_uncertainty_score":0.3693576},"labels":[],"label_agreement":null},{"id":"W4390113202","doi":"10.1111/dom.15420","title":"Reduced incidence of diabetes during the <scp>COVID</scp> ‐19 pandemic in Alberta: A time‐segmented longitudinal study of Alberta's Tomorrow Project","year":2023,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"Health Canada; Alberta Health; Alberta Cancer Foundation; Alberta Health Services; Government of Alberta; Partenariat Canadien Contre Le Cancer","keywords":"Pandemic; Medicine; Diabetes mellitus; Incidence (geometry); Demography; Confidence interval; Population; Coronavirus disease 2019 (COVID-19); Cohort study; Rate ratio; Emergency medicine; Environmental health; Internal medicine; Disease; Infectious disease (medical specialty); Endocrinology","score_opus":0.010861913100466202,"score_gpt":0.24809346156743775,"score_spread":0.23723154846697156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390113202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99774784,0.0013074224,3.5221908e-7,0.000023664797,0.0000844486,0.000666594,0.000030917472,0.00001807272,0.00012067291],"genre_scores_gemma":[0.99845964,0.00035325604,0.000012115319,0.000058739017,0.000048340702,0.00010197322,0.000070961854,0.000025289819,0.00086969417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979895,0.0002562914,0.00044706397,0.00049786066,0.00024745075,0.00056187925],"domain_scores_gemma":[0.9988486,0.00030835063,0.00027318057,0.00038855243,0.0000879163,0.00009339074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065767794,0.00027136964,0.00053865195,0.00019314418,0.00013665561,0.000028237173,0.0003442581,0.00016705233,0.0000050560684],"category_scores_gemma":[0.0010916945,0.00022062947,0.00013080428,0.00072007976,0.00016072243,0.000021446554,0.00033813913,0.00016605326,0.0000048174284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005989335,0.00033400988,0.8147679,0.000089687885,0.00021320819,7.2756507e-7,0.0012592523,0.000048326085,0.18296942,0.000007648606,0.00014947439,0.00015434432],"study_design_scores_gemma":[0.0014932486,0.00018984442,0.9664401,0.000052788306,0.00015631261,3.7540866e-7,0.00088136044,0.00015573183,0.029965699,0.00008240479,0.0004560383,0.00012612864],"about_ca_topic_score_codex":0.0017325446,"about_ca_topic_score_gemma":0.0018832763,"teacher_disagreement_score":0.15300372,"about_ca_system_score_codex":0.000014425201,"about_ca_system_score_gemma":0.00008692935,"threshold_uncertainty_score":0.8997009},"labels":[],"label_agreement":null},{"id":"W4390311701","doi":"10.1111/dom.15431","title":"Real‐world effectiveness and safety of oral semaglutide in people living with type 2 diabetes: A nationwide multicentre retrospective observational study ( <scp> ENDO <sup>2</sup> S‐RWD </scp> )","year":2023,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Semaglutide; Medicine; Type 2 diabetes; Tolerability; Clinical trial; Internal medicine; Dulaglutide; Retrospective cohort study; Medical prescription; Cohort; Diabetes mellitus; Adverse effect; Pharmacology; Liraglutide; Endocrinology","score_opus":0.01697452754513942,"score_gpt":0.2486603731151771,"score_spread":0.23168584557003769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390311701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289364,0.0010395953,0.0000020164732,0.0019479537,0.00021080834,0.003176792,0.00015438232,0.00013690886,0.00043789626],"genre_scores_gemma":[0.98750687,0.0008936248,0.00047802436,0.0066662915,0.00049814995,0.0004134712,0.00071216095,0.00015792412,0.0026735137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962154,0.00052099733,0.00061971537,0.0010220022,0.00080115814,0.0008207483],"domain_scores_gemma":[0.9963415,0.0022305932,0.00036490036,0.00049372134,0.00041180642,0.00015748068],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011415298,0.0007041392,0.0019488673,0.0008932936,0.00017512852,0.00008312531,0.00018151541,0.0003146617,0.000019069148],"category_scores_gemma":[0.000889958,0.00060458324,0.00014837405,0.0013691555,0.00017665749,0.00026085819,0.00031034782,0.00088685326,0.000010811696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003491312,0.000728218,0.98936963,0.0014808129,0.0017398923,0.000058523518,0.0019792449,0.00005731231,0.000052018095,0.000075372154,0.003803469,0.0006206125],"study_design_scores_gemma":[0.0044651646,0.00042079372,0.9831801,0.0013826962,0.0021662167,5.058221e-7,0.00052827934,0.0004959743,0.00014298107,0.00012128184,0.0068266406,0.00026933246],"about_ca_topic_score_codex":0.00048531184,"about_ca_topic_score_gemma":0.0007168916,"teacher_disagreement_score":0.006189478,"about_ca_system_score_codex":0.00019788377,"about_ca_system_score_gemma":0.00013982948,"threshold_uncertainty_score":0.9996405},"labels":[],"label_agreement":null},{"id":"W4390502136","doi":"10.1111/dom.15419","title":"Patterns of metformin use and glycated haemoglobin trends among patients with newly diagnosed type 2 diabetes in Alberta, Canada","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Metformin; Discontinuation; Medicine; Type 2 diabetes; Retrospective cohort study; Internal medicine; Cohort; Diabetes mellitus; Logistic regression; Cohort study; Pediatrics; Endocrinology","score_opus":0.0063257904242730615,"score_gpt":0.19644827907518556,"score_spread":0.1901224886509125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390502136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708796,0.0019345289,5.3206264e-7,0.00016458637,0.00018771172,0.00039303224,0.00010036484,0.000029687671,0.00010157807],"genre_scores_gemma":[0.9980439,0.0003088298,0.00008926552,0.00021787008,0.000025264013,0.000034590434,0.00032306844,0.000028894434,0.0009283296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986553,0.000041690295,0.00026748396,0.0003760476,0.00025363555,0.00040580335],"domain_scores_gemma":[0.99926585,0.00019034094,0.00006455102,0.00021816255,0.000073214695,0.00018786968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010940838,0.0002761359,0.00059764134,0.00031443025,0.000039654893,0.000067104214,0.00006254931,0.00007566965,0.000036512312],"category_scores_gemma":[0.00006423728,0.0002060801,0.00004508068,0.00045136764,0.00006875486,0.00030351125,0.000075886426,0.00012799587,9.395803e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023291272,0.00022447706,0.97620887,0.00030541417,0.0003787998,0.000027516953,0.00019096087,0.0000022252357,0.000037270576,0.00017999744,0.00028501012,0.022136165],"study_design_scores_gemma":[0.0024866997,0.00017246227,0.9891492,0.00035452348,0.0006815404,1.4646089e-7,0.00002868499,0.00021499509,0.0015429717,0.000023777511,0.005131025,0.00021394288],"about_ca_topic_score_codex":0.14443895,"about_ca_topic_score_gemma":0.2611765,"teacher_disagreement_score":0.11673756,"about_ca_system_score_codex":0.000047232308,"about_ca_system_score_gemma":0.00007321257,"threshold_uncertainty_score":0.8612583},"labels":[],"label_agreement":null},{"id":"W4390744416","doi":"10.1111/dom.15412","title":"Effect of basal insulin and omega 3 fatty acids on cognitive impairment in dysglycaemia: An exploratory analysis of the <scp>ORIGIN</scp> trial","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Sanofi","keywords":"Hazard ratio; Digit symbol substitution test; Confidence interval; Internal medicine; Placebo; Medicine; Insulin glargine; Post-hoc analysis; Proportional hazards model; Physical therapy; Psychology; Insulin; Hypoglycemia","score_opus":0.015012890294564029,"score_gpt":0.2985700707469004,"score_spread":0.28355718045233635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390744416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931199,0.005154215,0.0000061756355,0.0000878624,0.0004971058,0.00084857777,0.00020939672,0.000024655972,0.000052141582],"genre_scores_gemma":[0.999121,0.00047606777,0.000023723353,0.00014072986,0.00012948252,0.000055484415,0.000030324369,0.00001631096,0.000006852248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99722487,0.0011521579,0.0003683546,0.00040157497,0.00041993713,0.0004331306],"domain_scores_gemma":[0.9979797,0.0014143605,0.0000993286,0.00024052503,0.000068379275,0.0001976992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021824385,0.00022006877,0.0007765484,0.0006527969,0.00012234494,0.000057099904,0.0001498713,0.00016747591,0.0000054929083],"category_scores_gemma":[0.0005471613,0.00014956255,0.00018809998,0.0012270205,0.00029114034,0.00024286189,0.00009433345,0.0005014106,0.000001988049],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008145616,0.0018242009,0.8916556,0.0035366705,0.0017862737,0.000019126486,0.015215833,0.000053932286,0.02102128,0.0007005108,0.00020892957,0.055831976],"study_design_scores_gemma":[0.011510137,0.0020887863,0.7886687,0.0003250782,0.0010531169,1.7711093e-7,0.00046801803,0.0013852669,0.19398901,0.00022824692,0.00020139801,0.000082095146],"about_ca_topic_score_codex":0.00009830686,"about_ca_topic_score_gemma":0.0001105686,"teacher_disagreement_score":0.17296773,"about_ca_system_score_codex":0.000039979324,"about_ca_system_score_gemma":0.000076147306,"threshold_uncertainty_score":0.6098984},"labels":[],"label_agreement":null},{"id":"W4390892305","doi":"10.1111/dom.15425","title":"The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review","year":2024,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre","funders":"Sanofi","keywords":"Kidney disease; Type 2 diabetes; Medicine; Diabetes mellitus; Basal (medicine); Basal insulin; Disease; Renal function; Intensive care medicine; Internal medicine; Narrative review; Endocrinology","score_opus":0.01437076196548593,"score_gpt":0.301510869203142,"score_spread":0.2871401072376561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390892305","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027267786,0.969583,3.0457603e-8,0.00036887266,0.000083049876,0.0023674564,0.00009530236,0.000010275777,0.00022427709],"genre_scores_gemma":[0.0025191922,0.9963748,0.000008589507,0.000099254554,0.0001294807,0.0003170271,0.0001535622,0.000030727188,0.00036738339],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99804187,0.00034449509,0.0004576314,0.000375556,0.0003892962,0.00039117987],"domain_scores_gemma":[0.99869835,0.00032283703,0.00020177162,0.00049234397,0.000099889665,0.00018478402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006728511,0.00039055216,0.0019188635,0.0001879784,0.00010710914,0.000045963905,0.0002143683,0.000093862975,0.000017264825],"category_scores_gemma":[0.00015490629,0.00016092048,0.00025681002,0.0008372515,0.00034810998,0.0000595359,0.000104947314,0.0002767983,0.00000494383],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024766587,0.00067403726,0.006264578,0.14135638,0.0016640627,0.000007844683,0.00137841,5.630556e-8,0.0000032247483,0.0007627584,0.00090288935,0.84696096],"study_design_scores_gemma":[0.00051245635,0.00053030637,0.006835916,0.034725152,0.007127477,2.8190013e-7,0.0001234467,0.000020739499,0.000008940523,0.00019667707,0.9497424,0.00017623007],"about_ca_topic_score_codex":0.000009159674,"about_ca_topic_score_gemma":0.000018907656,"teacher_disagreement_score":0.9488395,"about_ca_system_score_codex":0.000038607002,"about_ca_system_score_gemma":0.0004219193,"threshold_uncertainty_score":0.65621465},"labels":[],"label_agreement":null},{"id":"W4390952355","doi":"10.1111/dom.15459","title":"Suicidality among users of glucagon‐like peptide‐1 receptor agonists: An emerging signal?","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Regional Municipality of Waterloo; University of Waterloo; University of Alberta","funders":"","keywords":"Exenatide; Semaglutide; Liraglutide; Dulaglutide; Lixisenatide; Weight loss; Medicine; Glucagon-like peptide 1 receptor; Adverse effect; Diabetes mellitus; Medical prescription; Obesity; Internal medicine; Type 2 diabetes; Endocrinology; Agonist; Pharmacology; Receptor","score_opus":0.013519707573142727,"score_gpt":0.2560227436641229,"score_spread":0.2425030360909802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390952355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887063,0.008011487,0.000028410062,0.00029589073,0.00052843423,0.00047022532,0.00004676118,0.00020826866,0.0017042159],"genre_scores_gemma":[0.99564254,0.00065919163,0.00081697403,0.00032015884,0.000225774,0.00004112658,0.00016722904,0.00003904888,0.0020879277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826854,0.00008646546,0.0003576688,0.00050761754,0.00032396245,0.00045571965],"domain_scores_gemma":[0.9991024,0.00006938714,0.00008067256,0.0003759014,0.00008439444,0.0002872579],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00054147444,0.00029154308,0.0006328329,0.00025798735,0.00011451405,0.00009935985,0.00011896848,0.000111362395,0.00029030073],"category_scores_gemma":[0.00003085201,0.0002475462,0.00020287736,0.00034738655,0.00021609654,0.0004568507,0.00010383523,0.00018680272,0.00003270256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009080481,0.0016057604,0.8268236,0.0031952611,0.0029109465,0.00005754335,0.0032139274,0.000012517129,0.04062846,0.012343989,0.005801869,0.10331532],"study_design_scores_gemma":[0.0015673634,0.00032241343,0.8042863,0.00050676387,0.0022852684,9.3459164e-7,0.00058119715,0.0008670761,0.04886363,0.00088104565,0.13931693,0.0005210534],"about_ca_topic_score_codex":0.00016016459,"about_ca_topic_score_gemma":0.000024091833,"teacher_disagreement_score":0.13351506,"about_ca_system_score_codex":0.00003733848,"about_ca_system_score_gemma":0.000045481866,"threshold_uncertainty_score":0.9999977},"labels":[],"label_agreement":null},{"id":"W4391116156","doi":"10.1111/dom.15450","title":"Defining diabetes status using medication groups in Medicare data: Trends in prescribing diabetes medications to patients without a diabetes diagnosis over time","year":2024,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Institute on Minority Health and Health Disparities; National Center for Chronic Disease Prevention and Health Promotion; National Institute of Diabetes and Digestive and Kidney Diseases; Centers for Disease Control and Prevention; American Diabetes Association; American Heart Association; Centers for Disease Control and Prevention Foundation; Amgen","keywords":"Biostatistics; Family medicine; Medicine; Diabetes mellitus; Public health; Epidemiology; Gerontology; Library science; Nursing; Internal medicine","score_opus":0.018043709059800447,"score_gpt":0.26786741231575556,"score_spread":0.2498237032559551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391116156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9360291,0.018409323,0.0000018006111,0.040469646,0.0010804046,0.0017997228,0.001628804,0.00025305036,0.00032818477],"genre_scores_gemma":[0.73359126,0.0026813112,0.0023696532,0.19911148,0.0033100243,0.0031057063,0.054093104,0.0006778143,0.0010596229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99142784,0.00044351327,0.0015010628,0.0023654397,0.0016460092,0.0026161307],"domain_scores_gemma":[0.9960789,0.0007579827,0.00048041026,0.0017789614,0.00016839408,0.00073535205],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015380633,0.0012730185,0.0025583685,0.0035232161,0.00021808918,0.00031458048,0.0008465466,0.0010641745,0.0003069736],"category_scores_gemma":[0.00090316427,0.0011801503,0.0002797031,0.0020453418,0.00034295252,0.0009171609,0.0014656128,0.0019631346,0.00011209389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000063908983,0.00054654374,0.87338674,0.0012321313,0.0009925631,0.000029370733,0.000642743,0.0000045100974,0.000068387184,0.00002897503,0.100935854,0.022125797],"study_design_scores_gemma":[0.0030206155,0.00015617142,0.7816738,0.0045194766,0.0043791397,1.739036e-7,0.000039692182,0.003945334,0.00022449157,0.00023684018,0.20060426,0.0011999918],"about_ca_topic_score_codex":0.00024897963,"about_ca_topic_score_gemma":0.00014766511,"teacher_disagreement_score":0.20243779,"about_ca_system_score_codex":0.00050497334,"about_ca_system_score_gemma":0.00022252128,"threshold_uncertainty_score":0.99906486},"labels":[],"label_agreement":null},{"id":"W4391151349","doi":"10.1111/dom.15463","title":"Postprandial glucose‐management strategies in type 1 diabetes: Current approaches and prospects with precision medicine and artificial intelligence","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"McGill University","keywords":"Postprandial; Type 2 diabetes; Medicine; Insulin; Diabetes mellitus; Meal; Internal medicine; Endocrinology; Intensive care medicine; Bioinformatics; Biology","score_opus":0.04824717584236721,"score_gpt":0.2997258717400016,"score_spread":0.2514786958976344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391151349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91224706,0.08450566,0.00007786793,0.0007793989,0.0002736209,0.00093708886,0.0000043857417,0.00006631996,0.0011085756],"genre_scores_gemma":[0.99070257,0.008437227,0.0003666937,0.000060818977,0.00023718264,0.000050723156,0.000030377842,0.000023815455,0.00009059194],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981765,0.00007107841,0.00028459428,0.00059563434,0.00040050378,0.00047169853],"domain_scores_gemma":[0.9993873,0.00013425577,0.000036584286,0.00019433272,0.00005121518,0.00019628297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080736296,0.00027200553,0.00050319737,0.00051745854,0.00010433027,0.00023878238,0.00008674638,0.00007936044,0.000026212647],"category_scores_gemma":[0.000058253976,0.000180853,0.000028874758,0.0006164184,0.0004499091,0.00033436422,0.00019138979,0.00034142027,0.000006956897],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033122845,0.00039838225,0.050622776,0.0046134866,0.00032066088,0.000055221604,0.002067468,0.0000093499475,0.0005212278,0.068456955,0.000114235896,0.87248904],"study_design_scores_gemma":[0.0026029157,0.0027850608,0.8778372,0.0060739308,0.0015244631,0.000004600514,0.003217824,0.01759502,0.0031412523,0.063595384,0.020552265,0.0010701023],"about_ca_topic_score_codex":0.000007554869,"about_ca_topic_score_gemma":0.0000158069,"teacher_disagreement_score":0.8714189,"about_ca_system_score_codex":0.000017805627,"about_ca_system_score_gemma":0.00003781258,"threshold_uncertainty_score":0.73749715},"labels":[],"label_agreement":null},{"id":"W4391317839","doi":"10.1111/dom.15455","title":"Obesity management from the perspectives of people living with obesity in Canada: A mixed‐methods study","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Obesity and Health Practices","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Obesity Network; University of Alberta; University of Calgary","funders":"Novo Nordisk Canada","keywords":"Psychological intervention; Obesity; Overweight; Psychology; Medicine; Nursing","score_opus":0.021239392146482062,"score_gpt":0.3633803032925362,"score_spread":0.3421409111460541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391317839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979511,0.015758919,0.00012297684,0.0008859774,0.0008480397,0.0016316398,0.00007827869,0.00006386639,0.0010992859],"genre_scores_gemma":[0.99532324,0.0017313287,0.0017039926,0.0004095852,0.00021851706,0.00016414764,0.0000059128465,0.000027453625,0.00041582694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941337,0.0034132807,0.00060732337,0.00065476116,0.0004609261,0.0007300012],"domain_scores_gemma":[0.99358803,0.0053214794,0.0002464123,0.0005273487,0.0001331036,0.0001836111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040716007,0.00030847095,0.0007992208,0.00016237862,0.0009537998,0.00004657277,0.00036956597,0.00013156788,0.00031241658],"category_scores_gemma":[0.0003102169,0.00021434446,0.0000651814,0.0007098551,0.00010300131,0.00042087722,0.0004851766,0.0011893787,0.000025305919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001966717,0.00056311284,0.9281106,0.000970438,0.00024664422,0.0000136980925,0.06401331,0.0000046636555,0.000009662211,0.0024723455,0.00051350676,0.003062338],"study_design_scores_gemma":[0.00044350568,0.00004220136,0.82655776,0.00071233616,0.0003090604,2.453024e-7,0.16806978,0.00013988647,0.000015188176,0.00058660004,0.0029297038,0.00019374963],"about_ca_topic_score_codex":0.71912175,"about_ca_topic_score_gemma":0.92633396,"teacher_disagreement_score":0.20721221,"about_ca_system_score_codex":0.00027735974,"about_ca_system_score_gemma":0.0010107287,"threshold_uncertainty_score":0.87407136},"labels":[],"label_agreement":null},{"id":"W4391607301","doi":"10.1111/dom.15479","title":"Effect of albiglutide on cardiovascular outcomes in older adults: A post hoc analysis of a randomized controlled trial","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"GlaxoSmithKline","keywords":"Medicine; Post-hoc analysis; Randomized controlled trial; Post hoc; Physical therapy; Internal medicine","score_opus":0.003015881425071274,"score_gpt":0.22961493926352047,"score_spread":0.2265990578384492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391607301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9595425,0.034653693,0.0000055942455,0.00009088877,0.0002777619,0.0049685338,0.00003288389,0.000035022833,0.0003931239],"genre_scores_gemma":[0.9979064,0.0010821506,0.000034012563,0.00008221094,0.000044074284,0.00054627255,0.000058778005,0.000015584696,0.00023053066],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99768496,0.00057631184,0.0006800433,0.00036069145,0.00044037378,0.00025759637],"domain_scores_gemma":[0.9978716,0.0014765311,0.0001252724,0.00037365334,0.000069690934,0.00008330025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028084756,0.00028282948,0.005996471,0.0011805322,0.00001968609,0.000021155329,0.00006832126,0.000094806084,0.000037558348],"category_scores_gemma":[0.00065810396,0.00016799908,0.0030936776,0.0006655557,0.00011113468,0.00007006261,0.00004360352,0.00011200674,0.000003282398],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83302486,0.0013677271,0.019731984,0.0015670205,0.115346454,0.000034980756,0.000751303,0.000040574527,0.00011951914,0.0011432577,0.000021491682,0.026850859],"study_design_scores_gemma":[0.8752748,0.00079349725,0.0480611,0.0003966779,0.07292588,6.7517774e-8,0.000023427932,0.0009856179,0.0012418341,0.000018867466,0.00014622058,0.00013200342],"about_ca_topic_score_codex":0.0001056123,"about_ca_topic_score_gemma":0.000009257438,"teacher_disagreement_score":0.04242057,"about_ca_system_score_codex":0.00001909635,"about_ca_system_score_gemma":0.000023208318,"threshold_uncertainty_score":0.6850804},"labels":[],"label_agreement":null},{"id":"W4391652120","doi":"10.1111/dom.15485","title":"Inter‐relationships between cardiovascular, renal and metabolic diseases: Underlying evidence and implications for integrated interdisciplinary care and management","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Diabetes Canada; University of Toronto","funders":"AstraZeneca","keywords":"Medicine; Intensive care medicine; Specialty; Disease; Health care; Internal medicine; Pathology","score_opus":0.04700399873108236,"score_gpt":0.30869696256568124,"score_spread":0.2616929638345989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391652120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7223309,0.2737667,0.0015334358,0.0007916951,0.000086080676,0.0011323326,0.00011869212,0.00009929817,0.0001408094],"genre_scores_gemma":[0.9830061,0.014152237,0.001947404,0.00006864407,0.00009366051,0.00033639147,0.00019397681,0.000026976917,0.00017458765],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987165,0.00007810666,0.00023312395,0.00057720754,0.00011585043,0.00027926677],"domain_scores_gemma":[0.9991347,0.00024534712,0.00003468716,0.0002761963,0.000065256296,0.00024380656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032692045,0.0002577379,0.0005375274,0.00029362697,0.00033963154,0.0002235454,0.000060887996,0.000077302655,0.0000025798702],"category_scores_gemma":[0.00004942951,0.00021164177,0.00014980228,0.0002208718,0.00016755899,0.00035803608,0.0003715114,0.00015561808,0.0000015792749],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023037694,0.00007039175,0.39907077,0.0032928067,0.0037325423,0.000007652589,0.0019204717,0.0000013167333,0.00009474326,0.016000409,0.00028421942,0.5755016],"study_design_scores_gemma":[0.00090217614,0.000096911856,0.9617244,0.0010315037,0.008925975,0.0000028118807,0.0009786686,0.00018418029,0.00006210935,0.0040937853,0.021770462,0.00022704204],"about_ca_topic_score_codex":0.000008099477,"about_ca_topic_score_gemma":0.0000062286026,"teacher_disagreement_score":0.5752746,"about_ca_system_score_codex":0.000027233034,"about_ca_system_score_gemma":0.00001760547,"threshold_uncertainty_score":0.86305016},"labels":[],"label_agreement":null},{"id":"W4392374089","doi":"10.1111/dom.15532","title":"Pre‐dinner walks may be superior to post‐dinner walks for glucose time in range in adults with type 1 diabetes on hybrid closed‐loop insulin delivery systems","year":2024,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"York University","funders":"","keywords":"Insulin delivery; Type 2 diabetes; Closed loop; Range (aeronautics); Loop (graph theory); Medicine; Mathematics; Diabetes mellitus; Endocrinology; Type 1 diabetes; Materials science; Combinatorics; Engineering","score_opus":0.010478018655082858,"score_gpt":0.2346140597039238,"score_spread":0.22413604104884094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392374089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91335964,0.015709264,4.322347e-7,0.063648395,0.0010333139,0.005097521,0.0006554239,0.00013993689,0.00035606837],"genre_scores_gemma":[0.7379152,0.0020158887,0.00026696926,0.21222451,0.00506962,0.0024153588,0.005306739,0.00062629336,0.034159396],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99445665,0.00031908051,0.00082137383,0.0015937708,0.0009870438,0.0018220615],"domain_scores_gemma":[0.997683,0.00053243106,0.00014917384,0.0008466489,0.0004257409,0.00036304194],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012628569,0.0010056767,0.0021760988,0.0020759916,0.00012494474,0.0003081145,0.00051160925,0.0008509462,0.00012600499],"category_scores_gemma":[0.00033302367,0.00076281436,0.0002830665,0.001010829,0.00021659021,0.0002785112,0.000387461,0.0021844362,0.0002658755],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038460062,0.0020343144,0.06822277,0.031465452,0.0025243873,0.0019197703,0.0016842042,0.000046147958,0.004108693,0.0001524871,0.8407219,0.04327388],"study_design_scores_gemma":[0.010097129,0.0026021716,0.08950467,0.01012997,0.0014245617,0.0000037120622,0.00011584441,0.0018981273,0.0031115052,0.0000902574,0.8789853,0.002036801],"about_ca_topic_score_codex":0.00013949869,"about_ca_topic_score_gemma":0.00005617177,"teacher_disagreement_score":0.17544441,"about_ca_system_score_codex":0.00017455092,"about_ca_system_score_gemma":0.0001809918,"threshold_uncertainty_score":0.9994823},"labels":[],"label_agreement":null},{"id":"W4392712963","doi":"10.1111/dom.15493","title":"Use of once‐daily oral semaglutide and associated clinical outcomes among adults with type 2 diabetes in routine clinical practice in Canada: A multicentre, prospective real‐world study ( <scp>PIONEER REAL</scp> Canada)","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; University of Calgary; Western University; LMC Diabetes & Endocrinology (Canada); Diabetes Canada; University of British Columbia","funders":"Novo Nordisk Pharma; Novo Nordisk","keywords":"Semaglutide; Medicine; Clinical endpoint; Confidence interval; Type 2 diabetes; Prospective cohort study; Internal medicine; Diabetes mellitus; Clinical trial; Endocrinology","score_opus":0.01958254838142105,"score_gpt":0.29132823680404685,"score_spread":0.2717456884226258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392712963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956829,0.0012889729,9.7113386e-8,0.00020462665,0.00041947357,0.0019404758,0.00006099901,0.00004853357,0.00035392196],"genre_scores_gemma":[0.9970379,0.0012799809,0.00030478637,0.0003746948,0.000055793258,0.00006568386,0.000057316345,0.00004089194,0.0007829616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99631226,0.0005329607,0.0010719224,0.0007761572,0.0006396252,0.00066706096],"domain_scores_gemma":[0.9959219,0.0028501484,0.00030908338,0.00034340087,0.0002739299,0.00030154403],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015271646,0.000404105,0.0015622476,0.00025867746,0.00005997937,0.00006500795,0.00010308673,0.00012143591,0.0000048197244],"category_scores_gemma":[0.0033175123,0.00030921336,0.00008237714,0.0008451376,0.00016800956,0.00035786643,0.00016337878,0.00059657806,8.7707093e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001065758,0.0017578229,0.99177754,0.00014509702,0.0013112702,0.0002674562,0.00069693115,0.00000800976,0.0000019305987,0.00007548564,0.0007127582,0.0031391163],"study_design_scores_gemma":[0.006140752,0.00043486108,0.9870683,0.00048503946,0.001679779,2.2088005e-7,0.0014267215,0.0013261855,0.00002253846,0.000012397141,0.0012309904,0.00017218989],"about_ca_topic_score_codex":0.94043946,"about_ca_topic_score_gemma":0.9967488,"teacher_disagreement_score":0.056309365,"about_ca_system_score_codex":0.00037566668,"about_ca_system_score_gemma":0.0011970601,"threshold_uncertainty_score":0.999936},"labels":[],"label_agreement":null},{"id":"W4392882969","doi":"10.1111/dom.15542","title":"Analyses of potential causal contributors to increased waist/hip ratio‐associated cardiometabolic disease: A combined and sex‐stratified Mendelian randomization study","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Public Health Ontario; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Mendelian randomization; Medicine; Internal medicine; Odds ratio; Waist–hip ratio; Type 2 diabetes; Endocrinology; Nonalcoholic fatty liver disease; Coronary artery disease; Diabetes mellitus; Body mass index; Waist; Fatty liver; Disease; Genetics; Biology; Genotype","score_opus":0.011430892367495041,"score_gpt":0.2735023999388374,"score_spread":0.26207150757134234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392882969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99073964,0.0067120274,0.0012770257,0.00013724859,0.00020259095,0.0006176376,0.00027014216,0.000024052706,0.00001962738],"genre_scores_gemma":[0.99857926,0.00039845597,0.00010005546,0.000121290555,0.00013346135,0.000065217246,0.00045906173,0.00001658316,0.00012660578],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99819434,0.0005450478,0.00039349892,0.0004310376,0.0001563815,0.0002797149],"domain_scores_gemma":[0.99925387,0.00007749863,0.00010562602,0.0002057838,0.00013941446,0.00021778684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000907588,0.00021049757,0.0006206486,0.0001693353,0.00014167753,0.00006621253,0.00008603288,0.0001352522,0.000007665393],"category_scores_gemma":[0.00064886606,0.00018754523,0.00011973033,0.0002934843,0.00007556652,0.000010457678,0.00009513819,0.000077598255,0.0000010531296],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035783584,0.00071665033,0.43885842,0.00011536406,0.003349927,0.00000904404,0.0005470436,0.0008338457,0.5506679,0.0004240765,0.0009423395,0.0031775606],"study_design_scores_gemma":[0.004087373,0.0002177469,0.9749056,0.000018950645,0.0013392501,5.1933796e-7,0.00018842699,0.0023954755,0.015546261,0.00024782645,0.0007550676,0.00029750122],"about_ca_topic_score_codex":0.00021125117,"about_ca_topic_score_gemma":0.00004311427,"teacher_disagreement_score":0.53604716,"about_ca_system_score_codex":0.000009045598,"about_ca_system_score_gemma":0.00008487412,"threshold_uncertainty_score":0.76478726},"labels":[],"label_agreement":null},{"id":"W4393379443","doi":"10.1111/dom.15575","title":"An update review of post‐transplant diabetes mellitus: Concept, risk factors, clinical implications and management","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Institute on Minority Health and Health Disparities; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institutes of Health; Novo Nordisk; Sanofi; Centers for Disease Control and Prevention; AstraZeneca; Eli Lilly and Company","keywords":"Intensive care medicine; Diabetes mellitus; Medicine; Endocrinology","score_opus":0.017913273642689142,"score_gpt":0.3167492510886116,"score_spread":0.2988359774459225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393379443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81493104,0.18288797,0.00005218413,0.00055114145,0.00012661055,0.00045813806,0.00086065184,0.000050816976,0.00008147018],"genre_scores_gemma":[0.60945886,0.3889032,0.00053726864,0.00056378084,0.00003158706,0.000014932993,0.0004574396,0.000010281707,0.000022626997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987391,0.000118536875,0.0004378386,0.000352609,0.00014640245,0.00020550117],"domain_scores_gemma":[0.9992243,0.00015312497,0.00007970866,0.00025836698,0.000061255945,0.000223212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003329445,0.00018821623,0.0005816541,0.00008846329,0.00007802692,0.000030893847,0.00006633473,0.00006944515,0.000043745546],"category_scores_gemma":[0.000013917623,0.00013169111,0.00015697497,0.00014131093,0.0001351191,0.00015402715,0.000016319234,0.00014233956,0.0000070353553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011675101,0.00031907434,0.9494347,0.012132039,0.001165107,0.000011319894,0.00024384269,2.851815e-7,0.00021486799,0.008186774,0.00006635999,0.028213952],"study_design_scores_gemma":[0.00068438007,0.00010669664,0.98399645,0.0039650025,0.0030640175,0.0000023239156,0.000017076589,0.000029869343,0.0010523141,0.0003783756,0.0065689078,0.00013455696],"about_ca_topic_score_codex":0.000021165035,"about_ca_topic_score_gemma":0.0000022765046,"teacher_disagreement_score":0.20601524,"about_ca_system_score_codex":0.0000052716,"about_ca_system_score_gemma":0.00001800184,"threshold_uncertainty_score":0.53702074},"labels":[],"label_agreement":null},{"id":"W4393986738","doi":"10.1111/dom.15588","title":"A comment on ‘Glucagon‐like peptide‐1 receptor agonists and risk of thyroid cancer: A systematic review and meta‐analysis of randomized controlled trials’","year":2024,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Meta-analysis; Medicine; Randomized controlled trial; Thyroid cancer; Oncology; Internal medicine; Cancer","score_opus":0.03499213468690576,"score_gpt":0.32371052415221996,"score_spread":0.2887183894653142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393986738","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041336942,0.9805862,0.0000017937582,0.00042094907,0.00016284548,0.01726514,0.0010264624,0.000034946603,0.00008834923],"genre_scores_gemma":[0.00009107131,0.9927114,0.00012009616,0.00076293334,0.000041923962,0.0051578125,0.00023538733,0.00004943882,0.0008299256],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99082553,0.004071338,0.0034927567,0.00073188625,0.000525583,0.0003528844],"domain_scores_gemma":[0.99130964,0.0042303847,0.0033470788,0.0006844795,0.00018250292,0.00024588298],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.011239682,0.0009864012,0.06786361,0.001075113,0.00007967821,0.00007083436,0.00015060019,0.00023450027,0.00009775719],"category_scores_gemma":[0.0019214075,0.0004902661,0.008157224,0.00073459453,0.0002615341,0.00005953028,0.00018177897,0.00032840925,0.0000046914947],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000450796,0.00018808652,0.0000050802196,0.49710518,0.49945903,0.0000013232255,0.00006718072,6.264077e-8,2.6710558e-7,0.0004268557,0.00048370444,0.0018124335],"study_design_scores_gemma":[0.032481134,0.00010217663,0.0000048324696,0.074992105,0.8586437,3.941661e-7,0.0000140562925,0.000015356665,0.0000035841747,0.000038228893,0.03341452,0.00028989074],"about_ca_topic_score_codex":0.0000993943,"about_ca_topic_score_gemma":0.000011719968,"teacher_disagreement_score":0.42211306,"about_ca_system_score_codex":0.000040927654,"about_ca_system_score_gemma":0.000086704924,"threshold_uncertainty_score":0.9997549},"labels":[],"label_agreement":null},{"id":"W4394819668","doi":"10.1111/dom.15587","title":"Prediction of cardiovascular risk factors from retinal fundus photographs: Validation of a deep learning algorithm in a prospective non‐interventional study in Kenya","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Retinal Imaging and Analysis","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"AstraZeneca","keywords":"Fundus (uterus); Retinal; Optometry; Prospective cohort study; Artificial intelligence; Medicine; Deep learning; Computer science; Ophthalmology; Machine learning; Algorithm; Surgery","score_opus":0.010462281717212233,"score_gpt":0.2386104851687193,"score_spread":0.22814820345150708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394819668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899283,0.008328422,0.0012021955,0.0000040687673,0.00008283832,0.00033490013,0.00006399993,0.000022108745,0.00003314801],"genre_scores_gemma":[0.99914753,0.00035696832,0.00030225795,9.401959e-7,0.000052975214,0.000023104534,0.00009025686,0.000010509636,0.000015447793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986036,0.00023431676,0.00037608488,0.0003233627,0.00032213976,0.00014053429],"domain_scores_gemma":[0.99955237,0.00007718455,0.00009650487,0.00013225558,0.000095823234,0.000045869707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079631346,0.00013130668,0.00058973354,0.0005196992,0.000032276745,0.000021083884,0.00003860379,0.000061461564,0.000021710883],"category_scores_gemma":[0.00013267685,0.00011454551,0.00034628971,0.0006396026,0.000064722335,0.00012841582,0.0000307596,0.00033728685,6.4175043e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019974046,0.0005768049,0.98626447,0.000110857975,0.0010672243,0.000009081621,0.0032958144,0.00019804531,0.0010374999,0.0000021709634,7.373507e-7,0.007417321],"study_design_scores_gemma":[0.0011167171,0.00018382711,0.96966445,0.00035813925,0.001619924,5.183788e-7,0.0017337896,0.01645448,0.008592787,0.00017642588,0.000024094443,0.00007483336],"about_ca_topic_score_codex":0.0027936217,"about_ca_topic_score_gemma":0.000022942195,"teacher_disagreement_score":0.016600005,"about_ca_system_score_codex":0.000024138237,"about_ca_system_score_gemma":0.0000171611,"threshold_uncertainty_score":0.46710303},"labels":[],"label_agreement":null},{"id":"W4396619349","doi":"10.1111/dom.15627","title":"Fluoroquinolones and the risk of severe hypoglycaemia among sulphonylurea users: Population‐based cohort study","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Hazard ratio; Amoxicillin; Cohort; Cohort study; Population; Confidence interval; Propensity score matching; Antibiotics","score_opus":0.006595623636002181,"score_gpt":0.23920413350775688,"score_spread":0.2326085098717547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396619349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916104,0.0069393977,0.000013646912,0.00021563857,0.00022068928,0.00082277803,0.00003840627,0.000051951167,0.00008710027],"genre_scores_gemma":[0.998411,0.0010190392,0.00016344035,0.00010396218,0.00012603062,0.000008537856,0.00002822469,0.000018904711,0.00012088942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998923,0.00012307343,0.00025367146,0.00027858105,0.00022988702,0.0001917823],"domain_scores_gemma":[0.99926054,0.00025103477,0.000075418306,0.0002414676,0.00006770985,0.00010382773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006439316,0.00017019942,0.00048794615,0.00011602433,0.00012516265,0.00005803095,0.00006975671,0.00007563083,0.000023198618],"category_scores_gemma":[0.00012820927,0.00010801146,0.00009797599,0.00020887355,0.00023640956,0.000079026046,0.00006829178,0.0002393406,0.0000028927884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055636443,0.00015144332,0.99607944,0.00016021523,0.00040782307,0.0000052818855,0.0004135988,0.00002397658,0.0001981744,0.00039121782,0.000111501664,0.0020017007],"study_design_scores_gemma":[0.002402339,0.000050067454,0.99002653,0.00008332758,0.0021442843,0.0000018307959,0.00009132512,0.0036478497,0.00074732245,0.00022559887,0.00045877625,0.00012074638],"about_ca_topic_score_codex":0.00047402128,"about_ca_topic_score_gemma":0.000016635691,"teacher_disagreement_score":0.006800579,"about_ca_system_score_codex":0.000006631416,"about_ca_system_score_gemma":0.000023874085,"threshold_uncertainty_score":0.44045794},"labels":[],"label_agreement":null},{"id":"W4396619388","doi":"10.1111/dom.15620","title":"Effect of semaglutide 2.4 mg on physical functioning and weight‐ and health‐related quality of life in adults with overweight or obesity: Patient‐reported outcomes from the <scp>STEP</scp> 1–4 trials","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; York University; University of Alberta","funders":"Novo Nordisk","keywords":"Medicine; Semaglutide; Overweight; Obesity; Quality of life (healthcare); Gerontology; Physical therapy; Internal medicine; Endocrinology; Type 2 diabetes; Diabetes mellitus; Nursing","score_opus":0.023055780584326592,"score_gpt":0.28391158455474164,"score_spread":0.260855803970415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396619388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841272,0.013803207,0.000003648743,0.00033792297,0.00018692629,0.0012997126,0.000067052446,0.000050833554,0.00012347972],"genre_scores_gemma":[0.9987037,0.0006432464,0.000077065444,0.0002747208,0.000060354276,0.000051524174,0.00006283419,0.000020846239,0.000105674524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99745786,0.00064765784,0.0007774409,0.00045717208,0.0003668663,0.00029299292],"domain_scores_gemma":[0.9957258,0.003389067,0.00038995082,0.00028127333,0.000045009267,0.00016889525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017813767,0.00031079102,0.0018132647,0.00016523905,0.00008681273,0.00003760132,0.000048132733,0.00009009499,0.000009308386],"category_scores_gemma":[0.00088225625,0.000157708,0.00013953555,0.0003164817,0.00015745948,0.00011664043,0.00008254578,0.00021166155,0.0000013504167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036742204,0.00054819393,0.9628479,0.0014842376,0.0017026553,0.000014294808,0.0024037363,0.0000019033037,0.00018537982,0.0006469827,0.00022412947,0.029573191],"study_design_scores_gemma":[0.0064925924,0.0012744027,0.986585,0.001181245,0.0012083284,6.286793e-7,0.00024998054,0.00030986214,0.0019822428,0.00019236463,0.00044273093,0.00008058521],"about_ca_topic_score_codex":0.0007044758,"about_ca_topic_score_gemma":0.00008440913,"teacher_disagreement_score":0.029492607,"about_ca_system_score_codex":0.000021846088,"about_ca_system_score_gemma":0.00005809515,"threshold_uncertainty_score":0.6431145},"labels":[],"label_agreement":null},{"id":"W4396809585","doi":"10.1111/dom.15647","title":"Validation of the Individualized Metabolic Surgery score in predicting long‐term remission of diabetes after duodenal switch‐type procedures","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Type 2 diabetes; Cohort; Retrospective cohort study; Cohort study; Internal medicine; Receiver operating characteristic; Sleeve gastrectomy; Area under the curve; Body mass index; Surgery; Diabetes mellitus; Obesity; Gastric bypass; Weight loss; Endocrinology","score_opus":0.015223607877313423,"score_gpt":0.2484808302039205,"score_spread":0.2332572223266071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396809585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96522063,0.033393748,0.0000018215967,0.0002020982,0.00072442694,0.00034753562,0.000026434254,0.00004254157,0.000040758783],"genre_scores_gemma":[0.99865675,0.0007919849,0.00006521661,0.00013591004,0.00019222128,0.00002398822,0.000027620717,0.000022441718,0.00008384387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819416,0.00018438457,0.0006037372,0.00030892648,0.00039255363,0.00031623567],"domain_scores_gemma":[0.9987356,0.0005985552,0.00018538532,0.00026745672,0.00011432183,0.00009864842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001194508,0.00021439961,0.0008301917,0.0003934126,0.000056356796,0.00003198091,0.00009927041,0.00017247915,0.00006091552],"category_scores_gemma":[0.001093395,0.00013959846,0.0002483071,0.0009090438,0.00011861529,0.00024894797,0.000113764116,0.00027067718,0.0000013447768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004653608,0.00011461777,0.98119557,0.0016100344,0.00016064053,0.0000038376247,0.0006472449,0.0000015687799,0.011654094,0.000079285244,0.00004557687,0.004441009],"study_design_scores_gemma":[0.000345446,0.000010650329,0.8529758,0.0011904212,0.0005392092,0.0000020325817,0.000017767126,0.000032367072,0.14438398,0.00021121504,0.00017870481,0.00011240105],"about_ca_topic_score_codex":0.00001648683,"about_ca_topic_score_gemma":0.000004411128,"teacher_disagreement_score":0.13272989,"about_ca_system_score_codex":0.000010254035,"about_ca_system_score_gemma":0.00023152854,"threshold_uncertainty_score":0.56926596},"labels":[],"label_agreement":null},{"id":"W4396937622","doi":"10.1111/dom.15654","title":"Determinants of serious health <scp>outcome‐free</scp> status in <scp>middle‐aged</scp> and older people with dysglycaemia: Exploratory analysis of the <scp>ORIGIN</scp> trial","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"McMaster University; Hamilton Health Sciences; Sanofi","keywords":"Medicine; Internal medicine; Body mass index; Diabetes mellitus; Kidney disease; Type 2 diabetes; Endocrinology","score_opus":0.015330514339238082,"score_gpt":0.258766844180464,"score_spread":0.2434363298412259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396937622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97590953,0.020994049,0.000015498896,0.00006731115,0.000534806,0.001794041,0.00021414309,0.0000916621,0.0003789463],"genre_scores_gemma":[0.9945798,0.002994215,0.000263498,0.00040289588,0.00013297048,0.00017145197,0.00007919084,0.00006552638,0.0013104877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960964,0.00030426978,0.0009812806,0.0008240046,0.0007403898,0.0010536786],"domain_scores_gemma":[0.9970347,0.0010440439,0.0004680155,0.0009030671,0.00012687822,0.00042325616],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011370407,0.00058052765,0.0021992275,0.0010189982,0.00018483112,0.000108381275,0.0003024886,0.00022896875,0.0000059369804],"category_scores_gemma":[0.00063074485,0.0004059031,0.00038121757,0.0022622894,0.00033311793,0.0003825846,0.0003495908,0.00045106385,0.0000036998663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032315358,0.00073610176,0.98096687,0.0017104624,0.0019204124,0.000031430645,0.0073565478,0.00001595924,0.00023491016,0.00034705867,0.0009061291,0.005741781],"study_design_scores_gemma":[0.014172929,0.00052380137,0.96540374,0.0004468167,0.0054124114,0.000001744768,0.0027125455,0.0003307743,0.0022773328,0.00015018178,0.008499771,0.000067972804],"about_ca_topic_score_codex":0.00038409416,"about_ca_topic_score_gemma":0.0015005866,"teacher_disagreement_score":0.018670222,"about_ca_system_score_codex":0.00009581429,"about_ca_system_score_gemma":0.00025629575,"threshold_uncertainty_score":0.9998393},"labels":[],"label_agreement":null},{"id":"W4397002346","doi":"10.1111/dom.15650","title":"Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the <scp>ORION</scp> ‐9, <scp>ORION</scp> ‐10 and <scp>ORION</scp> ‐11 Phase 3 randomized trials","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"NIHR Imperial Biomedical Research Centre; Imperial College London; Novartis Pharma; National Institute for Health and Care Research","keywords":"Medicine; Placebo; Prediabetes; Body mass index; Internal medicine; Post-hoc analysis; Type 2 diabetes; Obesity; Diabetes mellitus; Randomized controlled trial; Cholesterol; Adverse effect; Endocrinology; Gastroenterology; Pathology","score_opus":0.03341380485866252,"score_gpt":0.33047036542645913,"score_spread":0.2970565605677966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397002346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9305292,0.06299852,0.000021759117,0.00043581275,0.00095015246,0.0036918023,0.0007517207,0.00023898407,0.00038207942],"genre_scores_gemma":[0.9877877,0.0058958405,0.0005580911,0.0015642499,0.0007074151,0.0004380091,0.0003592632,0.00012469663,0.0025647248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99058896,0.0031103103,0.0020647892,0.0015194587,0.0011795358,0.0015369484],"domain_scores_gemma":[0.9800467,0.016705625,0.0010295144,0.0009371291,0.00048095084,0.00080007396],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.007056225,0.0013044418,0.0055706245,0.0013855156,0.0006631302,0.0003253779,0.00060472975,0.0008185599,0.00008973611],"category_scores_gemma":[0.011359871,0.00079267024,0.0010167633,0.002069768,0.0012473179,0.0007831865,0.000548263,0.0011595355,0.00003862906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028686086,0.013001376,0.8090659,0.0046109958,0.02640655,0.0006529578,0.022836894,0.00006758836,0.091765866,0.0028552604,0.013488411,0.012379636],"study_design_scores_gemma":[0.23938134,0.0016859102,0.44076836,0.0020697033,0.032476645,0.0000544154,0.0021381245,0.0006225788,0.22800997,0.0026765352,0.04973235,0.00038407132],"about_ca_topic_score_codex":0.0001611883,"about_ca_topic_score_gemma":0.00016221788,"teacher_disagreement_score":0.3682975,"about_ca_system_score_codex":0.00011739795,"about_ca_system_score_gemma":0.0006355153,"threshold_uncertainty_score":0.99997073},"labels":[],"label_agreement":null},{"id":"W4397012202","doi":"10.1111/dom.15657","title":"Development and first‐stage validation of a digital version of the Digit Symbol Substitution test for use in assessing cognitive function in older people with diabetes","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"MSD Sharp and Dohme","keywords":"Digit symbol substitution test; Cognition; Numerical digit; Correlation; Computer science; Psychology; Medicine; Mathematics; Arithmetic; Psychiatry; Pathology","score_opus":0.014431399278113799,"score_gpt":0.2546376924159936,"score_spread":0.2402062931378798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397012202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984461,0.0004665998,0.00018877123,0.000040371946,0.000040167226,0.000717083,0.000048244267,0.00000918279,0.000043492426],"genre_scores_gemma":[0.9996548,0.000030728115,0.00008253184,0.000014596871,0.000011375531,0.000055252276,0.000085979314,0.000007509961,0.000057215188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923694,0.000023568384,0.00018177912,0.00019232139,0.00019790632,0.00016747952],"domain_scores_gemma":[0.9994034,0.00034068798,0.0000492314,0.000052902556,0.0001157206,0.000038010858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024422,0.00009812851,0.00021581336,0.00019500492,0.00005860562,0.00009337216,0.000022671764,0.000045334153,0.0000053844537],"category_scores_gemma":[0.00021563559,0.0000679002,0.000029621102,0.00032675033,0.000088591725,0.0006234186,0.00004175728,0.000087847046,4.1564178e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048667673,0.00026514955,0.98864496,0.0007907158,0.000048603964,8.603245e-7,0.00058131875,0.0000012005172,0.0029418317,0.00004793577,0.0000019286467,0.006626847],"study_design_scores_gemma":[0.0015036362,0.00008485962,0.90253115,0.0011433591,0.00014906513,2.76362e-7,0.00040074813,0.0003472055,0.093574874,0.000033581135,0.00016299888,0.00006823264],"about_ca_topic_score_codex":0.000009929471,"about_ca_topic_score_gemma":0.000034688248,"teacher_disagreement_score":0.09063304,"about_ca_system_score_codex":0.000020033229,"about_ca_system_score_gemma":0.000083625564,"threshold_uncertainty_score":0.27688897},"labels":[],"label_agreement":null},{"id":"W4398252779","doi":"10.1111/dom.15682","title":"Comparative safety and cardiovascular effectiveness of sodium‐glucose cotransporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists in nursing homes","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute on Aging","keywords":"Medicine; Hazard ratio; Adverse effect; Internal medicine; Diabetic ketoacidosis; Diabetes mellitus; Heart failure; Type 2 diabetes; Population; Intensive care medicine; Confidence interval; Endocrinology","score_opus":0.007096238374035541,"score_gpt":0.2402489686211598,"score_spread":0.23315273024712427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398252779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88356537,0.11471349,0.000024219853,0.000057824698,0.0003130885,0.0007324331,0.000037823098,0.000048400816,0.00050733675],"genre_scores_gemma":[0.9927069,0.006759451,0.00022459636,0.000030414942,0.000067638495,0.0000328995,0.00008136882,0.000020550715,0.00007618375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852127,0.00016768872,0.00028776817,0.00049080304,0.00022182438,0.0003106558],"domain_scores_gemma":[0.99939334,0.0001649015,0.00003974475,0.00020112608,0.000045954468,0.00015492634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069265463,0.0002813026,0.0011082494,0.0002728696,0.0000777068,0.000054982833,0.00004115492,0.00010172516,0.000008153468],"category_scores_gemma":[0.000013118221,0.00024079716,0.00016743052,0.00026722217,0.00032604652,0.00022323272,0.000043105614,0.0001645472,0.000002622866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010789431,0.0019201963,0.65040284,0.0141428355,0.008410462,0.00014577416,0.013677172,0.000023568275,0.04486483,0.0088955965,0.00030245256,0.25613534],"study_design_scores_gemma":[0.0030948152,0.0001709692,0.9340457,0.0024512461,0.001754314,0.0000028194536,0.00034823772,0.00012366081,0.048269574,0.0003904906,0.009066134,0.00028204525],"about_ca_topic_score_codex":0.00004977702,"about_ca_topic_score_gemma":0.000007308321,"teacher_disagreement_score":0.28364286,"about_ca_system_score_codex":0.00003803312,"about_ca_system_score_gemma":0.00003115251,"threshold_uncertainty_score":0.9819423},"labels":[],"label_agreement":null},{"id":"W4399138329","doi":"10.1111/dom.15678","title":"Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the <scp>CANVAS</scp> Program and <scp>CREDENCE</scp> trial","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Seven Oaks General Hospital","funders":"Astellas Pharma; Novo Nordisk; AstraZeneca; Eli Lilly and Company; Amgen","keywords":"Kidney disease; Confidence interval; Credence; Medicine; Receiver operating characteristic; Renal function; Brier score; Internal medicine; Creatinine; Area under the curve; Albuminuria; Machine learning; Computer science","score_opus":0.01559221180745171,"score_gpt":0.273363173717535,"score_spread":0.2577709619100833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399138329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587304,0.037291575,0.000044903198,0.00029896825,0.0002731238,0.002664405,0.0005204527,0.00007082384,0.00010535955],"genre_scores_gemma":[0.9965561,0.0016141706,0.00015485536,0.00015087925,0.0004268504,0.0004920514,0.00039699755,0.000025971096,0.00018214512],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9982085,0.00018993566,0.00042967012,0.0003849271,0.00042723562,0.00035968606],"domain_scores_gemma":[0.9986226,0.0005130913,0.00017257816,0.00029827992,0.00010218939,0.0002912873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090197346,0.00023165242,0.00046001433,0.00014089761,0.0001705703,0.00007453485,0.00014719949,0.00013077744,0.0000038485764],"category_scores_gemma":[0.0020383045,0.0001406039,0.0002205158,0.0003527368,0.00026288678,0.00022448665,0.00009448833,0.00032549066,6.2280003e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080966123,0.0063273893,0.8142215,0.020635312,0.0012383726,0.0000127180165,0.007911195,0.0013463375,0.019196805,0.0063704196,0.0100364955,0.111893795],"study_design_scores_gemma":[0.037924826,0.0016304813,0.33670694,0.003384134,0.0051802592,0.0000038096643,0.00053577166,0.51504624,0.025571562,0.006937254,0.066939875,0.00013886575],"about_ca_topic_score_codex":0.000013092294,"about_ca_topic_score_gemma":0.0000019034514,"teacher_disagreement_score":0.5136999,"about_ca_system_score_codex":0.000031839892,"about_ca_system_score_gemma":0.00063307583,"threshold_uncertainty_score":0.57336605},"labels":[],"label_agreement":null},{"id":"W4399327175","doi":"10.1111/dom.15691","title":"Utilizing synchronous care to improve cardiovascular and renal health among patients with type 2 diabetes: Proof‐of‐concept results from the <scp>DECIDE</scp> ‐ <scp>CV</scp> clinical programme","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Janssen Research and Development; Novo Nordisk Foundation Center for Basic Metabolic Research; Boehringer Ingelheim","keywords":"Medicine; Type 2 diabetes; Internal medicine; Diabetes mellitus; Kidney disease; Mineralocorticoid receptor; Urology; Creatinine; Endocrinology; Aldosterone; Renal function; Outpatient clinic; Type 2 Diabetes Mellitus","score_opus":0.014026643978323644,"score_gpt":0.24731626414161395,"score_spread":0.2332896201632903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399327175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91538715,0.08043655,0.000027401164,0.0001032201,0.00061862747,0.0026522567,0.0003334095,0.00013479961,0.00030657978],"genre_scores_gemma":[0.99625945,0.0006553631,0.0010780017,0.00054417405,0.0004656614,0.0001401666,0.00057442987,0.000070144524,0.00021260149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99632037,0.00026081302,0.00074312993,0.0010890597,0.00064551376,0.0009411236],"domain_scores_gemma":[0.99712336,0.0009782722,0.00021003342,0.00082167785,0.00028432117,0.0005823331],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010477384,0.00049474306,0.0013196623,0.00015757892,0.00023555376,0.00019873297,0.00021469111,0.00018974039,0.0000019549946],"category_scores_gemma":[0.0008498329,0.00032241354,0.00034346088,0.00051363924,0.00037602923,0.00024894424,0.00030624197,0.00042661218,0.0000072012485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021049225,0.0005070821,0.5707463,0.0007116247,0.00420876,0.000017574326,0.005446745,0.0000148578865,0.000022603874,0.00009679729,0.0022749999,0.41593158],"study_design_scores_gemma":[0.0041869553,0.0018055994,0.89956653,0.0010153712,0.002713731,2.0051974e-7,0.0014946446,0.0001271321,0.0015452188,0.00006868445,0.087360874,0.00011504147],"about_ca_topic_score_codex":0.0002224478,"about_ca_topic_score_gemma":0.000047785474,"teacher_disagreement_score":0.41581655,"about_ca_system_score_codex":0.00006740504,"about_ca_system_score_gemma":0.00017744601,"threshold_uncertainty_score":0.9999228},"labels":[],"label_agreement":null},{"id":"W4399385130","doi":"10.1111/dom.15687","title":"Hypoglycaemia and kidney events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the <scp>VERTIS CV</scp> trial","year":2024,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"Pfizer","keywords":"Type 2 diabetes; Disease; Medicine; Diabetes mellitus; Atherosclerotic cardiovascular disease; Kidney disease; Internal medicine; Endocrinology","score_opus":0.03858505619028017,"score_gpt":0.2461420064499814,"score_spread":0.20755695025970122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399385130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9122097,0.058844898,0.000001045974,0.026363157,0.00051900576,0.0017444934,0.00021234433,0.00005967695,0.000045661967],"genre_scores_gemma":[0.678861,0.027856298,0.0003293628,0.26779613,0.008869301,0.0013388669,0.003403588,0.0004732132,0.011072217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966468,0.00034910045,0.00036874655,0.00089085405,0.00081397453,0.0009304982],"domain_scores_gemma":[0.9980469,0.0006018893,0.00008835113,0.0007314328,0.00009726902,0.00043418317],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079893274,0.00050822704,0.001130184,0.00021520814,0.000204795,0.00020210183,0.00022939895,0.0003750218,0.000017655571],"category_scores_gemma":[0.0008774001,0.0003290864,0.00020655614,0.0004916139,0.0003641183,0.00019872298,0.00036804055,0.0012594933,0.000018172443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015025922,0.00020350792,0.84339136,0.0018321045,0.005113241,0.000115035116,0.00053710985,0.000003634309,0.00012862627,0.000033587854,0.14562447,0.0028670637],"study_design_scores_gemma":[0.0070536383,0.00009809772,0.6803143,0.0009442979,0.0035156964,1.6039989e-7,0.000025397881,0.00023568289,0.000021723235,0.0005361769,0.30709824,0.00015660697],"about_ca_topic_score_codex":0.00009556398,"about_ca_topic_score_gemma":0.000010052984,"teacher_disagreement_score":0.24143298,"about_ca_system_score_codex":0.000030094641,"about_ca_system_score_gemma":0.00015380263,"threshold_uncertainty_score":0.99991614},"labels":[],"label_agreement":null},{"id":"W4399385154","doi":"10.1111/dom.15688","title":"The daunting task of recruiting insulin‐treated patients living with type 2 diabetes mellitus for intensive lifestyle interventions","year":2024,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Consumer Attitudes and Food Labeling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute; Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Psychological intervention; Type 2 Diabetes Mellitus; Medicine; Task (project management); Diabetes mellitus; Insulin; Intensive care medicine; Internal medicine; Endocrinology; Nursing; Engineering","score_opus":0.020176957520881254,"score_gpt":0.2597668365144375,"score_spread":0.23958987899355624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399385154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85351366,0.13270538,0.000014152274,0.011387187,0.0008200221,0.0011821556,0.0002153018,0.00008862217,0.00007349679],"genre_scores_gemma":[0.96014714,0.0036088803,0.0006114565,0.032611344,0.001407596,0.00018204212,0.0007168913,0.00016129942,0.0005533689],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978775,0.00010105168,0.00062972074,0.0005174736,0.00028368764,0.0005906132],"domain_scores_gemma":[0.99678934,0.0010861658,0.0003852536,0.000378103,0.0012666786,0.00009445343],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051041873,0.00040199992,0.0009388953,0.00022195272,0.0003194077,0.0001433673,0.00017394894,0.00033858477,0.000011169309],"category_scores_gemma":[0.0013958723,0.00026841718,0.00034762447,0.00032985618,0.00015564833,0.00009551051,0.00022298397,0.0010192633,0.0000073623096],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018781569,0.0008234921,0.70282596,0.039549164,0.021798465,0.000050396433,0.0044113393,0.0000062378767,0.0015620006,0.00035857683,0.13270903,0.095717505],"study_design_scores_gemma":[0.0029014654,0.0015350827,0.22990814,0.036632005,0.025690466,0.0000062038566,0.00055237644,0.001208219,0.0021386405,0.00040227023,0.6975113,0.0015138093],"about_ca_topic_score_codex":0.000041482534,"about_ca_topic_score_gemma":0.000017369279,"teacher_disagreement_score":0.5648023,"about_ca_system_score_codex":0.000026773556,"about_ca_system_score_gemma":0.000075962824,"threshold_uncertainty_score":0.9999768},"labels":[],"label_agreement":null},{"id":"W4399500926","doi":"10.1111/dom.15703","title":"Cost–utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy—An Italian healthcare system perspective","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Perspective (graphical); Basal insulin; Flash (photography); Continuous glucose monitoring; Medicine; Type 2 Diabetes Mellitus; Intensive care medicine; Diabetes mellitus; Basal (medicine); Insulin; Critically ill; Type 1 diabetes; Type 2 diabetes; Computer science; Internal medicine; Endocrinology; Artificial intelligence; Art","score_opus":0.022812358994186856,"score_gpt":0.2949182100260869,"score_spread":0.27210585103190005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399500926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9656081,0.03157194,0.0000054377037,0.00016120865,0.00021187103,0.0014060376,0.000059260496,0.00006853583,0.0009075743],"genre_scores_gemma":[0.99840146,0.0011522988,0.00009808121,0.000032093394,0.00008331666,0.00010395294,0.0000419589,0.000024144165,0.000062668216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754083,0.00037467774,0.00041321616,0.00051472115,0.0006891191,0.00046743997],"domain_scores_gemma":[0.99873585,0.00016753866,0.00011509361,0.00055800105,0.00028416928,0.00013937958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015853733,0.00026282287,0.0010016134,0.0006922515,0.00009239157,0.00008091132,0.00024026979,0.000096256445,0.000007613111],"category_scores_gemma":[0.000017231772,0.0001654416,0.00017400991,0.002228916,0.00013179034,0.00014064055,0.000077643956,0.00028982165,0.0000042465304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062236,0.0015623207,0.8677747,0.015538763,0.011003323,0.00009601423,0.013503262,0.00007919014,0.0005211772,0.025198618,0.000028967952,0.06407125],"study_design_scores_gemma":[0.0011901921,0.00054853404,0.96522087,0.0017308883,0.0022021586,2.1136857e-7,0.021440383,0.0042454726,0.0028606376,0.000044213673,0.00033704858,0.00017942114],"about_ca_topic_score_codex":0.00024000867,"about_ca_topic_score_gemma":0.000047876234,"teacher_disagreement_score":0.097446084,"about_ca_system_score_codex":0.00010364645,"about_ca_system_score_gemma":0.00004563316,"threshold_uncertainty_score":0.67465127},"labels":[],"label_agreement":null},{"id":"W4399545973","doi":"10.1111/dom.15711","title":"No association between semaglutide and postoperative pneumonia in people with diabetes undergoing elective surgery","year":2024,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Semaglutide; Medicine; Pneumonia; Diabetes mellitus; Surgery; General surgery; Internal medicine; Type 2 diabetes; Endocrinology","score_opus":0.0069880721845607605,"score_gpt":0.20729353006341633,"score_spread":0.20030545787885556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399545973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91573906,0.0062340484,9.3488933e-7,0.07554126,0.0002912246,0.00094334886,0.0001131504,0.00011593858,0.0010210306],"genre_scores_gemma":[0.7289318,0.003481804,0.00045634343,0.23523688,0.0037601602,0.0005905907,0.0025819845,0.00033890118,0.024621528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971465,0.00021070306,0.00041123395,0.00085767155,0.00048560393,0.0008883168],"domain_scores_gemma":[0.9980009,0.0012076031,0.00022341184,0.00026163648,0.00016564497,0.00014076848],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005756608,0.0006288738,0.0016890572,0.000669656,0.00013768075,0.0002188208,0.00007639413,0.0005637995,0.000019034314],"category_scores_gemma":[0.00023027719,0.000510736,0.00016199845,0.00048765968,0.00008473592,0.00022894306,0.00014900003,0.0012035705,0.000051529118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009761194,0.00007601361,0.9314925,0.0013148618,0.0020756323,0.00007613401,0.00032645682,3.5322074e-7,0.00009543148,0.000028684566,0.06322305,0.0012810858],"study_design_scores_gemma":[0.0009517689,0.00017583501,0.85665447,0.0011875742,0.003240962,7.731253e-7,0.000030886105,0.000030149495,0.00043719934,0.00028989554,0.13643335,0.00056716875],"about_ca_topic_score_codex":0.00008690348,"about_ca_topic_score_gemma":0.00016478525,"teacher_disagreement_score":0.18680726,"about_ca_system_score_codex":0.00030254887,"about_ca_system_score_gemma":0.00017336267,"threshold_uncertainty_score":0.9997344},"labels":[],"label_agreement":null},{"id":"W4399811711","doi":"10.1111/dom.15685","title":"Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the <scp>CREDENCE</scp> randomized trial","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care; University of British Columbia","funders":"Janssen Research and Development","keywords":"Canagliflozin; Medicine; Hazard ratio; Myocardial infarction; Internal medicine; Kidney disease; Proportional hazards model; Renal function; Stroke (engine); Heart failure; Confidence interval; Demography; Diabetes mellitus; Type 2 diabetes; Endocrinology","score_opus":0.00452194391986236,"score_gpt":0.20694754608862617,"score_spread":0.20242560216876382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399811711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794456,0.017547755,0.00003116112,0.00022454419,0.00021241223,0.0017227221,0.00008405825,0.00003342175,0.0006983266],"genre_scores_gemma":[0.99737155,0.0018270753,0.00013508066,0.00026903357,0.00005342625,0.0001127725,0.00004319318,0.000013564431,0.00017431495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979459,0.00048214445,0.00040604788,0.000503434,0.000355781,0.00030669378],"domain_scores_gemma":[0.99852735,0.0007420289,0.000078220415,0.00040916938,0.000051388837,0.00019185974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002787282,0.00027371396,0.0018991862,0.00047826918,0.00010357291,0.00007267521,0.000081471175,0.00010687038,0.00001258187],"category_scores_gemma":[0.0005495491,0.00015818697,0.0005997746,0.00096822676,0.0005026686,0.00015381814,0.0001417441,0.00021786807,2.6022198e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065343697,0.0003365579,0.9375233,0.0011138974,0.034779098,0.000020666928,0.001602898,0.000013116847,0.00003086231,0.0031450219,0.000041510346,0.014858716],"study_design_scores_gemma":[0.18692043,0.00005867189,0.77802783,0.00015029592,0.028565885,6.3055904e-7,0.00007608605,0.00057983986,0.00006828544,0.0005642238,0.004906499,0.00008129417],"about_ca_topic_score_codex":0.0005907403,"about_ca_topic_score_gemma":0.00018662398,"teacher_disagreement_score":0.18038607,"about_ca_system_score_codex":0.000019199382,"about_ca_system_score_gemma":0.00010708959,"threshold_uncertainty_score":0.64506775},"labels":[],"label_agreement":null},{"id":"W4400262071","doi":"10.1111/dom.15726","title":"Once‐weekly insulin icodec compared with daily basal insulin analogues in type 2 diabetes: Participant‐level meta‐analysis of the <scp>ONWARDS</scp> 1–5 trials","year":2024,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Novo Nordisk; Steno Diabetes Center Copenhagen","keywords":"Medicine; Basal insulin; Type 2 diabetes; Meta-analysis; Insulin; Internal medicine; Basal (medicine); Diabetes mellitus; Endocrinology","score_opus":0.2422899538052596,"score_gpt":0.3831252561748905,"score_spread":0.1408353023696309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400262071","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07563618,0.920169,0.000003039914,0.00012173227,0.00038859688,0.0023192584,0.0009711336,0.00006862954,0.00032240813],"genre_scores_gemma":[0.020520343,0.9755679,0.00021779913,0.0002886025,0.0002629266,0.0003748079,0.00080128753,0.00011995372,0.0018463805],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9919455,0.002135401,0.0021833016,0.0012075853,0.0012908891,0.0012373079],"domain_scores_gemma":[0.9947652,0.0021826597,0.0009829625,0.0013020561,0.00036478462,0.00040234416],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0061139665,0.001078545,0.012972585,0.002277583,0.00015263642,0.00021210291,0.00084344414,0.0005502987,0.000091233465],"category_scores_gemma":[0.0020213618,0.0005672352,0.0030791906,0.0068865274,0.0005973956,0.00020248994,0.00070324476,0.0013352059,0.000054302272],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006411063,0.0026259094,0.016337777,0.062937945,0.73198193,0.00007389247,0.0018334175,0.000085738895,0.00003083982,0.0008797427,0.0050293794,0.17811933],"study_design_scores_gemma":[0.0012306499,0.00015112101,0.026437245,0.0032267498,0.61027324,2.4898205e-7,0.00012554578,0.0003720499,0.00004279068,0.0001749721,0.35767153,0.00029388594],"about_ca_topic_score_codex":0.00008056135,"about_ca_topic_score_gemma":0.0002003531,"teacher_disagreement_score":0.35264215,"about_ca_system_score_codex":0.00006116707,"about_ca_system_score_gemma":0.0005810557,"threshold_uncertainty_score":0.9996779},"labels":[],"label_agreement":null},{"id":"W4400475255","doi":"10.1111/dom.15746","title":"The interaction effect between <scp>BMI</scp> , diabetes and age at diabetes onset on the risk of thyroid cancer: A population‐based cohort study in Shanghai, China","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Natural Science Foundation of China; Shanghai Municipal Health Commission","keywords":"Medicine; Thyroid cancer; Hazard ratio; Population; Internal medicine; Diabetes mellitus; Incidence (geometry); Cohort; Type 2 diabetes; Body mass index; Proportional hazards model; Cohort study; Cancer; Demography; Endocrinology; Confidence interval; Environmental health","score_opus":0.008275500570069656,"score_gpt":0.2595411814488906,"score_spread":0.25126568087882095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400475255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96958,0.027399248,2.3770113e-7,0.0004655527,0.00030889697,0.0018880155,0.00024220257,0.000056255434,0.000059593323],"genre_scores_gemma":[0.99608755,0.002644804,0.000006022518,0.00013746836,0.00017706354,0.00075181515,0.00008780495,0.000034120676,0.00007336044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780387,0.00052797765,0.00037602946,0.00050421787,0.0003647796,0.00042310756],"domain_scores_gemma":[0.9958898,0.0033826458,0.00015987922,0.00040540108,0.000033794135,0.00012850367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012634231,0.00034532996,0.000786396,0.00019954071,0.00034941113,0.00012382382,0.0001193925,0.00009783968,0.000010755548],"category_scores_gemma":[0.0003724758,0.00018954625,0.00016535755,0.00037105466,0.0001355746,0.00011765276,0.00010472434,0.00038413025,0.0000048347374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016079324,0.00025288353,0.9914876,0.00015583259,0.00076957257,0.000004384847,0.00053176045,0.000016509437,0.0002520338,0.00004181578,0.0003560536,0.0061154556],"study_design_scores_gemma":[0.0013325174,0.0005539109,0.985272,0.00039410332,0.0016356718,1.6677527e-7,0.00007879586,0.0003962662,0.00928007,0.00020226836,0.000758063,0.00009620094],"about_ca_topic_score_codex":0.00078439096,"about_ca_topic_score_gemma":0.0005202122,"teacher_disagreement_score":0.026507542,"about_ca_system_score_codex":0.0001337586,"about_ca_system_score_gemma":0.00003202942,"threshold_uncertainty_score":0.7729472},"labels":[],"label_agreement":null},{"id":"W4400696290","doi":"10.1111/dom.15770","title":"Effects of intensive treatment of Chinese women with gestational diabetes on the risk of offspring being overweight from 3 to 8 years of age","year":2024,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Natural Science Foundation of Tianjin City; National Natural Science Foundation of China; Eli Lilly and Company","keywords":"Offspring; Overweight; Gestational diabetes; Medicine; Diabetes mellitus; Obstetrics; Gestational age; Pregnancy; Obesity; Internal medicine; Gestation; Endocrinology; Biology","score_opus":0.0055565055311902825,"score_gpt":0.22163054203896906,"score_spread":0.2160740365077788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400696290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99044245,0.0019110279,0.0000036293077,0.0057159453,0.000106455635,0.0010176064,0.0007074516,0.000009687818,0.000085758955],"genre_scores_gemma":[0.9867391,0.00092002825,0.00045033722,0.010819875,0.00027595556,0.00017679363,0.00025663385,0.000043955755,0.00031733065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803865,0.00015718739,0.00038998455,0.00034877434,0.00071618456,0.00034921375],"domain_scores_gemma":[0.9970558,0.0018021199,0.00029810081,0.00033132953,0.00040803658,0.00010457807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021923002,0.00029453804,0.001092181,0.00041473875,0.000028442737,0.00001315608,0.00014106889,0.00013349505,0.000028687502],"category_scores_gemma":[0.0006071651,0.0001816838,0.000169538,0.0003003412,0.00023027364,0.000043277127,0.000105057115,0.0003339547,0.0000039780316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001535868,0.0038202489,0.6602159,0.040651448,0.041401893,0.00063964626,0.04359968,0.00025113623,0.11089753,0.0031173413,0.043405637,0.050463647],"study_design_scores_gemma":[0.0011434678,0.0010977128,0.95383036,0.001185027,0.00096644065,8.6818154e-8,0.00009990081,0.000035919424,0.030352611,0.0024336579,0.008694516,0.00016028593],"about_ca_topic_score_codex":0.0002136599,"about_ca_topic_score_gemma":0.000005749012,"teacher_disagreement_score":0.29361445,"about_ca_system_score_codex":0.000051148934,"about_ca_system_score_gemma":0.00007249026,"threshold_uncertainty_score":0.740885},"labels":[],"label_agreement":null},{"id":"W4400747098","doi":"10.1111/dom.15771","title":"Bariatric surgery and all‐cause mortality: A methodological review of studies using a non‐surgical comparator","year":2024,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Atara Biotherapeutics; Kowa Company; Amarin Corporation; Novo Nordisk; Merck; Novartis; Pfizer; Seqirus; AstraZeneca; National Institute of Diabetes and Digestive and Kidney Diseases; Boehringer Ingelheim","keywords":"Medicine; Surgical procedures; Surgery; General surgery; Intensive care medicine","score_opus":0.36883434458384223,"score_gpt":0.46638567469115594,"score_spread":0.0975513301073137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400747098","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022854613,0.97496784,0.0000036128647,0.0000850945,0.00092251203,0.0010065864,0.00007413575,0.000052982406,0.000032611166],"genre_scores_gemma":[0.00013654317,0.99794024,0.00070053077,0.00041359832,0.00058146927,0.000062824765,0.00005732454,0.00004856275,0.000058893056],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952779,0.0013001899,0.0016497994,0.00081837195,0.0004302893,0.00052347145],"domain_scores_gemma":[0.9942502,0.0041303122,0.0005954749,0.0004972758,0.00016886176,0.00035791166],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004993422,0.00077567116,0.010345721,0.0005332898,0.00009353479,0.00003601067,0.00011910316,0.0005100039,0.000034848814],"category_scores_gemma":[0.0016671817,0.00048118632,0.0014586904,0.0010297686,0.00031410722,0.000109120876,0.00038119493,0.000747418,0.00001012785],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000144487285,0.0002462951,0.0051226798,0.85503584,0.015580734,0.00045896583,0.00008014446,2.582239e-8,0.0000018331529,0.00069287507,0.002320412,0.12044573],"study_design_scores_gemma":[0.00031239775,0.0000290902,0.002399815,0.11048966,0.12531154,0.00031407084,0.000018249722,0.000008289128,0.0000051365373,0.00015871186,0.7603327,0.00062032335],"about_ca_topic_score_codex":0.000012616016,"about_ca_topic_score_gemma":4.100053e-7,"teacher_disagreement_score":0.7580123,"about_ca_system_score_codex":0.000034884386,"about_ca_system_score_gemma":0.00033375373,"threshold_uncertainty_score":0.99976397},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch","metaepi_narrow","metaepi_broad"],"domain":"methods","study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W4401033246","doi":"10.1111/dom.15769","title":"<scp>Glucagon‐like peptide</scp> ‐1 receptor agonists and <scp>sodium‐glucose cotransporter</scp> ‐2 inhibitors for the treatment of diabetes mellitus in liver transplant recipients","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"Toronto General and Western Hospital Foundation","keywords":"Medicine; Vildagliptin; Diabetes mellitus; Internal medicine; Combination therapy; Glucagon-like peptide-1; Gastroenterology; Body mass index; Glucagon-like peptide 1 receptor; Endocrinology; Pharmacology; Type 2 Diabetes Mellitus; Type 2 diabetes; Receptor","score_opus":0.013528296253285407,"score_gpt":0.24239407759248233,"score_spread":0.2288657813391969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401033246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9029332,0.09389979,0.000029275216,0.000099257784,0.00074250676,0.0013353387,0.0007858463,0.000060685277,0.00011414744],"genre_scores_gemma":[0.924863,0.07274684,0.00042707982,0.00014576141,0.0001708066,0.00022878128,0.00039476628,0.000049250764,0.00097372016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99777335,0.00008583737,0.0005897859,0.0006082488,0.0003270467,0.0006157187],"domain_scores_gemma":[0.997876,0.0013660342,0.00011476048,0.00028023796,0.000079389254,0.00028357052],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031635282,0.00047509593,0.0009253327,0.0002750395,0.00017425488,0.00008659454,0.00010587682,0.00020442822,0.000009451454],"category_scores_gemma":[0.000036361667,0.00031257092,0.00033972308,0.00031392233,0.00022901491,0.00021632828,0.000011319051,0.0001783582,0.000010590807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059904032,0.0017656835,0.9328868,0.002592515,0.0020612117,0.0000780914,0.014512223,0.0000074706973,0.008382614,0.0005312278,0.00027870171,0.03684356],"study_design_scores_gemma":[0.0055357907,0.0006967453,0.80976945,0.00124862,0.00259587,0.0000066743437,0.00028101922,0.00044087495,0.09944774,0.00016778125,0.07968509,0.00012432408],"about_ca_topic_score_codex":0.000107606924,"about_ca_topic_score_gemma":0.00006430443,"teacher_disagreement_score":0.12311733,"about_ca_system_score_codex":0.000052184063,"about_ca_system_score_gemma":0.00006428864,"threshold_uncertainty_score":0.99993265},"labels":[],"label_agreement":null},{"id":"W4401033736","doi":"10.1111/dom.15799","title":"Persistent disparities in insulin pump uptake despite a universal pump programme for type 1 diabetes in Ontario, Canada","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; St. Michael's Hospital; Hospital for Sick Children; University of Toronto","funders":"Canadian Statistical Sciences Institute; Banting Research Foundation","keywords":"Medicine; Insulin pump; Odds; Odds ratio; Disadvantage; Type 1 diabetes; Logistic regression; Demography; Population; Gerontology; Diabetes mellitus; Environmental health; Internal medicine; Endocrinology","score_opus":0.02646375995055204,"score_gpt":0.24533920333769985,"score_spread":0.21887544338714782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401033736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98560715,0.010937781,0.0000011876725,0.0012179816,0.00052190624,0.0010346248,0.000028844215,0.00004949956,0.0006010195],"genre_scores_gemma":[0.9942776,0.00028616938,0.00015142045,0.00035956624,0.00009522397,0.00010772613,0.0001366766,0.000029734978,0.004555873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796575,0.00005357229,0.00029112116,0.00045562786,0.00032385177,0.0009100537],"domain_scores_gemma":[0.999307,0.00014310982,0.000030027184,0.00019743334,0.00008550415,0.00023697379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006166056,0.0002453854,0.00053724396,0.00042899174,0.000081327635,0.000148577,0.0001432373,0.00012024528,0.000078764206],"category_scores_gemma":[0.00013460907,0.00021618225,0.0001273987,0.0005188041,0.000121328834,0.00021986545,0.0001284666,0.000432822,0.0000049984615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007767533,0.0003426993,0.96640813,0.0014021321,0.0003512528,0.000069067646,0.0005911049,0.0000156938,0.00030516562,0.0024321757,0.0008453129,0.0271596],"study_design_scores_gemma":[0.0016273416,0.00017056926,0.834271,0.0003850336,0.00023139709,2.6552914e-7,0.00028487673,0.0033833834,0.0003088518,0.00040939322,0.15866174,0.00026613992],"about_ca_topic_score_codex":0.3269249,"about_ca_topic_score_gemma":0.831674,"teacher_disagreement_score":0.50474906,"about_ca_system_score_codex":0.0003203166,"about_ca_system_score_gemma":0.0007035237,"threshold_uncertainty_score":0.88156563},"labels":[],"label_agreement":null},{"id":"W4401033823","doi":"10.1111/dom.15798","title":"Risk of new‐onset diabetes and efficacy of pharmacological weight loss therapy","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Esperion Therapeutics; Kowa Company; National Institutes of Health; Amarin Corporation; Brigham and Women's Hospital; National Heart, Lung, and Blood Institute; Pfizer; Amgen; AstraZeneca; Eli Lilly and Company; Eisai; American Heart Association","keywords":"Medicine; Pharmacotherapy; Weight loss; Diabetes mellitus; Intensive care medicine; Type 2 diabetes; Internal medicine; Obesity; Endocrinology","score_opus":0.012279429574224746,"score_gpt":0.2620909850618799,"score_spread":0.24981155548765516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401033823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9404876,0.05808879,0.0000048368006,0.00030936374,0.00024268268,0.00045333986,0.00005951242,0.000067339104,0.00028651705],"genre_scores_gemma":[0.97831506,0.020370169,0.00041295667,0.00020709466,0.00014419448,0.000016254342,0.000030087771,0.000018054778,0.00048615783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988099,0.00007434755,0.0002797942,0.00033299092,0.000199803,0.0003031725],"domain_scores_gemma":[0.9992393,0.0002588545,0.00008484622,0.00017844338,0.000042992608,0.00019551766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031376738,0.00022788918,0.00064057886,0.0001838169,0.000049676324,0.000025841513,0.00007624223,0.00009538592,0.0001329317],"category_scores_gemma":[0.00005356125,0.00015906825,0.00015525575,0.00023113983,0.00024031318,0.00011644887,0.000089808,0.00015168378,0.000006980883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008708499,0.0008026784,0.83801645,0.0003670934,0.0027418234,0.000010274252,0.00055091537,9.20902e-7,0.013131876,0.0013862685,0.0023823678,0.14052226],"study_design_scores_gemma":[0.0033219566,0.0002903399,0.8828224,0.0001241926,0.0022688513,5.535724e-7,0.000015869518,0.00013639306,0.0855447,0.0011174845,0.024199814,0.00015747389],"about_ca_topic_score_codex":0.00001544927,"about_ca_topic_score_gemma":5.893324e-7,"teacher_disagreement_score":0.14036478,"about_ca_system_score_codex":0.0000076020683,"about_ca_system_score_gemma":0.000032531207,"threshold_uncertainty_score":0.6486615},"labels":[],"label_agreement":null},{"id":"W4401434535","doi":"10.1111/dom.15834","title":"Real‐world impact of adding a glucagon‐like peptide‐1 receptor agonist compared with basal insulin on metabolic targets in adults living with type 2 diabetes and chronic kidney disease already treated with a sodium‐glucose co‐transporter‐2 inhibitor: The Impact GLP‐1 CKD study","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Novo Nordisk Canada; Novo Nordisk","keywords":"Medicine; Internal medicine; Glucagon-like peptide 1 receptor; Type 2 diabetes; Endocrinology; Cohort; Basal (medicine); Albuminuria; Diabetes mellitus; Insulin; Kidney disease; Liraglutide; Renal function; Population; Agonist; Receptor","score_opus":0.0077060772296730215,"score_gpt":0.24782676468415807,"score_spread":0.24012068745448506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401434535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98576975,0.010701003,8.970199e-7,0.000086314576,0.000092243725,0.002561785,0.00039840248,0.0001591781,0.00023043081],"genre_scores_gemma":[0.99713254,0.0014736502,0.00008287277,0.00010749852,0.00018440228,0.00024311729,0.00051183463,0.00011063197,0.00015346023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685633,0.00023997914,0.00051840104,0.0009284234,0.000556938,0.0008999538],"domain_scores_gemma":[0.99804616,0.00025677372,0.0002140996,0.0006094449,0.0001484569,0.0007250531],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051630207,0.00083888654,0.001449693,0.0006603513,0.00021808506,0.00020748138,0.00017585876,0.00008144667,0.00008396152],"category_scores_gemma":[0.000044655415,0.000444884,0.0001875292,0.0012173563,0.0003701302,0.00042754092,0.000072725205,0.00042881168,0.0000079331685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002375933,0.002767113,0.9831411,0.0006822037,0.0036507132,0.00009703129,0.002754234,0.00004996762,0.0012897088,0.000041834646,0.0004126665,0.002737499],"study_design_scores_gemma":[0.0073993336,0.004530464,0.97689056,0.0034715116,0.0028922865,8.954605e-7,0.00039504326,0.0009243129,0.0024566804,0.000007293402,0.00048247052,0.0005491697],"about_ca_topic_score_codex":0.0010431408,"about_ca_topic_score_gemma":0.00067937473,"teacher_disagreement_score":0.011362786,"about_ca_system_score_codex":0.00019188934,"about_ca_system_score_gemma":0.0004710961,"threshold_uncertainty_score":0.99980026},"labels":[],"label_agreement":null},{"id":"W4401447115","doi":"10.1111/dom.15794","title":"Real‐world safety profile of once‐weekly semaglutide in people with type 2 diabetes: Analysis of pooled data from the SemaglUtide Real‐world Evidence (SURE) programme","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Novo Nordisk","keywords":"Semaglutide; Medicine; Type 2 diabetes; Real world data; Pooled analysis; Diabetes mellitus; Internal medicine; Meta-analysis; Endocrinology; Data science; Liraglutide","score_opus":0.029476314409815265,"score_gpt":0.28172118628095005,"score_spread":0.2522448718711348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401447115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98117244,0.014255185,0.000008409623,0.001016086,0.00016815893,0.001362376,0.0005306419,0.00011113228,0.0013755644],"genre_scores_gemma":[0.99090445,0.0034289723,0.0018005881,0.00018972595,0.00012370628,0.00008333068,0.0012057405,0.000046041103,0.0022174278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99673945,0.00025284887,0.00078297494,0.0009049539,0.0006380889,0.0006816941],"domain_scores_gemma":[0.9967206,0.0010579901,0.00027964503,0.0015524098,0.00019284105,0.00019648156],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014892264,0.00042747307,0.0015980953,0.0007792986,0.000091340655,0.000081108985,0.00052843103,0.00008876662,0.00018185056],"category_scores_gemma":[0.00024312398,0.00027860567,0.00021222435,0.00472272,0.0002840761,0.00031769695,0.00044650928,0.00031268984,0.000013278304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015932845,0.00052827195,0.9729276,0.0007462402,0.0060662567,0.00001446363,0.00071674905,0.000030438667,0.0014704408,0.00093949115,0.0011091791,0.015291594],"study_design_scores_gemma":[0.0009743939,0.00017403637,0.96393,0.0015107698,0.016229209,9.2947985e-8,0.00017741251,0.0073769013,0.002232553,0.00014446139,0.006966699,0.000283488],"about_ca_topic_score_codex":0.0055944906,"about_ca_topic_score_gemma":0.02048928,"teacher_disagreement_score":0.015008106,"about_ca_system_score_codex":0.00008348808,"about_ca_system_score_gemma":0.00023586991,"threshold_uncertainty_score":0.9999666},"labels":[],"label_agreement":null},{"id":"W4401463253","doi":"10.1111/dom.15844","title":"Cystic fibrosis‐related diabetes develops from a combination of insulin secretion defects and insulin resistance","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Hôpital du Sacré-Cœur de Montréal; University of Alberta; Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Insulin resistance; Medicine; Internal medicine; Insulin; Endocrinology; Cystic fibrosis-related diabetes; Diabetes mellitus; Glucose tolerance test; Impaired glucose tolerance","score_opus":0.006704654826958133,"score_gpt":0.23817626737813097,"score_spread":0.23147161255117282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401463253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8658986,0.13282332,0.00007959425,0.00024392002,0.00017956393,0.00039423743,0.00014373662,0.00009841972,0.00013863262],"genre_scores_gemma":[0.993175,0.0026815997,0.0035556352,0.000060905568,0.000062684856,0.000037342903,0.00024725837,0.00002767242,0.00015185201],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982422,0.00015279635,0.00039453112,0.00046557537,0.00039204923,0.00035286933],"domain_scores_gemma":[0.9985632,0.00075116986,0.00009013859,0.00021405259,0.00017395747,0.0002075224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004775774,0.00022651903,0.0005705271,0.0002805819,0.00010569058,0.0000811028,0.00007879967,0.0001648301,0.00004467554],"category_scores_gemma":[0.001114114,0.00020289049,0.00007205757,0.00057819206,0.00028268775,0.00030886446,0.00009961096,0.00029954026,0.00001603535],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035907354,0.000511716,0.15146345,0.005865614,0.00062364043,0.000030867624,0.0022415218,0.0000063894045,0.7588224,0.010964053,0.000425279,0.06868599],"study_design_scores_gemma":[0.001630308,0.0001253525,0.9187039,0.0014660757,0.00031592813,0.0000010175451,0.000047497047,0.0021554094,0.05400826,0.015874757,0.005442578,0.00022891052],"about_ca_topic_score_codex":0.0000307703,"about_ca_topic_score_gemma":0.000016266513,"teacher_disagreement_score":0.76724046,"about_ca_system_score_codex":0.00003664322,"about_ca_system_score_gemma":0.000109226545,"threshold_uncertainty_score":0.8273634},"labels":[],"label_agreement":null},{"id":"W4401684784","doi":"10.1111/dom.15829","title":"Opportunities to optimize lifestyle interventions in combination with <scp>glucagon‐like peptide</scp> ‐1‐based therapy","year":2024,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Weight loss; Medicine; Type 2 diabetes; Discontinuation; Psychological intervention; Obesity; Disease; Diabetes mellitus; Intensive care medicine; Gerontology; Internal medicine; Endocrinology; Psychiatry","score_opus":0.06778202109263012,"score_gpt":0.310770133213144,"score_spread":0.24298811212051388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401684784","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013265832,0.98129714,0.000023243356,0.00022513485,0.00041034407,0.0026375502,0.000095564654,0.00016432849,0.0018808831],"genre_scores_gemma":[0.0003620634,0.9830175,0.0010047238,0.0007855169,0.00012245684,0.000985056,0.00086306717,0.0001026129,0.012756998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976818,0.00018321363,0.00061358436,0.0006506465,0.0003394876,0.00053126935],"domain_scores_gemma":[0.9987181,0.00020008892,0.00020031972,0.000464056,0.00009850603,0.00031892373],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053961296,0.00066675956,0.0021196494,0.001171994,0.00009226145,0.00018780399,0.00018352136,0.00022398218,0.000034554436],"category_scores_gemma":[0.00006195625,0.00047577743,0.00059795246,0.0005195364,0.000105413936,0.00017157158,0.00014059697,0.00039840766,0.00008238036],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013718242,0.0026665349,0.0010874893,0.040673442,0.0027565463,0.00016262595,0.0005072554,0.0000049108025,0.0000015944265,0.0026958308,0.009528268,0.93990177],"study_design_scores_gemma":[0.0017829284,0.00041214988,0.001767406,0.019626612,0.0055888337,0.0000020983157,0.0001050262,0.000021958831,0.000010419214,0.00006395119,0.97039497,0.00022366847],"about_ca_topic_score_codex":0.000025536001,"about_ca_topic_score_gemma":0.000021715861,"teacher_disagreement_score":0.9608667,"about_ca_system_score_codex":0.00009738086,"about_ca_system_score_gemma":0.00020179004,"threshold_uncertainty_score":0.9997694},"labels":[],"label_agreement":null},{"id":"W4402012272","doi":"10.1111/dom.15899","title":"Optimizing physician‐encounter frequency for type 2 diabetes patients in primary care based on cardiovascular risk assessment: A target trial emulation study","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Bruyère; University of Ottawa","funders":"Young Scientists Fund; University of Hong Kong; National Natural Science Foundation of China","keywords":"Medicine; Type 2 diabetes; Emulation; Primary care; Risk assessment; Diabetes mellitus; Internal medicine; Family medicine; Intensive care medicine","score_opus":0.02478251503964235,"score_gpt":0.3467474885368992,"score_spread":0.32196497349725683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402012272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98280257,0.0075762374,0.00010419981,0.000096560565,0.003039157,0.004472377,0.00039260634,0.00011916486,0.0013971073],"genre_scores_gemma":[0.9930754,0.00021308412,0.00158059,0.00287433,0.0006954718,0.00080367626,0.0006802239,0.000053234337,0.000023998602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967606,0.0009155912,0.00059729646,0.0006054627,0.00043972064,0.0006813219],"domain_scores_gemma":[0.99826854,0.0007765067,0.00014494902,0.00041173736,0.0002779508,0.00012029511],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014003402,0.0003065297,0.00090323307,0.00033254008,0.0006154029,0.000057309273,0.00014964835,0.00021833212,0.00002201767],"category_scores_gemma":[0.00015098309,0.00026628355,0.0002817407,0.00037182277,0.000029508172,0.0003928731,0.00008056046,0.00061706034,0.000012209701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004223409,0.0005861013,0.9795213,0.0021737455,0.00030886894,0.0000024434305,0.0035252376,0.000261169,0.000015061777,0.000115513874,0.00056591077,0.012502358],"study_design_scores_gemma":[0.020587793,0.00059040444,0.961409,0.0003190166,0.00055299164,3.0582346e-9,0.00042848015,0.0020110758,0.000015959975,0.000606795,0.013111907,0.0003666244],"about_ca_topic_score_codex":0.00015858315,"about_ca_topic_score_gemma":0.000053107524,"teacher_disagreement_score":0.020165453,"about_ca_system_score_codex":0.00046272462,"about_ca_system_score_gemma":0.0007034847,"threshold_uncertainty_score":0.99997896},"labels":[],"label_agreement":null},{"id":"W4402140134","doi":"10.1111/dom.15895","title":"Effects of ertugliflozin on uric acid and gout‐related outcomes in persons with type 2 diabetes and cardiovascular disease: Post hoc analyses from <scp>VERTIS CV</scp>","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"European Foundation for the Study of Diabetes; American Society of Nephrology; Pfizer; American Diabetes Association","keywords":"Medicine; Post-hoc analysis; Gout; Type 2 diabetes; Disease; Uric acid; Diabetes mellitus; Internal medicine; Endocrinology","score_opus":0.006852900927880108,"score_gpt":0.2233089835908114,"score_spread":0.2164560826629313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402140134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73794013,0.26114762,0.0000024863357,0.00011174882,0.00014457107,0.00041994953,0.000112996466,0.00007394844,0.00004655956],"genre_scores_gemma":[0.9947245,0.004399387,0.00016798919,0.00030878655,0.00007333175,0.000031532465,0.00008156074,0.00005257973,0.00016030941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978281,0.00019063956,0.0003063278,0.00073132024,0.0004701962,0.00047338175],"domain_scores_gemma":[0.99806577,0.00088837935,0.000065808876,0.00044790114,0.00007711843,0.0004550261],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028178992,0.00043531694,0.0013018078,0.00042669132,0.000090472866,0.000071514856,0.000099356206,0.00020218667,0.000011481407],"category_scores_gemma":[0.0009897032,0.00031798132,0.00022565463,0.00064525206,0.0002604662,0.00021728929,0.00011307904,0.0003953494,0.000008061087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005848747,0.00037621643,0.9331708,0.001513406,0.0070112003,0.00026060277,0.0022976804,0.000014605511,0.048743065,0.000066294706,0.00015181568,0.006335844],"study_design_scores_gemma":[0.0022013928,0.00025942377,0.9714039,0.0006116052,0.0059495866,0.000003250903,0.00018910956,0.00036744162,0.01762153,0.00009594535,0.0011029731,0.00019384014],"about_ca_topic_score_codex":0.00017183601,"about_ca_topic_score_gemma":0.0000071462405,"teacher_disagreement_score":0.2567844,"about_ca_system_score_codex":0.000025702197,"about_ca_system_score_gemma":0.00008716468,"threshold_uncertainty_score":0.9999272},"labels":[],"label_agreement":null},{"id":"W4402318599","doi":"10.1111/dom.15926","title":"Evaluating remission of type 2 diabetes using a metabolic intervention including fixed‐ratio insulin degludec and liraglutide: A randomized controlled trial","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; University of Calgary; Ottawa Hospital; University of Ottawa; Western University; Capital District Health Authority; McMaster University; University of Alberta; Population Health Research Institute","funders":"Novo Nordisk Foundation Center for Basic Metabolic Research","keywords":"Medicine; Liraglutide; Hazard ratio; Type 2 diabetes; Internal medicine; Diabetes mellitus; Randomized controlled trial; Regimen; Confidence interval; Body mass index; Metformin; Insulin; Endocrinology","score_opus":0.04193998720789953,"score_gpt":0.3412835895633655,"score_spread":0.299343602355466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402318599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9008751,0.09470651,0.00010800805,0.00011368215,0.0007310392,0.0031704055,0.0000065725003,0.00009127627,0.00019743216],"genre_scores_gemma":[0.99399227,0.0022003923,0.0028132712,0.000096825504,0.0002808735,0.0001891886,0.000042566753,0.00003376946,0.00035084743],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973819,0.00051351596,0.0008846417,0.00046345644,0.00039220828,0.0003642366],"domain_scores_gemma":[0.99850273,0.0006578997,0.00028063444,0.0002232191,0.00017168745,0.00016383622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033806034,0.00033651385,0.0022461177,0.00046660437,0.0001528755,0.00013492684,0.000069607864,0.00013977899,0.000049846236],"category_scores_gemma":[0.0016161263,0.00024207738,0.00045959646,0.0004057423,0.00016384892,0.00031156474,0.00018904885,0.00019299056,0.0000029929504],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4709691,0.0026241303,0.016484717,0.005923391,0.015459925,0.00002884838,0.003418603,0.000062067695,0.21459338,0.016822957,0.00017123339,0.25344163],"study_design_scores_gemma":[0.8850923,0.00046173309,0.004768178,0.0016915245,0.011343194,0.0000013120645,0.00007177161,0.07842595,0.015266866,0.0017054534,0.0008285198,0.00034315433],"about_ca_topic_score_codex":0.000028323637,"about_ca_topic_score_gemma":0.0000017680611,"teacher_disagreement_score":0.41412324,"about_ca_system_score_codex":0.000028945553,"about_ca_system_score_gemma":0.000075292235,"threshold_uncertainty_score":0.98716295},"labels":[],"label_agreement":null},{"id":"W4402370027","doi":"10.1111/dom.15917","title":"Glyburide use is associated with a greater likelihood of mortality or rehospitalization after acute coronary syndrome compared to gliclazide use in adults with type 2 diabetes: A cohort study","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alliance for Canadian Health Outcomes Research in Diabetes; University of Alberta","funders":"Canadian Institutes of Health Research; University of Alberta","keywords":"Medicine; Gliclazide; Acute coronary syndrome; Odds ratio; Internal medicine; Cardiac catheterization; Confidence interval; Diabetes mellitus; Type 2 diabetes; Logistic regression; Retrospective cohort study; Cohort; Cardiology; Myocardial infarction; Endocrinology; Insulin","score_opus":0.013000125573673261,"score_gpt":0.2507554099865906,"score_spread":0.23775528441291738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402370027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969103,0.00051065575,0.0000065185163,0.0000728505,0.0001713829,0.0019497618,0.00028471614,0.00008344115,0.000010412409],"genre_scores_gemma":[0.998347,0.00009459105,0.00013721449,0.000789027,0.000026628948,0.0002216266,0.00015428702,0.000045991415,0.00018363573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976981,0.00012107476,0.000498205,0.0006645454,0.00050243316,0.00051560864],"domain_scores_gemma":[0.99863493,0.00016271768,0.00007232477,0.00040589992,0.00042406793,0.00030005525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027103614,0.00036564213,0.0010715547,0.00025070386,0.00005619695,0.000104514846,0.0000913689,0.00014797915,0.00008225639],"category_scores_gemma":[0.00022622252,0.00024192545,0.000080810736,0.0007511385,0.00013045962,0.00052390754,0.000079773126,0.00023448929,0.0000056005624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00229801,0.0009990672,0.9915433,0.00023718546,0.0017002826,0.00075883325,0.0021893445,0.0000023758105,0.00009085462,0.0000070397737,0.0000588962,0.00011481952],"study_design_scores_gemma":[0.0050628353,0.0024990255,0.98694843,0.0021012926,0.0022960177,0.000009849812,0.000118347634,0.00032452788,0.00018317997,0.00001616003,0.00009649868,0.00034382127],"about_ca_topic_score_codex":0.00033437653,"about_ca_topic_score_gemma":0.00036099233,"teacher_disagreement_score":0.004594847,"about_ca_system_score_codex":0.00005223049,"about_ca_system_score_gemma":0.000099899335,"threshold_uncertainty_score":0.9865433},"labels":[],"label_agreement":null},{"id":"W4402381722","doi":"10.1111/dom.15811","title":"Time‐in‐range derived from self‐measured blood glucose in people with type 2 diabetes advancing to <scp>iGlarLixi</scp> : A participant‐level pooled analysis of three phase 3 <scp>LixiLan</scp> randomized controlled trials","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Sanofi","keywords":"Lixisenatide; Medicine; Type 2 diabetes; Diabetes mellitus; Internal medicine; Endocrinology; Exenatide","score_opus":0.021043760299329518,"score_gpt":0.2644955457325564,"score_spread":0.24345178543322687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402381722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9427228,0.05170474,0.00008543187,0.000118682416,0.00022852088,0.004524745,0.00024324626,0.00017693621,0.00019487471],"genre_scores_gemma":[0.99502164,0.0013513614,0.0013835775,0.00032422852,0.00014480733,0.000984503,0.00035050555,0.00006918426,0.00037018838],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9945579,0.0010353144,0.0016879194,0.0009423794,0.00069542194,0.0010810242],"domain_scores_gemma":[0.99141127,0.0068437834,0.00045609425,0.0005829058,0.0002417356,0.0004642259],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0054719136,0.00071329495,0.008626542,0.0017646302,0.000082862905,0.00015190405,0.00021523147,0.00022270015,0.00007582118],"category_scores_gemma":[0.006258044,0.00049732934,0.0009997673,0.002507533,0.00012266482,0.0003120365,0.00013146574,0.00029214978,0.000026932834],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013944309,0.012291534,0.5309321,0.0015552118,0.19181564,0.00035110555,0.025226338,0.0005998585,0.21064551,0.00035938027,0.0004649207,0.011814053],"study_design_scores_gemma":[0.4278273,0.00066307106,0.33690596,0.0010205563,0.17687513,4.2202507e-7,0.00073333,0.022929532,0.031559195,0.0003684364,0.0008083183,0.0003087533],"about_ca_topic_score_codex":0.00020626064,"about_ca_topic_score_gemma":0.0010290652,"teacher_disagreement_score":0.413883,"about_ca_system_score_codex":0.000060168117,"about_ca_system_score_gemma":0.00016600182,"threshold_uncertainty_score":0.9997478},"labels":[],"label_agreement":null},{"id":"W4402463578","doi":"10.1111/dom.15935","title":"Lipids and apolipoproteins and the risk of vascular disease and mortality outcomes in women and men with type 2 diabetes in the <scp>ADVANCE</scp> study","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Health and Medical Research Council; Medical Research Council; Servier","keywords":"Medicine; Hazard ratio; Apolipoprotein B; Internal medicine; Type 2 diabetes; Diabetes mellitus; Apolipoprotein A1; Endocrinology; Cholesterol; Proportional hazards model; Lipoprotein; Confounding; Confidence interval","score_opus":0.006155913341831345,"score_gpt":0.22707495390146615,"score_spread":0.2209190405596348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402463578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8894697,0.10842475,0.0000018511167,0.000112240334,0.000053508753,0.0018033879,0.0000453425,0.00002644856,0.00006277143],"genre_scores_gemma":[0.9873363,0.012002851,0.000051215742,0.00017984454,0.00010126893,0.00025538378,0.0000059487743,0.000028249122,0.00003896867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976338,0.0005727897,0.0003369615,0.00056484377,0.00043183184,0.0004597665],"domain_scores_gemma":[0.9985966,0.0005180843,0.00008060583,0.000521971,0.000052181458,0.0002305674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002857938,0.00034455594,0.0011588928,0.00018828266,0.00014434094,0.00014325204,0.00010927601,0.00008618296,0.0000017571328],"category_scores_gemma":[0.0005410674,0.0001854554,0.0000947192,0.00039457934,0.00075889047,0.00024785282,0.00016915223,0.00039285788,3.9953008e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003605329,0.00025762105,0.96971476,0.0006140017,0.0012219115,0.000014616732,0.0074196677,0.0000028126783,0.000024114379,0.0002282083,0.000007871165,0.020458385],"study_design_scores_gemma":[0.004502334,0.00020745645,0.98690456,0.0001609739,0.0015686679,0.0000013886206,0.0023687365,0.00029003926,0.00007231274,0.002579402,0.0012251234,0.00011900911],"about_ca_topic_score_codex":0.0017241047,"about_ca_topic_score_gemma":0.00049038074,"teacher_disagreement_score":0.09786657,"about_ca_system_score_codex":0.000013536983,"about_ca_system_score_gemma":0.000045813118,"threshold_uncertainty_score":0.75626516},"labels":[],"label_agreement":null},{"id":"W4402499648","doi":"10.1111/dom.15924","title":"The impact of overweight and obesity on health outcomes in the United States from 1990 to 2021","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Obesity, Physical Activity, Diet","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre","funders":"","keywords":"Medicine; Overweight; Obesity; Body mass index; Demography; Public health; Gerontology; Psychological intervention; Environmental health","score_opus":0.012499480336630599,"score_gpt":0.29211565015362334,"score_spread":0.2796161698169927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402499648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907104,0.003874439,0.0000021144795,0.004378662,0.00013319627,0.00052395184,0.00027140017,0.000025088288,0.000080767095],"genre_scores_gemma":[0.99694073,0.0015629182,0.000030734187,0.0011720235,0.00013678339,0.00001561366,0.000070728915,0.000016300595,0.000054159686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839485,0.0002919454,0.00025584348,0.0003423164,0.00032420328,0.00039083956],"domain_scores_gemma":[0.99793005,0.0013739818,0.00006178681,0.00037979538,0.000046393787,0.00020800387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065169897,0.0002444507,0.0006561247,0.0001704817,0.00016602686,0.00010247992,0.00014876359,0.0000684479,0.000017323211],"category_scores_gemma":[0.0001685208,0.00012287604,0.00015008169,0.00053508935,0.00014890838,0.00011251403,0.00012459946,0.0003910044,0.000013112151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004155232,0.0025265557,0.98309714,0.00013744556,0.00031676123,0.000009248421,0.0023399566,0.000012560875,0.00032906936,0.0041240877,0.0013873111,0.005678296],"study_design_scores_gemma":[0.00045375564,0.00029174198,0.9864938,0.00013943797,0.000093793205,4.94972e-7,0.00016219959,0.00043975536,0.00074341573,0.0072389273,0.0038203397,0.0001223091],"about_ca_topic_score_codex":0.005601709,"about_ca_topic_score_gemma":0.0002564712,"teacher_disagreement_score":0.006230357,"about_ca_system_score_codex":0.000044638717,"about_ca_system_score_gemma":0.000063962136,"threshold_uncertainty_score":0.8468145},"labels":[],"label_agreement":null},{"id":"W4402516471","doi":"10.1111/dom.15938","title":"The association of glycaemic risk factors and diabetes duration with risk of heart failure in people with type 2 diabetes: A systematic review and meta‐analysis","year":2024,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Health and Medical Research Council; La Trobe University","keywords":"Medicine; Type 2 diabetes; Meta-analysis; Diabetes mellitus; Hazard ratio; Internal medicine; Publication bias; Odds ratio; Confidence interval; Endocrinology","score_opus":0.00996980483077645,"score_gpt":0.24551313731623933,"score_spread":0.2355433324854629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402516471","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16302505,0.8338888,5.0773104e-7,0.000085533306,0.000024879948,0.002754988,0.00018920406,0.000022341734,0.0000086744685],"genre_scores_gemma":[0.026076421,0.97303104,0.00011587907,0.00003786712,0.000014047166,0.000356707,0.00016646922,0.000041480635,0.00016006596],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9970134,0.00068205275,0.0009534815,0.00053398474,0.00043357763,0.00038350534],"domain_scores_gemma":[0.9969079,0.0009155278,0.0013724843,0.0004950554,0.0001882373,0.00012082334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016636238,0.0006167723,0.0071534254,0.0004853083,0.00011306142,0.000083331266,0.000108768225,0.0002026391,0.0000069163575],"category_scores_gemma":[0.00038301843,0.00028649648,0.00058807834,0.0015497092,0.0001245629,0.00015680541,0.00009859058,0.0003737526,0.0000017846803],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004397327,0.0001103424,0.26036873,0.573685,0.16503814,5.554721e-7,0.00016023478,5.4640316e-7,7.7058843e-7,0.00005046484,0.00007096503,0.00050988526],"study_design_scores_gemma":[0.0003752642,0.0002110672,0.025608484,0.026796054,0.94157237,2.7988767e-7,0.00006000045,0.000019173924,0.000011175479,0.000024845658,0.005034004,0.00028728743],"about_ca_topic_score_codex":0.00007398736,"about_ca_topic_score_gemma":0.0004467279,"teacher_disagreement_score":0.77653426,"about_ca_system_score_codex":0.000055962675,"about_ca_system_score_gemma":0.000069854694,"threshold_uncertainty_score":0.9999587},"labels":[],"label_agreement":null},{"id":"W4402557297","doi":"10.1111/dom.15957","title":"Do nonglycaemic effects such as weight loss account for <scp>HbA1c</scp> lowering with efpeglenatide?: Insights from the <scp>AMPLITUDE‐</scp> O trial","year":2024,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Sanofi","keywords":"Medicine; Weight loss; Food science; Internal medicine; Obesity","score_opus":0.008594574529834389,"score_gpt":0.22687970568778146,"score_spread":0.21828513115794707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402557297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9262111,0.048057962,0.00005900657,0.011992911,0.0040180087,0.0067066727,0.00035542142,0.00035040572,0.002248516],"genre_scores_gemma":[0.45435318,0.011232351,0.0014731887,0.4286576,0.05008551,0.008323881,0.009278746,0.0013578734,0.035237677],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99448746,0.00019531803,0.0007599203,0.0018130755,0.0012239164,0.0015203272],"domain_scores_gemma":[0.99306285,0.0045371065,0.00043410395,0.001365688,0.00026241408,0.00033781806],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00051032123,0.0014736591,0.0023822105,0.0005031027,0.00044831017,0.00077843294,0.00070054666,0.0011020113,0.000018431852],"category_scores_gemma":[0.0005909222,0.00091974507,0.00073524157,0.0005240857,0.0003666459,0.00038183326,0.00047117344,0.0019034863,0.00022610658],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003345726,0.0009124607,0.0066693267,0.004999386,0.011484423,0.0011499166,0.002503989,0.0000024298397,0.00045601116,0.0014458034,0.9644101,0.005631557],"study_design_scores_gemma":[0.025359737,0.0007538219,0.009409968,0.0016793067,0.010270634,0.0000057125962,0.000077514815,0.000019337967,0.0043615215,0.004239717,0.94354904,0.0002736638],"about_ca_topic_score_codex":0.00012373763,"about_ca_topic_score_gemma":0.000023702858,"teacher_disagreement_score":0.4718579,"about_ca_system_score_codex":0.00015987642,"about_ca_system_score_gemma":0.00022019722,"threshold_uncertainty_score":0.9998013},"labels":[],"label_agreement":null},{"id":"W4402659510","doi":"10.1111/dom.15768","title":"Cardiovascular phenotypes in type 2 diabetes: Latent class analysis of the <scp>CANVAS</scp> Program and <scp>CREDENCE</scp> trial","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; McGill University Health Centre; Sunnybrook Health Science Centre; Ontario Brain Institute; University of Ottawa; Wilfrid Laurier University; McGill University","funders":"Ministry of Colleges and Universities; Canada Research Chairs; Mach-Gaensslen Foundation of Canada","keywords":"Canagliflozin; Medicine; Phenotype; Type 2 diabetes; Hazard ratio; Internal medicine; Clinical endpoint; Proportional hazards model; Latent class model; Empagliflozin; Diabetes mellitus; Clinical trial; Endocrinology; Confidence interval; Biology; Genetics","score_opus":0.012888779664216043,"score_gpt":0.23788790500090937,"score_spread":0.22499912533669333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402659510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9181421,0.07863233,0.0000021451042,0.00008479974,0.0006104192,0.0014897296,0.00003767155,0.00010744883,0.0008933498],"genre_scores_gemma":[0.994303,0.0038684446,0.00017624581,0.00018238087,0.00019928614,0.00017288241,0.000084281615,0.000033973065,0.0009795385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758977,0.00018724382,0.00044220826,0.00063022855,0.00054439984,0.0006061521],"domain_scores_gemma":[0.9986482,0.00036300547,0.00009975813,0.00058933574,0.000104397135,0.0001952612],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00088547973,0.00036281886,0.0012864149,0.00055599987,0.00010418391,0.0001447498,0.00018355169,0.00018284423,0.000009569747],"category_scores_gemma":[0.00035916918,0.00025063922,0.00066226046,0.0017747367,0.0002561347,0.00018909184,0.00023091976,0.0002788614,0.0000093870585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054333657,0.0018198916,0.8365893,0.0017091398,0.036399122,0.00004030371,0.0026156327,0.00019108724,0.0012915938,0.003065133,0.0019298426,0.11429463],"study_design_scores_gemma":[0.0073382077,0.00038736244,0.81912225,0.00027240484,0.02448853,3.8449394e-7,0.00023249547,0.0026448772,0.0022948077,0.0004195103,0.14271104,0.000088155604],"about_ca_topic_score_codex":0.00007086844,"about_ca_topic_score_gemma":0.000036397792,"teacher_disagreement_score":0.1407812,"about_ca_system_score_codex":0.000041993822,"about_ca_system_score_gemma":0.000072819494,"threshold_uncertainty_score":0.9999946},"labels":[],"label_agreement":null},{"id":"W4402722805","doi":"10.1111/dom.15940","title":"A novel, centrally acting mammalian aminosterol, <scp>ENT</scp> ‐03, induces weight loss in obese and lean rodents","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Weston Family Foundation; Weston Brain Institute","keywords":"Medicine; Weight loss; Pharmacology; Cell biology; Endocrinology; Internal medicine; Obesity; Biology","score_opus":0.008218874300047111,"score_gpt":0.2178197142001367,"score_spread":0.2096008399000896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402722805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98541355,0.013487664,0.00013012919,0.000057596353,0.00051295833,0.00017090532,0.000037176942,0.000024124565,0.00016591007],"genre_scores_gemma":[0.9965125,0.0019237364,0.00045558714,0.00023841257,0.0003550362,0.000013634883,0.000060741488,0.000030323221,0.00041004908],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985036,0.000051203762,0.00024297334,0.0005568432,0.00015740347,0.00048792467],"domain_scores_gemma":[0.9995322,0.00003661085,0.00005630376,0.00017020204,0.000033186454,0.00017147786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035534424,0.00025593303,0.00028634403,0.00011662467,0.000112918846,0.00017885289,0.00015148178,0.00022783625,0.000015032078],"category_scores_gemma":[0.0000809035,0.00023566064,0.000075928016,0.00013691265,0.00006808218,0.000035432746,0.00019060636,0.00021692476,0.0000076679935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000051033585,0.00008516959,0.033018272,0.00015184337,0.000080041566,0.00001671622,0.00056589785,0.0000041376343,0.9585891,0.00037813897,0.0000958851,0.0070097204],"study_design_scores_gemma":[0.00079914316,0.00006768421,0.115667835,0.00016756965,0.000079582715,0.000010481576,0.00020309431,0.00017423567,0.849071,0.00032155833,0.033222593,0.0002151672],"about_ca_topic_score_codex":0.00003742124,"about_ca_topic_score_gemma":0.000031759693,"teacher_disagreement_score":0.10951802,"about_ca_system_score_codex":0.000008511958,"about_ca_system_score_gemma":0.000030953008,"threshold_uncertainty_score":0.9609962},"labels":[],"label_agreement":null},{"id":"W4403469908","doi":"10.1111/dom.15999","title":"Use of continuous glucose monitoring and hybrid closed‐loop therapy in pregnancy","year":2024,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Calgary","funders":"Fonds Wetenschappelijk Onderzoek","keywords":"Medicine; Pregnancy; Randomized controlled trial; Type 1 diabetes; Type 2 diabetes; Gestational diabetes; Population; Insulin; Continuous glucose monitoring; Insulin pump; Diabetes mellitus; Obstetrics; Intensive care medicine; Gestation; Internal medicine; Endocrinology","score_opus":0.06510419955570805,"score_gpt":0.3303641960014682,"score_spread":0.26525999644576015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403469908","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23377083,0.76451033,1.9791688e-7,0.000017135317,0.000320092,0.0011924392,0.000040901792,0.00003532558,0.00011274282],"genre_scores_gemma":[0.0027834051,0.9946599,0.00009959362,0.000015511487,0.00021291459,0.00011029922,0.000051589628,0.00006254712,0.0020042448],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978776,0.00017428196,0.0005575975,0.0005614476,0.00031911774,0.0005099714],"domain_scores_gemma":[0.99900603,0.00020438721,0.00015658619,0.00038680393,0.00007293129,0.00017324365],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045230822,0.00044877228,0.0024190857,0.00068008737,0.000045810622,0.00011931109,0.000146662,0.00021754492,0.000013224619],"category_scores_gemma":[0.00012713,0.00031709785,0.00029527253,0.00042364097,0.00018883865,0.0001814284,0.00027953924,0.000626548,0.000011641078],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006605838,0.00019930881,0.00759321,0.027861385,0.0004923736,0.00006032768,0.000054797976,2.0243995e-8,0.000025895013,0.0001406186,0.00008780004,0.9634777],"study_design_scores_gemma":[0.0010912379,0.00016250527,0.015846273,0.05073621,0.002562205,0.0000028844572,0.000013343007,0.000011644738,0.00040150937,0.00021380429,0.92851305,0.00044533328],"about_ca_topic_score_codex":0.0000247297,"about_ca_topic_score_gemma":9.20532e-7,"teacher_disagreement_score":0.9630323,"about_ca_system_score_codex":0.000019769104,"about_ca_system_score_gemma":0.000083999825,"threshold_uncertainty_score":0.9999281},"labels":[],"label_agreement":null},{"id":"W4403610206","doi":"10.1111/dom.16020","title":"Body mass index trajectories and time in target range after delivery and long‐term type 2 diabetes risk in women with a history of gestational diabetes mellitus","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of General Medical Sciences; Chinese Diabetes Society; European Foundation for the Study of Diabetes; Eli Lilly and Company","keywords":"Medicine; Gestational diabetes; Body mass index; Hazard ratio; Type 2 diabetes; Diabetes mellitus; Confidence interval; Proportional hazards model; Pregnancy; Obstetrics; Internal medicine; Family history; Type 2 Diabetes Mellitus; Endocrinology; Gestation","score_opus":0.004958246095399305,"score_gpt":0.2064604280609,"score_spread":0.2015021819655007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403610206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9147373,0.08443686,0.0000033160995,0.000098507895,0.00007526637,0.00043406492,0.00009607944,0.000025041054,0.00009360029],"genre_scores_gemma":[0.9943171,0.0045805383,0.00030615568,0.00015280896,0.000049469763,0.0001512839,0.000057555655,0.000023073513,0.000362009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983131,0.00013445129,0.00027797796,0.00041299852,0.000347721,0.00051373],"domain_scores_gemma":[0.9991923,0.00029192105,0.000056193323,0.0001378758,0.000103767605,0.00021793737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005740127,0.00023731159,0.0005358175,0.0005563818,0.0000290835,0.000046504967,0.000057897505,0.0000942727,0.00011467729],"category_scores_gemma":[0.000105311556,0.00020024084,0.000030748357,0.00029752764,0.0003264661,0.00033424541,0.000070467104,0.0002760628,0.0000044164585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021991329,0.00014568893,0.9892043,0.0016191133,0.0002178765,0.00003289676,0.0010961824,0.000005671872,0.001690309,0.00010249537,0.00009362683,0.0055719344],"study_design_scores_gemma":[0.0014614831,0.00024292152,0.99375045,0.00032132323,0.00011819596,2.8510783e-7,0.00005804107,0.001235392,0.00024985056,0.00094530435,0.0014108747,0.00020588932],"about_ca_topic_score_codex":0.000039302406,"about_ca_topic_score_gemma":0.000029441268,"teacher_disagreement_score":0.07985633,"about_ca_system_score_codex":0.00012676185,"about_ca_system_score_gemma":0.00014819918,"threshold_uncertainty_score":0.8165585},"labels":[],"label_agreement":null},{"id":"W4404547136","doi":"10.1111/dom.16079","title":"Effects of sotagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease stages 3 and 4","year":2024,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Merck Canada; University of Toronto; Diabetes Canada; Banting and Best Diabetes Centre, University of Toronto; Heart and Stroke Foundation of Canada; Gilead Sciences; Department of Medicine, University of Toronto; Sanofi; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Kidney disease; Internal medicine; Renal function; Placebo; Diabetes mellitus; Erythropoietin; Type 2 diabetes; Anemia; Adverse effect; Clinical trial; Endocrinology; Pathology","score_opus":0.0033236803224837904,"score_gpt":0.19446411755313533,"score_spread":0.19114043723065155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404547136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96227926,0.025800237,8.487809e-8,0.010120225,0.00028463063,0.0012510702,0.00015089472,0.000046245546,0.00006733311],"genre_scores_gemma":[0.89818615,0.004161426,0.00008701761,0.093440875,0.0007782642,0.00016242266,0.001315634,0.00014910112,0.0017190907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810493,0.00008136269,0.0002582477,0.000673415,0.00036174824,0.00052031426],"domain_scores_gemma":[0.9990573,0.00015563985,0.00011478611,0.00031286277,0.00006090531,0.00029853886],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012117854,0.0005176145,0.0010188137,0.00046752085,0.000049173483,0.000065233224,0.000076073935,0.000262861,0.0000142395265],"category_scores_gemma":[0.00009579141,0.0003813684,0.00007056755,0.00023407488,0.0002268704,0.00011440549,0.00015716467,0.0005161993,0.000005895969],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007378133,0.00041273492,0.9067973,0.015277101,0.0008804379,0.00011892964,0.00009911002,2.984013e-7,0.000055976605,0.000106004816,0.07006961,0.0061087036],"study_design_scores_gemma":[0.0037582584,0.000684988,0.86116743,0.0024821372,0.0028669182,4.493601e-8,0.0000023845512,0.0000149836105,0.00064504123,0.0001447957,0.12786126,0.00037174186],"about_ca_topic_score_codex":0.00001078826,"about_ca_topic_score_gemma":0.0000034101436,"teacher_disagreement_score":0.08332065,"about_ca_system_score_codex":0.00005443834,"about_ca_system_score_gemma":0.000088548535,"threshold_uncertainty_score":0.9998638},"labels":[],"label_agreement":null},{"id":"W4404829385","doi":"10.1111/dom.16104","title":"The effect of altered sleep timing on glycaemic outcomes: Systematic review of human intervention studies","year":2024,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Sleep and related disorders","field":"Psychology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Impact; Université Laval; Centre Hospitalier Universitaire de Sherbrooke; McMaster University; Université de Sherbrooke","funders":"Canadian Institutes of Health Research; Diabetes Fonds; ZonMw; Health~Holland","keywords":"Medicine; Sleep (system call); Sleep deprivation; Postprandial; Population; Intervention (counseling); Randomized controlled trial; MEDLINE; Weight loss; Physical therapy; Internal medicine; Diabetes mellitus; Obesity; Circadian rhythm; Psychiatry; Endocrinology; Environmental health","score_opus":0.035291748644090876,"score_gpt":0.38718610493173883,"score_spread":0.351894356287648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404829385","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034212705,0.9918036,4.265716e-7,0.000015315469,0.0020364367,0.0023790968,0.00003449533,0.000034838074,0.0002745165],"genre_scores_gemma":[0.0006753161,0.9983138,0.0000012783636,0.000037477275,0.000050958854,0.00041544947,0.000035902744,0.00004229842,0.00042752884],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99605733,0.0015979431,0.0014379586,0.00038963076,0.00023439403,0.0002827655],"domain_scores_gemma":[0.9969119,0.0013082275,0.0010218287,0.0006485024,0.00006252195,0.000047008638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020909018,0.00050459144,0.0046987985,0.00024226701,0.00012702095,0.000020014579,0.00036121465,0.00027970935,0.000019791463],"category_scores_gemma":[0.00051733886,0.00024094063,0.0014239589,0.0003065597,0.00020098702,0.00003209644,0.00013338754,0.00048414545,0.0000722391],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002294703,0.00006776183,0.000023458348,0.9214719,0.009751441,0.0000014594935,0.00021091306,1.9778232e-8,2.2398855e-7,0.00081326184,0.00038497476,0.067272276],"study_design_scores_gemma":[0.0005037867,0.00022831403,0.000033297547,0.9237298,0.05986574,0.000002256572,0.000106895655,5.265518e-7,0.000004896682,0.00011559803,0.015151992,0.00025691275],"about_ca_topic_score_codex":0.00000985539,"about_ca_topic_score_gemma":0.0000016753274,"teacher_disagreement_score":0.06701536,"about_ca_system_score_codex":0.000021606413,"about_ca_system_score_gemma":0.0000076148285,"threshold_uncertainty_score":0.9825274},"labels":[],"label_agreement":null},{"id":"W4404869373","doi":"10.1111/dom.16099","title":"Role of the liver in the sustained normalisation of A1c over 2 years following short‐term insulin therapy in early type 2 diabetes","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; McMaster University; Western University; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research; McMaster University; Sanofi","keywords":"Medicine; Metformin; Internal medicine; Waist; Type 2 diabetes; Odds ratio; Diabetes mellitus; Insulin; Body mass index; Insulin resistance; Insulin glargine; Logistic regression; Endocrinology","score_opus":0.008941085984602894,"score_gpt":0.2288545028136899,"score_spread":0.21991341682908702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404869373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97454715,0.024488257,3.2819608e-7,0.000078986406,0.00019340373,0.00035313683,0.000008293678,0.000014386871,0.00031604126],"genre_scores_gemma":[0.99882007,0.00075860193,0.000021923648,0.00025817184,0.000064557455,0.000015446514,0.000009725588,0.000011311765,0.000040224477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998988,0.00014118025,0.0002632616,0.0001617989,0.00023912826,0.00020667487],"domain_scores_gemma":[0.99944943,0.00021641774,0.00004156711,0.0002173362,0.000040541407,0.000034696026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005975628,0.00012008732,0.00034107885,0.00018020993,0.000027446546,0.000024563553,0.000105070365,0.00008904062,0.00002813213],"category_scores_gemma":[0.00015297787,0.00007361932,0.00012298045,0.0005818781,0.00008369344,0.00015258913,0.000036572907,0.00018452006,0.0000019642923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026251548,0.00013221258,0.9488398,0.000107187596,0.0000805633,0.0000027302483,0.0040855603,0.0000026880612,0.035853628,0.0007167147,0.000025579291,0.010127124],"study_design_scores_gemma":[0.00070655346,0.00007010262,0.98175687,0.00017052193,0.00009962105,1.787156e-7,0.00027687952,0.000447436,0.015242259,0.00042453854,0.00073124503,0.00007377639],"about_ca_topic_score_codex":0.00011380298,"about_ca_topic_score_gemma":0.00001275059,"teacher_disagreement_score":0.032917127,"about_ca_system_score_codex":0.000014785963,"about_ca_system_score_gemma":0.00005708813,"threshold_uncertainty_score":0.30021086},"labels":[],"label_agreement":null},{"id":"W4405012042","doi":"10.1111/dom.16112","title":"The effect of <scp>HbA1c</scp> variability on the efficacy of intensive blood pressure control in patients with type 2 diabetes","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; Health Sciences Centre; University of Calgary","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Internal medicine; Blood pressure; Diabetes mellitus; Type 2 diabetes; Hazard ratio; Stroke (engine); Myocardial infarction; Confidence interval; Endocrinology","score_opus":0.004920806540793517,"score_gpt":0.20467399816139045,"score_spread":0.19975319162059693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405012042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95782226,0.04045551,4.217933e-7,0.00036681304,0.00023343312,0.0008614227,0.0000423886,0.000022659422,0.00019506308],"genre_scores_gemma":[0.9989158,0.0002118261,0.0000065122354,0.00068496075,0.00007077106,0.000027681208,0.0000062265085,0.000015172799,0.00006104429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853116,0.00035942267,0.00026982775,0.00027596232,0.0002958114,0.00026783082],"domain_scores_gemma":[0.9926597,0.006323517,0.00009114587,0.00037846595,0.0004885978,0.00005858092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009993882,0.0002076997,0.0008357471,0.00007175213,0.00010338786,0.000022068672,0.00011194803,0.000094730836,0.000004525436],"category_scores_gemma":[0.0028663187,0.000089793575,0.00010379919,0.0002756926,0.00033643944,0.000049575046,0.0000710831,0.0003230067,0.0000022964466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021320998,0.0003565087,0.98813444,0.00064818125,0.0037634762,0.0000024714884,0.0006521694,0.000004465619,0.0016644886,0.00063532474,0.0018554856,0.002069801],"study_design_scores_gemma":[0.003199655,0.00090998254,0.9622583,0.00038448922,0.0068526245,2.1417628e-7,0.000046655983,0.00007671831,0.018180732,0.00010920082,0.00792759,0.000053868],"about_ca_topic_score_codex":0.000011988062,"about_ca_topic_score_gemma":0.000002124628,"teacher_disagreement_score":0.041093517,"about_ca_system_score_codex":0.0000015155251,"about_ca_system_score_gemma":0.00002651633,"threshold_uncertainty_score":0.36616758},"labels":[],"label_agreement":null},{"id":"W4405452583","doi":"10.1111/dom.16115","title":"Metformin and risk of adverse pregnancy outcomes among pregnant women with gestational diabetes in the United Kingdom: A population‐based cohort study","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; McGill University","keywords":"Medicine; Gestational diabetes; Metformin; Obstetrics; Pregnancy; Cohort; Cohort study; Population; Diabetes mellitus; Gynecology; Gestation; Internal medicine; Environmental health; Endocrinology","score_opus":0.014996314846974277,"score_gpt":0.2693624350464781,"score_spread":0.25436612019950383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405452583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681187,0.0010464779,0.000013018588,0.00008861521,0.00003282816,0.0018610626,0.00007014156,0.000032413438,0.000043600983],"genre_scores_gemma":[0.99877757,0.0001854968,0.0003215423,0.00008113222,0.000012015447,0.0003820475,0.00013781729,0.00001665721,0.00008573279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981579,0.00024642405,0.00029580784,0.00033048153,0.0006009186,0.00036843616],"domain_scores_gemma":[0.998917,0.000533006,0.00008802644,0.00022432372,0.00010859613,0.00012906766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009895166,0.00019926138,0.0004330618,0.00056646933,0.000102978134,0.000043937693,0.00009419857,0.000043904518,0.000024591405],"category_scores_gemma":[0.00025347393,0.00011927511,0.00004453791,0.00064672285,0.00013868089,0.00023967333,0.000055683373,0.00022111913,0.0000013519691],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019995041,0.00045480864,0.9946708,0.0005422616,0.00052357203,0.000015528454,0.0010666964,0.00008050119,0.000015265767,0.0008151261,0.0000061293736,0.00178932],"study_design_scores_gemma":[0.0016070636,0.00029059718,0.99302137,0.0005107735,0.0005116725,2.1414567e-7,0.0005615608,0.0027696525,0.000038535392,0.00044363784,0.00011235709,0.00013258155],"about_ca_topic_score_codex":0.00066473207,"about_ca_topic_score_gemma":0.00015084441,"teacher_disagreement_score":0.0026891513,"about_ca_system_score_codex":0.000033444467,"about_ca_system_score_gemma":0.000056336794,"threshold_uncertainty_score":0.4863898},"labels":[],"label_agreement":null},{"id":"W4405600257","doi":"10.1111/dom.16050","title":"Long‐term weight loss and cardiorenal outcomes by baseline <scp>BMI</scp> in the <scp>VERTIS CV</scp> trial","year":2024,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Pfizer","keywords":"Medicine; Weight loss; Cardiorenal syndrome; Body mass index; Baseline (sea); Term (time); Internal medicine; Cardiology; Heart failure; Obesity","score_opus":0.008480813377605586,"score_gpt":0.2372306698724115,"score_spread":0.22874985649480592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405600257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94866836,0.046588253,0.00003278805,0.0008431848,0.0008270049,0.0011375635,0.00013355445,0.000120498946,0.0016487697],"genre_scores_gemma":[0.98335314,0.0068160873,0.000103238,0.002007911,0.00061643554,0.00018776121,0.00030086483,0.000049547,0.006564998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974635,0.00021912494,0.00043696526,0.000650791,0.00051475887,0.000714837],"domain_scores_gemma":[0.99825835,0.00092882087,0.00007299581,0.00043550393,0.00004671666,0.00025761157],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001082179,0.00046624214,0.0009433337,0.0002840217,0.00015205026,0.00025825485,0.00019594967,0.00017993024,0.000016869602],"category_scores_gemma":[0.00034588674,0.00030166263,0.00027226377,0.00039332602,0.00020717729,0.00030077467,0.00016964071,0.0003650149,0.00004173858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000695068,0.0011934416,0.875221,0.0007472484,0.0019350067,0.000374997,0.002142377,8.968979e-7,0.0006435992,0.0019332115,0.06000734,0.055731364],"study_design_scores_gemma":[0.015927676,0.00020845672,0.69428694,0.00016316655,0.0016031055,0.0000061796873,0.00013211196,0.00009748597,0.0016275258,0.0003826369,0.28547323,0.00009151842],"about_ca_topic_score_codex":0.00004911828,"about_ca_topic_score_gemma":0.000019971128,"teacher_disagreement_score":0.22546588,"about_ca_system_score_codex":0.000034242363,"about_ca_system_score_gemma":0.000042777134,"threshold_uncertainty_score":0.99994355},"labels":[],"label_agreement":null},{"id":"W4405829028","doi":"10.1111/dom.16169","title":"Impact of the timing of metformin administration on the plasma lactate response to intraduodenal glucose infusion in type 2 diabetes","year":2024,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Royal Adelaide Hospital; University of Adelaide; Hospital Research Foundation","keywords":"Medicine; Metformin; Type 2 diabetes; Internal medicine; Plasma glucose; Diabetes mellitus; Endocrinology; Plasma concentration; Continuous glucose monitoring; Pharmacology; Type 1 diabetes","score_opus":0.01272841719396867,"score_gpt":0.2564239995365676,"score_spread":0.24369558234259892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405829028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94875836,0.045547683,5.5596126e-7,0.0042694653,0.00058106205,0.00047681015,0.0003033196,0.0000070252117,0.000055715896],"genre_scores_gemma":[0.97030395,0.008431728,0.000043617572,0.019952632,0.00079870486,0.000058479756,0.00014663681,0.000055165012,0.00020911],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977161,0.0005015896,0.00049203605,0.00047550586,0.00036036296,0.00045438422],"domain_scores_gemma":[0.9986667,0.0002148588,0.00027137823,0.000631692,0.00014123291,0.0000741242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010381391,0.00039961835,0.00062792405,0.00022169248,0.000076947734,0.000050943647,0.00045138682,0.0005186893,0.000038657883],"category_scores_gemma":[0.00059347844,0.00023941834,0.00031544926,0.00043157896,0.00017906158,0.000012055189,0.00024281086,0.0006854726,0.000006862033],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017338351,0.0004380743,0.010561836,0.0011813544,0.0013785891,0.000016527074,0.0013979882,0.0001318817,0.63619363,0.00018057712,0.2535426,0.09324312],"study_design_scores_gemma":[0.0004580837,0.00052398327,0.04674803,0.00036516448,0.000277922,0.0000011073216,0.0000206367,0.00008278895,0.57960427,0.00026160225,0.3712621,0.0003943005],"about_ca_topic_score_codex":0.000027201371,"about_ca_topic_score_gemma":0.000025117773,"teacher_disagreement_score":0.11771949,"about_ca_system_score_codex":0.000026936317,"about_ca_system_score_gemma":0.00030082755,"threshold_uncertainty_score":0.9763197},"labels":[],"label_agreement":null},{"id":"W4406106519","doi":"10.1111/dom.16154","title":"Metabolic interventions as adjunctive therapies to insulin in type 1 diabetes: Current clinical landscape and perspectives","year":2025,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research; Servier; University of Toronto","keywords":"Medicine; Type 2 diabetes; Adjunctive treatment; Psychological intervention; Intensive care medicine; Diabetes mellitus; Internal medicine; Endocrinology; Psychiatry","score_opus":0.08353014946425638,"score_gpt":0.41418216357173954,"score_spread":0.3306520141074831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406106519","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.041869514,0.9541272,0.0000019304605,0.00029040492,0.0007532468,0.002099952,0.000075117496,0.00006105773,0.0007215767],"genre_scores_gemma":[0.0019649884,0.99534535,0.00011914945,0.00018333686,0.00038852196,0.000268977,0.00015010082,0.000045427372,0.0015341539],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963735,0.0006937501,0.00090163853,0.000994272,0.0003508728,0.0006859696],"domain_scores_gemma":[0.9981387,0.0005334662,0.00020202888,0.0005019095,0.0002335591,0.00039030644],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016096173,0.0006008247,0.0033916202,0.0014614357,0.00013182349,0.0001435604,0.0002857804,0.00034074124,0.000110305686],"category_scores_gemma":[0.0013376984,0.00045043806,0.0007402995,0.0013899946,0.00027295962,0.0001642163,0.0006671005,0.0011025982,0.00007285345],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021190677,0.0008001577,0.012830024,0.017176278,0.0010560759,0.0000043320592,0.00040499578,6.079023e-8,2.3661327e-7,0.0020446612,0.00045909014,0.96520287],"study_design_scores_gemma":[0.0011649758,0.00022124486,0.08940066,0.01849739,0.0030512055,2.9947375e-7,0.0001876641,0.000007489769,0.0000010221634,0.00044934422,0.8865933,0.00042542975],"about_ca_topic_score_codex":0.0000075906023,"about_ca_topic_score_gemma":0.000013146258,"teacher_disagreement_score":0.96477747,"about_ca_system_score_codex":0.000030484218,"about_ca_system_score_gemma":0.0002679358,"threshold_uncertainty_score":0.9997947},"labels":[],"label_agreement":null},{"id":"W4406225861","doi":"10.1111/dom.16190","title":"Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the <scp>CANVAS</scp> Program and <scp>CREDENCE</scp> trial","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Janssen Research and Development","keywords":"Canagliflozin; Medicine; Tolerability; Internal medicine; Adverse effect; Renal function; Kidney disease; Diabetes mellitus; Type 2 diabetes; Endocrinology","score_opus":0.005007696488987766,"score_gpt":0.21690827824916928,"score_spread":0.2119005817601815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406225861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764062,0.018784944,0.000021324351,0.0005645751,0.00017997682,0.0030262133,0.00012519205,0.00009634474,0.0007952412],"genre_scores_gemma":[0.9925176,0.0028910476,0.0006325903,0.0017374248,0.00009618787,0.0005144827,0.0003438106,0.000027354175,0.0012394851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751157,0.00022731954,0.0004299423,0.00077777397,0.00044087993,0.000612505],"domain_scores_gemma":[0.99810433,0.0006741936,0.000120309036,0.00065208034,0.00009784351,0.00035124665],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006918083,0.0004632804,0.0015761134,0.0003869903,0.00023907947,0.00019201012,0.00016945672,0.00016532054,0.0000061002825],"category_scores_gemma":[0.0005570864,0.00029799558,0.0003354274,0.0010214933,0.00029207452,0.00018801219,0.00022353772,0.00027485602,0.0000018295876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016329298,0.0006923103,0.9631082,0.00018282526,0.012200148,0.000021188185,0.0011567243,0.000004561051,0.0000061772535,0.00039172213,0.0010131128,0.02105977],"study_design_scores_gemma":[0.042498406,0.00020533905,0.90758723,0.00024092162,0.013666195,2.873127e-7,0.0009602386,0.00022127997,0.000092631984,0.00014592937,0.034309153,0.000072389535],"about_ca_topic_score_codex":0.002558047,"about_ca_topic_score_gemma":0.0011360558,"teacher_disagreement_score":0.055520937,"about_ca_system_score_codex":0.000041889118,"about_ca_system_score_gemma":0.000108960994,"threshold_uncertainty_score":0.9999472},"labels":[],"label_agreement":null},{"id":"W4406252582","doi":"10.1111/dom.16176","title":"Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the <scp>SURMOUNT</scp> ‐1 to ‐4 trials","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Eli Lilly and Company","keywords":"Medicine; Nausea; Placebo; Tolerability; Weight loss; Overweight; Adverse effect; Vomiting; Internal medicine; Type 2 diabetes; Antiemetic; Weight management; Diabetes mellitus; Clinical endpoint; Clinical trial; Obesity; Gastroenterology; Endocrinology; Alternative medicine","score_opus":0.01263508857942536,"score_gpt":0.2473143678169976,"score_spread":0.23467927923757223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406252582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967017,0.00084103463,0.000031317373,0.00060603884,0.000038656155,0.0015093639,0.000023838473,0.0000473397,0.00020066985],"genre_scores_gemma":[0.99722993,0.000082648054,0.0019652098,0.0004441974,0.00003868633,0.0000774432,0.00003266709,0.000018295625,0.000110930174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973801,0.0005572148,0.0004853266,0.0006779705,0.00033825147,0.0005611665],"domain_scores_gemma":[0.9981122,0.00091130426,0.00019246442,0.00032443533,0.00024659483,0.00021298484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019343775,0.00039541948,0.0011668251,0.00028611126,0.0001692126,0.00009145063,0.000108355656,0.00008458917,0.0000061108053],"category_scores_gemma":[0.00323008,0.00022130283,0.000038359594,0.0010007084,0.00038126163,0.0002490662,0.000065244705,0.00047286443,7.843836e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009237899,0.0006608348,0.99585414,0.00031349596,0.000075719916,0.000014323226,0.0009983105,0.00000867979,0.00025692084,0.00008454511,0.000054753815,0.00075448136],"study_design_scores_gemma":[0.005045264,0.0014242561,0.98840153,0.0024449057,0.00038266907,0.000045808458,0.0011036785,0.00023517405,0.00041733874,0.00028182036,0.000100690304,0.000116851086],"about_ca_topic_score_codex":0.00035434554,"about_ca_topic_score_gemma":0.0026807652,"teacher_disagreement_score":0.007452601,"about_ca_system_score_codex":0.00005044683,"about_ca_system_score_gemma":0.00018053371,"threshold_uncertainty_score":0.90244675},"labels":[],"label_agreement":null},{"id":"W4406382034","doi":"10.1111/dom.16197","title":"Long‐term blood glucose control via glucose‐activated transcriptional regulation of insulin analogue in type 1 diabetes mice","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College; University of Toronto","funders":"National Natural Science Foundation of China","keywords":"Medicine; Insulin; Type 2 diabetes; Internal medicine; Term (time); Endocrinology; Blood sugar regulation; Diabetes mellitus","score_opus":0.00739398338393703,"score_gpt":0.2198384020662056,"score_spread":0.21244441868226857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406382034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97789794,0.020509098,0.00009362829,0.00027784443,0.0003290276,0.0004640355,0.000050909104,0.000056046567,0.0003214514],"genre_scores_gemma":[0.9977661,0.00067831564,0.00020250578,0.00085064163,0.000083960345,0.00002678417,0.00021691319,0.0000148227955,0.00015999179],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984151,0.00015109881,0.000493274,0.0003558065,0.00022847684,0.00035620705],"domain_scores_gemma":[0.9990144,0.00023275593,0.0001311204,0.00024460198,0.00023618751,0.00014097536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004008795,0.0002456501,0.00080275204,0.000472038,0.000074076306,0.000020575897,0.00008503906,0.00021565943,0.0001165058],"category_scores_gemma":[0.00030034946,0.00022754964,0.0001257862,0.00074157707,0.0001601687,0.00019202357,0.000023232624,0.0002310295,0.0000074491913],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017337821,0.0005202718,0.43370005,0.0002428969,0.00026516107,0.0000013570211,0.00006160304,0.000007630133,0.5608846,0.0006007526,0.000023583976,0.003518725],"study_design_scores_gemma":[0.004750958,0.00008859371,0.6865064,0.00019251915,0.00058717764,5.451407e-7,0.000008814693,0.0004416394,0.30648065,0.000554523,0.00026425644,0.00012393654],"about_ca_topic_score_codex":0.000045083758,"about_ca_topic_score_gemma":0.000013000335,"teacher_disagreement_score":0.25440395,"about_ca_system_score_codex":0.000026341026,"about_ca_system_score_gemma":0.00010175384,"threshold_uncertainty_score":0.9279205},"labels":[],"label_agreement":null},{"id":"W4406917166","doi":"10.1111/dom.16206","title":"Striving for early effective glycaemic and weight management in type 2 diabetes: A narrative review","year":2025,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Eli Lilly and Company","keywords":"Medicine; Type 2 diabetes; Insulin resistance; Narrative review; Intensive care medicine; Weight loss; Obesity; Diabetes mellitus; Internal medicine; Endocrinology","score_opus":0.01211267877879356,"score_gpt":0.29370002212965113,"score_spread":0.28158734335085756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406917166","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007333796,0.9807795,0.0000036270505,0.00008933664,0.00037787197,0.010243349,0.000061149774,0.000062122905,0.001049227],"genre_scores_gemma":[0.00014786309,0.9940958,0.0004442558,0.0005517055,0.00011456716,0.0025218145,0.00028763394,0.000048826638,0.0017875176],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973674,0.00022906139,0.00062769314,0.00090203504,0.0002167826,0.0006570569],"domain_scores_gemma":[0.9985228,0.00048793404,0.0002664062,0.00044285844,0.00009494596,0.00018506608],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006696343,0.0007386656,0.0035738465,0.0006217756,0.00013081296,0.000063564905,0.00016513412,0.0002557534,0.000015436555],"category_scores_gemma":[0.00018038168,0.0005831163,0.00040210166,0.00075796695,0.00010228161,0.00015735073,0.00030534086,0.00033662736,0.0000093023955],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009463247,0.00018431166,0.00080063596,0.19070017,0.0017506947,0.000011300934,0.000114910035,1.4860168e-8,2.4813315e-7,0.00053903426,0.0010907537,0.8047985],"study_design_scores_gemma":[0.0017798616,0.00020688615,0.005305539,0.1302126,0.01477802,5.783196e-7,0.000022996837,0.000004163471,0.000004565195,0.00028657666,0.8469053,0.0004929024],"about_ca_topic_score_codex":0.000004998096,"about_ca_topic_score_gemma":0.0000036464496,"teacher_disagreement_score":0.8458145,"about_ca_system_score_codex":0.00011116352,"about_ca_system_score_gemma":0.00007140934,"threshold_uncertainty_score":0.99966204},"labels":[],"label_agreement":null},{"id":"W4407183248","doi":"10.1111/dom.16214","title":"Effect of <scp>iGlarLixi</scp> on continuous glucose monitoring—measured time in range in insulin‐naive adults with suboptimally controlled type 2 diabetes","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Sanofi-Aventis Deutschland; Sanofi","keywords":"Medicine; Lixisenatide; Insulin glargine; Type 2 diabetes; Postprandial; Insulin; Glucagon-like peptide 1 receptor; Hypoglycemia; Diabetes mellitus; Internal medicine; Type 1 diabetes; Endocrinology; Basal insulin; Receptor; Agonist","score_opus":0.0044178126924421385,"score_gpt":0.2323221658458761,"score_spread":0.22790435315343394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407183248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97946197,0.015322204,5.910475e-7,0.00009936166,0.00022385047,0.0022293336,0.000010880322,0.000053251228,0.0025985842],"genre_scores_gemma":[0.9975246,0.0006626575,0.00007207063,0.00011404934,0.00009030046,0.00015514591,0.000027247508,0.000029553703,0.0013243345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973417,0.00045414895,0.00047104876,0.0005116889,0.000498088,0.0007233123],"domain_scores_gemma":[0.99784344,0.0012335307,0.00014605916,0.00037299027,0.00024350891,0.00016048831],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018488083,0.00038044772,0.0017159092,0.0008887348,0.00006137245,0.000050364208,0.00020938391,0.0002136258,0.0000099210165],"category_scores_gemma":[0.0016032185,0.00027624535,0.00014157686,0.0009965954,0.00019409735,0.00014924683,0.00011714551,0.00049719465,0.00002110129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00233139,0.0008361375,0.97173357,0.0011200727,0.00044784517,0.000033831016,0.00035222564,0.000016807982,0.0069801444,0.000086113454,0.00010733491,0.015954498],"study_design_scores_gemma":[0.037971634,0.0016722181,0.9023261,0.0017559946,0.0004162789,9.235179e-8,0.000070158734,0.0006317518,0.054467376,0.000052785716,0.0004986914,0.00013689892],"about_ca_topic_score_codex":0.000029521421,"about_ca_topic_score_gemma":0.0000096233225,"teacher_disagreement_score":0.06940748,"about_ca_system_score_codex":0.000044305565,"about_ca_system_score_gemma":0.00007696167,"threshold_uncertainty_score":0.99996895},"labels":[],"label_agreement":null},{"id":"W4407192481","doi":"10.1111/dom.16230","title":"Effectiveness of gemigliptin on risk of major adverse kidney events in people with type 2 diabetes: A Korean cohort study","year":2025,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"LG Chem","keywords":"Medicine; Type 2 diabetes; Cohort; Adverse effect; Internal medicine; Cohort study; Diabetes mellitus; Endocrinology","score_opus":0.004209678543887113,"score_gpt":0.2166906158163506,"score_spread":0.21248093727246348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407192481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992802,0.00066170556,9.531683e-7,0.0009609008,0.00034720806,0.0041919965,0.00021941992,0.00003948271,0.00077633635],"genre_scores_gemma":[0.9864965,0.0004447348,0.00009571126,0.010309219,0.00017589772,0.00039821322,0.00085706566,0.00006837004,0.0011542889],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687225,0.000630377,0.000537359,0.00078185584,0.0006234187,0.0005547611],"domain_scores_gemma":[0.9980029,0.00046919947,0.00042820233,0.0007875069,0.00017321337,0.00013898696],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011117905,0.00060202007,0.0022812067,0.0008007249,0.000055343902,0.000007905202,0.0002181588,0.000362519,0.00003452434],"category_scores_gemma":[0.00027169767,0.00046648143,0.00021653787,0.0007272975,0.00011472009,0.0000879468,0.00017847515,0.00078374456,0.000006174078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025958676,0.0020747844,0.9816964,0.005134079,0.0037168097,0.000028592149,0.00017927233,0.000004380588,0.000071425406,0.000016697273,0.0064193914,0.00039852678],"study_design_scores_gemma":[0.0064358227,0.0012279295,0.97492266,0.0030104124,0.0071964427,1.1529592e-7,0.00004745334,0.000009621666,0.001743764,0.000059017217,0.0049982397,0.00034851444],"about_ca_topic_score_codex":0.0002907199,"about_ca_topic_score_gemma":0.000044022807,"teacher_disagreement_score":0.009348319,"about_ca_system_score_codex":0.00008245727,"about_ca_system_score_gemma":0.00015407773,"threshold_uncertainty_score":0.9997787},"labels":[],"label_agreement":null},{"id":"W4407192491","doi":"10.1111/dom.16220","title":"Efficacy of high‐intensity interval training in individuals with type 2 diabetes mellitus: An umbrella review of systematic reviews and meta‐analyses","year":2025,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Cardiovascular and exercise physiology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia","funders":"","keywords":"Medicine; High-intensity interval training; Cardiorespiratory fitness; Meta-analysis; Systematic review; Interval training; Physical therapy; Confidence interval; Internal medicine; Type 2 diabetes; Guideline; Diabetes mellitus; MEDLINE; Endocrinology; Pathology","score_opus":0.11198731395931047,"score_gpt":0.365820510315809,"score_spread":0.2538331963564985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407192491","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014093142,0.9823703,0.000002351909,0.000011446796,0.00011155764,0.0032870371,0.000074578966,0.000016264474,0.00003331392],"genre_scores_gemma":[0.0020145585,0.99688673,0.0003936923,0.00019557904,0.0000580386,0.0001754542,0.00022413368,0.000031774085,0.000020026922],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9953251,0.0015910111,0.0017483031,0.0006531634,0.0003169341,0.00036551364],"domain_scores_gemma":[0.99695677,0.0007689372,0.0009254666,0.00090012175,0.00027562794,0.000173054],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0030608424,0.0006534939,0.021150747,0.00053863705,0.000037607697,0.000015799384,0.00022965616,0.0002774899,0.000019928091],"category_scores_gemma":[0.0013691264,0.0003896569,0.0014955382,0.00092397653,0.0002517171,0.00009924771,0.00017597195,0.00042880233,0.0000020939522],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015251361,0.00012963022,0.000034768214,0.9299676,0.010462931,0.000002809391,0.00016676323,1.9980689e-7,0.0000058085034,0.000051129628,0.0000237571,0.05913934],"study_design_scores_gemma":[0.00077176664,0.00017233528,0.001653734,0.68699265,0.2934934,0.000014952318,0.000035706707,0.0000016055301,0.00010483686,0.00006116971,0.016272169,0.00042566928],"about_ca_topic_score_codex":0.000054115404,"about_ca_topic_score_gemma":0.000005853933,"teacher_disagreement_score":0.28303045,"about_ca_system_score_codex":0.00001611339,"about_ca_system_score_gemma":0.00020063076,"threshold_uncertainty_score":0.9998555},"labels":[],"label_agreement":null},{"id":"W4407348979","doi":"10.1111/dom.16235","title":"Characterization of the effect of naltrexone/bupropion on body composition","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bausch Health (Canada); McGill University Health Centre","funders":"Health Canada; Bausch Health; Orexigen Therapeutics","keywords":"Lean body mass; Placebo; Medicine; Bupropion; Internal medicine; Body mass index; Naltrexone; Weight loss; Endocrinology; Animal science; Obesity; Antagonist; Body weight; Smoking cessation; Biology","score_opus":0.003677726107854942,"score_gpt":0.2417478207140669,"score_spread":0.23807009460621195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407348979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998288,0.00035189863,0.000010669572,0.0003602901,0.00024405273,0.0004238933,0.000019939389,0.000012095514,0.00028917275],"genre_scores_gemma":[0.9993001,0.00011318915,0.000011032431,0.00034872515,0.000026710113,0.000013025874,0.00003769683,0.0000031996797,0.00014629358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99942255,0.00013671351,0.00014148494,0.000114428585,0.000092345384,0.000092489696],"domain_scores_gemma":[0.99964255,0.00007262674,0.00008562891,0.00013234951,0.00003945799,0.00002736905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015324797,0.00009150222,0.0003128831,0.000079430625,0.00007277612,0.000002493819,0.000043372118,0.000070775684,0.000011136037],"category_scores_gemma":[0.000022764621,0.000057024274,0.00007878685,0.00013698627,0.00008856399,0.000035617144,0.00003087335,0.00009339939,0.0000017764938],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013839471,0.00022971489,0.25335586,0.0002437049,0.000116362724,4.1312737e-7,0.00003758977,5.72797e-7,0.7436386,0.00061999704,0.000015909243,0.0016028803],"study_design_scores_gemma":[0.0008368015,0.00010813203,0.49731287,0.00010177805,0.00032849718,2.3505896e-7,6.744642e-7,0.000027758118,0.5010733,0.000029520521,0.00016148965,0.000018922276],"about_ca_topic_score_codex":0.0000048893066,"about_ca_topic_score_gemma":2.6034584e-7,"teacher_disagreement_score":0.243957,"about_ca_system_score_codex":0.000011578767,"about_ca_system_score_gemma":0.000016855824,"threshold_uncertainty_score":0.23253824},"labels":[],"label_agreement":null},{"id":"W4407379624","doi":"10.1111/dom.16242","title":"Mechanisms of diabetic cardiomyopathy: Focus on inflammation","year":2025,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Diabetic cardiomyopathy; Medicine; Cardiomyopathy; Coronary artery disease; Heart failure; Inflammation; Diabetes mellitus; Disease; Bioinformatics; Therapeutic approach; Insulin resistance; Cardiology; Internal medicine; Intensive care medicine; Endocrinology","score_opus":0.012505314081733516,"score_gpt":0.2510559400740218,"score_spread":0.2385506259922883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407379624","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025207282,0.99402547,0.00015342531,0.000023270402,0.00083115546,0.0010259885,0.000084356536,0.0000646983,0.0012708791],"genre_scores_gemma":[0.0022681549,0.9966763,0.000093286275,0.000042305055,0.00021485453,0.00007606138,0.00015589931,0.00003212598,0.00044097987],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99817264,0.00024016711,0.00052090577,0.00042338308,0.00038133474,0.0002615954],"domain_scores_gemma":[0.9987522,0.0001784753,0.00023401847,0.000565853,0.00011825077,0.00015124468],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049829273,0.0004122882,0.0030709389,0.0005902962,0.000076398115,0.000021827791,0.00009335202,0.00042843958,0.0000345325],"category_scores_gemma":[0.00023658521,0.0003085055,0.0014200192,0.00043837726,0.00006700583,0.000049190367,0.00008126193,0.0003761627,0.000026998576],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000053065924,0.000054104596,0.00013653135,0.019871512,0.0010448013,0.0000046802097,0.00002389054,4.4679004e-7,0.000018993107,0.003801192,0.00007434133,0.9749642],"study_design_scores_gemma":[0.0008430501,0.00008539313,0.005565567,0.012332576,0.013299801,0.000006248944,0.000010552489,0.0000030392498,0.00095004746,0.0010525371,0.96546715,0.00038401148],"about_ca_topic_score_codex":0.000013358176,"about_ca_topic_score_gemma":8.4584275e-7,"teacher_disagreement_score":0.97458017,"about_ca_system_score_codex":0.00003786849,"about_ca_system_score_gemma":0.00019938944,"threshold_uncertainty_score":0.9999367},"labels":[],"label_agreement":null},{"id":"W4407384717","doi":"10.1111/dom.16231","title":"Efficacy and hypoglycaemia outcomes with once‐weekly insulin icodec versus once‐daily basal insulin in individuals with type 2 diabetes by kidney function: A post hoc participant‐level analysis of the <scp>ONWARDS</scp> 1–5 trials","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada); Trillium Health Centre","funders":"Novo Nordisk","keywords":"Medicine; Post-hoc analysis; Basal insulin; Internal medicine; Insulin; Type 2 diabetes; Basal (medicine); Diabetes mellitus; Endocrinology; Renal function","score_opus":0.040088998702929604,"score_gpt":0.29897232845642047,"score_spread":0.2588833297534909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407384717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880952,0.008331541,0.000009295904,0.0012574957,0.00026578445,0.0011989499,0.00031757896,0.00004225155,0.00048189226],"genre_scores_gemma":[0.9951382,0.0006092241,0.0002634371,0.0017455972,0.00006279298,0.00008850646,0.00019436172,0.000029883375,0.0018679656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99637973,0.00056580495,0.0007779663,0.00068776193,0.000797987,0.0007907667],"domain_scores_gemma":[0.99647,0.0018704688,0.00036182968,0.00062819157,0.00031902877,0.00035052022],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022800732,0.0004613244,0.0021073222,0.00090030767,0.0002164001,0.00014122929,0.00031998166,0.00023112223,0.000039055583],"category_scores_gemma":[0.0032621801,0.00027349015,0.00021456523,0.003229169,0.00055792066,0.0002496221,0.00031962976,0.00050709705,0.000004944293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005740399,0.0008141385,0.977611,0.0002938747,0.0078981295,0.000002924064,0.00077505497,0.000032588963,0.0011793346,0.00026897504,0.0017662543,0.008783709],"study_design_scores_gemma":[0.01485583,0.0007591235,0.9604522,0.00030309852,0.009823206,5.663714e-8,0.00041227267,0.00021246879,0.001993253,0.00008235713,0.010946183,0.00015996736],"about_ca_topic_score_codex":0.0000704244,"about_ca_topic_score_gemma":0.00009623697,"teacher_disagreement_score":0.017158793,"about_ca_system_score_codex":0.00004282651,"about_ca_system_score_gemma":0.00043241022,"threshold_uncertainty_score":0.99997175},"labels":[],"label_agreement":null},{"id":"W4408026290","doi":"10.1111/dom.16278","title":"What do the guidelines say about use of biosimilar insulin therapy? Simple practical considerations to guide clinicians in different patient subgroups—Sharing Canadian perspectives","year":2025,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Medicine; Biosimilar; Simple (philosophy); Intensive care medicine; Medical physics; Internal medicine; Epistemology","score_opus":0.09275575179041569,"score_gpt":0.381834232375524,"score_spread":0.2890784805851083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408026290","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007981186,0.98610705,0.000012064055,0.003100058,0.0008512904,0.0013361799,0.0005504509,0.000018455432,0.000043286404],"genre_scores_gemma":[0.0011209566,0.99407375,0.00071930623,0.0035893894,0.00008574516,0.00011203649,0.000075254466,0.000024797744,0.00019879146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959599,0.0012172515,0.0013494347,0.000760431,0.00008413028,0.00062889874],"domain_scores_gemma":[0.9958046,0.0027247092,0.0003301891,0.00066572137,0.00033987506,0.00013488776],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010364009,0.00055818603,0.002180163,0.0005137441,0.00031520426,0.00022885624,0.00025361028,0.00075768965,0.00026600683],"category_scores_gemma":[0.003690533,0.00033398997,0.00047011834,0.0004506125,0.0003657196,0.00020649288,0.0002941061,0.0008013462,0.0000070695946],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029569559,0.00068545796,0.0020479816,0.0014137697,0.0016265605,0.000015238852,0.0020206938,0.0000023496561,0.00008928205,0.011107093,0.0144177675,0.9665442],"study_design_scores_gemma":[0.00029373815,0.00006532378,0.0030097575,0.002955104,0.00073183066,0.0000047111666,0.0006099811,0.0000034011287,0.00019242591,0.00059998967,0.99115723,0.00037648348],"about_ca_topic_score_codex":0.003814224,"about_ca_topic_score_gemma":0.011434687,"teacher_disagreement_score":0.97673947,"about_ca_system_score_codex":0.00008408241,"about_ca_system_score_gemma":0.0005226963,"threshold_uncertainty_score":0.9999112},"labels":[],"label_agreement":null},{"id":"W4408244332","doi":"10.1111/dom.16315","title":"The coordinated changes in insulin sensitivity and insulin secretion associated with the remission of type 2 diabetes following short‐term insulin therapy","year":2025,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Banting and Best Diabetes Centre, University of Toronto; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Medicine; Insulin; Type 2 diabetes; Internal medicine; Insulin sensitivity; Term (time); Endocrinology; Diabetes mellitus; Type 1 diabetes; Insulin resistance","score_opus":0.014500087350177777,"score_gpt":0.2512828135866966,"score_spread":0.2367827262365188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408244332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8865461,0.025784964,9.897692e-7,0.085800186,0.00026434156,0.0012886133,0.000042938154,0.00005261267,0.00021927332],"genre_scores_gemma":[0.9595975,0.012442162,0.000015324875,0.02555087,0.00040219075,0.00006919817,0.00058880734,0.000056704306,0.0012772246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996664,0.00091685983,0.00039603474,0.0005984597,0.00065977767,0.00076487253],"domain_scores_gemma":[0.9975306,0.0013232569,0.00023433435,0.00051200617,0.00029995214,0.00009986163],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002656924,0.00049981696,0.0011560196,0.0004225183,0.0003878077,0.00014411578,0.00023331163,0.0006886971,0.00000858417],"category_scores_gemma":[0.0006926388,0.0002764999,0.0001405566,0.0010457358,0.0004464028,0.00012084114,0.0002943156,0.0017520337,0.0000010675292],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065227906,0.0008095243,0.57367116,0.0022457906,0.004477555,0.00024630222,0.001471354,0.0000051909765,0.017471839,0.000076385084,0.061297815,0.33757478],"study_design_scores_gemma":[0.0032678912,0.0003781734,0.8698102,0.0021367574,0.0007861962,4.0571254e-7,0.00010003129,0.0008624692,0.0040959185,0.00014983866,0.11789131,0.0005207566],"about_ca_topic_score_codex":0.00003760466,"about_ca_topic_score_gemma":0.00009852034,"teacher_disagreement_score":0.337054,"about_ca_system_score_codex":0.000051018153,"about_ca_system_score_gemma":0.00012121876,"threshold_uncertainty_score":0.9999687},"labels":[],"label_agreement":null},{"id":"W4408585020","doi":"10.1111/dom.16328","title":"Efficacy and hypoglycaemia outcomes with once‐weekly insulin icodec versus once‐daily basal insulin in type 2 diabetes according to baseline glucagon‐like peptide‐1 receptor agonist and sodium‐glucose co‐transporter‐2 inhibitor use: A post hoc analysis of <scp>ONWARDS</scp> 1–5","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Novo Nordisk","keywords":"Medicine; Internal medicine; Basal (medicine); Type 2 diabetes; Insulin; Hypoglycemia; Diabetes mellitus; Endocrinology; Glucagon-like peptide 1 receptor; Glucagon-like peptide-1; Post-hoc analysis; Agonist; Receptor","score_opus":0.011744945684002967,"score_gpt":0.25189143007267056,"score_spread":0.2401464843886676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408585020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892358,0.007997711,0.000016925034,0.0005784538,0.00040225653,0.0012122211,0.00031836084,0.000086415545,0.00015183374],"genre_scores_gemma":[0.9924507,0.0025384186,0.002230877,0.0013732348,0.0000878796,0.00008086268,0.0005828274,0.000048881626,0.00060630566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99677575,0.00016537635,0.000792559,0.0009995294,0.00047225237,0.0007945511],"domain_scores_gemma":[0.99739313,0.001049598,0.00025180043,0.00056433206,0.000289212,0.0004519074],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007313178,0.0006706932,0.002009954,0.001389961,0.00019423482,0.00018525876,0.00019440228,0.00023971323,0.000016843129],"category_scores_gemma":[0.0006284586,0.0005642797,0.00019845409,0.0019953263,0.00032675394,0.0004432537,0.00020869139,0.0003528008,0.0000075279518],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013872901,0.0012278715,0.9566886,0.00048338174,0.004284022,0.000022800248,0.0013075691,0.000029716337,0.007545749,0.00015642881,0.00038058893,0.026486002],"study_design_scores_gemma":[0.013707795,0.0011458349,0.9545956,0.00043229896,0.006465314,1.5629577e-7,0.00075387186,0.00028075496,0.009790359,0.00001547996,0.0124825835,0.00032989832],"about_ca_topic_score_codex":0.00022188059,"about_ca_topic_score_gemma":0.00032682047,"teacher_disagreement_score":0.026156105,"about_ca_system_score_codex":0.00010460568,"about_ca_system_score_gemma":0.00019605857,"threshold_uncertainty_score":0.9996809},"labels":[],"label_agreement":null},{"id":"W4408745570","doi":"10.1111/dom.16266","title":"<scp>FRONTIER</scp> : <scp>FReeStyle</scp> Libre system use in Ontario among people with diabetes in the <scp>IC</scp> / <scp>ES</scp> database—Evidence from real‐world practice: Patients on basal insulin, glucagon‐like peptide 1 receptor agonist or oral therapies","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Abbott (Canada); Diabetes Canada; Montreal Clinical Research Institute; Western University","funders":"Abbott Diabetes Care","keywords":"Medicine; Basal (medicine); Insulin; Basal insulin; Diabetes mellitus; Liraglutide; Type 2 diabetes; Type 2 Diabetes Mellitus; Hypoglycemia; Internal medicine; Endocrinology","score_opus":0.01834633413073169,"score_gpt":0.2501892040016411,"score_spread":0.23184286987090938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408745570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823552,0.006839909,0.00001886736,0.0002863954,0.0012693971,0.0041175927,0.00044104684,0.00030208635,0.0043695234],"genre_scores_gemma":[0.9566807,0.0034775215,0.0020098956,0.0026031781,0.0005258353,0.0010124891,0.0018798521,0.00023993339,0.031570554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9891667,0.00201003,0.0015585538,0.0022339793,0.0023157552,0.0027149946],"domain_scores_gemma":[0.9794236,0.015988197,0.000911118,0.0022330692,0.00071067933,0.0007333644],"candidate_categories":["metaresearch","metaepi_narrow","scholarly_communication","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0037880458,0.0014909063,0.0025154357,0.0016761133,0.00083670724,0.0015164913,0.0016747029,0.0005805501,0.000019182951],"category_scores_gemma":[0.0111649,0.0010571544,0.00036615523,0.0033204947,0.00079248514,0.003500008,0.0011258294,0.0027601174,0.00009659442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066708184,0.0022461945,0.930399,0.0009951532,0.001009185,0.000095430216,0.007867383,0.000027025106,0.00031825792,0.00036908276,0.055453274,0.001153298],"study_design_scores_gemma":[0.0049830927,0.00060728984,0.81570435,0.003235494,0.0009137566,5.030661e-7,0.010113575,0.0003972795,0.0016101185,0.00007844786,0.16220856,0.0001475331],"about_ca_topic_score_codex":0.02290344,"about_ca_topic_score_gemma":0.11464683,"teacher_disagreement_score":0.114694655,"about_ca_system_score_codex":0.00053054997,"about_ca_system_score_gemma":0.0008565864,"threshold_uncertainty_score":0.999784},"labels":[],"label_agreement":null},{"id":"W4408745647","doi":"10.1111/dom.16341","title":"A meta‐analysis of adverse offspring health outcomes in patients with gestational diabetes mellitus","year":2025,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gestational diabetes; Meta-analysis; Offspring; Confidence interval; Odds ratio; Overweight; Publication bias; Subgroup analysis; Obesity; Internal medicine; Blood pressure; Diabetes mellitus; Obstetrics; Pregnancy; Endocrinology; Gestation","score_opus":0.03191254537991806,"score_gpt":0.31505639557028775,"score_spread":0.2831438501903697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408745647","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029324098,0.96782136,0.000007949689,0.00009908068,0.00004382425,0.0017892957,0.000807544,0.000021932015,0.00008494498],"genre_scores_gemma":[0.0026833164,0.9933749,0.0010175899,0.00031295547,0.00001207081,0.00032578112,0.0018706641,0.000027532962,0.00037517908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99678385,0.0003342782,0.0008839842,0.0005999443,0.0007824159,0.00061554916],"domain_scores_gemma":[0.9979001,0.00067912485,0.00046103148,0.00042687546,0.00025803025,0.00027482683],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007315201,0.0004927984,0.005789458,0.0023041507,0.00007535326,0.000017550756,0.0001811178,0.00013667057,0.00007355625],"category_scores_gemma":[0.00018296915,0.00034249874,0.001154216,0.001744749,0.00012892256,0.00013851281,0.00016628897,0.00034382456,0.0000038440103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023521085,0.0017653443,0.39204958,0.082669854,0.3325783,0.000004181008,0.00012962661,0.00004697374,9.051182e-8,0.0019511938,0.00004140453,0.18873993],"study_design_scores_gemma":[0.000999921,0.00009335435,0.74766004,0.0015951257,0.2073163,1.5925963e-8,0.000009308174,0.000019454059,8.059238e-7,0.0000451799,0.042004295,0.00025620277],"about_ca_topic_score_codex":0.00007024742,"about_ca_topic_score_gemma":0.000045645254,"teacher_disagreement_score":0.35561046,"about_ca_system_score_codex":0.000077067445,"about_ca_system_score_gemma":0.00043515302,"threshold_uncertainty_score":0.9999027},"labels":[],"label_agreement":null},{"id":"W4409691646","doi":"10.1111/dom.16371","title":"The interplay between heart failure and chronic kidney disease","year":2025,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Bayer","keywords":"Medicine; Kidney disease; Heart failure; Mineralocorticoid receptor; Intensive care medicine; Disease; Diabetes mellitus; Blood pressure; Internal medicine; Hyperkalemia; Endocrinology; Cardiology; Aldosterone","score_opus":0.010128089709059636,"score_gpt":0.28731579467443796,"score_spread":0.2771877049653783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409691646","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00094229385,0.9953453,0.0000020682633,0.001216547,0.00030539383,0.0015712415,0.000212199,0.00007372259,0.000331267],"genre_scores_gemma":[0.00024416044,0.9935038,0.00006996789,0.00050521444,0.0004954723,0.00024364107,0.00049303414,0.00003453864,0.0044101365],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981467,0.00015447795,0.00039543072,0.00056394725,0.00021322396,0.0005262043],"domain_scores_gemma":[0.9983014,0.00035008116,0.00013224182,0.0005671391,0.000040563133,0.0006086152],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003348496,0.0005365584,0.0019067532,0.00021006144,0.00032034173,0.00017347217,0.00017884259,0.0001900116,0.000023906396],"category_scores_gemma":[0.00019973259,0.0003250469,0.0004206651,0.0002448531,0.00021681776,0.00009650707,0.0004006843,0.00036448962,0.00003070248],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000037491438,0.00008273892,0.0053982777,0.032110177,0.0014902845,0.0000068864015,0.000014387015,6.134912e-9,2.6263828e-7,0.0012083242,0.018871248,0.94081366],"study_design_scores_gemma":[0.00057995936,0.000042370164,0.006506802,0.010957832,0.011919375,5.156966e-7,0.000004054922,0.0000012047321,0.000002770921,0.00017145023,0.96954894,0.00026475344],"about_ca_topic_score_codex":0.0000043481214,"about_ca_topic_score_gemma":0.0000034076857,"teacher_disagreement_score":0.9506777,"about_ca_system_score_codex":0.00006042488,"about_ca_system_score_gemma":0.00033940692,"threshold_uncertainty_score":0.9999201},"labels":[],"label_agreement":null},{"id":"W4409893677","doi":"10.1111/dom.16415","title":"Clinically meaningful improvements in treatment satisfaction in insulin‐naïve people with type 2 diabetes post initiation of insulin glargine 300 U/ <scp>mL</scp> : A post hoc analysis of real‐world <scp>ATOS</scp> study","year":2025,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Sanofi","keywords":"Medicine; Insulin glargine; Post-hoc analysis; Type 2 diabetes; Insulin; Internal medicine; Endocrinology; Type 2 Diabetes Mellitus; Diabetes mellitus","score_opus":0.01288432946621716,"score_gpt":0.27468092034625646,"score_spread":0.2617965908800393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409893677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99138796,0.0021452417,0.0000016589297,0.0019318085,0.00027049216,0.003007789,0.00042144142,0.000054998905,0.0007785771],"genre_scores_gemma":[0.9839845,0.0030024336,0.00020914963,0.007530632,0.0003126815,0.00025191467,0.003216606,0.00008321328,0.0014088921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940708,0.0006802128,0.0018066433,0.0011898753,0.0012019566,0.0010504855],"domain_scores_gemma":[0.99513555,0.0017014995,0.0010697929,0.0009181774,0.0009778446,0.00019711918],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016775964,0.0008152592,0.0033646966,0.0050910786,0.00010270297,0.000092780945,0.00034985738,0.00063369673,0.000029780698],"category_scores_gemma":[0.0013075015,0.0006729006,0.00040116324,0.0052989055,0.00019428875,0.00033065665,0.00032962902,0.0013429413,0.0000064363535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112596805,0.0025597117,0.977219,0.0013203205,0.0059153344,0.000045802837,0.0020692216,0.000031809162,0.00061781553,0.000018194223,0.001286937,0.0088032475],"study_design_scores_gemma":[0.007456063,0.003278132,0.9754882,0.00057961803,0.007292932,7.7900125e-8,0.00077351386,0.00039944088,0.00058686995,0.000045303324,0.0039265654,0.00017332564],"about_ca_topic_score_codex":0.0021656414,"about_ca_topic_score_gemma":0.00744574,"teacher_disagreement_score":0.008629922,"about_ca_system_score_codex":0.00022137174,"about_ca_system_score_gemma":0.0003956897,"threshold_uncertainty_score":0.9995722},"labels":[],"label_agreement":null},{"id":"W4409979848","doi":"10.1111/dom.16426","title":"Social disadvantage and technology use among adults with type 1 diabetes in Quebec: A cross‐sectional study using data from the Canadian <scp>T1D</scp> ( <scp>BETTER</scp> ) Registry","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Diabetes Canada; Montreal Clinical Research Institute; McGill University Health Centre; University of Ottawa; McGill University; Université Laval; University of Toronto; Public Health Ontario; Université de Montréal; Hospital for Sick Children; University Health Network; Ottawa Hospital; Centre hospitalier universitaire de Québec; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Breakthrough T1D Canada; Novo Nordisk; Sanofi; Diabetes Canada; Eli Lilly and Company; Canadian Institutes of Health Research; Diabetes Action Research and Education Foundation","keywords":"Medicine; Odds ratio; Disadvantage; Odds; Insulin pump; Cross-sectional study; Type 1 diabetes; Demography; Insulin; Logistic regression; Confidence interval; Diabetes mellitus; Gerontology; Environmental health; Internal medicine; Endocrinology","score_opus":0.023483228402835045,"score_gpt":0.2922524543133965,"score_spread":0.26876922591056146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409979848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99616474,0.0015792137,0.0000016618111,0.00031595546,0.00020934262,0.0010892769,0.00019956914,0.000063314925,0.00037691745],"genre_scores_gemma":[0.99680376,0.00009295345,0.00011007801,0.0003906414,0.00022685231,0.00004109185,0.0003252226,0.000031538704,0.00197784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973766,0.00017696182,0.00033911242,0.0008285042,0.0004172639,0.00086150714],"domain_scores_gemma":[0.9980517,0.00066609675,0.00012197505,0.0007577921,0.00018864995,0.00021379936],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007300203,0.00033155252,0.00059407484,0.00057399005,0.0007428723,0.0005885433,0.00051962613,0.00029129084,0.0000067964593],"category_scores_gemma":[0.001263282,0.00024649108,0.00004115943,0.0011345214,0.0009088958,0.00063200993,0.0007027147,0.00075241947,0.000004332693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000097190905,0.00024226843,0.99556273,0.000108874665,0.00040466624,0.000031225554,0.0006284117,0.0000014917812,0.00019526611,0.00012298074,0.0012980243,0.0013943606],"study_design_scores_gemma":[0.002247633,0.00005847141,0.98418856,0.00016925366,0.00033959147,2.8212213e-7,0.0017585657,0.00081190834,0.00013853738,0.00024128515,0.009966927,0.000078960344],"about_ca_topic_score_codex":0.10194702,"about_ca_topic_score_gemma":0.4842083,"teacher_disagreement_score":0.38226128,"about_ca_system_score_codex":0.00009473618,"about_ca_system_score_gemma":0.00031904771,"threshold_uncertainty_score":0.99999875},"labels":[],"label_agreement":null},{"id":"W4410132355","doi":"10.1111/dom.16431","title":"Fasting and postprandial kidney haemodynamic effects of empagliflozin and linagliptin in mono‐ and combination therapy compared to gliclazide in overweight people with type 2 diabetes ( <scp>RACELINES</scp> ): A randomised, double‐blind trial","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Amsterdam University Medical Centers; Boehringer Ingelheim","keywords":"Empagliflozin; Medicine; Linagliptin; Postprandial; Renal function; Type 2 diabetes; Gliclazide; Internal medicine; Endocrinology; Urology; Metformin; Diabetes mellitus; Glycosuria; Effective renal plasma flow; Renal blood flow","score_opus":0.0077083763909527505,"score_gpt":0.24274227196848683,"score_spread":0.23503389557753407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410132355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882345,0.0073541603,0.00001025004,0.0003332851,0.00019449586,0.003693115,0.000009420631,0.000029859473,0.00014089259],"genre_scores_gemma":[0.9969493,0.0018509569,0.00033981318,0.0004196956,0.00004976505,0.0002004727,0.00005825335,0.000021015021,0.00011069894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836046,0.00014561482,0.0004211292,0.00048129717,0.0001928463,0.00039867617],"domain_scores_gemma":[0.99872065,0.00065072457,0.0001373407,0.00018428525,0.000092478724,0.00021455428],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058768934,0.00033023424,0.001112766,0.0006463518,0.00008496989,0.00008166204,0.000064666245,0.00012826103,0.0000015473917],"category_scores_gemma":[0.00040369868,0.00026915595,0.000045453875,0.00062457076,0.00011119238,0.00021679167,0.00012060077,0.0001740729,4.6817635e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03818033,0.0015638273,0.93290335,0.0013981439,0.0005500529,0.00001197909,0.0026759352,0.000014207369,0.008545438,0.0006884072,0.00007708517,0.013391236],"study_design_scores_gemma":[0.32701954,0.00093436247,0.66290325,0.0006910988,0.0004209234,3.9057542e-7,0.000111205816,0.0016105166,0.005634464,0.00026770864,0.0002727789,0.00013378027],"about_ca_topic_score_codex":0.00013685277,"about_ca_topic_score_gemma":0.00013794703,"teacher_disagreement_score":0.28883922,"about_ca_system_score_codex":0.000026174743,"about_ca_system_score_gemma":0.000060341834,"threshold_uncertainty_score":0.99997604},"labels":[],"label_agreement":null},{"id":"W4410871301","doi":"10.1111/dom.16469","title":"Why, how and in whom should we measure levels of lipoprotein(a): A review of the latest evidence and clinical implications","year":2025,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Eli Lilly Canada; National Institutes of Health; Ionis Pharmaceuticals; Regeneron Pharmaceuticals; Novartis; Novo Nordisk; Esperion Therapeutics; Arrowhead Pharmaceuticals; Merck; NewAmsterdam Pharma; Boehringer Ingelheim; Amgen; Eli Lilly and Company; 89bio","keywords":"Medicine; Disease; Atherosclerotic cardiovascular disease; Lipoprotein(a); Statin; Guideline; Intensive care medicine; Familial hypercholesterolemia; Risk factor; PCSK9; Epidemiology; Narrative review; Bioinformatics; Internal medicine; Lipoprotein; Pathology; Cholesterol; LDL receptor","score_opus":0.10622161136636724,"score_gpt":0.37055368627367347,"score_spread":0.26433207490730626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410871301","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020734612,0.9894079,0.000006607617,0.005067542,0.00009874032,0.003157324,0.000150484,0.000009835969,0.00002809851],"genre_scores_gemma":[0.0017497364,0.9969058,0.00017559463,0.00080734753,0.00012544947,0.00014972893,0.000008274784,0.000018779085,0.00005927029],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99711585,0.0008311438,0.00091125997,0.0005190388,0.00036878514,0.00025394114],"domain_scores_gemma":[0.9976284,0.0005233319,0.00048542925,0.0009655852,0.00023137797,0.0001658969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032745942,0.0003365421,0.003707966,0.00014357429,0.000093706854,0.000025245565,0.0002066592,0.00039802605,0.000004966868],"category_scores_gemma":[0.0022903932,0.00020702732,0.00069284166,0.0006223212,0.00039378874,0.00009479844,0.00028308158,0.00067982473,2.4656438e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000020990724,0.000077780984,0.0036282865,0.2571289,0.00026602228,6.441521e-7,0.00001676658,4.450227e-9,0.0000019679594,0.00014971403,0.000167922,0.7385599],"study_design_scores_gemma":[0.0004041481,0.000037290374,0.14888757,0.35367158,0.005052078,0.000012185232,0.0000039992638,5.2827545e-7,0.0000106994,0.00013301299,0.49161214,0.00017476894],"about_ca_topic_score_codex":0.00012924493,"about_ca_topic_score_gemma":0.000066924724,"teacher_disagreement_score":0.73838514,"about_ca_system_score_codex":0.000017456576,"about_ca_system_score_gemma":0.00063811487,"threshold_uncertainty_score":0.8442329},"labels":[],"label_agreement":null},{"id":"W4410901256","doi":"10.1111/dom.16478","title":"Effects of dapagliflozin on sodium excretion, blood pressure and volume status in patients with type 2 diabetes and/or chronic kidney disease: The <scp>DAPASALT</scp> trial","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"AstraZeneca; AstraZeneca Mölndal","keywords":"Dapagliflozin; Medicine; Type 2 diabetes; Kidney disease; Blood pressure; Diabetes mellitus; Internal medicine; Excretion; Endocrinology; Sodium; Urology","score_opus":0.0032523616165991685,"score_gpt":0.19932043480933004,"score_spread":0.19606807319273087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410901256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9702271,0.02705545,7.353283e-7,0.00016514408,0.0002574669,0.0020362556,0.00005178595,0.00003381945,0.00017219562],"genre_scores_gemma":[0.99582803,0.0017153766,0.000035031844,0.0005675095,0.000096647826,0.00013499503,0.000107427324,0.00002037734,0.0014945815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984989,0.00013503614,0.00024089229,0.00041041514,0.00026144728,0.00045331416],"domain_scores_gemma":[0.99893165,0.00031202848,0.00010830007,0.00029639955,0.00008658916,0.00026504137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021875594,0.00028259348,0.00059293053,0.00020372581,0.00011330401,0.000051687453,0.000082883715,0.00008752835,0.000009093046],"category_scores_gemma":[0.0005161163,0.00017348633,0.000047874444,0.0003160913,0.0002217312,0.00012687172,0.00012670316,0.00016175146,0.0000015970912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012785399,0.0016222559,0.9851446,0.002276395,0.0013810056,0.000003970789,0.00023625296,0.000002053784,0.00017404124,0.00074011367,0.0017092595,0.0054315035],"study_design_scores_gemma":[0.039040696,0.0012999721,0.93013334,0.0005147246,0.004659339,1.7500458e-8,0.000015341442,0.0000741893,0.0014655028,0.00015550926,0.022559335,0.00008200756],"about_ca_topic_score_codex":0.000016251372,"about_ca_topic_score_gemma":0.0000067871097,"teacher_disagreement_score":0.055011243,"about_ca_system_score_codex":0.000012950239,"about_ca_system_score_gemma":0.000121074634,"threshold_uncertainty_score":0.7074567},"labels":[],"label_agreement":null},{"id":"W4411078217","doi":"10.1111/dom.16513","title":"A1c versus oral glucose tolerance test for chronic glycemic surveillance in women with previous gestational diabetes","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Gestational diabetes; Internal medicine; Diabetes mellitus; Insulin resistance; Glycemic; Type 2 diabetes; Endocrinology; Glucose tolerance test; Pregnancy; Glycemic index; Insulin; Gestation","score_opus":0.008721685529246128,"score_gpt":0.2612230939032517,"score_spread":0.2525014083740056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411078217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98904,0.008220753,0.00007572439,0.0008750193,0.0001417931,0.0011694795,0.00011914889,0.000046007724,0.00031204792],"genre_scores_gemma":[0.99553806,0.0010931673,0.001166647,0.00067785825,0.000085496,0.00073431054,0.00014655145,0.000018672637,0.0005392139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822867,0.00005573686,0.00025679346,0.00043140983,0.00029084898,0.000736555],"domain_scores_gemma":[0.9986698,0.0006563615,0.00006508926,0.00022501365,0.00020358537,0.00018014904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042617103,0.00022568995,0.00050147827,0.0002603194,0.0001170792,0.000058249178,0.00012634869,0.00007190241,0.000029683952],"category_scores_gemma":[0.00048511653,0.00019690461,0.000047873422,0.00045033457,0.0001572409,0.00017348152,0.000071926544,0.00018495452,0.000006879594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033640207,0.0012465251,0.88362116,0.003911258,0.0006625122,0.000013596801,0.00037196462,0.0003487064,0.006992354,0.005240553,0.0015431574,0.09268417],"study_design_scores_gemma":[0.010326476,0.0006956655,0.9642871,0.00021755497,0.000065749206,1.695442e-7,0.0000431493,0.0016222033,0.0014303664,0.0010172406,0.020085422,0.00020891921],"about_ca_topic_score_codex":0.000017119042,"about_ca_topic_score_gemma":0.000083904044,"teacher_disagreement_score":0.09247525,"about_ca_system_score_codex":0.00017195978,"about_ca_system_score_gemma":0.00025955556,"threshold_uncertainty_score":0.8029537},"labels":[],"label_agreement":null},{"id":"W4411214651","doi":"10.1111/dom.16528","title":"A simplified protocol based on a standardized meal‐stimulated beta‐cell response to stratify people living with non‐insulin‐treated type 2 diabetes","year":2025,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Université de Montréal; Ottawa Hospital; University of Ottawa","funders":"Ottawa Hospital Research Institute","keywords":"Medicine; Insulin; Beta cell; BETA (programming language); Type 2 diabetes; Diabetes mellitus; Internal medicine; Type 1 diabetes; Meal; Oncology; Endocrinology; Islet","score_opus":0.00905740798181033,"score_gpt":0.2502071142431937,"score_spread":0.24114970626138338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411214651","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90597326,0.00015998601,0.000035838457,0.036657263,0.00029294234,0.05175022,0.0033188364,0.00045708282,0.0013546031],"genre_scores_gemma":[0.28502196,0.000030154231,0.0023112537,0.66040254,0.0016814198,0.037029043,0.0067881886,0.0003749446,0.0063604764],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950568,0.0007061703,0.0007572846,0.0013024098,0.0009826208,0.0011947119],"domain_scores_gemma":[0.9950566,0.002140258,0.00034252877,0.0011596521,0.0007571537,0.0005437887],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010108796,0.0011222302,0.0024823097,0.001057583,0.0003502651,0.00023638678,0.0002745313,0.001094456,0.00037697642],"category_scores_gemma":[0.0012292493,0.00087270513,0.00030947453,0.0014637696,0.00014243112,0.000119667944,0.000119284705,0.0016335192,0.00006030769],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010636086,0.0015520487,0.07609694,0.0068845837,0.0016861443,0.00017793081,0.00045149616,0.00035624727,0.019580664,0.0000054612274,0.88169277,0.0008796444],"study_design_scores_gemma":[0.020377507,0.0040633837,0.28564256,0.005282879,0.004442249,0.0000018968108,0.000045114273,0.002965425,0.034090664,0.000024823761,0.64098716,0.0020762964],"about_ca_topic_score_codex":0.000067595254,"about_ca_topic_score_gemma":0.00000655059,"teacher_disagreement_score":0.62374526,"about_ca_system_score_codex":0.00013517059,"about_ca_system_score_gemma":0.00092911714,"threshold_uncertainty_score":0.99937236},"labels":[],"label_agreement":null},{"id":"W4411349501","doi":"10.1111/dom.16511","title":"Continuous glucose monitoring‐derived time in range is associated with changes in cognitive function test scores in Japanese patients with type 2 diabetes mellitus","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology","keywords":"Medicine; Type 2 Diabetes Mellitus; Continuous glucose monitoring; Cognition; Internal medicine; Diabetes mellitus; Test (biology); Endocrinology; Type 1 diabetes; Psychiatry","score_opus":0.007333343211527844,"score_gpt":0.2366238890478479,"score_spread":0.22929054583632005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411349501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99380517,0.004451336,3.2601977e-7,0.000115838746,0.000072682946,0.0011426494,0.000041154053,0.00003144252,0.00033940017],"genre_scores_gemma":[0.9984568,0.00043806687,0.000009518432,0.00030735348,0.000031627027,0.00014478232,0.0001302917,0.000018639279,0.00046294427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982834,0.00015966689,0.00022321232,0.00042157387,0.00034515333,0.00056701805],"domain_scores_gemma":[0.9989699,0.00035676666,0.00007915051,0.00012075614,0.000366518,0.00010691049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041962927,0.00025595145,0.0006411172,0.00059143844,0.000061463914,0.000048724865,0.00006553574,0.00012803251,0.000060771243],"category_scores_gemma":[0.0005003085,0.0002011711,0.000028266442,0.0010726762,0.00015414448,0.0001838472,0.00006293453,0.00031602656,0.0000090915455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005283612,0.0014864359,0.98811793,0.00010025848,0.00017015656,0.00001957651,0.00070230995,1.656374e-7,0.0021931613,0.0000012767728,0.000013197364,0.0066671437],"study_design_scores_gemma":[0.0103655,0.0007956184,0.97124565,0.001534433,0.00028896553,9.522171e-8,0.00031556902,0.000033542226,0.015140977,0.00003193721,0.00004437331,0.00020334491],"about_ca_topic_score_codex":0.00012787445,"about_ca_topic_score_gemma":0.00032663753,"teacher_disagreement_score":0.016872313,"about_ca_system_score_codex":0.000056612764,"about_ca_system_score_gemma":0.000071529874,"threshold_uncertainty_score":0.82035196},"labels":[],"label_agreement":null},{"id":"W4411450861","doi":"10.1111/dom.16535","title":"Interaction between dietary omega‐3 polyunsaturated fatty acids, obesity and gut microbiota in preclinical models: A systematic review of randomized controlled trials","year":2025,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diet and metabolism studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Natural Science Foundation of China","keywords":"Medicine; Gut flora; Polyunsaturated fatty acid; Randomized controlled trial; Obesity; Bioinformatics; Internal medicine; Fatty acid; Immunology; Biochemistry; Biology","score_opus":0.06835631774634332,"score_gpt":0.3650874740205751,"score_spread":0.2967311562742318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411450861","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029038063,0.977583,0.000010542373,0.000115670264,0.00074691727,0.01804443,0.00030366133,0.000056219586,0.00023574686],"genre_scores_gemma":[0.0010602644,0.99615955,0.00023864354,0.0002995153,0.00026848164,0.0011996633,0.00037345215,0.000042971133,0.00035747205],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98361456,0.0076137995,0.0068536117,0.00091705675,0.0004491936,0.00055178534],"domain_scores_gemma":[0.9825659,0.012373843,0.0036197912,0.0007390099,0.00043719873,0.00026429226],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.017237106,0.0011277543,0.060147773,0.0009030433,0.00011102445,0.00006805831,0.00026256003,0.00074748957,0.000012644415],"category_scores_gemma":[0.023766594,0.00066830445,0.00405101,0.0007296945,0.000362058,0.00025679922,0.00032864595,0.0010030109,0.000003893461],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023851395,0.0003436119,0.00013808877,0.9674481,0.008778217,0.000004242978,0.00013416992,3.5781753e-8,0.000008379064,0.00011244308,0.00010146872,0.020546101],"study_design_scores_gemma":[0.07484893,0.000037865015,0.00093227,0.7733509,0.14419593,0.000003545045,0.000031902717,0.000014842106,0.0000048807165,0.00018780284,0.0058810893,0.00051005],"about_ca_topic_score_codex":0.00004269364,"about_ca_topic_score_gemma":0.000005986409,"teacher_disagreement_score":0.19409722,"about_ca_system_score_codex":0.000046978108,"about_ca_system_score_gemma":0.00034939407,"threshold_uncertainty_score":0.9995768},"labels":[],"label_agreement":null},{"id":"W4411592381","doi":"10.1111/dom.16547","title":"Impact of social disadvantage on clinical and health care use indicators in adults with type 1 diabetes using insulin pumps in Ontario, Canada","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; St. Michael's Hospital; Hospital for Sick Children; Institute for Clinical Evaluative Sciences; Women's College Hospital; University of Toronto","funders":"Canadian Statistical Sciences Institute; Banting Research Foundation","keywords":"Medicine; Type 2 diabetes; Disadvantage; Diabetes mellitus; Insulin; Intensive care medicine; Gerontology; Environmental health; Internal medicine; Endocrinology","score_opus":0.02236670991544468,"score_gpt":0.3367042641964723,"score_spread":0.3143375542810276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411592381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973174,0.0016852809,1.8857332e-7,0.00013963082,0.00009968903,0.00054581446,0.000027481568,0.000007827607,0.00017673764],"genre_scores_gemma":[0.9991809,0.00017724767,0.000072033814,0.00037624338,0.000028512297,0.0000062575887,0.000054259417,0.000012491195,0.000092025446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840015,0.00013912449,0.00039637947,0.00034066732,0.00025589077,0.0004678092],"domain_scores_gemma":[0.9993841,0.000119355485,0.000108219385,0.00016397581,0.000059963015,0.00016440926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004780116,0.00019125458,0.000766064,0.000619292,0.00008034187,0.00002636442,0.000080025806,0.00010573873,0.000015771278],"category_scores_gemma":[0.00010403703,0.00014542155,0.00005581692,0.0007300899,0.00019697998,0.00012094918,0.00010822907,0.0004791216,2.1155894e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020249537,0.00027364533,0.9894342,0.00038052053,0.00013096462,0.000007280812,0.00072179275,0.0000075638527,0.000013878101,0.00012535759,0.00006765589,0.008634661],"study_design_scores_gemma":[0.003217025,0.00033082807,0.99483764,0.00050074083,0.00006222727,3.6775624e-8,0.00023751077,0.00008414432,0.00005229489,0.000017143057,0.0005363867,0.00012404924],"about_ca_topic_score_codex":0.45151713,"about_ca_topic_score_gemma":0.76474166,"teacher_disagreement_score":0.31322452,"about_ca_system_score_codex":0.00023144826,"about_ca_system_score_gemma":0.0012483799,"threshold_uncertainty_score":0.5930119},"labels":[],"label_agreement":null},{"id":"W4411926911","doi":"10.1111/dom.16586","title":"Male–female differences in insulin sensitivity and β‐cell function in <scp>US</scp> elders with and without abdominal obesity: An exploratory study with an in‐depth race/ethnicity analysis","year":2025,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Obesity and Health Practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Ethnic group; Race (biology); Insulin sensitivity; Exploratory analysis; Obesity; Internal medicine; Endocrinology; Gerontology; Insulin resistance; Gender studies","score_opus":0.0348069362960227,"score_gpt":0.3221611709363408,"score_spread":0.28735423464031806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411926911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99101067,0.002963285,0.00003812081,0.0027597914,0.00020305619,0.0026594384,0.00008926152,0.00007371678,0.00020267036],"genre_scores_gemma":[0.9704697,0.002273891,0.00031249507,0.025592947,0.0004334556,0.00031493884,0.00015934,0.00005201998,0.000391193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98739696,0.007864456,0.0010125081,0.0017437761,0.0006488892,0.0013334091],"domain_scores_gemma":[0.9955774,0.0022401286,0.0008482265,0.000712982,0.00023394846,0.00038729084],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0046821935,0.0008909399,0.0027543865,0.002000842,0.00089497614,0.00014551407,0.00023172623,0.0013551521,0.000023712704],"category_scores_gemma":[0.00024913487,0.0007463002,0.000066792745,0.0016564706,0.00040447933,0.001701299,0.00029502882,0.005565073,0.000005588152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033567438,0.0014044306,0.97901857,0.0021588737,0.00027774504,0.00016369294,0.01578096,0.000013386074,0.000015655029,0.0000075764115,0.00025923055,0.0005641848],"study_design_scores_gemma":[0.0043555866,0.00082275335,0.96545553,0.0006935007,0.0018319112,0.000002326382,0.023908358,0.00053791824,0.000011725523,0.000061008843,0.0018710821,0.00044829195],"about_ca_topic_score_codex":0.006824049,"about_ca_topic_score_gemma":0.29036137,"teacher_disagreement_score":0.28353733,"about_ca_system_score_codex":0.00011259373,"about_ca_system_score_gemma":0.00055399357,"threshold_uncertainty_score":0.9999413},"labels":[],"label_agreement":null},{"id":"W4412039181","doi":"10.1111/dom.16556","title":"<scp>GABA</scp> ameliorates diet‐induced hepatic steatosis and insulin resistance by inhibiting macrophage activation","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"GABA and Rice Research","field":"Agricultural and Biological Sciences","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Natural Science Foundation of China","keywords":"Internal medicine; Endocrinology; Insulin resistance; Steatosis; TLR4; Inflammation; Tumor necrosis factor alpha; Fatty liver; Downregulation and upregulation; Medicine; Insulin; Biology; Biochemistry","score_opus":0.010259452201056266,"score_gpt":0.22263661944470367,"score_spread":0.2123771672436474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412039181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99013776,0.008211048,0.0000015683414,0.0005923628,0.000052715706,0.00023417217,0.00005831023,0.000049231923,0.00066281063],"genre_scores_gemma":[0.99704283,0.0016471131,0.000048399354,0.00024977463,0.00007668085,0.000025177043,0.000040622832,0.0000014708647,0.00086793024],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99869806,0.00016148026,0.0001950554,0.00036277305,0.0001898126,0.0003928089],"domain_scores_gemma":[0.9991022,0.0005555291,0.00007686935,0.000050772927,0.00008738572,0.00012729203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003804305,0.00017103205,0.00028119909,0.000038631602,0.0005062358,0.00018902833,0.00012697012,0.00013306313,0.000009643833],"category_scores_gemma":[0.00035021134,0.0000781303,0.000046992838,0.00057197013,0.00008970054,0.00024122027,0.00013561848,0.00020837683,0.000004931059],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000064927376,0.00008121908,0.032521,0.00007282381,0.000025440711,7.4376544e-7,0.00013019075,9.039993e-8,0.9371121,0.00031489634,0.00046149013,0.02927351],"study_design_scores_gemma":[0.00022483073,0.00004170194,0.7545593,0.00008238706,0.000027088307,8.888735e-8,0.00035633426,0.000035432357,0.23720601,0.0010196606,0.0063682143,0.000078992365],"about_ca_topic_score_codex":0.00014174785,"about_ca_topic_score_gemma":0.00009913729,"teacher_disagreement_score":0.72203827,"about_ca_system_score_codex":0.000011771943,"about_ca_system_score_gemma":0.000009772833,"threshold_uncertainty_score":0.3893608},"labels":[],"label_agreement":null},{"id":"W4412137963","doi":"10.1111/dom.16589","title":"Glucagon‐like peptide‐1 is involved in fasting and postprandial blood flow regulation of subcutaneous adipose tissue","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Postprandial; Adipose tissue; Internal medicine; Subcutaneous adipose tissue; Endocrinology; Glucagon-like peptide-1; Glucagon; Subcutaneous tissue; Diabetes mellitus; Type 2 diabetes; Insulin; Pathology","score_opus":0.006408039506782344,"score_gpt":0.22035362042486573,"score_spread":0.21394558091808338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412137963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98898864,0.008859451,0.000013985998,0.00034879326,0.00016088289,0.0005439719,0.000018227145,0.000034685974,0.0010313357],"genre_scores_gemma":[0.9964064,0.00059485127,0.0012290945,0.00046767152,0.00005198033,0.000018892946,0.000055351225,0.000012013089,0.0011637412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989056,0.00004800427,0.0003004949,0.00031535546,0.00015189899,0.00027864546],"domain_scores_gemma":[0.99947214,0.00008591397,0.00008297376,0.00020297614,0.00006455713,0.0000914483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023254783,0.00019340073,0.00053260726,0.0003067243,0.000069166694,0.000028825156,0.00005157426,0.000104467144,0.000030454134],"category_scores_gemma":[0.000065920045,0.00018030858,0.000054549884,0.00027773072,0.0000921828,0.000121364705,0.000095570555,0.00010476813,0.0000025275315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043666127,0.0012395644,0.79428256,0.001638164,0.0011104718,0.00006040853,0.0023016164,0.000012049678,0.060317047,0.0021866348,0.00043083035,0.13598399],"study_design_scores_gemma":[0.00531236,0.00036932758,0.93295825,0.00043147116,0.001846177,0.0000024084811,0.00010962947,0.0008420398,0.05192687,0.001130917,0.0048502674,0.00022030248],"about_ca_topic_score_codex":0.000077311284,"about_ca_topic_score_gemma":0.000052924708,"teacher_disagreement_score":0.13867567,"about_ca_system_score_codex":0.000013961191,"about_ca_system_score_gemma":0.000029592415,"threshold_uncertainty_score":0.73527706},"labels":[],"label_agreement":null},{"id":"W4412387251","doi":"10.1111/dom.16604","title":"Persisting plasma proinsulin levels in a cohort of 482 individuals with long‐standing type 1 diabetes mellitus","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"H2020 European Research Council; Canadian Institutes of Health Research; Novo Nordisk; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Nierstichting; Amsterdam University Medical Centers","keywords":"Proinsulin; Medicine; Internal medicine; C-peptide; Endocrinology; Type 2 Diabetes Mellitus; Insulin; Diabetes mellitus; Prohormone; Insulin resistance; Cohort; Hormone","score_opus":0.006606379954291627,"score_gpt":0.2191964284383908,"score_spread":0.21259004848409918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412387251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864615,0.01206127,0.000013536834,0.00006345901,0.00009944072,0.0003022678,0.00006486868,0.0000133554795,0.00092027994],"genre_scores_gemma":[0.9985182,0.00061147194,0.00037450352,0.00015050586,0.000031819163,0.000022250604,0.000080476726,0.00001646729,0.00019429643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986424,0.00008776929,0.00027975015,0.00040236494,0.00015202587,0.00043572095],"domain_scores_gemma":[0.99942803,0.000049967362,0.00013513255,0.00020685306,0.00010972951,0.0000703086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050998013,0.00021786001,0.00044366496,0.0001568281,0.00009692963,0.000042310217,0.00016140702,0.00017983548,0.000008779028],"category_scores_gemma":[0.0002254497,0.0001977705,0.00006876505,0.00040936316,0.0001371707,0.000014525451,0.00012716593,0.00013751941,0.0000011212708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000133201665,0.00013486583,0.9774896,0.00012266051,0.00030784126,6.2566744e-7,0.00011790007,0.00002839701,0.018057728,0.0002418587,0.000058229514,0.0034269935],"study_design_scores_gemma":[0.0011743843,0.00009641549,0.8924699,0.00019338039,0.00018493176,1.3854935e-7,0.000153366,0.00009961258,0.10213249,0.00019824496,0.003022618,0.00027454415],"about_ca_topic_score_codex":0.000018545898,"about_ca_topic_score_gemma":0.000035151133,"teacher_disagreement_score":0.0850197,"about_ca_system_score_codex":0.000011964555,"about_ca_system_score_gemma":0.00009508458,"threshold_uncertainty_score":0.8064847},"labels":[],"label_agreement":null},{"id":"W4412389382","doi":"10.1111/dom.16605","title":"Differential effects of a multidomain intervention on cognitive decline in older adults with type 2 diabetes according to white matter hyperintensity status: A secondary analysis of the J‐ <scp>MIND</scp> ‐Diabetes","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Japan Society for the Promotion of Science; National Center for Geriatrics and Gerontology; Japan Agency for Medical Research and Development","keywords":"Medicine; Type 2 diabetes; Dementia; Randomized controlled trial; Cognitive decline; Physical therapy; Neuropsychology; Diabetes mellitus; Cognition; Hyperintensity; Gerontology; Internal medicine; Psychiatry; Disease; Magnetic resonance imaging","score_opus":0.003608446829115093,"score_gpt":0.24624485721727485,"score_spread":0.24263641038815975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412389382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977446,0.0005004729,0.00005153305,0.000075588796,0.00013834509,0.0012188698,0.00007699386,0.000010737125,0.00018283562],"genre_scores_gemma":[0.9987389,0.000046046876,0.000072800554,0.0007438516,0.00002093174,0.00008048098,0.00007566894,0.00001497493,0.00020637606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802727,0.00027390325,0.00039578576,0.0004337367,0.0003630986,0.0005062238],"domain_scores_gemma":[0.99841964,0.00060339394,0.00016088494,0.00024701323,0.00043255702,0.00013649873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031853447,0.00025695452,0.00091113715,0.0008851555,0.000072670526,0.000030884574,0.00012425317,0.00009694768,0.0000745949],"category_scores_gemma":[0.00063038635,0.00017759022,0.00025001477,0.001471505,0.00018130337,0.00010234403,0.00029011516,0.0003056515,0.0000041367925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018679706,0.001077507,0.9780309,0.0011684714,0.001531697,0.0000023816515,0.00080620346,0.0000017748489,0.010487614,0.000006196538,0.000021996037,0.006678465],"study_design_scores_gemma":[0.004387307,0.00034828443,0.85075474,0.0022527324,0.0022155694,6.723287e-8,0.000800161,0.00027329434,0.13886236,0.000017998447,0.000020155829,0.00006733483],"about_ca_topic_score_codex":0.00005031158,"about_ca_topic_score_gemma":0.000086784465,"teacher_disagreement_score":0.12837476,"about_ca_system_score_codex":0.000026073763,"about_ca_system_score_gemma":0.000053562453,"threshold_uncertainty_score":0.7241919},"labels":[],"label_agreement":null},{"id":"W4412487404","doi":"10.1111/dom.16608","title":"Prevalence of <scp>SGLT2</scp> inhibitor and <scp>GLP1</scp> receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Faculty of Medicine and Health, University of Sydney; Eli Lilly Australia; George Institute for Global Health; University of Melbourne; Boehringer Ingelheim; Australian Government; Australian Commission on Safety and Quality in Health Care; University of New South Wales; Ian Potter Foundation; David and Elaine Potter Foundation; Eli Lilly and Company","keywords":"Medicine; Renal function; Kidney disease; Internal medicine; Type 2 diabetes; Population; Medical prescription; Diabetes mellitus; Creatinine; Endocrinology; Urology; Gastroenterology; Pharmacology","score_opus":0.006482020705146322,"score_gpt":0.2306823558687402,"score_spread":0.22420033516359386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412487404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794441,0.014444148,0.0000011406968,0.00003909361,0.000105332656,0.0009462229,0.0048768553,0.000027392616,0.0001157301],"genre_scores_gemma":[0.98879087,0.0017476706,0.00039470734,0.00018167749,0.000035889963,0.0000680117,0.007981179,0.000020133173,0.00077984354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981828,0.00011674192,0.00039119998,0.0005890958,0.00030207736,0.00041809815],"domain_scores_gemma":[0.9986126,0.00009859208,0.00019782213,0.00051683304,0.000179006,0.00039514634],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019784766,0.00032594922,0.00088667515,0.0005826268,0.00010658232,0.00005559091,0.00013504384,0.00010462961,0.000008626748],"category_scores_gemma":[0.00021669903,0.00027409111,0.000072003306,0.0007788671,0.00036360967,0.00038676796,0.00018943222,0.00013427399,7.211708e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021963851,0.00068655994,0.98902947,0.0040960265,0.0012827673,0.0000010084593,0.00038062586,0.000006312011,0.0009038256,0.000083908504,0.0013499907,0.0021575703],"study_design_scores_gemma":[0.002703043,0.00031749942,0.97292066,0.0006615218,0.008053989,2.3887907e-8,0.0001391363,0.000087130626,0.0020541968,0.00002143506,0.0129639385,0.00007745785],"about_ca_topic_score_codex":0.000051058185,"about_ca_topic_score_gemma":0.0000534387,"teacher_disagreement_score":0.016108813,"about_ca_system_score_codex":0.000057762973,"about_ca_system_score_gemma":0.00014175047,"threshold_uncertainty_score":0.99997115},"labels":[],"label_agreement":null},{"id":"W4412514208","doi":"10.1111/dom.16627","title":"A cost‐effectiveness analysis of behavioural, pharmacological, and surgical obesity treatments in Canada","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Obesity; Intensive care medicine; Internal medicine","score_opus":0.029851293783844077,"score_gpt":0.2933600414834586,"score_spread":0.2635087476996145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412514208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99461395,0.0045943763,0.000002340345,0.000091692214,0.00014180128,0.00035447843,0.00005195285,0.0000106547395,0.0001387864],"genre_scores_gemma":[0.9987767,0.0008939887,0.000027304939,0.00016171922,0.000010262999,0.000028832257,0.000029529125,0.0000033439235,0.0000683558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888337,0.00021058845,0.00025639334,0.00026982016,0.0001363839,0.00024345588],"domain_scores_gemma":[0.9990522,0.00058753986,0.00006130391,0.00011827844,0.000049741488,0.00013089723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037064962,0.00015627734,0.0009900645,0.00031867155,0.000063861255,0.000008864801,0.000044256874,0.000085165855,0.000051664396],"category_scores_gemma":[0.00006647192,0.000121560166,0.00011810851,0.00093267846,0.000075871365,0.000058537342,0.00006137394,0.0001392597,1.9609602e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000799094,0.00033757524,0.99389327,0.00006731491,0.0011451339,0.000053201064,0.000033548404,0.000004771843,0.00026130446,0.00015555085,0.00001934484,0.0039490648],"study_design_scores_gemma":[0.0021662293,0.000016063108,0.98767155,0.000029704786,0.0057741576,0.0000011097057,0.000044742992,0.00016812886,0.003664219,0.000033770164,0.00033448427,0.00009582468],"about_ca_topic_score_codex":0.20400585,"about_ca_topic_score_gemma":0.043922644,"teacher_disagreement_score":0.1600832,"about_ca_system_score_codex":0.00009080232,"about_ca_system_score_gemma":0.00023981468,"threshold_uncertainty_score":0.97352326},"labels":[],"label_agreement":null},{"id":"W4412514240","doi":"10.1111/dom.16623","title":"Improved glycemic regulation on exercise compared to non‐exercise days in a real‐world setting in individuals recently diagnosed with type 2 diabetes: A secondary analysis of the <scp>MOTIVATE T2D</scp> randomised controlled trial","year":2025,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Okanagan University College; Kelowna General Hospital; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Medical Research Council; Canadian Institutes of Health Research","keywords":"Medicine; Type 2 diabetes; Glycemic; Physical therapy; Diabetes mellitus; Physical medicine and rehabilitation; Endocrinology","score_opus":0.010300296114305461,"score_gpt":0.25189338613509543,"score_spread":0.24159309002078996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412514240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97722113,0.0008904867,0.000001324661,0.005525663,0.00046291173,0.014295239,0.00014929479,0.000051066374,0.0014028734],"genre_scores_gemma":[0.94611764,0.0013753166,0.00027036513,0.03705882,0.0007356864,0.0030697107,0.002557221,0.00016351903,0.008651711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944526,0.0007901625,0.0014440004,0.0011142744,0.0010420714,0.0011568936],"domain_scores_gemma":[0.99513656,0.0024335145,0.0008152391,0.0010841864,0.00032942093,0.00020108483],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025786494,0.00078097085,0.004676174,0.0042963917,0.00015681474,0.00014452123,0.000588728,0.00060493615,0.00005076533],"category_scores_gemma":[0.0012977559,0.00053361664,0.00063325284,0.0054827505,0.00021441064,0.0001737245,0.00035769484,0.0019020346,0.0000036966612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16759671,0.0045741242,0.6083604,0.008388059,0.020120766,0.00012922443,0.0066840737,0.0010893033,0.003351982,0.000030886204,0.15846425,0.021210214],"study_design_scores_gemma":[0.47923532,0.00034285896,0.493651,0.0049393517,0.01123675,2.7466251e-8,0.00010459437,0.0030908582,0.0011267512,0.00007270684,0.0058514643,0.0003483201],"about_ca_topic_score_codex":0.0001578227,"about_ca_topic_score_gemma":0.00021218532,"teacher_disagreement_score":0.3116386,"about_ca_system_score_codex":0.00013992305,"about_ca_system_score_gemma":0.00035841472,"threshold_uncertainty_score":0.9997115},"labels":[],"label_agreement":null},{"id":"W4412638791","doi":"10.1111/dom.16621","title":"Effect of semaglutide versus placebo on cardiorenal outcomes by prior cardiovascular disease and baseline body mass index: Pooled post hoc analysis of <scp>SUSTAIN</scp> 6 and <scp>PIONEER</scp> 6","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ted Rogers Centre for Heart Research","funders":"Novo Nordisk","keywords":"Mace; Semaglutide; Medicine; Placebo; Myocardial infarction; Internal medicine; Population; Body mass index; Post-hoc analysis; Heart failure; Type 2 diabetes; Cardiology; Diabetes mellitus; Endocrinology; Percutaneous coronary intervention","score_opus":0.0035217352849685655,"score_gpt":0.22256093028326052,"score_spread":0.21903919499829194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412638791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9597568,0.03804421,0.00006178048,0.000095187075,0.000164051,0.0011858149,0.00030978685,0.000051344956,0.0003310294],"genre_scores_gemma":[0.99646693,0.0019438254,0.000096266725,0.00019301625,0.000036851798,0.00008257829,0.00029944783,0.000027215783,0.0008538413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99741226,0.00036987243,0.00045867672,0.0006636318,0.00057754613,0.0005180292],"domain_scores_gemma":[0.996988,0.0016155029,0.00017349378,0.000651927,0.0001835767,0.0003875129],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012671482,0.00049601763,0.0021580532,0.00085967925,0.0001408,0.000048823396,0.0001196289,0.00015296381,0.000003144052],"category_scores_gemma":[0.0013806465,0.00039347672,0.00072435464,0.0007484694,0.00024668153,0.000113578455,0.00018886062,0.0001869152,0.0000011389925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005658495,0.0005364758,0.9134136,0.0021707823,0.061590843,0.00004182962,0.00019102523,0.00021143793,0.0018008323,0.00039099966,0.0010870539,0.017999297],"study_design_scores_gemma":[0.014923843,0.0006498635,0.8852822,0.00017481053,0.07994856,1.741664e-7,0.00022120637,0.0014518148,0.009147764,0.000034284607,0.008049288,0.00011617379],"about_ca_topic_score_codex":0.0001035816,"about_ca_topic_score_gemma":0.000004962931,"teacher_disagreement_score":0.03671016,"about_ca_system_score_codex":0.000041221756,"about_ca_system_score_gemma":0.000056910303,"threshold_uncertainty_score":0.9998517},"labels":[],"label_agreement":null},{"id":"W4412726703","doi":"10.1111/dom.16660","title":"Evaluating biased agonism of glucagon‐like peptide‐1 ( <scp>GLP</scp> ‐1) receptors to improve cellular bioenergetics: A systematic review","year":2025,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Brain and Cognition Discovery Foundation; University Health Network","funders":"","keywords":"Medicine; Agonism; Glucagon-like peptide-1; Receptor; Bioenergetics; Exenatide; Pharmacology; Endocrinology; Internal medicine; Cell biology; Diabetes mellitus; Type 2 diabetes; Biology","score_opus":0.01946024597199198,"score_gpt":0.294103723815944,"score_spread":0.27464347784395204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412726703","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0059476397,0.98896646,0.00026730783,0.000007953617,0.0012257033,0.0032593193,0.00021652495,0.000028983712,0.00008007427],"genre_scores_gemma":[0.00007303391,0.9937402,0.0022090222,0.0004455059,0.00030939665,0.0006130554,0.0005930441,0.00008899579,0.001927749],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950394,0.0009745174,0.0016639628,0.0011502433,0.00047325875,0.00069864234],"domain_scores_gemma":[0.99680835,0.0002999429,0.0010816023,0.0011157641,0.000364064,0.00033030126],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002381265,0.00090395607,0.0043145902,0.00031827454,0.00018339125,0.00008234589,0.0007030046,0.00068790617,0.000025513893],"category_scores_gemma":[0.0025140878,0.0007488469,0.0011362839,0.0005433893,0.000085976055,0.00001115509,0.00051548064,0.00034332095,0.000019778065],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000014528902,0.0001072111,0.0000021843891,0.9207495,0.00084189535,0.0000015548706,0.000060924962,0.0000031661502,0.04214207,0.00011818741,0.00086315966,0.035108726],"study_design_scores_gemma":[0.0004387228,0.00032930306,0.0000011897943,0.40960774,0.011328755,0.0000028148054,0.00006457867,0.000022975028,0.09049942,0.000076751596,0.48693165,0.0006960994],"about_ca_topic_score_codex":0.000014794003,"about_ca_topic_score_gemma":0.0000018188158,"teacher_disagreement_score":0.5111417,"about_ca_system_score_codex":0.00002840925,"about_ca_system_score_gemma":0.00037878967,"threshold_uncertainty_score":0.9994963},"labels":[],"label_agreement":null},{"id":"W4412727804","doi":"10.1111/dom.16649","title":"Lack of evidence for obesity paradox in patients with cardiovascular disease: A <scp>UK BioBank</scp> cohort study","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary; Alberta Health Services","funders":"National Natural Science Foundation of China","keywords":"Medicine; Biobank; Cohort; Disease; Obesity; Cohort study; Internal medicine; Bioinformatics","score_opus":0.025935746169836713,"score_gpt":0.2775707495157185,"score_spread":0.25163500334588174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412727804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888327,0.009434737,0.00040836434,0.000026137079,0.00010087528,0.0011010655,0.000064200714,0.0000054051347,0.00002651323],"genre_scores_gemma":[0.99858785,0.00050722464,0.0003941285,0.000119923585,0.00003592301,0.00014342582,0.000075017364,0.000008459772,0.00012807445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986257,0.00020645704,0.00027324635,0.00045926106,0.0001459599,0.0002893971],"domain_scores_gemma":[0.99904776,0.00013084877,0.000102107326,0.00045681934,0.00018453113,0.00007796285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008958964,0.0001683346,0.00052909984,0.00007644943,0.00008509919,0.000011800481,0.00015167675,0.00011724549,0.0000010191169],"category_scores_gemma":[0.0010116459,0.000133291,0.00014971389,0.00017410396,0.00009068866,0.000006659099,0.0001169655,0.000066224144,4.9262314e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023140848,0.0003696577,0.9977802,0.00006131434,0.0005569272,2.172115e-7,0.00003337126,0.00012690698,0.00011631844,0.000039595598,0.00020671955,0.0006855999],"study_design_scores_gemma":[0.0013616415,0.00012949707,0.99511653,0.00003553856,0.00050338136,2.0847676e-8,0.000046093573,0.00003671921,0.00051051076,0.00019994215,0.0019844072,0.00007568679],"about_ca_topic_score_codex":0.00008049337,"about_ca_topic_score_gemma":0.000039782135,"teacher_disagreement_score":0.009755121,"about_ca_system_score_codex":0.000009848117,"about_ca_system_score_gemma":0.00007102325,"threshold_uncertainty_score":0.54354495},"labels":[],"label_agreement":null},{"id":"W4412943684","doi":"10.1111/dom.70008","title":"Continuous glucose monitoring in noninsulin‐treated type 2 diabetes: A critical review of reported trials with an updated systematic review and meta‐analysis of randomised controlled trials","year":2025,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surrey Memorial Hospital; University of British Columbia; McGill University; Jewish General Hospital; Trillium Health Centre; University of Toronto; Western University; St. Michael's Hospital; LMC Diabetes & Endocrinology (Canada)","funders":"Abbott Canada","keywords":"Medicine; Observational study; Meta-analysis; Randomized controlled trial; Type 2 diabetes; Internal medicine; Continuous glucose monitoring; Subgroup analysis; Systematic review; Type 2 Diabetes Mellitus; Diabetes mellitus; MEDLINE; Insulin; Glycemic; Endocrinology","score_opus":0.09041100860655103,"score_gpt":0.39798537852435506,"score_spread":0.307574369917804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412943684","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016938156,0.97543156,0.0000020731964,0.000079640005,0.00008468763,0.02235145,0.00022358798,0.00004364745,0.00008951054],"genre_scores_gemma":[0.00031455595,0.996245,0.00016225397,0.00021402731,0.000043748827,0.0018870056,0.0007800233,0.00005032755,0.0003030029],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9786632,0.011330189,0.0075801257,0.00094160816,0.0008498169,0.0006350798],"domain_scores_gemma":[0.98166424,0.010724123,0.0044484898,0.0013368231,0.0014470739,0.0003792502],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.038155735,0.0009848616,0.07735246,0.0019904368,0.00006863181,0.00007007275,0.00033361776,0.00041703536,0.00018876448],"category_scores_gemma":[0.046766337,0.0005244071,0.0041999132,0.0039867987,0.00028304674,0.00018118773,0.00016073728,0.0005408534,0.0000012430658],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036109568,0.0004094261,0.00010849259,0.75885725,0.23761122,0.000018689363,0.0000123729205,6.367777e-8,0.0000057365255,0.000025308243,0.000024552466,0.0025657658],"study_design_scores_gemma":[0.01063955,0.00015551268,0.000053374508,0.33999065,0.6481896,5.7854885e-7,0.000007910971,0.000011566991,0.00003153305,0.0000064019014,0.00063901814,0.0002743413],"about_ca_topic_score_codex":0.000019994499,"about_ca_topic_score_gemma":0.0000029310222,"teacher_disagreement_score":0.41886663,"about_ca_system_score_codex":0.00003161881,"about_ca_system_score_gemma":0.0003564727,"threshold_uncertainty_score":0.99972075},"labels":[],"label_agreement":null},{"id":"W4412943903","doi":"10.1111/dom.70013","title":"Glucagon‐like peptide‐1 receptor agonists and the risk of nonarteritic anterior ischaemic optic neuropathy: A systematic review and meta‐analysis of observational studies","year":2025,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Intraoperative Neuromonitoring and Anesthetic Effects","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bruyère; Queensway-Carleton Hospital; LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Medicine; Anterior ischemic optic neuropathy; Observational study; Meta-analysis; Optic neuropathy; Internal medicine; Ophthalmology; Optic nerve","score_opus":0.0428331031382486,"score_gpt":0.33048534707194094,"score_spread":0.2876522439336923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412943903","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036321808,0.96093893,0.0000012843429,0.00013680485,0.00011872673,0.002246246,0.0002147805,0.000013656112,0.000007742091],"genre_scores_gemma":[0.0021016235,0.99668854,0.00013588922,0.0003343537,0.000037690752,0.00039064954,0.00003507624,0.000021477645,0.00025472234],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.996217,0.0017155494,0.0011030978,0.00047083106,0.00027585772,0.0002176683],"domain_scores_gemma":[0.99602133,0.002286589,0.0007977609,0.00046093634,0.00034425018,0.00008915698],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016486933,0.0005056382,0.010702187,0.00028969665,0.00015603466,0.000029804494,0.00014028842,0.00011844907,0.0000061197084],"category_scores_gemma":[0.0015621532,0.00027120454,0.0011251946,0.0006165814,0.00061187847,0.00006341137,0.00013928444,0.00033975983,8.7158134e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007637676,0.000064841246,0.00009926846,0.92650944,0.07200219,0.0000057734314,0.0002503721,1.2004136e-7,0.000011443523,0.00028774663,0.00000997101,0.0007511699],"study_design_scores_gemma":[0.00041133893,0.00007961702,0.0006299857,0.10550613,0.8917642,0.000025046564,0.00003152788,0.000014488424,0.000015955124,0.000012885889,0.0013093532,0.00019947646],"about_ca_topic_score_codex":0.000009961395,"about_ca_topic_score_gemma":9.499232e-7,"teacher_disagreement_score":0.8210033,"about_ca_system_score_codex":0.000009093725,"about_ca_system_score_gemma":0.000090556015,"threshold_uncertainty_score":0.999974},"labels":[],"label_agreement":null},{"id":"W4413117037","doi":"10.1111/dom.16597","title":"Adherence to app‐based dose guidance for once‐weekly insulin icodec in insulin‐naive individuals with type 2 diabetes: Post hoc analysis of <scp>ONWARDS</scp> 5","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Mobile Health and mHealth Applications","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Novo Nordisk","keywords":"Medicine; Insulin; Type 2 diabetes; Post-hoc analysis; Diabetes mellitus; Post hoc; Internal medicine; Endocrinology","score_opus":0.025197492805653105,"score_gpt":0.357253434947003,"score_spread":0.3320559421413499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413117037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817579,0.009701286,0.00057543744,0.0007370479,0.00029273794,0.005137351,0.0012700384,0.00008454165,0.00044369115],"genre_scores_gemma":[0.9708024,0.0011812039,0.007830565,0.011256488,0.00010722617,0.007879466,0.0004472006,0.00003665754,0.00045874302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99599904,0.00047405527,0.0012454118,0.0007915229,0.0003338045,0.0011561915],"domain_scores_gemma":[0.99483585,0.0023770893,0.00059591065,0.0007371351,0.00091807125,0.0005359376],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018849922,0.00036624062,0.0013930311,0.0011887855,0.000572534,0.000022075115,0.00044289505,0.00038467068,0.000030326111],"category_scores_gemma":[0.0016230204,0.00032861452,0.00013843861,0.00410006,0.00014709179,0.00015379666,0.00015787047,0.0005535657,0.000023455203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014129565,0.0006246937,0.9603683,0.0023021991,0.00040055104,4.4892855e-7,0.0019016747,0.00026520155,0.00057716144,0.005172612,0.0030336813,0.025212234],"study_design_scores_gemma":[0.0028362086,0.0003841949,0.893417,0.00056712225,0.0006919157,1.33911e-8,0.0005185491,0.00083071843,0.00046063977,0.00051396765,0.0996235,0.00015618645],"about_ca_topic_score_codex":0.0003588108,"about_ca_topic_score_gemma":0.0008994457,"teacher_disagreement_score":0.096589826,"about_ca_system_score_codex":0.000094673516,"about_ca_system_score_gemma":0.0014889962,"threshold_uncertainty_score":0.9999166},"labels":[],"label_agreement":null},{"id":"W4413358799","doi":"10.1111/dom.16652","title":"Binding kinetics, bias, receptor internalization and effects on insulin secretion in vitro and in vivo of a novel <scp>GLP</scp> ‐ <scp>1R</scp> / <scp>GIPR</scp> dual agonist, <scp>HISHS</scp> ‐2001","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Centre Hospitalier de l’Université de Montréal","funders":"Division of Diabetes, Endocrinology, and Metabolic Diseases; Institute of Nutrition, Metabolism and Diabetes; National Institute of Diabetes and Digestive and Kidney Diseases; Medical Research Council; Canadian Institutes of Health Research; National Institutes of Health; Eli Lilly and Company; Society for Endocrinology; Diabetes UK; Wellcome Trust; Canada Foundation for Innovation","keywords":"Receptor; Incretin; Agonist; Internalization; Internal medicine; Endocrinology; G protein-coupled receptor; Insulin; In vivo; Downregulation and upregulation; Glucagon-like peptide-1; Medicine; Glucagon-like peptide 1 receptor; Type 2 diabetes; Pharmacology; Diabetes mellitus; Chemistry; Biology; Biochemistry","score_opus":0.011660221750556832,"score_gpt":0.23365995100454845,"score_spread":0.2219997292539916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413358799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98359895,0.009971226,0.00018663841,0.000098179815,0.00083923584,0.0019031805,0.00016866623,0.00013076415,0.0031031696],"genre_scores_gemma":[0.9846169,0.00597493,0.0012552748,0.0010547753,0.00031067102,0.00020233262,0.0005093438,0.00009822374,0.005977552],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956823,0.00033690972,0.0010062734,0.0011619814,0.00062355783,0.0011889666],"domain_scores_gemma":[0.9957308,0.0026129207,0.00051022106,0.00051979354,0.00019764532,0.00042858353],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001247351,0.0008317552,0.0016400687,0.0017347953,0.00018779188,0.00023296571,0.00023759865,0.0005110294,0.0000049172104],"category_scores_gemma":[0.0043250783,0.00081319787,0.00018956867,0.0013145012,0.00030964694,0.00047502964,0.0004304789,0.000583013,0.000011935213],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000644132,0.0047399374,0.4225964,0.0047869026,0.0013498903,0.000081866674,0.005700913,0.000059785638,0.52565604,0.0025852034,0.015552209,0.016826458],"study_design_scores_gemma":[0.014024651,0.0007798225,0.4220029,0.0024902972,0.0012601225,0.0000045154843,0.0014390516,0.0020945522,0.46384263,0.0005482208,0.09136881,0.0001444172],"about_ca_topic_score_codex":0.00017608432,"about_ca_topic_score_gemma":0.00008853684,"teacher_disagreement_score":0.0758166,"about_ca_system_score_codex":0.00018558008,"about_ca_system_score_gemma":0.00009165615,"threshold_uncertainty_score":0.9994319},"labels":[],"label_agreement":null},{"id":"W4413800920","doi":"10.1111/dom.70063","title":"Impact of tirzepatide treatment on participant‐reported food craving and food preference: Secondary analyses of a phase 1 randomised controlled trial in people with obesity with dietary restriction","year":2025,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diet and metabolism studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Almond Board of California; Patient-Centered Outcomes Research Institute; Eli Lilly and Company; National Institute for Health and Care Research; WW International; Henry M. Jackson Foundation; Leona M. and Harry B. Helmsley Charitable Trust; National Institutes of Health; National Science Foundation","keywords":"Medicine; Placebo; Weight loss; Craving; Appetite; Obesity; Calorie; Internal medicine; Weight management; Type 2 diabetes; Randomized controlled trial; Glucagon-like peptide-1; Diabetes mellitus; Endocrinology; Psychiatry; Alternative medicine","score_opus":0.0654914884206259,"score_gpt":0.3232958927812491,"score_spread":0.2578044043606232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413800920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98838973,0.005128078,0.000004436085,0.0010319817,0.00014829724,0.0046525127,0.0003528825,0.00003096994,0.0002611042],"genre_scores_gemma":[0.9942025,0.0032456461,0.00008870453,0.001104824,0.00030107287,0.0005915356,0.00030567875,0.000030846684,0.00012921405],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99700516,0.00036620867,0.0010012647,0.00065063575,0.00046472266,0.00051198615],"domain_scores_gemma":[0.9975264,0.0007204446,0.00087969465,0.0004574368,0.00027452604,0.00014149107],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004114295,0.0006783796,0.0044799666,0.00073006557,0.00010721516,0.000027281325,0.000078266974,0.0003603012,0.000017199096],"category_scores_gemma":[0.00034663876,0.00039943415,0.00045100405,0.0005154144,0.00022091351,0.00012896943,0.0000486167,0.0006143123,1.347584e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6224028,0.009814808,0.30725265,0.0029341136,0.042821147,0.000114718954,0.0034073035,0.000023809536,0.0021572758,0.000017789902,0.0030229716,0.0060306494],"study_design_scores_gemma":[0.49530622,0.01089734,0.47704542,0.0005947759,0.01436276,0.0000014556215,0.0000690208,0.000028919549,0.0011408373,0.000035490964,0.00022461418,0.00029313265],"about_ca_topic_score_codex":0.00064948184,"about_ca_topic_score_gemma":0.00029449436,"teacher_disagreement_score":0.16979277,"about_ca_system_score_codex":0.00005002166,"about_ca_system_score_gemma":0.0006061722,"threshold_uncertainty_score":0.99984574},"labels":[],"label_agreement":null},{"id":"W4414023851","doi":"10.1111/dom.70103","title":"Olfactory training improves cognition and modifies brain networks in type 2 diabetes patients with mild cognitive impairment: A 16‐week randomised controlled trial","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Olfactory and Sensory Function Studies","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Fundamental Research Funds for the Central Universities","keywords":"Medicine; Cognition; Montreal Cognitive Assessment; Population; Effects of sleep deprivation on cognitive performance; Neuropsychology; Neuroimaging; Cognitive training; Audiology; Internal medicine; Psychiatry; Cognitive impairment","score_opus":0.038471055822457,"score_gpt":0.23091209854980024,"score_spread":0.19244104272734325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414023851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460113,0.0015630728,0.000021907264,0.0000911904,0.0006629735,0.002610401,0.00003814856,0.000062005565,0.00034914754],"genre_scores_gemma":[0.99790347,0.00025043788,0.000006794684,0.001298252,0.00007507318,0.00024221436,0.000022303548,0.00001424859,0.00018720537],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979519,0.00051830773,0.00037105836,0.0005212734,0.00018746697,0.00044997377],"domain_scores_gemma":[0.9974765,0.0020456275,0.00016590778,0.0000979801,0.00011694568,0.00009702449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042756723,0.00031280148,0.00086067163,0.00024992455,0.00039926838,0.00011076498,0.00006592882,0.00012533921,0.000013329477],"category_scores_gemma":[0.0012234091,0.0002395838,0.00008453336,0.00032809004,0.0003497339,0.00035774917,0.00006184853,0.00024162713,0.0000012191547],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.751799,0.0046168515,0.17247273,0.0005349092,0.0016091439,0.000011015549,0.011812706,0.000084902334,0.024650352,0.0011021153,0.0005384781,0.03076782],"study_design_scores_gemma":[0.7196137,0.0006779143,0.2691048,0.00019852404,0.0004927365,1.1395045e-7,0.0007582792,0.0008135616,0.006962611,0.0005988187,0.00030007545,0.00047889916],"about_ca_topic_score_codex":0.0000035505084,"about_ca_topic_score_gemma":0.00001226913,"teacher_disagreement_score":0.096632086,"about_ca_system_score_codex":0.00001500774,"about_ca_system_score_gemma":0.000037978265,"threshold_uncertainty_score":0.9769944},"labels":[],"label_agreement":null},{"id":"W4414083764","doi":"10.1111/dom.70081","title":"The healthcare and economic burden associated with inadequate risk factor control for type 2 diabetes in Hong Kong: A population‐based modelling study","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Hospital Authority; Hong Kong Government; Health Bureau","keywords":"Type 2 diabetes; Risk factor; Health care; Population; Control (management); Diabetes mellitus","score_opus":0.0198883013953585,"score_gpt":0.27086259360661497,"score_spread":0.25097429221125644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414083764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467427,0.0021590982,0.00006262127,0.0012003762,0.00021915829,0.0015900576,0.000040977935,0.000035070723,0.000018355571],"genre_scores_gemma":[0.9991526,0.00013157493,0.00007222882,0.00022791236,0.000070096175,0.00011051154,0.000060875707,0.000015334681,0.00015886534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988797,0.00013470871,0.0002552353,0.00029019147,0.000094011484,0.00034617927],"domain_scores_gemma":[0.9990604,0.00045203645,0.00013782081,0.00018201322,0.00008833564,0.000079426165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006516286,0.0001702439,0.00042813522,0.00018827322,0.00029821982,0.000102739294,0.0000678413,0.00006895044,0.0000025259947],"category_scores_gemma":[0.00019534054,0.00012582328,0.000037680733,0.00019413447,0.0000408682,0.00012853311,0.000023832963,0.00015027844,7.903179e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006201115,0.00010867484,0.9910968,0.000087034154,0.00021573078,1.1291895e-7,0.00024668482,0.00073445454,0.0000074692994,0.00029121086,0.00001809887,0.007131716],"study_design_scores_gemma":[0.0031789215,0.00014212666,0.906472,0.00010489399,0.0004186999,5.208993e-9,0.00027929244,0.08820769,0.000028889737,0.00083915045,0.00021005278,0.00011823999],"about_ca_topic_score_codex":0.00043037054,"about_ca_topic_score_gemma":0.0005814855,"teacher_disagreement_score":0.08747324,"about_ca_system_score_codex":0.00006563871,"about_ca_system_score_gemma":0.00007450316,"threshold_uncertainty_score":0.51309246},"labels":[],"label_agreement":null},{"id":"W4414085673","doi":"10.1111/dom.70121","title":"Cardiovascular risk reduction with glucagon‐like peptide‐1 receptor agonists is proportional to <scp>HbA1c</scp> lowering in type 2 diabetes: An updated meta‐regression analysis incorporating <scp>FLOW</scp> and <scp>SOUL</scp> trials","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University and Génome Québec Innovation Centre; McGill Genome Centre","funders":"Canadian Institutes of Health Research; Japan Student Services Organization; Fonds de Recherche du Québec - Santé; TD Bank","keywords":"Mace; Type 2 diabetes; Clinical trial; Surrogate endpoint; Agonist","score_opus":0.01665137745857425,"score_gpt":0.25970634202639736,"score_spread":0.2430549645678231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414085673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759167,0.020277364,0.00024425675,0.000097372606,0.00056442426,0.0020528308,0.0001295995,0.00020549321,0.0005119941],"genre_scores_gemma":[0.9854857,0.0024580886,0.006653217,0.0006551754,0.00036666368,0.00042171322,0.0014298325,0.00009095852,0.0024386637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946715,0.0007219572,0.0011594929,0.0015426371,0.0009005305,0.0010038646],"domain_scores_gemma":[0.99686223,0.00046701124,0.0006526683,0.0009400169,0.00046934496,0.0006087298],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003686981,0.00088202173,0.0032785635,0.0015197262,0.0005282987,0.00032991378,0.00024575277,0.0003633037,0.000021312155],"category_scores_gemma":[0.001482829,0.00066658726,0.0007870211,0.0031085338,0.00023154682,0.00072640454,0.00030809417,0.0005305763,0.000019317105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009050448,0.0024286658,0.8283662,0.001167312,0.09137204,0.00006604634,0.004078099,0.0024574408,0.013195238,0.0002920985,0.011355091,0.045131262],"study_design_scores_gemma":[0.0084073,0.0010507774,0.6851052,0.0007821955,0.0994178,0.00000327969,0.0029794546,0.0026086264,0.088488206,0.0008726094,0.109869234,0.00041531667],"about_ca_topic_score_codex":0.00017568839,"about_ca_topic_score_gemma":0.00006211101,"teacher_disagreement_score":0.143261,"about_ca_system_score_codex":0.00013286184,"about_ca_system_score_gemma":0.00016332725,"threshold_uncertainty_score":0.99957854},"labels":[],"label_agreement":null},{"id":"W4414159630","doi":"10.1111/dom.70134","title":"Association of point‐of‐care ultrasound‐derived subcutaneous fat thickness with <scp>DXA</scp> ‐measured body fat percentage in older adults","year":2025,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Body Composition Measurement Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"British Columbia Centre of Excellence for Women's Health; Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Vancouver Coastal Health Research Institute","keywords":"Ultrasound; Institutional review board; Subcutaneous fat; Magnetic resonance imaging; Body fat percentage; Hydrostatic pressure; Fat mass; Gold standard (test)","score_opus":0.004921113158432123,"score_gpt":0.20975459324745632,"score_spread":0.2048334800890242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414159630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834093,0.004771976,0.000081022525,0.007921829,0.00034302825,0.0021325583,0.00037764278,0.0002005022,0.00076215365],"genre_scores_gemma":[0.9668523,0.00107183,0.0010176182,0.028157432,0.00060009776,0.000108242435,0.0015066456,0.000083559,0.0006022762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960983,0.00048269326,0.0007838998,0.0007342636,0.0012665068,0.00063435873],"domain_scores_gemma":[0.99683607,0.0006136566,0.00073881104,0.00061986624,0.0010825073,0.00010908027],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005232297,0.0006237127,0.0018628769,0.00066663837,0.00009991359,0.000050190345,0.00028797812,0.0012718069,0.000029493556],"category_scores_gemma":[0.0005334955,0.00056832226,0.00028322337,0.00044664906,0.00017244392,0.00018026428,0.00008538643,0.0016834852,0.0000025594068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003278352,0.0012233985,0.59428144,0.01648164,0.0019592277,0.00030162523,0.00822039,0.0000018277939,0.20301113,0.00006172706,0.17310214,0.0010276539],"study_design_scores_gemma":[0.007749473,0.00061728933,0.67350364,0.011580408,0.004065936,0.000037632057,0.0011783623,0.000014159617,0.27539128,0.0001878828,0.0249851,0.0006888557],"about_ca_topic_score_codex":0.00015956353,"about_ca_topic_score_gemma":0.000064269014,"teacher_disagreement_score":0.14811704,"about_ca_system_score_codex":0.00024432287,"about_ca_system_score_gemma":0.00014306071,"threshold_uncertainty_score":0.9996768},"labels":[],"label_agreement":null},{"id":"W4414160028","doi":"10.1111/dom.70117","title":"A review of multidisciplinary care in metabolic dysfunction‐associated steatohepatitis and cardiometabolic disease, with a focus on Canada","year":2025,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada); Diabetes Canada; University of Toronto; Trillium Health Centre; Université Laval; University of Alberta; University of Calgary","funders":"Novo Nordisk","keywords":"Multidisciplinary approach; Steatohepatitis; Disease; Multisystem disease; Disease management; Primary care; Type 2 diabetes; Identification (biology); MEDLINE","score_opus":0.008767295967723358,"score_gpt":0.2520402595369037,"score_spread":0.24327296356918032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414160028","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019159192,0.9754782,1.0093796e-7,0.00008400815,0.00014254288,0.0025905177,0.0023080315,0.000023437944,0.00021398852],"genre_scores_gemma":[0.00689314,0.9909674,0.000018934114,0.00029657752,0.000057134013,0.0007877502,0.0008673021,0.000042104246,0.000069691116],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997398,0.00036655163,0.00063925947,0.0007296567,0.00044998337,0.0004165264],"domain_scores_gemma":[0.9981729,0.0002915849,0.00033952316,0.0005362443,0.00021708386,0.0004426884],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019386153,0.0006710176,0.0044872905,0.00048078486,0.00010670642,0.000019508749,0.00010926409,0.00015903544,0.000014055851],"category_scores_gemma":[0.00020641499,0.000470116,0.00041230812,0.00095610885,0.000101676385,0.00007218071,0.0001406634,0.00031127906,0.0000010482979],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042715215,0.000725464,0.08879608,0.27574572,0.0025086666,0.00013483435,0.000073870884,3.065985e-7,3.421128e-8,0.00024551715,0.0002910987,0.6314357],"study_design_scores_gemma":[0.0022158164,0.00010801588,0.4464456,0.24951813,0.027335169,0.0000024637193,0.00002845917,0.000001065381,0.0000027374185,0.000014155841,0.27387267,0.00045569197],"about_ca_topic_score_codex":0.027820827,"about_ca_topic_score_gemma":0.023696242,"teacher_disagreement_score":0.63098,"about_ca_system_score_codex":0.00016633776,"about_ca_system_score_gemma":0.002154352,"threshold_uncertainty_score":0.99977505},"labels":[],"label_agreement":null},{"id":"W4414292494","doi":"10.1111/dom.70135","title":"Coated glucose microbeads stimulate enteric hormone release and improve glucose tolerance in Phase 1 and 2 clinical trials","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ted Rogers Centre for Heart Research; Heart and Stroke Foundation; University of Toronto","funders":"","keywords":"Enteroendocrine cell; Clinical trial; Endogeny; Adverse effect; Glucagon-like peptide-1; Endocrine system; Hormone; In vitro","score_opus":0.02251802642745963,"score_gpt":0.3321211460644948,"score_spread":0.30960311963703513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414292494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9381558,0.059570976,0.00002631346,0.00045575513,0.00032616247,0.0012079377,0.00006437832,0.000057176327,0.00013551973],"genre_scores_gemma":[0.97547466,0.021759983,0.00036444585,0.0014185166,0.00009079053,0.0000529772,0.00008012162,0.000017130122,0.00074138405],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977207,0.00032712443,0.0008106081,0.0005944455,0.00012480901,0.0004223],"domain_scores_gemma":[0.9988599,0.00033812088,0.00017462461,0.00029609085,0.000060909075,0.00027034487],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001735374,0.00031709467,0.0014101833,0.00027491746,0.000092669754,0.00008346128,0.00006966569,0.00017000262,0.000013243877],"category_scores_gemma":[0.0005472848,0.00026469483,0.00013316367,0.00028414195,0.0001988156,0.00018081305,0.00018359449,0.00024576578,0.0000046381892],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001851438,0.0050258436,0.2123829,0.000730334,0.0013777987,0.00011046489,0.00033028887,0.0000013982071,0.1409151,0.0006703964,0.0013767866,0.63522726],"study_design_scores_gemma":[0.052055206,0.0007828326,0.8828606,0.0003843368,0.003033825,0.0000015504108,0.00007119446,0.0032730177,0.027718136,0.0005834543,0.028778119,0.00045771577],"about_ca_topic_score_codex":0.000045924484,"about_ca_topic_score_gemma":0.000011766509,"teacher_disagreement_score":0.67047775,"about_ca_system_score_codex":0.000022582677,"about_ca_system_score_gemma":0.00003910363,"threshold_uncertainty_score":0.9999805},"labels":[],"label_agreement":null},{"id":"W4414333164","doi":"10.1111/dom.70146","title":"Empagliflozin for the preservation of beta‐cell function in women with recent gestational diabetes: A randomized placebo‐controlled trial","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Empagliflozin; Randomized controlled trial; Gestation; Gestational age; Benzhydryl compounds; Pregnancy","score_opus":0.00959530191378957,"score_gpt":0.23369041963445186,"score_spread":0.2240951177206623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414333164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868186,0.0043644113,0.00058946124,0.0012707138,0.00036894222,0.0057302983,0.000017519913,0.000029008193,0.000811034],"genre_scores_gemma":[0.99226344,0.0006195494,0.0004566789,0.0013628763,0.00013996162,0.0038818058,0.00004989063,0.000014100706,0.0012117163],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983782,0.00025816963,0.00054197386,0.00026424433,0.0002468016,0.0003105813],"domain_scores_gemma":[0.99645805,0.002767468,0.00022289516,0.00021423987,0.00025897808,0.00007836458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019607774,0.00019599758,0.0011921487,0.00024384515,0.00011112722,0.000029395569,0.00006796728,0.00010606708,0.00006415082],"category_scores_gemma":[0.0011882908,0.000117420655,0.00013245623,0.000370511,0.00016201327,0.00015445227,0.000024115672,0.00014256484,0.0000011106854],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97758687,0.0006365237,0.0113873575,0.00038969435,0.0009484189,1.4774157e-7,0.000488355,0.000076261,0.0018196605,0.002021388,0.00044708728,0.0041982294],"study_design_scores_gemma":[0.90521485,0.00032970324,0.080415234,0.00011940173,0.0014550971,4.211284e-8,0.0001924567,0.0034158858,0.002569907,0.0018334908,0.0043337755,0.00012013496],"about_ca_topic_score_codex":0.000012377429,"about_ca_topic_score_gemma":0.0000042117454,"teacher_disagreement_score":0.072372004,"about_ca_system_score_codex":0.00003637859,"about_ca_system_score_gemma":0.0001907548,"threshold_uncertainty_score":0.47882754},"labels":[],"label_agreement":null},{"id":"W4414371052","doi":"10.1111/dom.70142","title":"Optimizing cardiovascular health with a type 2 diabetes remission program: Ultraprocessed food‐intake reduction, Mediterranean diet, chrononutrition and physical training—The <scp>DIABEPIC</scp> ‐2 pilot study","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Dietary Effects on Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire de Gériatrie de Montréal; Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Type 2 diabetes; Cardiovascular health; Randomized controlled trial; Diabetes mellitus; MEDLINE; Physical activity","score_opus":0.0277901829991459,"score_gpt":0.27876272054409107,"score_spread":0.2509725375449452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414371052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96132386,0.0336429,0.000020057965,0.0007960385,0.00034327921,0.0035210287,0.0000127432,0.00023499435,0.00010511548],"genre_scores_gemma":[0.9956933,0.0016872862,0.0009900649,0.000540646,0.0005843178,0.00033480444,0.00007782937,0.000044112665,0.000047589638],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971268,0.00043583836,0.00039252252,0.00078680133,0.0005104013,0.0007476287],"domain_scores_gemma":[0.99836665,0.00027799243,0.0001591248,0.0005377814,0.00023499863,0.00042342194],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013827278,0.00042005922,0.0012647948,0.00022503464,0.0006022947,0.00010397879,0.00013979524,0.00008462632,0.0000013632527],"category_scores_gemma":[0.00031438863,0.0002945515,0.00012616368,0.0008552557,0.0003258962,0.00024178984,0.00006356417,0.0005480648,0.0000012158297],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011954108,0.022439182,0.15255146,0.018735487,0.012250064,0.00003950413,0.06688823,0.0001457867,0.015213743,0.00033228166,0.0034537115,0.70675516],"study_design_scores_gemma":[0.014698775,0.048679266,0.88381857,0.0027431627,0.0047952426,0.00002467262,0.009022192,0.0016567712,0.0065552415,0.0006109074,0.02687531,0.0005198683],"about_ca_topic_score_codex":0.00005313701,"about_ca_topic_score_gemma":0.000010151368,"teacher_disagreement_score":0.73126715,"about_ca_system_score_codex":0.000055800614,"about_ca_system_score_gemma":0.0002895303,"threshold_uncertainty_score":0.99995065},"labels":[],"label_agreement":null},{"id":"W4414972078","doi":"10.1111/dom.70185","title":"Semaglutide withdrawal in adults with type 1 diabetes on pump therapy: A post‐hoc analysis from a double‐blinded randomized controlled trial","year":2025,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canada Research Chairs","keywords":"Semaglutide; Randomized controlled trial; Placebo; Insulin pump; Type 1 diabetes; Glycemic; Diabetes mellitus; Crossover study","score_opus":0.008097921347696638,"score_gpt":0.2304328707177119,"score_spread":0.22233494937001527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414972078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9372229,0.00963713,0.0000015548231,0.038573276,0.000715866,0.0122076,0.00014666973,0.00015241912,0.0013425592],"genre_scores_gemma":[0.60788274,0.0055680815,0.00044771968,0.36201653,0.0034300783,0.0054513477,0.0068190326,0.0001985334,0.008185963],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99464655,0.0007790795,0.0011592706,0.00140233,0.0009495574,0.0010631903],"domain_scores_gemma":[0.9959574,0.001816956,0.00065490353,0.0010121035,0.00034880868,0.00020986248],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001087942,0.0012269771,0.00836531,0.0021824106,0.00014479342,0.00021484193,0.00031751776,0.0008990393,0.00022495868],"category_scores_gemma":[0.0002925824,0.0007831467,0.0014335723,0.0014767159,0.000297548,0.00013498633,0.0001234546,0.0013656246,0.000024427847],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94595844,0.0012174568,0.0056931465,0.00030583653,0.036262363,0.00014490608,0.0003558307,0.000006317142,0.000015883374,0.00006925456,0.008127982,0.0018425757],"study_design_scores_gemma":[0.9366606,0.001238932,0.0075807446,0.0009220216,0.029323077,1.0456061e-7,0.000026953769,0.00019262839,0.00017888594,0.00016797737,0.022971237,0.0007368598],"about_ca_topic_score_codex":0.00039549905,"about_ca_topic_score_gemma":0.00014853562,"teacher_disagreement_score":0.32934022,"about_ca_system_score_codex":0.0000937343,"about_ca_system_score_gemma":0.00025723223,"threshold_uncertainty_score":0.99946195},"labels":[],"label_agreement":null},{"id":"W4415235069","doi":"10.1111/dom.70209","title":"Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the <scp>TRIUMPH</scp> registrational clinical trials","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Eli Lilly and Company","keywords":"Obstructive sleep apnea; Clinical trial; Disease; Obesity; Sleep apnea; MEDLINE","score_opus":0.044380771340370294,"score_gpt":0.3089905578648763,"score_spread":0.264609786524506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415235069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655241,0.029501094,0.0006941843,0.00048905687,0.0003292028,0.0030806703,0.00013879451,0.000010200058,0.00023272369],"genre_scores_gemma":[0.9914806,0.0038197099,0.002560223,0.00025497744,0.000175594,0.00030780266,0.00004378713,0.000011277256,0.0013460487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984037,0.00032587347,0.0006021409,0.00030046818,0.00018042495,0.00018737759],"domain_scores_gemma":[0.99536926,0.0038291253,0.00030893667,0.00027006774,0.00015222166,0.00007041914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013510243,0.0001912006,0.00081354956,0.00007868729,0.00019053511,0.00003348234,0.00007077516,0.00010054536,0.0000037708126],"category_scores_gemma":[0.0010900552,0.00011183139,0.00021985694,0.0001419899,0.0004289072,0.00008869641,0.00005987898,0.00006626618,3.020501e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002857856,0.0019178233,0.5619538,0.00058144226,0.0044659413,0.0000021042358,0.0014331003,0.00003386194,0.0022582575,0.041714236,0.0010944385,0.38425922],"study_design_scores_gemma":[0.008525388,0.0008333574,0.95142186,0.00010366758,0.00405243,0.0000010593884,0.0003522758,0.0006169336,0.010116754,0.008007573,0.015905797,0.00006289542],"about_ca_topic_score_codex":0.000007569761,"about_ca_topic_score_gemma":0.000008909746,"teacher_disagreement_score":0.3894681,"about_ca_system_score_codex":0.0000140313105,"about_ca_system_score_gemma":0.00007337573,"threshold_uncertainty_score":0.45603517},"labels":[],"label_agreement":null},{"id":"W4415278127","doi":"10.1111/dom.70201","title":"Effects of <scp>GLP</scp> ‐1 receptor agonists on cognitive function in patients with type 2 diabetes: A systematic review and meta‐analysis based on randomized controlled trials","year":2025,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":true,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Shandong First Medical University","keywords":"Cognition; Randomized controlled trial; Type 2 diabetes; Type 2 Diabetes Mellitus; Receptor; Clinical trial","score_opus":0.013704273603037687,"score_gpt":0.2685342083474067,"score_spread":0.25482993474436905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415278127","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025872034,0.96492773,0.000006664972,0.000015183518,0.00014615688,0.031924937,0.00014606433,0.00003889045,0.00020715014],"genre_scores_gemma":[0.0017169649,0.9895474,0.000041945215,0.001024825,0.00002578441,0.0060163294,0.00089421147,0.000045678084,0.0006868676],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9908333,0.0051910407,0.002115456,0.0008090705,0.00061045366,0.00044067198],"domain_scores_gemma":[0.9772307,0.019668637,0.0020957761,0.00047759296,0.00034198666,0.00018529566],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0054108314,0.0010385282,0.043076593,0.0016222754,0.00007403445,0.000060954695,0.00011657634,0.0002968362,0.000028882727],"category_scores_gemma":[0.012264839,0.0005350692,0.0035868569,0.0014266243,0.00013366228,0.00007942946,0.000056998044,0.0003141079,0.000010031074],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018956477,0.0010460607,0.00010175613,0.70544696,0.28905025,0.0000016173528,0.000016791555,3.8088703e-7,7.920399e-8,0.000054386575,0.000045180128,0.0023408867],"study_design_scores_gemma":[0.09613048,0.0004858552,0.0002637325,0.16169718,0.74058086,1.0296775e-8,0.000003048369,0.0000073433825,0.000006723737,0.000008397251,0.00065356697,0.0001628306],"about_ca_topic_score_codex":0.000003755172,"about_ca_topic_score_gemma":0.0000014549753,"teacher_disagreement_score":0.5437498,"about_ca_system_score_codex":0.0000467323,"about_ca_system_score_gemma":0.000118547876,"threshold_uncertainty_score":0.9997101},"labels":[],"label_agreement":null},{"id":"W4415603722","doi":"10.1111/dom.70213","title":"Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post‐hoc analysis of a double‐blinded, randomised, crossover trial","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canada Research Chairs","keywords":"Insulin pump; Type 1 diabetes; Semaglutide; Insulin; Bolus (digestion); Crossover study","score_opus":0.016742660790223504,"score_gpt":0.2860849597777098,"score_spread":0.2693422989874863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415603722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99261343,0.0020701422,0.0000016123695,0.00092807796,0.00010436519,0.0031967182,0.00004670338,0.000043161348,0.0009957693],"genre_scores_gemma":[0.9956189,0.000562498,0.00011294381,0.0019636487,0.00009125542,0.00021489516,0.0001090785,0.00003114432,0.0012956558],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9973441,0.00014858598,0.00045150018,0.0006615918,0.0007105365,0.00068369205],"domain_scores_gemma":[0.9984865,0.00021816013,0.00017461812,0.00054862525,0.0003531121,0.00021895055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009590123,0.00039021487,0.0014340152,0.0019260267,0.000102278085,0.00008761248,0.0002307526,0.00016245269,0.00016587389],"category_scores_gemma":[0.0001578509,0.00026104596,0.00015955379,0.0033957583,0.00018970422,0.0001406592,0.00015039791,0.00029014723,0.000013775582],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.769562,0.003182152,0.18241632,0.0006281553,0.008359384,0.000021107848,0.0012023648,0.00013599917,0.0042373533,0.00034321804,0.000229084,0.029682843],"study_design_scores_gemma":[0.42988607,0.0038701966,0.5506136,0.0009995312,0.0021663744,4.7330705e-8,0.000052483207,0.00071329024,0.008144431,0.00006649299,0.0030529061,0.0004346089],"about_ca_topic_score_codex":0.00010433715,"about_ca_topic_score_gemma":0.00026481375,"teacher_disagreement_score":0.36819726,"about_ca_system_score_codex":0.000044976747,"about_ca_system_score_gemma":0.00013284515,"threshold_uncertainty_score":0.9999842},"labels":[],"label_agreement":null},{"id":"W4415617104","doi":"10.1111/dom.70240","title":"Diabetes management in maternally inherited diabetes and deafness ( <scp>MIDD</scp> ): A review and a proposed treatment algorithm","year":2025,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Breakthrough T1D Canada","keywords":"Heteroplasmy; Diabetes mellitus; Pathophysiology; Oxidative stress; Type 2 diabetes; Insulin resistance; Diabetes management","score_opus":0.015172358154213203,"score_gpt":0.2733554057617461,"score_spread":0.2581830476075329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415617104","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06880449,0.92565763,0.0000028795455,0.00008920382,0.00023168954,0.0041119843,0.00020693398,0.00013487288,0.0007603217],"genre_scores_gemma":[0.00009865262,0.99262804,0.0013528139,0.0012585911,0.00012737486,0.0007895581,0.00037342784,0.000079144156,0.0032924237],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957914,0.0005095713,0.0011012872,0.0012423234,0.00035484182,0.0010006069],"domain_scores_gemma":[0.9976345,0.0007098832,0.00039686772,0.00063405297,0.000115989125,0.0005087461],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008649683,0.0011812504,0.0054015694,0.0008603986,0.00018163775,0.00017754461,0.00018633479,0.00046942156,0.000027045913],"category_scores_gemma":[0.00036497283,0.0008887393,0.00037517084,0.0009039328,0.00028114725,0.00019504821,0.00033642823,0.0004356464,0.000012776962],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000018499404,0.00040975126,0.009858047,0.1584672,0.0015631211,0.00003078773,0.00007085165,1.5880794e-8,0.000010785979,0.000114917035,0.00037575283,0.8290969],"study_design_scores_gemma":[0.0030879125,0.00022244897,0.026485726,0.07963469,0.02065477,0.00000810155,0.00003916453,0.000059779366,0.00010942214,0.00021787008,0.86893356,0.0005465703],"about_ca_topic_score_codex":0.000018202782,"about_ca_topic_score_gemma":0.0000026461819,"teacher_disagreement_score":0.8685578,"about_ca_system_score_codex":0.000116543946,"about_ca_system_score_gemma":0.00017392011,"threshold_uncertainty_score":0.9993563},"labels":[],"label_agreement":null},{"id":"W4415647739","doi":"10.1111/dom.70234","title":"Blood pressure and adverse cardiovascular outcomes in older people with type 2 diabetes and chronic kidney disease: Findings based on the Clinical Practice Research Datalink databases in England","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"NIHR Leicester Biomedical Research Centre; University of Leicester; Department of Health and Social Care; British Heart Foundation; National Institute for Health and Care Research","keywords":"Mace; Blood pressure; Type 2 diabetes; Clinical Practice; Older people; Type 2 Diabetes Mellitus; Adverse effect","score_opus":0.03171958744217211,"score_gpt":0.3215363430491205,"score_spread":0.28981675560694836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415647739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8605088,0.13456346,7.044643e-7,0.003923249,0.00010204268,0.00069009856,0.0001011009,0.000016475009,0.000094047835],"genre_scores_gemma":[0.9886418,0.0071916548,0.00013121693,0.0036567422,0.000089944544,0.00006363435,0.000060219572,0.000014568095,0.00015019535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977669,0.0005875277,0.00027019135,0.0005715445,0.0004172794,0.00038656782],"domain_scores_gemma":[0.99656147,0.0024073445,0.00003955988,0.0006084519,0.00017688166,0.00020629383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026549979,0.00021522261,0.0009031803,0.00023711537,0.00021228829,0.000044673565,0.00009736214,0.000081733284,0.000012058205],"category_scores_gemma":[0.003641008,0.00013143882,0.00006542748,0.00043477266,0.00031913622,0.00020815655,0.00026471078,0.00062273635,0.0000012590391],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016014247,0.0005346632,0.994563,0.0005378866,0.0016103265,0.00004180394,0.00024596148,0.0000036873046,0.00003842547,0.00020699487,0.0012192571,0.0008378579],"study_design_scores_gemma":[0.0044463146,0.00007839064,0.8225463,0.0004889154,0.0049956245,8.692456e-7,0.00010519153,0.00021364306,0.0001455947,0.000019201085,0.16683356,0.00012639313],"about_ca_topic_score_codex":0.00013515246,"about_ca_topic_score_gemma":0.00013710166,"teacher_disagreement_score":0.1720167,"about_ca_system_score_codex":0.0000032783514,"about_ca_system_score_gemma":0.00020157214,"threshold_uncertainty_score":0.5359919},"labels":[],"label_agreement":null},{"id":"W4415655700","doi":"10.1111/dom.70253","title":"An indirect treatment comparison of tirzepatide 10 and 15 mg versus high‐dose semaglutide 7.2 mg in people with obesity and type 2 diabetes","year":2025,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Semaglutide; Type 2 diabetes; Placebo; Obesity; Clinical trial; Weight loss; Trial registration","score_opus":0.013812651318188382,"score_gpt":0.25427623198390936,"score_spread":0.240463580665721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415655700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793183,0.012420252,6.1240263e-7,0.0058539077,0.00030519327,0.0013292512,0.00016797666,0.000085880245,0.00051862764],"genre_scores_gemma":[0.982994,0.0028555137,0.00093020545,0.008786935,0.00041974403,0.00016539925,0.0015768073,0.0000811268,0.002190275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971272,0.00023193202,0.0005274572,0.0009525573,0.00040638904,0.0007544937],"domain_scores_gemma":[0.9982885,0.00039052585,0.00030159936,0.0006494117,0.00013685542,0.00023309025],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002797514,0.0007905467,0.002428831,0.0006665386,0.0001479235,0.000091078284,0.0001506239,0.0005017605,0.000060417322],"category_scores_gemma":[0.000067515684,0.00062875357,0.00011145605,0.0004857444,0.00027300374,0.00018394,0.0001745005,0.00052971096,0.0000060279135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034036377,0.0013036705,0.96433854,0.0016915408,0.0018056028,0.000050845807,0.00073424116,0.0000030631188,0.00017862365,0.00006148065,0.013669847,0.015822155],"study_design_scores_gemma":[0.008581826,0.00221624,0.9146696,0.00059804635,0.0049566547,5.872408e-7,0.00010199114,0.0002067995,0.0027689964,0.000087932545,0.06517794,0.00063343905],"about_ca_topic_score_codex":0.000561911,"about_ca_topic_score_gemma":0.000776395,"teacher_disagreement_score":0.05150809,"about_ca_system_score_codex":0.0001146203,"about_ca_system_score_gemma":0.00012705849,"threshold_uncertainty_score":0.9996164},"labels":[],"label_agreement":null},{"id":"W4415818676","doi":"10.1111/dom.70252","title":"Real‐world incidence and risk factors of level 3 (severe) hypoglycaemia in adults with type 1 or 2 diabetes ( <scp>iNPHORM</scp> , United States)","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Montgomery County Government","keywords":"Incidence (geometry); Type 2 diabetes; Diabetes mellitus; Hypoglycemia; Type 1 diabetes; MEDLINE","score_opus":0.014857774270946355,"score_gpt":0.25894904067679003,"score_spread":0.24409126640584367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415818676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956047,0.0021428831,0.000003867627,0.00008119398,0.00010646086,0.00069583557,0.00008906175,0.000051677187,0.0012243179],"genre_scores_gemma":[0.9859339,0.007119743,0.0005230733,0.00018458381,0.000034015568,0.000023178558,0.000167729,0.000026632919,0.0059871394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979284,0.000159289,0.0003906419,0.00048714707,0.00039037754,0.0006441563],"domain_scores_gemma":[0.99813735,0.0008227293,0.00016339778,0.0003648246,0.00029914174,0.0002125293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065131695,0.0003237353,0.0008083028,0.0011616998,0.00012762363,0.000054203112,0.00019018142,0.00013447476,0.000019676156],"category_scores_gemma":[0.0008027007,0.00022172237,0.000048750586,0.0022789792,0.0003689356,0.00023691238,0.00026599242,0.0004496974,0.000003661601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012199796,0.00023912091,0.9915921,0.0011647899,0.00030551766,0.000008651506,0.00069257483,0.000013891665,0.00049274386,0.0002942923,0.000740944,0.0043333806],"study_design_scores_gemma":[0.0027817665,0.0002472675,0.9818629,0.0008571743,0.00038219168,1.4931358e-7,0.00055682176,0.00089517236,0.0059046727,0.0003862019,0.0059922244,0.00013347277],"about_ca_topic_score_codex":0.0009663869,"about_ca_topic_score_gemma":0.0006237479,"teacher_disagreement_score":0.009729209,"about_ca_system_score_codex":0.00003337861,"about_ca_system_score_gemma":0.00012744364,"threshold_uncertainty_score":0.9041576},"labels":[],"label_agreement":null},{"id":"W4415896261","doi":"10.1111/dom.70196","title":"Survodutide for treatment of obesity: Baseline characteristics of participants in a randomized, double‐blind, placebo‐controlled, phase 3 trial ( <scp>SYNCHRONIZE</scp> ™‐1)","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"Boehringer Ingelheim","keywords":"Tolerability; Cohort; Weight loss; Baseline (sea); Cohort study; Obesity","score_opus":0.028426785054407305,"score_gpt":0.30824914136559417,"score_spread":0.27982235631118685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415896261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827643,0.0067988276,0.00027218697,0.00014143574,0.00047062116,0.00890384,0.00016606764,0.00003376679,0.00044894803],"genre_scores_gemma":[0.9926513,0.002483278,0.0005441427,0.0001204784,0.00016980468,0.0016845334,0.0002549755,0.000023676188,0.0020678304],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971284,0.0002918528,0.0012574358,0.00045770474,0.00025113428,0.0006134539],"domain_scores_gemma":[0.9967421,0.0019778633,0.00047344764,0.00041325117,0.00021234815,0.00018094057],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001938505,0.00041123838,0.0038860848,0.00055506406,0.00007127232,0.00003083295,0.000107253494,0.00016304523,0.000014991971],"category_scores_gemma":[0.0012714209,0.00031482297,0.0006147107,0.00034465457,0.00022305558,0.000117498406,0.000062675485,0.0000719584,0.000002278606],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9166077,0.015724983,0.029034814,0.001271445,0.0047824616,0.0000128894235,0.00067308586,0.0000057377874,0.0012806397,0.0038440689,0.0001860128,0.026576173],"study_design_scores_gemma":[0.96519107,0.00091358926,0.0056054536,0.0002366866,0.0071690576,1.1354134e-7,0.00007856097,0.0019143346,0.014439242,0.00035241758,0.0039902017,0.00010929065],"about_ca_topic_score_codex":0.0000800652,"about_ca_topic_score_gemma":0.000033728706,"teacher_disagreement_score":0.048583366,"about_ca_system_score_codex":0.00006361046,"about_ca_system_score_gemma":0.00016983764,"threshold_uncertainty_score":0.9999304},"labels":[],"label_agreement":null},{"id":"W4416093687","doi":"10.1111/dom.70289","title":"Effects of <scp>SGLT2</scp> inhibitors across the spectrum of albuminuria in cardiovascular–kidney–metabolic conditions: A pooled analysis of randomised trials","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Janssen Research and Development; Canadian Institutes of Health Research; Raymond and Beverly Sackler Institute for Biological, Physical and Engineering Sciences, Yale University; Fundação para a Ciência e a Tecnologia; Boehringer Ingelheim; McGill University; Yale University; Eli Lilly and Company","keywords":"Albuminuria; Pooled analysis; Meta-analysis; Kidney disease; Kidney; Clinical trial","score_opus":0.006465847211660236,"score_gpt":0.2536120545076286,"score_spread":0.24714620729596834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416093687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94794106,0.04917761,0.000024829724,0.00012351415,0.00025744003,0.0020571207,0.00011590851,0.000018436303,0.00028407533],"genre_scores_gemma":[0.99680585,0.0022966804,0.000061671664,0.00020178668,0.00005263124,0.00019506634,0.00008460308,0.000012976542,0.00028871902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971975,0.0006474541,0.001026579,0.00035636115,0.00038312344,0.00038899796],"domain_scores_gemma":[0.9972568,0.0014879208,0.00044984632,0.00056904537,0.00012100044,0.00011535192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028635513,0.00028533852,0.0034706295,0.000845281,0.00006774224,0.000019420037,0.00016886793,0.00013733188,0.000009559859],"category_scores_gemma":[0.0025744138,0.00019692768,0.0015366556,0.0020657065,0.00025109155,0.00009726528,0.00012442251,0.00013760394,0.0000010391739],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087408454,0.0055333953,0.6042752,0.0066890945,0.25081468,0.00002741703,0.007060114,0.00029376167,0.09104056,0.0105864415,0.0021146026,0.02069064],"study_design_scores_gemma":[0.022847379,0.00004632587,0.63207,0.00026932306,0.049640182,7.7045975e-8,0.00028630064,0.00006908078,0.29224044,0.0004887728,0.0019785692,0.00006353453],"about_ca_topic_score_codex":0.00017607817,"about_ca_topic_score_gemma":0.000024586423,"teacher_disagreement_score":0.2011999,"about_ca_system_score_codex":0.000016679543,"about_ca_system_score_gemma":0.00007890327,"threshold_uncertainty_score":0.8030478},"labels":[],"label_agreement":null},{"id":"W4416093819","doi":"10.1111/dom.70264","title":"Sodium glucose co‐transporter 2 inhibitors versus dipeptidyl peptidase‐4 inhibitors and the risk of ventricular arrhythmia among patients with type 2 diabetes: A population‐based cohort study","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; Deutsche Forschungsgemeinschaft; McGill University","keywords":"Cohort study; Type 2 diabetes; Cohort; Type 2 Diabetes Mellitus; Sodium; Dipeptidyl peptidase-4","score_opus":0.0034519751134909848,"score_gpt":0.2028476780419693,"score_spread":0.1993957029284783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416093819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99468136,0.0016586914,0.0000043528216,0.00007163027,0.0003626493,0.0029113784,0.00004360674,0.0000559834,0.00021037206],"genre_scores_gemma":[0.9990717,0.00010112152,0.000071397575,0.00012371143,0.000095397576,0.000144424,0.00026661146,0.000025424213,0.000100178055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980025,0.00019040266,0.0004496885,0.00048698383,0.00047756158,0.00039286184],"domain_scores_gemma":[0.9987405,0.00020149237,0.0002610463,0.00045971407,0.0001875276,0.00014970922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005802962,0.0003688897,0.0008729228,0.0003020416,0.00023854186,0.000054832875,0.00009232455,0.0001048945,0.000018332334],"category_scores_gemma":[0.00010773312,0.00023409144,0.00015001695,0.0005348879,0.00031388426,0.00017767004,0.00006708235,0.00021468743,0.0000025866582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005218499,0.00081073114,0.99468136,0.00017759026,0.0015953082,0.000006086304,0.00019346598,0.0000122868405,0.000008286425,0.000062770836,0.00009930674,0.0018309355],"study_design_scores_gemma":[0.01909944,0.00041788362,0.97281086,0.00019962441,0.0053002257,2.6885626e-8,0.0001166209,0.00011041325,0.0011123428,0.000042384552,0.0005711471,0.00021899705],"about_ca_topic_score_codex":0.00017310595,"about_ca_topic_score_gemma":0.000043536085,"teacher_disagreement_score":0.021870488,"about_ca_system_score_codex":0.000039023183,"about_ca_system_score_gemma":0.00003717309,"threshold_uncertainty_score":0.9545972},"labels":[],"label_agreement":null},{"id":"W4416133916","doi":"10.1111/dom.70263","title":"Baseline characteristics in the <scp>SYNCHRONIZE</scp> ™‐2 randomized phase 3 trial of survodutide, a glucagon receptor/ <scp>GLP</scp> ‐1 receptor dual agonist, for obesity in people with type 2 diabetes","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"Boehringer Ingelheim","keywords":"Tolerability; Type 2 diabetes; Baseline (sea); Obesity; Glucagon-like peptide 1 receptor; Diabetes mellitus; Glucagon-like peptide-1; Randomized controlled trial","score_opus":0.009285637839900903,"score_gpt":0.2505621433897121,"score_spread":0.2412765055498112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416133916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98815066,0.0043058833,0.00008303239,0.0003142116,0.000870568,0.005367709,0.00026044715,0.00006415911,0.0005833052],"genre_scores_gemma":[0.99121594,0.0025120478,0.0011532987,0.00075165834,0.0003951596,0.0008567192,0.0012784613,0.000051529812,0.001785208],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961427,0.0007732185,0.0010443782,0.0006944994,0.00046308312,0.00088211347],"domain_scores_gemma":[0.9945149,0.0039384533,0.00044304907,0.00060784776,0.00032303092,0.00017271575],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00425299,0.0005697936,0.0024973033,0.000540087,0.00017252742,0.00011263394,0.00027102517,0.00025149723,0.000021009484],"category_scores_gemma":[0.004536756,0.00040309498,0.00032040005,0.0011315942,0.00032569582,0.00023411025,0.00013697319,0.00037960344,0.000009224303],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06931151,0.03525307,0.78266853,0.0069123385,0.0059249657,0.00003988588,0.009348762,0.000014894222,0.013816508,0.008938543,0.026865855,0.040905148],"study_design_scores_gemma":[0.7285479,0.0017268185,0.16689216,0.0007775617,0.0036177551,5.4254565e-7,0.00081126916,0.001071415,0.016935151,0.0005190373,0.07887383,0.00022656334],"about_ca_topic_score_codex":0.00009156579,"about_ca_topic_score_gemma":0.00012116325,"teacher_disagreement_score":0.6592364,"about_ca_system_score_codex":0.00008530824,"about_ca_system_score_gemma":0.00026011642,"threshold_uncertainty_score":0.9998421},"labels":[],"label_agreement":null},{"id":"W4416306192","doi":"10.1111/dom.70290","title":"The value and impact of weight reduction from the perspective of people with type 2 diabetes in the <scp>United States</scp>","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Perspective (graphical); Type 2 diabetes; Weight loss; Value (mathematics); Reduction (mathematics); Type 2 Diabetes Mellitus","score_opus":0.005560948907691396,"score_gpt":0.23543700322753458,"score_spread":0.22987605431984318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416306192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98121285,0.017099239,0.000001914809,0.0009686219,0.00015361018,0.00030900433,0.00003389604,0.0000091101965,0.00021174538],"genre_scores_gemma":[0.9968316,0.002726571,0.00002942502,0.0002208006,0.000072712544,0.000009577012,0.000025913238,0.000006519244,0.000076893855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899185,0.0002737887,0.00019695544,0.00016795179,0.00016176738,0.00020770553],"domain_scores_gemma":[0.9971995,0.0022020473,0.000115093935,0.00027503105,0.00017101136,0.00003736718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000739093,0.00013814849,0.0003947792,0.000115509836,0.000157992,0.000025407708,0.00010941918,0.00006609919,0.000004069031],"category_scores_gemma":[0.0005408654,0.000057830177,0.00007991903,0.0008663755,0.00024215892,0.00007495102,0.000043704833,0.00022060794,3.3340896e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037719463,0.00011296493,0.986968,0.000032088097,0.00042335535,4.4952134e-7,0.0067663267,0.00001181284,0.00080550695,0.0034485222,0.0006877463,0.000705516],"study_design_scores_gemma":[0.0006606703,0.000074462114,0.9852892,0.000057296253,0.00047969868,6.8692685e-7,0.0053005484,0.00017766703,0.0027401166,0.0040984824,0.0010916474,0.00002952822],"about_ca_topic_score_codex":0.0016215513,"about_ca_topic_score_gemma":0.00005077758,"teacher_disagreement_score":0.015618729,"about_ca_system_score_codex":0.000015810076,"about_ca_system_score_gemma":0.00008349213,"threshold_uncertainty_score":0.24513113},"labels":[],"label_agreement":null},{"id":"W4416340615","doi":"10.1111/dom.70299","title":"Despite lower haemoglobin A1c with second‐generation automated insulin delivery systems, mental burden remains high for all adults with type 1 diabetes: A <scp>BETTER</scp> registry analysis","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ste. Anne's Hospital; Centre Hospitalier de l’Université de Montréal; McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Breakthrough T1D Canada; Canadian Institutes of Health Research; Institut de Recherche Clinique De Montréal; Juvenile Diabetes Research Foundation Canada","keywords":"Diabetes mellitus; Type 2 diabetes; Insulin delivery; Type 1 diabetes; Insulin; MEDLINE","score_opus":0.008780291928723458,"score_gpt":0.23852788126642827,"score_spread":0.2297475893377048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416340615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915245,0.0050038346,0.0000923663,0.0003686299,0.00034377238,0.0018278228,0.00018842715,0.00027075846,0.00037986579],"genre_scores_gemma":[0.99007297,0.00029463205,0.0012599198,0.0009419427,0.00030490814,0.0002177189,0.0015746945,0.00004516436,0.005288034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973617,0.0001522114,0.00042870102,0.00077040645,0.00048847636,0.0007985058],"domain_scores_gemma":[0.9982697,0.00017450335,0.00020844484,0.0005897889,0.0004945942,0.00026301708],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000628995,0.0004265598,0.001012422,0.00072371785,0.0002796119,0.00025956225,0.00022371521,0.00022745627,0.000026864385],"category_scores_gemma":[0.00013210392,0.0003183952,0.0001553856,0.0013994048,0.00019457738,0.00030571216,0.00013475952,0.00026455385,0.000010880558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015220704,0.0029577063,0.75161564,0.011801495,0.048216227,0.00017491965,0.0027171893,0.001397729,0.06406521,0.002248887,0.09889513,0.0143877575],"study_design_scores_gemma":[0.019016465,0.0020038793,0.68192405,0.0020860431,0.016441133,0.0000023112727,0.000967416,0.14888157,0.01839155,0.00010420789,0.10929017,0.0008912079],"about_ca_topic_score_codex":0.00007105856,"about_ca_topic_score_gemma":0.00014521182,"teacher_disagreement_score":0.14748384,"about_ca_system_score_codex":0.00008350641,"about_ca_system_score_gemma":0.00013074031,"threshold_uncertainty_score":0.9999268},"labels":[],"label_agreement":null},{"id":"W4416614007","doi":"10.1111/dom.70309","title":"Sensory network dysregulation in type 2 diabetes: Linking olfactory, visual, and cognitive function","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Olfactory and Sensory Function Studies","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Nanjing Drum Tower Hospital; Nanjing University; National Natural Science Foundation of China; Jiangsu Commission of Health","keywords":"Sensory system; Cognition; Olfaction; Sensory processing; Olfactory system; Cognitive impairment","score_opus":0.05179596970855555,"score_gpt":0.2601387451670569,"score_spread":0.20834277545850133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416614007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99240625,0.00518544,0.00006285941,0.00008257722,0.0012682463,0.0002465068,0.000008622253,0.000082007246,0.00065748347],"genre_scores_gemma":[0.99728316,0.0005197037,0.000014461278,0.001528642,0.00017570597,0.000012183951,0.000007997301,0.00001082154,0.0004473474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848115,0.0002986722,0.00023836223,0.0004771834,0.00014161823,0.0003630231],"domain_scores_gemma":[0.9991049,0.0005769657,0.00008433756,0.000098696604,0.00007066471,0.00006440351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030339934,0.0002085774,0.00035365229,0.00020478001,0.00044204007,0.00008451611,0.00004481677,0.0001331013,0.000019597821],"category_scores_gemma":[0.0004060089,0.00020086342,0.00004040072,0.0004996338,0.0001974535,0.0003320109,0.00009303234,0.00024340618,0.000011376574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013402627,0.0001724691,0.8985896,0.00018887811,0.000095496755,0.0000030008496,0.0007105184,0.00009214133,0.06508065,0.0036279133,0.00015355059,0.031151757],"study_design_scores_gemma":[0.00069086096,0.00005158675,0.9714873,0.00013522785,0.00015722444,2.194376e-7,0.00014722742,0.0010028023,0.016551761,0.0023331705,0.0072118747,0.0002307578],"about_ca_topic_score_codex":0.0000030226504,"about_ca_topic_score_gemma":0.000010616279,"teacher_disagreement_score":0.07289769,"about_ca_system_score_codex":0.000011639314,"about_ca_system_score_gemma":0.000019486632,"threshold_uncertainty_score":0.8190972},"labels":[],"label_agreement":null},{"id":"W4416677995","doi":"10.1111/dom.70302","title":"A nationwide 12‐month observatory of automated insulin delivery shows improved glucose control, sustained adoption, and reduced acute severe events","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Société Francophone du Diabète","keywords":"Continuous glucose monitoring; Insulin; Insulin delivery; Diabetes mellitus","score_opus":0.006234940366201611,"score_gpt":0.23634416803472066,"score_spread":0.23010922766851905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416677995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915494,0.0061640316,0.00004580299,0.00069162576,0.00026487894,0.0007250619,0.0001486453,0.00013602916,0.00027457238],"genre_scores_gemma":[0.99630517,0.0010284028,0.00048158554,0.0015614992,0.000053231317,0.000052403666,0.000092924456,0.000014903147,0.00040987215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845475,0.0000994159,0.0005003592,0.00037179902,0.00021133422,0.0003623316],"domain_scores_gemma":[0.9987361,0.00016979611,0.000120921366,0.00025414783,0.00050601165,0.00021305244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026802073,0.00025644008,0.0007770686,0.0001857066,0.000160487,0.000023447219,0.000094723124,0.00023631033,0.000018260029],"category_scores_gemma":[0.00040193048,0.00022769405,0.00012723803,0.00020990439,0.00014872757,0.00020567431,0.0000839883,0.00020892004,0.0000012008653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048942184,0.0021663615,0.53335214,0.0020326034,0.003795001,0.000043067255,0.0011974114,0.000009764117,0.40912172,0.005830068,0.0011742371,0.036383417],"study_design_scores_gemma":[0.020723252,0.00032253953,0.9576228,0.00031946087,0.0021445728,0.0000049360274,0.00021200662,0.008421469,0.0060368683,0.0011926348,0.0026555262,0.00034392727],"about_ca_topic_score_codex":0.00006846252,"about_ca_topic_score_gemma":0.0000136213985,"teacher_disagreement_score":0.4242707,"about_ca_system_score_codex":0.000027836984,"about_ca_system_score_gemma":0.00018079104,"threshold_uncertainty_score":0.92850935},"labels":[],"label_agreement":null},{"id":"W4416766283","doi":"10.1111/dom.70317","title":"<scp>PIONEER REAL</scp> Saudi Arabia: A multicentre, prospective, real‐world study of once‐daily oral semaglutide use in adults with type 2 diabetes in Saudi Arabia","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Novo Nordisk","keywords":"Semaglutide; Type 2 diabetes; Population; Diabetes mellitus; Patient satisfaction","score_opus":0.009816013317230697,"score_gpt":0.23889823068596952,"score_spread":0.22908221736873882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416766283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991526,0.0019671828,7.595331e-7,0.00006934424,0.00021082835,0.003121102,0.000023406772,0.0000989837,0.0029823703],"genre_scores_gemma":[0.993389,0.0013143597,0.00059904554,0.00020298865,0.000044817494,0.00024239738,0.000059984864,0.00004187575,0.004105534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969587,0.00021300343,0.00067856733,0.0008567451,0.0004451538,0.00084783405],"domain_scores_gemma":[0.99835414,0.00033067883,0.00023969382,0.0006187338,0.00026035425,0.00019637407],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005125364,0.00052282965,0.0014438153,0.0009845911,0.00009481967,0.000064572676,0.00018234612,0.00013987551,0.000010794522],"category_scores_gemma":[0.00034917778,0.00043110017,0.00010098166,0.0019068721,0.0001767412,0.0003556398,0.00021084856,0.0003838124,0.000008596967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021557427,0.004761285,0.98794293,0.0006218088,0.00055330666,0.000044262735,0.0018693287,0.000044876746,0.0004176811,0.0004730427,0.0005407035,0.0025151912],"study_design_scores_gemma":[0.013763992,0.0006005623,0.97852445,0.0011779779,0.0009890279,1.3326076e-7,0.0010181379,0.00038714302,0.001776477,0.00017642922,0.0013850968,0.00020054926],"about_ca_topic_score_codex":0.0025218,"about_ca_topic_score_gemma":0.01611071,"teacher_disagreement_score":0.013588911,"about_ca_system_score_codex":0.0001451141,"about_ca_system_score_gemma":0.00009358313,"threshold_uncertainty_score":0.9998141},"labels":[],"label_agreement":null},{"id":"W4416943866","doi":"10.1111/dom.70318","title":"Evaluating the use of virtual reality for weight management: A systematic review and meta‐analysis","year":2025,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Mobile Health and mHealth Applications","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Winnipeg Regional Health Authority; Seven Oaks General Hospital; Manitoba Health; University of Manitoba","funders":"","keywords":"Virtual reality; Weight loss; Clinical trial; Behaviour change; MEDLINE","score_opus":0.22602604883332192,"score_gpt":0.49227600908563357,"score_spread":0.2662499602523116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416943866","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000026181729,0.96559554,0.00039815254,0.00045420977,0.00010677398,0.032009285,0.0013271183,0.00003576064,0.00007056761],"genre_scores_gemma":[0.0000014289999,0.9286576,0.0009674968,0.002888375,0.00004976195,0.0649492,0.00028272555,0.000023540013,0.0021798809],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99228317,0.0037295672,0.0024152198,0.00066394755,0.00028983608,0.0006182388],"domain_scores_gemma":[0.9891894,0.007079737,0.0019526819,0.0012121194,0.0003164478,0.00024960807],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006438565,0.00047417567,0.008218267,0.00035802266,0.0011117223,0.000021528142,0.0003510001,0.00033480063,0.000047400867],"category_scores_gemma":[0.0011333153,0.00027274378,0.0012031301,0.0012063283,0.00010989083,0.00009599702,0.00030588487,0.00054761185,0.000005683952],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000014562081,0.000033401968,0.0000033704296,0.9327188,0.026175933,6.030774e-8,0.000037812817,2.840323e-7,4.465774e-9,0.01928668,0.0006731781,0.02106901],"study_design_scores_gemma":[0.00011685265,0.000011062553,0.000020076526,0.038573656,0.5711539,1.1036041e-7,0.0000104745495,0.000026432168,1.2279048e-8,0.00019403483,0.3897695,0.00012392671],"about_ca_topic_score_codex":0.00007287216,"about_ca_topic_score_gemma":0.000034907203,"teacher_disagreement_score":0.89414513,"about_ca_system_score_codex":0.000034471923,"about_ca_system_score_gemma":0.00036274872,"threshold_uncertainty_score":0.99997246},"labels":[],"label_agreement":null},{"id":"W4417194820","doi":"10.1111/dom.70350","title":"Clinical implications of intentional weight loss in people living with type 2 diabetes: A real‐world database study","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surrey Memorial Hospital; University of British Columbia","funders":"Novo Nordisk","keywords":"Weight loss; Obesity; Type 2 diabetes; Excess weight; Body weight; MEDLINE; Population","score_opus":0.018258725063390387,"score_gpt":0.30766603273482757,"score_spread":0.2894073076714372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417194820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969226,0.0011382496,0.000016892425,0.000526102,0.00028963576,0.00040725118,0.000026325924,0.000029260402,0.000643663],"genre_scores_gemma":[0.99791414,0.0005608764,0.00037549,0.00042842916,0.00008870022,0.000033618624,0.000040369534,0.000009406069,0.0005489689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858594,0.00017963888,0.00050011434,0.00033620247,0.00014790343,0.00025022082],"domain_scores_gemma":[0.9982441,0.000979291,0.000115025054,0.00038549048,0.00016812047,0.00010793931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010696534,0.00014926554,0.0007035866,0.00036750286,0.00007461942,0.000012340212,0.00010268058,0.000064589505,0.000058708578],"category_scores_gemma":[0.0004820347,0.00011609219,0.000091266644,0.0011024844,0.00011017667,0.00013179699,0.00013419318,0.00026131392,0.0000034074574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035020224,0.0014008305,0.9930209,0.00012871387,0.00021602999,0.0000020201317,0.00014274113,3.8238278e-7,0.00008266924,0.0028684183,0.00020621301,0.0018960765],"study_design_scores_gemma":[0.001248172,0.00006316117,0.9964665,0.0002207813,0.0004958834,3.5375055e-7,0.000095675474,0.00002495,0.000083422245,0.00022339614,0.0009714968,0.00010621983],"about_ca_topic_score_codex":0.00011147893,"about_ca_topic_score_gemma":0.00046567933,"teacher_disagreement_score":0.003445603,"about_ca_system_score_codex":0.000015375013,"about_ca_system_score_gemma":0.00016432758,"threshold_uncertainty_score":0.47341022},"labels":[],"label_agreement":null},{"id":"W4417290268","doi":"10.1111/dom.70358","title":"Efficacy and hypoglycaemia outcomes of once‐weekly insulin icodec versus once‐daily basal insulin comparators across baseline <scp>HbA1c</scp> , <scp>BMI</scp> and duration of type 2 diabetes subgroups: A post hoc analysis of <scp>ONWARDS</scp> 1–5","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Management and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre","funders":"Novo Nordisk","keywords":"Basal insulin; Post-hoc analysis; Type 2 diabetes; Post hoc; Basal (medicine); Baseline (sea); Insulin; Diabetes mellitus","score_opus":0.016734233936958613,"score_gpt":0.2936411475909479,"score_spread":0.2769069136539893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417290268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767597,0.020481333,0.000030464282,0.00015368249,0.0004094984,0.0010299191,0.00046435435,0.000071514136,0.00059957115],"genre_scores_gemma":[0.99367005,0.0035196997,0.0006237524,0.0002852026,0.00011251234,0.000034641234,0.0005013508,0.000048512793,0.001204306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99508685,0.00044722954,0.0014423154,0.00096956117,0.0009913398,0.0010627281],"domain_scores_gemma":[0.99194777,0.005016772,0.0007576258,0.0008021022,0.0010161712,0.00045955367],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022140031,0.0006922978,0.0028452699,0.0014405557,0.0002891791,0.00013812189,0.00043084729,0.0004476007,0.000011336779],"category_scores_gemma":[0.0065021855,0.0006036313,0.0004054276,0.0031384618,0.0011224429,0.0004584211,0.0006216121,0.0005860955,0.000006935266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022487779,0.0016764636,0.9522479,0.0018387737,0.0070812264,0.000008192911,0.0030443238,0.000096082826,0.01786541,0.0007396441,0.0012459536,0.013931114],"study_design_scores_gemma":[0.009805294,0.0009429683,0.9495988,0.00026944026,0.0048399945,1.6227897e-7,0.0018424691,0.0046751234,0.022227723,0.00013321829,0.005549563,0.000115252784],"about_ca_topic_score_codex":0.00012449284,"about_ca_topic_score_gemma":0.00008816645,"teacher_disagreement_score":0.016961634,"about_ca_system_score_codex":0.00005559443,"about_ca_system_score_gemma":0.00024706358,"threshold_uncertainty_score":0.9996415},"labels":[],"label_agreement":null},{"id":"W4417292863","doi":"10.1111/dom.70375","title":"Use of sodium‐glucose cotransporter‐2 inhibitors among older adults with type 2 diabetes mellitus in British Columbia","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Trillium Health Centre; Women's College Hospital; University of Toronto; University of British Columbia","funders":"Ministry of Health, British Columbia","keywords":"Type 2 Diabetes Mellitus; Type 2 diabetes; Diabetes mellitus; Disease; Kidney disease","score_opus":0.0049636346903255005,"score_gpt":0.19019516505616174,"score_spread":0.18523153036583623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417292863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98901933,0.009351317,0.000001722479,0.00005354095,0.00023618482,0.0010218523,0.000033951055,0.00006259088,0.00021950755],"genre_scores_gemma":[0.99573255,0.0020606401,0.00039095466,0.00035471827,0.00003694029,0.000064003136,0.00012558895,0.00002430851,0.0012103042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983806,0.000051407922,0.00039756592,0.0004544211,0.00023785303,0.00047816566],"domain_scores_gemma":[0.9992009,0.00007630202,0.00011031589,0.00031339237,0.00014803318,0.00015106819],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018626159,0.00021481983,0.0007879028,0.00020383179,0.00007439799,0.00013443976,0.000086339176,0.00013856289,0.00005235835],"category_scores_gemma":[0.00004333262,0.0002554117,0.000099193145,0.00059335696,0.0002488615,0.0003253412,0.00006029901,0.00017258483,0.0000025210497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035257777,0.00086145126,0.9644853,0.0007073256,0.00034618445,0.000026916741,0.00021044583,0.0000011353517,0.00029379464,0.00003405081,0.00066213444,0.03233599],"study_design_scores_gemma":[0.0039083133,0.0001436812,0.9821206,0.0018491939,0.00078564807,2.2947448e-7,0.0000947761,0.000056617315,0.0069478224,0.00006402475,0.0038040152,0.00022509578],"about_ca_topic_score_codex":0.0032991725,"about_ca_topic_score_gemma":0.012253851,"teacher_disagreement_score":0.032110892,"about_ca_system_score_codex":0.000025731772,"about_ca_system_score_gemma":0.000051041327,"threshold_uncertainty_score":0.9999898},"labels":[],"label_agreement":null},{"id":"W4417319772","doi":"10.1111/dom.70385","title":"Literature‐informed ensemble machine learning for three‐year diabetic kidney disease risk prediction in type 2 diabetes: Development, validation, and deployment of the <scp>PSMMC NephraRisk</scp> model","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"Prince Sultan Military Medical City","keywords":"Software deployment; Ensemble learning; Ensemble forecasting; Predictive modelling; Risk assessment; Disease; Clinical decision making; Kidney disease","score_opus":0.009021138665120606,"score_gpt":0.22723824409419288,"score_spread":0.21821710542907227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417319772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784828,0.019458715,0.00019656758,0.00015346149,0.00020399288,0.0010594331,0.00023356362,0.000057446854,0.00015404541],"genre_scores_gemma":[0.995901,0.0015129609,0.0006753124,0.00067011133,0.00006155469,0.00015156843,0.0004408723,0.00002700769,0.00055960595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831116,0.000088756,0.00047319898,0.00040985306,0.00025228385,0.00046477187],"domain_scores_gemma":[0.9985741,0.00032128266,0.0001879002,0.00031865563,0.00019335086,0.0004047396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004881144,0.0002862596,0.0005268012,0.00026695253,0.00027562917,0.000070721835,0.000120933735,0.00014890381,0.0000058489923],"category_scores_gemma":[0.0028478124,0.00022192171,0.00012358668,0.0005200339,0.0001239571,0.00023749132,0.00015563518,0.00031072093,0.0000015965467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036243324,0.00023120349,0.99137574,0.0012934766,0.00020312051,2.524688e-7,0.00060221774,0.00024365613,0.0013288095,0.0004026817,0.0009670347,0.0033155566],"study_design_scores_gemma":[0.0037221464,0.000050336457,0.92168623,0.0009591804,0.00093438185,8.792053e-8,0.000040085462,0.0465325,0.012983566,0.003382869,0.0095991865,0.000109439105],"about_ca_topic_score_codex":0.000011035967,"about_ca_topic_score_gemma":0.000012285447,"teacher_disagreement_score":0.06968953,"about_ca_system_score_codex":0.000057662695,"about_ca_system_score_gemma":0.0007299822,"threshold_uncertainty_score":0.90497047},"labels":[],"label_agreement":null},{"id":"W4417319939","doi":"10.1111/dom.70382","title":"Injection‐site and dermatologic reactions associated with glucagon‐like peptide‐1 receptor agonists: Insights from meta‐analysis of randomised controlled trials and real‐world evidence","year":2025,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Exenatide; MEDLINE; Clinical trial; Randomized controlled trial; Glucagon-like peptide 1 receptor; Meta-analysis","score_opus":0.031821337890528704,"score_gpt":0.28201902779756494,"score_spread":0.2501976899070362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417319939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94832486,0.048431944,0.00003805123,0.00055732956,0.000117046395,0.001616077,0.00007345262,0.000075061034,0.0007661896],"genre_scores_gemma":[0.9865246,0.009442304,0.00044765722,0.0005876439,0.00002690548,0.0003119045,0.00019518133,0.0000125529605,0.0024512855],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9972565,0.0009118944,0.0008216607,0.00051076186,0.0002465673,0.00025257294],"domain_scores_gemma":[0.99461913,0.0041057444,0.0005880587,0.00031597904,0.00021577974,0.0001552983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014180549,0.00034649976,0.004519275,0.0008881964,0.00025861745,0.00009421438,0.00006240725,0.00012618599,0.00007169657],"category_scores_gemma":[0.0014762377,0.00022002686,0.00059469615,0.0010698256,0.00022273566,0.00026555994,0.0000763972,0.0001659876,0.0000012735667],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005320226,0.0011209171,0.25498244,0.00035851344,0.7236348,0.000011483859,0.0010517059,0.000021388161,0.0082904585,0.0028629133,0.000917679,0.0014275111],"study_design_scores_gemma":[0.03554237,0.00010691299,0.4457746,0.000207123,0.5131241,1.9141906e-7,0.00015073284,0.000281626,0.0025531452,0.00046590072,0.001568118,0.00022513444],"about_ca_topic_score_codex":0.0006934813,"about_ca_topic_score_gemma":0.0007063381,"teacher_disagreement_score":0.21051063,"about_ca_system_score_codex":0.0000344665,"about_ca_system_score_gemma":0.000057429344,"threshold_uncertainty_score":0.89724356},"labels":[],"label_agreement":null}]}